data_1qsv_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1qsv _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.43 -45.32 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.903 2.402 . . . . 0.0 111.214 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -64.26 144.65 56.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.646 1.178 . . . . 0.0 111.129 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.6 t -78.12 -47.14 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 143.46 51.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.286 1.434 . . . . 0.0 108.889 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.5 ptm -139.94 163.0 33.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.037 0.935 . . . . 0.0 109.683 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.55 155.72 32.14 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.592 0.757 . . . . 0.0 110.307 169.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.7 t -82.71 -69.04 0.65 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.48 -52.77 0.36 Allowed 'General case' 0 CA--C 1.523 -0.063 0 C-N-CA 125.454 1.502 . . . . 0.0 108.107 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.7 mt -75.86 127.06 86.24 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.12 146.89 16.53 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.833 3.022 . . . . 0.0 112.722 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.24 117.57 9.44 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.4 mm -81.12 97.52 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.4 mt -89.75 110.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -80.07 81.16 6.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.453 1.101 . . . . 0.0 108.942 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.8 ptm -89.82 176.03 6.99 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.491 1.116 . . . . 0.0 112.114 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.4 m -146.46 142.03 27.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.153 1.381 . . . . 0.0 107.356 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.03 146.77 52.49 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.989 0.516 . . . . 0.0 110.909 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.43 -11.71 54.46 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.554 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -89.84 165.96 13.81 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.534 1.167 . . . . 0.0 110.983 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 95.49 2.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.062 0.945 . . . . 0.0 109.019 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.87 104.55 17.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.218 1.007 . . . . 0.0 108.963 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.85 129.43 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.11 99.58 17.54 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.82 85.14 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.217 2.611 . . . . 0.0 111.425 -167.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.4 48.31 2.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.59 1.156 . . . . 0.0 109.593 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.697 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.0 ptt180 -67.92 157.29 35.31 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.617 0.767 . . . . 0.0 110.902 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.34 147.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.476 1.11 . . . . 0.0 110.896 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.5 p -55.65 -48.42 75.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.594 1.158 . . . . 0.0 111.487 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.6 m -113.29 109.58 51.46 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 124.849 1.26 . . . . 0.0 107.819 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.23 -32.89 11.09 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 124.528 3.485 . . . . 0.0 114.247 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -50.74 -37.56 42.52 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.649 1.58 . . . . 0.0 112.284 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.1 mt -51.68 -51.76 25.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 124.746 1.219 . . . . 0.0 110.453 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 68.23 111.68 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.514 1.525 . . . . 0.0 111.462 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.8 t -89.5 151.69 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.0 109.063 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 m -112.96 121.53 44.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.758 1.223 . . . . 0.0 107.979 172.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.51 98.18 11.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.644 0.777 . . . . 0.0 109.026 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -90.77 174.4 7.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.592 0.757 . . . . 0.0 109.977 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -144.26 145.05 31.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.155 1.382 . . . . 0.0 107.613 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.9 134.2 92.5 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.673 0.789 . . . . 0.0 110.638 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.9 -58.96 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.928 1.01 . . . . 0.0 111.853 0.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -140.28 41.94 1.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.567 1.147 . . . . 0.0 110.06 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -79.6 156.85 27.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.7 m -132.76 113.15 12.62 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.662 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.91 86.28 6.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.3 mm -60.49 127.11 86.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 109.604 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 86.14 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.969 2.446 . . . . 0.0 109.955 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -58.18 -25.29 61.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.916 1.286 . . . . 0.0 113.233 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 72.69 33.74 60.27 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.08 -61.33 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.126 1.37 . . . . 0.0 107.973 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -99.67 -53.08 3.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.681 1.193 . . . . 0.0 108.468 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.47 89.06 3.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -96.38 119.23 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -89.0 94.75 10.06 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.441 0.696 . . . . 0.0 109.142 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -89.85 98.68 11.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.697 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 68.1 p -51.96 -27.05 11.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 113.734 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.28 17.72 23.52 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.138 0.975 . . . . 0.0 113.167 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -144.78 -56.45 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.809 0.731 . . . . 0.0 110.894 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.97 -169.61 38.2 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.15 110.6 21.32 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 172.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.1 mt -92.22 94.72 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.561 1.544 . . . . 0.0 108.342 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.28 95.68 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -53.43 -37.13 62.26 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.673 1.189 . . . . 0.0 113.112 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -130.79 96.29 4.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.165 0.986 . . . . 0.0 108.566 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.23 140.86 57.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 111.574 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.8 p -133.06 179.97 5.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.52 1.128 . . . . 0.0 109.42 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -54.49 -30.65 53.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.679 1.192 . . . . 0.0 112.12 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -58.77 -20.63 51.44 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.48 1.112 . . . . 0.0 112.032 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -115.48 37.65 3.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.184 1.394 . . . . 0.0 110.82 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -120.75 100.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.7 -165.0 34.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 57.9 tp -89.29 91.72 8.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.041 0.936 . . . . 0.0 109.285 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.6 152.91 37.59 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.4 m -143.27 105.98 4.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.225 1.01 . . . . 0.0 108.515 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 87.1 m -74.11 132.71 42.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -130.81 142.08 50.37 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.323 1.049 . . . . 0.0 110.205 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.97 115.07 4.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.52 0.728 . . . . 0.0 110.315 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 53.9 m -89.81 124.07 34.34 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 44.8 t -118.74 -101.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.607 0.763 . . . . 0.0 109.448 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -88.29 59.07 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.969 1.308 . . . . 0.0 109.712 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 57.66 38.97 90.28 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -150.31 124.05 9.19 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.432 1.093 . . . . 0.0 108.492 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 65.5 tp -83.41 116.16 22.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.374 1.07 . . . . 0.0 109.5 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -100.58 151.94 21.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 164.28 35.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.713 0.405 . . . . 0.0 111.176 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.5 t -154.4 139.54 17.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.483 0.713 . . . . 0.0 109.797 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -106.65 147.04 30.02 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.959 1.304 . . . . 0.0 112.836 -168.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -142.78 104.79 4.4 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.13 109.64 18.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.5 p -89.59 94.49 9.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 109.014 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -89.87 128.36 36.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.971 1.709 . . . . 0.0 109.537 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 . . . . . 0 C--N 1.339 0.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.922 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.25 -53.59 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.754 2.303 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.11 144.71 50.19 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.033 0.933 . . . . 0.0 111.736 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.4 46.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.57 -85.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.231 1.412 . . . . 0.0 108.121 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 ttt 71.08 132.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.631 1.972 . . . . 0.0 113.315 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.68 147.39 53.11 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.708 0.803 . . . . 0.0 110.058 173.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -77.96 -57.66 3.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -32.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.245 1.018 . . . . 0.0 111.646 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.79 117.77 69.15 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 135.59 68.74 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.03 2.487 . . . . 0.0 110.954 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -68.06 133.74 49.48 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.7 mm -82.34 95.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.755 0.822 . . . . 0.0 108.879 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.69 101.96 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -74.36 85.98 1.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.462 1.105 . . . . 0.0 108.951 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 9.6 ptm -89.17 166.86 13.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.629 0.772 . . . . 0.0 111.233 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.9 m -139.35 126.0 20.62 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.37 141.61 58.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.431 0.692 . . . . 0.0 110.342 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.97 -19.61 41.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.864 -0.965 . . . . 0.0 112.785 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -89.99 165.48 14.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.511 1.155 . . . . 0.0 110.749 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.32 96.01 2.76 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 109.197 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.98 109.96 20.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 108.975 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.51 127.15 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 44.2 mm -104.15 93.12 5.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.56 114.8 3.95 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.729 2.286 . . . . 0.0 109.877 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.7 p -162.42 56.22 0.22 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.816 0.847 . . . . 0.0 109.387 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 188' ' ' SER . 37.3 ptt180 -64.36 158.53 23.34 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.49 0.716 . . . . 0.0 110.861 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.73 168.29 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.399 1.08 . . . . 0.0 110.369 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.7 p -53.27 -39.19 63.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.307 1.443 . . . . 0.0 112.407 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 m -159.9 152.67 17.87 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 110.148 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.92 -20.33 51.43 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.559 2.839 . . . . 0.0 112.104 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.99 -28.61 66.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.106 1.362 . . . . 0.0 111.927 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.81 -45.48 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.775 0.83 . . . . 0.0 109.05 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.8 m 66.4 95.25 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.728 1.611 . . . . 0.0 110.861 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.47 144.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.358 1.063 . . . . 0.0 109.356 -173.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.0 m -115.75 124.81 51.72 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.643 1.177 . . . . 0.0 108.833 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.3 tp -89.71 100.31 13.14 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.761 0.824 . . . . 0.0 109.434 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.96 170.24 10.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.136 0.974 . . . . 0.0 109.76 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -147.14 148.55 31.69 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -58.89 132.32 86.71 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.633 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -79.26 -59.46 0.11 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.937 1.013 . . . . 0.0 111.741 3.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.6 mt -144.09 46.65 1.43 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.541 1.136 . . . . 0.0 109.753 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.75 164.8 25.31 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 m -145.07 100.29 3.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.7 mt -89.67 72.45 7.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.575 1.15 . . . . 0.0 108.439 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.8 mm -56.25 124.63 61.45 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.851 1.26 . . . . 0.0 110.385 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.22 107.34 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.925 3.083 . . . . 0.0 112.682 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.0 -29.89 58.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.307 0.643 . . . . 0.0 110.867 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.95 19.32 51.61 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.341 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -132.17 -58.68 0.95 Allowed 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.63 1.172 . . . . 0.0 108.157 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -78.42 -65.78 0.94 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.17 94.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.4 mt -95.79 117.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -89.17 124.35 34.27 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -127.03 107.98 10.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.567 1.147 . . . . 0.0 108.766 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.1 p -56.43 -25.49 50.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 0.0 113.304 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -76.0 -23.38 55.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.834 0.853 . . . . 0.0 112.243 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -129.57 -65.84 0.83 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.74 0.816 . . . . 0.0 111.035 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.89 35.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.02 111.98 23.26 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.9 99.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.218 1.407 . . . . 0.0 107.373 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 16.2 mt -97.69 96.67 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.7 1.2 . . . . 0.0 108.046 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 81.9 p -53.15 -35.47 59.79 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.693 1.197 . . . . 0.0 114.114 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -140.62 88.63 2.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.826 0.851 . . . . 0.0 109.201 -174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.16 155.73 19.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.927 0.491 . . . . 0.0 112.25 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.6 p -146.32 -176.78 5.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 109.28 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -55.23 -32.63 62.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.573 1.149 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -59.1 -19.34 43.66 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 112.509 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -93.59 -34.66 13.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.253 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.74 120.36 9.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.03 -136.87 5.65 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.4 tp -120.48 87.76 2.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.041 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 57.2 mt -69.28 149.35 48.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.887 0.875 . . . . 0.0 108.946 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 45.2 m -146.38 113.27 6.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 56.9 m -82.03 122.01 27.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -118.07 145.55 44.75 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.95 133.95 10.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.882 0.873 . . . . 0.0 109.869 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 57.2 m -102.12 131.55 48.55 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.731 0.813 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.88 118.6 34.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.4 m120 43.94 59.06 3.32 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.594 1.558 . . . . 0.0 112.058 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.87 -24.96 6.22 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.554 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -89.22 102.7 15.36 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.504 1.152 . . . . 0.0 109.195 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.09 103.74 4.66 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.27 149.28 23.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.31 146.03 51.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.249 1.42 . . . . 0.0 107.947 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 71.0 p -136.84 111.84 8.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -88.24 145.22 25.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.214 1.005 . . . . 0.0 111.138 -172.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -146.15 109.4 4.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.548 1.539 . . . . 0.0 108.172 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.81 105.86 15.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 93.9 9.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.169 0.988 . . . . 0.0 109.31 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -91.14 146.38 23.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.652 1.181 . . . . 0.0 107.974 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 173.733 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 119.022 -0.513 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.38 -47.34 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.325 2.683 . . . . 0.0 110.29 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -68.16 161.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.018 1.327 . . . . 0.0 112.154 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.8 t -110.55 -58.5 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.68 120.25 29.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.5 ptm -133.72 154.82 50.67 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.816 0.846 . . . . 0.0 109.534 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.29 157.75 28.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.01 0.524 . . . . 0.0 111.177 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -97.09 -136.57 0.26 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -94.24 93.87 8.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.8 mt 127.95 121.22 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 131.025 3.73 . . . . 0.0 107.564 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.64 149.99 17.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.312 3.341 . . . . 0.0 113.343 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.59 116.69 6.45 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -76.64 100.65 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.86 121.38 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.938 0.895 . . . . 0.0 108.923 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -77.22 94.18 4.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 108.518 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.57 151.3 22.0 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.896 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 43.7 m -129.07 124.57 35.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -56.24 -73.46 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.73 55.98 4.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.478 0.561 . . . . 0.0 112.341 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -143.31 -97.61 0.11 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.15 1.38 . . . . 0.0 108.065 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -166.0 152.74 9.61 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.764 1.226 . . . . 0.0 108.626 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.1 tp -143.63 108.31 4.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.964 1.306 . . . . 0.0 108.472 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 131.21 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.08 94.13 28.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.04 80.88 2.88 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.309 2.672 . . . . 0.0 111.428 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.02 54.12 1.04 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.361 1.064 . . . . 0.0 109.171 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -68.86 162.28 26.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.16 0.984 . . . . 0.0 111.48 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.79 170.98 12.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.433 1.093 . . . . 0.0 113.075 -169.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.2 p -77.12 -19.83 56.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.632 1.973 . . . . 0.0 112.572 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 t -156.92 140.54 11.37 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.186 0.903 . . . . 0.0 110.274 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -47.81 -39.67 31.49 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.647 3.565 . . . . 0.0 115.454 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.52 -21.78 62.86 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 52.9 mt -80.57 76.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 49.4 m -67.83 123.23 19.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -89.47 142.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 109.357 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 25.8 m -93.18 106.01 18.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 38.1 tp -89.2 118.58 29.0 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -122.91 -177.91 3.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.094 1.358 . . . . 0.0 109.434 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -152.62 150.3 29.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.77 131.5 78.58 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.996 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.84 -61.09 0.03 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.822 0.972 . . . . 0.0 111.972 5.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -142.34 48.48 1.56 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.858 1.263 . . . . 0.0 109.057 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.84 177.25 6.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.187 0.595 . . . . 0.0 109.942 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.3 m -146.04 104.41 3.83 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.87 81.67 6.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.52 130.84 92.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.13 0.972 . . . . 0.0 109.151 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.64 85.38 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.138 2.559 . . . . 0.0 110.426 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -61.37 -22.1 64.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.166 1.386 . . . . 0.0 113.216 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 74.67 26.1 68.23 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.442 0.565 . . . . 0.0 112.811 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.92 -66.02 0.76 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -79.84 -64.59 1.15 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.2 mt -89.87 91.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.576 1.15 . . . . 0.0 108.047 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.75 116.67 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 108.271 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -89.38 109.07 20.02 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.585 0.754 . . . . 0.0 109.891 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -107.22 108.56 20.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.4 p -63.51 -18.76 64.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -109.7 18.77 19.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.316 1.046 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -149.03 -55.61 0.19 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.715 0.689 . . . . 0.0 110.836 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.23 -170.91 32.78 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.97 113.8 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.91 97.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.28 91.93 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.3 p -70.32 -7.73 44.94 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.912 0.885 . . . . 0.0 113.287 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -150.04 99.97 2.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -81.2 160.8 24.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 44.5 p -142.51 169.84 16.83 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.966 0.906 . . . . 0.0 109.682 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -53.19 -37.33 61.85 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.491 1.116 . . . . 0.0 111.659 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -55.05 -37.89 67.31 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.186 1.394 . . . . 0.0 111.226 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.44 17.53 11.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.92 1.288 . . . . 0.0 112.23 -171.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 79.5 mt -86.32 116.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 145.4 -160.01 28.0 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 121.455 0.475 . . . . 0.0 112.869 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.52 86.19 6.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.398 1.079 . . . . 0.0 110.511 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -69.69 144.2 52.91 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.5 m -139.04 107.89 5.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.251 1.02 . . . . 0.0 108.923 -173.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.4 m -81.63 138.4 35.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -134.58 145.57 48.8 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.755 0.822 . . . . 0.0 110.526 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.71 144.63 15.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.137 0.975 . . . . 0.0 109.325 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -120.88 142.75 49.38 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.877 1.271 . . . . 0.0 109.562 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.74 153.3 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 52.99 -99.0 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.318 1.447 . . . . 0.0 110.623 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -149.66 47.38 0.62 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.83 129.54 16.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.421 1.088 . . . . 0.0 109.986 177.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.8 tp -81.76 144.87 30.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.555 . . . . 0.0 109.796 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -126.61 154.81 43.45 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.904 1.281 . . . . 0.0 108.204 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -150.44 163.29 38.77 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.071 0.548 . . . . 0.0 110.828 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.4 t -151.29 140.9 21.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.76 0.824 . . . . 0.0 109.487 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -115.09 146.23 41.53 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.995 1.318 . . . . 0.0 112.717 -168.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -143.26 105.04 4.35 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.425 1.49 . . . . 0.0 108.554 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.63 103.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.8 p -89.73 95.38 10.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.261 1.024 . . . . 0.0 108.783 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -89.69 141.17 28.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.815 0.446 . . . . 0.0 109.844 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 124.926 1.291 . . . . 0.0 109.872 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.58 -52.76 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.937 2.425 . . . . 0.0 110.766 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -68.38 125.61 27.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.071 0.948 . . . . 0.0 111.323 -173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.4 t -74.05 -42.4 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -70.77 -79.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.607 0.763 . . . . 0.0 110.253 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 tpt 69.36 137.77 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.59 1.956 . . . . 0.0 112.641 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -147.05 0.19 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.0 110.104 172.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.4 t -134.72 -67.38 0.56 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -145.65 -53.62 0.27 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 125.027 1.331 . . . . 0.0 108.908 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -69.15 130.56 91.14 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.419 1.088 . . . . 0.0 108.285 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.52 139.15 33.82 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.857 2.371 . . . . 0.0 110.18 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -74.81 127.53 33.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -79.81 105.64 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.576 0.75 . . . . 0.0 110.054 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.2 mt -96.83 110.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -76.9 88.35 3.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.7 ptm -89.92 142.04 28.08 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.327 0.651 . . . . 0.0 111.641 -170.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 60.6 m -114.56 110.04 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.16 152.36 28.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.754 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.2 -36.57 3.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.258 0.932 . . . . 0.0 110.961 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -89.42 -177.0 5.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.93 0.892 . . . . 0.0 111.457 -171.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.68 99.68 9.75 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.699 0.8 . . . . 0.0 109.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 39.3 tp -92.76 104.25 16.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.184 0.994 . . . . 0.0 109.169 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.93 121.56 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.96 104.73 27.28 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 169.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.12 37.5 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.173 2.582 . . . . 0.0 113.443 -161.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 28.4 p -87.84 57.74 4.5 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-O 121.429 0.633 . . . . 0.0 110.271 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.919 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -75.94 153.49 36.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.42 1.088 . . . . 0.0 110.291 176.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.31 169.92 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.208 1.403 . . . . 0.0 110.3 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.9 p -61.85 -42.33 98.92 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.882 0.873 . . . . 0.0 111.805 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 m -143.93 140.54 17.25 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.935 0.894 . . . . 0.0 109.731 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -28.42 29.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.607 2.872 . . . . 0.0 112.761 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.29 -24.55 65.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.383 0.673 . . . . 0.0 112.282 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -52.18 -40.13 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.878 1.271 . . . . 0.0 110.238 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.5 m 67.58 99.09 0.05 Allowed 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.494 1.518 . . . . 0.0 110.681 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.16 122.62 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.2 m -88.12 107.78 18.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.71 95.23 10.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.796 0.839 . . . . 0.0 109.631 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -89.91 166.74 13.32 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.599 0.759 . . . . 0.0 110.377 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.72 142.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.138 0.975 . . . . 0.0 109.26 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.54 132.83 93.11 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 111.395 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 -59.65 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 119.992 1.033 . . . . 0.0 112.18 3.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.5 mt -138.31 36.93 2.29 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.45 152.65 34.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.7 m -131.71 113.27 13.36 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.026 0.93 . . . . 0.0 108.646 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.79 80.61 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.0 128.72 89.66 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.19 0.996 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.28 86.18 1.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.965 2.443 . . . . 0.0 110.358 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.35 -23.17 64.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.939 1.296 . . . . 0.0 112.889 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.9 67.69 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.884 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -135.36 -63.13 0.69 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.949 1.3 . . . . 0.0 108.231 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -85.24 -59.28 2.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.9 mt -89.62 91.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.9 mt -93.58 113.46 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -89.13 123.44 33.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.0 0.52 . . . . 0.0 109.823 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -127.61 114.63 17.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.919 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 48.0 p -57.13 -29.6 63.7 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.311 0.644 . . . . 0.0 112.51 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -80.6 -29.2 36.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.886 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -114.45 -50.32 2.8 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.891 0.876 . . . . 0.0 111.374 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 150.2 -164.85 29.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.11 105.81 18.03 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -89.14 90.96 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 24.4 mt -82.11 81.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.8 p -46.84 -47.7 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.85 2.06 . . . . 0.0 112.933 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -118.48 92.14 3.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.91 156.28 31.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.598 0.759 . . . . 0.0 110.758 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 60.4 p -137.96 167.66 21.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.752 1.221 . . . . 0.0 108.829 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -53.26 -30.9 40.87 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.298 1.039 . . . . 0.0 112.257 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -52.69 -36.37 57.11 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.8 -32.71 74.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.473 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.9 mt -53.48 111.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.08 0.952 . . . . 0.0 110.15 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 159.5 -171.7 35.98 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.82 99.2 11.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.164 0.986 . . . . 0.0 109.027 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.23 157.26 30.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.2 m -147.77 99.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.126 1.371 . . . . 0.0 108.042 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 24.6 m -79.15 131.35 36.19 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -124.28 135.32 53.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.165 0.986 . . . . 0.0 109.69 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.98 158.16 36.07 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.484 0.713 . . . . 0.0 110.495 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.9 m -138.0 146.79 43.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.62 1.168 . . . . 0.0 109.617 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.13 -70.69 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.901 1.28 . . . . 0.0 108.468 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -98.0 36.0 1.63 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.949 0.9 . . . . 0.0 111.421 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.05 30.05 74.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.441 0.544 . . . . 0.0 112.154 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -90.01 -43.32 10.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.694 1.198 . . . . 0.0 111.032 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 52.6 tp 66.24 89.29 0.1 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.911 1.684 . . . . 0.0 109.455 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -89.52 154.94 19.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.446 1.098 . . . . 0.0 108.381 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -140.26 159.12 42.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.686 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.9 t -151.84 123.34 7.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -108.85 149.92 28.41 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.606 1.162 . . . . 0.0 111.621 -168.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -142.89 113.67 7.53 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.307 1.043 . . . . 0.0 109.236 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.6 tt -84.5 106.72 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.1 p -89.26 99.48 12.46 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -89.32 138.58 31.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.749 1.62 . . . . 0.0 109.603 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 124.072 0.949 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -32.76 10.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.157 1.905 . . . . 0.0 111.118 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -56.74 129.85 42.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.073 1.349 . . . . 0.0 112.045 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.87 -54.93 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.583 0.753 . . . . 0.0 109.214 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.52 148.39 32.22 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.991 0.917 . . . . 0.0 109.348 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 ttp -147.65 135.43 21.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.421 1.089 . . . . 0.0 108.632 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -61.77 137.88 58.28 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.246 0.618 . . . . 0.0 110.035 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.9 p -74.18 -51.1 16.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.62 0.368 . . . . 0.0 110.675 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -155.07 -53.67 0.09 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 109.579 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.6 mm -83.98 119.88 74.07 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.075 0.95 . . . . 0.0 108.791 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.24 139.61 86.32 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.279 2.653 . . . . 0.0 111.225 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.24 136.44 57.18 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -89.22 91.34 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.279 1.032 . . . . 0.0 108.262 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -88.78 108.29 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -73.27 95.84 2.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.805 1.242 . . . . 0.0 109.541 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 19.0 ptm -102.1 162.64 12.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.847 1.259 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 75.2 m -133.16 130.28 38.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -58.94 119.91 8.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.471 0.709 . . . . 0.0 109.176 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 121.2 -33.64 4.28 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.648 1.118 . . . . 0.0 111.719 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -89.0 171.05 10.15 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.967 0.884 . . . . 0.0 110.673 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -71.53 148.4 46.75 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.199 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.5 tp -139.77 106.75 5.43 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.63 128.58 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.39 98.27 13.97 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.79 79.43 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.507 2.804 . . . . 0.0 111.027 -165.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.9 p -126.9 42.19 3.37 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.484 1.114 . . . . 0.0 110.344 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -58.02 158.32 6.9 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.152 0.981 . . . . 0.0 110.919 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.33 154.23 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 110.716 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.3 p -61.24 -44.29 97.5 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.751 1.22 . . . . 0.0 110.818 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -104.29 103.49 39.11 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.2 -11.43 32.17 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.718 2.945 . . . . 0.0 113.777 -170.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.76 -21.24 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.663 0.785 . . . . 0.0 111.908 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.12 106.46 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.7 m -74.16 117.11 15.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.41 150.87 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.13 0.972 . . . . 0.0 108.575 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 m -103.18 111.45 23.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 108.449 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.8 tp -89.48 101.26 13.94 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -91.62 170.52 9.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.623 0.769 . . . . 0.0 110.22 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -145.99 146.37 30.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.65 1.18 . . . . 0.0 108.556 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.67 133.58 82.58 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.881 0.873 . . . . 0.0 110.772 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.42 -59.57 0.11 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.682 0 CA-C-N 119.816 0.97 . . . . 0.0 111.87 0.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -141.46 38.63 1.7 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.755 1.222 . . . . 0.0 109.804 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -77.37 153.99 33.19 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 43.7 m -125.12 111.58 15.48 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.927 0.891 . . . . 0.0 109.147 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.7 mp -89.98 82.62 6.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.09 129.03 90.22 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.01 0.924 . . . . 0.0 109.175 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -72.8 85.51 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.138 2.558 . . . . 0.0 110.319 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.96 -22.36 64.37 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.015 1.326 . . . . 0.0 113.327 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 69.34 44.75 63.82 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -150.07 -67.09 0.2 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -90.7 -55.08 3.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.5 mt -93.23 89.7 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -98.13 121.09 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.119 0.968 . . . . 0.0 108.503 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -89.08 93.87 9.74 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -89.79 96.91 10.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.6 p -61.73 -13.63 24.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -101.26 4.8 42.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 112.079 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -140.32 -58.7 0.54 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.848 0.859 . . . . 0.0 110.668 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.6 -169.42 37.85 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.738 1.161 . . . . 0.0 110.336 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -89.09 110.86 21.53 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.68 94.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.75 1.22 . . . . 0.0 107.834 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.89 95.73 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.1 p -60.67 -28.87 68.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.155 0.982 . . . . 0.0 113.511 -170.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.41 89.94 2.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.02 119.35 9.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.224 0.61 . . . . 0.0 110.043 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 39.3 p -89.94 171.67 9.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.349 0.66 . . . . 0.0 109.255 174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.95 -33.2 62.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.63 0.772 . . . . 0.0 111.493 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -59.57 -32.4 70.32 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.38 1.072 . . . . 0.0 111.932 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.22 -8.96 58.19 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.968 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -71.79 107.86 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.985 1.266 . . . . 0.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 158.39 -160.83 31.26 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.5 98.58 11.72 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.372 1.069 . . . . 0.0 109.917 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.36 154.04 25.46 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.31 0.644 . . . . 0.0 109.332 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 54.9 m -146.71 106.29 3.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.096 0.958 . . . . 0.0 109.409 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.88 140.09 43.58 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -135.71 138.69 42.99 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.161 0.985 . . . . 0.0 110.288 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.71 140.37 18.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.98 0.912 . . . . 0.0 109.976 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 55.9 m -122.52 92.65 3.76 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.661 1.184 . . . . 0.0 108.863 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.33 -62.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.101 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -92.11 174.13 7.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.47 1.108 . . . . 0.0 109.497 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.92 2.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -148.32 -44.73 0.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.388 1.075 . . . . 0.0 110.981 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.2 tp 70.63 128.91 0.03 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 126.796 2.038 . . . . 0.0 110.158 -170.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.02 147.31 50.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.655 1.182 . . . . 0.0 107.927 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -150.59 158.76 44.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.87 0.468 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 49.6 p -136.6 132.12 34.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.935 0.894 . . . . 0.0 108.824 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -111.62 144.71 40.43 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.681 1.192 . . . . 0.0 110.782 -169.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -146.47 117.54 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.441 1.096 . . . . 0.0 109.023 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.01 107.57 19.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -89.33 98.99 12.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -89.14 126.4 35.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.228 1.411 . . . . 0.0 109.249 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.91 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.83 -50.45 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.093 2.529 . . . . 0.0 111.474 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -76.7 146.41 38.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.817 0.847 . . . . 0.0 112.476 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.64 55.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -166.36 -71.66 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.8 tpt 69.76 157.07 0.15 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 111.349 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.97 172.14 13.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.0 0.92 . . . . 0.0 109.32 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.8 t -145.02 -66.28 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.304 0.641 . . . . 0.0 110.383 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -95.08 -64.35 1.07 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.47 0.708 . . . . 0.0 112.624 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.76 113.42 64.93 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.388 1.075 . . . . 0.0 110.195 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.83 142.69 96.36 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.317 2.678 . . . . 0.0 111.122 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -73.05 128.24 34.91 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.6 85.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.306 0.642 . . . . 0.0 109.378 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 mt -92.55 80.25 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -60.55 135.62 57.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.43 175.63 11.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.604 0.761 . . . . 0.0 111.196 -171.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -146.97 142.8 27.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.536 1.534 . . . . 0.0 108.162 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 150.63 44.72 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.119 0.567 . . . . 0.0 111.24 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.8 -34.41 4.07 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.557 0.599 . . . . 0.0 112.042 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -88.98 157.02 18.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.248 1.019 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.92 136.0 54.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.084 0.554 . . . . 0.0 110.469 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.5 tp -122.6 114.27 20.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.576 1.55 . . . . 0.0 107.847 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.49 127.58 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.7 mm -106.26 100.08 27.33 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 171.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.67 62.3 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.554 2.836 . . . . 0.0 111.492 -169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -104.11 51.49 0.78 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.029 0.932 . . . . 0.0 109.305 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -66.26 161.75 21.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 m -127.62 166.51 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 0.0 111.709 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 p -65.34 -36.58 84.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.067 1.347 . . . . 0.0 112.035 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 51.3 m -145.42 146.22 29.14 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.453 0.701 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.79 -42.86 24.39 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.65 3.566 . . . . 0.0 115.004 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -59.12 -20.26 52.01 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.028 0.931 . . . . 0.0 113.245 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 23.1 mm -77.71 74.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 27.7 m -70.19 120.1 15.38 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.243 0.617 . . . . 0.0 109.812 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.72 147.16 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.102 0.961 . . . . 0.0 109.641 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.8 m -106.17 113.31 26.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.22 121.66 31.74 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -126.22 173.65 9.11 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -138.82 149.24 44.72 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.949 0.899 . . . . 0.0 108.785 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -58.16 133.39 84.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.637 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.5 -59.85 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.72 0 CA-C-N 119.943 1.015 . . . . 0.0 112.197 3.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -142.01 40.27 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.305 1.042 . . . . 0.0 110.391 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.48 149.56 40.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.2 m -132.53 110.19 10.31 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.62 85.19 5.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.805 1.242 . . . . 0.0 108.26 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.39 127.6 93.39 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.54 104.6 1.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.876 2.384 . . . . 0.0 110.722 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.29 -31.48 71.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.637 0.775 . . . . 0.0 111.991 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.11 17.91 45.23 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.611 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -133.23 -58.99 0.89 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.599 1.16 . . . . 0.0 108.516 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.6 tpp85 -78.03 -66.04 0.9 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.52 92.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 68.8 mt -92.07 114.68 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -88.92 93.26 9.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -89.84 103.06 15.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.9 p -54.74 -29.16 52.98 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -108.32 24.98 12.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.135 0.974 . . . . 0.0 111.902 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -146.63 -58.57 0.29 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.162 0.585 . . . . 0.0 110.673 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.9 -172.25 37.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.92 0.772 . . . . 0.0 111.172 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -89.27 109.23 20.14 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.4 96.0 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.986 1.314 . . . . 0.0 107.616 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.98 101.21 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 80.3 p -57.09 -36.15 70.26 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -139.36 99.14 3.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.43 163.82 10.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.554 0.741 . . . . 0.0 112.027 -173.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.8 p -131.01 155.21 47.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.027 0.931 . . . . 0.0 109.709 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -56.51 -30.27 62.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.238 1.015 . . . . 0.0 111.777 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.04 -24.14 51.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.687 1.195 . . . . 0.0 112.441 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -86.04 -9.29 57.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.226 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.23 105.86 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.228 0.922 . . . . 0.0 108.63 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.94 -163.22 34.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.85 89.72 8.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.015 0.926 . . . . 0.0 109.481 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 45.1 mt -69.1 147.4 51.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 102.79 3.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.885 1.274 . . . . 0.0 108.318 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 75.0 m -80.7 138.91 36.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -134.69 142.23 46.75 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.184 0.993 . . . . 0.0 110.145 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.97 126.36 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.134 0.973 . . . . 0.0 109.25 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 85.5 m -103.19 134.21 46.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.657 1.183 . . . . 0.0 109.158 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.72 -78.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.392 0.677 . . . . 0.0 109.968 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.84 49.4 1.77 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.681 0.792 . . . . 0.0 110.965 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.96 38.46 60.35 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -170.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -150.06 121.02 7.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.178 1.391 . . . . 0.0 107.657 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.0 tt -77.56 111.2 13.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -92.05 154.09 18.98 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -151.47 162.99 39.98 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.827 0.451 . . . . 0.0 112.147 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.0 t -148.13 135.6 20.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.916 0.886 . . . . 0.0 108.782 169.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.71 152.47 34.22 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.195 0.998 . . . . 0.0 111.952 -169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -145.0 118.49 9.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.149 1.379 . . . . 0.0 109.005 -173.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.08 111.48 22.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.0 p -89.87 103.3 15.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.21 0.604 . . . . 0.0 109.65 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -89.38 134.12 34.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.131 0.973 . . . . 0.0 109.203 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.802 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -73.35 -46.68 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.058 2.505 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -69.61 152.15 45.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 111.948 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.57 -50.57 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -79.15 -82.22 0.1 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.128 0.971 . . . . 0.0 110.532 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.8 ttt 66.83 139.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.553 1.941 . . . . 0.0 112.032 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -146.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.741 1.216 . . . . 0.0 110.588 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 p -129.79 -69.07 0.69 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 108.072 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 -38.31 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.447 1.499 . . . . 0.0 109.989 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.08 125.95 92.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -69.66 129.4 17.64 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.804 2.336 . . . . 0.0 109.636 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.94 123.63 20.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.334 0.654 . . . . 0.0 111.011 -169.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.22 117.11 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.755 1.222 . . . . 0.0 108.953 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.01 133.67 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.57 1.148 . . . . 0.0 109.204 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -84.3 147.96 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.804 1.242 . . . . 0.0 109.043 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -150.1 167.18 27.56 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.329 0.652 . . . . 0.0 111.619 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.1 m -140.25 113.64 8.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -52.11 136.51 29.57 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.52 0.728 . . . . 0.0 110.62 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.47 -38.64 3.02 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.499 1.047 . . . . 0.0 110.948 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -89.5 166.36 13.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.632 0.773 . . . . 0.0 110.546 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.88 144.75 52.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.366 0.666 . . . . 0.0 109.914 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 51.0 tp -134.86 152.9 52.13 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.175 1.39 . . . . 0.0 107.768 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.79 135.52 63.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.052 0.941 . . . . 0.0 108.483 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.4 mm -109.14 97.19 24.17 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.47 68.84 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.55 2.833 . . . . 0.0 112.525 -163.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -116.2 55.14 0.81 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.656 1.182 . . . . 0.0 109.795 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 188' ' ' SER . 25.6 ptt-85 -69.0 161.45 28.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.256 1.422 . . . . 0.0 111.023 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.36 165.19 17.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.856 1.262 . . . . 0.0 112.393 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 38.2 p -73.02 -27.51 61.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.807 1.643 . . . . 0.0 112.473 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -142.21 136.19 14.72 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.945 0.898 . . . . 0.0 109.161 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 -25.96 50.61 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.389 2.726 . . . . 0.0 113.297 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -62.55 -23.03 66.77 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.349 0.522 . . . . 0.0 112.154 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.1 mt -80.14 78.82 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.7 m -66.55 121.33 15.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.7 t -89.27 145.24 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.7 m -103.75 122.65 45.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.28 132.17 35.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -130.98 175.34 9.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.695 1.198 . . . . 0.0 109.3 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -151.52 147.98 27.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.053 0.941 . . . . 0.0 109.295 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.91 135.74 87.28 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 110.15 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.91 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.902 1.001 . . . . 0.0 112.007 1.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.2 mt -140.56 41.74 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.451 1.101 . . . . 0.0 109.979 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -82.67 139.65 33.58 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 84.8 m -116.93 112.01 20.43 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.45 72.14 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.876 1.27 . . . . 0.0 109.111 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.7 mm -56.34 126.69 69.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.792 0.837 . . . . 0.0 109.609 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.7 103.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.995 3.13 . . . . 0.0 112.684 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.84 -19.47 57.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.752 0.821 . . . . 0.0 111.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.13 -5.27 83.63 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.626 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -105.26 -63.88 1.19 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.564 1.182 . . . . 0.0 107.901 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -79.26 -64.91 1.08 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.836 0.854 . . . . 0.0 108.725 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.33 97.57 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 89.9 mt -99.64 117.6 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -88.95 121.5 31.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -124.35 112.39 16.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.135 1.374 . . . . 0.0 107.878 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.622 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 28.9 p -59.31 -25.95 64.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 113.502 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -111.39 27.5 9.62 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.134 0.973 . . . . 0.0 111.93 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -149.14 -53.33 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.927 0.491 . . . . 0.0 110.266 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 145.88 -159.77 28.0 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.24 110.82 21.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.07 98.6 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.4 mm -83.05 82.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 69.7 p -55.15 -33.28 62.81 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.286 1.035 . . . . 0.0 113.47 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 89.42 2.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.86 158.43 16.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.984 0.514 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.6 p -136.12 161.27 36.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.733 0.813 . . . . 0.0 109.879 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -57.11 -32.78 66.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.889 0.875 . . . . 0.0 111.398 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.42 -34.39 70.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.358 1.063 . . . . 0.0 111.44 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.97 13.49 10.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.326 1.05 . . . . 0.0 112.484 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -85.14 121.8 37.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.71 -159.44 25.4 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.288 0.471 . . . . 0.0 112.794 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.89 91.45 6.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.596 1.158 . . . . 0.0 110.743 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.96 160.31 30.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.668 0.787 . . . . 0.0 109.475 170.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.1 m -147.81 102.04 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.717 1.207 . . . . 0.0 109.087 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.6 m -75.28 139.35 42.45 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -138.37 139.02 38.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.601 0.761 . . . . 0.0 111.187 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.52 152.83 27.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.796 1.239 . . . . 0.0 109.822 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.2 m -135.71 107.99 7.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.98 -64.18 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -150.06 114.13 5.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.363 1.065 . . . . 0.0 108.58 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 81.86 -59.69 4.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.78 0.705 . . . . 0.0 113.143 170.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.03 135.62 33.45 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.298 0.639 . . . . 0.0 110.694 -169.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.55 105.5 11.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -89.52 135.09 33.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -150.73 160.39 43.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.538 0.335 . . . . 0.0 110.824 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.8 t -152.86 130.59 11.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.477 0.711 . . . . 0.0 109.97 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -104.57 150.99 24.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.673 1.189 . . . . 0.0 112.066 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -140.18 113.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.525 1.13 . . . . 0.0 108.812 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -82.99 101.63 11.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.5 p -89.17 92.58 9.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -89.8 165.79 13.94 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.369 178.378 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.67 -51.58 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.422 2.748 . . . . 0.0 111.63 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -71.54 119.65 16.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 111.574 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.01 -53.22 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 126.24 54.83 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.124 1.37 . . . . 0.0 107.832 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.1 ptm -128.49 170.3 13.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.963 1.305 . . . . 0.0 109.685 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.56 147.41 52.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 m -90.6 -136.44 0.13 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.96 104.14 16.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.4 mm 108.64 127.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 130.742 3.617 . . . . 0.0 107.924 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.68 137.65 15.46 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.236 3.291 . . . . 0.0 113.066 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.27 126.7 30.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -80.78 100.0 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.17 105.83 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -83.41 76.61 9.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.373 1.469 . . . . 0.0 109.231 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.33 171.85 9.46 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.107 0.563 . . . . 0.0 111.041 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.9 m -143.46 116.82 9.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.58 164.94 10.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 94.21 -41.06 2.64 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.2 mtp-105 -88.88 -179.57 5.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.774 1.629 . . . . 0.0 109.674 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.75 137.38 45.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.34 103.93 11.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.22 125.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 mm -101.08 100.73 13.84 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -83.79 48.99 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 112.846 -161.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -91.59 57.61 3.32 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.84 0.856 . . . . 0.0 110.378 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -56.73 143.2 37.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.118 0.967 . . . . 0.0 111.126 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.59 165.94 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.817 1.247 . . . . 0.0 110.591 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.376 1.07 . . . . 0.0 112.508 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.2 m -155.5 146.7 16.64 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.644 0.777 . . . . 0.0 110.299 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.5 -30.63 28.8 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.724 2.949 . . . . 0.0 111.855 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -56.36 -27.32 55.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.101 1.36 . . . . 0.0 112.497 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.4 -35.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.135 1.374 . . . . 0.0 110.861 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m 67.59 88.52 0.11 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.314 1.446 . . . . 0.0 110.028 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.45 132.56 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 108.835 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 m -102.31 119.11 38.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.327 1.051 . . . . 0.0 108.721 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.4 tp -89.49 101.52 14.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -89.48 165.23 14.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.056 0.942 . . . . 0.0 109.905 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -147.8 146.39 29.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.31 1.044 . . . . 0.0 108.928 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.81 134.91 89.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.605 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.91 -58.69 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 119.854 0.984 . . . . 0.0 111.819 0.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.1 mt -139.89 38.94 1.98 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.794 1.238 . . . . 0.0 109.824 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -80.76 160.29 24.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -137.85 114.41 10.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.876 0.87 . . . . 0.0 109.034 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 mp -89.9 83.98 6.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.73 121.76 75.14 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.65 120.65 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.309 2.673 . . . . 0.0 112.735 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -81.25 -15.43 55.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.475 0.71 . . . . 0.0 111.565 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 66.76 29.98 75.54 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.057 0.837 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -139.94 -67.55 0.43 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.575 1.15 . . . . 0.0 108.169 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.7 ttp-105 -79.16 -56.16 4.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 mt -89.57 90.08 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.432 1.493 . . . . 0.0 106.998 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 67.8 mt -90.83 113.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -89.01 93.2 9.52 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.41 99.48 12.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.3 p -57.82 -26.82 62.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -76.87 -19.29 57.64 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.122 0.969 . . . . 0.0 112.423 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -125.83 -64.59 1.05 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.063 0.945 . . . . 0.0 110.752 -173.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 170.56 -173.36 44.41 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 117.9 0.318 . . . . 0.0 112.332 -173.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -89.36 107.55 19.13 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.2 mt -89.82 94.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 31.0 mt -81.96 85.87 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.9 p -52.15 -35.75 49.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.41 1.484 . . . . 0.0 114.3 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -123.44 91.87 3.57 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.003 0.921 . . . . 0.0 108.878 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.63 40.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.325 0.65 . . . . 0.0 110.242 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 77.9 p -138.66 172.34 13.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.66 1.184 . . . . 0.0 109.273 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -59.17 -26.84 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.648 0.779 . . . . 0.0 112.016 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -53.73 -43.92 69.47 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.402 0.681 . . . . 0.0 110.74 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -68.76 -8.37 42.47 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.0 131.15 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 143.15 -108.31 0.51 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 45.4 tp -157.14 111.34 2.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.0 109.413 -170.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -101.44 150.51 22.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.227 1.011 . . . . 0.0 109.089 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 98.2 m -142.86 116.52 9.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.102 0.961 . . . . 0.0 109.143 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 30.5 m -81.91 142.49 32.42 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -129.96 142.72 50.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.511 1.124 . . . . 0.0 109.984 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.265 1.026 . . . . 0.0 110.104 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.0 m -142.03 132.64 25.42 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.5 t -135.49 -76.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.971 0.908 . . . . 0.0 108.856 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -85.35 51.18 2.11 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.805 0.842 . . . . 0.0 110.774 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.8 -31.53 1.48 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.664 0.649 . . . . 0.0 113.511 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -88.62 142.69 27.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.782 1.233 . . . . 0.0 109.98 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.7 tp -80.02 106.16 11.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -89.02 146.6 24.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 157.32 42.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.471 0.708 . . . . 0.0 110.045 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 t -147.0 129.72 16.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.434 0.694 . . . . 0.0 109.753 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -102.56 141.01 36.08 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.64 1.576 . . . . 0.0 112.487 -169.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -140.34 100.6 3.93 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.076 1.351 . . . . 0.0 108.893 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.5 110.48 16.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.517 1.127 . . . . 0.0 108.639 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.6 p -89.59 89.02 7.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.801 0.84 . . . . 0.0 109.762 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -95.03 89.44 5.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 . . . . . 0 N--CA 1.455 -0.212 0 C-N-CA 122.979 0.512 . . . . 0.0 110.335 178.787 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.89 -50.63 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.534 2.156 . . . . 0.0 111.211 -170.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -77.33 159.93 29.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.992 0.917 . . . . 0.0 111.449 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.16 -61.41 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.05 123.88 32.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 23.4 ttt -144.51 145.44 31.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.508 0.723 . . . . 0.0 110.208 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -152.74 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.655 1.182 . . . . 0.0 110.622 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.1 t -131.43 -64.82 0.79 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.005 0.922 . . . . 0.0 108.924 170.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.71 -36.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.579 0.752 . . . . 0.0 111.579 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.4 mt -81.36 116.59 63.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.03 136.15 71.32 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.007 2.471 . . . . 0.0 111.743 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.39 124.43 24.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.352 0.661 . . . . 0.0 109.948 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.9 126.56 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.4 mt -130.08 137.56 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.512 1.125 . . . . 0.0 108.131 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -89.3 102.07 14.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.332 1.053 . . . . 0.0 108.772 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -89.31 176.42 6.94 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 m -147.82 130.4 15.89 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.67 141.38 55.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.969 0.908 . . . . 0.0 110.157 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.82 -42.94 2.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.231 0.443 . . . . 0.0 112.156 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -89.85 -179.28 5.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.814 0.845 . . . . 0.0 112.049 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -66.19 149.73 49.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.1 tp -148.03 112.37 5.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.266 1.026 . . . . 0.0 108.716 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.92 132.11 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.4 mm -108.23 96.4 18.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.92 46.51 1.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.261 2.641 . . . . 0.0 113.714 -163.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 26.0 p -89.81 59.77 4.74 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.501 0.72 . . . . 0.0 109.138 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -71.2 156.79 39.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.689 0.796 . . . . 0.0 110.884 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.53 167.7 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.905 1.282 . . . . 0.0 111.664 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.6 p -63.33 -33.77 76.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.006 1.322 . . . . 0.0 111.695 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.7 m -157.68 151.14 18.97 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 124.376 1.071 . . . . 0.0 109.733 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.54 -31.66 87.53 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.389 2.726 . . . . 0.0 111.64 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.25 -32.26 16.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.768 1.627 . . . . 0.0 112.559 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.4 mm -51.72 -41.95 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.56 1.144 . . . . 0.0 111.043 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.0 m 63.15 91.01 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.207 1.403 . . . . 0.0 111.168 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.45 133.13 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 109.483 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.9 m -98.45 114.29 26.6 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 tp -89.46 106.85 18.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -94.42 158.13 15.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 110.213 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -129.18 136.95 50.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.732 1.613 . . . . 0.0 106.677 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -55.92 126.7 66.77 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.32 -170.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -77.47 -62.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.616 0 CA-C-N 119.733 0.94 . . . . 0.0 112.851 6.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.1 mt -143.79 37.81 1.32 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.172 0.989 . . . . 0.0 110.244 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.23 126.84 31.73 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.7 m -89.82 115.59 27.27 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.325 0.65 . . . . 0.0 110.157 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.67 86.7 6.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.02 130.35 94.46 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.208 1.003 . . . . 0.0 109.101 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.8 81.95 1.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.209 2.606 . . . . 0.0 110.002 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.63 -18.65 62.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.036 1.334 . . . . 0.0 113.137 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.23 26.48 70.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.602 0.62 . . . . 0.0 112.679 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -140.27 -63.66 0.48 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.758 1.223 . . . . 0.0 108.53 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -88.45 -57.36 2.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.713 1.205 . . . . 0.0 107.951 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.5 mt -89.97 93.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.8 mt -93.5 112.19 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -89.08 95.37 10.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.168 0.587 . . . . 0.0 109.691 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.97 97.55 11.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.6 p -50.53 -37.47 39.44 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -97.27 21.2 10.32 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 112.504 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -147.46 -57.69 0.25 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.978 0.808 . . . . 0.0 111.317 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 161.5 -177.05 37.95 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.046 0.831 . . . . 0.0 111.187 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.13 110.19 20.96 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.12 93.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 50.2 mt -83.09 100.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.8 p -63.94 -39.38 94.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.037 0.535 . . . . 0.0 112.286 -172.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -118.97 90.59 3.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.524 1.13 . . . . 0.0 108.693 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.86 124.15 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 67.3 p -91.83 166.77 12.58 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.0 110.94 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -57.39 -34.1 68.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.251 1.02 . . . . 0.0 111.804 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -56.14 -33.94 65.65 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.418 1.087 . . . . 0.0 111.477 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.75 -2.85 31.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.031 0.932 . . . . 0.0 112.651 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.06 87.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 163.39 -163.1 35.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.1 tp -86.95 117.12 25.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 110.795 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 95.5 mt -99.93 150.26 22.58 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.503 1.521 . . . . 0.0 109.114 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 51.3 m -146.7 103.33 3.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.746 1.218 . . . . 0.0 108.867 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 48.6 m -74.97 143.93 43.42 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.91 140.0 43.74 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.063 0.945 . . . . 0.0 109.611 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.36 114.82 6.32 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.652 0.781 . . . . 0.0 110.52 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.7 m -89.94 125.76 35.49 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.809 1.244 . . . . 0.0 109.481 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.17 -71.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.154 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -145.7 94.26 2.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.02 -53.56 4.76 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.558 0.599 . . . . 0.0 111.762 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 145.25 25.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.303 1.041 . . . . 0.0 109.25 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.3 156.02 28.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.717 0.77 . . . . 0.0 111.433 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -124.75 154.83 40.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.582 1.953 . . . . 0.0 106.027 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -136.86 158.57 44.15 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.05 0.386 . . . . 0.0 111.4 -175.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.7 m -144.13 109.89 5.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -106.67 151.9 24.49 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.404 0.682 . . . . 0.0 111.171 -170.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -142.39 127.51 18.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.317 1.047 . . . . 0.0 109.008 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.0 tt -87.09 97.17 10.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.8 p -89.0 88.76 7.71 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.38 154.36 20.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 7.3 ptm85 . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 118.266 0.485 . . . . 0.0 111.185 175.818 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -73.81 -39.99 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.779 2.319 . . . . 0.0 110.135 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -59.63 135.94 57.83 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.081 0.952 . . . . 0.0 110.898 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.25 -43.78 97.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.55 148.05 31.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.133 1.373 . . . . 0.0 108.176 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ptm -127.57 165.13 20.52 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.538 1.135 . . . . 0.0 110.546 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 152.09 26.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.423 0.689 . . . . 0.0 110.106 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.1 t -80.26 -69.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -143.56 -53.97 0.37 Allowed 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.937 1.295 . . . . 0.0 108.659 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 88.8 mt -72.87 127.93 88.86 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -67.65 119.89 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.558 2.172 . . . . 0.0 108.893 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.8 116.84 2.74 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.118 0.967 . . . . 0.0 109.701 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.7 mt -78.49 102.24 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.15 68.66 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -59.2 128.32 36.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.14 169.1 18.82 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.754 0.311 . . . . 0.0 111.732 -170.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 m -112.55 138.48 49.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 107.994 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.91 165.83 12.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.166 0.587 . . . . 0.0 111.587 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.24 -43.14 3.21 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.957 0.789 . . . . 0.0 111.998 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -89.18 174.78 7.67 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.407 1.083 . . . . 0.0 110.823 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.91 160.33 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.143 -174.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 49.4 tp -148.9 111.97 4.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.627 1.171 . . . . 0.0 108.608 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.02 125.11 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -104.81 102.54 35.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.13 61.01 6.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.603 2.868 . . . . 0.0 111.591 -167.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 31.8 p -105.16 50.09 0.79 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.906 0.882 . . . . 0.0 109.327 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.99 153.92 42.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.008 1.323 . . . . 0.0 110.507 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 m -116.06 160.37 15.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 124.407 1.083 . . . . 0.0 111.277 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.3 p -70.15 -57.45 4.92 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.616 1.167 . . . . 0.0 109.744 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.4 p -100.07 111.73 62.72 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.83 -12.84 33.58 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.615 2.877 . . . . 0.0 113.389 -168.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -69.05 -22.85 64.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.082 0.401 . . . . 0.0 111.266 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 32.6 mt -78.35 83.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -66.3 127.37 31.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.353 1.061 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 70.2 t -89.59 146.64 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.053 0.941 . . . . 0.0 109.243 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 m -106.93 111.36 23.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.773 1.229 . . . . 0.0 108.153 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.8 tp -89.37 98.07 11.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -89.75 169.84 10.94 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.957 0.903 . . . . 0.0 109.52 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -148.63 145.83 27.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.634 0.774 . . . . 0.0 109.194 169.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.77 133.76 78.76 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.653 172.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.16 -59.89 0.1 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 119.978 1.028 . . . . 0.0 112.057 2.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.5 mt -144.23 39.22 1.31 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 110.034 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -81.93 152.13 26.92 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.1 m -130.72 108.53 9.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.739 1.216 . . . . 0.0 108.309 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.74 82.65 6.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.008 0.923 . . . . 0.0 108.573 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 129.14 93.79 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.48 90.15 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.882 2.388 . . . . 0.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -59.52 -24.21 63.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.311 1.444 . . . . 0.0 113.173 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 75.61 28.54 61.13 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.427 0.537 . . . . 0.0 112.819 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.55 -58.4 0.68 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.897 1.279 . . . . 0.0 108.385 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -85.1 -55.14 4.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.197 1.399 . . . . 0.0 108.567 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.8 100.1 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 125.048 1.339 . . . . 0.0 108.134 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.13 118.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -89.15 94.36 9.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.78 100.91 13.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.7 p -56.45 -26.93 55.35 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -114.59 32.16 6.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.285 1.434 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -150.09 -58.35 0.19 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.301 0.64 . . . . 0.0 110.378 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 155.68 -171.13 33.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.691 1.138 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -89.4 106.4 18.42 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.35 90.89 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 52.1 mt -79.48 95.14 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.1 p -61.66 -25.76 67.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.9 90.02 2.55 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.788 0.835 . . . . 0.0 108.958 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.7 128.32 35.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.435 1.094 . . . . 0.0 111.265 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 54.0 p -147.89 179.52 7.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.976 1.31 . . . . 0.0 109.45 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -39.18 -35.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.91 2.084 . . . . 0.0 113.691 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -42.87 -44.43 4.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.517 1.927 . . . . 0.0 112.361 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -103.33 -10.09 18.95 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 113.847 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.87 111.82 7.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.415 1.007 . . . . 0.0 109.709 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 151.23 -162.15 29.39 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.9 tp -81.77 90.31 6.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.29 146.96 54.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.829 0.852 . . . . 0.0 108.971 172.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 48.8 m -143.39 99.25 3.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.48 1.112 . . . . 0.0 108.169 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.53 132.18 43.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -126.57 141.62 51.8 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.262 1.025 . . . . 0.0 109.826 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.31 106.5 3.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.014 0.926 . . . . 0.0 109.708 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.1 m -91.2 107.17 19.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.307 1.043 . . . . 0.0 108.609 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -79.69 -61.65 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -130.23 -114.98 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.39 -17.27 78.86 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.43 107.42 19.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.001 0.92 . . . . 0.0 110.275 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.69 101.13 12.48 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -89.43 152.28 21.57 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -150.36 162.64 40.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.489 0.315 . . . . 0.0 111.411 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.0 t -146.0 135.28 22.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.997 0.919 . . . . 0.0 109.319 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -112.55 149.79 32.22 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.579 1.152 . . . . 0.0 111.989 -168.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -146.04 133.55 20.85 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.643 1.177 . . . . 0.0 109.191 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -102.79 105.68 16.14 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 105.58 17.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.26 134.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.652 1.181 . . . . 0.0 108.666 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.584 1.154 . . . . 0.0 109.529 176.685 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -169.65 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.598 2.865 . . . . 0.0 110.905 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 75.88 103.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 126.045 1.738 . . . . 0.0 111.782 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.12 -48.78 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -105.55 111.28 23.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.8 ptm -120.28 156.35 31.42 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.074 0.95 . . . . 0.0 110.113 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -179.54 2.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.72 0.808 . . . . 0.0 110.82 174.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 m -142.98 -154.77 0.54 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.98 92.46 0.72 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.6 mt 114.43 117.43 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 131.485 3.914 . . . . 0.0 107.122 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.44 142.0 24.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.212 3.275 . . . . 0.0 113.366 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.94 110.57 3.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mt -74.03 133.01 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.8 115.7 43.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.47 86.9 4.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.026 0.93 . . . . 0.0 109.385 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 18.8 ptm -89.61 158.9 17.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.193 0.997 . . . . 0.0 111.148 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.5 m -124.57 108.23 11.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -63.48 152.1 39.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 111.023 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 97.94 -34.52 5.14 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -89.47 177.23 6.62 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -74.78 135.37 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.44 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.01 109.64 11.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.755 1.222 . . . . 0.0 109.192 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.6 t -89.94 122.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -93.17 108.45 33.02 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.39 84.03 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.414 2.742 . . . . 0.0 110.381 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.9 p -140.45 45.88 1.82 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.777 0.831 . . . . 0.0 109.801 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.6 ptt180 -69.03 157.8 36.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.98 175.55 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.706 1.603 . . . . 0.0 109.459 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.0 p -73.33 -71.94 0.28 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.406 0.682 . . . . 0.0 110.413 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -99.66 151.21 37.38 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.501 1.121 . . . . 0.0 110.639 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.98 -30.24 39.58 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.871 2.381 . . . . 0.0 110.794 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -50.76 -30.57 14.37 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.2 1.8 . . . . 0.0 112.827 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 mm -50.27 -41.31 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.825 1.25 . . . . 0.0 111.047 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 61.07 80.98 0.2 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.08 1.352 . . . . 0.0 110.686 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.55 138.99 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.9 m -118.74 129.29 55.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.087 1.355 . . . . 0.0 107.951 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.47 100.89 13.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -89.39 168.88 11.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.749 1.22 . . . . 0.0 109.949 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -143.96 137.69 27.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.526 1.53 . . . . 0.0 107.865 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -60.58 134.32 91.68 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 118.631 -0.7 . . . . 0.0 110.556 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.4 -59.72 0.11 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 119.901 1.0 . . . . 0.0 112.01 -0.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.07 40.51 1.79 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.589 1.156 . . . . 0.0 110.164 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.56 167.42 14.61 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.8 m -146.78 133.27 19.73 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.627 0.371 . . . . 0.0 110.723 -173.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.24 87.5 3.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.527 1.531 . . . . 0.0 107.089 175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mm -61.85 129.37 91.62 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.963 0.905 . . . . 0.0 109.544 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.29 79.83 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.261 2.641 . . . . 0.0 110.382 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.61 -25.72 67.52 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 113.318 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.43 43.22 54.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -150.09 -57.79 0.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.746 1.218 . . . . 0.0 108.317 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -95.95 -49.87 5.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.383 1.473 . . . . 0.0 107.914 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.4 mt -103.0 93.52 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 124.43 1.092 . . . . 0.0 108.424 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.8 119.71 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -90.0 100.6 13.39 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.152 0.581 . . . . 0.0 109.496 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -95.79 108.17 20.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 172.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.661 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 53.3 p -55.67 -35.12 65.64 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.362 0.665 . . . . 0.0 112.392 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -101.29 21.53 13.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.935 0.894 . . . . 0.0 112.661 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -145.9 -55.88 0.29 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.658 0.663 . . . . 0.0 111.51 171.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 159.19 -172.98 35.97 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -89.61 112.63 23.92 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.54 97.05 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.472 1.109 . . . . 0.0 108.599 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.71 98.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.4 p -59.02 -35.21 72.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.541 1.136 . . . . 0.0 113.303 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -130.32 81.73 2.02 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.527 1.131 . . . . 0.0 108.337 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 156.77 24.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.381 0.672 . . . . 0.0 111.734 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 70.3 p -145.66 -178.4 6.08 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.21 1.404 . . . . 0.0 109.06 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -54.74 -32.54 59.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.127 0.971 . . . . 0.0 112.376 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -31.45 55.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.494 0.718 . . . . 0.0 111.872 176.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -81.7 -40.62 22.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.519 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.11 119.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 118.467 0.576 . . . . 0.0 109.668 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.34 -160.51 20.72 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.352 0.977 . . . . 0.0 111.178 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 41.1 tp -79.26 84.36 5.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.142 0.977 . . . . 0.0 111.142 -172.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 43.5 mt -75.61 153.83 37.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.4 m -148.88 115.35 5.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.15 125.92 30.84 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -128.19 148.18 50.6 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.68 0.792 . . . . 0.0 110.517 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.29 133.1 10.36 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.265 0.626 . . . . 0.0 110.857 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.6 m -89.66 114.65 26.31 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.17 141.52 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 64.78 -76.93 0.04 OUTLIER 'General case' 0 C--N 1.343 0.287 0 C-N-CA 126.304 1.842 . . . . 0.0 110.269 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -171.8 44.45 0.18 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -150.05 127.69 11.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.572 1.149 . . . . 0.0 108.741 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.2 tp -81.03 102.54 10.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.123 0.969 . . . . 0.0 108.829 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -89.23 153.39 20.95 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -140.3 153.38 46.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.474 1.11 . . . . 0.0 109.953 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.7 t -149.35 122.81 9.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.365 0.666 . . . . 0.0 109.348 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -98.27 148.23 23.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.169 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.65 103.49 4.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.297 1.439 . . . . 0.0 108.56 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.29 94.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.2 p -88.39 99.08 11.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -89.47 172.1 9.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.596 1.158 . . . . 0.0 109.706 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? . . . . . 0 N--CA 1.451 -0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 109.585 173.701 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.93 -62.24 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.662 2.241 . . . . 0.0 110.549 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -75.14 130.22 38.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.18 0.992 . . . . 0.0 112.327 -173.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.11 -59.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -91.74 123.84 35.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ptm -152.03 166.23 32.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.834 0.854 . . . . 0.0 110.282 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -170.75 0.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.305 1.042 . . . . 0.0 110.971 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.8 t -123.08 -68.85 0.86 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.42 -52.81 0.72 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.01 1.324 . . . . 0.0 109.063 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.1 mm -72.78 130.54 85.22 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.26 149.76 64.18 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.594 2.196 . . . . 0.0 109.989 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.73 121.29 15.11 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.8 110.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.907 0.883 . . . . 0.0 108.755 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.37 93.52 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -74.72 81.77 2.07 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.24 1.016 . . . . 0.0 109.237 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 170.53 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.61 0.764 . . . . 0.0 111.89 -169.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -121.61 118.41 29.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.818 1.247 . . . . 0.0 108.165 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.1 149.79 22.74 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.97 -34.0 3.46 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.718 0.675 . . . . 0.0 112.079 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -89.82 176.11 6.96 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.857 0.863 . . . . 0.0 110.854 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.213 0.605 . . . . 0.0 111.706 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.6 tp -140.69 105.14 4.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.297 1.439 . . . . 0.0 107.718 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.2 t -89.85 132.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -108.99 94.61 15.15 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -84.66 66.33 6.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.319 2.68 . . . . 0.0 111.741 -166.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.6 p -100.83 58.73 0.92 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.125 0.97 . . . . 0.0 108.756 171.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -69.95 155.69 40.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.623 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 169.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.574 1.149 . . . . 0.0 111.953 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 p -67.89 -65.69 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.044 1.338 . . . . 0.0 110.072 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -111.97 149.98 41.69 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.647 1.179 . . . . 0.0 110.398 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.86 -27.62 43.5 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.516 2.81 . . . . 0.0 112.889 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.06 -16.69 60.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.9 mm -77.27 83.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 55.8 m -73.34 113.3 10.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.9 t -89.41 142.59 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.772 0.829 . . . . 0.0 109.256 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -98.97 111.8 24.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.26 100.32 13.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.75 168.43 12.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.32 0.648 . . . . 0.0 110.382 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -143.96 145.63 32.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.979 1.312 . . . . 0.0 108.342 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -58.19 134.25 84.5 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.007 0.923 . . . . 0.0 110.772 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.37 -59.13 0.13 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.784 0.959 . . . . 0.0 111.745 0.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -140.89 38.89 1.8 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.741 1.217 . . . . 0.0 109.859 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -79.19 158.85 27.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.4 m -131.44 126.02 34.02 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.76 0.824 . . . . 0.0 109.232 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.83 99.56 10.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.171 1.388 . . . . 0.0 107.533 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.32 128.81 93.09 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.39 85.3 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.892 2.395 . . . . 0.0 109.825 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.84 -22.31 62.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.171 1.388 . . . . 0.0 113.246 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 76.84 26.29 62.91 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.575 -0.569 . . . . 0.0 112.679 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.38 -63.77 0.58 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.827 1.251 . . . . 0.0 108.365 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -85.44 -60.09 2.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 27.4 mt -89.81 93.37 4.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.6 mt -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -88.95 96.36 10.69 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.33 105.13 17.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.7 p -51.68 -51.26 57.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.082 0.953 . . . . 0.0 112.9 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -95.07 28.97 2.57 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.825 . . . . 0.0 112.382 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -144.95 -60.39 0.36 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.765 0.826 . . . . 0.0 110.987 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 158.45 -176.09 35.45 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -89.36 107.52 19.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 mt -89.32 95.44 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.14 87.69 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.4 p -56.39 -31.55 63.96 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.713 1.205 . . . . 0.0 113.702 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -139.74 86.97 2.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.8 162.12 9.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.81 0.844 . . . . 0.0 111.43 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.6 p -126.8 153.16 45.97 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 0.0 108.801 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -53.62 -32.62 52.03 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.01 0.924 . . . . 0.0 111.829 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -55.74 -36.23 67.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.524 1.129 . . . . 0.0 111.82 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.44 -0.37 29.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.125 0.97 . . . . 0.0 112.938 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.0 mt -72.64 121.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 162.28 -116.51 0.72 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.77 107.32 4.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.056 0.942 . . . . 0.0 109.164 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.1 152.24 20.69 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.1 m -142.33 109.79 5.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.138 0.975 . . . . 0.0 108.389 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 77.6 m -76.78 136.38 38.99 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -130.7 142.63 50.43 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.392 1.077 . . . . 0.0 110.185 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.25 39.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.428 1.091 . . . . 0.0 109.516 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.5 m -142.19 127.25 18.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.02 -76.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 0.0 109.233 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.37 52.52 2.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.98 44.44 56.23 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.216 0.913 . . . . 0.0 111.669 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -150.09 128.78 12.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.539 1.136 . . . . 0.0 108.35 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.29 104.31 9.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -89.61 139.05 30.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -150.78 166.1 31.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.866 0.303 . . . . 0.0 111.442 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.57 137.47 14.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.917 0.887 . . . . 0.0 109.779 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -105.86 143.26 34.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.227 1.411 . . . . 0.0 112.75 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.97 103.55 4.66 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.586 1.555 . . . . 0.0 108.571 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.61 109.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 p -89.27 97.7 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -89.36 160.42 16.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.787 1.235 . . . . 0.0 108.695 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.852 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.06 -47.23 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.913 2.408 . . . . 0.0 110.633 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.6 143.45 53.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 111.995 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -79.25 -52.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -109.58 122.77 48.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.577 1.551 . . . . 0.0 108.842 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.4 ptm -122.3 157.6 31.38 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.146 0.978 . . . . 0.0 109.736 170.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.24 162.77 28.88 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.849 0.46 . . . . 0.0 110.717 173.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -92.62 -136.66 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -97.26 106.52 18.86 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 25.4 mm 119.73 122.3 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 131.688 3.995 . . . . 0.0 107.332 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -44.81 139.29 7.77 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.668 3.579 . . . . 0.0 114.101 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.45 119.2 10.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.225 0.61 . . . . 0.0 110.213 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.77 103.34 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.201 1.4 . . . . 0.0 108.861 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.0 mt -108.89 123.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.205 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -81.47 91.98 6.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.02 1.328 . . . . 0.0 108.726 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 13.9 ptm -89.3 168.34 12.33 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 111.803 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 m -136.67 142.58 43.18 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.23 1.412 . . . . 0.0 108.637 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.64 148.63 51.64 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.941 0.897 . . . . 0.0 110.85 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.34 -41.58 2.93 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.564 0.602 . . . . 0.0 113.228 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -88.64 -179.05 5.95 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.437 0.695 . . . . 0.0 110.586 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.2 156.22 39.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.5 tp -150.01 111.41 4.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.59 134.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -109.67 93.32 13.99 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 170.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.63 77.72 3.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.452 2.768 . . . . 0.0 112.163 -166.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.3 p -124.6 46.84 2.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.449 1.5 . . . . 0.0 109.814 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 188' ' ' SER . 29.4 ptt-85 -63.01 158.45 19.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.873 0.869 . . . . 0.0 111.006 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.2 m -114.31 155.22 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 124.427 1.091 . . . . 0.0 111.51 -174.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 p -57.68 -61.31 2.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.115 1.366 . . . . 0.0 109.873 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.8 t -98.56 120.33 59.39 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.291 1.037 . . . . 0.0 108.957 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.76 -32.69 6.31 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 125.08 3.853 . . . . 0.0 114.912 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -57.97 -27.96 63.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.591 1.156 . . . . 0.0 112.657 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.6 94.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 33.2 m -71.28 118.12 13.67 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.2 t -89.61 147.9 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.063 0.945 . . . . 0.0 109.18 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.3 m -101.75 111.24 23.43 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.379 1.072 . . . . 0.0 108.229 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.33 102.63 15.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -89.92 168.29 12.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.73 0.812 . . . . 0.0 110.183 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -146.61 146.25 30.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.75 1.22 . . . . 0.0 108.214 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 134.65 85.14 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.915 0.886 . . . . 0.0 110.777 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.33 -59.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.685 0 CA-C-N 119.737 0.942 . . . . 0.0 111.857 0.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.05 38.82 1.77 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 109.715 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -78.23 155.14 30.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 61.9 m -127.63 113.71 16.42 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.05 0.94 . . . . 0.0 109.101 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.78 87.57 7.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.9 133.92 95.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.169 0.988 . . . . 0.0 108.836 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.89 83.75 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.39 2.726 . . . . 0.0 110.779 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -69.61 -18.05 63.58 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 113.069 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.7 31.8 73.68 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -133.59 -71.86 0.51 Allowed 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -82.94 -56.2 3.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.5 mm -89.31 84.41 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.7 114.08 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -89.07 94.81 10.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.229 0.611 . . . . 0.0 109.74 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -89.84 95.81 10.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 77.7 p -58.46 -21.39 51.27 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -108.66 24.89 12.41 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.677 1.191 . . . . 0.0 111.856 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -147.03 -57.56 0.26 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.453 0.701 . . . . 0.0 110.264 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.21 -168.95 35.97 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.227 1.394 . . . . 0.0 109.878 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.0 114.36 25.54 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.15 96.95 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 21.8 mm -75.87 80.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.7 p -56.92 -35.33 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.829 1.252 . . . . 0.0 113.292 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -118.96 88.24 2.89 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.503 1.121 . . . . 0.0 108.675 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.64 144.52 52.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.24 0.616 . . . . 0.0 110.419 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 75.3 p -138.35 167.48 21.78 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.324 1.05 . . . . 0.0 110.602 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -61.38 -36.65 80.83 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.244 1.017 . . . . 0.0 111.45 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -52.65 -41.86 64.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.814 0.846 . . . . 0.0 110.697 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.68 0.62 29.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 112.828 -174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.0 mt -73.89 109.79 6.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 161.6 -162.57 34.03 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 117.953 0.342 . . . . 0.0 112.263 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -92.68 103.0 15.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.914 1.285 . . . . 0.0 110.164 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.01 155.44 19.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.766 0.827 . . . . 0.0 108.827 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 38.7 m -149.74 114.01 5.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.278 0.631 . . . . 0.0 109.891 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 57.0 m -80.86 138.7 36.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -131.55 137.4 48.45 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.512 1.125 . . . . 0.0 109.399 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.41 151.39 28.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.8 0.84 . . . . 0.0 109.46 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.4 m -129.98 139.37 51.07 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.436 1.094 . . . . 0.0 108.949 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t -132.03 136.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.45 -85.34 0.02 OUTLIER 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -157.99 46.84 0.46 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -143.14 116.85 9.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.974 1.31 . . . . 0.0 107.83 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.9 tp -77.79 143.8 37.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.89 0.876 . . . . 0.0 109.31 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -132.51 150.13 52.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.25 1.42 . . . . 0.0 108.059 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -141.74 157.48 44.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.23 1.012 . . . . 0.0 110.137 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.7 t -155.53 130.98 9.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.022 0.529 . . . . 0.0 110.131 169.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -109.42 143.41 39.04 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.499 1.519 . . . . 0.0 111.968 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -141.25 109.11 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 108.95 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.5 tt -90.19 101.9 14.62 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -89.75 91.33 8.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.156 0.983 . . . . 0.0 108.355 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -93.11 150.79 20.27 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 118.534 0.606 . . . . 0.0 109.808 175.04 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.12 -48.05 0.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.531 2.821 . . . . 0.0 112.032 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -68.12 140.84 56.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.443 0.697 . . . . 0.0 111.947 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -89.63 -53.84 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -75.64 -81.79 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.436 1.094 . . . . 0.0 110.454 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . 0.259 26.5 ptm 51.49 172.35 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.99 2.516 . . . . 0.0 115.314 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.0 -146.32 0.05 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.902 1.681 . . . . 0.0 110.016 174.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.5 p -131.93 -81.14 0.51 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -128.68 -51.03 1.25 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.619 1.568 . . . . 0.0 108.175 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.26 129.58 79.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.16 135.32 45.1 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.709 2.939 . . . . 0.0 112.391 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.37 128.96 37.99 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.43 127.36 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.5 mt -123.59 133.41 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -96.81 84.16 3.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.457 1.503 . . . . 0.0 107.487 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 8.2 ptm -89.03 164.35 15.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.892 0.377 . . . . 0.0 111.185 -172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -149.46 131.88 15.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.82 155.53 33.69 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.089 0.555 . . . . 0.0 110.706 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.01 -42.73 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -89.05 173.38 8.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.914 1.286 . . . . 0.0 110.94 -172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.49 137.43 44.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.995 0.918 . . . . 0.0 110.269 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.3 tp -127.71 106.95 9.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.479 1.512 . . . . 0.0 107.742 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.2 t -90.56 132.34 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.01 97.52 25.29 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.85 82.16 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.642 2.894 . . . . 0.0 111.667 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.1 p -127.34 55.35 1.6 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.083 1.353 . . . . 0.0 109.206 174.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -65.95 155.45 36.47 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 111.038 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.07 177.43 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.357 1.463 . . . . 0.0 108.53 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -78.88 -29.7 44.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.161 0.984 . . . . 0.0 111.959 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.6 m -149.13 146.41 21.27 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.382 0.673 . . . . 0.0 110.127 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.38 -31.99 33.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.569 2.846 . . . . 0.0 112.743 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -58.56 -26.56 63.71 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.593 0.757 . . . . 0.0 112.359 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.5 mm -54.61 -40.34 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.704 1.201 . . . . 0.0 110.605 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.7 m 61.96 91.2 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.986 1.314 . . . . 0.0 111.431 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.6 t -88.95 143.4 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 91.6 m -104.99 122.43 45.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.2 tp -89.18 125.37 35.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -125.4 -176.4 3.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.079 0.952 . . . . 0.0 109.9 174.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -143.65 143.87 31.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.36 1.864 . . . . 0.0 107.205 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.55 128.03 67.53 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 123.548 0.739 . . . . 0.0 111.23 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.35 -61.77 0.04 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.877 0.992 . . . . 0.0 112.101 1.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.73 39.99 1.4 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.579 1.152 . . . . 0.0 110.275 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -77.98 122.6 25.75 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.8 m -89.73 114.32 25.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.002 0.521 . . . . 0.0 111.001 -169.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 mp -90.01 87.06 6.76 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.47 129.79 93.86 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.78 88.45 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.14 2.56 . . . . 0.0 110.148 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.7 -23.6 67.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.588 1.155 . . . . 0.0 113.071 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.56 20.2 60.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.566 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.76 -60.48 0.83 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.527 1.131 . . . . 0.0 108.174 173.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -78.68 -68.08 0.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.7 mt -89.47 91.93 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 95.0 mt -93.13 118.51 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -88.98 96.33 10.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -89.87 101.78 14.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 77.6 p -52.7 -37.81 59.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.915 0.886 . . . . 0.0 113.215 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -99.0 25.83 6.36 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.984 0.914 . . . . 0.0 112.182 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -150.39 -56.69 0.17 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.513 0.597 . . . . 0.0 111.382 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.44 -173.45 34.9 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -89.42 114.78 26.29 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.1 mt -94.66 94.1 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.95 88.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 79.9 p -57.56 -38.19 74.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.196 1.399 . . . . 0.0 112.453 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -119.55 88.88 3.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.236 1.015 . . . . 0.0 108.517 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.97 146.19 55.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.749 0.419 . . . . 0.0 110.517 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 81.1 p -137.66 173.0 12.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 109.142 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -51.63 -31.27 24.67 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.266 1.427 . . . . 0.0 112.258 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -52.07 -35.94 49.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 112.374 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -87.8 -5.42 58.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.055 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.6 mt -72.15 116.06 13.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 120.251 1.387 . . . . 0.0 108.347 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.15 -104.51 0.26 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.5 tp -152.3 96.72 2.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.917 0.887 . . . . 0.0 109.183 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.4 155.98 23.19 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.171 0.589 . . . . 0.0 109.565 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 30.4 m -146.67 106.26 3.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.753 1.221 . . . . 0.0 109.156 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 47.7 m -78.45 143.16 36.95 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -136.29 135.17 38.72 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.507 1.123 . . . . 0.0 109.899 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.62 164.05 37.75 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.359 1.064 . . . . 0.0 110.327 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.7 m -146.07 135.93 23.43 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.878 0.871 . . . . 0.0 108.736 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.9 -78.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.223 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -88.23 49.91 1.88 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.703 -170.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.28 -24.55 1.71 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.614 0.626 . . . . 0.0 113.45 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -88.91 132.99 34.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.732 1.213 . . . . 0.0 109.585 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.5 tp -76.43 107.82 8.96 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.45 143.05 27.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.21 161.38 42.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.711 0.405 . . . . 0.0 110.529 174.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.8 t -153.84 133.85 13.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.568 0.747 . . . . 0.0 109.37 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -110.36 151.93 26.85 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.844 1.258 . . . . 0.0 112.793 -168.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.55 104.41 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.435 1.494 . . . . 0.0 108.861 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.3 tt -78.23 99.4 6.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.115 0.966 . . . . 0.0 108.635 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.1 p -90.09 90.84 8.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.413 1.485 . . . . 0.0 109.606 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -89.95 155.06 19.38 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.143 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 119.654 -0.212 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.23 -40.91 1.45 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.103 2.535 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -68.44 118.46 11.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.217 1.007 . . . . 0.0 112.069 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.13 -58.4 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -93.14 134.48 35.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.3 ptm -159.96 170.38 21.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.208 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -153.26 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.748 1.619 . . . . 0.0 110.722 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.7 t -133.11 -69.02 0.57 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.71 -56.25 0.57 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 124.919 1.288 . . . . 0.0 108.671 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.77 132.2 94.8 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.29 129.11 20.76 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.525 2.15 . . . . 0.0 109.503 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.1 117.55 6.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.579 0.752 . . . . 0.0 110.697 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mm -72.75 110.6 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.789 1.236 . . . . 0.0 108.634 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 mt -118.14 113.1 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 124.551 1.14 . . . . 0.0 108.559 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 136.41 42.96 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -144.83 157.81 44.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.923 0.489 . . . . 0.0 111.154 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.5 m -105.03 114.62 28.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.83 140.14 56.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.071 0.549 . . . . 0.0 110.232 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 101.4 -35.03 5.18 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.356 0.979 . . . . 0.0 111.202 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -89.63 -177.81 5.38 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.741 0.817 . . . . 0.0 111.446 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.16 148.0 50.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.4 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.0 tp -145.24 106.82 4.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.427 1.091 . . . . 0.0 108.744 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.7 t -94.41 120.53 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.592 1.157 . . . . 0.0 107.887 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.7 mm -89.95 109.79 35.31 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.0 72.54 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.437 2.758 . . . . 0.0 111.081 -168.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 20.3 p -126.02 50.96 1.81 Allowed 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 124.63 1.172 . . . . 0.0 109.563 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.367 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.9 174.22 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.7 1.6 . . . . 0.0 109.331 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -74.99 -29.01 60.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -148.29 144.28 18.53 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.624 0.647 . . . . 0.0 111.607 -169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.1 -39.75 26.09 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.501 3.467 . . . . 0.0 113.535 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -49.34 -37.22 23.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.455 1.502 . . . . 0.0 112.083 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.1 mt -77.97 87.63 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.8 m -78.09 110.6 13.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.46 150.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.375 1.07 . . . . 0.0 108.28 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.9 m -110.46 124.68 52.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.186 0.994 . . . . 0.0 108.646 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 tp -89.4 101.13 13.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.55 169.05 11.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.013 0.925 . . . . 0.0 109.892 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.49 145.58 31.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 108.118 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -57.36 134.27 81.5 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.586 0.754 . . . . 0.0 110.872 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.27 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.707 0 CA-C-N 119.819 0.971 . . . . 0.0 111.716 -0.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.3 39.27 1.74 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.721 1.208 . . . . 0.0 109.996 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -79.66 161.35 25.89 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 171.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -138.44 120.63 15.76 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.368 0.667 . . . . 0.0 110.027 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.4 mp -92.18 81.05 5.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.9 mm -60.94 120.4 53.56 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.421 1.088 . . . . 0.0 109.655 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.79 119.49 6.78 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.149 2.566 . . . . 0.0 111.958 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -84.68 -16.17 42.78 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.632 0.773 . . . . 0.0 111.621 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.81 39.8 89.76 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -150.28 -66.91 0.2 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.711 0.804 . . . . 0.0 109.004 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.7 -54.95 3.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.652 1.181 . . . . 0.0 107.852 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 54.4 mt -95.52 91.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.11 120.31 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -88.93 94.62 10.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -89.43 99.44 12.44 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.8 p -51.04 -41.29 59.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -97.88 24.7 6.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.218 1.007 . . . . 0.0 112.292 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -145.81 -57.08 0.31 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.454 0.701 . . . . 0.0 110.94 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.54 -173.6 37.12 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.02 110.06 20.81 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.3 mt -91.4 93.15 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.078 1.351 . . . . 0.0 108.125 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.31 100.82 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.6 p -61.89 -32.15 72.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.733 0.813 . . . . 0.0 112.608 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.03 95.16 4.5 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.589 1.156 . . . . 0.0 108.915 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.8 138.88 44.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.154 0.581 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 72.8 p -142.84 -178.56 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.902 1.281 . . . . 0.0 109.357 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -45.66 -40.77 9.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.21 1.404 . . . . 0.0 112.109 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -51.99 -32.08 32.22 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.314 1.446 . . . . 0.0 112.472 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -90.16 -38.23 13.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.286 1.034 . . . . 0.0 110.786 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.2 mt -65.95 106.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.324 0.65 . . . . 0.0 109.864 -171.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.28 29.07 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 47.4 tp -83.32 87.82 6.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.472 1.109 . . . . 0.0 109.659 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 89.7 mt -76.73 154.71 33.86 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.02 0.928 . . . . 0.0 109.148 172.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -148.97 112.11 4.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.331 0.652 . . . . 0.0 109.585 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 66.5 m -78.44 132.92 37.5 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -131.21 143.38 50.54 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.994 0.918 . . . . 0.0 110.962 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.76 172.92 17.36 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.034 1.334 . . . . 0.0 109.524 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 75.1 m -144.42 139.54 28.44 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.087 0.955 . . . . 0.0 108.874 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.63 -75.53 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.78 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.94 46.92 1.24 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.844 0.858 . . . . 0.0 111.546 -170.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.77 41.03 50.12 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -170.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -149.27 120.59 7.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.326 1.45 . . . . 0.0 107.376 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.74 111.49 7.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -90.16 143.36 26.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -150.43 161.73 41.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.577 0.351 . . . . 0.0 110.631 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 t -153.02 132.01 12.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.757 0.823 . . . . 0.0 109.153 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -105.84 144.66 32.26 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.975 1.31 . . . . 0.0 111.552 -169.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -139.29 113.19 8.6 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.081 1.352 . . . . 0.0 109.038 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -88.87 99.16 12.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.0 p -89.57 106.81 18.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -112.39 179.61 3.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.224 1.41 . . . . 0.0 110.557 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 . . . . . 0 CA--C 1.53 0.188 0 C-N-CA 123.846 0.858 . . . . 0.0 112.111 -178.374 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -82.05 -175.86 2.73 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.72 2.947 . . . . 0.0 110.319 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 73.88 103.11 0.07 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.555 1.942 . . . . 0.0 111.948 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.22 -52.54 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -96.26 78.18 3.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.024 0.93 . . . . 0.0 108.728 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ttt -80.94 139.91 35.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -172.78 0.3 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.363 1.065 . . . . 0.0 112.076 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.4 t -148.48 -162.37 1.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 108.891 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.7 95.94 0.69 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 32.4 mm 116.6 120.08 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 1 C-N-CA 132.131 4.172 . . . . 0.0 107.332 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.15 139.59 32.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.346 2.697 . . . . 0.0 110.113 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -65.78 130.08 42.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.267 0.627 . . . . 0.0 111.273 -177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -72.52 138.03 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.396 1.078 . . . . 0.0 109.82 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.8 mt -128.45 127.87 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.017 1.327 . . . . 0.0 107.873 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -90.9 125.05 35.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -150.31 176.6 10.74 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.498 0.719 . . . . 0.0 110.367 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.3 m -150.08 143.05 24.86 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 170.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.77 141.56 55.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.483 0.313 . . . . 0.0 110.16 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.5 -35.75 4.81 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.11 0.862 . . . . 0.0 111.69 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.76 169.78 11.34 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.708 0.754 . . . . 0.0 110.586 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.49 147.73 37.63 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.22 108.88 4.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -171.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.75 130.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -106.87 97.27 16.96 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.59 77.3 4.11 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.068 2.512 . . . . 0.0 111.134 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -115.46 53.66 0.83 Allowed 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.918 1.287 . . . . 0.0 109.183 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -66.47 148.39 51.95 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.273 0.629 . . . . 0.0 110.738 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.08 175.58 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 109.793 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.9 p -67.26 -40.49 86.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.832 0.853 . . . . 0.0 111.823 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -150.74 149.04 24.71 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.274 0.63 . . . . 0.0 111.064 -171.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.23 -37.98 40.58 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.749 2.966 . . . . 0.0 112.613 166.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -53.24 -29.26 31.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.975 1.71 . . . . 0.0 113.03 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.8 mm -55.5 -34.74 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.012 0.925 . . . . 0.0 110.796 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.1 m 63.85 80.23 0.24 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.313 1.445 . . . . 0.0 110.564 173.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.79 141.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.6 m -120.92 128.57 52.89 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.681 1.192 . . . . 0.0 108.173 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.1 tp -89.16 131.79 35.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -134.77 177.24 7.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 109.651 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -146.62 148.94 32.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.995 0.918 . . . . 0.0 109.439 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.11 137.52 88.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.586 0.754 . . . . 0.0 109.721 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.74 -59.28 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.985 1.031 . . . . 0.0 111.857 0.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.3 mt -140.01 42.98 1.94 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.615 1.166 . . . . 0.0 109.768 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.65 145.28 27.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.9 m -122.2 128.55 51.34 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 124.202 1.001 . . . . 0.0 108.659 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.0 mt -111.9 79.23 1.19 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.656 1.582 . . . . 0.0 107.693 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.55 132.66 91.12 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 109.613 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.86 87.08 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.25 2.634 . . . . 0.0 110.402 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.26 -23.2 66.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.809 1.244 . . . . 0.0 112.859 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 82.84 17.43 67.81 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.573 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -129.07 -63.16 0.97 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -73.87 -68.43 0.52 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.7 mt -89.5 95.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.0 mt -95.9 115.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -89.35 117.07 28.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.475 0.71 . . . . 0.0 110.005 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -115.01 108.63 16.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.9 p -58.54 -29.42 66.33 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.74 0.816 . . . . 0.0 113.176 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -102.6 22.64 13.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.917 0.887 . . . . 0.0 112.177 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -149.17 -57.86 0.21 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.457 0.571 . . . . 0.0 111.115 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.58 -172.11 34.27 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -89.35 113.0 24.24 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.87 95.06 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.71 89.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 170.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 65.1 p -60.08 -35.04 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.785 1.234 . . . . 0.0 112.54 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.05 93.89 4.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.282 1.033 . . . . 0.0 108.391 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.26 150.81 38.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.468 0.707 . . . . 0.0 110.398 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 38.5 p -146.31 171.49 14.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.678 1.191 . . . . 0.0 109.208 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -51.42 -34.71 36.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.421 1.088 . . . . 0.0 111.621 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -56.59 -26.82 56.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.97 1.308 . . . . 0.0 112.071 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -82.9 -39.59 21.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.485 0.714 . . . . 0.0 111.839 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.2 108.4 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.119 0.967 . . . . 0.0 110.369 -169.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 147.23 -162.48 28.62 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.989 0.804 . . . . 0.0 111.334 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.19 88.3 6.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.226 1.01 . . . . 0.0 109.255 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.5 154.5 41.82 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.108 0.963 . . . . 0.0 109.298 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.0 m -149.73 108.75 3.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.039 0.936 . . . . 0.0 109.308 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.8 m -79.83 133.26 36.27 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -127.95 141.57 51.5 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.276 1.03 . . . . 0.0 110.078 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.42 120.69 6.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.117 0.967 . . . . 0.0 109.637 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.4 m -100.53 77.61 1.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.793 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.93 -52.65 29.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -109.41 177.78 4.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.613 1.165 . . . . 0.0 108.748 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.96 70.65 1.48 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 169.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -145.56 -43.25 0.22 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.566 1.547 . . . . 0.0 110.289 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp 64.11 91.22 0.08 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.854 1.662 . . . . 0.0 109.681 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -89.48 147.4 24.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -150.52 164.24 36.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.542 0.337 . . . . 0.0 111.61 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.2 t -147.11 129.12 15.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.701 1.2 . . . . 0.0 108.233 174.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -107.68 151.4 25.71 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.24 1.416 . . . . 0.0 112.688 -168.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -144.88 121.91 11.39 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.993 1.317 . . . . 0.0 108.956 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.24 102.51 14.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.1 p -89.57 124.15 34.29 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.64 0.776 . . . . 0.0 109.419 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -120.68 147.3 45.46 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.905 0.882 . . . . 0.0 110.133 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 . . . . . 0 N--CA 1.451 -0.413 0 C-N-CA 123.796 0.838 . . . . 0.0 109.894 178.684 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.81 -171.98 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.531 2.821 . . . . 0.0 111.401 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 77.57 104.81 0.07 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 127.199 2.2 . . . . 0.0 111.6 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.26 -50.39 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.465 1.106 . . . . 0.0 109.343 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.62 -70.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.399 0.68 . . . . 0.0 109.518 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ttt 64.23 116.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.569 1.948 . . . . 0.0 112.834 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.64 151.46 47.26 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.1 p -78.56 -62.64 1.62 Allowed 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.148 -0.345 . . . . 0.0 110.263 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -158.77 -51.66 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.426 1.09 . . . . 0.0 109.055 -171.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 34.6 mm -79.69 126.9 79.54 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.14 139.82 34.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.665 2.91 . . . . 0.0 112.519 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.18 119.75 12.6 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.4 mm -77.66 102.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.3 mt -92.22 143.66 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.337 1.055 . . . . 0.0 108.208 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -120.64 79.91 1.55 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.533 1.133 . . . . 0.0 110.12 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -89.5 -177.72 5.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.527 1.131 . . . . 0.0 111.064 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -142.31 117.57 10.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 169.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.65 123.55 9.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.631 0.773 . . . . 0.0 109.983 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.36 -39.74 2.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.823 1.201 . . . . 0.0 111.167 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -89.31 165.63 14.28 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.695 0.748 . . . . 0.0 111.363 -171.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -67.71 129.87 41.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -128.0 124.47 37.27 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.484 1.113 . . . . 0.0 109.561 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.03 134.76 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.5 mm -101.09 100.85 14.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.4 76.23 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 111.108 -165.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.1 p -125.58 45.02 2.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.291 1.037 . . . . 0.0 110.406 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 0.817 ' HB2' ' O ' ' A' ' 188' ' ' SER . 41.1 ptt180 -67.25 151.38 47.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.906 0.483 . . . . 0.0 110.771 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.1 175.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.929 1.292 . . . . 0.0 111.366 -169.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.1 p -75.73 -24.28 56.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -172.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.7 m -158.36 149.92 16.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.031 0.832 . . . . 0.0 110.824 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.72 -36.35 41.47 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.011 3.141 . . . . 0.0 113.654 168.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.59 -36.59 35.62 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.327 1.851 . . . . 0.0 111.935 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 41.6 mm -50.46 -42.74 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.861 1.264 . . . . 0.0 111.19 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 60.58 83.71 0.14 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.037 1.335 . . . . 0.0 111.044 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.68 147.49 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.609 0.764 . . . . 0.0 108.987 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.3 m -124.83 138.77 54.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.84 1.256 . . . . 0.0 107.852 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.0 tp -88.93 125.75 35.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -128.26 -179.55 5.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.878 1.271 . . . . 0.0 110.035 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -147.72 148.19 30.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 108.223 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -58.1 134.22 84.17 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.116 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.72 -59.97 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.962 1.022 . . . . 0.0 111.828 0.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.8 mt -141.83 38.26 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 110.162 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.6 148.28 40.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 170.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 91.0 m -125.75 118.32 25.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.757 0.823 . . . . 0.0 109.904 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.04 88.67 6.2 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 79.5 mt -61.36 130.44 91.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.636 0.775 . . . . 0.0 109.306 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.37 85.32 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.204 2.602 . . . . 0.0 110.247 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -60.78 -22.92 64.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.275 1.43 . . . . 0.0 113.28 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.72 28.07 65.89 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 118.374 0.534 . . . . 0.0 112.646 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.56 -64.26 0.72 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.078 1.351 . . . . 0.0 107.705 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -84.6 -58.43 2.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.8 mt -91.74 89.78 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 78.4 mt -95.22 116.35 36.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -89.1 129.55 35.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -135.6 122.17 20.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.289 1.036 . . . . 0.0 108.289 170.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 60.7 p -58.8 -26.46 64.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 112.379 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -98.75 10.93 40.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.883 0.873 . . . . 0.0 113.147 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -145.55 -57.85 0.32 Allowed 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.83 0.741 . . . . 0.0 110.603 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.31 -164.66 29.36 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.79 111.41 22.4 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.53 97.41 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.1 110.84 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 92.1 p -65.15 -35.62 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.518 0.599 . . . . 0.0 112.499 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -140.33 101.84 4.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.836 1.255 . . . . 0.0 107.99 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.11 157.58 25.1 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.365 0.666 . . . . 0.0 110.177 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 80.3 p -133.06 164.28 27.37 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.725 0.81 . . . . 0.0 110.177 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -59.63 -32.13 70.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.283 0.633 . . . . 0.0 110.969 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -60.3 -25.74 65.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.262 1.025 . . . . 0.0 111.947 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.29 -12.29 59.63 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.654 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.61 105.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.44 1.018 . . . . 0.0 109.212 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.82 -159.04 28.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.5 81.36 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.918 0.887 . . . . 0.0 110.562 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 97.9 mt -65.83 150.91 47.8 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 27.7 m -150.01 114.64 5.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.466 0.706 . . . . 0.0 109.416 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 84.6 m -78.23 124.48 28.12 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -121.55 141.49 51.01 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.316 1.047 . . . . 0.0 110.447 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.07 102.06 2.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.558 1.143 . . . . 0.0 109.198 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.2 m -89.88 86.34 6.61 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.92 -56.07 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.279 0.632 . . . . 0.0 109.786 -174.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -158.03 -75.51 0.08 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.981 0.913 . . . . 0.0 109.415 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.29 -46.54 78.1 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 123.362 0.506 . . . . 0.0 112.398 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -140.06 162.39 35.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.235 0.614 . . . . 0.0 111.395 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.59 101.96 9.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -89.85 133.2 34.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.55 161.71 42.02 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 62.7 p -139.72 133.6 30.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.518 1.127 . . . . 0.0 109.086 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -106.87 145.55 32.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.209 1.004 . . . . 0.0 111.743 -170.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -143.06 105.43 4.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.714 1.606 . . . . 0.0 109.235 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.69 108.67 19.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.9 p -89.26 90.65 8.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.462 0.705 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -89.61 103.43 16.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 . . . . . 0 CA--C 1.531 0.23 0 CA-C-N 118.993 0.815 . . . . 0.0 110.777 -177.246 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.39 -37.41 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.166 2.577 . . . . 0.0 111.37 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -62.08 143.42 56.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 112.366 -174.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.29 -55.85 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -92.45 126.75 37.67 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 108.922 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.17 141.01 42.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.077 1.351 . . . . 0.0 108.996 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.16 121.09 12.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -68.91 -39.51 79.62 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.8 -0.563 . . . . 0.0 111.222 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -158.92 -58.34 0.07 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.6 mm -87.77 130.99 44.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.96 147.4 26.22 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.549 2.833 . . . . 0.0 112.429 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.87 118.98 11.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.2 94.68 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.6 mt -89.54 108.28 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -76.9 89.25 3.49 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.09 0.956 . . . . 0.0 108.552 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -104.36 173.51 6.27 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.395 1.478 . . . . 0.0 111.387 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 94.1 m -138.36 120.74 15.96 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -59.67 144.67 47.31 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.719 0.408 . . . . 0.0 110.364 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.22 -37.32 3.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -89.15 170.15 10.86 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.728 0.811 . . . . 0.0 110.672 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.57 145.57 54.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.815 0.446 . . . . 0.0 110.813 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.5 tp -143.31 108.5 5.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.88 1.272 . . . . 0.0 108.451 -172.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.64 131.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mm -108.63 91.52 8.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.73 89.19 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.459 2.773 . . . . 0.0 111.851 -164.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.7 p -135.62 48.73 2.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.557 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . 1.284 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -62.87 157.38 21.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.253 0.549 . . . . 0.0 112.174 176.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.85 175.01 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.819 1.648 . . . . 0.0 108.94 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 p -63.7 -42.4 97.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.474 0.71 . . . . 0.0 112.04 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.9 m -142.72 140.89 19.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.999 0.92 . . . . 0.0 110.24 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.17 -26.9 42.03 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.669 2.913 . . . . 0.0 112.027 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -52.77 -31.82 40.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.313 1.445 . . . . 0.0 112.082 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.78 -35.07 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.982 1.313 . . . . 0.0 110.915 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 m 69.02 91.29 0.09 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.537 1.535 . . . . 0.0 110.383 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.33 141.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.8 m -110.45 126.84 54.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.719 1.208 . . . . 0.0 108.092 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.0 tp -89.23 133.34 34.48 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -133.82 174.82 10.04 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.767 1.227 . . . . 0.0 109.764 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -149.23 148.21 29.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.645 0.778 . . . . 0.0 109.413 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.7 134.95 82.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.928 0.891 . . . . 0.0 109.96 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.27 -59.2 0.13 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 119.917 1.006 . . . . 0.0 111.697 1.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -142.52 44.2 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.597 1.159 . . . . 0.0 109.943 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -82.03 152.03 26.84 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 89.7 m -131.71 119.09 20.87 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.133 0.973 . . . . 0.0 108.942 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.95 113.35 26.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.283 1.433 . . . . 0.0 108.569 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.74 130.9 74.96 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.74 91.4 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.861 2.374 . . . . 0.0 109.731 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -64.31 -22.6 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.478 1.111 . . . . 0.0 113.144 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.48 59.22 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.233 -0.76 . . . . 0.0 113.428 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -137.12 -60.12 0.69 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.649 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -79.7 -66.48 0.87 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -89.56 94.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 40.9 mt -94.6 121.68 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -89.21 127.83 35.78 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.09 100.8 4.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.773 1.229 . . . . 0.0 108.38 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' SER . . . . . 1.284 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.7 p -53.79 -27.74 30.91 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -73.01 -28.43 62.36 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.113 0.965 . . . . 0.0 112.611 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.31 -63.34 1.34 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.728 0.811 . . . . 0.0 110.65 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.21 26.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.84 111.71 22.83 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.35 94.54 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.14 85.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -58.19 -29.5 65.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.481 1.512 . . . . 0.0 113.336 -170.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -132.62 97.25 4.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.09 156.91 36.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.055 0.542 . . . . 0.0 110.393 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 43.0 p -125.53 154.43 42.15 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.143 0.977 . . . . 0.0 109.67 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -55.28 -32.55 62.5 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.172 0.989 . . . . 0.0 111.671 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -53.49 -37.35 62.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.642 1.177 . . . . 0.0 111.481 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -83.34 4.37 27.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.397 1.079 . . . . 0.0 113.2 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.3 mt -73.87 115.51 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.62 -111.5 0.48 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.8 tp -144.98 100.71 3.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.96 0.904 . . . . 0.0 109.975 -172.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.7 156.67 19.88 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.816 0.846 . . . . 0.0 109.128 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.7 m -147.28 117.73 7.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.395 1.078 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 60.4 m -85.04 140.01 31.33 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -133.94 147.44 51.06 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.995 0.918 . . . . 0.0 109.91 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.91 130.63 6.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.332 0.653 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.8 m -100.06 133.88 43.8 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.954 1.302 . . . . 0.0 109.329 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.7 t -100.49 -62.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.261 1.024 . . . . 0.0 108.524 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -140.31 84.79 1.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.066 0.947 . . . . 0.0 109.106 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.22 -57.47 5.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.05 0.834 . . . . 0.0 111.928 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.49 129.25 36.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.766 0.827 . . . . 0.0 110.289 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.86 156.8 30.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.634 0.73 . . . . 0.0 111.046 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -125.41 154.57 41.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -151.2 162.74 40.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 t -151.44 141.42 22.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.924 0.89 . . . . 0.0 109.639 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.17 147.49 32.42 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.288 1.435 . . . . 0.0 112.794 -168.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -143.76 101.9 3.83 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.457 1.503 . . . . 0.0 109.118 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.1 tt -80.31 110.98 16.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 108.772 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.9 p -89.4 93.29 9.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.532 1.133 . . . . 0.0 109.024 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -89.92 120.56 31.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.23 1.412 . . . . 0.0 108.749 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.662 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.65 -61.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.56 2.173 . . . . 0.0 111.341 -173.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -71.56 132.9 45.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.348 0.659 . . . . 0.0 111.729 -171.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.89 -61.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -81.98 109.59 16.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ttt -123.92 123.6 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.92 0.888 . . . . 0.0 110.252 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.95 147.3 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.998 0.919 . . . . 0.0 110.709 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 m -154.44 -58.5 0.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.064 1.345 . . . . 0.0 109.25 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -97.32 79.74 2.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.867 0.867 . . . . 0.0 110.273 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.4 mm 78.36 128.4 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 128.142 2.577 . . . . 0.0 109.748 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.74 138.32 33.32 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.348 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.67 120.55 11.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.099 0.56 . . . . 0.0 109.981 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.8 mm -76.53 122.6 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.0 mt -122.75 102.94 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -75.79 83.79 2.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.283 1.033 . . . . 0.0 109.524 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -92.87 155.62 17.49 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.068 0.947 . . . . 0.0 111.383 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 83.5 m -115.72 112.77 22.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -57.7 137.58 56.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.465 0.706 . . . . 0.0 109.88 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 104.31 -36.38 4.42 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.15 0.881 . . . . 0.0 111.385 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.5 179.48 6.05 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.525 0.73 . . . . 0.0 110.897 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.06 137.82 45.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.29 108.79 8.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.85 -175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -90.0 128.85 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 108.176 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -109.25 94.02 14.58 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.68 100.47 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.347 2.698 . . . . 0.0 110.643 -166.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -145.03 59.14 1.3 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 110.126 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -66.9 155.67 37.82 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.03 164.81 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.733 1.213 . . . . 0.0 110.646 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -61.85 -45.25 94.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.509 1.524 . . . . 0.0 111.517 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.0 m -135.82 145.67 53.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.321 1.048 . . . . 0.0 110.204 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.48 -26.09 34.66 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.352 2.701 . . . . 0.0 111.366 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -53.97 -29.31 42.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.781 1.632 . . . . 0.0 112.312 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.57 -51.91 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.066 0.946 . . . . 0.0 109.873 172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 11.7 m 63.39 93.39 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.494 1.517 . . . . 0.0 110.612 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.02 144.5 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.763 0.825 . . . . 0.0 109.231 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.5 m -112.76 129.82 56.29 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.764 1.226 . . . . 0.0 107.739 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.97 126.4 35.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -126.4 -177.34 3.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.326 1.051 . . . . 0.0 109.424 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -159.24 147.77 17.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 108.889 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.33 134.91 85.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.962 0.905 . . . . 0.0 110.645 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.41 -58.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.897 0.999 . . . . 0.0 111.649 0.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -141.82 38.46 1.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.71 1.204 . . . . 0.0 109.765 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.1 139.5 38.07 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 87.5 m -113.81 114.63 26.55 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.606 0.762 . . . . 0.0 109.477 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.98 85.43 6.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.4 129.32 88.99 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.412 0.685 . . . . 0.0 109.522 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.69 81.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.116 2.544 . . . . 0.0 109.921 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -60.42 -23.09 64.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.622 1.569 . . . . 0.0 113.426 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.29 32.67 65.1 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.58 0.61 . . . . 0.0 112.167 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -138.91 -59.12 0.6 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.235 1.414 . . . . 0.0 108.162 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -94.67 -56.57 2.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.813 1.245 . . . . 0.0 108.411 171.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.2 96.67 6.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 125.362 1.465 . . . . 0.0 108.179 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.63 148.08 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -120.31 138.58 53.63 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 125.113 1.365 . . . . 0.0 109.313 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -141.81 116.44 9.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.94 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 80.2 p -53.92 -32.52 53.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.947 1.299 . . . . 0.0 112.992 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.1 mtm-85 -83.28 -5.78 59.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.738 0.815 . . . . 0.0 112.848 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -141.13 -62.21 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.196 0.907 . . . . 0.0 111.719 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.45 -162.04 31.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.0 123.03 38.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.8 mp -103.28 98.12 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.01 96.27 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.1 p -55.9 -40.22 72.73 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.234 1.414 . . . . 0.0 112.842 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.13 99.67 6.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.821 1.248 . . . . 0.0 107.848 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.72 139.27 56.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.393 0.677 . . . . 0.0 110.527 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 59.3 p -131.98 -177.43 4.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.189 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -51.14 -32.2 22.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.032 1.333 . . . . 0.0 112.387 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -53.71 -29.77 40.74 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.508 1.123 . . . . 0.0 112.171 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -110.6 47.24 0.99 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.752 0.821 . . . . 0.0 110.918 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.09 94.28 2.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 150.23 -158.29 27.6 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.821 1.2 . . . . 0.0 110.445 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.4 tp -85.93 92.29 8.62 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.857 0.863 . . . . 0.0 109.949 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.63 159.11 31.53 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.7 m -148.26 108.28 4.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.195 0.998 . . . . 0.0 109.29 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.23 118.83 19.36 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -113.58 131.85 55.95 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.682 1.193 . . . . 0.0 110.297 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.16 50.3 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.303 1.441 . . . . 0.0 109.501 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 93.8 m -140.73 118.43 11.66 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.07 -54.95 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.847 0.859 . . . . 0.0 109.353 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -130.39 -65.08 0.82 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.173 0.989 . . . . 0.0 109.554 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -166.93 40.68 0.25 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -93.67 -47.08 6.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.209 1.404 . . . . 0.0 110.343 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 tp 63.68 88.56 0.1 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.932 1.693 . . . . 0.0 110.35 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.55 140.82 29.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.76 141.53 40.93 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.298 0.639 . . . . 0.0 109.909 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 35.3 p -133.44 123.89 26.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 108.099 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -102.3 144.59 30.6 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.031 0.932 . . . . 0.0 112.813 -169.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -142.96 107.72 4.87 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.857 1.663 . . . . 0.0 108.252 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.58 108.51 20.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.852 0.861 . . . . 0.0 109.174 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 32.1 p -89.62 114.82 26.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.099 0.96 . . . . 0.0 109.925 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -89.85 135.78 33.43 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.316 1.046 . . . . 0.0 109.148 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 169.722 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.87 -27.21 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.19 2.594 . . . . 0.0 111.405 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -65.58 132.24 48.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.101 1.361 . . . . 0.0 112.554 -169.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.44 -49.63 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -81.38 101.26 9.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.28 0.632 . . . . 0.0 109.697 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.57 136.33 33.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 139' ' ' TYR . 1.2 p90 -79.42 48.16 0.88 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.623 0.769 . . . . 0.0 111.352 175.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 m -34.25 111.46 0.11 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.718 2.007 . . . . 0.0 110.76 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 1.61 71.52 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.838 2.455 . . . . 0.0 114.748 -167.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.7 mt 157.56 132.33 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 129.466 3.106 . . . . 0.0 108.584 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 148.11 60.16 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.316 2.677 . . . . 0.0 110.613 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.01 119.37 14.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.243 0.617 . . . . 0.0 109.472 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -78.99 99.81 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.63 115.44 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -80.09 83.61 5.95 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.691 1.197 . . . . 0.0 108.652 173.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -89.34 172.99 8.63 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.218 0.607 . . . . 0.0 112.159 -169.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.7 m -142.24 114.07 8.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.608 1.163 . . . . 0.0 108.189 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.55 145.51 18.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.884 0.873 . . . . 0.0 110.883 174.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.01 -48.17 1.8 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.144 0.878 . . . . 0.0 111.155 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -89.52 -178.21 5.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.796 0.838 . . . . 0.0 111.057 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.98 142.42 49.38 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.119 0.568 . . . . 0.0 110.948 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -139.72 110.18 6.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.455 1.502 . . . . 0.0 106.998 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.1 t -90.49 134.81 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.58 93.55 8.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.56 80.27 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.186 2.59 . . . . 0.0 111.977 -164.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 25.1 p -120.32 52.8 1.12 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.569 1.148 . . . . 0.0 110.722 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -57.56 147.81 25.89 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.288 1.035 . . . . 0.0 110.956 172.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -113.27 155.75 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 123.983 0.913 . . . . 0.0 111.305 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.0 p -70.02 -32.95 71.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.563 1.545 . . . . 0.0 111.496 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -126.38 113.04 23.38 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 124.979 1.312 . . . . 0.0 107.462 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -68.42 -20.51 41.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.238 2.625 . . . . 0.0 111.582 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -52.9 -36.25 59.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.688 172.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.78 86.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 30.8 m -66.64 126.18 28.14 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.804 0.842 . . . . 0.0 108.97 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.65 149.63 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.035 0.934 . . . . 0.0 109.634 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.5 m -105.84 115.78 30.82 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.912 1.285 . . . . 0.0 108.06 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 tp -89.62 104.17 16.75 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.378 0.671 . . . . 0.0 109.397 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.92 173.37 7.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 109.8 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -148.94 146.86 28.05 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.406 1.082 . . . . 0.0 108.666 169.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.62 134.5 86.07 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.816 0.846 . . . . 0.0 110.37 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.52 -59.39 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.883 0.994 . . . . 0.0 111.92 0.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.75 41.29 1.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.571 1.148 . . . . 0.0 109.944 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -83.27 153.31 24.73 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 m -123.78 107.87 11.89 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.277 1.031 . . . . 0.0 108.641 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.2 78.22 5.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.8 mt -59.66 131.44 88.55 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.357 1.063 . . . . 0.0 109.868 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.17 87.95 0.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.255 2.637 . . . . 0.0 110.31 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.39 -23.08 66.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.323 1.049 . . . . 0.0 112.743 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.89 -15.3 61.89 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.719 -1.045 . . . . 0.0 113.674 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.86 -60.58 1.65 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.508 1.154 . . . . 0.0 109.441 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -76.54 -67.72 0.67 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 mt -89.77 99.17 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.1 mt -98.7 120.75 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -89.09 95.95 10.52 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.012 0.525 . . . . 0.0 109.716 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.94 101.1 13.81 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.9 p -56.9 -27.81 61.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.157 0.983 . . . . 0.0 113.634 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -104.53 22.37 15.1 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.31 1.044 . . . . 0.0 112.153 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -147.09 -60.06 0.28 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.572 0.624 . . . . 0.0 110.306 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.5 -168.14 35.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.56 112.64 23.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.96 98.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -82.98 97.28 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 72.8 p -61.21 -37.53 83.33 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.153 0.981 . . . . 0.0 112.345 -175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -121.21 87.96 2.85 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.532 1.133 . . . . 0.0 109.28 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.07 163.23 15.25 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.319 0.247 . . . . 0.0 110.7 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 46.5 p -139.86 160.25 40.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.899 0.88 . . . . 0.0 109.947 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -58.71 -34.26 71.13 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.74 0.816 . . . . 0.0 110.869 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -61.12 -34.61 75.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.966 0.907 . . . . 0.0 111.275 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.95 -8.4 56.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.596 0.758 . . . . 0.0 112.645 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.5 mt -65.4 127.26 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.01 -119.97 0.95 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.7 tp -144.76 95.25 2.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.234 1.014 . . . . 0.0 108.797 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 153.42 28.96 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 41.1 m -143.57 102.86 4.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.196 0.998 . . . . 0.0 108.979 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.72 132.09 43.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -134.03 135.59 43.46 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.125 0.97 . . . . 0.0 109.672 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.14 119.48 8.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.583 1.153 . . . . 0.0 108.613 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 m -89.69 59.13 4.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.082 0.553 . . . . 0.0 110.275 -172.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.86 141.06 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 57.53 24.43 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.051 1.34 . . . . 0.0 112.177 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.1 -5.9 23.83 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.112 -0.827 . . . . 0.0 113.231 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -89.92 129.56 36.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.573 1.186 . . . . 0.0 108.255 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.38 85.91 1.12 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.501 0.72 . . . . 0.0 109.439 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -88.93 141.24 28.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.65 162.9 39.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.228 0.611 . . . . 0.0 111.449 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.7 t -143.23 128.34 18.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.974 1.309 . . . . 0.0 107.713 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -106.07 150.98 25.25 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.416 1.486 . . . . 0.0 112.446 -169.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -142.74 105.3 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.488 1.515 . . . . 0.0 108.573 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -79.4 108.64 13.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.5 p -89.23 91.65 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -98.17 121.82 40.57 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.653 1.581 . . . . 0.0 107.608 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 . . . . . 0 C--N 1.34 0.157 0 CA-C-N 119.097 0.862 . . . . 0.0 109.699 174.225 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 55.0 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 119.845 -0.121 . . . . 0.0 111.204 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.27 -61.14 2.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.23 0.612 . . . . 0.0 109.821 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.2 p -86.65 68.17 10.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.65 -74.31 0.06 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -172.81 128.51 0.55 Allowed Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.555 1.142 . . . . 0.0 108.221 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.43 -45.32 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.903 2.402 . . . . 0.0 111.214 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -64.26 144.65 56.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.646 1.178 . . . . 0.0 111.129 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.6 t -78.12 -47.14 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 143.46 51.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.286 1.434 . . . . 0.0 108.889 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.5 ptm -139.94 163.0 33.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.037 0.935 . . . . 0.0 109.683 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.55 155.72 32.14 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.592 0.757 . . . . 0.0 110.307 169.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.7 t -82.71 -69.04 0.65 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.48 -52.77 0.36 Allowed 'General case' 0 CA--C 1.523 -0.063 0 C-N-CA 125.454 1.502 . . . . 0.0 108.107 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.7 mt -75.86 127.06 86.24 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.12 146.89 16.53 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.833 3.022 . . . . 0.0 112.722 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.24 117.57 9.44 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.4 mm -81.12 97.52 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.4 mt -89.75 110.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -80.07 81.16 6.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.453 1.101 . . . . 0.0 108.942 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.8 ptm -89.82 176.03 6.99 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.491 1.116 . . . . 0.0 112.114 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.4 m -146.46 142.03 27.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.153 1.381 . . . . 0.0 107.356 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.03 146.77 52.49 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.989 0.516 . . . . 0.0 110.909 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.43 -11.71 54.46 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.554 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -89.84 165.96 13.81 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.534 1.167 . . . . 0.0 110.983 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 95.49 2.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.062 0.945 . . . . 0.0 109.019 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.87 104.55 17.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.218 1.007 . . . . 0.0 108.963 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.85 129.43 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.11 99.58 17.54 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.82 85.14 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.217 2.611 . . . . 0.0 111.425 -167.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.4 48.31 2.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.59 1.156 . . . . 0.0 109.593 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.697 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.0 ptt180 -67.92 157.29 35.31 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.617 0.767 . . . . 0.0 110.902 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.34 147.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.476 1.11 . . . . 0.0 110.896 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.5 p -55.65 -48.42 75.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.594 1.158 . . . . 0.0 111.487 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.6 m -113.29 109.58 51.46 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 124.849 1.26 . . . . 0.0 107.819 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.23 -32.89 11.09 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 124.528 3.485 . . . . 0.0 114.247 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -50.74 -37.56 42.52 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.649 1.58 . . . . 0.0 112.284 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.1 mt -51.68 -51.76 25.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 124.746 1.219 . . . . 0.0 110.453 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 68.23 111.68 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.514 1.525 . . . . 0.0 111.462 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.8 t -89.5 151.69 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.0 109.063 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 m -112.96 121.53 44.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.758 1.223 . . . . 0.0 107.979 172.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.51 98.18 11.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.644 0.777 . . . . 0.0 109.026 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -90.77 174.4 7.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.592 0.757 . . . . 0.0 109.977 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -144.26 145.05 31.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.155 1.382 . . . . 0.0 107.613 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.9 134.2 92.5 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.673 0.789 . . . . 0.0 110.638 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.9 -58.96 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.928 1.01 . . . . 0.0 111.853 0.402 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -140.28 41.94 1.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.567 1.147 . . . . 0.0 110.06 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -79.6 156.85 27.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.7 m -132.76 113.15 12.62 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.662 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.91 86.28 6.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.3 mm -60.49 127.11 86.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 109.604 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 86.14 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.969 2.446 . . . . 0.0 109.955 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -58.18 -25.29 61.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.916 1.286 . . . . 0.0 113.233 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 72.69 33.74 60.27 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.08 -61.33 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.126 1.37 . . . . 0.0 107.973 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -99.67 -53.08 3.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.681 1.193 . . . . 0.0 108.468 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.47 89.06 3.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -96.38 119.23 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -89.0 94.75 10.06 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.441 0.696 . . . . 0.0 109.142 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -89.85 98.68 11.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.697 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 68.1 p -51.96 -27.05 11.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 113.734 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.28 17.72 23.52 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.138 0.975 . . . . 0.0 113.167 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -144.78 -56.45 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.809 0.731 . . . . 0.0 110.894 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.97 -169.61 38.2 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.15 110.6 21.32 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 172.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.1 mt -92.22 94.72 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.561 1.544 . . . . 0.0 108.342 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.28 95.68 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -53.43 -37.13 62.26 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.673 1.189 . . . . 0.0 113.112 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -130.79 96.29 4.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.165 0.986 . . . . 0.0 108.566 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.23 140.86 57.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 111.574 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.8 p -133.06 179.97 5.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.52 1.128 . . . . 0.0 109.42 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -54.49 -30.65 53.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.679 1.192 . . . . 0.0 112.12 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -58.77 -20.63 51.44 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.48 1.112 . . . . 0.0 112.032 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -115.48 37.65 3.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.184 1.394 . . . . 0.0 110.82 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -120.75 100.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.7 -165.0 34.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 57.9 tp -89.29 91.72 8.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.041 0.936 . . . . 0.0 109.285 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.6 152.91 37.59 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.4 m -143.27 105.98 4.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.225 1.01 . . . . 0.0 108.515 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 87.1 m -74.11 132.71 42.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -130.81 142.08 50.37 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.323 1.049 . . . . 0.0 110.205 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.97 115.07 4.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.52 0.728 . . . . 0.0 110.315 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 53.9 m -89.81 124.07 34.34 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 44.8 t -118.74 -101.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.607 0.763 . . . . 0.0 109.448 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -88.29 59.07 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.969 1.308 . . . . 0.0 109.712 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 57.66 38.97 90.28 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -172.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -150.31 124.05 9.19 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.432 1.093 . . . . 0.0 108.492 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 65.5 tp -83.41 116.16 22.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.374 1.07 . . . . 0.0 109.5 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -100.58 151.94 21.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 164.28 35.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.713 0.405 . . . . 0.0 111.176 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.5 t -154.4 139.54 17.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.483 0.713 . . . . 0.0 109.797 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -106.65 147.04 30.02 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.959 1.304 . . . . 0.0 112.836 -168.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -142.78 104.79 4.4 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.13 109.64 18.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.5 p -89.59 94.49 9.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 109.014 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -89.87 128.36 36.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.971 1.709 . . . . 0.0 109.537 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -66.37 109.93 2.9 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -58.99 144.1 46.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.535 1.134 . . . . 0.0 110.44 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 60.2 p -81.4 66.36 6.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.889 0.876 . . . . 0.0 109.393 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -127.72 -53.95 1.33 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.219 1.407 . . . . 0.0 110.165 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.2 t -164.67 -163.5 0.73 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.275 1.43 . . . . 0.0 108.312 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.771 -1.109 . . . . 0.0 109.456 174.542 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 120.771 0.319 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.04 165.35 16.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.647 0.779 . . . . 0.0 111.04 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.9 p -61.34 -42.11 98.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.661 1.184 . . . . 0.0 110.842 171.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -166.56 -111.82 0.25 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -169.56 134.18 1.24 Allowed Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.25 -53.59 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.754 2.303 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.11 144.71 50.19 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.033 0.933 . . . . 0.0 111.736 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.4 46.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.57 -85.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.231 1.412 . . . . 0.0 108.121 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 ttt 71.08 132.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.631 1.972 . . . . 0.0 113.315 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.68 147.39 53.11 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.708 0.803 . . . . 0.0 110.058 173.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -77.96 -57.66 3.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -32.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.245 1.018 . . . . 0.0 111.646 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.79 117.77 69.15 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.12 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 135.59 68.74 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.03 2.487 . . . . 0.0 110.954 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -68.06 133.74 49.48 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.7 mm -82.34 95.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.755 0.822 . . . . 0.0 108.879 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.69 101.96 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -74.36 85.98 1.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.462 1.105 . . . . 0.0 108.951 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 9.6 ptm -89.17 166.86 13.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.629 0.772 . . . . 0.0 111.233 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.9 m -139.35 126.0 20.62 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.37 141.61 58.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.431 0.692 . . . . 0.0 110.342 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.97 -19.61 41.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.864 -0.965 . . . . 0.0 112.785 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -89.99 165.48 14.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.511 1.155 . . . . 0.0 110.749 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.32 96.01 2.76 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 109.197 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.98 109.96 20.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 108.975 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.51 127.15 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.553 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 44.2 mm -104.15 93.12 5.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.56 114.8 3.95 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.729 2.286 . . . . 0.0 109.877 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.7 p -162.42 56.22 0.22 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.816 0.847 . . . . 0.0 109.387 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.524 ' HB2' ' O ' ' A' ' 188' ' ' SER . 37.3 ptt180 -64.36 158.53 23.34 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.49 0.716 . . . . 0.0 110.861 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.73 168.29 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.399 1.08 . . . . 0.0 110.369 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.7 p -53.27 -39.19 63.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.307 1.443 . . . . 0.0 112.407 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 m -159.9 152.67 17.87 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 110.148 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.92 -20.33 51.43 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.559 2.839 . . . . 0.0 112.104 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.99 -28.61 66.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.106 1.362 . . . . 0.0 111.927 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.81 -45.48 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.775 0.83 . . . . 0.0 109.05 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.8 m 66.4 95.25 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.728 1.611 . . . . 0.0 110.861 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.47 144.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.358 1.063 . . . . 0.0 109.356 -173.159 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.0 m -115.75 124.81 51.72 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.643 1.177 . . . . 0.0 108.833 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.3 tp -89.71 100.31 13.14 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.761 0.824 . . . . 0.0 109.434 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.96 170.24 10.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.136 0.974 . . . . 0.0 109.76 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -147.14 148.55 31.69 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -58.89 132.32 86.71 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.633 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -79.26 -59.46 0.11 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.937 1.013 . . . . 0.0 111.741 3.278 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.6 mt -144.09 46.65 1.43 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.541 1.136 . . . . 0.0 109.753 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.75 164.8 25.31 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 m -145.07 100.29 3.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.7 mt -89.67 72.45 7.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.575 1.15 . . . . 0.0 108.439 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.8 mm -56.25 124.63 61.45 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.851 1.26 . . . . 0.0 110.385 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.22 107.34 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.925 3.083 . . . . 0.0 112.682 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.0 -29.89 58.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.307 0.643 . . . . 0.0 110.867 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.95 19.32 51.61 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.341 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -132.17 -58.68 0.95 Allowed 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.63 1.172 . . . . 0.0 108.157 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -78.42 -65.78 0.94 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.17 94.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.4 mt -95.79 117.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -89.17 124.35 34.27 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -127.03 107.98 10.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.567 1.147 . . . . 0.0 108.766 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.524 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.1 p -56.43 -25.49 50.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 0.0 113.304 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -76.0 -23.38 55.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.834 0.853 . . . . 0.0 112.243 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -129.57 -65.84 0.83 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.74 0.816 . . . . 0.0 111.035 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.89 35.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.02 111.98 23.26 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.116 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.9 99.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.218 1.407 . . . . 0.0 107.373 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 16.2 mt -97.69 96.67 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.7 1.2 . . . . 0.0 108.046 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 81.9 p -53.15 -35.47 59.79 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.693 1.197 . . . . 0.0 114.114 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -140.62 88.63 2.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.826 0.851 . . . . 0.0 109.201 -174.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.16 155.73 19.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.927 0.491 . . . . 0.0 112.25 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.6 p -146.32 -176.78 5.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 109.28 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -55.23 -32.63 62.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.573 1.149 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -59.1 -19.34 43.66 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 112.509 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -93.59 -34.66 13.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.253 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.74 120.36 9.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.03 -136.87 5.65 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.4 tp -120.48 87.76 2.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.041 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 57.2 mt -69.28 149.35 48.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.887 0.875 . . . . 0.0 108.946 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 45.2 m -146.38 113.27 6.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 56.9 m -82.03 122.01 27.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -118.07 145.55 44.75 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.95 133.95 10.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.882 0.873 . . . . 0.0 109.869 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 57.2 m -102.12 131.55 48.55 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.731 0.813 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.88 118.6 34.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.4 m120 43.94 59.06 3.32 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.594 1.558 . . . . 0.0 112.058 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.87 -24.96 6.22 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.554 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -89.22 102.7 15.36 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.504 1.152 . . . . 0.0 109.195 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.09 103.74 4.66 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.27 149.28 23.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.31 146.03 51.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.249 1.42 . . . . 0.0 107.947 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 71.0 p -136.84 111.84 8.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -88.24 145.22 25.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.214 1.005 . . . . 0.0 111.138 -172.844 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -146.15 109.4 4.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.548 1.539 . . . . 0.0 108.172 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.81 105.86 15.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 93.9 9.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.169 0.988 . . . . 0.0 109.31 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -91.14 146.38 23.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.652 1.181 . . . . 0.0 107.974 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -71.54 139.17 49.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -68.6 161.86 27.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.117 0.967 . . . . 0.0 109.893 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 39.5 p -52.45 128.83 26.95 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.098 0.959 . . . . 0.0 110.264 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -89.05 64.14 6.97 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.616 0.767 . . . . 0.0 109.164 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 31.5 p -76.24 -61.71 1.86 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.93 1.292 . . . . 0.0 109.611 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.092 -1.432 . . . . 0.0 109.413 179.312 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -158.16 156.91 31.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.738 1.215 . . . . 0.0 109.13 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.7 p -54.73 -56.72 16.24 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.074 1.349 . . . . 0.0 110.203 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.37 64.34 0.02 OUTLIER Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -72.55 123.88 90.08 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 119.022 -0.513 . . . . 0.0 109.78 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.38 -47.34 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.325 2.683 . . . . 0.0 110.29 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -68.16 161.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.018 1.327 . . . . 0.0 112.154 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.8 t -110.55 -58.5 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.68 120.25 29.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.5 ptm -133.72 154.82 50.67 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.816 0.846 . . . . 0.0 109.534 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.29 157.75 28.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.01 0.524 . . . . 0.0 111.177 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -97.09 -136.57 0.26 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -94.24 93.87 8.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.8 mt 127.95 121.22 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 131.025 3.73 . . . . 0.0 107.564 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.64 149.99 17.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.312 3.341 . . . . 0.0 113.343 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.59 116.69 6.45 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -76.64 100.65 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.86 121.38 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.938 0.895 . . . . 0.0 108.923 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -77.22 94.18 4.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 108.518 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.57 151.3 22.0 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.896 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 43.7 m -129.07 124.57 35.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -56.24 -73.46 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.73 55.98 4.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.478 0.561 . . . . 0.0 112.341 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -143.31 -97.61 0.11 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.15 1.38 . . . . 0.0 108.065 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -166.0 152.74 9.61 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.764 1.226 . . . . 0.0 108.626 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.1 tp -143.63 108.31 4.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.964 1.306 . . . . 0.0 108.472 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 131.21 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.08 94.13 28.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.04 80.88 2.88 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.309 2.672 . . . . 0.0 111.428 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.02 54.12 1.04 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.361 1.064 . . . . 0.0 109.171 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -68.86 162.28 26.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.16 0.984 . . . . 0.0 111.48 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.79 170.98 12.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.433 1.093 . . . . 0.0 113.075 -169.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.2 p -77.12 -19.83 56.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.632 1.973 . . . . 0.0 112.572 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 t -156.92 140.54 11.37 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.186 0.903 . . . . 0.0 110.274 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -47.81 -39.67 31.49 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.647 3.565 . . . . 0.0 115.454 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.52 -21.78 62.86 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 52.9 mt -80.57 76.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 49.4 m -67.83 123.23 19.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -89.47 142.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 109.357 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 25.8 m -93.18 106.01 18.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 38.1 tp -89.2 118.58 29.0 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -122.91 -177.91 3.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.094 1.358 . . . . 0.0 109.434 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -152.62 150.3 29.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.77 131.5 78.58 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.996 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.84 -61.09 0.03 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.822 0.972 . . . . 0.0 111.972 5.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -142.34 48.48 1.56 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.858 1.263 . . . . 0.0 109.057 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.84 177.25 6.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.187 0.595 . . . . 0.0 109.942 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.3 m -146.04 104.41 3.83 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.87 81.67 6.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.52 130.84 92.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.13 0.972 . . . . 0.0 109.151 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.64 85.38 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.138 2.559 . . . . 0.0 110.426 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -61.37 -22.1 64.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.166 1.386 . . . . 0.0 113.216 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 74.67 26.1 68.23 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.442 0.565 . . . . 0.0 112.811 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.92 -66.02 0.76 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -79.84 -64.59 1.15 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.2 mt -89.87 91.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.576 1.15 . . . . 0.0 108.047 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.75 116.67 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 108.271 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -89.38 109.07 20.02 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.585 0.754 . . . . 0.0 109.891 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -107.22 108.56 20.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.4 p -63.51 -18.76 64.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -109.7 18.77 19.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.316 1.046 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -149.03 -55.61 0.19 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.715 0.689 . . . . 0.0 110.836 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.23 -170.91 32.78 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.97 113.8 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.91 97.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.28 91.93 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.3 p -70.32 -7.73 44.94 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.912 0.885 . . . . 0.0 113.287 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -150.04 99.97 2.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -81.2 160.8 24.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 44.5 p -142.51 169.84 16.83 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.966 0.906 . . . . 0.0 109.682 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -53.19 -37.33 61.85 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.491 1.116 . . . . 0.0 111.659 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -55.05 -37.89 67.31 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.186 1.394 . . . . 0.0 111.226 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.44 17.53 11.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.92 1.288 . . . . 0.0 112.23 -171.557 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 79.5 mt -86.32 116.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 145.4 -160.01 28.0 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 121.455 0.475 . . . . 0.0 112.869 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.52 86.19 6.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.398 1.079 . . . . 0.0 110.511 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -69.69 144.2 52.91 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.5 m -139.04 107.89 5.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.251 1.02 . . . . 0.0 108.923 -173.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.4 m -81.63 138.4 35.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -134.58 145.57 48.8 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.755 0.822 . . . . 0.0 110.526 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.71 144.63 15.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.137 0.975 . . . . 0.0 109.325 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -120.88 142.75 49.38 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.877 1.271 . . . . 0.0 109.562 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.74 153.3 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 52.99 -99.0 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.318 1.447 . . . . 0.0 110.623 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -149.66 47.38 0.62 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.83 129.54 16.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.421 1.088 . . . . 0.0 109.986 177.531 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.8 tp -81.76 144.87 30.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.555 . . . . 0.0 109.796 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -126.61 154.81 43.45 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.904 1.281 . . . . 0.0 108.204 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -150.44 163.29 38.77 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.071 0.548 . . . . 0.0 110.828 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.4 t -151.29 140.9 21.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.76 0.824 . . . . 0.0 109.487 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -115.09 146.23 41.53 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.995 1.318 . . . . 0.0 112.717 -168.802 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -143.26 105.04 4.35 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.425 1.49 . . . . 0.0 108.554 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.63 103.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.8 p -89.73 95.38 10.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.261 1.024 . . . . 0.0 108.783 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -89.69 141.17 28.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.815 0.446 . . . . 0.0 109.844 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 98.6 2.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.926 1.291 . . . . 0.0 109.872 -173.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.25 107.88 20.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.405 1.082 . . . . 0.0 108.246 177.047 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 39.9 p -61.3 -49.57 76.49 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.525 0.73 . . . . 0.0 110.528 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -150.44 152.16 33.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.48 1.112 . . . . 0.0 108.908 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.5 t -72.09 142.3 49.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.142 0.577 . . . . 0.0 109.533 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 116.922 -1.514 . . . . 0.0 109.884 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.35 -47.52 15.65 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.712 0.805 . . . . 0.0 110.036 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.7 m -155.68 101.13 2.13 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 163.57 71.91 0.02 OUTLIER Glycine 0 C--N 1.336 0.575 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -110.99 129.37 24.04 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.731 1.213 . . . . 0.0 108.135 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.58 -52.76 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.937 2.425 . . . . 0.0 110.766 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -68.38 125.61 27.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.071 0.948 . . . . 0.0 111.323 -173.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.4 t -74.05 -42.4 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -70.77 -79.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.607 0.763 . . . . 0.0 110.253 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 tpt 69.36 137.77 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.59 1.956 . . . . 0.0 112.641 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -147.05 0.19 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.0 110.104 172.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.4 t -134.72 -67.38 0.56 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -145.65 -53.62 0.27 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 125.027 1.331 . . . . 0.0 108.908 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -69.15 130.56 91.14 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.419 1.088 . . . . 0.0 108.285 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.52 139.15 33.82 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.857 2.371 . . . . 0.0 110.18 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -74.81 127.53 33.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -79.81 105.64 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.576 0.75 . . . . 0.0 110.054 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.2 mt -96.83 110.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -76.9 88.35 3.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.7 ptm -89.92 142.04 28.08 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.327 0.651 . . . . 0.0 111.641 -170.258 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 60.6 m -114.56 110.04 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.16 152.36 28.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.754 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.2 -36.57 3.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.258 0.932 . . . . 0.0 110.961 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -89.42 -177.0 5.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.93 0.892 . . . . 0.0 111.457 -171.677 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.68 99.68 9.75 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.699 0.8 . . . . 0.0 109.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 39.3 tp -92.76 104.25 16.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.184 0.994 . . . . 0.0 109.169 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.93 121.56 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.96 104.73 27.28 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 169.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.12 37.5 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.173 2.582 . . . . 0.0 113.443 -161.186 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 28.4 p -87.84 57.74 4.5 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-O 121.429 0.633 . . . . 0.0 110.271 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.919 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -75.94 153.49 36.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.42 1.088 . . . . 0.0 110.291 176.97 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.31 169.92 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.208 1.403 . . . . 0.0 110.3 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.9 p -61.85 -42.33 98.92 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.882 0.873 . . . . 0.0 111.805 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 m -143.93 140.54 17.25 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.935 0.894 . . . . 0.0 109.731 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -28.42 29.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.607 2.872 . . . . 0.0 112.761 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.29 -24.55 65.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.383 0.673 . . . . 0.0 112.282 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -52.18 -40.13 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.878 1.271 . . . . 0.0 110.238 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.5 m 67.58 99.09 0.05 Allowed 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.494 1.518 . . . . 0.0 110.681 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.16 122.62 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.2 m -88.12 107.78 18.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.71 95.23 10.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.796 0.839 . . . . 0.0 109.631 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -89.91 166.74 13.32 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.599 0.759 . . . . 0.0 110.377 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.72 142.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.138 0.975 . . . . 0.0 109.26 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.54 132.83 93.11 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 111.395 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 -59.65 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 119.992 1.033 . . . . 0.0 112.18 3.745 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.5 mt -138.31 36.93 2.29 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.45 152.65 34.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.7 m -131.71 113.27 13.36 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.026 0.93 . . . . 0.0 108.646 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.79 80.61 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.0 128.72 89.66 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.19 0.996 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.28 86.18 1.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.965 2.443 . . . . 0.0 110.358 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.35 -23.17 64.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.939 1.296 . . . . 0.0 112.889 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.9 67.69 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.884 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -135.36 -63.13 0.69 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.949 1.3 . . . . 0.0 108.231 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -85.24 -59.28 2.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.9 mt -89.62 91.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.9 mt -93.58 113.46 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -89.13 123.44 33.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.0 0.52 . . . . 0.0 109.823 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -127.61 114.63 17.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.33 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.919 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 48.0 p -57.13 -29.6 63.7 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.311 0.644 . . . . 0.0 112.51 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -80.6 -29.2 36.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.886 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -114.45 -50.32 2.8 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.891 0.876 . . . . 0.0 111.374 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 150.2 -164.85 29.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.11 105.81 18.03 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -89.14 90.96 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 24.4 mt -82.11 81.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.8 p -46.84 -47.7 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.85 2.06 . . . . 0.0 112.933 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -118.48 92.14 3.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.666 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.91 156.28 31.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.598 0.759 . . . . 0.0 110.758 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 60.4 p -137.96 167.66 21.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.752 1.221 . . . . 0.0 108.829 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -53.26 -30.9 40.87 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.298 1.039 . . . . 0.0 112.257 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -52.69 -36.37 57.11 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.8 -32.71 74.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.473 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.9 mt -53.48 111.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.08 0.952 . . . . 0.0 110.15 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 159.5 -171.7 35.98 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.82 99.2 11.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.164 0.986 . . . . 0.0 109.027 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.23 157.26 30.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.2 m -147.77 99.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.126 1.371 . . . . 0.0 108.042 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 24.6 m -79.15 131.35 36.19 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -124.28 135.32 53.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.165 0.986 . . . . 0.0 109.69 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.98 158.16 36.07 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.484 0.713 . . . . 0.0 110.495 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.9 m -138.0 146.79 43.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.62 1.168 . . . . 0.0 109.617 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.13 -70.69 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.901 1.28 . . . . 0.0 108.468 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -98.0 36.0 1.63 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.949 0.9 . . . . 0.0 111.421 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.05 30.05 74.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.441 0.544 . . . . 0.0 112.154 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -90.01 -43.32 10.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.694 1.198 . . . . 0.0 111.032 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 52.6 tp 66.24 89.29 0.1 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.911 1.684 . . . . 0.0 109.455 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -89.52 154.94 19.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.446 1.098 . . . . 0.0 108.381 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -140.26 159.12 42.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.686 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.9 t -151.84 123.34 7.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -108.85 149.92 28.41 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.606 1.162 . . . . 0.0 111.621 -168.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -142.89 113.67 7.53 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.307 1.043 . . . . 0.0 109.236 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.6 tt -84.5 106.72 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.1 p -89.26 99.48 12.46 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -89.32 138.58 31.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.749 1.62 . . . . 0.0 109.603 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.0 97.08 2.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.072 0.949 . . . . 0.0 109.489 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -94.28 133.17 38.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.092 1.757 . . . . 0.0 108.556 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 35.9 p -68.0 -91.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -150.21 48.01 0.91 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.292 1.037 . . . . 0.0 109.63 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 43.9 p -82.62 -60.48 2.17 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.897 0.479 . . . . 0.0 109.784 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 C--O 1.249 1.055 0 C-N-CA 124.206 1.002 . . . . 0.0 109.071 177.552 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -53.39 -49.84 66.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.851 0.86 . . . . 0.0 109.383 171.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.3 p -77.77 91.44 4.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -40.93 -66.72 0.84 Allowed Glycine 0 C--N 1.342 0.898 0 C-N-CA 125.964 1.745 . . . . 0.0 112.892 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.64 154.03 1.01 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 127.398 2.279 . . . . 0.0 107.107 172.226 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -32.76 10.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.157 1.905 . . . . 0.0 111.118 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -56.74 129.85 42.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.073 1.349 . . . . 0.0 112.045 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.87 -54.93 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.583 0.753 . . . . 0.0 109.214 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.52 148.39 32.22 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.991 0.917 . . . . 0.0 109.348 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 ttp -147.65 135.43 21.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.421 1.089 . . . . 0.0 108.632 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -61.77 137.88 58.28 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.246 0.618 . . . . 0.0 110.035 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.9 p -74.18 -51.1 16.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.62 0.368 . . . . 0.0 110.675 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -155.07 -53.67 0.09 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 109.579 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.6 mm -83.98 119.88 74.07 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.075 0.95 . . . . 0.0 108.791 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.24 139.61 86.32 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.279 2.653 . . . . 0.0 111.225 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.24 136.44 57.18 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -89.22 91.34 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.279 1.032 . . . . 0.0 108.262 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -88.78 108.29 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -73.27 95.84 2.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.805 1.242 . . . . 0.0 109.541 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 19.0 ptm -102.1 162.64 12.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.847 1.259 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 75.2 m -133.16 130.28 38.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -58.94 119.91 8.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.471 0.709 . . . . 0.0 109.176 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 121.2 -33.64 4.28 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.648 1.118 . . . . 0.0 111.719 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -89.0 171.05 10.15 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.967 0.884 . . . . 0.0 110.673 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -71.53 148.4 46.75 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.199 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.5 tp -139.77 106.75 5.43 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.63 128.58 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.39 98.27 13.97 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.79 79.43 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.507 2.804 . . . . 0.0 111.027 -165.797 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.9 p -126.9 42.19 3.37 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.484 1.114 . . . . 0.0 110.344 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -58.02 158.32 6.9 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.152 0.981 . . . . 0.0 110.919 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.33 154.23 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 110.716 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.3 p -61.24 -44.29 97.5 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.751 1.22 . . . . 0.0 110.818 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -104.29 103.49 39.11 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.2 -11.43 32.17 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.718 2.945 . . . . 0.0 113.777 -170.321 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.76 -21.24 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.663 0.785 . . . . 0.0 111.908 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.12 106.46 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.7 m -74.16 117.11 15.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.41 150.87 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.13 0.972 . . . . 0.0 108.575 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 m -103.18 111.45 23.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 108.449 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.8 tp -89.48 101.26 13.94 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -91.62 170.52 9.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.623 0.769 . . . . 0.0 110.22 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -145.99 146.37 30.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.65 1.18 . . . . 0.0 108.556 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.67 133.58 82.58 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.881 0.873 . . . . 0.0 110.772 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.42 -59.57 0.11 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.682 0 CA-C-N 119.816 0.97 . . . . 0.0 111.87 0.911 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -141.46 38.63 1.7 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.755 1.222 . . . . 0.0 109.804 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -77.37 153.99 33.19 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 43.7 m -125.12 111.58 15.48 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.927 0.891 . . . . 0.0 109.147 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.7 mp -89.98 82.62 6.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.09 129.03 90.22 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.01 0.924 . . . . 0.0 109.175 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -72.8 85.51 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.138 2.558 . . . . 0.0 110.319 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.96 -22.36 64.37 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.015 1.326 . . . . 0.0 113.327 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 69.34 44.75 63.82 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -150.07 -67.09 0.2 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -90.7 -55.08 3.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.5 mt -93.23 89.7 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -98.13 121.09 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.119 0.968 . . . . 0.0 108.503 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -89.08 93.87 9.74 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -89.79 96.91 10.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.6 p -61.73 -13.63 24.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -101.26 4.8 42.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 112.079 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -140.32 -58.7 0.54 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.848 0.859 . . . . 0.0 110.668 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.6 -169.42 37.85 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.738 1.161 . . . . 0.0 110.336 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -89.09 110.86 21.53 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.68 94.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.75 1.22 . . . . 0.0 107.834 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.89 95.73 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.1 p -60.67 -28.87 68.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.155 0.982 . . . . 0.0 113.511 -170.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.41 89.94 2.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.02 119.35 9.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.224 0.61 . . . . 0.0 110.043 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 39.3 p -89.94 171.67 9.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.349 0.66 . . . . 0.0 109.255 174.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.95 -33.2 62.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.63 0.772 . . . . 0.0 111.493 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -59.57 -32.4 70.32 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.38 1.072 . . . . 0.0 111.932 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.22 -8.96 58.19 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.968 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -71.79 107.86 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.985 1.266 . . . . 0.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 158.39 -160.83 31.26 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.5 98.58 11.72 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.372 1.069 . . . . 0.0 109.917 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.36 154.04 25.46 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.31 0.644 . . . . 0.0 109.332 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 54.9 m -146.71 106.29 3.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.096 0.958 . . . . 0.0 109.409 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.88 140.09 43.58 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -135.71 138.69 42.99 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.161 0.985 . . . . 0.0 110.288 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.71 140.37 18.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.98 0.912 . . . . 0.0 109.976 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 55.9 m -122.52 92.65 3.76 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.661 1.184 . . . . 0.0 108.863 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.33 -62.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.101 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -92.11 174.13 7.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.47 1.108 . . . . 0.0 109.497 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.92 2.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -148.32 -44.73 0.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.388 1.075 . . . . 0.0 110.981 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.2 tp 70.63 128.91 0.03 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 126.796 2.038 . . . . 0.0 110.158 -170.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.02 147.31 50.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.655 1.182 . . . . 0.0 107.927 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -150.59 158.76 44.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.87 0.468 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 49.6 p -136.6 132.12 34.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.935 0.894 . . . . 0.0 108.824 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -111.62 144.71 40.43 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.681 1.192 . . . . 0.0 110.782 -169.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -146.47 117.54 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.441 1.096 . . . . 0.0 109.023 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.01 107.57 19.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -89.33 98.99 12.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -89.14 126.4 35.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.228 1.411 . . . . 0.0 109.249 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -69.8 103.56 2.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -67.91 143.33 55.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.419 0.688 . . . . 0.0 111.753 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 67.2 p -72.8 -36.34 67.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.998 0.919 . . . . 0.0 110.836 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -147.04 164.15 33.96 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.765 1.226 . . . . 0.0 109.619 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t -124.59 46.32 2.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.704 1.202 . . . . 0.0 110.565 -173.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 20.4 tt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.991 -1.48 . . . . 0.0 110.383 -179.502 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 121.086 0.469 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.55 -70.0 0.27 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.69 0.796 . . . . 0.0 109.821 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.8 m -86.27 59.07 5.42 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.1 -127.64 0.93 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -77.89 117.36 65.36 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.83 -50.45 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.093 2.529 . . . . 0.0 111.474 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -76.7 146.41 38.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.817 0.847 . . . . 0.0 112.476 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.64 55.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -166.36 -71.66 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.8 tpt 69.76 157.07 0.15 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 111.349 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.97 172.14 13.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.0 0.92 . . . . 0.0 109.32 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.8 t -145.02 -66.28 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.304 0.641 . . . . 0.0 110.383 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -95.08 -64.35 1.07 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.47 0.708 . . . . 0.0 112.624 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.76 113.42 64.93 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.388 1.075 . . . . 0.0 110.195 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.83 142.69 96.36 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.317 2.678 . . . . 0.0 111.122 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -73.05 128.24 34.91 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.6 85.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.306 0.642 . . . . 0.0 109.378 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 mt -92.55 80.25 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -60.55 135.62 57.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.43 175.63 11.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.604 0.761 . . . . 0.0 111.196 -171.895 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -146.97 142.8 27.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.536 1.534 . . . . 0.0 108.162 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 150.63 44.72 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.119 0.567 . . . . 0.0 111.24 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.8 -34.41 4.07 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.557 0.599 . . . . 0.0 112.042 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -88.98 157.02 18.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.248 1.019 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.92 136.0 54.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.084 0.554 . . . . 0.0 110.469 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.5 tp -122.6 114.27 20.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.576 1.55 . . . . 0.0 107.847 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.49 127.58 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.7 mm -106.26 100.08 27.33 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 171.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.67 62.3 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.554 2.836 . . . . 0.0 111.492 -169.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -104.11 51.49 0.78 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.029 0.932 . . . . 0.0 109.305 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -66.26 161.75 21.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 m -127.62 166.51 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 0.0 111.709 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 p -65.34 -36.58 84.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.067 1.347 . . . . 0.0 112.035 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 51.3 m -145.42 146.22 29.14 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.453 0.701 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.79 -42.86 24.39 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.65 3.566 . . . . 0.0 115.004 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -59.12 -20.26 52.01 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.028 0.931 . . . . 0.0 113.245 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 23.1 mm -77.71 74.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 27.7 m -70.19 120.1 15.38 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.243 0.617 . . . . 0.0 109.812 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.72 147.16 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.102 0.961 . . . . 0.0 109.641 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.8 m -106.17 113.31 26.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.22 121.66 31.74 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -126.22 173.65 9.11 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -138.82 149.24 44.72 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.949 0.899 . . . . 0.0 108.785 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -58.16 133.39 84.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.637 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.5 -59.85 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.72 0 CA-C-N 119.943 1.015 . . . . 0.0 112.197 3.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -142.01 40.27 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.305 1.042 . . . . 0.0 110.391 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.48 149.56 40.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.2 m -132.53 110.19 10.31 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.62 85.19 5.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.805 1.242 . . . . 0.0 108.26 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.39 127.6 93.39 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.54 104.6 1.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.876 2.384 . . . . 0.0 110.722 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.29 -31.48 71.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.637 0.775 . . . . 0.0 111.991 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.11 17.91 45.23 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.611 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -133.23 -58.99 0.89 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.599 1.16 . . . . 0.0 108.516 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.6 tpp85 -78.03 -66.04 0.9 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.52 92.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 68.8 mt -92.07 114.68 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -88.92 93.26 9.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -89.84 103.06 15.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.9 p -54.74 -29.16 52.98 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -108.32 24.98 12.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.135 0.974 . . . . 0.0 111.902 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -146.63 -58.57 0.29 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.162 0.585 . . . . 0.0 110.673 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.9 -172.25 37.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.92 0.772 . . . . 0.0 111.172 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -89.27 109.23 20.14 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.4 96.0 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.986 1.314 . . . . 0.0 107.616 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.98 101.21 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 80.3 p -57.09 -36.15 70.26 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -139.36 99.14 3.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.43 163.82 10.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.554 0.741 . . . . 0.0 112.027 -173.747 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.8 p -131.01 155.21 47.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.027 0.931 . . . . 0.0 109.709 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -56.51 -30.27 62.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.238 1.015 . . . . 0.0 111.777 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.04 -24.14 51.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.687 1.195 . . . . 0.0 112.441 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -86.04 -9.29 57.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.226 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.23 105.86 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.228 0.922 . . . . 0.0 108.63 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.94 -163.22 34.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.85 89.72 8.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.015 0.926 . . . . 0.0 109.481 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 45.1 mt -69.1 147.4 51.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 102.79 3.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.885 1.274 . . . . 0.0 108.318 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 75.0 m -80.7 138.91 36.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -134.69 142.23 46.75 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.184 0.993 . . . . 0.0 110.145 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.97 126.36 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.134 0.973 . . . . 0.0 109.25 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 85.5 m -103.19 134.21 46.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.657 1.183 . . . . 0.0 109.158 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.72 -78.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.392 0.677 . . . . 0.0 109.968 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.84 49.4 1.77 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.681 0.792 . . . . 0.0 110.965 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.96 38.46 60.35 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -170.289 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -150.06 121.02 7.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.178 1.391 . . . . 0.0 107.657 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.0 tt -77.56 111.2 13.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -92.05 154.09 18.98 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -151.47 162.99 39.98 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.827 0.451 . . . . 0.0 112.147 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.0 t -148.13 135.6 20.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.916 0.886 . . . . 0.0 108.782 169.64 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.71 152.47 34.22 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.195 0.998 . . . . 0.0 111.952 -169.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -145.0 118.49 9.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.149 1.379 . . . . 0.0 109.005 -173.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.08 111.48 22.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.0 p -89.87 103.3 15.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.21 0.604 . . . . 0.0 109.65 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -89.38 134.12 34.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.131 0.973 . . . . 0.0 109.203 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -74.64 96.93 3.08 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -68.88 -47.95 64.6 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.877 0.308 . . . . 0.0 110.559 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 53.9 p -144.46 177.64 8.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.215 1.406 . . . . 0.0 108.818 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -131.61 63.3 1.61 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 61.4 p -112.59 170.75 7.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.847 1.659 . . . . 0.0 109.533 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.887 -1.53 . . . . 0.0 110.667 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 119.521 -0.276 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -74.17 -59.99 2.47 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.7 t -117.8 -18.56 9.55 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.784 1.633 . . . . 0.0 110.378 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.42 -84.63 0.74 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 -83.6 125.62 73.19 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -73.35 -46.68 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.058 2.505 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -69.61 152.15 45.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 111.948 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.57 -50.57 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -79.15 -82.22 0.1 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.128 0.971 . . . . 0.0 110.532 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.8 ttt 66.83 139.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.553 1.941 . . . . 0.0 112.032 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -146.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.741 1.216 . . . . 0.0 110.588 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 p -129.79 -69.07 0.69 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 108.072 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 -38.31 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.447 1.499 . . . . 0.0 109.989 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.08 125.95 92.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -69.66 129.4 17.64 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.804 2.336 . . . . 0.0 109.636 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.94 123.63 20.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.334 0.654 . . . . 0.0 111.011 -169.333 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.22 117.11 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.755 1.222 . . . . 0.0 108.953 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.01 133.67 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.57 1.148 . . . . 0.0 109.204 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -84.3 147.96 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.804 1.242 . . . . 0.0 109.043 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -150.1 167.18 27.56 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.329 0.652 . . . . 0.0 111.619 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.1 m -140.25 113.64 8.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -52.11 136.51 29.57 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.52 0.728 . . . . 0.0 110.62 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.47 -38.64 3.02 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.499 1.047 . . . . 0.0 110.948 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -89.5 166.36 13.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.632 0.773 . . . . 0.0 110.546 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.88 144.75 52.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.366 0.666 . . . . 0.0 109.914 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 51.0 tp -134.86 152.9 52.13 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.175 1.39 . . . . 0.0 107.768 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.79 135.52 63.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.052 0.941 . . . . 0.0 108.483 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.4 mm -109.14 97.19 24.17 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.47 68.84 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.55 2.833 . . . . 0.0 112.525 -163.436 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -116.2 55.14 0.81 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.656 1.182 . . . . 0.0 109.795 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.622 ' HB2' ' O ' ' A' ' 188' ' ' SER . 25.6 ptt-85 -69.0 161.45 28.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.256 1.422 . . . . 0.0 111.023 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.36 165.19 17.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.856 1.262 . . . . 0.0 112.393 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 38.2 p -73.02 -27.51 61.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.807 1.643 . . . . 0.0 112.473 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -142.21 136.19 14.72 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.945 0.898 . . . . 0.0 109.161 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 -25.96 50.61 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.389 2.726 . . . . 0.0 113.297 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -62.55 -23.03 66.77 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.349 0.522 . . . . 0.0 112.154 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.1 mt -80.14 78.82 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.7 m -66.55 121.33 15.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.7 t -89.27 145.24 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.7 m -103.75 122.65 45.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.28 132.17 35.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -130.98 175.34 9.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.695 1.198 . . . . 0.0 109.3 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -151.52 147.98 27.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.053 0.941 . . . . 0.0 109.295 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.91 135.74 87.28 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 110.15 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.91 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.902 1.001 . . . . 0.0 112.007 1.888 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.2 mt -140.56 41.74 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.451 1.101 . . . . 0.0 109.979 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -82.67 139.65 33.58 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 84.8 m -116.93 112.01 20.43 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.45 72.14 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.876 1.27 . . . . 0.0 109.111 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.7 mm -56.34 126.69 69.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.792 0.837 . . . . 0.0 109.609 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.7 103.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.995 3.13 . . . . 0.0 112.684 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.84 -19.47 57.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.752 0.821 . . . . 0.0 111.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.13 -5.27 83.63 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.626 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -105.26 -63.88 1.19 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.564 1.182 . . . . 0.0 107.901 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -79.26 -64.91 1.08 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.836 0.854 . . . . 0.0 108.725 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.33 97.57 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 89.9 mt -99.64 117.6 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -88.95 121.5 31.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -124.35 112.39 16.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.135 1.374 . . . . 0.0 107.878 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.622 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 28.9 p -59.31 -25.95 64.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 113.502 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -111.39 27.5 9.62 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.134 0.973 . . . . 0.0 111.93 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -149.14 -53.33 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.927 0.491 . . . . 0.0 110.266 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 145.88 -159.77 28.0 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.24 110.82 21.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.07 98.6 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.4 mm -83.05 82.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 69.7 p -55.15 -33.28 62.81 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.286 1.035 . . . . 0.0 113.47 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 89.42 2.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.86 158.43 16.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.984 0.514 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.6 p -136.12 161.27 36.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.733 0.813 . . . . 0.0 109.879 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -57.11 -32.78 66.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.889 0.875 . . . . 0.0 111.398 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.42 -34.39 70.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.358 1.063 . . . . 0.0 111.44 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.97 13.49 10.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.326 1.05 . . . . 0.0 112.484 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -85.14 121.8 37.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.71 -159.44 25.4 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.288 0.471 . . . . 0.0 112.794 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.89 91.45 6.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.596 1.158 . . . . 0.0 110.743 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.96 160.31 30.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.668 0.787 . . . . 0.0 109.475 170.037 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.1 m -147.81 102.04 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.717 1.207 . . . . 0.0 109.087 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.6 m -75.28 139.35 42.45 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -138.37 139.02 38.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.601 0.761 . . . . 0.0 111.187 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.52 152.83 27.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.796 1.239 . . . . 0.0 109.822 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.2 m -135.71 107.99 7.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.98 -64.18 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -150.06 114.13 5.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.363 1.065 . . . . 0.0 108.58 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 81.86 -59.69 4.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.78 0.705 . . . . 0.0 113.143 170.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.03 135.62 33.45 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.298 0.639 . . . . 0.0 110.694 -169.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.55 105.5 11.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -89.52 135.09 33.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -150.73 160.39 43.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.538 0.335 . . . . 0.0 110.824 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.8 t -152.86 130.59 11.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.477 0.711 . . . . 0.0 109.97 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -104.57 150.99 24.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.673 1.189 . . . . 0.0 112.066 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -140.18 113.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.525 1.13 . . . . 0.0 108.812 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -82.99 101.63 11.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.5 p -89.17 92.58 9.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -89.8 165.79 13.94 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.792 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 -70.69 -82.46 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.369 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -175.12 -165.91 0.2 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 34.9 p -70.31 94.47 0.93 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -88.72 66.14 7.96 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.5 t -74.99 168.51 19.83 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.006 0.922 . . . . 0.0 110.804 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.8 pt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.246 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.5 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -72.87 80.86 1.17 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.431 1.092 . . . . 0.0 109.424 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -127.8 -85.99 0.58 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.356 1.462 . . . . 0.0 108.982 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.88 -63.93 3.74 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.156 0.884 . . . . 0.0 110.976 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -159.51 152.6 18.36 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.644 1.178 . . . . 0.0 108.693 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.67 -51.58 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.422 2.748 . . . . 0.0 111.63 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -71.54 119.65 16.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 111.574 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.01 -53.22 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 126.24 54.83 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.124 1.37 . . . . 0.0 107.832 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.1 ptm -128.49 170.3 13.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.963 1.305 . . . . 0.0 109.685 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.56 147.41 52.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.018 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 m -90.6 -136.44 0.13 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.96 104.14 16.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.4 mm 108.64 127.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 130.742 3.617 . . . . 0.0 107.924 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.68 137.65 15.46 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.236 3.291 . . . . 0.0 113.066 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.27 126.7 30.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -80.78 100.0 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.17 105.83 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -83.41 76.61 9.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.373 1.469 . . . . 0.0 109.231 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.33 171.85 9.46 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.107 0.563 . . . . 0.0 111.041 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.9 m -143.46 116.82 9.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.58 164.94 10.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 94.21 -41.06 2.64 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.2 mtp-105 -88.88 -179.57 5.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.774 1.629 . . . . 0.0 109.674 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.75 137.38 45.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.34 103.93 11.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.22 125.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 mm -101.08 100.73 13.84 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -83.79 48.99 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 112.846 -161.901 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -91.59 57.61 3.32 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.84 0.856 . . . . 0.0 110.378 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -56.73 143.2 37.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.118 0.967 . . . . 0.0 111.126 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.59 165.94 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.817 1.247 . . . . 0.0 110.591 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.376 1.07 . . . . 0.0 112.508 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.2 m -155.5 146.7 16.64 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.644 0.777 . . . . 0.0 110.299 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.5 -30.63 28.8 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.724 2.949 . . . . 0.0 111.855 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -56.36 -27.32 55.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.101 1.36 . . . . 0.0 112.497 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.4 -35.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.135 1.374 . . . . 0.0 110.861 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m 67.59 88.52 0.11 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.314 1.446 . . . . 0.0 110.028 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.45 132.56 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 108.835 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 m -102.31 119.11 38.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.327 1.051 . . . . 0.0 108.721 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.4 tp -89.49 101.52 14.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -89.48 165.23 14.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.056 0.942 . . . . 0.0 109.905 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -147.8 146.39 29.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.31 1.044 . . . . 0.0 108.928 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.81 134.91 89.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.605 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.91 -58.69 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 119.854 0.984 . . . . 0.0 111.819 0.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.1 mt -139.89 38.94 1.98 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.794 1.238 . . . . 0.0 109.824 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -80.76 160.29 24.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -137.85 114.41 10.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.876 0.87 . . . . 0.0 109.034 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 mp -89.9 83.98 6.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.73 121.76 75.14 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.65 120.65 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.309 2.673 . . . . 0.0 112.735 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -81.25 -15.43 55.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.475 0.71 . . . . 0.0 111.565 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 66.76 29.98 75.54 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.057 0.837 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -139.94 -67.55 0.43 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.575 1.15 . . . . 0.0 108.169 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.7 ttp-105 -79.16 -56.16 4.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 mt -89.57 90.08 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.432 1.493 . . . . 0.0 106.998 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 67.8 mt -90.83 113.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -89.01 93.2 9.52 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.41 99.48 12.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.3 p -57.82 -26.82 62.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -76.87 -19.29 57.64 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.122 0.969 . . . . 0.0 112.423 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -125.83 -64.59 1.05 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.063 0.945 . . . . 0.0 110.752 -173.867 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 170.56 -173.36 44.41 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 117.9 0.318 . . . . 0.0 112.332 -173.79 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -89.36 107.55 19.13 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.2 mt -89.82 94.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 31.0 mt -81.96 85.87 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.317 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.9 p -52.15 -35.75 49.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.41 1.484 . . . . 0.0 114.3 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -123.44 91.87 3.57 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.003 0.921 . . . . 0.0 108.878 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.63 40.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.325 0.65 . . . . 0.0 110.242 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 77.9 p -138.66 172.34 13.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.66 1.184 . . . . 0.0 109.273 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -59.17 -26.84 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.648 0.779 . . . . 0.0 112.016 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -53.73 -43.92 69.47 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.402 0.681 . . . . 0.0 110.74 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -68.76 -8.37 42.47 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.0 131.15 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 143.15 -108.31 0.51 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 45.4 tp -157.14 111.34 2.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.0 109.413 -170.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -101.44 150.51 22.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.227 1.011 . . . . 0.0 109.089 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 98.2 m -142.86 116.52 9.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.102 0.961 . . . . 0.0 109.143 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 30.5 m -81.91 142.49 32.42 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -129.96 142.72 50.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.511 1.124 . . . . 0.0 109.984 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.265 1.026 . . . . 0.0 110.104 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.0 m -142.03 132.64 25.42 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.5 t -135.49 -76.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.971 0.908 . . . . 0.0 108.856 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -85.35 51.18 2.11 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.805 0.842 . . . . 0.0 110.774 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.8 -31.53 1.48 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.664 0.649 . . . . 0.0 113.511 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -88.62 142.69 27.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.782 1.233 . . . . 0.0 109.98 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.7 tp -80.02 106.16 11.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -89.02 146.6 24.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 157.32 42.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.471 0.708 . . . . 0.0 110.045 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 t -147.0 129.72 16.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.434 0.694 . . . . 0.0 109.753 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -102.56 141.01 36.08 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.64 1.576 . . . . 0.0 112.487 -169.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -140.34 100.6 3.93 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.076 1.351 . . . . 0.0 108.893 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.5 110.48 16.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.517 1.127 . . . . 0.0 108.639 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.6 p -89.59 89.02 7.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.801 0.84 . . . . 0.0 109.762 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -95.03 89.44 5.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -55.17 133.0 48.86 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.979 0.512 . . . . 0.0 110.335 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -167.09 171.57 10.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.842 0.857 . . . . 0.0 110.399 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 45.5 p -135.02 38.42 2.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.887 1.275 . . . . 0.0 108.626 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.41 48.44 0.89 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.258 1.023 . . . . 0.0 110.448 -173.12 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.6 t -62.82 -38.88 92.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.296 0.639 . . . . 0.0 110.921 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.7 pt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.949 176.082 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.5 89.33 2.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.723 0.409 . . . . 0.0 110.023 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.6 m -77.64 66.77 3.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.14 140.05 3.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.403 1.001 . . . . 0.0 110.766 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -62.35 132.04 93.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.89 -50.63 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.534 2.156 . . . . 0.0 111.211 -170.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -77.33 159.93 29.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.992 0.917 . . . . 0.0 111.449 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.16 -61.41 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.05 123.88 32.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 23.4 ttt -144.51 145.44 31.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.508 0.723 . . . . 0.0 110.208 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -152.74 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.655 1.182 . . . . 0.0 110.622 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.1 t -131.43 -64.82 0.79 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.005 0.922 . . . . 0.0 108.924 170.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.71 -36.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.579 0.752 . . . . 0.0 111.579 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.4 mt -81.36 116.59 63.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.03 136.15 71.32 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.007 2.471 . . . . 0.0 111.743 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.39 124.43 24.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.352 0.661 . . . . 0.0 109.948 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.9 126.56 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.4 mt -130.08 137.56 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.512 1.125 . . . . 0.0 108.131 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -89.3 102.07 14.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.332 1.053 . . . . 0.0 108.772 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -89.31 176.42 6.94 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 m -147.82 130.4 15.89 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.67 141.38 55.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.969 0.908 . . . . 0.0 110.157 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.82 -42.94 2.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.231 0.443 . . . . 0.0 112.156 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -89.85 -179.28 5.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.814 0.845 . . . . 0.0 112.049 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -66.19 149.73 49.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.1 tp -148.03 112.37 5.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.266 1.026 . . . . 0.0 108.716 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.92 132.11 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.4 mm -108.23 96.4 18.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.92 46.51 1.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.261 2.641 . . . . 0.0 113.714 -163.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 26.0 p -89.81 59.77 4.74 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.501 0.72 . . . . 0.0 109.138 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -71.2 156.79 39.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.689 0.796 . . . . 0.0 110.884 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.53 167.7 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.905 1.282 . . . . 0.0 111.664 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.6 p -63.33 -33.77 76.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.006 1.322 . . . . 0.0 111.695 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.7 m -157.68 151.14 18.97 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 124.376 1.071 . . . . 0.0 109.733 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.54 -31.66 87.53 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.389 2.726 . . . . 0.0 111.64 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.25 -32.26 16.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.768 1.627 . . . . 0.0 112.559 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.4 mm -51.72 -41.95 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.56 1.144 . . . . 0.0 111.043 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.0 m 63.15 91.01 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.207 1.403 . . . . 0.0 111.168 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.45 133.13 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 109.483 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.9 m -98.45 114.29 26.6 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 tp -89.46 106.85 18.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -94.42 158.13 15.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 110.213 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -129.18 136.95 50.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.732 1.613 . . . . 0.0 106.677 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -55.92 126.7 66.77 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.32 -170.07 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -77.47 -62.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.616 0 CA-C-N 119.733 0.94 . . . . 0.0 112.851 6.3 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.1 mt -143.79 37.81 1.32 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.172 0.989 . . . . 0.0 110.244 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.23 126.84 31.73 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.7 m -89.82 115.59 27.27 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.325 0.65 . . . . 0.0 110.157 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.67 86.7 6.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.02 130.35 94.46 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.208 1.003 . . . . 0.0 109.101 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.8 81.95 1.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.209 2.606 . . . . 0.0 110.002 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.63 -18.65 62.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.036 1.334 . . . . 0.0 113.137 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.23 26.48 70.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.602 0.62 . . . . 0.0 112.679 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -140.27 -63.66 0.48 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.758 1.223 . . . . 0.0 108.53 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -88.45 -57.36 2.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.713 1.205 . . . . 0.0 107.951 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.5 mt -89.97 93.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.8 mt -93.5 112.19 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -89.08 95.37 10.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.168 0.587 . . . . 0.0 109.691 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.97 97.55 11.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.6 p -50.53 -37.47 39.44 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -97.27 21.2 10.32 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 112.504 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -147.46 -57.69 0.25 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.978 0.808 . . . . 0.0 111.317 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 161.5 -177.05 37.95 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.046 0.831 . . . . 0.0 111.187 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.13 110.19 20.96 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.12 93.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 50.2 mt -83.09 100.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.8 p -63.94 -39.38 94.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.037 0.535 . . . . 0.0 112.286 -172.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -118.97 90.59 3.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.524 1.13 . . . . 0.0 108.693 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.86 124.15 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 67.3 p -91.83 166.77 12.58 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.0 110.94 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -57.39 -34.1 68.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.251 1.02 . . . . 0.0 111.804 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -56.14 -33.94 65.65 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.418 1.087 . . . . 0.0 111.477 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.75 -2.85 31.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.031 0.932 . . . . 0.0 112.651 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.06 87.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 163.39 -163.1 35.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.1 tp -86.95 117.12 25.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 110.795 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 95.5 mt -99.93 150.26 22.58 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.503 1.521 . . . . 0.0 109.114 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 51.3 m -146.7 103.33 3.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.746 1.218 . . . . 0.0 108.867 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 48.6 m -74.97 143.93 43.42 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.91 140.0 43.74 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.063 0.945 . . . . 0.0 109.611 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.36 114.82 6.32 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.652 0.781 . . . . 0.0 110.52 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.7 m -89.94 125.76 35.49 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.809 1.244 . . . . 0.0 109.481 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.17 -71.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.154 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -145.7 94.26 2.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.02 -53.56 4.76 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.558 0.599 . . . . 0.0 111.762 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 145.25 25.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.303 1.041 . . . . 0.0 109.25 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.3 156.02 28.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.717 0.77 . . . . 0.0 111.433 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -124.75 154.83 40.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.582 1.953 . . . . 0.0 106.027 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -136.86 158.57 44.15 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.05 0.386 . . . . 0.0 111.4 -175.242 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.7 m -144.13 109.89 5.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -106.67 151.9 24.49 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.404 0.682 . . . . 0.0 111.171 -170.261 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -142.39 127.51 18.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.317 1.047 . . . . 0.0 109.008 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.0 tt -87.09 97.17 10.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.8 p -89.0 88.76 7.71 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.38 154.36 20.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 7.3 ptm85 -63.2 -36.46 83.71 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.266 0.485 . . . . 0.0 111.185 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -176.96 168.8 2.45 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.072 1.349 . . . . 0.0 108.5 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 47.1 p -70.66 176.91 3.81 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.546 0.738 . . . . 0.0 109.279 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -88.36 83.41 6.88 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 24.0 p -61.42 -52.08 66.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.235 1.014 . . . . 0.0 109.862 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.852 -1.547 . . . . 0.0 110.027 -175.236 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 33.2 t . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.41 -49.99 73.27 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.027 0.931 . . . . 0.0 110.528 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.9 t -152.41 -0.76 0.28 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.482 0.713 . . . . 0.0 112.919 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.47 -156.28 32.23 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -73.97 123.01 88.91 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -73.81 -39.99 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.779 2.319 . . . . 0.0 110.135 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -59.63 135.94 57.83 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.081 0.952 . . . . 0.0 110.898 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.25 -43.78 97.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.55 148.05 31.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.133 1.373 . . . . 0.0 108.176 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ptm -127.57 165.13 20.52 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.538 1.135 . . . . 0.0 110.546 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 152.09 26.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.423 0.689 . . . . 0.0 110.106 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.1 t -80.26 -69.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -143.56 -53.97 0.37 Allowed 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.937 1.295 . . . . 0.0 108.659 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 88.8 mt -72.87 127.93 88.86 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -67.65 119.89 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.558 2.172 . . . . 0.0 108.893 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.8 116.84 2.74 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.118 0.967 . . . . 0.0 109.701 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.7 mt -78.49 102.24 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.15 68.66 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -59.2 128.32 36.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.14 169.1 18.82 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.754 0.311 . . . . 0.0 111.732 -170.552 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 m -112.55 138.48 49.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 107.994 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.91 165.83 12.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.166 0.587 . . . . 0.0 111.587 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.24 -43.14 3.21 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.957 0.789 . . . . 0.0 111.998 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -89.18 174.78 7.67 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.407 1.083 . . . . 0.0 110.823 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.91 160.33 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.143 -174.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 49.4 tp -148.9 111.97 4.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.627 1.171 . . . . 0.0 108.608 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.02 125.11 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -104.81 102.54 35.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.13 61.01 6.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.603 2.868 . . . . 0.0 111.591 -167.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 31.8 p -105.16 50.09 0.79 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.906 0.882 . . . . 0.0 109.327 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.99 153.92 42.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.008 1.323 . . . . 0.0 110.507 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 m -116.06 160.37 15.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 124.407 1.083 . . . . 0.0 111.277 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.3 p -70.15 -57.45 4.92 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.616 1.167 . . . . 0.0 109.744 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.4 p -100.07 111.73 62.72 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.83 -12.84 33.58 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.615 2.877 . . . . 0.0 113.389 -168.557 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -69.05 -22.85 64.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.082 0.401 . . . . 0.0 111.266 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 32.6 mt -78.35 83.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -66.3 127.37 31.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.353 1.061 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 70.2 t -89.59 146.64 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.053 0.941 . . . . 0.0 109.243 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 m -106.93 111.36 23.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.773 1.229 . . . . 0.0 108.153 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.8 tp -89.37 98.07 11.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -89.75 169.84 10.94 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.957 0.903 . . . . 0.0 109.52 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -148.63 145.83 27.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.634 0.774 . . . . 0.0 109.194 169.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.77 133.76 78.76 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.653 172.033 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.16 -59.89 0.1 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 119.978 1.028 . . . . 0.0 112.057 2.206 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.5 mt -144.23 39.22 1.31 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 110.034 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -81.93 152.13 26.92 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.1 m -130.72 108.53 9.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.739 1.216 . . . . 0.0 108.309 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.74 82.65 6.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.008 0.923 . . . . 0.0 108.573 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 129.14 93.79 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.48 90.15 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.882 2.388 . . . . 0.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -59.52 -24.21 63.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.311 1.444 . . . . 0.0 113.173 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 75.61 28.54 61.13 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.427 0.537 . . . . 0.0 112.819 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.55 -58.4 0.68 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.897 1.279 . . . . 0.0 108.385 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -85.1 -55.14 4.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.197 1.399 . . . . 0.0 108.567 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.8 100.1 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 125.048 1.339 . . . . 0.0 108.134 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.13 118.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -89.15 94.36 9.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.78 100.91 13.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.7 p -56.45 -26.93 55.35 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -114.59 32.16 6.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.285 1.434 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -150.09 -58.35 0.19 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.301 0.64 . . . . 0.0 110.378 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 155.68 -171.13 33.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.691 1.138 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -89.4 106.4 18.42 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.35 90.89 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 52.1 mt -79.48 95.14 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.1 p -61.66 -25.76 67.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.9 90.02 2.55 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.788 0.835 . . . . 0.0 108.958 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.7 128.32 35.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.435 1.094 . . . . 0.0 111.265 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 54.0 p -147.89 179.52 7.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.976 1.31 . . . . 0.0 109.45 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -39.18 -35.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.91 2.084 . . . . 0.0 113.691 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -42.87 -44.43 4.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.517 1.927 . . . . 0.0 112.361 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -103.33 -10.09 18.95 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 113.847 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.87 111.82 7.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.415 1.007 . . . . 0.0 109.709 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 151.23 -162.15 29.39 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.9 tp -81.77 90.31 6.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.29 146.96 54.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.829 0.852 . . . . 0.0 108.971 172.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 48.8 m -143.39 99.25 3.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.48 1.112 . . . . 0.0 108.169 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.53 132.18 43.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -126.57 141.62 51.8 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.262 1.025 . . . . 0.0 109.826 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.31 106.5 3.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.014 0.926 . . . . 0.0 109.708 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.1 m -91.2 107.17 19.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.307 1.043 . . . . 0.0 108.609 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -79.69 -61.65 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -130.23 -114.98 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.39 -17.27 78.86 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.43 107.42 19.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.001 0.92 . . . . 0.0 110.275 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.69 101.13 12.48 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -89.43 152.28 21.57 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -150.36 162.64 40.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.489 0.315 . . . . 0.0 111.411 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.0 t -146.0 135.28 22.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.997 0.919 . . . . 0.0 109.319 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -112.55 149.79 32.22 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.579 1.152 . . . . 0.0 111.989 -168.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -146.04 133.55 20.85 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.643 1.177 . . . . 0.0 109.191 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -102.79 105.68 16.14 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 105.58 17.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.26 134.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.652 1.181 . . . . 0.0 108.666 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -73.25 80.34 1.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.584 1.154 . . . . 0.0 109.529 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -87.03 70.41 10.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.619 1.168 . . . . 0.0 109.186 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 41.7 p -90.83 53.5 2.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 170.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -89.78 65.03 6.66 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.049 0.94 . . . . 0.0 108.591 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.9 p -85.65 62.29 7.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.163 0.985 . . . . 0.0 108.669 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.818 -175.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.873 -0.047 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.51 -41.36 94.19 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.87 1.268 . . . . 0.0 110.476 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.2 p -65.67 -46.16 80.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.476 1.11 . . . . 0.0 111.207 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.8 -140.42 9.41 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.107 0.86 . . . . 0.0 111.342 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -84.94 132.9 44.43 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.76 1.224 . . . . 0.0 108.351 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -169.65 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.598 2.865 . . . . 0.0 110.905 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 75.88 103.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 126.045 1.738 . . . . 0.0 111.782 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.12 -48.78 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.521 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -105.55 111.28 23.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.8 ptm -120.28 156.35 31.42 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.074 0.95 . . . . 0.0 110.113 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -179.54 2.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.72 0.808 . . . . 0.0 110.82 174.407 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 m -142.98 -154.77 0.54 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.98 92.46 0.72 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.6 mt 114.43 117.43 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 131.485 3.914 . . . . 0.0 107.122 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.44 142.0 24.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.212 3.275 . . . . 0.0 113.366 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.94 110.57 3.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mt -74.03 133.01 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.8 115.7 43.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.47 86.9 4.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.026 0.93 . . . . 0.0 109.385 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 18.8 ptm -89.61 158.9 17.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.193 0.997 . . . . 0.0 111.148 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.5 m -124.57 108.23 11.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -63.48 152.1 39.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 111.023 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 97.94 -34.52 5.14 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -89.47 177.23 6.62 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -74.78 135.37 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.44 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.01 109.64 11.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.755 1.222 . . . . 0.0 109.192 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.6 t -89.94 122.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -93.17 108.45 33.02 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.39 84.03 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.414 2.742 . . . . 0.0 110.381 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.9 p -140.45 45.88 1.82 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.777 0.831 . . . . 0.0 109.801 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.661 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.6 ptt180 -69.03 157.8 36.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.98 175.55 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.706 1.603 . . . . 0.0 109.459 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.0 p -73.33 -71.94 0.28 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.406 0.682 . . . . 0.0 110.413 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -99.66 151.21 37.38 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.501 1.121 . . . . 0.0 110.639 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.98 -30.24 39.58 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.871 2.381 . . . . 0.0 110.794 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -50.76 -30.57 14.37 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.2 1.8 . . . . 0.0 112.827 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 mm -50.27 -41.31 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.825 1.25 . . . . 0.0 111.047 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 61.07 80.98 0.2 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.08 1.352 . . . . 0.0 110.686 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.55 138.99 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.9 m -118.74 129.29 55.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.087 1.355 . . . . 0.0 107.951 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.47 100.89 13.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -89.39 168.88 11.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.749 1.22 . . . . 0.0 109.949 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -143.96 137.69 27.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.526 1.53 . . . . 0.0 107.865 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -60.58 134.32 91.68 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 118.631 -0.7 . . . . 0.0 110.556 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.4 -59.72 0.11 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 119.901 1.0 . . . . 0.0 112.01 -0.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.07 40.51 1.79 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.589 1.156 . . . . 0.0 110.164 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.56 167.42 14.61 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.8 m -146.78 133.27 19.73 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.627 0.371 . . . . 0.0 110.723 -173.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.24 87.5 3.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.527 1.531 . . . . 0.0 107.089 175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mm -61.85 129.37 91.62 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.963 0.905 . . . . 0.0 109.544 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.29 79.83 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.261 2.641 . . . . 0.0 110.382 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.61 -25.72 67.52 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 113.318 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.43 43.22 54.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -150.09 -57.79 0.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.746 1.218 . . . . 0.0 108.317 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -95.95 -49.87 5.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.383 1.473 . . . . 0.0 107.914 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.4 mt -103.0 93.52 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 124.43 1.092 . . . . 0.0 108.424 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.8 119.71 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -90.0 100.6 13.39 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.152 0.581 . . . . 0.0 109.496 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -95.79 108.17 20.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 172.006 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.661 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 53.3 p -55.67 -35.12 65.64 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.362 0.665 . . . . 0.0 112.392 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -101.29 21.53 13.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.935 0.894 . . . . 0.0 112.661 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -145.9 -55.88 0.29 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.658 0.663 . . . . 0.0 111.51 171.249 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 159.19 -172.98 35.97 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -89.61 112.63 23.92 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.54 97.05 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.472 1.109 . . . . 0.0 108.599 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.71 98.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.4 p -59.02 -35.21 72.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.541 1.136 . . . . 0.0 113.303 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -130.32 81.73 2.02 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.527 1.131 . . . . 0.0 108.337 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 156.77 24.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.381 0.672 . . . . 0.0 111.734 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 70.3 p -145.66 -178.4 6.08 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.21 1.404 . . . . 0.0 109.06 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -54.74 -32.54 59.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.127 0.971 . . . . 0.0 112.376 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -31.45 55.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.494 0.718 . . . . 0.0 111.872 176.162 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -81.7 -40.62 22.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.519 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.11 119.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 118.467 0.576 . . . . 0.0 109.668 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.34 -160.51 20.72 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.352 0.977 . . . . 0.0 111.178 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 41.1 tp -79.26 84.36 5.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.142 0.977 . . . . 0.0 111.142 -172.366 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 43.5 mt -75.61 153.83 37.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.267 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.4 m -148.88 115.35 5.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.15 125.92 30.84 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -128.19 148.18 50.6 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.68 0.792 . . . . 0.0 110.517 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.29 133.1 10.36 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.265 0.626 . . . . 0.0 110.857 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.6 m -89.66 114.65 26.31 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.17 141.52 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 64.78 -76.93 0.04 OUTLIER 'General case' 0 C--N 1.343 0.287 0 C-N-CA 126.304 1.842 . . . . 0.0 110.269 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -171.8 44.45 0.18 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -150.05 127.69 11.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.572 1.149 . . . . 0.0 108.741 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.2 tp -81.03 102.54 10.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.123 0.969 . . . . 0.0 108.829 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -89.23 153.39 20.95 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -140.3 153.38 46.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.474 1.11 . . . . 0.0 109.953 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.7 t -149.35 122.81 9.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.365 0.666 . . . . 0.0 109.348 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -98.27 148.23 23.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.169 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.65 103.49 4.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.297 1.439 . . . . 0.0 108.56 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.29 94.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.2 p -88.39 99.08 11.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -89.47 172.1 9.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.596 1.158 . . . . 0.0 109.706 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -67.17 -88.04 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 109.585 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -159.66 168.28 26.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.045 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 41.2 p -79.27 54.07 1.61 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.433 1.493 . . . . 0.0 110.82 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -147.3 -48.1 0.18 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.878 2.071 . . . . 0.0 107.048 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 32.1 m -61.1 -60.04 4.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 C--O 1.25 1.131 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 169.1 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.05 74.59 9.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.534 1.134 . . . . 0.0 109.576 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 t -59.7 157.1 12.53 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.298 1.439 . . . . 0.0 111.59 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.82 -39.31 97.28 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.676 0.655 . . . . 0.0 111.68 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -145.63 134.18 10.9 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.93 -62.24 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.662 2.241 . . . . 0.0 110.549 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -75.14 130.22 38.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.18 0.992 . . . . 0.0 112.327 -173.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.11 -59.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.21 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -91.74 123.84 35.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ptm -152.03 166.23 32.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.834 0.854 . . . . 0.0 110.282 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -170.75 0.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.305 1.042 . . . . 0.0 110.971 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.8 t -123.08 -68.85 0.86 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.42 -52.81 0.72 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.01 1.324 . . . . 0.0 109.063 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.1 mm -72.78 130.54 85.22 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.26 149.76 64.18 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.594 2.196 . . . . 0.0 109.989 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.73 121.29 15.11 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.8 110.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.907 0.883 . . . . 0.0 108.755 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.37 93.52 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -74.72 81.77 2.07 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.24 1.016 . . . . 0.0 109.237 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 170.53 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.61 0.764 . . . . 0.0 111.89 -169.752 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -121.61 118.41 29.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.818 1.247 . . . . 0.0 108.165 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.1 149.79 22.74 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.97 -34.0 3.46 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.718 0.675 . . . . 0.0 112.079 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -89.82 176.11 6.96 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.857 0.863 . . . . 0.0 110.854 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.213 0.605 . . . . 0.0 111.706 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.6 tp -140.69 105.14 4.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.297 1.439 . . . . 0.0 107.718 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.2 t -89.85 132.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -108.99 94.61 15.15 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -84.66 66.33 6.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.319 2.68 . . . . 0.0 111.741 -166.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.6 p -100.83 58.73 0.92 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.125 0.97 . . . . 0.0 108.756 171.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -69.95 155.69 40.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.623 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 169.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.574 1.149 . . . . 0.0 111.953 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 p -67.89 -65.69 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.044 1.338 . . . . 0.0 110.072 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -111.97 149.98 41.69 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.647 1.179 . . . . 0.0 110.398 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.86 -27.62 43.5 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.516 2.81 . . . . 0.0 112.889 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.06 -16.69 60.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.9 mm -77.27 83.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 55.8 m -73.34 113.3 10.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.9 t -89.41 142.59 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.772 0.829 . . . . 0.0 109.256 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -98.97 111.8 24.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.26 100.32 13.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.75 168.43 12.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.32 0.648 . . . . 0.0 110.382 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -143.96 145.63 32.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.979 1.312 . . . . 0.0 108.342 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -58.19 134.25 84.5 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.007 0.923 . . . . 0.0 110.772 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.37 -59.13 0.13 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.784 0.959 . . . . 0.0 111.745 0.071 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -140.89 38.89 1.8 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.741 1.217 . . . . 0.0 109.859 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -79.19 158.85 27.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.4 m -131.44 126.02 34.02 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.76 0.824 . . . . 0.0 109.232 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.83 99.56 10.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.171 1.388 . . . . 0.0 107.533 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.32 128.81 93.09 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.39 85.3 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.892 2.395 . . . . 0.0 109.825 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.84 -22.31 62.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.171 1.388 . . . . 0.0 113.246 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 76.84 26.29 62.91 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.575 -0.569 . . . . 0.0 112.679 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.38 -63.77 0.58 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.827 1.251 . . . . 0.0 108.365 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -85.44 -60.09 2.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 27.4 mt -89.81 93.37 4.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.6 mt -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -88.95 96.36 10.69 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.33 105.13 17.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.7 p -51.68 -51.26 57.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.082 0.953 . . . . 0.0 112.9 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -95.07 28.97 2.57 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.825 . . . . 0.0 112.382 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -144.95 -60.39 0.36 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.765 0.826 . . . . 0.0 110.987 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 158.45 -176.09 35.45 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -89.36 107.52 19.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 mt -89.32 95.44 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.14 87.69 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.4 p -56.39 -31.55 63.96 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.713 1.205 . . . . 0.0 113.702 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -139.74 86.97 2.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.8 162.12 9.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.81 0.844 . . . . 0.0 111.43 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.6 p -126.8 153.16 45.97 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 0.0 108.801 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -53.62 -32.62 52.03 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.01 0.924 . . . . 0.0 111.829 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -55.74 -36.23 67.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.524 1.129 . . . . 0.0 111.82 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.44 -0.37 29.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.125 0.97 . . . . 0.0 112.938 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.0 mt -72.64 121.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 162.28 -116.51 0.72 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.77 107.32 4.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.056 0.942 . . . . 0.0 109.164 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.1 152.24 20.69 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.1 m -142.33 109.79 5.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.138 0.975 . . . . 0.0 108.389 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 77.6 m -76.78 136.38 38.99 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -130.7 142.63 50.43 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.392 1.077 . . . . 0.0 110.185 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.25 39.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.428 1.091 . . . . 0.0 109.516 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.5 m -142.19 127.25 18.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.02 -76.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 0.0 109.233 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.37 52.52 2.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.98 44.44 56.23 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.216 0.913 . . . . 0.0 111.669 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -150.09 128.78 12.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.539 1.136 . . . . 0.0 108.35 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.29 104.31 9.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -89.61 139.05 30.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -150.78 166.1 31.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.866 0.303 . . . . 0.0 111.442 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.57 137.47 14.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.917 0.887 . . . . 0.0 109.779 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -105.86 143.26 34.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.227 1.411 . . . . 0.0 112.75 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.97 103.55 4.66 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.586 1.555 . . . . 0.0 108.571 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.61 109.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 p -89.27 97.7 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -89.36 160.42 16.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.787 1.235 . . . . 0.0 108.695 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -80.12 -116.71 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -174.21 -169.42 0.46 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.839 1.256 . . . . 0.0 108.324 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.4 p -74.8 78.09 2.09 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 169.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -88.77 79.08 7.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.758 0.79 . . . . 0.0 109.143 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.2 p -53.23 -45.23 68.61 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.611 1.164 . . . . 0.0 110.739 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.251 1.144 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 169.783 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.04 -52.26 66.52 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.657 0.783 . . . . 0.0 109.719 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.5 m -85.3 61.85 7.12 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.67 -92.76 0.6 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -171.03 133.77 0.93 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.06 -47.23 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.913 2.408 . . . . 0.0 110.633 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.6 143.45 53.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 111.995 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -79.25 -52.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -109.58 122.77 48.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.577 1.551 . . . . 0.0 108.842 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.4 ptm -122.3 157.6 31.38 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.146 0.978 . . . . 0.0 109.736 170.744 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -71.24 162.77 28.88 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.849 0.46 . . . . 0.0 110.717 173.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -92.62 -136.66 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -97.26 106.52 18.86 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 25.4 mm 119.73 122.3 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 131.688 3.995 . . . . 0.0 107.332 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -44.81 139.29 7.77 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.668 3.579 . . . . 0.0 114.101 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.45 119.2 10.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.225 0.61 . . . . 0.0 110.213 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.77 103.34 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.201 1.4 . . . . 0.0 108.861 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.0 mt -108.89 123.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.205 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -81.47 91.98 6.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.02 1.328 . . . . 0.0 108.726 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 13.9 ptm -89.3 168.34 12.33 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 111.803 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 m -136.67 142.58 43.18 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.23 1.412 . . . . 0.0 108.637 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.64 148.63 51.64 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.941 0.897 . . . . 0.0 110.85 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.34 -41.58 2.93 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.564 0.602 . . . . 0.0 113.228 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -88.64 -179.05 5.95 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.437 0.695 . . . . 0.0 110.586 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.2 156.22 39.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.5 tp -150.01 111.41 4.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.59 134.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -109.67 93.32 13.99 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 170.804 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.63 77.72 3.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.452 2.768 . . . . 0.0 112.163 -166.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.3 p -124.6 46.84 2.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.449 1.5 . . . . 0.0 109.814 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.462 ' HB2' ' O ' ' A' ' 188' ' ' SER . 29.4 ptt-85 -63.01 158.45 19.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.873 0.869 . . . . 0.0 111.006 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.2 m -114.31 155.22 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 124.427 1.091 . . . . 0.0 111.51 -174.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 p -57.68 -61.31 2.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.115 1.366 . . . . 0.0 109.873 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.8 t -98.56 120.33 59.39 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.291 1.037 . . . . 0.0 108.957 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.76 -32.69 6.31 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 125.08 3.853 . . . . 0.0 114.912 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -57.97 -27.96 63.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.591 1.156 . . . . 0.0 112.657 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.6 94.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 33.2 m -71.28 118.12 13.67 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.2 t -89.61 147.9 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.063 0.945 . . . . 0.0 109.18 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.3 m -101.75 111.24 23.43 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.379 1.072 . . . . 0.0 108.229 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.33 102.63 15.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -89.92 168.29 12.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.73 0.812 . . . . 0.0 110.183 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -146.61 146.25 30.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.75 1.22 . . . . 0.0 108.214 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 134.65 85.14 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.915 0.886 . . . . 0.0 110.777 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.33 -59.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.685 0 CA-C-N 119.737 0.942 . . . . 0.0 111.857 0.556 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.05 38.82 1.77 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 109.715 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -78.23 155.14 30.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 61.9 m -127.63 113.71 16.42 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.05 0.94 . . . . 0.0 109.101 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.78 87.57 7.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.9 133.92 95.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.169 0.988 . . . . 0.0 108.836 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.89 83.75 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.39 2.726 . . . . 0.0 110.779 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -69.61 -18.05 63.58 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 113.069 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.7 31.8 73.68 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -133.59 -71.86 0.51 Allowed 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -82.94 -56.2 3.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.5 mm -89.31 84.41 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.7 114.08 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -89.07 94.81 10.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.229 0.611 . . . . 0.0 109.74 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -89.84 95.81 10.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.462 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 77.7 p -58.46 -21.39 51.27 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -108.66 24.89 12.41 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.677 1.191 . . . . 0.0 111.856 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -147.03 -57.56 0.26 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.453 0.701 . . . . 0.0 110.264 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.21 -168.95 35.97 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.227 1.394 . . . . 0.0 109.878 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.0 114.36 25.54 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.15 96.95 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 21.8 mm -75.87 80.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.7 p -56.92 -35.33 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.829 1.252 . . . . 0.0 113.292 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -118.96 88.24 2.89 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.503 1.121 . . . . 0.0 108.675 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.64 144.52 52.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.24 0.616 . . . . 0.0 110.419 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 75.3 p -138.35 167.48 21.78 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.324 1.05 . . . . 0.0 110.602 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -61.38 -36.65 80.83 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.244 1.017 . . . . 0.0 111.45 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -52.65 -41.86 64.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.814 0.846 . . . . 0.0 110.697 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.68 0.62 29.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 112.828 -174.669 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.0 mt -73.89 109.79 6.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 161.6 -162.57 34.03 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 117.953 0.342 . . . . 0.0 112.263 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -92.68 103.0 15.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.914 1.285 . . . . 0.0 110.164 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.01 155.44 19.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.766 0.827 . . . . 0.0 108.827 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 38.7 m -149.74 114.01 5.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.278 0.631 . . . . 0.0 109.891 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 57.0 m -80.86 138.7 36.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -131.55 137.4 48.45 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.512 1.125 . . . . 0.0 109.399 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.41 151.39 28.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.8 0.84 . . . . 0.0 109.46 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.4 m -129.98 139.37 51.07 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.436 1.094 . . . . 0.0 108.949 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t -132.03 136.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.45 -85.34 0.02 OUTLIER 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -157.99 46.84 0.46 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -143.14 116.85 9.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.974 1.31 . . . . 0.0 107.83 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.9 tp -77.79 143.8 37.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.89 0.876 . . . . 0.0 109.31 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -132.51 150.13 52.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.25 1.42 . . . . 0.0 108.059 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -141.74 157.48 44.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.23 1.012 . . . . 0.0 110.137 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.7 t -155.53 130.98 9.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.022 0.529 . . . . 0.0 110.131 169.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -109.42 143.41 39.04 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.499 1.519 . . . . 0.0 111.968 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -141.25 109.11 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 108.95 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.5 tt -90.19 101.9 14.62 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -89.75 91.33 8.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.156 0.983 . . . . 0.0 108.355 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -93.11 150.79 20.27 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -61.48 147.72 44.29 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.534 0.606 . . . . 0.0 109.808 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -63.78 -166.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.915 0.886 . . . . 0.0 112.745 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 43.3 p -69.41 79.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.371 1.068 . . . . 0.0 110.192 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -89.21 77.69 7.45 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.9 p -82.05 59.38 4.36 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.889 1.275 . . . . 0.0 110.362 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.68 -179.066 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.647 0.26 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -157.2 148.32 21.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.923 0.889 . . . . 0.0 109.138 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t -64.95 -24.12 67.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.948 0.899 . . . . 0.0 112.483 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.52 -62.53 3.62 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -167.11 157.45 10.06 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.582 0.753 . . . . 0.0 110.489 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.12 -48.05 0.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.531 2.821 . . . . 0.0 112.032 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -68.12 140.84 56.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.443 0.697 . . . . 0.0 111.947 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -89.63 -53.84 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -75.64 -81.79 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.436 1.094 . . . . 0.0 110.454 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . 0.259 26.5 ptm 51.49 172.35 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.99 2.516 . . . . 0.0 115.314 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.0 -146.32 0.05 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.902 1.681 . . . . 0.0 110.016 174.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.5 p -131.93 -81.14 0.51 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -128.68 -51.03 1.25 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.619 1.568 . . . . 0.0 108.175 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.26 129.58 79.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.16 135.32 45.1 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.709 2.939 . . . . 0.0 112.391 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.37 128.96 37.99 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.43 127.36 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.5 mt -123.59 133.41 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -96.81 84.16 3.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.457 1.503 . . . . 0.0 107.487 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 8.2 ptm -89.03 164.35 15.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.892 0.377 . . . . 0.0 111.185 -172.843 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -149.46 131.88 15.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.82 155.53 33.69 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.089 0.555 . . . . 0.0 110.706 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.01 -42.73 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -89.05 173.38 8.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.914 1.286 . . . . 0.0 110.94 -172.173 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.49 137.43 44.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.995 0.918 . . . . 0.0 110.269 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.3 tp -127.71 106.95 9.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.479 1.512 . . . . 0.0 107.742 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.2 t -90.56 132.34 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.01 97.52 25.29 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.85 82.16 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.642 2.894 . . . . 0.0 111.667 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.1 p -127.34 55.35 1.6 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.083 1.353 . . . . 0.0 109.206 174.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -65.95 155.45 36.47 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 111.038 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.07 177.43 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.357 1.463 . . . . 0.0 108.53 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -78.88 -29.7 44.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.161 0.984 . . . . 0.0 111.959 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.6 m -149.13 146.41 21.27 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.382 0.673 . . . . 0.0 110.127 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.38 -31.99 33.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.569 2.846 . . . . 0.0 112.743 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -58.56 -26.56 63.71 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.593 0.757 . . . . 0.0 112.359 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.5 mm -54.61 -40.34 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.704 1.201 . . . . 0.0 110.605 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.7 m 61.96 91.2 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.986 1.314 . . . . 0.0 111.431 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.6 t -88.95 143.4 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 91.6 m -104.99 122.43 45.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.2 tp -89.18 125.37 35.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -125.4 -176.4 3.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.079 0.952 . . . . 0.0 109.9 174.098 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -143.65 143.87 31.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.36 1.864 . . . . 0.0 107.205 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.55 128.03 67.53 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 123.548 0.739 . . . . 0.0 111.23 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.35 -61.77 0.04 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.877 0.992 . . . . 0.0 112.101 1.294 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.73 39.99 1.4 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.579 1.152 . . . . 0.0 110.275 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -77.98 122.6 25.75 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.8 m -89.73 114.32 25.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.002 0.521 . . . . 0.0 111.001 -169.543 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 mp -90.01 87.06 6.76 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.774 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.47 129.79 93.86 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.78 88.45 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.14 2.56 . . . . 0.0 110.148 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.7 -23.6 67.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.588 1.155 . . . . 0.0 113.071 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.56 20.2 60.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.566 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.76 -60.48 0.83 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.527 1.131 . . . . 0.0 108.174 173.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -78.68 -68.08 0.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.7 mt -89.47 91.93 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 95.0 mt -93.13 118.51 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -88.98 96.33 10.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -89.87 101.78 14.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 77.6 p -52.7 -37.81 59.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.915 0.886 . . . . 0.0 113.215 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -99.0 25.83 6.36 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.984 0.914 . . . . 0.0 112.182 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -150.39 -56.69 0.17 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.513 0.597 . . . . 0.0 111.382 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.44 -173.45 34.9 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -89.42 114.78 26.29 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.1 mt -94.66 94.1 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.95 88.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 79.9 p -57.56 -38.19 74.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.196 1.399 . . . . 0.0 112.453 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -119.55 88.88 3.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.236 1.015 . . . . 0.0 108.517 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.97 146.19 55.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.749 0.419 . . . . 0.0 110.517 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 81.1 p -137.66 173.0 12.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 109.142 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -51.63 -31.27 24.67 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.266 1.427 . . . . 0.0 112.258 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -52.07 -35.94 49.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 112.374 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -87.8 -5.42 58.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.055 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.6 mt -72.15 116.06 13.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 120.251 1.387 . . . . 0.0 108.347 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.15 -104.51 0.26 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.824 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.5 tp -152.3 96.72 2.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.917 0.887 . . . . 0.0 109.183 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.4 155.98 23.19 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.171 0.589 . . . . 0.0 109.565 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 30.4 m -146.67 106.26 3.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.753 1.221 . . . . 0.0 109.156 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 47.7 m -78.45 143.16 36.95 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -136.29 135.17 38.72 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.507 1.123 . . . . 0.0 109.899 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.62 164.05 37.75 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.359 1.064 . . . . 0.0 110.327 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.7 m -146.07 135.93 23.43 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.878 0.871 . . . . 0.0 108.736 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.9 -78.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.223 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -88.23 49.91 1.88 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.703 -170.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.28 -24.55 1.71 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.614 0.626 . . . . 0.0 113.45 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -88.91 132.99 34.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.732 1.213 . . . . 0.0 109.585 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.5 tp -76.43 107.82 8.96 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.45 143.05 27.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.21 161.38 42.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.711 0.405 . . . . 0.0 110.529 174.028 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.8 t -153.84 133.85 13.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.568 0.747 . . . . 0.0 109.37 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -110.36 151.93 26.85 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.844 1.258 . . . . 0.0 112.793 -168.889 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.55 104.41 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.435 1.494 . . . . 0.0 108.861 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.3 tt -78.23 99.4 6.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.115 0.966 . . . . 0.0 108.635 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.1 p -90.09 90.84 8.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.413 1.485 . . . . 0.0 109.606 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -89.95 155.06 19.38 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -74.46 127.52 33.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -68.53 -35.81 77.96 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.668 1.187 . . . . 0.0 111.437 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.6 p -45.21 -37.62 4.71 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.763 1.625 . . . . 0.0 111.52 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -134.34 74.45 1.54 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.964 0.905 . . . . 0.0 109.077 169.528 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 53.3 m -54.9 110.49 0.67 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.953 1.301 . . . . 0.0 109.077 170.346 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.76 -1.591 . . . . 0.0 111.464 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.8 t . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -63.3 -36.15 82.71 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.988 0.915 . . . . 0.0 110.103 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.2 p -95.95 52.28 1.3 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.51 68.83 3.46 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -65.76 143.56 98.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 122.411 0.284 . . . . 0.0 110.624 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.23 -40.91 1.45 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.103 2.535 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -68.44 118.46 11.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.217 1.007 . . . . 0.0 112.069 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.13 -58.4 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -93.14 134.48 35.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.3 ptm -159.96 170.38 21.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.208 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -153.26 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.748 1.619 . . . . 0.0 110.722 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.7 t -133.11 -69.02 0.57 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.71 -56.25 0.57 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 124.919 1.288 . . . . 0.0 108.671 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.77 132.2 94.8 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.29 129.11 20.76 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.525 2.15 . . . . 0.0 109.503 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.1 117.55 6.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.579 0.752 . . . . 0.0 110.697 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mm -72.75 110.6 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.789 1.236 . . . . 0.0 108.634 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 mt -118.14 113.1 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 124.551 1.14 . . . . 0.0 108.559 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 136.41 42.96 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.71 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -144.83 157.81 44.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.923 0.489 . . . . 0.0 111.154 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.5 m -105.03 114.62 28.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.83 140.14 56.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.071 0.549 . . . . 0.0 110.232 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 101.4 -35.03 5.18 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.356 0.979 . . . . 0.0 111.202 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -89.63 -177.81 5.38 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.741 0.817 . . . . 0.0 111.446 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.16 148.0 50.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.4 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.0 tp -145.24 106.82 4.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.427 1.091 . . . . 0.0 108.744 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.7 t -94.41 120.53 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.592 1.157 . . . . 0.0 107.887 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.7 mm -89.95 109.79 35.31 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.0 72.54 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.437 2.758 . . . . 0.0 111.081 -168.133 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 20.3 p -126.02 50.96 1.81 Allowed 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 124.63 1.172 . . . . 0.0 109.563 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.367 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.9 174.22 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.7 1.6 . . . . 0.0 109.331 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -74.99 -29.01 60.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.536 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -148.29 144.28 18.53 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.624 0.647 . . . . 0.0 111.607 -169.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.1 -39.75 26.09 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.501 3.467 . . . . 0.0 113.535 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -49.34 -37.22 23.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.455 1.502 . . . . 0.0 112.083 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.1 mt -77.97 87.63 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.8 m -78.09 110.6 13.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.46 150.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.375 1.07 . . . . 0.0 108.28 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.9 m -110.46 124.68 52.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.186 0.994 . . . . 0.0 108.646 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 tp -89.4 101.13 13.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.55 169.05 11.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.013 0.925 . . . . 0.0 109.892 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.49 145.58 31.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 108.118 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -57.36 134.27 81.5 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.586 0.754 . . . . 0.0 110.872 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.27 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.707 0 CA-C-N 119.819 0.971 . . . . 0.0 111.716 -0.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.3 39.27 1.74 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.721 1.208 . . . . 0.0 109.996 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -79.66 161.35 25.89 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 171.19 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -138.44 120.63 15.76 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.368 0.667 . . . . 0.0 110.027 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.4 mp -92.18 81.05 5.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.9 mm -60.94 120.4 53.56 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.421 1.088 . . . . 0.0 109.655 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.79 119.49 6.78 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.149 2.566 . . . . 0.0 111.958 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -84.68 -16.17 42.78 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.632 0.773 . . . . 0.0 111.621 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.81 39.8 89.76 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -150.28 -66.91 0.2 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.711 0.804 . . . . 0.0 109.004 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.7 -54.95 3.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.652 1.181 . . . . 0.0 107.852 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 54.4 mt -95.52 91.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.11 120.31 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -88.93 94.62 10.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -89.43 99.44 12.44 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.8 p -51.04 -41.29 59.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -97.88 24.7 6.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.218 1.007 . . . . 0.0 112.292 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -145.81 -57.08 0.31 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.454 0.701 . . . . 0.0 110.94 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.54 -173.6 37.12 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.02 110.06 20.81 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.3 mt -91.4 93.15 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.078 1.351 . . . . 0.0 108.125 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.31 100.82 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.6 p -61.89 -32.15 72.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.733 0.813 . . . . 0.0 112.608 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.03 95.16 4.5 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.589 1.156 . . . . 0.0 108.915 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.8 138.88 44.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.154 0.581 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 72.8 p -142.84 -178.56 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.902 1.281 . . . . 0.0 109.357 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -45.66 -40.77 9.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.21 1.404 . . . . 0.0 112.109 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -51.99 -32.08 32.22 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.314 1.446 . . . . 0.0 112.472 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -90.16 -38.23 13.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.286 1.034 . . . . 0.0 110.786 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.2 mt -65.95 106.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.324 0.65 . . . . 0.0 109.864 -171.546 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.28 29.07 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 47.4 tp -83.32 87.82 6.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.472 1.109 . . . . 0.0 109.659 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 89.7 mt -76.73 154.71 33.86 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.02 0.928 . . . . 0.0 109.148 172.012 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -148.97 112.11 4.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.331 0.652 . . . . 0.0 109.585 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 66.5 m -78.44 132.92 37.5 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.422 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -131.21 143.38 50.54 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.994 0.918 . . . . 0.0 110.962 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.76 172.92 17.36 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.034 1.334 . . . . 0.0 109.524 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 75.1 m -144.42 139.54 28.44 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.087 0.955 . . . . 0.0 108.874 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.63 -75.53 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.78 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.94 46.92 1.24 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.844 0.858 . . . . 0.0 111.546 -170.019 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.77 41.03 50.12 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -170.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -149.27 120.59 7.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.326 1.45 . . . . 0.0 107.376 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.74 111.49 7.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -90.16 143.36 26.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -150.43 161.73 41.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.577 0.351 . . . . 0.0 110.631 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 t -153.02 132.01 12.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.757 0.823 . . . . 0.0 109.153 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -105.84 144.66 32.26 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.975 1.31 . . . . 0.0 111.552 -169.445 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -139.29 113.19 8.6 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.081 1.352 . . . . 0.0 109.038 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -88.87 99.16 12.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.0 p -89.57 106.81 18.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -112.39 179.61 3.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.224 1.41 . . . . 0.0 110.557 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -64.19 172.42 2.46 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.846 0.858 . . . . 0.0 112.111 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -133.61 74.04 1.54 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.796 0.838 . . . . 0.0 109.223 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.1 p -83.06 62.07 6.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.96 0.904 . . . . 0.0 108.814 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -89.42 -55.24 3.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.138 0.975 . . . . 0.0 109.563 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.7 t -71.38 159.47 34.5 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.002 0.521 . . . . 0.0 110.235 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.174 -1.393 . . . . 0.0 108.526 179.483 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 120.293 0.092 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.74 -34.09 70.99 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.58 0.752 . . . . 0.0 110.876 172.433 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 p -59.54 118.01 5.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.496 1.118 . . . . 0.0 109.249 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.19 42.99 97.74 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.158 0.885 . . . . 0.0 111.919 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -97.91 113.08 63.26 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.164 0.986 . . . . 0.0 108.84 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -82.05 -175.86 2.73 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.72 2.947 . . . . 0.0 110.319 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 73.88 103.11 0.07 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.555 1.942 . . . . 0.0 111.948 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.22 -52.54 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -96.26 78.18 3.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.024 0.93 . . . . 0.0 108.728 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ttt -80.94 139.91 35.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -172.78 0.3 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.363 1.065 . . . . 0.0 112.076 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.4 t -148.48 -162.37 1.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 108.891 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.7 95.94 0.69 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.633 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 32.4 mm 116.6 120.08 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 1 C-N-CA 132.131 4.172 . . . . 0.0 107.332 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.15 139.59 32.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.346 2.697 . . . . 0.0 110.113 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -65.78 130.08 42.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.267 0.627 . . . . 0.0 111.273 -177.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -72.52 138.03 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.396 1.078 . . . . 0.0 109.82 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.8 mt -128.45 127.87 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.017 1.327 . . . . 0.0 107.873 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -90.9 125.05 35.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -150.31 176.6 10.74 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.498 0.719 . . . . 0.0 110.367 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.3 m -150.08 143.05 24.86 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 170.737 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.77 141.56 55.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.483 0.313 . . . . 0.0 110.16 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.5 -35.75 4.81 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.11 0.862 . . . . 0.0 111.69 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.76 169.78 11.34 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.708 0.754 . . . . 0.0 110.586 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.49 147.73 37.63 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.247 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.22 108.88 4.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -171.123 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.75 130.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -106.87 97.27 16.96 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.59 77.3 4.11 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.068 2.512 . . . . 0.0 111.134 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -115.46 53.66 0.83 Allowed 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.918 1.287 . . . . 0.0 109.183 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -66.47 148.39 51.95 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.273 0.629 . . . . 0.0 110.738 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.08 175.58 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 109.793 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.9 p -67.26 -40.49 86.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.832 0.853 . . . . 0.0 111.823 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -150.74 149.04 24.71 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.274 0.63 . . . . 0.0 111.064 -171.019 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.23 -37.98 40.58 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.749 2.966 . . . . 0.0 112.613 166.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -53.24 -29.26 31.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.975 1.71 . . . . 0.0 113.03 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.8 mm -55.5 -34.74 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.012 0.925 . . . . 0.0 110.796 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.1 m 63.85 80.23 0.24 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.313 1.445 . . . . 0.0 110.564 173.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.79 141.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.6 m -120.92 128.57 52.89 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.681 1.192 . . . . 0.0 108.173 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.1 tp -89.16 131.79 35.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -134.77 177.24 7.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 109.651 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -146.62 148.94 32.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.995 0.918 . . . . 0.0 109.439 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.11 137.52 88.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.586 0.754 . . . . 0.0 109.721 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.74 -59.28 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.985 1.031 . . . . 0.0 111.857 0.706 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.3 mt -140.01 42.98 1.94 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.615 1.166 . . . . 0.0 109.768 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.65 145.28 27.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.9 m -122.2 128.55 51.34 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 124.202 1.001 . . . . 0.0 108.659 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.0 mt -111.9 79.23 1.19 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.656 1.582 . . . . 0.0 107.693 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.55 132.66 91.12 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 109.613 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.86 87.08 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.25 2.634 . . . . 0.0 110.402 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.26 -23.2 66.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.809 1.244 . . . . 0.0 112.859 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 82.84 17.43 67.81 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.573 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -129.07 -63.16 0.97 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -73.87 -68.43 0.52 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.815 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.7 mt -89.5 95.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.0 mt -95.9 115.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -89.35 117.07 28.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.475 0.71 . . . . 0.0 110.005 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -115.01 108.63 16.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.9 p -58.54 -29.42 66.33 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.74 0.816 . . . . 0.0 113.176 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -102.6 22.64 13.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.917 0.887 . . . . 0.0 112.177 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -149.17 -57.86 0.21 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.457 0.571 . . . . 0.0 111.115 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.58 -172.11 34.27 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -89.35 113.0 24.24 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.87 95.06 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.71 89.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 170.108 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 65.1 p -60.08 -35.04 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.785 1.234 . . . . 0.0 112.54 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.05 93.89 4.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.282 1.033 . . . . 0.0 108.391 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.26 150.81 38.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.468 0.707 . . . . 0.0 110.398 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 38.5 p -146.31 171.49 14.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.678 1.191 . . . . 0.0 109.208 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -51.42 -34.71 36.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.421 1.088 . . . . 0.0 111.621 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -56.59 -26.82 56.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.97 1.308 . . . . 0.0 112.071 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -82.9 -39.59 21.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.485 0.714 . . . . 0.0 111.839 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.2 108.4 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.119 0.967 . . . . 0.0 110.369 -169.7 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 147.23 -162.48 28.62 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.989 0.804 . . . . 0.0 111.334 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.19 88.3 6.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.226 1.01 . . . . 0.0 109.255 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.5 154.5 41.82 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.108 0.963 . . . . 0.0 109.298 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.0 m -149.73 108.75 3.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.039 0.936 . . . . 0.0 109.308 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.8 m -79.83 133.26 36.27 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -127.95 141.57 51.5 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.276 1.03 . . . . 0.0 110.078 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.42 120.69 6.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.117 0.967 . . . . 0.0 109.637 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.4 m -100.53 77.61 1.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.793 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.93 -52.65 29.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -109.41 177.78 4.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.613 1.165 . . . . 0.0 108.748 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.96 70.65 1.48 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 169.72 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -145.56 -43.25 0.22 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.566 1.547 . . . . 0.0 110.289 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp 64.11 91.22 0.08 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.854 1.662 . . . . 0.0 109.681 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -89.48 147.4 24.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.998 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -150.52 164.24 36.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.542 0.337 . . . . 0.0 111.61 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.2 t -147.11 129.12 15.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.701 1.2 . . . . 0.0 108.233 174.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -107.68 151.4 25.71 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.24 1.416 . . . . 0.0 112.688 -168.803 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -144.88 121.91 11.39 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.993 1.317 . . . . 0.0 108.956 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.24 102.51 14.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.1 p -89.57 124.15 34.29 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.64 0.776 . . . . 0.0 109.419 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -120.68 147.3 45.46 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.905 0.882 . . . . 0.0 110.133 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -79.16 104.01 9.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.796 0.838 . . . . 0.0 109.894 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.27 170.31 14.77 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.413 0.685 . . . . 0.0 111.27 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.6 p -126.44 -67.31 0.87 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.094 1.358 . . . . 0.0 107.627 173.579 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -100.07 145.98 27.31 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.888 1.275 . . . . 0.0 108.441 169.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 33.7 p -83.3 -70.91 0.53 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.729 0.812 . . . . 0.0 109.01 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.9 mm . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.187 -1.387 . . . . 0.0 108.498 -179.552 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.3 m . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.66 -52.28 18.71 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.253 0.621 . . . . 0.0 109.374 171.881 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.4 m -161.66 146.51 13.21 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.875 2.07 . . . . 0.0 106.868 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 160.58 -80.17 0.15 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -164.85 114.07 0.88 Allowed Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 124.059 0.944 . . . . 0.0 108.746 172.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.81 -171.98 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.531 2.821 . . . . 0.0 111.401 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 77.57 104.81 0.07 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 127.199 2.2 . . . . 0.0 111.6 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.26 -50.39 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.465 1.106 . . . . 0.0 109.343 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.62 -70.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.399 0.68 . . . . 0.0 109.518 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ttt 64.23 116.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.569 1.948 . . . . 0.0 112.834 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.64 151.46 47.26 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.1 p -78.56 -62.64 1.62 Allowed 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.148 -0.345 . . . . 0.0 110.263 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -158.77 -51.66 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.426 1.09 . . . . 0.0 109.055 -171.139 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 34.6 mm -79.69 126.9 79.54 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.14 139.82 34.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.665 2.91 . . . . 0.0 112.519 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.18 119.75 12.6 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.4 mm -77.66 102.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.3 mt -92.22 143.66 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.337 1.055 . . . . 0.0 108.208 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -120.64 79.91 1.55 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.533 1.133 . . . . 0.0 110.12 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -89.5 -177.72 5.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.527 1.131 . . . . 0.0 111.064 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -142.31 117.57 10.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 169.202 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.65 123.55 9.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.631 0.773 . . . . 0.0 109.983 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.36 -39.74 2.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.823 1.201 . . . . 0.0 111.167 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -89.31 165.63 14.28 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.695 0.748 . . . . 0.0 111.363 -171.359 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -67.71 129.87 41.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -128.0 124.47 37.27 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.484 1.113 . . . . 0.0 109.561 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.03 134.76 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.5 mm -101.09 100.85 14.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.4 76.23 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 111.108 -165.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.1 p -125.58 45.02 2.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.291 1.037 . . . . 0.0 110.406 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 0.817 ' HB2' ' O ' ' A' ' 188' ' ' SER . 41.1 ptt180 -67.25 151.38 47.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.906 0.483 . . . . 0.0 110.771 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.1 175.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.929 1.292 . . . . 0.0 111.366 -169.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.1 p -75.73 -24.28 56.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -172.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.7 m -158.36 149.92 16.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.031 0.832 . . . . 0.0 110.824 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.72 -36.35 41.47 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.011 3.141 . . . . 0.0 113.654 168.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.59 -36.59 35.62 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.327 1.851 . . . . 0.0 111.935 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 41.6 mm -50.46 -42.74 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.861 1.264 . . . . 0.0 111.19 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 60.58 83.71 0.14 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.037 1.335 . . . . 0.0 111.044 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.68 147.49 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.609 0.764 . . . . 0.0 108.987 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.3 m -124.83 138.77 54.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.84 1.256 . . . . 0.0 107.852 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.0 tp -88.93 125.75 35.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -128.26 -179.55 5.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.878 1.271 . . . . 0.0 110.035 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -147.72 148.19 30.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 108.223 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -58.1 134.22 84.17 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.116 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.72 -59.97 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.962 1.022 . . . . 0.0 111.828 0.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.8 mt -141.83 38.26 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 110.162 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.6 148.28 40.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 170.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 91.0 m -125.75 118.32 25.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.757 0.823 . . . . 0.0 109.904 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.04 88.67 6.2 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 79.5 mt -61.36 130.44 91.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.636 0.775 . . . . 0.0 109.306 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.37 85.32 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.204 2.602 . . . . 0.0 110.247 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -60.78 -22.92 64.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.275 1.43 . . . . 0.0 113.28 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.72 28.07 65.89 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 118.374 0.534 . . . . 0.0 112.646 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.56 -64.26 0.72 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.078 1.351 . . . . 0.0 107.705 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -84.6 -58.43 2.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.8 mt -91.74 89.78 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 78.4 mt -95.22 116.35 36.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -89.1 129.55 35.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -135.6 122.17 20.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.289 1.036 . . . . 0.0 108.289 170.384 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 60.7 p -58.8 -26.46 64.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 112.379 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -98.75 10.93 40.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.883 0.873 . . . . 0.0 113.147 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -145.55 -57.85 0.32 Allowed 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.83 0.741 . . . . 0.0 110.603 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.31 -164.66 29.36 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.79 111.41 22.4 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.53 97.41 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.1 110.84 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 92.1 p -65.15 -35.62 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.518 0.599 . . . . 0.0 112.499 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -140.33 101.84 4.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.836 1.255 . . . . 0.0 107.99 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.11 157.58 25.1 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.365 0.666 . . . . 0.0 110.177 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 80.3 p -133.06 164.28 27.37 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.725 0.81 . . . . 0.0 110.177 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -59.63 -32.13 70.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.283 0.633 . . . . 0.0 110.969 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -60.3 -25.74 65.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.262 1.025 . . . . 0.0 111.947 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.29 -12.29 59.63 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.654 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.61 105.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.44 1.018 . . . . 0.0 109.212 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.82 -159.04 28.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.5 81.36 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.918 0.887 . . . . 0.0 110.562 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 97.9 mt -65.83 150.91 47.8 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 27.7 m -150.01 114.64 5.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.466 0.706 . . . . 0.0 109.416 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 84.6 m -78.23 124.48 28.12 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -121.55 141.49 51.01 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.316 1.047 . . . . 0.0 110.447 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.07 102.06 2.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.558 1.143 . . . . 0.0 109.198 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.2 m -89.88 86.34 6.61 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.92 -56.07 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.279 0.632 . . . . 0.0 109.786 -174.263 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -158.03 -75.51 0.08 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.981 0.913 . . . . 0.0 109.415 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.29 -46.54 78.1 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 123.362 0.506 . . . . 0.0 112.398 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -140.06 162.39 35.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.235 0.614 . . . . 0.0 111.395 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.59 101.96 9.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -89.85 133.2 34.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.55 161.71 42.02 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 62.7 p -139.72 133.6 30.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.518 1.127 . . . . 0.0 109.086 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -106.87 145.55 32.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.209 1.004 . . . . 0.0 111.743 -170.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -143.06 105.43 4.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.714 1.606 . . . . 0.0 109.235 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.69 108.67 19.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.9 p -89.26 90.65 8.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.462 0.705 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -89.61 103.43 16.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 -56.28 143.45 33.92 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.993 0.815 . . . . 0.0 110.777 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.38 138.39 57.56 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 35.2 p -64.96 -47.71 76.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.67 0.788 . . . . 0.0 109.893 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.02 149.83 30.91 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.143 1.377 . . . . 0.0 109.333 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 m -81.62 73.16 8.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.854 0.862 . . . . 0.0 109.371 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 50.1 mt . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.226 -1.368 . . . . 0.0 107.714 178.979 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 120.697 0.284 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.94 65.42 6.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.9 0.88 . . . . 0.0 109.458 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.2 m -75.5 76.58 2.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.921 1.288 . . . . 0.0 110.027 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.4 -134.29 2.55 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.976 -2.049 . . . . 0.0 107.976 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -75.41 126.84 87.17 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 117.431 0.616 . . . . 0.0 109.393 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.39 -37.41 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.166 2.577 . . . . 0.0 111.37 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -62.08 143.42 56.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 112.366 -174.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.29 -55.85 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -92.45 126.75 37.67 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 108.922 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.17 141.01 42.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.077 1.351 . . . . 0.0 108.996 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.16 121.09 12.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.549 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -68.91 -39.51 79.62 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.8 -0.563 . . . . 0.0 111.222 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -158.92 -58.34 0.07 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.6 mm -87.77 130.99 44.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.96 147.4 26.22 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.549 2.833 . . . . 0.0 112.429 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.87 118.98 11.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.2 94.68 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.6 mt -89.54 108.28 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -76.9 89.25 3.49 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.09 0.956 . . . . 0.0 108.552 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -104.36 173.51 6.27 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.395 1.478 . . . . 0.0 111.387 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 94.1 m -138.36 120.74 15.96 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -59.67 144.67 47.31 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.719 0.408 . . . . 0.0 110.364 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.22 -37.32 3.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -89.15 170.15 10.86 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.728 0.811 . . . . 0.0 110.672 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.57 145.57 54.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.815 0.446 . . . . 0.0 110.813 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.5 tp -143.31 108.5 5.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.88 1.272 . . . . 0.0 108.451 -172.064 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.64 131.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mm -108.63 91.52 8.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.73 89.19 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.459 2.773 . . . . 0.0 111.851 -164.368 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.7 p -135.62 48.73 2.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.557 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . 1.284 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -62.87 157.38 21.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.253 0.549 . . . . 0.0 112.174 176.603 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.85 175.01 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.819 1.648 . . . . 0.0 108.94 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 p -63.7 -42.4 97.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.474 0.71 . . . . 0.0 112.04 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.9 m -142.72 140.89 19.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.999 0.92 . . . . 0.0 110.24 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.17 -26.9 42.03 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.669 2.913 . . . . 0.0 112.027 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -52.77 -31.82 40.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.313 1.445 . . . . 0.0 112.082 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.78 -35.07 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.982 1.313 . . . . 0.0 110.915 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 m 69.02 91.29 0.09 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.537 1.535 . . . . 0.0 110.383 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.33 141.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.8 m -110.45 126.84 54.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.719 1.208 . . . . 0.0 108.092 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.0 tp -89.23 133.34 34.48 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -133.82 174.82 10.04 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.767 1.227 . . . . 0.0 109.764 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -149.23 148.21 29.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.645 0.778 . . . . 0.0 109.413 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.7 134.95 82.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.928 0.891 . . . . 0.0 109.96 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.27 -59.2 0.13 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 119.917 1.006 . . . . 0.0 111.697 1.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -142.52 44.2 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.597 1.159 . . . . 0.0 109.943 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -82.03 152.03 26.84 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 89.7 m -131.71 119.09 20.87 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.133 0.973 . . . . 0.0 108.942 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.95 113.35 26.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.283 1.433 . . . . 0.0 108.569 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.74 130.9 74.96 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.74 91.4 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.861 2.374 . . . . 0.0 109.731 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -64.31 -22.6 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.478 1.111 . . . . 0.0 113.144 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.48 59.22 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.233 -0.76 . . . . 0.0 113.428 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -137.12 -60.12 0.69 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.649 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -79.7 -66.48 0.87 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -89.56 94.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 40.9 mt -94.6 121.68 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -89.21 127.83 35.78 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.09 100.8 4.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.773 1.229 . . . . 0.0 108.38 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' SER . . . . . 1.284 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.7 p -53.79 -27.74 30.91 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -73.01 -28.43 62.36 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.113 0.965 . . . . 0.0 112.611 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.31 -63.34 1.34 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.728 0.811 . . . . 0.0 110.65 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.21 26.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.84 111.71 22.83 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.35 94.54 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.14 85.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -58.19 -29.5 65.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.481 1.512 . . . . 0.0 113.336 -170.774 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -132.62 97.25 4.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.09 156.91 36.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.055 0.542 . . . . 0.0 110.393 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 43.0 p -125.53 154.43 42.15 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.143 0.977 . . . . 0.0 109.67 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -55.28 -32.55 62.5 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.172 0.989 . . . . 0.0 111.671 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -53.49 -37.35 62.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.642 1.177 . . . . 0.0 111.481 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -83.34 4.37 27.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.397 1.079 . . . . 0.0 113.2 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.3 mt -73.87 115.51 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.62 -111.5 0.48 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.8 tp -144.98 100.71 3.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.96 0.904 . . . . 0.0 109.975 -172.022 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.7 156.67 19.88 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.816 0.846 . . . . 0.0 109.128 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.7 m -147.28 117.73 7.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.395 1.078 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 60.4 m -85.04 140.01 31.33 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -133.94 147.44 51.06 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.995 0.918 . . . . 0.0 109.91 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.91 130.63 6.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.332 0.653 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.8 m -100.06 133.88 43.8 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.954 1.302 . . . . 0.0 109.329 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.7 t -100.49 -62.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.261 1.024 . . . . 0.0 108.524 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -140.31 84.79 1.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.066 0.947 . . . . 0.0 109.106 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.22 -57.47 5.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.05 0.834 . . . . 0.0 111.928 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.49 129.25 36.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.766 0.827 . . . . 0.0 110.289 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.86 156.8 30.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.634 0.73 . . . . 0.0 111.046 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -125.41 154.57 41.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -151.2 162.74 40.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 t -151.44 141.42 22.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.924 0.89 . . . . 0.0 109.639 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.17 147.49 32.42 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.288 1.435 . . . . 0.0 112.794 -168.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -143.76 101.9 3.83 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.457 1.503 . . . . 0.0 109.118 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.1 tt -80.31 110.98 16.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 108.772 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.9 p -89.4 93.29 9.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.532 1.133 . . . . 0.0 109.024 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -89.92 120.56 31.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.23 1.412 . . . . 0.0 108.749 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -73.11 109.58 6.75 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -66.89 -57.4 7.03 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.268 1.027 . . . . 0.0 111.346 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 6.3 p -91.36 78.6 5.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -88.01 65.45 8.23 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 73.6 p -85.73 66.23 9.53 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.68 1.592 . . . . 0.0 108.886 -175.392 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.31 -1.329 . . . . 0.0 108.909 -178.853 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -166.46 142.08 4.59 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.109 0.964 . . . . 0.0 109.4 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.6 p -123.86 58.69 1.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.891 1.276 . . . . 0.0 108.005 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -129.02 -61.16 0.11 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -121.37 126.82 26.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 169.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.65 -61.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.56 2.173 . . . . 0.0 111.341 -173.782 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -71.56 132.9 45.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.348 0.659 . . . . 0.0 111.729 -171.674 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.89 -61.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -81.98 109.59 16.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ttt -123.92 123.6 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.92 0.888 . . . . 0.0 110.252 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.95 147.3 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.998 0.919 . . . . 0.0 110.709 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 m -154.44 -58.5 0.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.064 1.345 . . . . 0.0 109.25 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -97.32 79.74 2.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.867 0.867 . . . . 0.0 110.273 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.4 mm 78.36 128.4 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 128.142 2.577 . . . . 0.0 109.748 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.74 138.32 33.32 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.348 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.67 120.55 11.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.099 0.56 . . . . 0.0 109.981 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.8 mm -76.53 122.6 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.0 mt -122.75 102.94 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -75.79 83.79 2.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.283 1.033 . . . . 0.0 109.524 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -92.87 155.62 17.49 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.068 0.947 . . . . 0.0 111.383 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 83.5 m -115.72 112.77 22.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -57.7 137.58 56.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.465 0.706 . . . . 0.0 109.88 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 104.31 -36.38 4.42 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.15 0.881 . . . . 0.0 111.385 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.5 179.48 6.05 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.525 0.73 . . . . 0.0 110.897 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.06 137.82 45.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.29 108.79 8.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.85 -175.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -90.0 128.85 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 108.176 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -109.25 94.02 14.58 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.68 100.47 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.347 2.698 . . . . 0.0 110.643 -166.399 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -145.03 59.14 1.3 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 110.126 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -66.9 155.67 37.82 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.03 164.81 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.733 1.213 . . . . 0.0 110.646 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -61.85 -45.25 94.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.509 1.524 . . . . 0.0 111.517 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.0 m -135.82 145.67 53.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.321 1.048 . . . . 0.0 110.204 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.48 -26.09 34.66 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.352 2.701 . . . . 0.0 111.366 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -53.97 -29.31 42.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.781 1.632 . . . . 0.0 112.312 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.57 -51.91 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.066 0.946 . . . . 0.0 109.873 172.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 11.7 m 63.39 93.39 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.494 1.517 . . . . 0.0 110.612 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.02 144.5 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.763 0.825 . . . . 0.0 109.231 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.5 m -112.76 129.82 56.29 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.764 1.226 . . . . 0.0 107.739 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.97 126.4 35.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -126.4 -177.34 3.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.326 1.051 . . . . 0.0 109.424 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -159.24 147.77 17.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 108.889 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.33 134.91 85.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.962 0.905 . . . . 0.0 110.645 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.41 -58.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.897 0.999 . . . . 0.0 111.649 0.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -141.82 38.46 1.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.71 1.204 . . . . 0.0 109.765 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.1 139.5 38.07 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 87.5 m -113.81 114.63 26.55 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.606 0.762 . . . . 0.0 109.477 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.98 85.43 6.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.4 129.32 88.99 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.412 0.685 . . . . 0.0 109.522 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.69 81.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.116 2.544 . . . . 0.0 109.921 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -60.42 -23.09 64.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.622 1.569 . . . . 0.0 113.426 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.29 32.67 65.1 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.58 0.61 . . . . 0.0 112.167 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -138.91 -59.12 0.6 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.235 1.414 . . . . 0.0 108.162 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -94.67 -56.57 2.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.813 1.245 . . . . 0.0 108.411 171.186 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.2 96.67 6.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 125.362 1.465 . . . . 0.0 108.179 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.63 148.08 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -120.31 138.58 53.63 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 125.113 1.365 . . . . 0.0 109.313 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -141.81 116.44 9.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.94 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 80.2 p -53.92 -32.52 53.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.947 1.299 . . . . 0.0 112.992 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.1 mtm-85 -83.28 -5.78 59.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.738 0.815 . . . . 0.0 112.848 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -141.13 -62.21 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.196 0.907 . . . . 0.0 111.719 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.45 -162.04 31.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.0 123.03 38.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.635 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.8 mp -103.28 98.12 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.01 96.27 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.1 p -55.9 -40.22 72.73 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.234 1.414 . . . . 0.0 112.842 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.13 99.67 6.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.821 1.248 . . . . 0.0 107.848 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.72 139.27 56.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.393 0.677 . . . . 0.0 110.527 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 59.3 p -131.98 -177.43 4.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.189 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -51.14 -32.2 22.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.032 1.333 . . . . 0.0 112.387 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -53.71 -29.77 40.74 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.508 1.123 . . . . 0.0 112.171 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -110.6 47.24 0.99 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.752 0.821 . . . . 0.0 110.918 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.09 94.28 2.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 150.23 -158.29 27.6 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.821 1.2 . . . . 0.0 110.445 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.4 tp -85.93 92.29 8.62 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.857 0.863 . . . . 0.0 109.949 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.63 159.11 31.53 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.7 m -148.26 108.28 4.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.195 0.998 . . . . 0.0 109.29 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.23 118.83 19.36 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -113.58 131.85 55.95 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.682 1.193 . . . . 0.0 110.297 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.16 50.3 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.303 1.441 . . . . 0.0 109.501 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 93.8 m -140.73 118.43 11.66 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.07 -54.95 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.847 0.859 . . . . 0.0 109.353 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -130.39 -65.08 0.82 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.173 0.989 . . . . 0.0 109.554 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -166.93 40.68 0.25 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -93.67 -47.08 6.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.209 1.404 . . . . 0.0 110.343 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 tp 63.68 88.56 0.1 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.932 1.693 . . . . 0.0 110.35 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.55 140.82 29.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.76 141.53 40.93 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.298 0.639 . . . . 0.0 109.909 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 35.3 p -133.44 123.89 26.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 108.099 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -102.3 144.59 30.6 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.031 0.932 . . . . 0.0 112.813 -169.202 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -142.96 107.72 4.87 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.857 1.663 . . . . 0.0 108.252 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.58 108.51 20.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.852 0.861 . . . . 0.0 109.174 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 32.1 p -89.62 114.82 26.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.099 0.96 . . . . 0.0 109.925 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -89.85 135.78 33.43 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.316 1.046 . . . . 0.0 109.148 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -75.82 105.21 6.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -76.48 74.2 3.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.369 1.468 . . . . 0.0 109.953 -175.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 26.0 p -65.87 -66.68 0.52 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.117 0.967 . . . . 0.0 109.493 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -89.78 -71.64 0.6 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.926 0.891 . . . . 0.0 108.712 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.1 t -156.55 41.14 0.35 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.252 1.021 . . . . 0.0 109.167 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 19.8 mm . . . . . 0 C--O 1.25 1.111 0 CA-C-O 116.992 -1.48 . . . . 0.0 109.33 -173.092 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.631 0.253 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -78.68 76.38 5.18 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.088 0.955 . . . . 0.0 110.189 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.0 t -140.8 158.98 43.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.343 1.457 . . . . 0.0 108.237 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.53 -65.46 3.41 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -169.754 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -73.58 153.15 89.67 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 123.845 0.858 . . . . 0.0 109.958 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.87 -27.21 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.19 2.594 . . . . 0.0 111.405 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -65.58 132.24 48.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.101 1.361 . . . . 0.0 112.554 -169.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.44 -49.63 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -81.38 101.26 9.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.28 0.632 . . . . 0.0 109.697 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.57 136.33 33.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 139' ' ' TYR . 1.2 p90 -79.42 48.16 0.88 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.623 0.769 . . . . 0.0 111.352 175.242 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 m -34.25 111.46 0.11 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.718 2.007 . . . . 0.0 110.76 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 1.61 71.52 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.838 2.455 . . . . 0.0 114.748 -167.127 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.7 mt 157.56 132.33 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 129.466 3.106 . . . . 0.0 108.584 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 148.11 60.16 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.316 2.677 . . . . 0.0 110.613 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.01 119.37 14.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.243 0.617 . . . . 0.0 109.472 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -78.99 99.81 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.63 115.44 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -80.09 83.61 5.95 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.691 1.197 . . . . 0.0 108.652 173.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -89.34 172.99 8.63 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.218 0.607 . . . . 0.0 112.159 -169.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.7 m -142.24 114.07 8.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.608 1.163 . . . . 0.0 108.189 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.55 145.51 18.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.884 0.873 . . . . 0.0 110.883 174.227 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.01 -48.17 1.8 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.144 0.878 . . . . 0.0 111.155 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -89.52 -178.21 5.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.796 0.838 . . . . 0.0 111.057 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.98 142.42 49.38 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.119 0.568 . . . . 0.0 110.948 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -139.72 110.18 6.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.455 1.502 . . . . 0.0 106.998 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.1 t -90.49 134.81 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.129 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.58 93.55 8.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.56 80.27 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.186 2.59 . . . . 0.0 111.977 -164.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 25.1 p -120.32 52.8 1.12 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.569 1.148 . . . . 0.0 110.722 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -57.56 147.81 25.89 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.288 1.035 . . . . 0.0 110.956 172.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -113.27 155.75 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 123.983 0.913 . . . . 0.0 111.305 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.0 p -70.02 -32.95 71.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.563 1.545 . . . . 0.0 111.496 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -126.38 113.04 23.38 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 124.979 1.312 . . . . 0.0 107.462 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -68.42 -20.51 41.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.238 2.625 . . . . 0.0 111.582 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -52.9 -36.25 59.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.688 172.055 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.78 86.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 30.8 m -66.64 126.18 28.14 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.804 0.842 . . . . 0.0 108.97 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.65 149.63 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.035 0.934 . . . . 0.0 109.634 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.5 m -105.84 115.78 30.82 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.912 1.285 . . . . 0.0 108.06 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 tp -89.62 104.17 16.75 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.378 0.671 . . . . 0.0 109.397 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.92 173.37 7.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 109.8 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -148.94 146.86 28.05 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.406 1.082 . . . . 0.0 108.666 169.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.62 134.5 86.07 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.816 0.846 . . . . 0.0 110.37 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.52 -59.39 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.883 0.994 . . . . 0.0 111.92 0.712 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.75 41.29 1.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.571 1.148 . . . . 0.0 109.944 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -83.27 153.31 24.73 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 m -123.78 107.87 11.89 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.277 1.031 . . . . 0.0 108.641 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.2 78.22 5.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.8 mt -59.66 131.44 88.55 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.357 1.063 . . . . 0.0 109.868 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.17 87.95 0.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.255 2.637 . . . . 0.0 110.31 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.39 -23.08 66.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.323 1.049 . . . . 0.0 112.743 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.89 -15.3 61.89 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.719 -1.045 . . . . 0.0 113.674 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.86 -60.58 1.65 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.508 1.154 . . . . 0.0 109.441 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -76.54 -67.72 0.67 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 mt -89.77 99.17 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.1 mt -98.7 120.75 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -89.09 95.95 10.52 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.012 0.525 . . . . 0.0 109.716 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.94 101.1 13.81 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.9 p -56.9 -27.81 61.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.157 0.983 . . . . 0.0 113.634 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -104.53 22.37 15.1 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.31 1.044 . . . . 0.0 112.153 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -147.09 -60.06 0.28 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.572 0.624 . . . . 0.0 110.306 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.5 -168.14 35.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.56 112.64 23.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.96 98.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -82.98 97.28 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 72.8 p -61.21 -37.53 83.33 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.153 0.981 . . . . 0.0 112.345 -175.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -121.21 87.96 2.85 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.532 1.133 . . . . 0.0 109.28 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.07 163.23 15.25 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.319 0.247 . . . . 0.0 110.7 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 46.5 p -139.86 160.25 40.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.899 0.88 . . . . 0.0 109.947 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -58.71 -34.26 71.13 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.74 0.816 . . . . 0.0 110.869 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -61.12 -34.61 75.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.966 0.907 . . . . 0.0 111.275 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.95 -8.4 56.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.596 0.758 . . . . 0.0 112.645 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.5 mt -65.4 127.26 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.01 -119.97 0.95 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.7 tp -144.76 95.25 2.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.234 1.014 . . . . 0.0 108.797 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 153.42 28.96 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 41.1 m -143.57 102.86 4.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.196 0.998 . . . . 0.0 108.979 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.72 132.09 43.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -134.03 135.59 43.46 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.125 0.97 . . . . 0.0 109.672 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.14 119.48 8.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.583 1.153 . . . . 0.0 108.613 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 m -89.69 59.13 4.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.082 0.553 . . . . 0.0 110.275 -172.213 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.86 141.06 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 57.53 24.43 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.051 1.34 . . . . 0.0 112.177 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.1 -5.9 23.83 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.112 -0.827 . . . . 0.0 113.231 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -89.92 129.56 36.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.573 1.186 . . . . 0.0 108.255 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.38 85.91 1.12 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.501 0.72 . . . . 0.0 109.439 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -88.93 141.24 28.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.65 162.9 39.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.228 0.611 . . . . 0.0 111.449 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.7 t -143.23 128.34 18.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.974 1.309 . . . . 0.0 107.713 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -106.07 150.98 25.25 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.416 1.486 . . . . 0.0 112.446 -169.088 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -142.74 105.3 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.488 1.515 . . . . 0.0 108.573 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -79.4 108.64 13.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.5 p -89.23 91.65 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -98.17 121.82 40.57 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.653 1.581 . . . . 0.0 107.608 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -68.2 143.16 55.44 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.097 0.862 . . . . 0.0 109.699 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 157.63 24.69 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.736 169.299 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 70.2 p -75.15 -8.64 57.14 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.202 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -89.25 46.91 1.42 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.442 0.697 . . . . 0.0 111.107 -171.244 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 t -167.07 179.31 5.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.238 1.415 . . . . 0.0 108.97 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.2 pt . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.774 -1.584 . . . . 0.0 111.294 -179.801 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.43 -45.32 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.903 2.402 . . . . 0.0 111.214 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -64.26 144.65 56.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.646 1.178 . . . . 0.0 111.129 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.6 t -78.12 -47.14 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 143.46 51.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.286 1.434 . . . . 0.0 108.889 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.5 ptm -139.94 163.0 33.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.037 0.935 . . . . 0.0 109.683 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.55 155.72 32.14 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.592 0.757 . . . . 0.0 110.307 169.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.7 t -82.71 -69.04 0.65 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.48 -52.77 0.36 Allowed 'General case' 0 CA--C 1.523 -0.063 0 C-N-CA 125.454 1.502 . . . . 0.0 108.107 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.7 mt -75.86 127.06 86.24 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.12 146.89 16.53 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.833 3.022 . . . . 0.0 112.722 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.24 117.57 9.44 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.4 mm -81.12 97.52 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.4 mt -89.75 110.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -80.07 81.16 6.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.453 1.101 . . . . 0.0 108.942 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.8 ptm -89.82 176.03 6.99 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.491 1.116 . . . . 0.0 112.114 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.4 m -146.46 142.03 27.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.153 1.381 . . . . 0.0 107.356 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.03 146.77 52.49 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.989 0.516 . . . . 0.0 110.909 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.43 -11.71 54.46 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.554 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -89.84 165.96 13.81 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.534 1.167 . . . . 0.0 110.983 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 95.49 2.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.062 0.945 . . . . 0.0 109.019 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.87 104.55 17.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.218 1.007 . . . . 0.0 108.963 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.85 129.43 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.11 99.58 17.54 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.82 85.14 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.217 2.611 . . . . 0.0 111.425 -167.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.4 48.31 2.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.59 1.156 . . . . 0.0 109.593 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.699 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.0 ptt180 -67.92 157.29 35.31 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.617 0.767 . . . . 0.0 110.902 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.34 147.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.476 1.11 . . . . 0.0 110.896 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.5 p -55.65 -48.42 75.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.594 1.158 . . . . 0.0 111.487 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.6 m -113.29 109.58 51.46 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 124.849 1.26 . . . . 0.0 107.819 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.23 -32.89 11.09 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 124.528 3.485 . . . . 0.0 114.247 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -50.74 -37.56 42.52 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.649 1.58 . . . . 0.0 112.284 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.1 mt -51.68 -51.76 25.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 124.746 1.219 . . . . 0.0 110.453 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 68.23 111.68 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.514 1.525 . . . . 0.0 111.462 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.8 t -89.5 151.69 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.0 109.063 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 m -112.96 121.53 44.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.758 1.223 . . . . 0.0 107.979 172.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.51 98.18 11.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.644 0.777 . . . . 0.0 109.026 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -90.77 174.4 7.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.592 0.757 . . . . 0.0 109.977 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -144.26 145.05 31.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.155 1.382 . . . . 0.0 107.613 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.9 134.2 92.5 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.673 0.789 . . . . 0.0 110.638 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.9 -58.96 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.928 1.01 . . . . 0.0 111.853 0.402 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -140.28 41.94 1.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.567 1.147 . . . . 0.0 110.06 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -79.6 156.85 27.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.7 m -132.76 113.15 12.62 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.662 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.91 86.28 6.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.3 mm -60.49 127.11 86.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 109.604 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 86.14 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.969 2.446 . . . . 0.0 109.955 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -58.18 -25.29 61.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.916 1.286 . . . . 0.0 113.233 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 72.69 33.74 60.27 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.08 -61.33 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.126 1.37 . . . . 0.0 107.973 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -99.67 -53.08 3.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.681 1.193 . . . . 0.0 108.468 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.47 89.06 3.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -96.38 119.23 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -89.0 94.75 10.06 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.441 0.696 . . . . 0.0 109.142 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -89.85 98.68 11.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.699 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 68.1 p -51.96 -27.05 11.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 113.734 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.28 17.72 23.52 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.138 0.975 . . . . 0.0 113.167 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -144.78 -56.45 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.809 0.731 . . . . 0.0 110.894 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.97 -169.61 38.2 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.15 110.6 21.32 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 172.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.1 mt -92.22 94.72 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.561 1.544 . . . . 0.0 108.342 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.28 95.68 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -53.43 -37.13 62.26 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.673 1.189 . . . . 0.0 113.112 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -130.79 96.29 4.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.165 0.986 . . . . 0.0 108.566 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.23 140.86 57.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 111.574 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.8 p -133.06 179.97 5.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.52 1.128 . . . . 0.0 109.42 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -54.49 -30.65 53.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.679 1.192 . . . . 0.0 112.12 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -58.77 -20.63 51.44 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.48 1.112 . . . . 0.0 112.032 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -115.48 37.65 3.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.184 1.394 . . . . 0.0 110.82 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -120.75 100.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.7 -165.0 34.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 57.9 tp -89.29 91.72 8.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.041 0.936 . . . . 0.0 109.285 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.6 152.91 37.59 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.4 m -143.27 105.98 4.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.225 1.01 . . . . 0.0 108.515 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 87.1 m -74.11 132.71 42.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -130.81 142.08 50.37 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.323 1.049 . . . . 0.0 110.205 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.97 115.07 4.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.52 0.728 . . . . 0.0 110.315 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 53.9 m -89.81 124.07 34.34 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 44.8 t -118.74 -101.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.607 0.763 . . . . 0.0 109.448 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -88.29 59.07 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.969 1.308 . . . . 0.0 109.712 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 57.66 38.97 90.28 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -150.31 124.05 9.19 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.432 1.093 . . . . 0.0 108.492 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 65.5 tp -83.41 116.16 22.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.374 1.07 . . . . 0.0 109.5 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -100.58 151.94 21.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 164.28 35.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.713 0.405 . . . . 0.0 111.176 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.5 t -154.4 139.54 17.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.483 0.713 . . . . 0.0 109.797 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -106.65 147.04 30.02 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.959 1.304 . . . . 0.0 112.836 -168.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -142.78 104.79 4.4 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.13 109.64 18.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.5 p -89.59 94.49 9.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 109.014 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -89.87 128.36 36.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.971 1.709 . . . . 0.0 109.537 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 . . . . . 0 C--N 1.339 0.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.922 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.25 -53.59 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.754 2.303 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.11 144.71 50.19 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.033 0.933 . . . . 0.0 111.736 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.4 46.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.57 -85.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.231 1.412 . . . . 0.0 108.121 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 ttt 71.08 132.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.631 1.972 . . . . 0.0 113.315 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.68 147.39 53.11 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.708 0.803 . . . . 0.0 110.058 173.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -77.96 -57.66 3.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -32.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.245 1.018 . . . . 0.0 111.646 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.79 117.77 69.15 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.12 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 135.59 68.74 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.03 2.487 . . . . 0.0 110.954 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -68.06 133.74 49.48 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.7 mm -82.34 95.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.755 0.822 . . . . 0.0 108.879 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.69 101.96 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -74.36 85.98 1.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.462 1.105 . . . . 0.0 108.951 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 9.6 ptm -89.17 166.86 13.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.629 0.772 . . . . 0.0 111.233 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.9 m -139.35 126.0 20.62 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.37 141.61 58.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.431 0.692 . . . . 0.0 110.342 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.97 -19.61 41.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.864 -0.965 . . . . 0.0 112.785 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -89.99 165.48 14.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.511 1.155 . . . . 0.0 110.749 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.32 96.01 2.76 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 109.197 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.98 109.96 20.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 108.975 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.51 127.15 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.553 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 44.2 mm -104.15 93.12 5.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.56 114.8 3.95 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.729 2.286 . . . . 0.0 109.877 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.7 p -162.42 56.22 0.22 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.816 0.847 . . . . 0.0 109.387 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 188' ' ' SER . 37.3 ptt180 -64.36 158.53 23.34 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.49 0.716 . . . . 0.0 110.861 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.73 168.29 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.399 1.08 . . . . 0.0 110.369 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.7 p -53.27 -39.19 63.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.307 1.443 . . . . 0.0 112.407 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 m -159.9 152.67 17.87 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 110.148 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.92 -20.33 51.43 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.559 2.839 . . . . 0.0 112.104 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.99 -28.61 66.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.106 1.362 . . . . 0.0 111.927 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.81 -45.48 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.775 0.83 . . . . 0.0 109.05 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.8 m 66.4 95.25 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.728 1.611 . . . . 0.0 110.861 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.47 144.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.358 1.063 . . . . 0.0 109.356 -173.159 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.0 m -115.75 124.81 51.72 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.643 1.177 . . . . 0.0 108.833 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.3 tp -89.71 100.31 13.14 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.761 0.824 . . . . 0.0 109.434 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.96 170.24 10.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.136 0.974 . . . . 0.0 109.76 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -147.14 148.55 31.69 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -58.89 132.32 86.71 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.633 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -79.26 -59.46 0.11 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.937 1.013 . . . . 0.0 111.741 3.278 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.6 mt -144.09 46.65 1.43 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.541 1.136 . . . . 0.0 109.753 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.75 164.8 25.31 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.602 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 m -145.07 100.29 3.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.7 mt -89.67 72.45 7.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.575 1.15 . . . . 0.0 108.439 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.8 mm -56.25 124.63 61.45 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.851 1.26 . . . . 0.0 110.385 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.22 107.34 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.925 3.083 . . . . 0.0 112.682 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.0 -29.89 58.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.307 0.643 . . . . 0.0 110.867 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.95 19.32 51.61 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.341 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -132.17 -58.68 0.95 Allowed 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.63 1.172 . . . . 0.0 108.157 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -78.42 -65.78 0.94 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.17 94.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.4 mt -95.79 117.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -89.17 124.35 34.27 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -127.03 107.98 10.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.567 1.147 . . . . 0.0 108.766 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.1 p -56.43 -25.49 50.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 0.0 113.304 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -76.0 -23.38 55.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.834 0.853 . . . . 0.0 112.243 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -129.57 -65.84 0.83 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.74 0.816 . . . . 0.0 111.035 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.89 35.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.02 111.98 23.26 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.116 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.9 99.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.218 1.407 . . . . 0.0 107.373 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 16.2 mt -97.69 96.67 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.7 1.2 . . . . 0.0 108.046 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 81.9 p -53.15 -35.47 59.79 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.693 1.197 . . . . 0.0 114.114 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -140.62 88.63 2.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.826 0.851 . . . . 0.0 109.201 -174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.16 155.73 19.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.927 0.491 . . . . 0.0 112.25 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.6 p -146.32 -176.78 5.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 109.28 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -55.23 -32.63 62.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.573 1.149 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -59.1 -19.34 43.66 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 112.509 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -93.59 -34.66 13.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.253 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.74 120.36 9.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.03 -136.87 5.65 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.4 tp -120.48 87.76 2.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.041 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 57.2 mt -69.28 149.35 48.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.887 0.875 . . . . 0.0 108.946 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 45.2 m -146.38 113.27 6.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 56.9 m -82.03 122.01 27.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -118.07 145.55 44.75 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.95 133.95 10.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.882 0.873 . . . . 0.0 109.869 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 57.2 m -102.12 131.55 48.55 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.731 0.813 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.88 118.6 34.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.4 m120 43.94 59.06 3.32 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.594 1.558 . . . . 0.0 112.058 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.87 -24.96 6.22 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.554 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -89.22 102.7 15.36 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.504 1.152 . . . . 0.0 109.195 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.09 103.74 4.66 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.27 149.28 23.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.31 146.03 51.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.249 1.42 . . . . 0.0 107.947 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 71.0 p -136.84 111.84 8.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -88.24 145.22 25.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.214 1.005 . . . . 0.0 111.138 -172.844 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -146.15 109.4 4.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.548 1.539 . . . . 0.0 108.172 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.81 105.86 15.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 93.9 9.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.169 0.988 . . . . 0.0 109.31 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -91.14 146.38 23.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.652 1.181 . . . . 0.0 107.974 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 173.733 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 119.022 -0.513 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.38 -47.34 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.325 2.683 . . . . 0.0 110.29 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -68.16 161.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.018 1.327 . . . . 0.0 112.154 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.8 t -110.55 -58.5 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.68 120.25 29.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.5 ptm -133.72 154.82 50.67 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.816 0.846 . . . . 0.0 109.534 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.29 157.75 28.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.01 0.524 . . . . 0.0 111.177 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -97.09 -136.57 0.26 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -94.24 93.87 8.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.8 mt 127.95 121.22 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 131.025 3.73 . . . . 0.0 107.564 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.64 149.99 17.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.312 3.341 . . . . 0.0 113.343 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.59 116.69 6.45 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -76.64 100.65 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.86 121.38 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.938 0.895 . . . . 0.0 108.923 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -77.22 94.18 4.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 108.518 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.57 151.3 22.0 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.896 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 43.7 m -129.07 124.57 35.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -56.24 -73.46 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.73 55.98 4.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.478 0.561 . . . . 0.0 112.341 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -143.31 -97.61 0.11 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.15 1.38 . . . . 0.0 108.065 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -166.0 152.74 9.61 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.764 1.226 . . . . 0.0 108.626 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.1 tp -143.63 108.31 4.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.964 1.306 . . . . 0.0 108.472 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 131.21 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.08 94.13 28.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.04 80.88 2.88 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.309 2.672 . . . . 0.0 111.428 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.02 54.12 1.04 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.361 1.064 . . . . 0.0 109.171 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -68.86 162.28 26.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.16 0.984 . . . . 0.0 111.48 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.79 170.98 12.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.433 1.093 . . . . 0.0 113.075 -169.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.2 p -77.12 -19.83 56.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.632 1.973 . . . . 0.0 112.572 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 t -156.92 140.54 11.37 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.186 0.903 . . . . 0.0 110.274 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -47.81 -39.67 31.49 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.647 3.565 . . . . 0.0 115.454 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.52 -21.78 62.86 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 52.9 mt -80.57 76.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 49.4 m -67.83 123.23 19.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -89.47 142.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 109.357 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 25.8 m -93.18 106.01 18.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 38.1 tp -89.2 118.58 29.0 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -122.91 -177.91 3.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.094 1.358 . . . . 0.0 109.434 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -152.62 150.3 29.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.77 131.5 78.58 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.996 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.84 -61.09 0.03 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.822 0.972 . . . . 0.0 111.972 5.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -142.34 48.48 1.56 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.858 1.263 . . . . 0.0 109.057 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.84 177.25 6.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.187 0.595 . . . . 0.0 109.942 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.3 m -146.04 104.41 3.83 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.87 81.67 6.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.52 130.84 92.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.13 0.972 . . . . 0.0 109.151 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.64 85.38 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.138 2.559 . . . . 0.0 110.426 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -61.37 -22.1 64.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.166 1.386 . . . . 0.0 113.216 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 74.67 26.1 68.23 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.442 0.565 . . . . 0.0 112.811 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.92 -66.02 0.76 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -79.84 -64.59 1.15 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.2 mt -89.87 91.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.576 1.15 . . . . 0.0 108.047 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.75 116.67 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 108.271 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -89.38 109.07 20.02 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.585 0.754 . . . . 0.0 109.891 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -107.22 108.56 20.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.4 p -63.51 -18.76 64.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -109.7 18.77 19.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.316 1.046 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -149.03 -55.61 0.19 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.715 0.689 . . . . 0.0 110.836 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.23 -170.91 32.78 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.97 113.8 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.91 97.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.28 91.93 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.3 p -70.32 -7.73 44.94 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.912 0.885 . . . . 0.0 113.287 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -150.04 99.97 2.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -81.2 160.8 24.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 44.5 p -142.51 169.84 16.83 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.966 0.906 . . . . 0.0 109.682 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -53.19 -37.33 61.85 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.491 1.116 . . . . 0.0 111.659 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -55.05 -37.89 67.31 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.186 1.394 . . . . 0.0 111.226 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.44 17.53 11.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.92 1.288 . . . . 0.0 112.23 -171.557 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 79.5 mt -86.32 116.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 145.4 -160.01 28.0 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 121.455 0.475 . . . . 0.0 112.869 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.52 86.19 6.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.398 1.079 . . . . 0.0 110.511 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -69.69 144.2 52.91 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.5 m -139.04 107.89 5.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.251 1.02 . . . . 0.0 108.923 -173.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.4 m -81.63 138.4 35.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -134.58 145.57 48.8 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.755 0.822 . . . . 0.0 110.526 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.71 144.63 15.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.137 0.975 . . . . 0.0 109.325 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -120.88 142.75 49.38 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.877 1.271 . . . . 0.0 109.562 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.74 153.3 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 52.99 -99.0 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.318 1.447 . . . . 0.0 110.623 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -149.66 47.38 0.62 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.83 129.54 16.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.421 1.088 . . . . 0.0 109.986 177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.8 tp -81.76 144.87 30.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.555 . . . . 0.0 109.796 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -126.61 154.81 43.45 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.904 1.281 . . . . 0.0 108.204 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -150.44 163.29 38.77 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.071 0.548 . . . . 0.0 110.828 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.4 t -151.29 140.9 21.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.76 0.824 . . . . 0.0 109.487 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -115.09 146.23 41.53 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.995 1.318 . . . . 0.0 112.717 -168.802 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -143.26 105.04 4.35 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.425 1.49 . . . . 0.0 108.554 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.63 103.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.8 p -89.73 95.38 10.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.261 1.024 . . . . 0.0 108.783 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -89.69 141.17 28.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.815 0.446 . . . . 0.0 109.844 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 124.926 1.291 . . . . 0.0 109.872 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.58 -52.76 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.937 2.425 . . . . 0.0 110.766 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -68.38 125.61 27.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.071 0.948 . . . . 0.0 111.323 -173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.4 t -74.05 -42.4 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -70.77 -79.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.607 0.763 . . . . 0.0 110.253 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 tpt 69.36 137.77 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.59 1.956 . . . . 0.0 112.641 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -147.05 0.19 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.0 110.104 172.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.4 t -134.72 -67.38 0.56 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -145.65 -53.62 0.27 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 125.027 1.331 . . . . 0.0 108.908 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -69.15 130.56 91.14 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.419 1.088 . . . . 0.0 108.285 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.52 139.15 33.82 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.857 2.371 . . . . 0.0 110.18 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -74.81 127.53 33.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -79.81 105.64 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.576 0.75 . . . . 0.0 110.054 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.2 mt -96.83 110.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -76.9 88.35 3.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.7 ptm -89.92 142.04 28.08 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.327 0.651 . . . . 0.0 111.641 -170.258 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 60.6 m -114.56 110.04 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.16 152.36 28.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.754 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.2 -36.57 3.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.258 0.932 . . . . 0.0 110.961 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -89.42 -177.0 5.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.93 0.892 . . . . 0.0 111.457 -171.677 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.68 99.68 9.75 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.699 0.8 . . . . 0.0 109.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 39.3 tp -92.76 104.25 16.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.184 0.994 . . . . 0.0 109.169 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.93 121.56 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.96 104.73 27.28 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 169.946 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.12 37.5 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.173 2.582 . . . . 0.0 113.443 -161.186 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 28.4 p -87.84 57.74 4.5 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-O 121.429 0.633 . . . . 0.0 110.271 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.884 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -75.94 153.49 36.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.42 1.088 . . . . 0.0 110.291 176.97 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.31 169.92 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.208 1.403 . . . . 0.0 110.3 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.9 p -61.85 -42.33 98.92 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.882 0.873 . . . . 0.0 111.805 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 m -143.93 140.54 17.25 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.935 0.894 . . . . 0.0 109.731 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -28.42 29.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.607 2.872 . . . . 0.0 112.761 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.29 -24.55 65.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.383 0.673 . . . . 0.0 112.282 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -52.18 -40.13 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.878 1.271 . . . . 0.0 110.238 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.5 m 67.58 99.09 0.05 Allowed 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.494 1.518 . . . . 0.0 110.681 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.16 122.62 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.2 m -88.12 107.78 18.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.71 95.23 10.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.796 0.839 . . . . 0.0 109.631 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -89.91 166.74 13.32 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.599 0.759 . . . . 0.0 110.377 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.72 142.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.138 0.975 . . . . 0.0 109.26 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.54 132.83 93.11 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 111.395 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 -59.65 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 119.992 1.033 . . . . 0.0 112.18 3.745 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.5 mt -138.31 36.93 2.29 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.45 152.65 34.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.7 m -131.71 113.27 13.36 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.026 0.93 . . . . 0.0 108.646 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.79 80.61 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.0 128.72 89.66 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.19 0.996 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.28 86.18 1.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.965 2.443 . . . . 0.0 110.358 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.35 -23.17 64.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.939 1.296 . . . . 0.0 112.889 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.9 67.69 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.884 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -135.36 -63.13 0.69 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.949 1.3 . . . . 0.0 108.231 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -85.24 -59.28 2.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.9 mt -89.62 91.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.9 mt -93.58 113.46 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -89.13 123.44 33.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.0 0.52 . . . . 0.0 109.823 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -127.61 114.63 17.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.33 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.884 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 48.0 p -57.13 -29.6 63.7 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.311 0.644 . . . . 0.0 112.51 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -80.6 -29.2 36.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.886 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -114.45 -50.32 2.8 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.891 0.876 . . . . 0.0 111.374 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 150.2 -164.85 29.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.11 105.81 18.03 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -89.14 90.96 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 24.4 mt -82.11 81.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.8 p -46.84 -47.7 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.85 2.06 . . . . 0.0 112.933 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -118.48 92.14 3.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.666 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.91 156.28 31.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.598 0.759 . . . . 0.0 110.758 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 60.4 p -137.96 167.66 21.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.752 1.221 . . . . 0.0 108.829 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -53.26 -30.9 40.87 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.298 1.039 . . . . 0.0 112.257 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -52.69 -36.37 57.11 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.8 -32.71 74.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.473 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.9 mt -53.48 111.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.08 0.952 . . . . 0.0 110.15 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 159.5 -171.7 35.98 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.82 99.2 11.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.164 0.986 . . . . 0.0 109.027 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.23 157.26 30.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.2 m -147.77 99.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.126 1.371 . . . . 0.0 108.042 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 24.6 m -79.15 131.35 36.19 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -124.28 135.32 53.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.165 0.986 . . . . 0.0 109.69 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.98 158.16 36.07 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.484 0.713 . . . . 0.0 110.495 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.9 m -138.0 146.79 43.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.62 1.168 . . . . 0.0 109.617 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.13 -70.69 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.901 1.28 . . . . 0.0 108.468 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -98.0 36.0 1.63 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.949 0.9 . . . . 0.0 111.421 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.05 30.05 74.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.441 0.544 . . . . 0.0 112.154 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -90.01 -43.32 10.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.694 1.198 . . . . 0.0 111.032 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 52.6 tp 66.24 89.29 0.1 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.911 1.684 . . . . 0.0 109.455 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -89.52 154.94 19.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.446 1.098 . . . . 0.0 108.381 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -140.26 159.12 42.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.686 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.9 t -151.84 123.34 7.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -108.85 149.92 28.41 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.606 1.162 . . . . 0.0 111.621 -168.986 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -142.89 113.67 7.53 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.307 1.043 . . . . 0.0 109.236 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.6 tt -84.5 106.72 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.1 p -89.26 99.48 12.46 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -89.32 138.58 31.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.749 1.62 . . . . 0.0 109.603 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 124.072 0.949 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -32.76 10.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.157 1.905 . . . . 0.0 111.118 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -56.74 129.85 42.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.073 1.349 . . . . 0.0 112.045 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.87 -54.93 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.583 0.753 . . . . 0.0 109.214 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.52 148.39 32.22 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.991 0.917 . . . . 0.0 109.348 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 ttp -147.65 135.43 21.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.421 1.089 . . . . 0.0 108.632 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -61.77 137.88 58.28 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.246 0.618 . . . . 0.0 110.035 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.9 p -74.18 -51.1 16.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.62 0.368 . . . . 0.0 110.675 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -155.07 -53.67 0.09 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 109.579 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.6 mm -83.98 119.88 74.07 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.075 0.95 . . . . 0.0 108.791 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.24 139.61 86.32 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.279 2.653 . . . . 0.0 111.225 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.24 136.44 57.18 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -89.22 91.34 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.279 1.032 . . . . 0.0 108.262 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -88.78 108.29 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -73.27 95.84 2.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.805 1.242 . . . . 0.0 109.541 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 19.0 ptm -102.1 162.64 12.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.847 1.259 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 75.2 m -133.16 130.28 38.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -58.94 119.91 8.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.471 0.709 . . . . 0.0 109.176 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 121.2 -33.64 4.28 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.648 1.118 . . . . 0.0 111.719 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -89.0 171.05 10.15 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.967 0.884 . . . . 0.0 110.673 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -71.53 148.4 46.75 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.199 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.5 tp -139.77 106.75 5.43 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.63 128.58 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.39 98.27 13.97 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.79 79.43 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.507 2.804 . . . . 0.0 111.027 -165.797 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.9 p -126.9 42.19 3.37 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.484 1.114 . . . . 0.0 110.344 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -58.02 158.32 6.9 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.152 0.981 . . . . 0.0 110.919 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.33 154.23 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 110.716 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.3 p -61.24 -44.29 97.5 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.751 1.22 . . . . 0.0 110.818 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -104.29 103.49 39.11 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.2 -11.43 32.17 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.718 2.945 . . . . 0.0 113.777 -170.321 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.76 -21.24 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.663 0.785 . . . . 0.0 111.908 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.12 106.46 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.7 m -74.16 117.11 15.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.41 150.87 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.13 0.972 . . . . 0.0 108.575 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 m -103.18 111.45 23.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 108.449 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.8 tp -89.48 101.26 13.94 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -91.62 170.52 9.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.623 0.769 . . . . 0.0 110.22 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -145.99 146.37 30.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.65 1.18 . . . . 0.0 108.556 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.67 133.58 82.58 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.881 0.873 . . . . 0.0 110.772 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.42 -59.57 0.11 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.682 0 CA-C-N 119.816 0.97 . . . . 0.0 111.87 0.911 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -141.46 38.63 1.7 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.755 1.222 . . . . 0.0 109.804 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -77.37 153.99 33.19 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 43.7 m -125.12 111.58 15.48 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.927 0.891 . . . . 0.0 109.147 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.7 mp -89.98 82.62 6.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.09 129.03 90.22 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.01 0.924 . . . . 0.0 109.175 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -72.8 85.51 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.138 2.558 . . . . 0.0 110.319 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.96 -22.36 64.37 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.015 1.326 . . . . 0.0 113.327 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 69.34 44.75 63.82 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -150.07 -67.09 0.2 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -90.7 -55.08 3.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.5 mt -93.23 89.7 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -98.13 121.09 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.119 0.968 . . . . 0.0 108.503 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -89.08 93.87 9.74 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -89.79 96.91 10.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.6 p -61.73 -13.63 24.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -101.26 4.8 42.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 112.079 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -140.32 -58.7 0.54 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.848 0.859 . . . . 0.0 110.668 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.6 -169.42 37.85 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.738 1.161 . . . . 0.0 110.336 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -89.09 110.86 21.53 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.68 94.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.75 1.22 . . . . 0.0 107.834 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.89 95.73 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.1 p -60.67 -28.87 68.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.155 0.982 . . . . 0.0 113.511 -170.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.41 89.94 2.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.02 119.35 9.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.224 0.61 . . . . 0.0 110.043 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 39.3 p -89.94 171.67 9.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.349 0.66 . . . . 0.0 109.255 174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.95 -33.2 62.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.63 0.772 . . . . 0.0 111.493 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -59.57 -32.4 70.32 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.38 1.072 . . . . 0.0 111.932 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.22 -8.96 58.19 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.968 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -71.79 107.86 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.985 1.266 . . . . 0.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 158.39 -160.83 31.26 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.5 98.58 11.72 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.372 1.069 . . . . 0.0 109.917 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.36 154.04 25.46 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.31 0.644 . . . . 0.0 109.332 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 54.9 m -146.71 106.29 3.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.096 0.958 . . . . 0.0 109.409 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.88 140.09 43.58 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -135.71 138.69 42.99 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.161 0.985 . . . . 0.0 110.288 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.71 140.37 18.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.98 0.912 . . . . 0.0 109.976 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 55.9 m -122.52 92.65 3.76 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.661 1.184 . . . . 0.0 108.863 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.33 -62.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.101 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -92.11 174.13 7.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.47 1.108 . . . . 0.0 109.497 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.92 2.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -148.32 -44.73 0.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.388 1.075 . . . . 0.0 110.981 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.2 tp 70.63 128.91 0.03 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 126.796 2.038 . . . . 0.0 110.158 -170.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.02 147.31 50.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.655 1.182 . . . . 0.0 107.927 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -150.59 158.76 44.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.87 0.468 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 49.6 p -136.6 132.12 34.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.935 0.894 . . . . 0.0 108.824 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -111.62 144.71 40.43 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.681 1.192 . . . . 0.0 110.782 -169.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -146.47 117.54 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.441 1.096 . . . . 0.0 109.023 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.01 107.57 19.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -89.33 98.99 12.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -89.14 126.4 35.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.228 1.411 . . . . 0.0 109.249 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.91 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.83 -50.45 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.093 2.529 . . . . 0.0 111.474 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -76.7 146.41 38.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.817 0.847 . . . . 0.0 112.476 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.64 55.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -166.36 -71.66 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.8 tpt 69.76 157.07 0.15 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 111.349 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.97 172.14 13.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.0 0.92 . . . . 0.0 109.32 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.8 t -145.02 -66.28 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.304 0.641 . . . . 0.0 110.383 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -95.08 -64.35 1.07 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.47 0.708 . . . . 0.0 112.624 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.76 113.42 64.93 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.388 1.075 . . . . 0.0 110.195 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.83 142.69 96.36 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.317 2.678 . . . . 0.0 111.122 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -73.05 128.24 34.91 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.6 85.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.306 0.642 . . . . 0.0 109.378 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 mt -92.55 80.25 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -60.55 135.62 57.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.43 175.63 11.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.604 0.761 . . . . 0.0 111.196 -171.895 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -146.97 142.8 27.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.536 1.534 . . . . 0.0 108.162 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 150.63 44.72 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.119 0.567 . . . . 0.0 111.24 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.8 -34.41 4.07 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.557 0.599 . . . . 0.0 112.042 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -88.98 157.02 18.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.248 1.019 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.92 136.0 54.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.084 0.554 . . . . 0.0 110.469 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.5 tp -122.6 114.27 20.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.576 1.55 . . . . 0.0 107.847 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.49 127.58 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.7 mm -106.26 100.08 27.33 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 171.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.67 62.3 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.554 2.836 . . . . 0.0 111.492 -169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -104.11 51.49 0.78 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.029 0.932 . . . . 0.0 109.305 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -66.26 161.75 21.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 m -127.62 166.51 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 0.0 111.709 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 p -65.34 -36.58 84.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.067 1.347 . . . . 0.0 112.035 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 51.3 m -145.42 146.22 29.14 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.453 0.701 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.79 -42.86 24.39 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.65 3.566 . . . . 0.0 115.004 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -59.12 -20.26 52.01 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.028 0.931 . . . . 0.0 113.245 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 23.1 mm -77.71 74.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 27.7 m -70.19 120.1 15.38 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.243 0.617 . . . . 0.0 109.812 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.72 147.16 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.102 0.961 . . . . 0.0 109.641 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.8 m -106.17 113.31 26.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.22 121.66 31.74 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -126.22 173.65 9.11 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -138.82 149.24 44.72 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.949 0.899 . . . . 0.0 108.785 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -58.16 133.39 84.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.637 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.5 -59.85 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.72 0 CA-C-N 119.943 1.015 . . . . 0.0 112.197 3.375 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -142.01 40.27 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.305 1.042 . . . . 0.0 110.391 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.48 149.56 40.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.2 m -132.53 110.19 10.31 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.62 85.19 5.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.805 1.242 . . . . 0.0 108.26 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.39 127.6 93.39 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.54 104.6 1.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.876 2.384 . . . . 0.0 110.722 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.29 -31.48 71.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.637 0.775 . . . . 0.0 111.991 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.11 17.91 45.23 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.611 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -133.23 -58.99 0.89 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.599 1.16 . . . . 0.0 108.516 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.6 tpp85 -78.03 -66.04 0.9 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.52 92.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 68.8 mt -92.07 114.68 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -88.92 93.26 9.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -89.84 103.06 15.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.9 p -54.74 -29.16 52.98 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -108.32 24.98 12.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.135 0.974 . . . . 0.0 111.902 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -146.63 -58.57 0.29 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.162 0.585 . . . . 0.0 110.673 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.9 -172.25 37.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.92 0.772 . . . . 0.0 111.172 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -89.27 109.23 20.14 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.4 96.0 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.986 1.314 . . . . 0.0 107.616 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.98 101.21 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 80.3 p -57.09 -36.15 70.26 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -139.36 99.14 3.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.43 163.82 10.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.554 0.741 . . . . 0.0 112.027 -173.747 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.8 p -131.01 155.21 47.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.027 0.931 . . . . 0.0 109.709 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -56.51 -30.27 62.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.238 1.015 . . . . 0.0 111.777 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.04 -24.14 51.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.687 1.195 . . . . 0.0 112.441 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -86.04 -9.29 57.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.226 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.23 105.86 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.228 0.922 . . . . 0.0 108.63 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.94 -163.22 34.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.85 89.72 8.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.015 0.926 . . . . 0.0 109.481 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 45.1 mt -69.1 147.4 51.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 102.79 3.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.885 1.274 . . . . 0.0 108.318 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 75.0 m -80.7 138.91 36.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -134.69 142.23 46.75 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.184 0.993 . . . . 0.0 110.145 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.97 126.36 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.134 0.973 . . . . 0.0 109.25 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 85.5 m -103.19 134.21 46.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.657 1.183 . . . . 0.0 109.158 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.72 -78.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.392 0.677 . . . . 0.0 109.968 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.84 49.4 1.77 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.681 0.792 . . . . 0.0 110.965 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.96 38.46 60.35 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -170.289 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -150.06 121.02 7.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.178 1.391 . . . . 0.0 107.657 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.0 tt -77.56 111.2 13.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -92.05 154.09 18.98 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -151.47 162.99 39.98 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.827 0.451 . . . . 0.0 112.147 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.0 t -148.13 135.6 20.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.916 0.886 . . . . 0.0 108.782 169.64 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.71 152.47 34.22 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.195 0.998 . . . . 0.0 111.952 -169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -145.0 118.49 9.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.149 1.379 . . . . 0.0 109.005 -173.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.08 111.48 22.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.0 p -89.87 103.3 15.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.21 0.604 . . . . 0.0 109.65 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -89.38 134.12 34.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.131 0.973 . . . . 0.0 109.203 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.802 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -73.35 -46.68 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.058 2.505 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -69.61 152.15 45.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 111.948 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.57 -50.57 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -79.15 -82.22 0.1 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.128 0.971 . . . . 0.0 110.532 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.8 ttt 66.83 139.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.553 1.941 . . . . 0.0 112.032 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -146.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.741 1.216 . . . . 0.0 110.588 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 p -129.79 -69.07 0.69 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 108.072 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 -38.31 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.447 1.499 . . . . 0.0 109.989 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.08 125.95 92.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -69.66 129.4 17.64 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.804 2.336 . . . . 0.0 109.636 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.94 123.63 20.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.334 0.654 . . . . 0.0 111.011 -169.333 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.22 117.11 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.755 1.222 . . . . 0.0 108.953 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.01 133.67 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.57 1.148 . . . . 0.0 109.204 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -84.3 147.96 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.804 1.242 . . . . 0.0 109.043 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -150.1 167.18 27.56 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.329 0.652 . . . . 0.0 111.619 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.1 m -140.25 113.64 8.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -52.11 136.51 29.57 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.52 0.728 . . . . 0.0 110.62 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.47 -38.64 3.02 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.499 1.047 . . . . 0.0 110.948 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -89.5 166.36 13.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.632 0.773 . . . . 0.0 110.546 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.88 144.75 52.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.366 0.666 . . . . 0.0 109.914 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 51.0 tp -134.86 152.9 52.13 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.175 1.39 . . . . 0.0 107.768 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.79 135.52 63.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.052 0.941 . . . . 0.0 108.483 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.4 mm -109.14 97.19 24.17 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.47 68.84 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.55 2.833 . . . . 0.0 112.525 -163.436 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -116.2 55.14 0.81 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.656 1.182 . . . . 0.0 109.795 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 188' ' ' SER . 25.6 ptt-85 -69.0 161.45 28.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.256 1.422 . . . . 0.0 111.023 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.36 165.19 17.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.856 1.262 . . . . 0.0 112.393 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 38.2 p -73.02 -27.51 61.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.807 1.643 . . . . 0.0 112.473 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -142.21 136.19 14.72 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.945 0.898 . . . . 0.0 109.161 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 -25.96 50.61 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.389 2.726 . . . . 0.0 113.297 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -62.55 -23.03 66.77 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.349 0.522 . . . . 0.0 112.154 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.1 mt -80.14 78.82 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.7 m -66.55 121.33 15.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.7 t -89.27 145.24 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.7 m -103.75 122.65 45.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.28 132.17 35.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -130.98 175.34 9.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.695 1.198 . . . . 0.0 109.3 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -151.52 147.98 27.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.053 0.941 . . . . 0.0 109.295 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.91 135.74 87.28 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 110.15 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.91 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.902 1.001 . . . . 0.0 112.007 1.888 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.2 mt -140.56 41.74 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.451 1.101 . . . . 0.0 109.979 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -82.67 139.65 33.58 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 84.8 m -116.93 112.01 20.43 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.45 72.14 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.876 1.27 . . . . 0.0 109.111 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.7 mm -56.34 126.69 69.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.792 0.837 . . . . 0.0 109.609 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.7 103.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.995 3.13 . . . . 0.0 112.684 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.84 -19.47 57.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.752 0.821 . . . . 0.0 111.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.13 -5.27 83.63 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.626 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -105.26 -63.88 1.19 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.564 1.182 . . . . 0.0 107.901 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -79.26 -64.91 1.08 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.836 0.854 . . . . 0.0 108.725 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.33 97.57 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 89.9 mt -99.64 117.6 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -88.95 121.5 31.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -124.35 112.39 16.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.135 1.374 . . . . 0.0 107.878 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.626 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 28.9 p -59.31 -25.95 64.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 113.502 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -111.39 27.5 9.62 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.134 0.973 . . . . 0.0 111.93 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -149.14 -53.33 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.927 0.491 . . . . 0.0 110.266 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 145.88 -159.77 28.0 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.24 110.82 21.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.07 98.6 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.4 mm -83.05 82.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 69.7 p -55.15 -33.28 62.81 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.286 1.035 . . . . 0.0 113.47 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 89.42 2.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.86 158.43 16.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.984 0.514 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.6 p -136.12 161.27 36.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.733 0.813 . . . . 0.0 109.879 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -57.11 -32.78 66.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.889 0.875 . . . . 0.0 111.398 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.42 -34.39 70.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.358 1.063 . . . . 0.0 111.44 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.97 13.49 10.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.326 1.05 . . . . 0.0 112.484 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -85.14 121.8 37.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.71 -159.44 25.4 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.288 0.471 . . . . 0.0 112.794 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.89 91.45 6.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.596 1.158 . . . . 0.0 110.743 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.96 160.31 30.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.668 0.787 . . . . 0.0 109.475 170.037 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.1 m -147.81 102.04 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.717 1.207 . . . . 0.0 109.087 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.6 m -75.28 139.35 42.45 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -138.37 139.02 38.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.601 0.761 . . . . 0.0 111.187 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.52 152.83 27.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.796 1.239 . . . . 0.0 109.822 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.2 m -135.71 107.99 7.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.98 -64.18 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -150.06 114.13 5.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.363 1.065 . . . . 0.0 108.58 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 81.86 -59.69 4.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.78 0.705 . . . . 0.0 113.143 170.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.03 135.62 33.45 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.298 0.639 . . . . 0.0 110.694 -169.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.55 105.5 11.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -89.52 135.09 33.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -150.73 160.39 43.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.538 0.335 . . . . 0.0 110.824 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.8 t -152.86 130.59 11.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.477 0.711 . . . . 0.0 109.97 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -104.57 150.99 24.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.673 1.189 . . . . 0.0 112.066 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -140.18 113.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.525 1.13 . . . . 0.0 108.812 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -82.99 101.63 11.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.5 p -89.17 92.58 9.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -89.8 165.79 13.94 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.792 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.369 178.378 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.67 -51.58 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.422 2.748 . . . . 0.0 111.63 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -71.54 119.65 16.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 111.574 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.01 -53.22 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 126.24 54.83 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.124 1.37 . . . . 0.0 107.832 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.1 ptm -128.49 170.3 13.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.963 1.305 . . . . 0.0 109.685 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.56 147.41 52.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.018 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 m -90.6 -136.44 0.13 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.96 104.14 16.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.4 mm 108.64 127.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 130.742 3.617 . . . . 0.0 107.924 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.68 137.65 15.46 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.236 3.291 . . . . 0.0 113.066 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.27 126.7 30.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -80.78 100.0 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.17 105.83 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -83.41 76.61 9.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.373 1.469 . . . . 0.0 109.231 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.33 171.85 9.46 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.107 0.563 . . . . 0.0 111.041 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.9 m -143.46 116.82 9.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.58 164.94 10.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 94.21 -41.06 2.64 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.2 mtp-105 -88.88 -179.57 5.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.774 1.629 . . . . 0.0 109.674 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.75 137.38 45.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.34 103.93 11.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.22 125.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 mm -101.08 100.73 13.84 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -83.79 48.99 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 112.846 -161.901 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -91.59 57.61 3.32 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.84 0.856 . . . . 0.0 110.378 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -56.73 143.2 37.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.118 0.967 . . . . 0.0 111.126 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.59 165.94 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.817 1.247 . . . . 0.0 110.591 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.376 1.07 . . . . 0.0 112.508 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.2 m -155.5 146.7 16.64 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.644 0.777 . . . . 0.0 110.299 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.5 -30.63 28.8 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.724 2.949 . . . . 0.0 111.855 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -56.36 -27.32 55.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.101 1.36 . . . . 0.0 112.497 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.4 -35.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.135 1.374 . . . . 0.0 110.861 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m 67.59 88.52 0.11 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.314 1.446 . . . . 0.0 110.028 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.45 132.56 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 108.835 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 m -102.31 119.11 38.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.327 1.051 . . . . 0.0 108.721 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.4 tp -89.49 101.52 14.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -89.48 165.23 14.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.056 0.942 . . . . 0.0 109.905 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -147.8 146.39 29.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.31 1.044 . . . . 0.0 108.928 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.81 134.91 89.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.605 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.91 -58.69 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 119.854 0.984 . . . . 0.0 111.819 0.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.1 mt -139.89 38.94 1.98 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.794 1.238 . . . . 0.0 109.824 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -80.76 160.29 24.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -137.85 114.41 10.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.876 0.87 . . . . 0.0 109.034 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 mp -89.9 83.98 6.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.73 121.76 75.14 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.65 120.65 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.309 2.673 . . . . 0.0 112.735 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -81.25 -15.43 55.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.475 0.71 . . . . 0.0 111.565 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 66.76 29.98 75.54 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.057 0.837 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -139.94 -67.55 0.43 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.575 1.15 . . . . 0.0 108.169 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.7 ttp-105 -79.16 -56.16 4.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 mt -89.57 90.08 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.432 1.493 . . . . 0.0 106.998 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 67.8 mt -90.83 113.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -89.01 93.2 9.52 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.41 99.48 12.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.3 p -57.82 -26.82 62.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -76.87 -19.29 57.64 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.122 0.969 . . . . 0.0 112.423 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -125.83 -64.59 1.05 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.063 0.945 . . . . 0.0 110.752 -173.867 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 170.56 -173.36 44.41 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 117.9 0.318 . . . . 0.0 112.332 -173.79 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -89.36 107.55 19.13 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.2 mt -89.82 94.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 31.0 mt -81.96 85.87 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.317 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.9 p -52.15 -35.75 49.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.41 1.484 . . . . 0.0 114.3 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -123.44 91.87 3.57 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.003 0.921 . . . . 0.0 108.878 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.63 40.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.325 0.65 . . . . 0.0 110.242 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 77.9 p -138.66 172.34 13.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.66 1.184 . . . . 0.0 109.273 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -59.17 -26.84 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.648 0.779 . . . . 0.0 112.016 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -53.73 -43.92 69.47 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.402 0.681 . . . . 0.0 110.74 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -68.76 -8.37 42.47 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.0 131.15 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 143.15 -108.31 0.51 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 45.4 tp -157.14 111.34 2.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.0 109.413 -170.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -101.44 150.51 22.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.227 1.011 . . . . 0.0 109.089 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 98.2 m -142.86 116.52 9.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.102 0.961 . . . . 0.0 109.143 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 30.5 m -81.91 142.49 32.42 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -129.96 142.72 50.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.511 1.124 . . . . 0.0 109.984 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.265 1.026 . . . . 0.0 110.104 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.0 m -142.03 132.64 25.42 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.5 t -135.49 -76.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.971 0.908 . . . . 0.0 108.856 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -85.35 51.18 2.11 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.805 0.842 . . . . 0.0 110.774 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.8 -31.53 1.48 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.664 0.649 . . . . 0.0 113.511 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -88.62 142.69 27.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.782 1.233 . . . . 0.0 109.98 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.7 tp -80.02 106.16 11.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -89.02 146.6 24.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 157.32 42.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.471 0.708 . . . . 0.0 110.045 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 t -147.0 129.72 16.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.434 0.694 . . . . 0.0 109.753 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -102.56 141.01 36.08 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.64 1.576 . . . . 0.0 112.487 -169.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -140.34 100.6 3.93 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.076 1.351 . . . . 0.0 108.893 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.5 110.48 16.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.517 1.127 . . . . 0.0 108.639 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.6 p -89.59 89.02 7.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.801 0.84 . . . . 0.0 109.762 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -95.03 89.44 5.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 . . . . . 0 N--CA 1.455 -0.212 0 C-N-CA 122.979 0.512 . . . . 0.0 110.335 178.787 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.89 -50.63 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.534 2.156 . . . . 0.0 111.211 -170.56 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -77.33 159.93 29.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.992 0.917 . . . . 0.0 111.449 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.16 -61.41 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.05 123.88 32.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 23.4 ttt -144.51 145.44 31.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.508 0.723 . . . . 0.0 110.208 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -152.74 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.655 1.182 . . . . 0.0 110.622 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.1 t -131.43 -64.82 0.79 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.005 0.922 . . . . 0.0 108.924 170.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.71 -36.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.579 0.752 . . . . 0.0 111.579 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.4 mt -81.36 116.59 63.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.03 136.15 71.32 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.007 2.471 . . . . 0.0 111.743 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.39 124.43 24.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.352 0.661 . . . . 0.0 109.948 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.9 126.56 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.4 mt -130.08 137.56 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.512 1.125 . . . . 0.0 108.131 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -89.3 102.07 14.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.332 1.053 . . . . 0.0 108.772 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -89.31 176.42 6.94 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 m -147.82 130.4 15.89 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.67 141.38 55.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.969 0.908 . . . . 0.0 110.157 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.82 -42.94 2.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.231 0.443 . . . . 0.0 112.156 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -89.85 -179.28 5.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.814 0.845 . . . . 0.0 112.049 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -66.19 149.73 49.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.1 tp -148.03 112.37 5.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.266 1.026 . . . . 0.0 108.716 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.92 132.11 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.4 mm -108.23 96.4 18.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.92 46.51 1.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.261 2.641 . . . . 0.0 113.714 -163.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 26.0 p -89.81 59.77 4.74 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.501 0.72 . . . . 0.0 109.138 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -71.2 156.79 39.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.689 0.796 . . . . 0.0 110.884 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.53 167.7 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.905 1.282 . . . . 0.0 111.664 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.6 p -63.33 -33.77 76.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.006 1.322 . . . . 0.0 111.695 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.7 m -157.68 151.14 18.97 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 124.376 1.071 . . . . 0.0 109.733 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.54 -31.66 87.53 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.389 2.726 . . . . 0.0 111.64 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.25 -32.26 16.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.768 1.627 . . . . 0.0 112.559 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.4 mm -51.72 -41.95 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.56 1.144 . . . . 0.0 111.043 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.0 m 63.15 91.01 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.207 1.403 . . . . 0.0 111.168 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.45 133.13 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 109.483 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.9 m -98.45 114.29 26.6 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 tp -89.46 106.85 18.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -94.42 158.13 15.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 110.213 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -129.18 136.95 50.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.732 1.613 . . . . 0.0 106.677 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -55.92 126.7 66.77 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.32 -170.07 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -77.47 -62.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.616 0 CA-C-N 119.733 0.94 . . . . 0.0 112.851 6.3 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.1 mt -143.79 37.81 1.32 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.172 0.989 . . . . 0.0 110.244 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.23 126.84 31.73 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.7 m -89.82 115.59 27.27 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.325 0.65 . . . . 0.0 110.157 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.67 86.7 6.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.02 130.35 94.46 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.208 1.003 . . . . 0.0 109.101 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.8 81.95 1.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.209 2.606 . . . . 0.0 110.002 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.63 -18.65 62.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.036 1.334 . . . . 0.0 113.137 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.23 26.48 70.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.602 0.62 . . . . 0.0 112.679 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -140.27 -63.66 0.48 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.758 1.223 . . . . 0.0 108.53 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -88.45 -57.36 2.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.713 1.205 . . . . 0.0 107.951 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.5 mt -89.97 93.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.8 mt -93.5 112.19 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -89.08 95.37 10.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.168 0.587 . . . . 0.0 109.691 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.97 97.55 11.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.6 p -50.53 -37.47 39.44 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -97.27 21.2 10.32 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 112.504 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -147.46 -57.69 0.25 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.978 0.808 . . . . 0.0 111.317 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 161.5 -177.05 37.95 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.046 0.831 . . . . 0.0 111.187 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.13 110.19 20.96 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.12 93.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 50.2 mt -83.09 100.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.8 p -63.94 -39.38 94.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.037 0.535 . . . . 0.0 112.286 -172.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -118.97 90.59 3.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.524 1.13 . . . . 0.0 108.693 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.86 124.15 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 67.3 p -91.83 166.77 12.58 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.0 110.94 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -57.39 -34.1 68.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.251 1.02 . . . . 0.0 111.804 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -56.14 -33.94 65.65 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.418 1.087 . . . . 0.0 111.477 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.75 -2.85 31.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.031 0.932 . . . . 0.0 112.651 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.06 87.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 163.39 -163.1 35.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.1 tp -86.95 117.12 25.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 110.795 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 95.5 mt -99.93 150.26 22.58 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.503 1.521 . . . . 0.0 109.114 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 51.3 m -146.7 103.33 3.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.746 1.218 . . . . 0.0 108.867 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 48.6 m -74.97 143.93 43.42 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.91 140.0 43.74 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.063 0.945 . . . . 0.0 109.611 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.36 114.82 6.32 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.652 0.781 . . . . 0.0 110.52 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.7 m -89.94 125.76 35.49 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.809 1.244 . . . . 0.0 109.481 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.17 -71.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.154 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -145.7 94.26 2.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.02 -53.56 4.76 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.558 0.599 . . . . 0.0 111.762 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 145.25 25.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.303 1.041 . . . . 0.0 109.25 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.3 156.02 28.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.717 0.77 . . . . 0.0 111.433 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -124.75 154.83 40.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.582 1.953 . . . . 0.0 106.027 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -136.86 158.57 44.15 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.05 0.386 . . . . 0.0 111.4 -175.242 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.7 m -144.13 109.89 5.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -106.67 151.9 24.49 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.404 0.682 . . . . 0.0 111.171 -170.261 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -142.39 127.51 18.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.317 1.047 . . . . 0.0 109.008 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.0 tt -87.09 97.17 10.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.8 p -89.0 88.76 7.71 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.38 154.36 20.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 7.3 ptm85 . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 118.266 0.485 . . . . 0.0 111.185 175.818 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -73.81 -39.99 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.779 2.319 . . . . 0.0 110.135 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -59.63 135.94 57.83 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.081 0.952 . . . . 0.0 110.898 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.25 -43.78 97.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.55 148.05 31.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.133 1.373 . . . . 0.0 108.176 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ptm -127.57 165.13 20.52 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.538 1.135 . . . . 0.0 110.546 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 152.09 26.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.423 0.689 . . . . 0.0 110.106 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.1 t -80.26 -69.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -143.56 -53.97 0.37 Allowed 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.937 1.295 . . . . 0.0 108.659 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 88.8 mt -72.87 127.93 88.86 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -67.65 119.89 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.558 2.172 . . . . 0.0 108.893 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.8 116.84 2.74 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.118 0.967 . . . . 0.0 109.701 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.7 mt -78.49 102.24 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.15 68.66 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -59.2 128.32 36.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.14 169.1 18.82 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.754 0.311 . . . . 0.0 111.732 -170.552 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 m -112.55 138.48 49.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 107.994 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.91 165.83 12.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.166 0.587 . . . . 0.0 111.587 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.24 -43.14 3.21 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.957 0.789 . . . . 0.0 111.998 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -89.18 174.78 7.67 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.407 1.083 . . . . 0.0 110.823 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.91 160.33 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.143 -174.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 49.4 tp -148.9 111.97 4.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.627 1.171 . . . . 0.0 108.608 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.02 125.11 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -104.81 102.54 35.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.13 61.01 6.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.603 2.868 . . . . 0.0 111.591 -167.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 31.8 p -105.16 50.09 0.79 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.906 0.882 . . . . 0.0 109.327 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.99 153.92 42.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.008 1.323 . . . . 0.0 110.507 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 m -116.06 160.37 15.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 124.407 1.083 . . . . 0.0 111.277 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.3 p -70.15 -57.45 4.92 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.616 1.167 . . . . 0.0 109.744 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.4 p -100.07 111.73 62.72 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.83 -12.84 33.58 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.615 2.877 . . . . 0.0 113.389 -168.557 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -69.05 -22.85 64.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.082 0.401 . . . . 0.0 111.266 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 32.6 mt -78.35 83.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -66.3 127.37 31.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.353 1.061 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 70.2 t -89.59 146.64 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.053 0.941 . . . . 0.0 109.243 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 m -106.93 111.36 23.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.773 1.229 . . . . 0.0 108.153 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.8 tp -89.37 98.07 11.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -89.75 169.84 10.94 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.957 0.903 . . . . 0.0 109.52 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -148.63 145.83 27.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.634 0.774 . . . . 0.0 109.194 169.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.77 133.76 78.76 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.653 172.033 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.16 -59.89 0.1 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 119.978 1.028 . . . . 0.0 112.057 2.206 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.5 mt -144.23 39.22 1.31 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 110.034 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -81.93 152.13 26.92 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.1 m -130.72 108.53 9.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.739 1.216 . . . . 0.0 108.309 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.74 82.65 6.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.008 0.923 . . . . 0.0 108.573 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 129.14 93.79 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.48 90.15 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.882 2.388 . . . . 0.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -59.52 -24.21 63.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.311 1.444 . . . . 0.0 113.173 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 75.61 28.54 61.13 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.427 0.537 . . . . 0.0 112.819 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.55 -58.4 0.68 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.897 1.279 . . . . 0.0 108.385 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -85.1 -55.14 4.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.197 1.399 . . . . 0.0 108.567 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.8 100.1 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 125.048 1.339 . . . . 0.0 108.134 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.13 118.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -89.15 94.36 9.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.78 100.91 13.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.7 p -56.45 -26.93 55.35 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -114.59 32.16 6.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.285 1.434 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -150.09 -58.35 0.19 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.301 0.64 . . . . 0.0 110.378 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 155.68 -171.13 33.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.691 1.138 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -89.4 106.4 18.42 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.35 90.89 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 52.1 mt -79.48 95.14 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.1 p -61.66 -25.76 67.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -135.9 90.02 2.55 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.788 0.835 . . . . 0.0 108.958 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.7 128.32 35.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.435 1.094 . . . . 0.0 111.265 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 54.0 p -147.89 179.52 7.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.976 1.31 . . . . 0.0 109.45 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -39.18 -35.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.91 2.084 . . . . 0.0 113.691 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -42.87 -44.43 4.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.517 1.927 . . . . 0.0 112.361 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -103.33 -10.09 18.95 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 113.847 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.87 111.82 7.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.415 1.007 . . . . 0.0 109.709 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 151.23 -162.15 29.39 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.9 tp -81.77 90.31 6.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.29 146.96 54.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.829 0.852 . . . . 0.0 108.971 172.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 48.8 m -143.39 99.25 3.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.48 1.112 . . . . 0.0 108.169 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.53 132.18 43.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -126.57 141.62 51.8 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.262 1.025 . . . . 0.0 109.826 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.31 106.5 3.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.014 0.926 . . . . 0.0 109.708 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.1 m -91.2 107.17 19.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.307 1.043 . . . . 0.0 108.609 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -79.69 -61.65 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -130.23 -114.98 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.39 -17.27 78.86 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.43 107.42 19.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.001 0.92 . . . . 0.0 110.275 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.69 101.13 12.48 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -89.43 152.28 21.57 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -150.36 162.64 40.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.489 0.315 . . . . 0.0 111.411 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.0 t -146.0 135.28 22.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.997 0.919 . . . . 0.0 109.319 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -112.55 149.79 32.22 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.579 1.152 . . . . 0.0 111.989 -168.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -146.04 133.55 20.85 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.643 1.177 . . . . 0.0 109.191 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -102.79 105.68 16.14 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 105.58 17.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.26 134.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.652 1.181 . . . . 0.0 108.666 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.584 1.154 . . . . 0.0 109.529 176.685 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -169.65 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.598 2.865 . . . . 0.0 110.905 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 75.88 103.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 126.045 1.738 . . . . 0.0 111.782 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.12 -48.78 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.521 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -105.55 111.28 23.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.8 ptm -120.28 156.35 31.42 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.074 0.95 . . . . 0.0 110.113 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -179.54 2.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.72 0.808 . . . . 0.0 110.82 174.407 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 m -142.98 -154.77 0.54 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.98 92.46 0.72 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.6 mt 114.43 117.43 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 131.485 3.914 . . . . 0.0 107.122 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.44 142.0 24.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.212 3.275 . . . . 0.0 113.366 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.94 110.57 3.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mt -74.03 133.01 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.8 115.7 43.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.47 86.9 4.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.026 0.93 . . . . 0.0 109.385 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 18.8 ptm -89.61 158.9 17.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.193 0.997 . . . . 0.0 111.148 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.5 m -124.57 108.23 11.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -63.48 152.1 39.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 111.023 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 97.94 -34.52 5.14 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -89.47 177.23 6.62 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -74.78 135.37 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.44 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.01 109.64 11.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.755 1.222 . . . . 0.0 109.192 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.6 t -89.94 122.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -93.17 108.45 33.02 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.39 84.03 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.414 2.742 . . . . 0.0 110.381 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.9 p -140.45 45.88 1.82 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.777 0.831 . . . . 0.0 109.801 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.6 ptt180 -69.03 157.8 36.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.98 175.55 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.706 1.603 . . . . 0.0 109.459 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.0 p -73.33 -71.94 0.28 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.406 0.682 . . . . 0.0 110.413 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -99.66 151.21 37.38 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.501 1.121 . . . . 0.0 110.639 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.98 -30.24 39.58 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.871 2.381 . . . . 0.0 110.794 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -50.76 -30.57 14.37 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.2 1.8 . . . . 0.0 112.827 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 mm -50.27 -41.31 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.825 1.25 . . . . 0.0 111.047 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 61.07 80.98 0.2 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.08 1.352 . . . . 0.0 110.686 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.55 138.99 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.9 m -118.74 129.29 55.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.087 1.355 . . . . 0.0 107.951 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.47 100.89 13.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -89.39 168.88 11.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.749 1.22 . . . . 0.0 109.949 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -143.96 137.69 27.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.526 1.53 . . . . 0.0 107.865 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -60.58 134.32 91.68 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 118.631 -0.7 . . . . 0.0 110.556 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.4 -59.72 0.11 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 119.901 1.0 . . . . 0.0 112.01 -0.811 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.07 40.51 1.79 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.589 1.156 . . . . 0.0 110.164 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.56 167.42 14.61 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.8 m -146.78 133.27 19.73 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.627 0.371 . . . . 0.0 110.723 -173.043 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.24 87.5 3.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.527 1.531 . . . . 0.0 107.089 175.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mm -61.85 129.37 91.62 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.963 0.905 . . . . 0.0 109.544 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.29 79.83 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.261 2.641 . . . . 0.0 110.382 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.61 -25.72 67.52 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 113.318 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.43 43.22 54.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -150.09 -57.79 0.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.746 1.218 . . . . 0.0 108.317 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -95.95 -49.87 5.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.383 1.473 . . . . 0.0 107.914 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.4 mt -103.0 93.52 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 124.43 1.092 . . . . 0.0 108.424 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.8 119.71 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -90.0 100.6 13.39 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.152 0.581 . . . . 0.0 109.496 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -95.79 108.17 20.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 172.006 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 53.3 p -55.67 -35.12 65.64 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.362 0.665 . . . . 0.0 112.392 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -101.29 21.53 13.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.935 0.894 . . . . 0.0 112.661 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -145.9 -55.88 0.29 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.658 0.663 . . . . 0.0 111.51 171.249 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 159.19 -172.98 35.97 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -89.61 112.63 23.92 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.54 97.05 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.472 1.109 . . . . 0.0 108.599 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.71 98.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.4 p -59.02 -35.21 72.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.541 1.136 . . . . 0.0 113.303 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -130.32 81.73 2.02 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.527 1.131 . . . . 0.0 108.337 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 156.77 24.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.381 0.672 . . . . 0.0 111.734 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 70.3 p -145.66 -178.4 6.08 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.21 1.404 . . . . 0.0 109.06 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -54.74 -32.54 59.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.127 0.971 . . . . 0.0 112.376 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -31.45 55.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.494 0.718 . . . . 0.0 111.872 176.162 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -81.7 -40.62 22.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.519 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.11 119.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 118.467 0.576 . . . . 0.0 109.668 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.34 -160.51 20.72 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.352 0.977 . . . . 0.0 111.178 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 41.1 tp -79.26 84.36 5.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.142 0.977 . . . . 0.0 111.142 -172.366 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 43.5 mt -75.61 153.83 37.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.267 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.4 m -148.88 115.35 5.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.15 125.92 30.84 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -128.19 148.18 50.6 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.68 0.792 . . . . 0.0 110.517 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.29 133.1 10.36 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.265 0.626 . . . . 0.0 110.857 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.6 m -89.66 114.65 26.31 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.212 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.17 141.52 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 64.78 -76.93 0.04 OUTLIER 'General case' 0 C--N 1.343 0.287 0 C-N-CA 126.304 1.842 . . . . 0.0 110.269 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -171.8 44.45 0.18 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -150.05 127.69 11.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.572 1.149 . . . . 0.0 108.741 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.2 tp -81.03 102.54 10.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.123 0.969 . . . . 0.0 108.829 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -89.23 153.39 20.95 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -140.3 153.38 46.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.474 1.11 . . . . 0.0 109.953 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.7 t -149.35 122.81 9.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.365 0.666 . . . . 0.0 109.348 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -98.27 148.23 23.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.169 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.65 103.49 4.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.297 1.439 . . . . 0.0 108.56 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.29 94.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.2 p -88.39 99.08 11.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -89.47 172.1 9.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.596 1.158 . . . . 0.0 109.706 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? . . . . . 0 N--CA 1.451 -0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 109.585 173.701 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.93 -62.24 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.662 2.241 . . . . 0.0 110.549 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -75.14 130.22 38.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.18 0.992 . . . . 0.0 112.327 -173.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.11 -59.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.21 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -91.74 123.84 35.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ptm -152.03 166.23 32.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.834 0.854 . . . . 0.0 110.282 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -170.75 0.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.305 1.042 . . . . 0.0 110.971 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.8 t -123.08 -68.85 0.86 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.42 -52.81 0.72 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.01 1.324 . . . . 0.0 109.063 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.1 mm -72.78 130.54 85.22 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.26 149.76 64.18 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.594 2.196 . . . . 0.0 109.989 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.73 121.29 15.11 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.8 110.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.907 0.883 . . . . 0.0 108.755 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.37 93.52 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -74.72 81.77 2.07 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.24 1.016 . . . . 0.0 109.237 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 170.53 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.61 0.764 . . . . 0.0 111.89 -169.752 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -121.61 118.41 29.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.818 1.247 . . . . 0.0 108.165 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.1 149.79 22.74 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.97 -34.0 3.46 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.718 0.675 . . . . 0.0 112.079 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -89.82 176.11 6.96 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.857 0.863 . . . . 0.0 110.854 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.213 0.605 . . . . 0.0 111.706 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.6 tp -140.69 105.14 4.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.297 1.439 . . . . 0.0 107.718 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.2 t -89.85 132.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -108.99 94.61 15.15 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -84.66 66.33 6.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.319 2.68 . . . . 0.0 111.741 -166.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.6 p -100.83 58.73 0.92 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.125 0.97 . . . . 0.0 108.756 171.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -69.95 155.69 40.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.623 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 169.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.574 1.149 . . . . 0.0 111.953 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 p -67.89 -65.69 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.044 1.338 . . . . 0.0 110.072 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -111.97 149.98 41.69 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.647 1.179 . . . . 0.0 110.398 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.86 -27.62 43.5 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.516 2.81 . . . . 0.0 112.889 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.06 -16.69 60.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.9 mm -77.27 83.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 55.8 m -73.34 113.3 10.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.9 t -89.41 142.59 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.772 0.829 . . . . 0.0 109.256 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -98.97 111.8 24.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.26 100.32 13.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.75 168.43 12.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.32 0.648 . . . . 0.0 110.382 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -143.96 145.63 32.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.979 1.312 . . . . 0.0 108.342 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -58.19 134.25 84.5 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.007 0.923 . . . . 0.0 110.772 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.37 -59.13 0.13 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.784 0.959 . . . . 0.0 111.745 0.071 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -140.89 38.89 1.8 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.741 1.217 . . . . 0.0 109.859 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -79.19 158.85 27.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.4 m -131.44 126.02 34.02 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.76 0.824 . . . . 0.0 109.232 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.83 99.56 10.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.171 1.388 . . . . 0.0 107.533 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.32 128.81 93.09 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.39 85.3 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.892 2.395 . . . . 0.0 109.825 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.84 -22.31 62.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.171 1.388 . . . . 0.0 113.246 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 76.84 26.29 62.91 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.575 -0.569 . . . . 0.0 112.679 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.38 -63.77 0.58 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.827 1.251 . . . . 0.0 108.365 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -85.44 -60.09 2.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 27.4 mt -89.81 93.37 4.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.6 mt -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -88.95 96.36 10.69 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.33 105.13 17.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.7 p -51.68 -51.26 57.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.082 0.953 . . . . 0.0 112.9 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -95.07 28.97 2.57 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.825 . . . . 0.0 112.382 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -144.95 -60.39 0.36 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.765 0.826 . . . . 0.0 110.987 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 158.45 -176.09 35.45 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -89.36 107.52 19.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 mt -89.32 95.44 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.14 87.69 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.4 p -56.39 -31.55 63.96 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.713 1.205 . . . . 0.0 113.702 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -139.74 86.97 2.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.8 162.12 9.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.81 0.844 . . . . 0.0 111.43 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.6 p -126.8 153.16 45.97 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 0.0 108.801 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -53.62 -32.62 52.03 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.01 0.924 . . . . 0.0 111.829 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -55.74 -36.23 67.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.524 1.129 . . . . 0.0 111.82 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.44 -0.37 29.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.125 0.97 . . . . 0.0 112.938 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.0 mt -72.64 121.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 162.28 -116.51 0.72 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.77 107.32 4.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.056 0.942 . . . . 0.0 109.164 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.1 152.24 20.69 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.1 m -142.33 109.79 5.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.138 0.975 . . . . 0.0 108.389 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 77.6 m -76.78 136.38 38.99 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -130.7 142.63 50.43 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.392 1.077 . . . . 0.0 110.185 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.25 39.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.428 1.091 . . . . 0.0 109.516 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.5 m -142.19 127.25 18.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.02 -76.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 0.0 109.233 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.37 52.52 2.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.98 44.44 56.23 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.216 0.913 . . . . 0.0 111.669 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -150.09 128.78 12.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.539 1.136 . . . . 0.0 108.35 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.29 104.31 9.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -89.61 139.05 30.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -150.78 166.1 31.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.866 0.303 . . . . 0.0 111.442 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.57 137.47 14.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.917 0.887 . . . . 0.0 109.779 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -105.86 143.26 34.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.227 1.411 . . . . 0.0 112.75 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.97 103.55 4.66 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.586 1.555 . . . . 0.0 108.571 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.61 109.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 p -89.27 97.7 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -89.36 160.42 16.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.787 1.235 . . . . 0.0 108.695 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.852 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.06 -47.23 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.913 2.408 . . . . 0.0 110.633 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.6 143.45 53.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 111.995 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -79.25 -52.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -109.58 122.77 48.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.577 1.551 . . . . 0.0 108.842 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.4 ptm -122.3 157.6 31.38 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.146 0.978 . . . . 0.0 109.736 170.744 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 218' ' ' THR . 0.2 OUTLIER -71.24 162.77 28.88 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.849 0.46 . . . . 0.0 110.717 173.858 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -92.62 -136.66 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -97.26 106.52 18.86 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 25.4 mm 119.73 122.3 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 131.688 3.995 . . . . 0.0 107.332 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -44.81 139.29 7.77 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.668 3.579 . . . . 0.0 114.101 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.45 119.2 10.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.225 0.61 . . . . 0.0 110.213 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.77 103.34 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.201 1.4 . . . . 0.0 108.861 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.0 mt -108.89 123.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.205 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -81.47 91.98 6.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.02 1.328 . . . . 0.0 108.726 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 13.9 ptm -89.3 168.34 12.33 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 111.803 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 m -136.67 142.58 43.18 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.23 1.412 . . . . 0.0 108.637 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.64 148.63 51.64 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.941 0.897 . . . . 0.0 110.85 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.34 -41.58 2.93 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.564 0.602 . . . . 0.0 113.228 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -88.64 -179.05 5.95 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.437 0.695 . . . . 0.0 110.586 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.2 156.22 39.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.5 tp -150.01 111.41 4.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.59 134.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -109.67 93.32 13.99 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 170.804 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.63 77.72 3.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.452 2.768 . . . . 0.0 112.163 -166.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.3 p -124.6 46.84 2.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.449 1.5 . . . . 0.0 109.814 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 188' ' ' SER . 29.4 ptt-85 -63.01 158.45 19.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.873 0.869 . . . . 0.0 111.006 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.2 m -114.31 155.22 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 124.427 1.091 . . . . 0.0 111.51 -174.279 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 p -57.68 -61.31 2.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.115 1.366 . . . . 0.0 109.873 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.8 t -98.56 120.33 59.39 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.291 1.037 . . . . 0.0 108.957 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.76 -32.69 6.31 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 125.08 3.853 . . . . 0.0 114.912 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -57.97 -27.96 63.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.591 1.156 . . . . 0.0 112.657 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.6 94.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 33.2 m -71.28 118.12 13.67 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.2 t -89.61 147.9 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.063 0.945 . . . . 0.0 109.18 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.3 m -101.75 111.24 23.43 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.379 1.072 . . . . 0.0 108.229 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.33 102.63 15.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -89.92 168.29 12.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.73 0.812 . . . . 0.0 110.183 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -146.61 146.25 30.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.75 1.22 . . . . 0.0 108.214 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 134.65 85.14 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.915 0.886 . . . . 0.0 110.777 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.33 -59.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.685 0 CA-C-N 119.737 0.942 . . . . 0.0 111.857 0.556 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.05 38.82 1.77 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 109.715 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -78.23 155.14 30.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 61.9 m -127.63 113.71 16.42 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.05 0.94 . . . . 0.0 109.101 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.78 87.57 7.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.9 133.92 95.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.169 0.988 . . . . 0.0 108.836 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.89 83.75 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.39 2.726 . . . . 0.0 110.779 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -69.61 -18.05 63.58 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 113.069 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.7 31.8 73.68 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -133.59 -71.86 0.51 Allowed 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -82.94 -56.2 3.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.5 mm -89.31 84.41 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.7 114.08 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -89.07 94.81 10.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.229 0.611 . . . . 0.0 109.74 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -89.84 95.81 10.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 77.7 p -58.46 -21.39 51.27 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -108.66 24.89 12.41 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.677 1.191 . . . . 0.0 111.856 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -147.03 -57.56 0.26 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.453 0.701 . . . . 0.0 110.264 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.21 -168.95 35.97 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.227 1.394 . . . . 0.0 109.878 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.0 114.36 25.54 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.15 96.95 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 21.8 mm -75.87 80.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.7 p -56.92 -35.33 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.829 1.252 . . . . 0.0 113.292 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -118.96 88.24 2.89 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.503 1.121 . . . . 0.0 108.675 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.64 144.52 52.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.24 0.616 . . . . 0.0 110.419 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 75.3 p -138.35 167.48 21.78 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.324 1.05 . . . . 0.0 110.602 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -61.38 -36.65 80.83 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.244 1.017 . . . . 0.0 111.45 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -52.65 -41.86 64.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.814 0.846 . . . . 0.0 110.697 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.68 0.62 29.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 112.828 -174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.0 mt -73.89 109.79 6.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 161.6 -162.57 34.03 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 117.953 0.342 . . . . 0.0 112.263 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -92.68 103.0 15.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.914 1.285 . . . . 0.0 110.164 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.01 155.44 19.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.766 0.827 . . . . 0.0 108.827 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 38.7 m -149.74 114.01 5.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.278 0.631 . . . . 0.0 109.891 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 57.0 m -80.86 138.7 36.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -131.55 137.4 48.45 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.512 1.125 . . . . 0.0 109.399 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.41 151.39 28.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.8 0.84 . . . . 0.0 109.46 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.4 m -129.98 139.37 51.07 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.436 1.094 . . . . 0.0 108.949 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t -132.03 136.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.45 -85.34 0.02 OUTLIER 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -157.99 46.84 0.46 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -143.14 116.85 9.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.974 1.31 . . . . 0.0 107.83 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.9 tp -77.79 143.8 37.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.89 0.876 . . . . 0.0 109.31 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -132.51 150.13 52.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.25 1.42 . . . . 0.0 108.059 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -141.74 157.48 44.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.23 1.012 . . . . 0.0 110.137 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 139' ' ' TYR . 2.7 t -155.53 130.98 9.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.022 0.529 . . . . 0.0 110.131 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -109.42 143.41 39.04 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.499 1.519 . . . . 0.0 111.968 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -141.25 109.11 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 108.95 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.5 tt -90.19 101.9 14.62 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -89.75 91.33 8.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.156 0.983 . . . . 0.0 108.355 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -93.11 150.79 20.27 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 118.534 0.606 . . . . 0.0 109.808 175.04 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.12 -48.05 0.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.531 2.821 . . . . 0.0 112.032 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -68.12 140.84 56.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.443 0.697 . . . . 0.0 111.947 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -89.63 -53.84 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -75.64 -81.79 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.436 1.094 . . . . 0.0 110.454 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . 0.259 26.5 ptm 51.49 172.35 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.99 2.516 . . . . 0.0 115.314 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.0 -146.32 0.05 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.902 1.681 . . . . 0.0 110.016 174.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.5 p -131.93 -81.14 0.51 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -128.68 -51.03 1.25 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.619 1.568 . . . . 0.0 108.175 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.26 129.58 79.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.16 135.32 45.1 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.709 2.939 . . . . 0.0 112.391 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.37 128.96 37.99 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.43 127.36 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.5 mt -123.59 133.41 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -96.81 84.16 3.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.457 1.503 . . . . 0.0 107.487 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 8.2 ptm -89.03 164.35 15.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.892 0.377 . . . . 0.0 111.185 -172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -149.46 131.88 15.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.82 155.53 33.69 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.089 0.555 . . . . 0.0 110.706 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.01 -42.73 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -89.05 173.38 8.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.914 1.286 . . . . 0.0 110.94 -172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.49 137.43 44.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.995 0.918 . . . . 0.0 110.269 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.3 tp -127.71 106.95 9.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.479 1.512 . . . . 0.0 107.742 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.2 t -90.56 132.34 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.01 97.52 25.29 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.85 82.16 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.642 2.894 . . . . 0.0 111.667 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.1 p -127.34 55.35 1.6 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.083 1.353 . . . . 0.0 109.206 174.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -65.95 155.45 36.47 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 111.038 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.07 177.43 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.357 1.463 . . . . 0.0 108.53 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -78.88 -29.7 44.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.161 0.984 . . . . 0.0 111.959 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.6 m -149.13 146.41 21.27 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.382 0.673 . . . . 0.0 110.127 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.38 -31.99 33.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.569 2.846 . . . . 0.0 112.743 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -58.56 -26.56 63.71 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.593 0.757 . . . . 0.0 112.359 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.5 mm -54.61 -40.34 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.704 1.201 . . . . 0.0 110.605 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.7 m 61.96 91.2 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.986 1.314 . . . . 0.0 111.431 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.6 t -88.95 143.4 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 91.6 m -104.99 122.43 45.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.2 tp -89.18 125.37 35.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -125.4 -176.4 3.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.079 0.952 . . . . 0.0 109.9 174.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -143.65 143.87 31.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.36 1.864 . . . . 0.0 107.205 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.55 128.03 67.53 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 123.548 0.739 . . . . 0.0 111.23 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.35 -61.77 0.04 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.877 0.992 . . . . 0.0 112.101 1.294 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.73 39.99 1.4 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.579 1.152 . . . . 0.0 110.275 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -77.98 122.6 25.75 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.8 m -89.73 114.32 25.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.002 0.521 . . . . 0.0 111.001 -169.543 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 mp -90.01 87.06 6.76 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.774 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.47 129.79 93.86 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.78 88.45 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.14 2.56 . . . . 0.0 110.148 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.7 -23.6 67.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.588 1.155 . . . . 0.0 113.071 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.56 20.2 60.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.566 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.76 -60.48 0.83 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.527 1.131 . . . . 0.0 108.174 173.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -78.68 -68.08 0.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.7 mt -89.47 91.93 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 95.0 mt -93.13 118.51 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -88.98 96.33 10.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -89.87 101.78 14.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 77.6 p -52.7 -37.81 59.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.915 0.886 . . . . 0.0 113.215 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -99.0 25.83 6.36 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.984 0.914 . . . . 0.0 112.182 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -150.39 -56.69 0.17 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.513 0.597 . . . . 0.0 111.382 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.44 -173.45 34.9 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -89.42 114.78 26.29 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.1 mt -94.66 94.1 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.95 88.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 79.9 p -57.56 -38.19 74.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.196 1.399 . . . . 0.0 112.453 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -119.55 88.88 3.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.236 1.015 . . . . 0.0 108.517 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.97 146.19 55.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.749 0.419 . . . . 0.0 110.517 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 81.1 p -137.66 173.0 12.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 109.142 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -51.63 -31.27 24.67 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.266 1.427 . . . . 0.0 112.258 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -52.07 -35.94 49.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 112.374 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -87.8 -5.42 58.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.055 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.6 mt -72.15 116.06 13.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 120.251 1.387 . . . . 0.0 108.347 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.15 -104.51 0.26 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.824 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.5 tp -152.3 96.72 2.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.917 0.887 . . . . 0.0 109.183 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.4 155.98 23.19 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.171 0.589 . . . . 0.0 109.565 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 30.4 m -146.67 106.26 3.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.753 1.221 . . . . 0.0 109.156 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 47.7 m -78.45 143.16 36.95 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -136.29 135.17 38.72 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.507 1.123 . . . . 0.0 109.899 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.62 164.05 37.75 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.359 1.064 . . . . 0.0 110.327 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.7 m -146.07 135.93 23.43 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.878 0.871 . . . . 0.0 108.736 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.9 -78.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.223 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -88.23 49.91 1.88 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.703 -170.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.28 -24.55 1.71 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.614 0.626 . . . . 0.0 113.45 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -88.91 132.99 34.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.732 1.213 . . . . 0.0 109.585 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.5 tp -76.43 107.82 8.96 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.45 143.05 27.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.853 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.21 161.38 42.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.711 0.405 . . . . 0.0 110.529 174.028 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.8 t -153.84 133.85 13.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.568 0.747 . . . . 0.0 109.37 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -110.36 151.93 26.85 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.844 1.258 . . . . 0.0 112.793 -168.889 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.55 104.41 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.435 1.494 . . . . 0.0 108.861 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.3 tt -78.23 99.4 6.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.115 0.966 . . . . 0.0 108.635 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.1 p -90.09 90.84 8.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.413 1.485 . . . . 0.0 109.606 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -89.95 155.06 19.38 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.143 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 119.654 -0.212 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.23 -40.91 1.45 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.103 2.535 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -68.44 118.46 11.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.217 1.007 . . . . 0.0 112.069 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.13 -58.4 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -93.14 134.48 35.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.3 ptm -159.96 170.38 21.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.208 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -153.26 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.748 1.619 . . . . 0.0 110.722 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.7 t -133.11 -69.02 0.57 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.71 -56.25 0.57 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 124.919 1.288 . . . . 0.0 108.671 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.77 132.2 94.8 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.29 129.11 20.76 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.525 2.15 . . . . 0.0 109.503 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.1 117.55 6.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.579 0.752 . . . . 0.0 110.697 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mm -72.75 110.6 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.789 1.236 . . . . 0.0 108.634 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 mt -118.14 113.1 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 124.551 1.14 . . . . 0.0 108.559 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 136.41 42.96 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.71 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -144.83 157.81 44.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.923 0.489 . . . . 0.0 111.154 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.5 m -105.03 114.62 28.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.83 140.14 56.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.071 0.549 . . . . 0.0 110.232 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 101.4 -35.03 5.18 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.356 0.979 . . . . 0.0 111.202 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -89.63 -177.81 5.38 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.741 0.817 . . . . 0.0 111.446 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.16 148.0 50.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.4 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.0 tp -145.24 106.82 4.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.427 1.091 . . . . 0.0 108.744 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.7 t -94.41 120.53 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.592 1.157 . . . . 0.0 107.887 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.7 mm -89.95 109.79 35.31 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.0 72.54 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.437 2.758 . . . . 0.0 111.081 -168.133 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 20.3 p -126.02 50.96 1.81 Allowed 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 124.63 1.172 . . . . 0.0 109.563 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.367 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.9 174.22 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.7 1.6 . . . . 0.0 109.331 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -74.99 -29.01 60.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.536 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -148.29 144.28 18.53 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.624 0.647 . . . . 0.0 111.607 -169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.1 -39.75 26.09 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.501 3.467 . . . . 0.0 113.535 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -49.34 -37.22 23.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.455 1.502 . . . . 0.0 112.083 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.1 mt -77.97 87.63 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.8 m -78.09 110.6 13.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.46 150.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.375 1.07 . . . . 0.0 108.28 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.9 m -110.46 124.68 52.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.186 0.994 . . . . 0.0 108.646 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 tp -89.4 101.13 13.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.55 169.05 11.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.013 0.925 . . . . 0.0 109.892 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.49 145.58 31.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 108.118 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -57.36 134.27 81.5 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.586 0.754 . . . . 0.0 110.872 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.27 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.707 0 CA-C-N 119.819 0.971 . . . . 0.0 111.716 -0.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.3 39.27 1.74 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.721 1.208 . . . . 0.0 109.996 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -79.66 161.35 25.89 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 171.19 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -138.44 120.63 15.76 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.368 0.667 . . . . 0.0 110.027 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.4 mp -92.18 81.05 5.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.9 mm -60.94 120.4 53.56 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.421 1.088 . . . . 0.0 109.655 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.79 119.49 6.78 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.149 2.566 . . . . 0.0 111.958 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -84.68 -16.17 42.78 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.632 0.773 . . . . 0.0 111.621 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.81 39.8 89.76 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -150.28 -66.91 0.2 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.711 0.804 . . . . 0.0 109.004 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.7 -54.95 3.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.652 1.181 . . . . 0.0 107.852 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 54.4 mt -95.52 91.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.11 120.31 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -88.93 94.62 10.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -89.43 99.44 12.44 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.8 p -51.04 -41.29 59.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -97.88 24.7 6.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.218 1.007 . . . . 0.0 112.292 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -145.81 -57.08 0.31 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.454 0.701 . . . . 0.0 110.94 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.54 -173.6 37.12 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.02 110.06 20.81 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.3 mt -91.4 93.15 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.078 1.351 . . . . 0.0 108.125 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.31 100.82 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.6 p -61.89 -32.15 72.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.733 0.813 . . . . 0.0 112.608 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.03 95.16 4.5 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.589 1.156 . . . . 0.0 108.915 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.8 138.88 44.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.154 0.581 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 72.8 p -142.84 -178.56 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.902 1.281 . . . . 0.0 109.357 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -45.66 -40.77 9.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.21 1.404 . . . . 0.0 112.109 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -51.99 -32.08 32.22 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.314 1.446 . . . . 0.0 112.472 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -90.16 -38.23 13.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.286 1.034 . . . . 0.0 110.786 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.2 mt -65.95 106.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.324 0.65 . . . . 0.0 109.864 -171.546 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.28 29.07 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 47.4 tp -83.32 87.82 6.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.472 1.109 . . . . 0.0 109.659 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 89.7 mt -76.73 154.71 33.86 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.02 0.928 . . . . 0.0 109.148 172.012 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -148.97 112.11 4.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.331 0.652 . . . . 0.0 109.585 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 66.5 m -78.44 132.92 37.5 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.422 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -131.21 143.38 50.54 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.994 0.918 . . . . 0.0 110.962 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.76 172.92 17.36 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.034 1.334 . . . . 0.0 109.524 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 75.1 m -144.42 139.54 28.44 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.087 0.955 . . . . 0.0 108.874 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.63 -75.53 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.78 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.94 46.92 1.24 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.844 0.858 . . . . 0.0 111.546 -170.019 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.77 41.03 50.12 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -170.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -149.27 120.59 7.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.326 1.45 . . . . 0.0 107.376 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.74 111.49 7.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -90.16 143.36 26.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -150.43 161.73 41.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.577 0.351 . . . . 0.0 110.631 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 t -153.02 132.01 12.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.757 0.823 . . . . 0.0 109.153 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -105.84 144.66 32.26 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.975 1.31 . . . . 0.0 111.552 -169.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -139.29 113.19 8.6 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.081 1.352 . . . . 0.0 109.038 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -88.87 99.16 12.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.0 p -89.57 106.81 18.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -112.39 179.61 3.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.224 1.41 . . . . 0.0 110.557 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 . . . . . 0 CA--C 1.53 0.188 0 C-N-CA 123.846 0.858 . . . . 0.0 112.111 -178.374 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -82.05 -175.86 2.73 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.72 2.947 . . . . 0.0 110.319 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 73.88 103.11 0.07 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.555 1.942 . . . . 0.0 111.948 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.22 -52.54 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -96.26 78.18 3.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.024 0.93 . . . . 0.0 108.728 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ttt -80.94 139.91 35.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -172.78 0.3 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.363 1.065 . . . . 0.0 112.076 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.4 t -148.48 -162.37 1.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 108.891 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.7 95.94 0.69 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 32.4 mm 116.6 120.08 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 1 C-N-CA 132.131 4.172 . . . . 0.0 107.332 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.15 139.59 32.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.346 2.697 . . . . 0.0 110.113 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -65.78 130.08 42.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.267 0.627 . . . . 0.0 111.273 -177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -72.52 138.03 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.396 1.078 . . . . 0.0 109.82 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.8 mt -128.45 127.87 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.017 1.327 . . . . 0.0 107.873 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -90.9 125.05 35.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -150.31 176.6 10.74 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.498 0.719 . . . . 0.0 110.367 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.3 m -150.08 143.05 24.86 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 170.737 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.77 141.56 55.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.483 0.313 . . . . 0.0 110.16 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.5 -35.75 4.81 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.11 0.862 . . . . 0.0 111.69 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.76 169.78 11.34 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.708 0.754 . . . . 0.0 110.586 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.49 147.73 37.63 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.247 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.22 108.88 4.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -171.123 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.75 130.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -106.87 97.27 16.96 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.59 77.3 4.11 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.068 2.512 . . . . 0.0 111.134 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -115.46 53.66 0.83 Allowed 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.918 1.287 . . . . 0.0 109.183 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -66.47 148.39 51.95 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.273 0.629 . . . . 0.0 110.738 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.08 175.58 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 109.793 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.9 p -67.26 -40.49 86.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.832 0.853 . . . . 0.0 111.823 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -150.74 149.04 24.71 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.274 0.63 . . . . 0.0 111.064 -171.019 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.23 -37.98 40.58 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.749 2.966 . . . . 0.0 112.613 166.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -53.24 -29.26 31.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.975 1.71 . . . . 0.0 113.03 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.8 mm -55.5 -34.74 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.012 0.925 . . . . 0.0 110.796 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.1 m 63.85 80.23 0.24 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.313 1.445 . . . . 0.0 110.564 173.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.79 141.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.6 m -120.92 128.57 52.89 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.681 1.192 . . . . 0.0 108.173 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.1 tp -89.16 131.79 35.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -134.77 177.24 7.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 109.651 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -146.62 148.94 32.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.995 0.918 . . . . 0.0 109.439 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.11 137.52 88.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.586 0.754 . . . . 0.0 109.721 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.74 -59.28 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.985 1.031 . . . . 0.0 111.857 0.706 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.3 mt -140.01 42.98 1.94 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.615 1.166 . . . . 0.0 109.768 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.65 145.28 27.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.9 m -122.2 128.55 51.34 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 124.202 1.001 . . . . 0.0 108.659 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.0 mt -111.9 79.23 1.19 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.656 1.582 . . . . 0.0 107.693 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.55 132.66 91.12 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 109.613 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.86 87.08 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.25 2.634 . . . . 0.0 110.402 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.26 -23.2 66.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.809 1.244 . . . . 0.0 112.859 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 82.84 17.43 67.81 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.573 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -129.07 -63.16 0.97 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -73.87 -68.43 0.52 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.815 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.7 mt -89.5 95.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.0 mt -95.9 115.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -89.35 117.07 28.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.475 0.71 . . . . 0.0 110.005 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -115.01 108.63 16.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.9 p -58.54 -29.42 66.33 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.74 0.816 . . . . 0.0 113.176 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -102.6 22.64 13.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.917 0.887 . . . . 0.0 112.177 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -149.17 -57.86 0.21 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.457 0.571 . . . . 0.0 111.115 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.58 -172.11 34.27 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -89.35 113.0 24.24 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.87 95.06 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.71 89.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 170.108 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 65.1 p -60.08 -35.04 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.785 1.234 . . . . 0.0 112.54 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.05 93.89 4.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.282 1.033 . . . . 0.0 108.391 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.26 150.81 38.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.468 0.707 . . . . 0.0 110.398 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 38.5 p -146.31 171.49 14.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.678 1.191 . . . . 0.0 109.208 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -51.42 -34.71 36.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.421 1.088 . . . . 0.0 111.621 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -56.59 -26.82 56.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.97 1.308 . . . . 0.0 112.071 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -82.9 -39.59 21.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.485 0.714 . . . . 0.0 111.839 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.2 108.4 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.119 0.967 . . . . 0.0 110.369 -169.7 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 147.23 -162.48 28.62 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.989 0.804 . . . . 0.0 111.334 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.19 88.3 6.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.226 1.01 . . . . 0.0 109.255 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.5 154.5 41.82 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.108 0.963 . . . . 0.0 109.298 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.0 m -149.73 108.75 3.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.039 0.936 . . . . 0.0 109.308 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.8 m -79.83 133.26 36.27 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -127.95 141.57 51.5 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.276 1.03 . . . . 0.0 110.078 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.42 120.69 6.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.117 0.967 . . . . 0.0 109.637 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.4 m -100.53 77.61 1.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.793 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.93 -52.65 29.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -109.41 177.78 4.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.613 1.165 . . . . 0.0 108.748 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.96 70.65 1.48 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 169.72 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -145.56 -43.25 0.22 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.566 1.547 . . . . 0.0 110.289 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp 64.11 91.22 0.08 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.854 1.662 . . . . 0.0 109.681 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -89.48 147.4 24.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.998 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -150.52 164.24 36.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.542 0.337 . . . . 0.0 111.61 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.2 t -147.11 129.12 15.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.701 1.2 . . . . 0.0 108.233 174.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -107.68 151.4 25.71 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.24 1.416 . . . . 0.0 112.688 -168.803 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -144.88 121.91 11.39 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.993 1.317 . . . . 0.0 108.956 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.24 102.51 14.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.1 p -89.57 124.15 34.29 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.64 0.776 . . . . 0.0 109.419 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -120.68 147.3 45.46 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.905 0.882 . . . . 0.0 110.133 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 . . . . . 0 N--CA 1.451 -0.413 0 C-N-CA 123.796 0.838 . . . . 0.0 109.894 178.684 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.81 -171.98 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.531 2.821 . . . . 0.0 111.401 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 77.57 104.81 0.07 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 127.199 2.2 . . . . 0.0 111.6 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.26 -50.39 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.465 1.106 . . . . 0.0 109.343 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.62 -70.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.399 0.68 . . . . 0.0 109.518 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ttt 64.23 116.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.569 1.948 . . . . 0.0 112.834 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.64 151.46 47.26 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.1 p -78.56 -62.64 1.62 Allowed 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.148 -0.345 . . . . 0.0 110.263 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -158.77 -51.66 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.426 1.09 . . . . 0.0 109.055 -171.139 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 34.6 mm -79.69 126.9 79.54 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.14 139.82 34.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.665 2.91 . . . . 0.0 112.519 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.18 119.75 12.6 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.4 mm -77.66 102.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.3 mt -92.22 143.66 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.337 1.055 . . . . 0.0 108.208 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -120.64 79.91 1.55 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.533 1.133 . . . . 0.0 110.12 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -89.5 -177.72 5.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.527 1.131 . . . . 0.0 111.064 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -142.31 117.57 10.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 169.202 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.65 123.55 9.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.631 0.773 . . . . 0.0 109.983 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.36 -39.74 2.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.823 1.201 . . . . 0.0 111.167 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -89.31 165.63 14.28 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.695 0.748 . . . . 0.0 111.363 -171.359 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -67.71 129.87 41.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -128.0 124.47 37.27 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.484 1.113 . . . . 0.0 109.561 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.03 134.76 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.5 mm -101.09 100.85 14.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.4 76.23 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 111.108 -165.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.1 p -125.58 45.02 2.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.291 1.037 . . . . 0.0 110.406 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 0.817 ' HB2' ' O ' ' A' ' 188' ' ' SER . 41.1 ptt180 -67.25 151.38 47.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.906 0.483 . . . . 0.0 110.771 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.1 175.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.929 1.292 . . . . 0.0 111.366 -169.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.1 p -75.73 -24.28 56.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -172.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.7 m -158.36 149.92 16.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.031 0.832 . . . . 0.0 110.824 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.72 -36.35 41.47 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.011 3.141 . . . . 0.0 113.654 168.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.59 -36.59 35.62 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.327 1.851 . . . . 0.0 111.935 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 41.6 mm -50.46 -42.74 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.861 1.264 . . . . 0.0 111.19 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 60.58 83.71 0.14 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.037 1.335 . . . . 0.0 111.044 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.68 147.49 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.609 0.764 . . . . 0.0 108.987 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.3 m -124.83 138.77 54.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.84 1.256 . . . . 0.0 107.852 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.0 tp -88.93 125.75 35.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -128.26 -179.55 5.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.878 1.271 . . . . 0.0 110.035 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -147.72 148.19 30.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 108.223 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -58.1 134.22 84.17 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.116 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.72 -59.97 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.962 1.022 . . . . 0.0 111.828 0.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.8 mt -141.83 38.26 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 110.162 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.6 148.28 40.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 170.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 91.0 m -125.75 118.32 25.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.757 0.823 . . . . 0.0 109.904 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.04 88.67 6.2 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 79.5 mt -61.36 130.44 91.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.636 0.775 . . . . 0.0 109.306 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.37 85.32 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.204 2.602 . . . . 0.0 110.247 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -60.78 -22.92 64.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.275 1.43 . . . . 0.0 113.28 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.72 28.07 65.89 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 118.374 0.534 . . . . 0.0 112.646 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.56 -64.26 0.72 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.078 1.351 . . . . 0.0 107.705 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -84.6 -58.43 2.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.8 mt -91.74 89.78 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 78.4 mt -95.22 116.35 36.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -89.1 129.55 35.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -135.6 122.17 20.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.289 1.036 . . . . 0.0 108.289 170.384 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 60.7 p -58.8 -26.46 64.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 112.379 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -98.75 10.93 40.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.883 0.873 . . . . 0.0 113.147 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -145.55 -57.85 0.32 Allowed 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.83 0.741 . . . . 0.0 110.603 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.31 -164.66 29.36 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.79 111.41 22.4 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.53 97.41 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.1 110.84 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 92.1 p -65.15 -35.62 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.518 0.599 . . . . 0.0 112.499 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -140.33 101.84 4.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.836 1.255 . . . . 0.0 107.99 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.11 157.58 25.1 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.365 0.666 . . . . 0.0 110.177 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 80.3 p -133.06 164.28 27.37 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.725 0.81 . . . . 0.0 110.177 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -59.63 -32.13 70.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.283 0.633 . . . . 0.0 110.969 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -60.3 -25.74 65.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.262 1.025 . . . . 0.0 111.947 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.29 -12.29 59.63 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.654 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.61 105.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.44 1.018 . . . . 0.0 109.212 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.82 -159.04 28.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.5 81.36 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.918 0.887 . . . . 0.0 110.562 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 97.9 mt -65.83 150.91 47.8 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 27.7 m -150.01 114.64 5.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.466 0.706 . . . . 0.0 109.416 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 84.6 m -78.23 124.48 28.12 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -121.55 141.49 51.01 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.316 1.047 . . . . 0.0 110.447 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.07 102.06 2.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.558 1.143 . . . . 0.0 109.198 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.2 m -89.88 86.34 6.61 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.92 -56.07 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.279 0.632 . . . . 0.0 109.786 -174.263 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -158.03 -75.51 0.08 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.981 0.913 . . . . 0.0 109.415 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.29 -46.54 78.1 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 123.362 0.506 . . . . 0.0 112.398 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -140.06 162.39 35.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.235 0.614 . . . . 0.0 111.395 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.59 101.96 9.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -89.85 133.2 34.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.55 161.71 42.02 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 62.7 p -139.72 133.6 30.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.518 1.127 . . . . 0.0 109.086 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -106.87 145.55 32.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.209 1.004 . . . . 0.0 111.743 -170.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -143.06 105.43 4.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.714 1.606 . . . . 0.0 109.235 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.69 108.67 19.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.9 p -89.26 90.65 8.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.462 0.705 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -89.61 103.43 16.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 . . . . . 0 CA--C 1.531 0.23 0 CA-C-N 118.993 0.815 . . . . 0.0 110.777 -177.246 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.39 -37.41 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.166 2.577 . . . . 0.0 111.37 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -62.08 143.42 56.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 112.366 -174.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.29 -55.85 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -92.45 126.75 37.67 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 108.922 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.17 141.01 42.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.077 1.351 . . . . 0.0 108.996 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.16 121.09 12.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.549 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -68.91 -39.51 79.62 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.8 -0.563 . . . . 0.0 111.222 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -158.92 -58.34 0.07 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.6 mm -87.77 130.99 44.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.96 147.4 26.22 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.549 2.833 . . . . 0.0 112.429 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.87 118.98 11.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.2 94.68 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.6 mt -89.54 108.28 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -76.9 89.25 3.49 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.09 0.956 . . . . 0.0 108.552 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -104.36 173.51 6.27 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.395 1.478 . . . . 0.0 111.387 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 94.1 m -138.36 120.74 15.96 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -59.67 144.67 47.31 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.719 0.408 . . . . 0.0 110.364 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.22 -37.32 3.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -89.15 170.15 10.86 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.728 0.811 . . . . 0.0 110.672 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.57 145.57 54.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.815 0.446 . . . . 0.0 110.813 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.5 tp -143.31 108.5 5.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.88 1.272 . . . . 0.0 108.451 -172.064 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.64 131.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mm -108.63 91.52 8.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.73 89.19 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.459 2.773 . . . . 0.0 111.851 -164.368 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.7 p -135.62 48.73 2.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.557 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ARG . . . . . 1.283 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -62.87 157.38 21.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.253 0.549 . . . . 0.0 112.174 176.603 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.85 175.01 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.819 1.648 . . . . 0.0 108.94 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 p -63.7 -42.4 97.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.474 0.71 . . . . 0.0 112.04 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.9 m -142.72 140.89 19.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.999 0.92 . . . . 0.0 110.24 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.17 -26.9 42.03 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.669 2.913 . . . . 0.0 112.027 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -52.77 -31.82 40.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.313 1.445 . . . . 0.0 112.082 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.78 -35.07 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.982 1.313 . . . . 0.0 110.915 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 m 69.02 91.29 0.09 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.537 1.535 . . . . 0.0 110.383 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.33 141.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.8 m -110.45 126.84 54.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.719 1.208 . . . . 0.0 108.092 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.0 tp -89.23 133.34 34.48 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -133.82 174.82 10.04 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.767 1.227 . . . . 0.0 109.764 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -149.23 148.21 29.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.645 0.778 . . . . 0.0 109.413 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.7 134.95 82.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.928 0.891 . . . . 0.0 109.96 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.27 -59.2 0.13 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 119.917 1.006 . . . . 0.0 111.697 1.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -142.52 44.2 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.597 1.159 . . . . 0.0 109.943 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -82.03 152.03 26.84 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 89.7 m -131.71 119.09 20.87 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.133 0.973 . . . . 0.0 108.942 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.95 113.35 26.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.283 1.433 . . . . 0.0 108.569 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.74 130.9 74.96 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.74 91.4 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.861 2.374 . . . . 0.0 109.731 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -64.31 -22.6 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.478 1.111 . . . . 0.0 113.144 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.48 59.22 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.233 -0.76 . . . . 0.0 113.428 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -137.12 -60.12 0.69 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.649 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -79.7 -66.48 0.87 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -89.56 94.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 40.9 mt -94.6 121.68 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -89.21 127.83 35.78 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.09 100.8 4.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.773 1.229 . . . . 0.0 108.38 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' SER . . . . . 1.283 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.7 p -53.79 -27.74 30.91 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -73.01 -28.43 62.36 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.113 0.965 . . . . 0.0 112.611 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.31 -63.34 1.34 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.728 0.811 . . . . 0.0 110.65 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.21 26.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.84 111.71 22.83 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.35 94.54 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.14 85.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -58.19 -29.5 65.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.481 1.512 . . . . 0.0 113.336 -170.774 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -132.62 97.25 4.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.09 156.91 36.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.055 0.542 . . . . 0.0 110.393 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 43.0 p -125.53 154.43 42.15 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.143 0.977 . . . . 0.0 109.67 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -55.28 -32.55 62.5 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.172 0.989 . . . . 0.0 111.671 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -53.49 -37.35 62.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.642 1.177 . . . . 0.0 111.481 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -83.34 4.37 27.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.397 1.079 . . . . 0.0 113.2 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.3 mt -73.87 115.51 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.62 -111.5 0.48 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.8 tp -144.98 100.71 3.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.96 0.904 . . . . 0.0 109.975 -172.022 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.7 156.67 19.88 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.816 0.846 . . . . 0.0 109.128 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.7 m -147.28 117.73 7.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.395 1.078 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 60.4 m -85.04 140.01 31.33 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -133.94 147.44 51.06 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.995 0.918 . . . . 0.0 109.91 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.91 130.63 6.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.332 0.653 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.8 m -100.06 133.88 43.8 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.954 1.302 . . . . 0.0 109.329 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.7 t -100.49 -62.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.261 1.024 . . . . 0.0 108.524 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -140.31 84.79 1.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.066 0.947 . . . . 0.0 109.106 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.22 -57.47 5.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.05 0.834 . . . . 0.0 111.928 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.49 129.25 36.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.766 0.827 . . . . 0.0 110.289 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.86 156.8 30.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.634 0.73 . . . . 0.0 111.046 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -125.41 154.57 41.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -151.2 162.74 40.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 t -151.44 141.42 22.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.924 0.89 . . . . 0.0 109.639 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -109.17 147.49 32.42 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.288 1.435 . . . . 0.0 112.794 -168.952 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -143.76 101.9 3.83 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.457 1.503 . . . . 0.0 109.118 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.1 tt -80.31 110.98 16.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 108.772 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.9 p -89.4 93.29 9.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.532 1.133 . . . . 0.0 109.024 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -89.92 120.56 31.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.23 1.412 . . . . 0.0 108.749 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.662 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.65 -61.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.56 2.173 . . . . 0.0 111.341 -173.782 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -71.56 132.9 45.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.348 0.659 . . . . 0.0 111.729 -171.674 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.89 -61.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -81.98 109.59 16.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ttt -123.92 123.6 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.92 0.888 . . . . 0.0 110.252 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.95 147.3 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.998 0.919 . . . . 0.0 110.709 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 m -154.44 -58.5 0.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.064 1.345 . . . . 0.0 109.25 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -97.32 79.74 2.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.867 0.867 . . . . 0.0 110.273 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.4 mm 78.36 128.4 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 128.142 2.577 . . . . 0.0 109.748 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.74 138.32 33.32 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.348 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.67 120.55 11.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.099 0.56 . . . . 0.0 109.981 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.8 mm -76.53 122.6 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.0 mt -122.75 102.94 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -75.79 83.79 2.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.283 1.033 . . . . 0.0 109.524 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -92.87 155.62 17.49 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.068 0.947 . . . . 0.0 111.383 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 83.5 m -115.72 112.77 22.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -57.7 137.58 56.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.465 0.706 . . . . 0.0 109.88 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 104.31 -36.38 4.42 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.15 0.881 . . . . 0.0 111.385 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.5 179.48 6.05 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.525 0.73 . . . . 0.0 110.897 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.06 137.82 45.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.29 108.79 8.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.85 -175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -90.0 128.85 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 108.176 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -109.25 94.02 14.58 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.68 100.47 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.347 2.698 . . . . 0.0 110.643 -166.399 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -145.03 59.14 1.3 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 110.126 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -66.9 155.67 37.82 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.03 164.81 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.733 1.213 . . . . 0.0 110.646 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -61.85 -45.25 94.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.509 1.524 . . . . 0.0 111.517 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.0 m -135.82 145.67 53.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.321 1.048 . . . . 0.0 110.204 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.48 -26.09 34.66 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.352 2.701 . . . . 0.0 111.366 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -53.97 -29.31 42.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.781 1.632 . . . . 0.0 112.312 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.57 -51.91 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.066 0.946 . . . . 0.0 109.873 172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 11.7 m 63.39 93.39 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.494 1.517 . . . . 0.0 110.612 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.02 144.5 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.763 0.825 . . . . 0.0 109.231 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.5 m -112.76 129.82 56.29 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.764 1.226 . . . . 0.0 107.739 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.97 126.4 35.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -126.4 -177.34 3.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.326 1.051 . . . . 0.0 109.424 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -159.24 147.77 17.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 108.889 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.33 134.91 85.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.962 0.905 . . . . 0.0 110.645 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.41 -58.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.897 0.999 . . . . 0.0 111.649 0.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -141.82 38.46 1.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.71 1.204 . . . . 0.0 109.765 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.1 139.5 38.07 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 87.5 m -113.81 114.63 26.55 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.606 0.762 . . . . 0.0 109.477 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.98 85.43 6.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.4 129.32 88.99 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.412 0.685 . . . . 0.0 109.522 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.69 81.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.116 2.544 . . . . 0.0 109.921 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -60.42 -23.09 64.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.622 1.569 . . . . 0.0 113.426 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.29 32.67 65.1 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.58 0.61 . . . . 0.0 112.167 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -138.91 -59.12 0.6 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.235 1.414 . . . . 0.0 108.162 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -94.67 -56.57 2.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.813 1.245 . . . . 0.0 108.411 171.186 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.2 96.67 6.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 125.362 1.465 . . . . 0.0 108.179 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.63 148.08 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -120.31 138.58 53.63 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 125.113 1.365 . . . . 0.0 109.313 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -141.81 116.44 9.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.94 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 80.2 p -53.92 -32.52 53.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.947 1.299 . . . . 0.0 112.992 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.1 mtm-85 -83.28 -5.78 59.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.738 0.815 . . . . 0.0 112.848 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -141.13 -62.21 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.196 0.907 . . . . 0.0 111.719 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.45 -162.04 31.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.0 123.03 38.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.635 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.8 mp -103.28 98.12 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.01 96.27 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.1 p -55.9 -40.22 72.73 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.234 1.414 . . . . 0.0 112.842 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.13 99.67 6.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.821 1.248 . . . . 0.0 107.848 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.72 139.27 56.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.393 0.677 . . . . 0.0 110.527 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 59.3 p -131.98 -177.43 4.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.189 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -51.14 -32.2 22.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.032 1.333 . . . . 0.0 112.387 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -53.71 -29.77 40.74 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.508 1.123 . . . . 0.0 112.171 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -110.6 47.24 0.99 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.752 0.821 . . . . 0.0 110.918 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.09 94.28 2.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 150.23 -158.29 27.6 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.821 1.2 . . . . 0.0 110.445 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.4 tp -85.93 92.29 8.62 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.857 0.863 . . . . 0.0 109.949 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.63 159.11 31.53 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.7 m -148.26 108.28 4.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.195 0.998 . . . . 0.0 109.29 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.23 118.83 19.36 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -113.58 131.85 55.95 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.682 1.193 . . . . 0.0 110.297 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.16 50.3 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.303 1.441 . . . . 0.0 109.501 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 93.8 m -140.73 118.43 11.66 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.07 -54.95 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.847 0.859 . . . . 0.0 109.353 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -130.39 -65.08 0.82 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.173 0.989 . . . . 0.0 109.554 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -166.93 40.68 0.25 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -93.67 -47.08 6.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.209 1.404 . . . . 0.0 110.343 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 tp 63.68 88.56 0.1 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.932 1.693 . . . . 0.0 110.35 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.55 140.82 29.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.76 141.53 40.93 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.298 0.639 . . . . 0.0 109.909 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 35.3 p -133.44 123.89 26.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 108.099 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -102.3 144.59 30.6 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.031 0.932 . . . . 0.0 112.813 -169.202 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -142.96 107.72 4.87 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.857 1.663 . . . . 0.0 108.252 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.58 108.51 20.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.852 0.861 . . . . 0.0 109.174 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 32.1 p -89.62 114.82 26.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.099 0.96 . . . . 0.0 109.925 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -89.85 135.78 33.43 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.316 1.046 . . . . 0.0 109.148 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 169.722 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.87 -27.21 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.19 2.594 . . . . 0.0 111.405 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -65.58 132.24 48.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.101 1.361 . . . . 0.0 112.554 -169.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.44 -49.63 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -81.38 101.26 9.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.28 0.632 . . . . 0.0 109.697 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.57 136.33 33.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 139' ' ' TYR . 1.2 p90 -79.42 48.16 0.88 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.623 0.769 . . . . 0.0 111.352 175.242 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 m -34.25 111.46 0.11 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.718 2.007 . . . . 0.0 110.76 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 1.61 71.52 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.838 2.455 . . . . 0.0 114.748 -167.127 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.7 mt 157.56 132.33 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 129.466 3.106 . . . . 0.0 108.584 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 148.11 60.16 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.316 2.677 . . . . 0.0 110.613 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.01 119.37 14.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.243 0.617 . . . . 0.0 109.472 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -78.99 99.81 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.63 115.44 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -80.09 83.61 5.95 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.691 1.197 . . . . 0.0 108.652 173.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -89.34 172.99 8.63 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.218 0.607 . . . . 0.0 112.159 -169.952 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.7 m -142.24 114.07 8.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.608 1.163 . . . . 0.0 108.189 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.55 145.51 18.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.884 0.873 . . . . 0.0 110.883 174.227 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.01 -48.17 1.8 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.144 0.878 . . . . 0.0 111.155 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -89.52 -178.21 5.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.796 0.838 . . . . 0.0 111.057 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.98 142.42 49.38 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.119 0.568 . . . . 0.0 110.948 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -139.72 110.18 6.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.455 1.502 . . . . 0.0 106.998 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.1 t -90.49 134.81 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.129 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.58 93.55 8.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.56 80.27 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.186 2.59 . . . . 0.0 111.977 -164.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 25.1 p -120.32 52.8 1.12 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.569 1.148 . . . . 0.0 110.722 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -57.56 147.81 25.89 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.288 1.035 . . . . 0.0 110.956 172.897 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -113.27 155.75 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 123.983 0.913 . . . . 0.0 111.305 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.0 p -70.02 -32.95 71.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.563 1.545 . . . . 0.0 111.496 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -126.38 113.04 23.38 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 124.979 1.312 . . . . 0.0 107.462 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -68.42 -20.51 41.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.238 2.625 . . . . 0.0 111.582 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -52.9 -36.25 59.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.688 172.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.78 86.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 30.8 m -66.64 126.18 28.14 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.804 0.842 . . . . 0.0 108.97 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.65 149.63 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.035 0.934 . . . . 0.0 109.634 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.5 m -105.84 115.78 30.82 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.912 1.285 . . . . 0.0 108.06 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 tp -89.62 104.17 16.75 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.378 0.671 . . . . 0.0 109.397 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.92 173.37 7.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 109.8 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -148.94 146.86 28.05 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.406 1.082 . . . . 0.0 108.666 169.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.62 134.5 86.07 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.816 0.846 . . . . 0.0 110.37 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.52 -59.39 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.883 0.994 . . . . 0.0 111.92 0.712 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.75 41.29 1.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.571 1.148 . . . . 0.0 109.944 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -83.27 153.31 24.73 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 m -123.78 107.87 11.89 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.277 1.031 . . . . 0.0 108.641 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.2 78.22 5.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.8 mt -59.66 131.44 88.55 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.357 1.063 . . . . 0.0 109.868 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.17 87.95 0.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.255 2.637 . . . . 0.0 110.31 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.39 -23.08 66.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.323 1.049 . . . . 0.0 112.743 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.89 -15.3 61.89 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.719 -1.045 . . . . 0.0 113.674 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.86 -60.58 1.65 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.508 1.154 . . . . 0.0 109.441 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -76.54 -67.72 0.67 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 mt -89.77 99.17 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.1 mt -98.7 120.75 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -89.09 95.95 10.52 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.012 0.525 . . . . 0.0 109.716 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.94 101.1 13.81 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.9 p -56.9 -27.81 61.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.157 0.983 . . . . 0.0 113.634 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -104.53 22.37 15.1 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.31 1.044 . . . . 0.0 112.153 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -147.09 -60.06 0.28 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.572 0.624 . . . . 0.0 110.306 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.5 -168.14 35.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.56 112.64 23.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.96 98.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -82.98 97.28 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.444 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 72.8 p -61.21 -37.53 83.33 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.153 0.981 . . . . 0.0 112.345 -175.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -121.21 87.96 2.85 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.532 1.133 . . . . 0.0 109.28 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.07 163.23 15.25 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.319 0.247 . . . . 0.0 110.7 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 46.5 p -139.86 160.25 40.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.899 0.88 . . . . 0.0 109.947 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -58.71 -34.26 71.13 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.74 0.816 . . . . 0.0 110.869 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -61.12 -34.61 75.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.966 0.907 . . . . 0.0 111.275 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.95 -8.4 56.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.596 0.758 . . . . 0.0 112.645 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.5 mt -65.4 127.26 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.01 -119.97 0.95 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.7 tp -144.76 95.25 2.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.234 1.014 . . . . 0.0 108.797 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 153.42 28.96 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 41.1 m -143.57 102.86 4.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.196 0.998 . . . . 0.0 108.979 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.72 132.09 43.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -134.03 135.59 43.46 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.125 0.97 . . . . 0.0 109.672 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.14 119.48 8.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.583 1.153 . . . . 0.0 108.613 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 m -89.69 59.13 4.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.082 0.553 . . . . 0.0 110.275 -172.213 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.86 141.06 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 57.53 24.43 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.051 1.34 . . . . 0.0 112.177 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.1 -5.9 23.83 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.112 -0.827 . . . . 0.0 113.231 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -89.92 129.56 36.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.573 1.186 . . . . 0.0 108.255 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.38 85.91 1.12 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.501 0.72 . . . . 0.0 109.439 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -88.93 141.24 28.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.65 162.9 39.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.228 0.611 . . . . 0.0 111.449 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.7 t -143.23 128.34 18.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.974 1.309 . . . . 0.0 107.713 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -106.07 150.98 25.25 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.416 1.486 . . . . 0.0 112.446 -169.088 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -142.74 105.3 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.488 1.515 . . . . 0.0 108.573 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -79.4 108.64 13.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.5 p -89.23 91.65 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -98.17 121.82 40.57 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.653 1.581 . . . . 0.0 107.608 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 . . . . . 0 C--N 1.34 0.157 0 CA-C-N 119.097 0.862 . . . . 0.0 109.699 174.225 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.477 ' N ' ' HG1' ' A' ' 161' ' ' THR . 55.0 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 119.845 -0.121 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.27 -61.14 2.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.23 0.612 . . . . 0.0 109.821 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.2 p -86.65 68.17 10.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.65 -74.31 0.06 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -172.81 128.51 0.55 Allowed Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.555 1.142 . . . . 0.0 108.221 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.43 -45.32 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.903 2.402 . . . . 0.0 111.214 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -64.26 144.65 56.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.646 1.178 . . . . 0.0 111.129 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.6 t -78.12 -47.14 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 143.46 51.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.286 1.434 . . . . 0.0 108.889 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.5 ptm -139.94 163.0 33.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.037 0.935 . . . . 0.0 109.683 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.55 155.72 32.14 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.592 0.757 . . . . 0.0 110.307 169.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.7 t -82.71 -69.04 0.65 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.48 -52.77 0.36 Allowed 'General case' 0 CA--C 1.523 -0.063 0 C-N-CA 125.454 1.502 . . . . 0.0 108.107 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.7 mt -75.86 127.06 86.24 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.12 146.89 16.53 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.833 3.022 . . . . 0.0 112.722 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.24 117.57 9.44 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.4 mm -81.12 97.52 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.4 mt -89.75 110.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -80.07 81.16 6.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.453 1.101 . . . . 0.0 108.942 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.8 ptm -89.82 176.03 6.99 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.491 1.116 . . . . 0.0 112.114 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.4 m -146.46 142.03 27.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.153 1.381 . . . . 0.0 107.356 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.03 146.77 52.49 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.989 0.516 . . . . 0.0 110.909 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.43 -11.71 54.46 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.554 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -89.84 165.96 13.81 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.534 1.167 . . . . 0.0 110.983 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 95.49 2.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.062 0.945 . . . . 0.0 109.019 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.87 104.55 17.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.218 1.007 . . . . 0.0 108.963 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.85 129.43 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.11 99.58 17.54 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.82 85.14 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.217 2.611 . . . . 0.0 111.425 -167.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.4 48.31 2.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.59 1.156 . . . . 0.0 109.593 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.699 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.0 ptt180 -67.92 157.29 35.31 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.617 0.767 . . . . 0.0 110.902 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.34 147.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.476 1.11 . . . . 0.0 110.896 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.477 ' HG1' ' N ' ' A' ' 129' ' ' SER . 41.5 p -55.65 -48.42 75.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.594 1.158 . . . . 0.0 111.487 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.6 m -113.29 109.58 51.46 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 124.849 1.26 . . . . 0.0 107.819 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.23 -32.89 11.09 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 124.528 3.485 . . . . 0.0 114.247 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -50.74 -37.56 42.52 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.649 1.58 . . . . 0.0 112.284 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.1 mt -51.68 -51.76 25.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 124.746 1.219 . . . . 0.0 110.453 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 68.23 111.68 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.514 1.525 . . . . 0.0 111.462 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.8 t -89.5 151.69 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.0 109.063 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 m -112.96 121.53 44.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.758 1.223 . . . . 0.0 107.979 172.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.51 98.18 11.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.644 0.777 . . . . 0.0 109.026 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -90.77 174.4 7.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.592 0.757 . . . . 0.0 109.977 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -144.26 145.05 31.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.155 1.382 . . . . 0.0 107.613 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.9 134.2 92.5 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.673 0.789 . . . . 0.0 110.638 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.9 -58.96 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.928 1.01 . . . . 0.0 111.853 0.402 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -140.28 41.94 1.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.567 1.147 . . . . 0.0 110.06 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -79.6 156.85 27.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.7 m -132.76 113.15 12.62 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.662 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.91 86.28 6.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.3 mm -60.49 127.11 86.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 109.604 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 86.14 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.969 2.446 . . . . 0.0 109.955 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -58.18 -25.29 61.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.916 1.286 . . . . 0.0 113.233 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 72.69 33.74 60.27 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.08 -61.33 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.126 1.37 . . . . 0.0 107.973 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -99.67 -53.08 3.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.681 1.193 . . . . 0.0 108.468 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.47 89.06 3.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -96.38 119.23 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -89.0 94.75 10.06 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.441 0.696 . . . . 0.0 109.142 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -89.85 98.68 11.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.699 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 68.1 p -51.96 -27.05 11.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 113.734 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.28 17.72 23.52 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.138 0.975 . . . . 0.0 113.167 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -144.78 -56.45 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.809 0.731 . . . . 0.0 110.894 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.97 -169.61 38.2 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.15 110.6 21.32 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 172.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.1 mt -92.22 94.72 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.561 1.544 . . . . 0.0 108.342 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.28 95.68 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -53.43 -37.13 62.26 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.673 1.189 . . . . 0.0 113.112 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -130.79 96.29 4.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.165 0.986 . . . . 0.0 108.566 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.23 140.86 57.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 111.574 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.8 p -133.06 179.97 5.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.52 1.128 . . . . 0.0 109.42 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -54.49 -30.65 53.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.679 1.192 . . . . 0.0 112.12 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -58.77 -20.63 51.44 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.48 1.112 . . . . 0.0 112.032 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -115.48 37.65 3.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.184 1.394 . . . . 0.0 110.82 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -120.75 100.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.7 -165.0 34.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 57.9 tp -89.29 91.72 8.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.041 0.936 . . . . 0.0 109.285 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.6 152.91 37.59 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.4 m -143.27 105.98 4.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.225 1.01 . . . . 0.0 108.515 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 87.1 m -74.11 132.71 42.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -130.81 142.08 50.37 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.323 1.049 . . . . 0.0 110.205 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.97 115.07 4.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.52 0.728 . . . . 0.0 110.315 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 53.9 m -89.81 124.07 34.34 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 44.8 t -118.74 -101.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.607 0.763 . . . . 0.0 109.448 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -88.29 59.07 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.969 1.308 . . . . 0.0 109.712 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 57.66 38.97 90.28 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -172.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -150.31 124.05 9.19 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.432 1.093 . . . . 0.0 108.492 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 65.5 tp -83.41 116.16 22.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.374 1.07 . . . . 0.0 109.5 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -100.58 151.94 21.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 164.28 35.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.713 0.405 . . . . 0.0 111.176 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.5 t -154.4 139.54 17.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.483 0.713 . . . . 0.0 109.797 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 42.7 m-80 -106.65 147.04 30.02 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.959 1.304 . . . . 0.0 112.836 -168.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -142.78 104.79 4.4 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.13 109.64 18.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.5 p -89.59 94.49 9.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 109.014 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -89.87 128.36 36.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.971 1.709 . . . . 0.0 109.537 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -66.37 109.93 2.9 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -58.99 144.1 46.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.535 1.134 . . . . 0.0 110.44 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 60.2 p -81.4 66.36 6.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.889 0.876 . . . . 0.0 109.393 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -127.72 -53.95 1.33 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.219 1.407 . . . . 0.0 110.165 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.2 t -164.67 -163.5 0.73 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.275 1.43 . . . . 0.0 108.312 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.771 -1.109 . . . . 0.0 109.456 174.542 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 120.771 0.319 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.04 165.35 16.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.647 0.779 . . . . 0.0 111.04 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.9 p -61.34 -42.11 98.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.661 1.184 . . . . 0.0 110.842 171.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -166.56 -111.82 0.25 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -169.56 134.18 1.24 Allowed Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.25 -53.59 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.754 2.303 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.11 144.71 50.19 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.033 0.933 . . . . 0.0 111.736 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.4 46.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.57 -85.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.231 1.412 . . . . 0.0 108.121 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 ttt 71.08 132.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.631 1.972 . . . . 0.0 113.315 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.68 147.39 53.11 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.708 0.803 . . . . 0.0 110.058 173.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -77.96 -57.66 3.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -32.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.245 1.018 . . . . 0.0 111.646 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.79 117.77 69.15 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.12 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 135.59 68.74 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.03 2.487 . . . . 0.0 110.954 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -68.06 133.74 49.48 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.7 mm -82.34 95.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.755 0.822 . . . . 0.0 108.879 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.69 101.96 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -74.36 85.98 1.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.462 1.105 . . . . 0.0 108.951 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 9.6 ptm -89.17 166.86 13.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.629 0.772 . . . . 0.0 111.233 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.9 m -139.35 126.0 20.62 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.37 141.61 58.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.431 0.692 . . . . 0.0 110.342 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.97 -19.61 41.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.864 -0.965 . . . . 0.0 112.785 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -89.99 165.48 14.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.511 1.155 . . . . 0.0 110.749 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.32 96.01 2.76 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 109.197 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.98 109.96 20.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 108.975 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.51 127.15 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.553 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 44.2 mm -104.15 93.12 5.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.56 114.8 3.95 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.729 2.286 . . . . 0.0 109.877 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.7 p -162.42 56.22 0.22 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.816 0.847 . . . . 0.0 109.387 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 188' ' ' SER . 37.3 ptt180 -64.36 158.53 23.34 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.49 0.716 . . . . 0.0 110.861 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.73 168.29 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.399 1.08 . . . . 0.0 110.369 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.7 p -53.27 -39.19 63.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.307 1.443 . . . . 0.0 112.407 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 m -159.9 152.67 17.87 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 110.148 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.92 -20.33 51.43 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.559 2.839 . . . . 0.0 112.104 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.99 -28.61 66.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.106 1.362 . . . . 0.0 111.927 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.81 -45.48 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.775 0.83 . . . . 0.0 109.05 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.8 m 66.4 95.25 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.728 1.611 . . . . 0.0 110.861 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.47 144.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.358 1.063 . . . . 0.0 109.356 -173.159 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.0 m -115.75 124.81 51.72 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.643 1.177 . . . . 0.0 108.833 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.3 tp -89.71 100.31 13.14 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.761 0.824 . . . . 0.0 109.434 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.96 170.24 10.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.136 0.974 . . . . 0.0 109.76 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -147.14 148.55 31.69 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -58.89 132.32 86.71 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.633 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -79.26 -59.46 0.11 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.937 1.013 . . . . 0.0 111.741 3.278 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.6 mt -144.09 46.65 1.43 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.541 1.136 . . . . 0.0 109.753 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.75 164.8 25.31 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 m -145.07 100.29 3.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.7 mt -89.67 72.45 7.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.575 1.15 . . . . 0.0 108.439 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.8 mm -56.25 124.63 61.45 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.851 1.26 . . . . 0.0 110.385 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.22 107.34 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.925 3.083 . . . . 0.0 112.682 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.0 -29.89 58.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.307 0.643 . . . . 0.0 110.867 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.95 19.32 51.61 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.341 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -132.17 -58.68 0.95 Allowed 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.63 1.172 . . . . 0.0 108.157 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -78.42 -65.78 0.94 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.17 94.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.4 mt -95.79 117.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -89.17 124.35 34.27 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -127.03 107.98 10.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.567 1.147 . . . . 0.0 108.766 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.1 p -56.43 -25.49 50.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 0.0 113.304 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -76.0 -23.38 55.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.834 0.853 . . . . 0.0 112.243 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -129.57 -65.84 0.83 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.74 0.816 . . . . 0.0 111.035 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.89 35.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.02 111.98 23.26 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.116 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.9 99.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.218 1.407 . . . . 0.0 107.373 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 16.2 mt -97.69 96.67 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.7 1.2 . . . . 0.0 108.046 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 81.9 p -53.15 -35.47 59.79 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.693 1.197 . . . . 0.0 114.114 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -140.62 88.63 2.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.826 0.851 . . . . 0.0 109.201 -174.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.16 155.73 19.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.927 0.491 . . . . 0.0 112.25 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.6 p -146.32 -176.78 5.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 109.28 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -55.23 -32.63 62.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.573 1.149 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -59.1 -19.34 43.66 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 112.509 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -93.59 -34.66 13.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.253 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.74 120.36 9.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.03 -136.87 5.65 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.4 tp -120.48 87.76 2.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.041 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 57.2 mt -69.28 149.35 48.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.887 0.875 . . . . 0.0 108.946 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 45.2 m -146.38 113.27 6.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 56.9 m -82.03 122.01 27.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -118.07 145.55 44.75 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.95 133.95 10.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.882 0.873 . . . . 0.0 109.869 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 57.2 m -102.12 131.55 48.55 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.731 0.813 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.88 118.6 34.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.4 m120 43.94 59.06 3.32 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.594 1.558 . . . . 0.0 112.058 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.87 -24.96 6.22 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.554 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -89.22 102.7 15.36 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.504 1.152 . . . . 0.0 109.195 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.09 103.74 4.66 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.27 149.28 23.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.31 146.03 51.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.249 1.42 . . . . 0.0 107.947 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 71.0 p -136.84 111.84 8.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -88.24 145.22 25.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.214 1.005 . . . . 0.0 111.138 -172.844 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -146.15 109.4 4.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.548 1.539 . . . . 0.0 108.172 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.81 105.86 15.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 93.9 9.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.169 0.988 . . . . 0.0 109.31 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -91.14 146.38 23.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.652 1.181 . . . . 0.0 107.974 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -71.54 139.17 49.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -68.6 161.86 27.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.117 0.967 . . . . 0.0 109.893 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 39.5 p -52.45 128.83 26.95 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.098 0.959 . . . . 0.0 110.264 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -89.05 64.14 6.97 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.616 0.767 . . . . 0.0 109.164 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 31.5 p -76.24 -61.71 1.86 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.93 1.292 . . . . 0.0 109.611 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.092 -1.432 . . . . 0.0 109.413 179.312 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -158.16 156.91 31.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.738 1.215 . . . . 0.0 109.13 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.7 p -54.73 -56.72 16.24 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.074 1.349 . . . . 0.0 110.203 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.37 64.34 0.02 OUTLIER Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -72.55 123.88 90.08 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 119.022 -0.513 . . . . 0.0 109.78 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.38 -47.34 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.325 2.683 . . . . 0.0 110.29 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -68.16 161.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.018 1.327 . . . . 0.0 112.154 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.8 t -110.55 -58.5 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.68 120.25 29.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.5 ptm -133.72 154.82 50.67 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.816 0.846 . . . . 0.0 109.534 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.29 157.75 28.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.01 0.524 . . . . 0.0 111.177 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -97.09 -136.57 0.26 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -94.24 93.87 8.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.8 mt 127.95 121.22 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 131.025 3.73 . . . . 0.0 107.564 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.64 149.99 17.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.312 3.341 . . . . 0.0 113.343 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.59 116.69 6.45 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -76.64 100.65 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.86 121.38 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.938 0.895 . . . . 0.0 108.923 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -77.22 94.18 4.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 108.518 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.57 151.3 22.0 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.896 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 43.7 m -129.07 124.57 35.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -56.24 -73.46 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.73 55.98 4.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.478 0.561 . . . . 0.0 112.341 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -143.31 -97.61 0.11 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.15 1.38 . . . . 0.0 108.065 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -166.0 152.74 9.61 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.764 1.226 . . . . 0.0 108.626 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.1 tp -143.63 108.31 4.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.964 1.306 . . . . 0.0 108.472 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 131.21 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.08 94.13 28.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.04 80.88 2.88 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.309 2.672 . . . . 0.0 111.428 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.02 54.12 1.04 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.361 1.064 . . . . 0.0 109.171 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -68.86 162.28 26.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.16 0.984 . . . . 0.0 111.48 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.79 170.98 12.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.433 1.093 . . . . 0.0 113.075 -169.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.2 p -77.12 -19.83 56.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.632 1.973 . . . . 0.0 112.572 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 t -156.92 140.54 11.37 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.186 0.903 . . . . 0.0 110.274 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -47.81 -39.67 31.49 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.647 3.565 . . . . 0.0 115.454 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.52 -21.78 62.86 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 52.9 mt -80.57 76.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 49.4 m -67.83 123.23 19.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -89.47 142.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 109.357 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 25.8 m -93.18 106.01 18.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 38.1 tp -89.2 118.58 29.0 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -122.91 -177.91 3.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.094 1.358 . . . . 0.0 109.434 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -152.62 150.3 29.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.77 131.5 78.58 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.996 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.84 -61.09 0.03 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.822 0.972 . . . . 0.0 111.972 5.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -142.34 48.48 1.56 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.858 1.263 . . . . 0.0 109.057 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.84 177.25 6.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.187 0.595 . . . . 0.0 109.942 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.3 m -146.04 104.41 3.83 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.87 81.67 6.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.52 130.84 92.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.13 0.972 . . . . 0.0 109.151 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.64 85.38 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.138 2.559 . . . . 0.0 110.426 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -61.37 -22.1 64.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.166 1.386 . . . . 0.0 113.216 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 74.67 26.1 68.23 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.442 0.565 . . . . 0.0 112.811 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.92 -66.02 0.76 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -79.84 -64.59 1.15 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.2 mt -89.87 91.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.576 1.15 . . . . 0.0 108.047 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.75 116.67 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 108.271 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -89.38 109.07 20.02 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.585 0.754 . . . . 0.0 109.891 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -107.22 108.56 20.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.4 p -63.51 -18.76 64.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -109.7 18.77 19.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.316 1.046 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -149.03 -55.61 0.19 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.715 0.689 . . . . 0.0 110.836 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.23 -170.91 32.78 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.97 113.8 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.91 97.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.28 91.93 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.3 p -70.32 -7.73 44.94 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.912 0.885 . . . . 0.0 113.287 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -150.04 99.97 2.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -81.2 160.8 24.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 44.5 p -142.51 169.84 16.83 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.966 0.906 . . . . 0.0 109.682 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -53.19 -37.33 61.85 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.491 1.116 . . . . 0.0 111.659 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -55.05 -37.89 67.31 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.186 1.394 . . . . 0.0 111.226 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.44 17.53 11.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.92 1.288 . . . . 0.0 112.23 -171.557 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 79.5 mt -86.32 116.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 145.4 -160.01 28.0 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 121.455 0.475 . . . . 0.0 112.869 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.52 86.19 6.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.398 1.079 . . . . 0.0 110.511 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -69.69 144.2 52.91 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.5 m -139.04 107.89 5.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.251 1.02 . . . . 0.0 108.923 -173.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.4 m -81.63 138.4 35.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -134.58 145.57 48.8 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.755 0.822 . . . . 0.0 110.526 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.71 144.63 15.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.137 0.975 . . . . 0.0 109.325 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -120.88 142.75 49.38 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.877 1.271 . . . . 0.0 109.562 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.74 153.3 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 52.99 -99.0 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.318 1.447 . . . . 0.0 110.623 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -149.66 47.38 0.62 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.83 129.54 16.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.421 1.088 . . . . 0.0 109.986 177.531 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.8 tp -81.76 144.87 30.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.555 . . . . 0.0 109.796 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -126.61 154.81 43.45 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.904 1.281 . . . . 0.0 108.204 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -150.44 163.29 38.77 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.071 0.548 . . . . 0.0 110.828 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.4 t -151.29 140.9 21.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.76 0.824 . . . . 0.0 109.487 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 50.4 m-80 -115.09 146.23 41.53 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.995 1.318 . . . . 0.0 112.717 -168.802 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -143.26 105.04 4.35 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.425 1.49 . . . . 0.0 108.554 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.63 103.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.8 p -89.73 95.38 10.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.261 1.024 . . . . 0.0 108.783 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -89.69 141.17 28.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.815 0.446 . . . . 0.0 109.844 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 98.6 2.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.926 1.291 . . . . 0.0 109.872 -173.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.25 107.88 20.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.405 1.082 . . . . 0.0 108.246 177.047 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 39.9 p -61.3 -49.57 76.49 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.525 0.73 . . . . 0.0 110.528 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -150.44 152.16 33.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.48 1.112 . . . . 0.0 108.908 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.5 t -72.09 142.3 49.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.142 0.577 . . . . 0.0 109.533 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 116.922 -1.514 . . . . 0.0 109.884 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.35 -47.52 15.65 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.712 0.805 . . . . 0.0 110.036 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.7 m -155.68 101.13 2.13 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 163.57 71.91 0.02 OUTLIER Glycine 0 C--N 1.336 0.575 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -110.99 129.37 24.04 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.731 1.213 . . . . 0.0 108.135 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.58 -52.76 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.937 2.425 . . . . 0.0 110.766 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -68.38 125.61 27.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.071 0.948 . . . . 0.0 111.323 -173.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.4 t -74.05 -42.4 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -70.77 -79.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.607 0.763 . . . . 0.0 110.253 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 tpt 69.36 137.77 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.59 1.956 . . . . 0.0 112.641 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -147.05 0.19 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.0 110.104 172.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.4 t -134.72 -67.38 0.56 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -145.65 -53.62 0.27 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 125.027 1.331 . . . . 0.0 108.908 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -69.15 130.56 91.14 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.419 1.088 . . . . 0.0 108.285 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.52 139.15 33.82 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.857 2.371 . . . . 0.0 110.18 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -74.81 127.53 33.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -79.81 105.64 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.576 0.75 . . . . 0.0 110.054 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.2 mt -96.83 110.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -76.9 88.35 3.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.7 ptm -89.92 142.04 28.08 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.327 0.651 . . . . 0.0 111.641 -170.258 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 60.6 m -114.56 110.04 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.16 152.36 28.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.754 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.2 -36.57 3.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.258 0.932 . . . . 0.0 110.961 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -89.42 -177.0 5.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.93 0.892 . . . . 0.0 111.457 -171.677 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.68 99.68 9.75 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.699 0.8 . . . . 0.0 109.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 39.3 tp -92.76 104.25 16.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.184 0.994 . . . . 0.0 109.169 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.93 121.56 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.96 104.73 27.28 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 169.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.12 37.5 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.173 2.582 . . . . 0.0 113.443 -161.186 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 28.4 p -87.84 57.74 4.5 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-O 121.429 0.633 . . . . 0.0 110.271 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.884 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -75.94 153.49 36.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.42 1.088 . . . . 0.0 110.291 176.97 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.31 169.92 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.208 1.403 . . . . 0.0 110.3 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.9 p -61.85 -42.33 98.92 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.882 0.873 . . . . 0.0 111.805 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 m -143.93 140.54 17.25 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.935 0.894 . . . . 0.0 109.731 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -28.42 29.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.607 2.872 . . . . 0.0 112.761 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.29 -24.55 65.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.383 0.673 . . . . 0.0 112.282 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -52.18 -40.13 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.878 1.271 . . . . 0.0 110.238 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.5 m 67.58 99.09 0.05 Allowed 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.494 1.518 . . . . 0.0 110.681 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.16 122.62 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.2 m -88.12 107.78 18.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.71 95.23 10.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.796 0.839 . . . . 0.0 109.631 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -89.91 166.74 13.32 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.599 0.759 . . . . 0.0 110.377 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.72 142.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.138 0.975 . . . . 0.0 109.26 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.54 132.83 93.11 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 111.395 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 -59.65 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 119.992 1.033 . . . . 0.0 112.18 3.745 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.5 mt -138.31 36.93 2.29 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.45 152.65 34.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.7 m -131.71 113.27 13.36 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.026 0.93 . . . . 0.0 108.646 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.79 80.61 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.0 128.72 89.66 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.19 0.996 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.28 86.18 1.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.965 2.443 . . . . 0.0 110.358 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.35 -23.17 64.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.939 1.296 . . . . 0.0 112.889 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.9 67.69 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.884 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -135.36 -63.13 0.69 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.949 1.3 . . . . 0.0 108.231 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -85.24 -59.28 2.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.9 mt -89.62 91.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.9 mt -93.58 113.46 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -89.13 123.44 33.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.0 0.52 . . . . 0.0 109.823 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -127.61 114.63 17.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.33 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.884 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 48.0 p -57.13 -29.6 63.7 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.311 0.644 . . . . 0.0 112.51 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -80.6 -29.2 36.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.886 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -114.45 -50.32 2.8 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.891 0.876 . . . . 0.0 111.374 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 150.2 -164.85 29.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.11 105.81 18.03 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -89.14 90.96 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 24.4 mt -82.11 81.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.8 p -46.84 -47.7 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.85 2.06 . . . . 0.0 112.933 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -118.48 92.14 3.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.666 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.91 156.28 31.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.598 0.759 . . . . 0.0 110.758 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 60.4 p -137.96 167.66 21.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.752 1.221 . . . . 0.0 108.829 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -53.26 -30.9 40.87 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.298 1.039 . . . . 0.0 112.257 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -52.69 -36.37 57.11 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.8 -32.71 74.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.473 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.9 mt -53.48 111.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.08 0.952 . . . . 0.0 110.15 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 159.5 -171.7 35.98 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.82 99.2 11.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.164 0.986 . . . . 0.0 109.027 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.23 157.26 30.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.2 m -147.77 99.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.126 1.371 . . . . 0.0 108.042 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 24.6 m -79.15 131.35 36.19 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -124.28 135.32 53.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.165 0.986 . . . . 0.0 109.69 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.98 158.16 36.07 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.484 0.713 . . . . 0.0 110.495 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.9 m -138.0 146.79 43.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.62 1.168 . . . . 0.0 109.617 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.13 -70.69 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.901 1.28 . . . . 0.0 108.468 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -98.0 36.0 1.63 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.949 0.9 . . . . 0.0 111.421 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.05 30.05 74.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.441 0.544 . . . . 0.0 112.154 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -90.01 -43.32 10.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.694 1.198 . . . . 0.0 111.032 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 52.6 tp 66.24 89.29 0.1 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.911 1.684 . . . . 0.0 109.455 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -89.52 154.94 19.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.446 1.098 . . . . 0.0 108.381 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -140.26 159.12 42.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.686 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.9 t -151.84 123.34 7.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -108.85 149.92 28.41 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.606 1.162 . . . . 0.0 111.621 -168.986 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -142.89 113.67 7.53 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.307 1.043 . . . . 0.0 109.236 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.6 tt -84.5 106.72 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.1 p -89.26 99.48 12.46 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -89.32 138.58 31.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.749 1.62 . . . . 0.0 109.603 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.0 97.08 2.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.072 0.949 . . . . 0.0 109.489 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -94.28 133.17 38.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.092 1.757 . . . . 0.0 108.556 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 35.9 p -68.0 -91.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -150.21 48.01 0.91 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.292 1.037 . . . . 0.0 109.63 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 43.9 p -82.62 -60.48 2.17 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.897 0.479 . . . . 0.0 109.784 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 C--O 1.249 1.055 0 C-N-CA 124.206 1.002 . . . . 0.0 109.071 177.552 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -53.39 -49.84 66.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.851 0.86 . . . . 0.0 109.383 171.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.3 p -77.77 91.44 4.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -40.93 -66.72 0.84 Allowed Glycine 0 C--N 1.342 0.898 0 C-N-CA 125.964 1.745 . . . . 0.0 112.892 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.64 154.03 1.01 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 127.398 2.279 . . . . 0.0 107.107 172.226 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -32.76 10.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.157 1.905 . . . . 0.0 111.118 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -56.74 129.85 42.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.073 1.349 . . . . 0.0 112.045 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.87 -54.93 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.583 0.753 . . . . 0.0 109.214 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.52 148.39 32.22 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.991 0.917 . . . . 0.0 109.348 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 ttp -147.65 135.43 21.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.421 1.089 . . . . 0.0 108.632 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -61.77 137.88 58.28 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.246 0.618 . . . . 0.0 110.035 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.9 p -74.18 -51.1 16.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.62 0.368 . . . . 0.0 110.675 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -155.07 -53.67 0.09 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 109.579 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.6 mm -83.98 119.88 74.07 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.075 0.95 . . . . 0.0 108.791 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.24 139.61 86.32 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.279 2.653 . . . . 0.0 111.225 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.24 136.44 57.18 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -89.22 91.34 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.279 1.032 . . . . 0.0 108.262 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -88.78 108.29 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -73.27 95.84 2.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.805 1.242 . . . . 0.0 109.541 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 19.0 ptm -102.1 162.64 12.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.847 1.259 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 75.2 m -133.16 130.28 38.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -58.94 119.91 8.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.471 0.709 . . . . 0.0 109.176 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 121.2 -33.64 4.28 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.648 1.118 . . . . 0.0 111.719 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -89.0 171.05 10.15 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.967 0.884 . . . . 0.0 110.673 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -71.53 148.4 46.75 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.199 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.5 tp -139.77 106.75 5.43 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.63 128.58 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.39 98.27 13.97 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.79 79.43 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.507 2.804 . . . . 0.0 111.027 -165.797 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.9 p -126.9 42.19 3.37 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.484 1.114 . . . . 0.0 110.344 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -58.02 158.32 6.9 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.152 0.981 . . . . 0.0 110.919 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.33 154.23 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 110.716 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.3 p -61.24 -44.29 97.5 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.751 1.22 . . . . 0.0 110.818 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -104.29 103.49 39.11 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.2 -11.43 32.17 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.718 2.945 . . . . 0.0 113.777 -170.321 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.76 -21.24 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.663 0.785 . . . . 0.0 111.908 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.12 106.46 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.7 m -74.16 117.11 15.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.41 150.87 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.13 0.972 . . . . 0.0 108.575 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 m -103.18 111.45 23.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 108.449 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.8 tp -89.48 101.26 13.94 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -91.62 170.52 9.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.623 0.769 . . . . 0.0 110.22 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -145.99 146.37 30.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.65 1.18 . . . . 0.0 108.556 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.67 133.58 82.58 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.881 0.873 . . . . 0.0 110.772 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.42 -59.57 0.11 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.682 0 CA-C-N 119.816 0.97 . . . . 0.0 111.87 0.911 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -141.46 38.63 1.7 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.755 1.222 . . . . 0.0 109.804 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -77.37 153.99 33.19 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 43.7 m -125.12 111.58 15.48 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.927 0.891 . . . . 0.0 109.147 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.7 mp -89.98 82.62 6.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.09 129.03 90.22 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.01 0.924 . . . . 0.0 109.175 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -72.8 85.51 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.138 2.558 . . . . 0.0 110.319 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.96 -22.36 64.37 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.015 1.326 . . . . 0.0 113.327 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 69.34 44.75 63.82 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -150.07 -67.09 0.2 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -90.7 -55.08 3.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.5 mt -93.23 89.7 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -98.13 121.09 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.119 0.968 . . . . 0.0 108.503 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -89.08 93.87 9.74 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -89.79 96.91 10.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.6 p -61.73 -13.63 24.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -101.26 4.8 42.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 112.079 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -140.32 -58.7 0.54 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.848 0.859 . . . . 0.0 110.668 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.6 -169.42 37.85 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.738 1.161 . . . . 0.0 110.336 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -89.09 110.86 21.53 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.68 94.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.75 1.22 . . . . 0.0 107.834 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.89 95.73 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.1 p -60.67 -28.87 68.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.155 0.982 . . . . 0.0 113.511 -170.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.41 89.94 2.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.02 119.35 9.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.224 0.61 . . . . 0.0 110.043 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 39.3 p -89.94 171.67 9.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.349 0.66 . . . . 0.0 109.255 174.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.95 -33.2 62.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.63 0.772 . . . . 0.0 111.493 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -59.57 -32.4 70.32 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.38 1.072 . . . . 0.0 111.932 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.22 -8.96 58.19 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.968 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -71.79 107.86 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.985 1.266 . . . . 0.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 158.39 -160.83 31.26 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.5 98.58 11.72 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.372 1.069 . . . . 0.0 109.917 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.36 154.04 25.46 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.31 0.644 . . . . 0.0 109.332 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 54.9 m -146.71 106.29 3.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.096 0.958 . . . . 0.0 109.409 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.88 140.09 43.58 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -135.71 138.69 42.99 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.161 0.985 . . . . 0.0 110.288 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.71 140.37 18.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.98 0.912 . . . . 0.0 109.976 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 55.9 m -122.52 92.65 3.76 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.661 1.184 . . . . 0.0 108.863 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.33 -62.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.101 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -92.11 174.13 7.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.47 1.108 . . . . 0.0 109.497 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.92 2.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -148.32 -44.73 0.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.388 1.075 . . . . 0.0 110.981 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.2 tp 70.63 128.91 0.03 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 126.796 2.038 . . . . 0.0 110.158 -170.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.02 147.31 50.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.655 1.182 . . . . 0.0 107.927 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -150.59 158.76 44.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.87 0.468 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 49.6 p -136.6 132.12 34.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.935 0.894 . . . . 0.0 108.824 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -111.62 144.71 40.43 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.681 1.192 . . . . 0.0 110.782 -169.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -146.47 117.54 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.441 1.096 . . . . 0.0 109.023 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.01 107.57 19.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -89.33 98.99 12.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -89.14 126.4 35.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.228 1.411 . . . . 0.0 109.249 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -69.8 103.56 2.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -67.91 143.33 55.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.419 0.688 . . . . 0.0 111.753 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 67.2 p -72.8 -36.34 67.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.998 0.919 . . . . 0.0 110.836 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -147.04 164.15 33.96 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.765 1.226 . . . . 0.0 109.619 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t -124.59 46.32 2.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.704 1.202 . . . . 0.0 110.565 -173.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 20.4 tt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.991 -1.48 . . . . 0.0 110.383 -179.502 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 121.086 0.469 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.55 -70.0 0.27 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.69 0.796 . . . . 0.0 109.821 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.8 m -86.27 59.07 5.42 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.1 -127.64 0.93 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -77.89 117.36 65.36 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.83 -50.45 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.093 2.529 . . . . 0.0 111.474 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -76.7 146.41 38.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.817 0.847 . . . . 0.0 112.476 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.64 55.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -166.36 -71.66 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.8 tpt 69.76 157.07 0.15 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 111.349 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.97 172.14 13.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.0 0.92 . . . . 0.0 109.32 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.8 t -145.02 -66.28 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.304 0.641 . . . . 0.0 110.383 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -95.08 -64.35 1.07 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.47 0.708 . . . . 0.0 112.624 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.76 113.42 64.93 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.388 1.075 . . . . 0.0 110.195 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.83 142.69 96.36 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.317 2.678 . . . . 0.0 111.122 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -73.05 128.24 34.91 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.6 85.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.306 0.642 . . . . 0.0 109.378 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 mt -92.55 80.25 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -60.55 135.62 57.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.43 175.63 11.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.604 0.761 . . . . 0.0 111.196 -171.895 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -146.97 142.8 27.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.536 1.534 . . . . 0.0 108.162 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 150.63 44.72 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.119 0.567 . . . . 0.0 111.24 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.8 -34.41 4.07 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.557 0.599 . . . . 0.0 112.042 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -88.98 157.02 18.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.248 1.019 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.92 136.0 54.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.084 0.554 . . . . 0.0 110.469 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.5 tp -122.6 114.27 20.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.576 1.55 . . . . 0.0 107.847 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.49 127.58 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.7 mm -106.26 100.08 27.33 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 171.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.67 62.3 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.554 2.836 . . . . 0.0 111.492 -169.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -104.11 51.49 0.78 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.029 0.932 . . . . 0.0 109.305 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -66.26 161.75 21.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 m -127.62 166.51 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 0.0 111.709 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 p -65.34 -36.58 84.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.067 1.347 . . . . 0.0 112.035 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 51.3 m -145.42 146.22 29.14 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.453 0.701 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.79 -42.86 24.39 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.65 3.566 . . . . 0.0 115.004 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -59.12 -20.26 52.01 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.028 0.931 . . . . 0.0 113.245 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 23.1 mm -77.71 74.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 27.7 m -70.19 120.1 15.38 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.243 0.617 . . . . 0.0 109.812 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.72 147.16 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.102 0.961 . . . . 0.0 109.641 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.8 m -106.17 113.31 26.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.22 121.66 31.74 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -126.22 173.65 9.11 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -138.82 149.24 44.72 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.949 0.899 . . . . 0.0 108.785 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -58.16 133.39 84.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.637 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.5 -59.85 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.72 0 CA-C-N 119.943 1.015 . . . . 0.0 112.197 3.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -142.01 40.27 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.305 1.042 . . . . 0.0 110.391 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.48 149.56 40.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.2 m -132.53 110.19 10.31 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.62 85.19 5.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.805 1.242 . . . . 0.0 108.26 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.39 127.6 93.39 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.54 104.6 1.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.876 2.384 . . . . 0.0 110.722 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.29 -31.48 71.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.637 0.775 . . . . 0.0 111.991 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.11 17.91 45.23 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.611 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -133.23 -58.99 0.89 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.599 1.16 . . . . 0.0 108.516 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.6 tpp85 -78.03 -66.04 0.9 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.52 92.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 68.8 mt -92.07 114.68 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -88.92 93.26 9.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -89.84 103.06 15.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.9 p -54.74 -29.16 52.98 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -108.32 24.98 12.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.135 0.974 . . . . 0.0 111.902 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -146.63 -58.57 0.29 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.162 0.585 . . . . 0.0 110.673 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.9 -172.25 37.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.92 0.772 . . . . 0.0 111.172 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -89.27 109.23 20.14 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.4 96.0 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.986 1.314 . . . . 0.0 107.616 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.98 101.21 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 80.3 p -57.09 -36.15 70.26 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -139.36 99.14 3.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.43 163.82 10.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.554 0.741 . . . . 0.0 112.027 -173.747 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.8 p -131.01 155.21 47.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.027 0.931 . . . . 0.0 109.709 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -56.51 -30.27 62.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.238 1.015 . . . . 0.0 111.777 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.04 -24.14 51.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.687 1.195 . . . . 0.0 112.441 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -86.04 -9.29 57.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.226 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.23 105.86 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.228 0.922 . . . . 0.0 108.63 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.94 -163.22 34.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.85 89.72 8.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.015 0.926 . . . . 0.0 109.481 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 45.1 mt -69.1 147.4 51.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 102.79 3.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.885 1.274 . . . . 0.0 108.318 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 75.0 m -80.7 138.91 36.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -134.69 142.23 46.75 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.184 0.993 . . . . 0.0 110.145 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.97 126.36 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.134 0.973 . . . . 0.0 109.25 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 85.5 m -103.19 134.21 46.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.657 1.183 . . . . 0.0 109.158 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.72 -78.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.392 0.677 . . . . 0.0 109.968 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.84 49.4 1.77 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.681 0.792 . . . . 0.0 110.965 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.96 38.46 60.35 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -170.289 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -150.06 121.02 7.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.178 1.391 . . . . 0.0 107.657 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.0 tt -77.56 111.2 13.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -92.05 154.09 18.98 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -151.47 162.99 39.98 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.827 0.451 . . . . 0.0 112.147 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.0 t -148.13 135.6 20.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.916 0.886 . . . . 0.0 108.782 169.64 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.71 152.47 34.22 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.195 0.998 . . . . 0.0 111.952 -169.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -145.0 118.49 9.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.149 1.379 . . . . 0.0 109.005 -173.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.08 111.48 22.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.0 p -89.87 103.3 15.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.21 0.604 . . . . 0.0 109.65 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -89.38 134.12 34.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.131 0.973 . . . . 0.0 109.203 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -74.64 96.93 3.08 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -68.88 -47.95 64.6 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.877 0.308 . . . . 0.0 110.559 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 53.9 p -144.46 177.64 8.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.215 1.406 . . . . 0.0 108.818 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -131.61 63.3 1.61 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 61.4 p -112.59 170.75 7.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.847 1.659 . . . . 0.0 109.533 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.887 -1.53 . . . . 0.0 110.667 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 119.521 -0.276 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -74.17 -59.99 2.47 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.7 t -117.8 -18.56 9.55 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.784 1.633 . . . . 0.0 110.378 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.42 -84.63 0.74 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 -83.6 125.62 73.19 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -73.35 -46.68 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.058 2.505 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -69.61 152.15 45.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 111.948 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.57 -50.57 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -79.15 -82.22 0.1 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.128 0.971 . . . . 0.0 110.532 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.8 ttt 66.83 139.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.553 1.941 . . . . 0.0 112.032 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -146.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.741 1.216 . . . . 0.0 110.588 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 p -129.79 -69.07 0.69 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 108.072 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 -38.31 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.447 1.499 . . . . 0.0 109.989 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.08 125.95 92.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -69.66 129.4 17.64 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.804 2.336 . . . . 0.0 109.636 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.94 123.63 20.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.334 0.654 . . . . 0.0 111.011 -169.333 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.22 117.11 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.755 1.222 . . . . 0.0 108.953 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.01 133.67 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.57 1.148 . . . . 0.0 109.204 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -84.3 147.96 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.804 1.242 . . . . 0.0 109.043 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -150.1 167.18 27.56 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.329 0.652 . . . . 0.0 111.619 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.1 m -140.25 113.64 8.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -52.11 136.51 29.57 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.52 0.728 . . . . 0.0 110.62 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.47 -38.64 3.02 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.499 1.047 . . . . 0.0 110.948 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -89.5 166.36 13.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.632 0.773 . . . . 0.0 110.546 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.88 144.75 52.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.366 0.666 . . . . 0.0 109.914 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 51.0 tp -134.86 152.9 52.13 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.175 1.39 . . . . 0.0 107.768 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.79 135.52 63.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.052 0.941 . . . . 0.0 108.483 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.4 mm -109.14 97.19 24.17 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.47 68.84 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.55 2.833 . . . . 0.0 112.525 -163.436 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -116.2 55.14 0.81 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.656 1.182 . . . . 0.0 109.795 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 188' ' ' SER . 25.6 ptt-85 -69.0 161.45 28.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.256 1.422 . . . . 0.0 111.023 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.36 165.19 17.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.856 1.262 . . . . 0.0 112.393 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 38.2 p -73.02 -27.51 61.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.807 1.643 . . . . 0.0 112.473 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -142.21 136.19 14.72 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.945 0.898 . . . . 0.0 109.161 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 -25.96 50.61 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.389 2.726 . . . . 0.0 113.297 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -62.55 -23.03 66.77 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.349 0.522 . . . . 0.0 112.154 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.1 mt -80.14 78.82 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.7 m -66.55 121.33 15.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.7 t -89.27 145.24 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.7 m -103.75 122.65 45.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.28 132.17 35.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -130.98 175.34 9.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.695 1.198 . . . . 0.0 109.3 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -151.52 147.98 27.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.053 0.941 . . . . 0.0 109.295 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.91 135.74 87.28 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 110.15 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.91 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.902 1.001 . . . . 0.0 112.007 1.888 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.2 mt -140.56 41.74 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.451 1.101 . . . . 0.0 109.979 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -82.67 139.65 33.58 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 84.8 m -116.93 112.01 20.43 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.45 72.14 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.876 1.27 . . . . 0.0 109.111 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.7 mm -56.34 126.69 69.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.792 0.837 . . . . 0.0 109.609 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.7 103.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.995 3.13 . . . . 0.0 112.684 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.84 -19.47 57.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.752 0.821 . . . . 0.0 111.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.13 -5.27 83.63 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.626 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -105.26 -63.88 1.19 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.564 1.182 . . . . 0.0 107.901 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -79.26 -64.91 1.08 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.836 0.854 . . . . 0.0 108.725 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.33 97.57 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 89.9 mt -99.64 117.6 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -88.95 121.5 31.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -124.35 112.39 16.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.135 1.374 . . . . 0.0 107.878 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.626 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 28.9 p -59.31 -25.95 64.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 113.502 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -111.39 27.5 9.62 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.134 0.973 . . . . 0.0 111.93 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -149.14 -53.33 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.927 0.491 . . . . 0.0 110.266 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 145.88 -159.77 28.0 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.24 110.82 21.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.07 98.6 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.4 mm -83.05 82.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 69.7 p -55.15 -33.28 62.81 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.286 1.035 . . . . 0.0 113.47 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 89.42 2.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.86 158.43 16.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.984 0.514 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.6 p -136.12 161.27 36.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.733 0.813 . . . . 0.0 109.879 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -57.11 -32.78 66.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.889 0.875 . . . . 0.0 111.398 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.42 -34.39 70.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.358 1.063 . . . . 0.0 111.44 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.97 13.49 10.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.326 1.05 . . . . 0.0 112.484 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -85.14 121.8 37.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.71 -159.44 25.4 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.288 0.471 . . . . 0.0 112.794 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.89 91.45 6.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.596 1.158 . . . . 0.0 110.743 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.96 160.31 30.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.668 0.787 . . . . 0.0 109.475 170.037 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.1 m -147.81 102.04 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.717 1.207 . . . . 0.0 109.087 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.6 m -75.28 139.35 42.45 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -138.37 139.02 38.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.601 0.761 . . . . 0.0 111.187 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.52 152.83 27.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.796 1.239 . . . . 0.0 109.822 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.2 m -135.71 107.99 7.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.98 -64.18 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -150.06 114.13 5.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.363 1.065 . . . . 0.0 108.58 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 81.86 -59.69 4.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.78 0.705 . . . . 0.0 113.143 170.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.03 135.62 33.45 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.298 0.639 . . . . 0.0 110.694 -169.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.55 105.5 11.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -89.52 135.09 33.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -150.73 160.39 43.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.538 0.335 . . . . 0.0 110.824 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.8 t -152.86 130.59 11.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.477 0.711 . . . . 0.0 109.97 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 62.2 m-80 -104.57 150.99 24.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.673 1.189 . . . . 0.0 112.066 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -140.18 113.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.525 1.13 . . . . 0.0 108.812 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -82.99 101.63 11.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.5 p -89.17 92.58 9.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -89.8 165.79 13.94 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.792 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 -70.69 -82.46 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.369 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -175.12 -165.91 0.2 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 34.9 p -70.31 94.47 0.93 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -88.72 66.14 7.96 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.5 t -74.99 168.51 19.83 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.006 0.922 . . . . 0.0 110.804 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.8 pt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.246 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.5 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -72.87 80.86 1.17 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.431 1.092 . . . . 0.0 109.424 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -127.8 -85.99 0.58 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.356 1.462 . . . . 0.0 108.982 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.88 -63.93 3.74 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.156 0.884 . . . . 0.0 110.976 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -159.51 152.6 18.36 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.644 1.178 . . . . 0.0 108.693 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.67 -51.58 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.422 2.748 . . . . 0.0 111.63 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -71.54 119.65 16.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 111.574 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.01 -53.22 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 126.24 54.83 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.124 1.37 . . . . 0.0 107.832 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.1 ptm -128.49 170.3 13.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.963 1.305 . . . . 0.0 109.685 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.56 147.41 52.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.018 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 m -90.6 -136.44 0.13 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.96 104.14 16.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.4 mm 108.64 127.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 130.742 3.617 . . . . 0.0 107.924 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.68 137.65 15.46 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.236 3.291 . . . . 0.0 113.066 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.27 126.7 30.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -80.78 100.0 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.17 105.83 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -83.41 76.61 9.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.373 1.469 . . . . 0.0 109.231 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.33 171.85 9.46 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.107 0.563 . . . . 0.0 111.041 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.9 m -143.46 116.82 9.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.58 164.94 10.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 94.21 -41.06 2.64 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.2 mtp-105 -88.88 -179.57 5.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.774 1.629 . . . . 0.0 109.674 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.75 137.38 45.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.34 103.93 11.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.22 125.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 mm -101.08 100.73 13.84 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -83.79 48.99 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 112.846 -161.901 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -91.59 57.61 3.32 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.84 0.856 . . . . 0.0 110.378 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -56.73 143.2 37.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.118 0.967 . . . . 0.0 111.126 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.59 165.94 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.817 1.247 . . . . 0.0 110.591 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.376 1.07 . . . . 0.0 112.508 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.2 m -155.5 146.7 16.64 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.644 0.777 . . . . 0.0 110.299 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.5 -30.63 28.8 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.724 2.949 . . . . 0.0 111.855 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -56.36 -27.32 55.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.101 1.36 . . . . 0.0 112.497 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.4 -35.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.135 1.374 . . . . 0.0 110.861 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m 67.59 88.52 0.11 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.314 1.446 . . . . 0.0 110.028 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.45 132.56 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 108.835 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 m -102.31 119.11 38.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.327 1.051 . . . . 0.0 108.721 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.4 tp -89.49 101.52 14.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -89.48 165.23 14.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.056 0.942 . . . . 0.0 109.905 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -147.8 146.39 29.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.31 1.044 . . . . 0.0 108.928 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.81 134.91 89.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.605 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.91 -58.69 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 119.854 0.984 . . . . 0.0 111.819 0.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.1 mt -139.89 38.94 1.98 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.794 1.238 . . . . 0.0 109.824 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -80.76 160.29 24.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -137.85 114.41 10.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.876 0.87 . . . . 0.0 109.034 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 mp -89.9 83.98 6.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.73 121.76 75.14 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.65 120.65 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.309 2.673 . . . . 0.0 112.735 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -81.25 -15.43 55.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.475 0.71 . . . . 0.0 111.565 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 66.76 29.98 75.54 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.057 0.837 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -139.94 -67.55 0.43 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.575 1.15 . . . . 0.0 108.169 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.7 ttp-105 -79.16 -56.16 4.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 mt -89.57 90.08 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.432 1.493 . . . . 0.0 106.998 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 67.8 mt -90.83 113.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -89.01 93.2 9.52 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.41 99.48 12.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.3 p -57.82 -26.82 62.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -76.87 -19.29 57.64 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.122 0.969 . . . . 0.0 112.423 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -125.83 -64.59 1.05 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.063 0.945 . . . . 0.0 110.752 -173.867 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 170.56 -173.36 44.41 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 117.9 0.318 . . . . 0.0 112.332 -173.79 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -89.36 107.55 19.13 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.2 mt -89.82 94.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 31.0 mt -81.96 85.87 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.317 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.9 p -52.15 -35.75 49.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.41 1.484 . . . . 0.0 114.3 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -123.44 91.87 3.57 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.003 0.921 . . . . 0.0 108.878 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.63 40.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.325 0.65 . . . . 0.0 110.242 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 77.9 p -138.66 172.34 13.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.66 1.184 . . . . 0.0 109.273 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -59.17 -26.84 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.648 0.779 . . . . 0.0 112.016 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -53.73 -43.92 69.47 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.402 0.681 . . . . 0.0 110.74 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -68.76 -8.37 42.47 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.0 131.15 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 143.15 -108.31 0.51 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 45.4 tp -157.14 111.34 2.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.0 109.413 -170.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -101.44 150.51 22.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.227 1.011 . . . . 0.0 109.089 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 98.2 m -142.86 116.52 9.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.102 0.961 . . . . 0.0 109.143 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 30.5 m -81.91 142.49 32.42 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -129.96 142.72 50.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.511 1.124 . . . . 0.0 109.984 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.265 1.026 . . . . 0.0 110.104 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.0 m -142.03 132.64 25.42 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.5 t -135.49 -76.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.971 0.908 . . . . 0.0 108.856 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -85.35 51.18 2.11 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.805 0.842 . . . . 0.0 110.774 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.8 -31.53 1.48 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.664 0.649 . . . . 0.0 113.511 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -88.62 142.69 27.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.782 1.233 . . . . 0.0 109.98 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.7 tp -80.02 106.16 11.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -89.02 146.6 24.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 157.32 42.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.471 0.708 . . . . 0.0 110.045 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 t -147.0 129.72 16.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.434 0.694 . . . . 0.0 109.753 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 56.3 m-80 -102.56 141.01 36.08 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.64 1.576 . . . . 0.0 112.487 -169.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -140.34 100.6 3.93 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.076 1.351 . . . . 0.0 108.893 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.5 110.48 16.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.517 1.127 . . . . 0.0 108.639 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.6 p -89.59 89.02 7.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.801 0.84 . . . . 0.0 109.762 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -95.03 89.44 5.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -55.17 133.0 48.86 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.979 0.512 . . . . 0.0 110.335 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -167.09 171.57 10.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.842 0.857 . . . . 0.0 110.399 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 45.5 p -135.02 38.42 2.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.887 1.275 . . . . 0.0 108.626 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.41 48.44 0.89 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.258 1.023 . . . . 0.0 110.448 -173.12 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.6 t -62.82 -38.88 92.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.296 0.639 . . . . 0.0 110.921 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.7 pt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.949 176.082 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.5 89.33 2.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.723 0.409 . . . . 0.0 110.023 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.6 m -77.64 66.77 3.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.14 140.05 3.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.403 1.001 . . . . 0.0 110.766 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -62.35 132.04 93.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.89 -50.63 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.534 2.156 . . . . 0.0 111.211 -170.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -77.33 159.93 29.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.992 0.917 . . . . 0.0 111.449 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.16 -61.41 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.05 123.88 32.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 23.4 ttt -144.51 145.44 31.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.508 0.723 . . . . 0.0 110.208 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -152.74 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.655 1.182 . . . . 0.0 110.622 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.1 t -131.43 -64.82 0.79 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.005 0.922 . . . . 0.0 108.924 170.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.71 -36.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.579 0.752 . . . . 0.0 111.579 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.4 mt -81.36 116.59 63.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.03 136.15 71.32 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.007 2.471 . . . . 0.0 111.743 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.39 124.43 24.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.352 0.661 . . . . 0.0 109.948 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.9 126.56 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.4 mt -130.08 137.56 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.512 1.125 . . . . 0.0 108.131 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -89.3 102.07 14.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.332 1.053 . . . . 0.0 108.772 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -89.31 176.42 6.94 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 m -147.82 130.4 15.89 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.67 141.38 55.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.969 0.908 . . . . 0.0 110.157 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.82 -42.94 2.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.231 0.443 . . . . 0.0 112.156 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -89.85 -179.28 5.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.814 0.845 . . . . 0.0 112.049 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -66.19 149.73 49.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.1 tp -148.03 112.37 5.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.266 1.026 . . . . 0.0 108.716 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.92 132.11 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.4 mm -108.23 96.4 18.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.92 46.51 1.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.261 2.641 . . . . 0.0 113.714 -163.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 26.0 p -89.81 59.77 4.74 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.501 0.72 . . . . 0.0 109.138 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -71.2 156.79 39.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.689 0.796 . . . . 0.0 110.884 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.53 167.7 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.905 1.282 . . . . 0.0 111.664 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.6 p -63.33 -33.77 76.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.006 1.322 . . . . 0.0 111.695 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.7 m -157.68 151.14 18.97 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 124.376 1.071 . . . . 0.0 109.733 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.54 -31.66 87.53 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.389 2.726 . . . . 0.0 111.64 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.25 -32.26 16.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.768 1.627 . . . . 0.0 112.559 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.4 mm -51.72 -41.95 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.56 1.144 . . . . 0.0 111.043 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.0 m 63.15 91.01 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.207 1.403 . . . . 0.0 111.168 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.45 133.13 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 109.483 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.9 m -98.45 114.29 26.6 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 tp -89.46 106.85 18.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -94.42 158.13 15.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 110.213 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -129.18 136.95 50.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.732 1.613 . . . . 0.0 106.677 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -55.92 126.7 66.77 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.32 -170.07 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -77.47 -62.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.616 0 CA-C-N 119.733 0.94 . . . . 0.0 112.851 6.3 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.1 mt -143.79 37.81 1.32 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.172 0.989 . . . . 0.0 110.244 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.23 126.84 31.73 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.7 m -89.82 115.59 27.27 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.325 0.65 . . . . 0.0 110.157 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.67 86.7 6.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.02 130.35 94.46 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.208 1.003 . . . . 0.0 109.101 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.8 81.95 1.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.209 2.606 . . . . 0.0 110.002 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.63 -18.65 62.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.036 1.334 . . . . 0.0 113.137 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.23 26.48 70.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.602 0.62 . . . . 0.0 112.679 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -140.27 -63.66 0.48 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.758 1.223 . . . . 0.0 108.53 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -88.45 -57.36 2.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.713 1.205 . . . . 0.0 107.951 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.5 mt -89.97 93.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.8 mt -93.5 112.19 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -89.08 95.37 10.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.168 0.587 . . . . 0.0 109.691 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.97 97.55 11.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.6 p -50.53 -37.47 39.44 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -97.27 21.2 10.32 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 112.504 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -147.46 -57.69 0.25 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.978 0.808 . . . . 0.0 111.317 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 161.5 -177.05 37.95 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.046 0.831 . . . . 0.0 111.187 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.13 110.19 20.96 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.12 93.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 50.2 mt -83.09 100.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.8 p -63.94 -39.38 94.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.037 0.535 . . . . 0.0 112.286 -172.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -118.97 90.59 3.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.524 1.13 . . . . 0.0 108.693 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.86 124.15 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 67.3 p -91.83 166.77 12.58 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.0 110.94 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -57.39 -34.1 68.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.251 1.02 . . . . 0.0 111.804 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -56.14 -33.94 65.65 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.418 1.087 . . . . 0.0 111.477 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.75 -2.85 31.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.031 0.932 . . . . 0.0 112.651 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.06 87.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 163.39 -163.1 35.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.1 tp -86.95 117.12 25.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 110.795 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 95.5 mt -99.93 150.26 22.58 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.503 1.521 . . . . 0.0 109.114 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 51.3 m -146.7 103.33 3.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.746 1.218 . . . . 0.0 108.867 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 48.6 m -74.97 143.93 43.42 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.91 140.0 43.74 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.063 0.945 . . . . 0.0 109.611 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.36 114.82 6.32 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.652 0.781 . . . . 0.0 110.52 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.7 m -89.94 125.76 35.49 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.809 1.244 . . . . 0.0 109.481 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.17 -71.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.154 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -145.7 94.26 2.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.02 -53.56 4.76 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.558 0.599 . . . . 0.0 111.762 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 145.25 25.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.303 1.041 . . . . 0.0 109.25 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.3 156.02 28.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.717 0.77 . . . . 0.0 111.433 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -124.75 154.83 40.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.582 1.953 . . . . 0.0 106.027 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -136.86 158.57 44.15 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.05 0.386 . . . . 0.0 111.4 -175.242 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.7 m -144.13 109.89 5.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -106.67 151.9 24.49 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.404 0.682 . . . . 0.0 111.171 -170.261 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -142.39 127.51 18.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.317 1.047 . . . . 0.0 109.008 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.0 tt -87.09 97.17 10.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.8 p -89.0 88.76 7.71 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.38 154.36 20.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 7.3 ptm85 -63.2 -36.46 83.71 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.266 0.485 . . . . 0.0 111.185 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -176.96 168.8 2.45 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.072 1.349 . . . . 0.0 108.5 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 47.1 p -70.66 176.91 3.81 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.546 0.738 . . . . 0.0 109.279 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -88.36 83.41 6.88 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 24.0 p -61.42 -52.08 66.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.235 1.014 . . . . 0.0 109.862 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.852 -1.547 . . . . 0.0 110.027 -175.236 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.464 ' N ' ' HG ' ' A' ' 162' ' ' SER . 33.2 t . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.41 -49.99 73.27 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.027 0.931 . . . . 0.0 110.528 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.9 t -152.41 -0.76 0.28 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.482 0.713 . . . . 0.0 112.919 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.47 -156.28 32.23 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -73.97 123.01 88.91 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -73.81 -39.99 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.779 2.319 . . . . 0.0 110.135 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -59.63 135.94 57.83 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.081 0.952 . . . . 0.0 110.898 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.25 -43.78 97.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.55 148.05 31.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.133 1.373 . . . . 0.0 108.176 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ptm -127.57 165.13 20.52 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.538 1.135 . . . . 0.0 110.546 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 152.09 26.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.423 0.689 . . . . 0.0 110.106 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.1 t -80.26 -69.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -143.56 -53.97 0.37 Allowed 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.937 1.295 . . . . 0.0 108.659 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 88.8 mt -72.87 127.93 88.86 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -67.65 119.89 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.558 2.172 . . . . 0.0 108.893 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.8 116.84 2.74 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.118 0.967 . . . . 0.0 109.701 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.7 mt -78.49 102.24 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.15 68.66 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -59.2 128.32 36.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.14 169.1 18.82 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.754 0.311 . . . . 0.0 111.732 -170.552 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 m -112.55 138.48 49.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 107.994 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.91 165.83 12.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.166 0.587 . . . . 0.0 111.587 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.24 -43.14 3.21 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.957 0.789 . . . . 0.0 111.998 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -89.18 174.78 7.67 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.407 1.083 . . . . 0.0 110.823 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.91 160.33 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.143 -174.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 49.4 tp -148.9 111.97 4.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.627 1.171 . . . . 0.0 108.608 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.02 125.11 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -104.81 102.54 35.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.13 61.01 6.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.603 2.868 . . . . 0.0 111.591 -167.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 31.8 p -105.16 50.09 0.79 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.906 0.882 . . . . 0.0 109.327 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.99 153.92 42.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.008 1.323 . . . . 0.0 110.507 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 m -116.06 160.37 15.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 124.407 1.083 . . . . 0.0 111.277 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.3 p -70.15 -57.45 4.92 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.616 1.167 . . . . 0.0 109.744 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.464 ' HG ' ' N ' ' A' ' 129' ' ' SER . 25.4 p -100.07 111.73 62.72 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.83 -12.84 33.58 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.615 2.877 . . . . 0.0 113.389 -168.557 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -69.05 -22.85 64.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.082 0.401 . . . . 0.0 111.266 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 32.6 mt -78.35 83.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -66.3 127.37 31.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.353 1.061 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 70.2 t -89.59 146.64 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.053 0.941 . . . . 0.0 109.243 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 m -106.93 111.36 23.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.773 1.229 . . . . 0.0 108.153 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.8 tp -89.37 98.07 11.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -89.75 169.84 10.94 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.957 0.903 . . . . 0.0 109.52 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -148.63 145.83 27.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.634 0.774 . . . . 0.0 109.194 169.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.77 133.76 78.76 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.653 172.033 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.16 -59.89 0.1 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 119.978 1.028 . . . . 0.0 112.057 2.206 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.5 mt -144.23 39.22 1.31 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 110.034 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -81.93 152.13 26.92 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.1 m -130.72 108.53 9.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.739 1.216 . . . . 0.0 108.309 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.74 82.65 6.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.008 0.923 . . . . 0.0 108.573 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 129.14 93.79 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.48 90.15 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.882 2.388 . . . . 0.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -59.52 -24.21 63.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.311 1.444 . . . . 0.0 113.173 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 75.61 28.54 61.13 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.427 0.537 . . . . 0.0 112.819 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.55 -58.4 0.68 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.897 1.279 . . . . 0.0 108.385 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -85.1 -55.14 4.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.197 1.399 . . . . 0.0 108.567 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.8 100.1 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 125.048 1.339 . . . . 0.0 108.134 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.13 118.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -89.15 94.36 9.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.78 100.91 13.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.7 p -56.45 -26.93 55.35 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -114.59 32.16 6.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.285 1.434 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -150.09 -58.35 0.19 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.301 0.64 . . . . 0.0 110.378 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 155.68 -171.13 33.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.691 1.138 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -89.4 106.4 18.42 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.35 90.89 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 52.1 mt -79.48 95.14 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.1 p -61.66 -25.76 67.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.2 t-20 -135.9 90.02 2.55 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.788 0.835 . . . . 0.0 108.958 -177.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.7 128.32 35.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.435 1.094 . . . . 0.0 111.265 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 54.0 p -147.89 179.52 7.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.976 1.31 . . . . 0.0 109.45 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -39.18 -35.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.91 2.084 . . . . 0.0 113.691 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -42.87 -44.43 4.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.517 1.927 . . . . 0.0 112.361 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -103.33 -10.09 18.95 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 113.847 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.87 111.82 7.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.415 1.007 . . . . 0.0 109.709 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 151.23 -162.15 29.39 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.9 tp -81.77 90.31 6.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.29 146.96 54.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.829 0.852 . . . . 0.0 108.971 172.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 48.8 m -143.39 99.25 3.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.48 1.112 . . . . 0.0 108.169 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.53 132.18 43.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -126.57 141.62 51.8 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.262 1.025 . . . . 0.0 109.826 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.31 106.5 3.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.014 0.926 . . . . 0.0 109.708 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.1 m -91.2 107.17 19.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.307 1.043 . . . . 0.0 108.609 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -79.69 -61.65 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -130.23 -114.98 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.39 -17.27 78.86 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.43 107.42 19.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.001 0.92 . . . . 0.0 110.275 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.69 101.13 12.48 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -89.43 152.28 21.57 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -150.36 162.64 40.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.489 0.315 . . . . 0.0 111.411 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.0 t -146.0 135.28 22.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.997 0.919 . . . . 0.0 109.319 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -112.55 149.79 32.22 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.579 1.152 . . . . 0.0 111.989 -168.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -146.04 133.55 20.85 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.643 1.177 . . . . 0.0 109.191 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -102.79 105.68 16.14 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 105.58 17.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.26 134.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.652 1.181 . . . . 0.0 108.666 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -73.25 80.34 1.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.584 1.154 . . . . 0.0 109.529 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -87.03 70.41 10.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.619 1.168 . . . . 0.0 109.186 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 41.7 p -90.83 53.5 2.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 170.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -89.78 65.03 6.66 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.049 0.94 . . . . 0.0 108.591 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.9 p -85.65 62.29 7.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.163 0.985 . . . . 0.0 108.669 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.818 -175.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.873 -0.047 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.51 -41.36 94.19 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.87 1.268 . . . . 0.0 110.476 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.2 p -65.67 -46.16 80.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.476 1.11 . . . . 0.0 111.207 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.8 -140.42 9.41 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.107 0.86 . . . . 0.0 111.342 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -84.94 132.9 44.43 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.76 1.224 . . . . 0.0 108.351 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -169.65 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.598 2.865 . . . . 0.0 110.905 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 75.88 103.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 126.045 1.738 . . . . 0.0 111.782 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.12 -48.78 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.521 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -105.55 111.28 23.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.8 ptm -120.28 156.35 31.42 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.074 0.95 . . . . 0.0 110.113 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -179.54 2.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.72 0.808 . . . . 0.0 110.82 174.407 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 m -142.98 -154.77 0.54 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.98 92.46 0.72 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.6 mt 114.43 117.43 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 131.485 3.914 . . . . 0.0 107.122 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.44 142.0 24.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.212 3.275 . . . . 0.0 113.366 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.94 110.57 3.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mt -74.03 133.01 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.8 115.7 43.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.47 86.9 4.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.026 0.93 . . . . 0.0 109.385 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 18.8 ptm -89.61 158.9 17.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.193 0.997 . . . . 0.0 111.148 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.5 m -124.57 108.23 11.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -63.48 152.1 39.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 111.023 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 97.94 -34.52 5.14 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -89.47 177.23 6.62 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -74.78 135.37 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.44 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.01 109.64 11.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.755 1.222 . . . . 0.0 109.192 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.6 t -89.94 122.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -93.17 108.45 33.02 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.39 84.03 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.414 2.742 . . . . 0.0 110.381 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.9 p -140.45 45.88 1.82 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.777 0.831 . . . . 0.0 109.801 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.6 ptt180 -69.03 157.8 36.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.98 175.55 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.706 1.603 . . . . 0.0 109.459 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.0 p -73.33 -71.94 0.28 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.406 0.682 . . . . 0.0 110.413 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -99.66 151.21 37.38 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.501 1.121 . . . . 0.0 110.639 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.98 -30.24 39.58 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.871 2.381 . . . . 0.0 110.794 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -50.76 -30.57 14.37 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.2 1.8 . . . . 0.0 112.827 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 mm -50.27 -41.31 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.825 1.25 . . . . 0.0 111.047 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 61.07 80.98 0.2 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.08 1.352 . . . . 0.0 110.686 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.55 138.99 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.9 m -118.74 129.29 55.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.087 1.355 . . . . 0.0 107.951 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.47 100.89 13.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -89.39 168.88 11.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.749 1.22 . . . . 0.0 109.949 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -143.96 137.69 27.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.526 1.53 . . . . 0.0 107.865 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -60.58 134.32 91.68 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 118.631 -0.7 . . . . 0.0 110.556 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.4 -59.72 0.11 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 119.901 1.0 . . . . 0.0 112.01 -0.811 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.07 40.51 1.79 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.589 1.156 . . . . 0.0 110.164 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.56 167.42 14.61 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.8 m -146.78 133.27 19.73 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.627 0.371 . . . . 0.0 110.723 -173.043 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.24 87.5 3.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.527 1.531 . . . . 0.0 107.089 175.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mm -61.85 129.37 91.62 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.963 0.905 . . . . 0.0 109.544 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.29 79.83 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.261 2.641 . . . . 0.0 110.382 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.61 -25.72 67.52 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 113.318 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.43 43.22 54.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -150.09 -57.79 0.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.746 1.218 . . . . 0.0 108.317 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -95.95 -49.87 5.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.383 1.473 . . . . 0.0 107.914 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.4 mt -103.0 93.52 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 124.43 1.092 . . . . 0.0 108.424 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.8 119.71 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -90.0 100.6 13.39 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.152 0.581 . . . . 0.0 109.496 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -95.79 108.17 20.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 172.006 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 53.3 p -55.67 -35.12 65.64 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.362 0.665 . . . . 0.0 112.392 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -101.29 21.53 13.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.935 0.894 . . . . 0.0 112.661 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -145.9 -55.88 0.29 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.658 0.663 . . . . 0.0 111.51 171.249 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 159.19 -172.98 35.97 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -89.61 112.63 23.92 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.54 97.05 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.472 1.109 . . . . 0.0 108.599 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.71 98.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.4 p -59.02 -35.21 72.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.541 1.136 . . . . 0.0 113.303 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -130.32 81.73 2.02 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.527 1.131 . . . . 0.0 108.337 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 156.77 24.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.381 0.672 . . . . 0.0 111.734 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 70.3 p -145.66 -178.4 6.08 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.21 1.404 . . . . 0.0 109.06 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -54.74 -32.54 59.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.127 0.971 . . . . 0.0 112.376 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -31.45 55.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.494 0.718 . . . . 0.0 111.872 176.162 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -81.7 -40.62 22.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.519 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.11 119.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 118.467 0.576 . . . . 0.0 109.668 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.34 -160.51 20.72 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.352 0.977 . . . . 0.0 111.178 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 41.1 tp -79.26 84.36 5.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.142 0.977 . . . . 0.0 111.142 -172.366 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 43.5 mt -75.61 153.83 37.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.267 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.4 m -148.88 115.35 5.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.15 125.92 30.84 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -128.19 148.18 50.6 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.68 0.792 . . . . 0.0 110.517 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.29 133.1 10.36 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.265 0.626 . . . . 0.0 110.857 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.6 m -89.66 114.65 26.31 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.212 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.17 141.52 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 64.78 -76.93 0.04 OUTLIER 'General case' 0 C--N 1.343 0.287 0 C-N-CA 126.304 1.842 . . . . 0.0 110.269 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -171.8 44.45 0.18 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -150.05 127.69 11.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.572 1.149 . . . . 0.0 108.741 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.2 tp -81.03 102.54 10.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.123 0.969 . . . . 0.0 108.829 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -89.23 153.39 20.95 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -140.3 153.38 46.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.474 1.11 . . . . 0.0 109.953 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.7 t -149.35 122.81 9.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.365 0.666 . . . . 0.0 109.348 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -98.27 148.23 23.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.169 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.65 103.49 4.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.297 1.439 . . . . 0.0 108.56 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.29 94.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.2 p -88.39 99.08 11.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -89.47 172.1 9.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.596 1.158 . . . . 0.0 109.706 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -67.17 -88.04 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 109.585 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -159.66 168.28 26.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.045 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 41.2 p -79.27 54.07 1.61 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.433 1.493 . . . . 0.0 110.82 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -147.3 -48.1 0.18 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.878 2.071 . . . . 0.0 107.048 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 32.1 m -61.1 -60.04 4.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.537 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 C--O 1.25 1.131 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 169.1 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.05 74.59 9.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.534 1.134 . . . . 0.0 109.576 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 t -59.7 157.1 12.53 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.298 1.439 . . . . 0.0 111.59 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.82 -39.31 97.28 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.676 0.655 . . . . 0.0 111.68 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -145.63 134.18 10.9 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.93 -62.24 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.662 2.241 . . . . 0.0 110.549 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -75.14 130.22 38.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.18 0.992 . . . . 0.0 112.327 -173.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.11 -59.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.21 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -91.74 123.84 35.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ptm -152.03 166.23 32.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.834 0.854 . . . . 0.0 110.282 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -170.75 0.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.305 1.042 . . . . 0.0 110.971 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.8 t -123.08 -68.85 0.86 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.42 -52.81 0.72 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.01 1.324 . . . . 0.0 109.063 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.1 mm -72.78 130.54 85.22 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.26 149.76 64.18 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.594 2.196 . . . . 0.0 109.989 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.73 121.29 15.11 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.8 110.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.907 0.883 . . . . 0.0 108.755 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.37 93.52 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -74.72 81.77 2.07 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.24 1.016 . . . . 0.0 109.237 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 170.53 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.61 0.764 . . . . 0.0 111.89 -169.752 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -121.61 118.41 29.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.818 1.247 . . . . 0.0 108.165 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.1 149.79 22.74 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.97 -34.0 3.46 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.718 0.675 . . . . 0.0 112.079 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -89.82 176.11 6.96 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.857 0.863 . . . . 0.0 110.854 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.213 0.605 . . . . 0.0 111.706 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.6 tp -140.69 105.14 4.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.297 1.439 . . . . 0.0 107.718 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.2 t -89.85 132.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -108.99 94.61 15.15 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -84.66 66.33 6.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.319 2.68 . . . . 0.0 111.741 -166.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.6 p -100.83 58.73 0.92 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.125 0.97 . . . . 0.0 108.756 171.422 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -69.95 155.69 40.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.623 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 169.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.574 1.149 . . . . 0.0 111.953 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 p -67.89 -65.69 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.044 1.338 . . . . 0.0 110.072 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -111.97 149.98 41.69 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.647 1.179 . . . . 0.0 110.398 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.86 -27.62 43.5 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.516 2.81 . . . . 0.0 112.889 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.06 -16.69 60.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.9 mm -77.27 83.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 55.8 m -73.34 113.3 10.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.9 t -89.41 142.59 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.772 0.829 . . . . 0.0 109.256 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -98.97 111.8 24.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.26 100.32 13.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.75 168.43 12.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.32 0.648 . . . . 0.0 110.382 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -143.96 145.63 32.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.979 1.312 . . . . 0.0 108.342 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -58.19 134.25 84.5 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.007 0.923 . . . . 0.0 110.772 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.37 -59.13 0.13 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.784 0.959 . . . . 0.0 111.745 0.071 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -140.89 38.89 1.8 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.741 1.217 . . . . 0.0 109.859 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -79.19 158.85 27.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.4 m -131.44 126.02 34.02 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.76 0.824 . . . . 0.0 109.232 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.83 99.56 10.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.171 1.388 . . . . 0.0 107.533 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.32 128.81 93.09 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.39 85.3 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.892 2.395 . . . . 0.0 109.825 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.84 -22.31 62.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.171 1.388 . . . . 0.0 113.246 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 76.84 26.29 62.91 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.575 -0.569 . . . . 0.0 112.679 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.38 -63.77 0.58 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.827 1.251 . . . . 0.0 108.365 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -85.44 -60.09 2.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 27.4 mt -89.81 93.37 4.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.6 mt -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -88.95 96.36 10.69 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.33 105.13 17.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.7 p -51.68 -51.26 57.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.082 0.953 . . . . 0.0 112.9 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -95.07 28.97 2.57 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.825 . . . . 0.0 112.382 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -144.95 -60.39 0.36 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.765 0.826 . . . . 0.0 110.987 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 158.45 -176.09 35.45 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -89.36 107.52 19.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 mt -89.32 95.44 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.14 87.69 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.4 p -56.39 -31.55 63.96 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.713 1.205 . . . . 0.0 113.702 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -139.74 86.97 2.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.8 162.12 9.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.81 0.844 . . . . 0.0 111.43 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.6 p -126.8 153.16 45.97 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 0.0 108.801 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -53.62 -32.62 52.03 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.01 0.924 . . . . 0.0 111.829 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -55.74 -36.23 67.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.524 1.129 . . . . 0.0 111.82 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.44 -0.37 29.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.125 0.97 . . . . 0.0 112.938 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.0 mt -72.64 121.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 162.28 -116.51 0.72 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.77 107.32 4.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.056 0.942 . . . . 0.0 109.164 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.1 152.24 20.69 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.1 m -142.33 109.79 5.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.138 0.975 . . . . 0.0 108.389 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 77.6 m -76.78 136.38 38.99 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -130.7 142.63 50.43 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.392 1.077 . . . . 0.0 110.185 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.25 39.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.428 1.091 . . . . 0.0 109.516 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.5 m -142.19 127.25 18.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.02 -76.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 0.0 109.233 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.37 52.52 2.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.98 44.44 56.23 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.216 0.913 . . . . 0.0 111.669 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -150.09 128.78 12.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.539 1.136 . . . . 0.0 108.35 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.29 104.31 9.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -89.61 139.05 30.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -150.78 166.1 31.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.866 0.303 . . . . 0.0 111.442 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.57 137.47 14.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.917 0.887 . . . . 0.0 109.779 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -105.86 143.26 34.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.227 1.411 . . . . 0.0 112.75 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.97 103.55 4.66 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.586 1.555 . . . . 0.0 108.571 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.61 109.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 p -89.27 97.7 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -89.36 160.42 16.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.787 1.235 . . . . 0.0 108.695 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -80.12 -116.71 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -174.21 -169.42 0.46 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.839 1.256 . . . . 0.0 108.324 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.4 p -74.8 78.09 2.09 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 169.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -88.77 79.08 7.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.758 0.79 . . . . 0.0 109.143 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.2 p -53.23 -45.23 68.61 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.611 1.164 . . . . 0.0 110.739 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.251 1.144 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 169.783 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.04 -52.26 66.52 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.657 0.783 . . . . 0.0 109.719 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.5 m -85.3 61.85 7.12 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.67 -92.76 0.6 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -171.03 133.77 0.93 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.06 -47.23 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.913 2.408 . . . . 0.0 110.633 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.6 143.45 53.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 111.995 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -79.25 -52.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -109.58 122.77 48.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.577 1.551 . . . . 0.0 108.842 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.4 ptm -122.3 157.6 31.38 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.146 0.978 . . . . 0.0 109.736 170.744 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 218' ' ' THR . 0.2 OUTLIER -71.24 162.77 28.88 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.849 0.46 . . . . 0.0 110.717 173.858 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -92.62 -136.66 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -97.26 106.52 18.86 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 25.4 mm 119.73 122.3 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 131.688 3.995 . . . . 0.0 107.332 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -44.81 139.29 7.77 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.668 3.579 . . . . 0.0 114.101 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.45 119.2 10.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.225 0.61 . . . . 0.0 110.213 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.77 103.34 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.201 1.4 . . . . 0.0 108.861 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.0 mt -108.89 123.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.205 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -81.47 91.98 6.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.02 1.328 . . . . 0.0 108.726 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 13.9 ptm -89.3 168.34 12.33 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 111.803 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 m -136.67 142.58 43.18 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.23 1.412 . . . . 0.0 108.637 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.64 148.63 51.64 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.941 0.897 . . . . 0.0 110.85 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.34 -41.58 2.93 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.564 0.602 . . . . 0.0 113.228 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -88.64 -179.05 5.95 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.437 0.695 . . . . 0.0 110.586 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.2 156.22 39.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.5 tp -150.01 111.41 4.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.59 134.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -109.67 93.32 13.99 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 170.804 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.63 77.72 3.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.452 2.768 . . . . 0.0 112.163 -166.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.3 p -124.6 46.84 2.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.449 1.5 . . . . 0.0 109.814 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 188' ' ' SER . 29.4 ptt-85 -63.01 158.45 19.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.873 0.869 . . . . 0.0 111.006 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.2 m -114.31 155.22 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 124.427 1.091 . . . . 0.0 111.51 -174.279 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 p -57.68 -61.31 2.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.115 1.366 . . . . 0.0 109.873 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.8 t -98.56 120.33 59.39 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.291 1.037 . . . . 0.0 108.957 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.76 -32.69 6.31 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 125.08 3.853 . . . . 0.0 114.912 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -57.97 -27.96 63.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.591 1.156 . . . . 0.0 112.657 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.6 94.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 33.2 m -71.28 118.12 13.67 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.2 t -89.61 147.9 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.063 0.945 . . . . 0.0 109.18 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.3 m -101.75 111.24 23.43 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.379 1.072 . . . . 0.0 108.229 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.33 102.63 15.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -89.92 168.29 12.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.73 0.812 . . . . 0.0 110.183 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -146.61 146.25 30.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.75 1.22 . . . . 0.0 108.214 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 134.65 85.14 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.915 0.886 . . . . 0.0 110.777 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.33 -59.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.685 0 CA-C-N 119.737 0.942 . . . . 0.0 111.857 0.556 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.05 38.82 1.77 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 109.715 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -78.23 155.14 30.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 61.9 m -127.63 113.71 16.42 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.05 0.94 . . . . 0.0 109.101 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.78 87.57 7.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.9 133.92 95.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.169 0.988 . . . . 0.0 108.836 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.89 83.75 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.39 2.726 . . . . 0.0 110.779 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -69.61 -18.05 63.58 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 113.069 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.7 31.8 73.68 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -133.59 -71.86 0.51 Allowed 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -82.94 -56.2 3.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.5 mm -89.31 84.41 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.7 114.08 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -89.07 94.81 10.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.229 0.611 . . . . 0.0 109.74 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -89.84 95.81 10.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 77.7 p -58.46 -21.39 51.27 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -108.66 24.89 12.41 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.677 1.191 . . . . 0.0 111.856 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -147.03 -57.56 0.26 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.453 0.701 . . . . 0.0 110.264 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.21 -168.95 35.97 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.227 1.394 . . . . 0.0 109.878 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.0 114.36 25.54 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.15 96.95 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 21.8 mm -75.87 80.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.7 p -56.92 -35.33 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.829 1.252 . . . . 0.0 113.292 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -118.96 88.24 2.89 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.503 1.121 . . . . 0.0 108.675 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.64 144.52 52.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.24 0.616 . . . . 0.0 110.419 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 75.3 p -138.35 167.48 21.78 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.324 1.05 . . . . 0.0 110.602 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -61.38 -36.65 80.83 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.244 1.017 . . . . 0.0 111.45 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -52.65 -41.86 64.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.814 0.846 . . . . 0.0 110.697 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.68 0.62 29.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 112.828 -174.669 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.0 mt -73.89 109.79 6.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 161.6 -162.57 34.03 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 117.953 0.342 . . . . 0.0 112.263 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -92.68 103.0 15.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.914 1.285 . . . . 0.0 110.164 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.01 155.44 19.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.766 0.827 . . . . 0.0 108.827 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 38.7 m -149.74 114.01 5.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.278 0.631 . . . . 0.0 109.891 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 57.0 m -80.86 138.7 36.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -131.55 137.4 48.45 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.512 1.125 . . . . 0.0 109.399 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.41 151.39 28.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.8 0.84 . . . . 0.0 109.46 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.4 m -129.98 139.37 51.07 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.436 1.094 . . . . 0.0 108.949 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t -132.03 136.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.45 -85.34 0.02 OUTLIER 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -157.99 46.84 0.46 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -143.14 116.85 9.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.974 1.31 . . . . 0.0 107.83 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.9 tp -77.79 143.8 37.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.89 0.876 . . . . 0.0 109.31 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -132.51 150.13 52.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.25 1.42 . . . . 0.0 108.059 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -141.74 157.48 44.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.23 1.012 . . . . 0.0 110.137 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 139' ' ' TYR . 2.7 t -155.53 130.98 9.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.022 0.529 . . . . 0.0 110.131 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -109.42 143.41 39.04 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.499 1.519 . . . . 0.0 111.968 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -141.25 109.11 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 108.95 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.5 tt -90.19 101.9 14.62 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -89.75 91.33 8.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.156 0.983 . . . . 0.0 108.355 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -93.11 150.79 20.27 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -61.48 147.72 44.29 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.534 0.606 . . . . 0.0 109.808 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -63.78 -166.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.915 0.886 . . . . 0.0 112.745 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 43.3 p -69.41 79.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.371 1.068 . . . . 0.0 110.192 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -89.21 77.69 7.45 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.9 p -82.05 59.38 4.36 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.889 1.275 . . . . 0.0 110.362 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.68 -179.066 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.647 0.26 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -157.2 148.32 21.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.923 0.889 . . . . 0.0 109.138 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t -64.95 -24.12 67.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.948 0.899 . . . . 0.0 112.483 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.52 -62.53 3.62 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -167.11 157.45 10.06 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.582 0.753 . . . . 0.0 110.489 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.12 -48.05 0.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.531 2.821 . . . . 0.0 112.032 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -68.12 140.84 56.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.443 0.697 . . . . 0.0 111.947 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -89.63 -53.84 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -75.64 -81.79 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.436 1.094 . . . . 0.0 110.454 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . 0.259 26.5 ptm 51.49 172.35 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.99 2.516 . . . . 0.0 115.314 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.0 -146.32 0.05 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.902 1.681 . . . . 0.0 110.016 174.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.5 p -131.93 -81.14 0.51 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -128.68 -51.03 1.25 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.619 1.568 . . . . 0.0 108.175 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.26 129.58 79.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.16 135.32 45.1 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.709 2.939 . . . . 0.0 112.391 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.37 128.96 37.99 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.43 127.36 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.5 mt -123.59 133.41 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -96.81 84.16 3.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.457 1.503 . . . . 0.0 107.487 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 8.2 ptm -89.03 164.35 15.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.892 0.377 . . . . 0.0 111.185 -172.843 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -149.46 131.88 15.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.82 155.53 33.69 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.089 0.555 . . . . 0.0 110.706 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.01 -42.73 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -89.05 173.38 8.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.914 1.286 . . . . 0.0 110.94 -172.173 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.49 137.43 44.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.995 0.918 . . . . 0.0 110.269 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.3 tp -127.71 106.95 9.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.479 1.512 . . . . 0.0 107.742 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.2 t -90.56 132.34 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.01 97.52 25.29 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.85 82.16 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.642 2.894 . . . . 0.0 111.667 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.1 p -127.34 55.35 1.6 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.083 1.353 . . . . 0.0 109.206 174.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -65.95 155.45 36.47 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 111.038 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.07 177.43 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.357 1.463 . . . . 0.0 108.53 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -78.88 -29.7 44.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.161 0.984 . . . . 0.0 111.959 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.6 m -149.13 146.41 21.27 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.382 0.673 . . . . 0.0 110.127 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.38 -31.99 33.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.569 2.846 . . . . 0.0 112.743 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -58.56 -26.56 63.71 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.593 0.757 . . . . 0.0 112.359 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.5 mm -54.61 -40.34 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.704 1.201 . . . . 0.0 110.605 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.7 m 61.96 91.2 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.986 1.314 . . . . 0.0 111.431 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.6 t -88.95 143.4 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 91.6 m -104.99 122.43 45.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.2 tp -89.18 125.37 35.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -125.4 -176.4 3.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.079 0.952 . . . . 0.0 109.9 174.098 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -143.65 143.87 31.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.36 1.864 . . . . 0.0 107.205 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.55 128.03 67.53 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 123.548 0.739 . . . . 0.0 111.23 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.35 -61.77 0.04 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.877 0.992 . . . . 0.0 112.101 1.294 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.73 39.99 1.4 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.579 1.152 . . . . 0.0 110.275 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -77.98 122.6 25.75 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.8 m -89.73 114.32 25.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.002 0.521 . . . . 0.0 111.001 -169.543 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 mp -90.01 87.06 6.76 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.774 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.47 129.79 93.86 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.78 88.45 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.14 2.56 . . . . 0.0 110.148 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.7 -23.6 67.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.588 1.155 . . . . 0.0 113.071 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.56 20.2 60.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.566 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.76 -60.48 0.83 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.527 1.131 . . . . 0.0 108.174 173.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -78.68 -68.08 0.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.7 mt -89.47 91.93 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 95.0 mt -93.13 118.51 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -88.98 96.33 10.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -89.87 101.78 14.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 77.6 p -52.7 -37.81 59.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.915 0.886 . . . . 0.0 113.215 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -99.0 25.83 6.36 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.984 0.914 . . . . 0.0 112.182 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -150.39 -56.69 0.17 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.513 0.597 . . . . 0.0 111.382 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.44 -173.45 34.9 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -89.42 114.78 26.29 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.1 mt -94.66 94.1 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.95 88.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 79.9 p -57.56 -38.19 74.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.196 1.399 . . . . 0.0 112.453 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -119.55 88.88 3.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.236 1.015 . . . . 0.0 108.517 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.97 146.19 55.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.749 0.419 . . . . 0.0 110.517 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 81.1 p -137.66 173.0 12.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 109.142 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -51.63 -31.27 24.67 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.266 1.427 . . . . 0.0 112.258 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -52.07 -35.94 49.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 112.374 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -87.8 -5.42 58.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.055 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.6 mt -72.15 116.06 13.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 120.251 1.387 . . . . 0.0 108.347 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.15 -104.51 0.26 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.824 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.5 tp -152.3 96.72 2.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.917 0.887 . . . . 0.0 109.183 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.4 155.98 23.19 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.171 0.589 . . . . 0.0 109.565 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 30.4 m -146.67 106.26 3.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.753 1.221 . . . . 0.0 109.156 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 47.7 m -78.45 143.16 36.95 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -136.29 135.17 38.72 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.507 1.123 . . . . 0.0 109.899 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.62 164.05 37.75 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.359 1.064 . . . . 0.0 110.327 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.7 m -146.07 135.93 23.43 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.878 0.871 . . . . 0.0 108.736 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.9 -78.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.223 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -88.23 49.91 1.88 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.703 -170.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.28 -24.55 1.71 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.614 0.626 . . . . 0.0 113.45 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -88.91 132.99 34.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.732 1.213 . . . . 0.0 109.585 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.5 tp -76.43 107.82 8.96 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.45 143.05 27.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.853 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.21 161.38 42.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.711 0.405 . . . . 0.0 110.529 174.028 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.8 t -153.84 133.85 13.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.568 0.747 . . . . 0.0 109.37 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -110.36 151.93 26.85 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.844 1.258 . . . . 0.0 112.793 -168.889 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.55 104.41 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.435 1.494 . . . . 0.0 108.861 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.3 tt -78.23 99.4 6.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.115 0.966 . . . . 0.0 108.635 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.1 p -90.09 90.84 8.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.413 1.485 . . . . 0.0 109.606 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -89.95 155.06 19.38 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -74.46 127.52 33.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -68.53 -35.81 77.96 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.668 1.187 . . . . 0.0 111.437 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.6 p -45.21 -37.62 4.71 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.763 1.625 . . . . 0.0 111.52 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -134.34 74.45 1.54 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.964 0.905 . . . . 0.0 109.077 169.528 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 53.3 m -54.9 110.49 0.67 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.953 1.301 . . . . 0.0 109.077 170.346 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.76 -1.591 . . . . 0.0 111.464 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.8 t . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -63.3 -36.15 82.71 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.988 0.915 . . . . 0.0 110.103 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.2 p -95.95 52.28 1.3 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.51 68.83 3.46 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -65.76 143.56 98.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 122.411 0.284 . . . . 0.0 110.624 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.23 -40.91 1.45 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.103 2.535 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -68.44 118.46 11.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.217 1.007 . . . . 0.0 112.069 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.13 -58.4 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -93.14 134.48 35.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.3 ptm -159.96 170.38 21.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.208 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -153.26 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.748 1.619 . . . . 0.0 110.722 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.7 t -133.11 -69.02 0.57 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.71 -56.25 0.57 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 124.919 1.288 . . . . 0.0 108.671 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.77 132.2 94.8 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.29 129.11 20.76 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.525 2.15 . . . . 0.0 109.503 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.1 117.55 6.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.579 0.752 . . . . 0.0 110.697 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mm -72.75 110.6 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.789 1.236 . . . . 0.0 108.634 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 mt -118.14 113.1 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 124.551 1.14 . . . . 0.0 108.559 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 136.41 42.96 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.71 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -144.83 157.81 44.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.923 0.489 . . . . 0.0 111.154 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.5 m -105.03 114.62 28.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.83 140.14 56.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.071 0.549 . . . . 0.0 110.232 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 101.4 -35.03 5.18 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.356 0.979 . . . . 0.0 111.202 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -89.63 -177.81 5.38 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.741 0.817 . . . . 0.0 111.446 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.16 148.0 50.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.4 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.0 tp -145.24 106.82 4.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.427 1.091 . . . . 0.0 108.744 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.7 t -94.41 120.53 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.592 1.157 . . . . 0.0 107.887 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.7 mm -89.95 109.79 35.31 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.0 72.54 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.437 2.758 . . . . 0.0 111.081 -168.133 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 20.3 p -126.02 50.96 1.81 Allowed 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 124.63 1.172 . . . . 0.0 109.563 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.367 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.9 174.22 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.7 1.6 . . . . 0.0 109.331 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -74.99 -29.01 60.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.536 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -148.29 144.28 18.53 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.624 0.647 . . . . 0.0 111.607 -169.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.1 -39.75 26.09 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.501 3.467 . . . . 0.0 113.535 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -49.34 -37.22 23.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.455 1.502 . . . . 0.0 112.083 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.1 mt -77.97 87.63 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.8 m -78.09 110.6 13.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.46 150.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.375 1.07 . . . . 0.0 108.28 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.9 m -110.46 124.68 52.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.186 0.994 . . . . 0.0 108.646 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 tp -89.4 101.13 13.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.55 169.05 11.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.013 0.925 . . . . 0.0 109.892 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.49 145.58 31.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 108.118 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -57.36 134.27 81.5 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.586 0.754 . . . . 0.0 110.872 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.27 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.707 0 CA-C-N 119.819 0.971 . . . . 0.0 111.716 -0.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.3 39.27 1.74 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.721 1.208 . . . . 0.0 109.996 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -79.66 161.35 25.89 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 171.19 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -138.44 120.63 15.76 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.368 0.667 . . . . 0.0 110.027 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.4 mp -92.18 81.05 5.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.9 mm -60.94 120.4 53.56 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.421 1.088 . . . . 0.0 109.655 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.79 119.49 6.78 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.149 2.566 . . . . 0.0 111.958 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -84.68 -16.17 42.78 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.632 0.773 . . . . 0.0 111.621 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.81 39.8 89.76 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -150.28 -66.91 0.2 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.711 0.804 . . . . 0.0 109.004 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.7 -54.95 3.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.652 1.181 . . . . 0.0 107.852 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 54.4 mt -95.52 91.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.11 120.31 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -88.93 94.62 10.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -89.43 99.44 12.44 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.8 p -51.04 -41.29 59.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -97.88 24.7 6.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.218 1.007 . . . . 0.0 112.292 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -145.81 -57.08 0.31 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.454 0.701 . . . . 0.0 110.94 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.54 -173.6 37.12 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.02 110.06 20.81 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.3 mt -91.4 93.15 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.078 1.351 . . . . 0.0 108.125 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.31 100.82 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.6 p -61.89 -32.15 72.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.733 0.813 . . . . 0.0 112.608 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.03 95.16 4.5 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.589 1.156 . . . . 0.0 108.915 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.8 138.88 44.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.154 0.581 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 72.8 p -142.84 -178.56 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.902 1.281 . . . . 0.0 109.357 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -45.66 -40.77 9.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.21 1.404 . . . . 0.0 112.109 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -51.99 -32.08 32.22 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.314 1.446 . . . . 0.0 112.472 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -90.16 -38.23 13.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.286 1.034 . . . . 0.0 110.786 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.2 mt -65.95 106.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.324 0.65 . . . . 0.0 109.864 -171.546 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.28 29.07 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 47.4 tp -83.32 87.82 6.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.472 1.109 . . . . 0.0 109.659 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 89.7 mt -76.73 154.71 33.86 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.02 0.928 . . . . 0.0 109.148 172.012 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -148.97 112.11 4.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.331 0.652 . . . . 0.0 109.585 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 66.5 m -78.44 132.92 37.5 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.422 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -131.21 143.38 50.54 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.994 0.918 . . . . 0.0 110.962 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.76 172.92 17.36 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.034 1.334 . . . . 0.0 109.524 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 75.1 m -144.42 139.54 28.44 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.087 0.955 . . . . 0.0 108.874 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.63 -75.53 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.78 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.94 46.92 1.24 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.844 0.858 . . . . 0.0 111.546 -170.019 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.77 41.03 50.12 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -170.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -149.27 120.59 7.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.326 1.45 . . . . 0.0 107.376 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.74 111.49 7.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -90.16 143.36 26.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -150.43 161.73 41.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.577 0.351 . . . . 0.0 110.631 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 t -153.02 132.01 12.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.757 0.823 . . . . 0.0 109.153 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -105.84 144.66 32.26 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.975 1.31 . . . . 0.0 111.552 -169.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -139.29 113.19 8.6 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.081 1.352 . . . . 0.0 109.038 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -88.87 99.16 12.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.0 p -89.57 106.81 18.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -112.39 179.61 3.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.224 1.41 . . . . 0.0 110.557 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -64.19 172.42 2.46 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.846 0.858 . . . . 0.0 112.111 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -133.61 74.04 1.54 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.796 0.838 . . . . 0.0 109.223 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.1 p -83.06 62.07 6.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.96 0.904 . . . . 0.0 108.814 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -89.42 -55.24 3.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.138 0.975 . . . . 0.0 109.563 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.7 t -71.38 159.47 34.5 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.002 0.521 . . . . 0.0 110.235 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.174 -1.393 . . . . 0.0 108.526 179.483 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 120.293 0.092 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.74 -34.09 70.99 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.58 0.752 . . . . 0.0 110.876 172.433 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 p -59.54 118.01 5.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.496 1.118 . . . . 0.0 109.249 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.19 42.99 97.74 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.158 0.885 . . . . 0.0 111.919 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -97.91 113.08 63.26 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.164 0.986 . . . . 0.0 108.84 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -82.05 -175.86 2.73 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.72 2.947 . . . . 0.0 110.319 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 73.88 103.11 0.07 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.555 1.942 . . . . 0.0 111.948 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.22 -52.54 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -96.26 78.18 3.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.024 0.93 . . . . 0.0 108.728 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ttt -80.94 139.91 35.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -172.78 0.3 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.363 1.065 . . . . 0.0 112.076 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.4 t -148.48 -162.37 1.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 108.891 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.7 95.94 0.69 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 32.4 mm 116.6 120.08 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 1 C-N-CA 132.131 4.172 . . . . 0.0 107.332 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.15 139.59 32.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.346 2.697 . . . . 0.0 110.113 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -65.78 130.08 42.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.267 0.627 . . . . 0.0 111.273 -177.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -72.52 138.03 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.396 1.078 . . . . 0.0 109.82 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.8 mt -128.45 127.87 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.017 1.327 . . . . 0.0 107.873 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -90.9 125.05 35.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -150.31 176.6 10.74 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.498 0.719 . . . . 0.0 110.367 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.3 m -150.08 143.05 24.86 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 170.737 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.77 141.56 55.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.483 0.313 . . . . 0.0 110.16 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.5 -35.75 4.81 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.11 0.862 . . . . 0.0 111.69 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.76 169.78 11.34 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.708 0.754 . . . . 0.0 110.586 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.49 147.73 37.63 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.247 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.22 108.88 4.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -171.123 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.75 130.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -106.87 97.27 16.96 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.59 77.3 4.11 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.068 2.512 . . . . 0.0 111.134 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -115.46 53.66 0.83 Allowed 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.918 1.287 . . . . 0.0 109.183 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -66.47 148.39 51.95 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.273 0.629 . . . . 0.0 110.738 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.08 175.58 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 109.793 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.9 p -67.26 -40.49 86.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.832 0.853 . . . . 0.0 111.823 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -150.74 149.04 24.71 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.274 0.63 . . . . 0.0 111.064 -171.019 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.23 -37.98 40.58 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.749 2.966 . . . . 0.0 112.613 166.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -53.24 -29.26 31.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.975 1.71 . . . . 0.0 113.03 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.8 mm -55.5 -34.74 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.012 0.925 . . . . 0.0 110.796 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.1 m 63.85 80.23 0.24 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.313 1.445 . . . . 0.0 110.564 173.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.79 141.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.6 m -120.92 128.57 52.89 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.681 1.192 . . . . 0.0 108.173 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.1 tp -89.16 131.79 35.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -134.77 177.24 7.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 109.651 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -146.62 148.94 32.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.995 0.918 . . . . 0.0 109.439 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.11 137.52 88.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.586 0.754 . . . . 0.0 109.721 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.74 -59.28 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.985 1.031 . . . . 0.0 111.857 0.706 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.3 mt -140.01 42.98 1.94 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.615 1.166 . . . . 0.0 109.768 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.65 145.28 27.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.9 m -122.2 128.55 51.34 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 124.202 1.001 . . . . 0.0 108.659 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.0 mt -111.9 79.23 1.19 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.656 1.582 . . . . 0.0 107.693 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.55 132.66 91.12 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 109.613 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.86 87.08 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.25 2.634 . . . . 0.0 110.402 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.26 -23.2 66.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.809 1.244 . . . . 0.0 112.859 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 82.84 17.43 67.81 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.573 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -129.07 -63.16 0.97 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -73.87 -68.43 0.52 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.815 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.7 mt -89.5 95.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.0 mt -95.9 115.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -89.35 117.07 28.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.475 0.71 . . . . 0.0 110.005 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -115.01 108.63 16.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.9 p -58.54 -29.42 66.33 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.74 0.816 . . . . 0.0 113.176 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -102.6 22.64 13.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.917 0.887 . . . . 0.0 112.177 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -149.17 -57.86 0.21 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.457 0.571 . . . . 0.0 111.115 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.58 -172.11 34.27 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -89.35 113.0 24.24 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.87 95.06 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.71 89.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 170.108 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 65.1 p -60.08 -35.04 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.785 1.234 . . . . 0.0 112.54 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.05 93.89 4.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.282 1.033 . . . . 0.0 108.391 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.26 150.81 38.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.468 0.707 . . . . 0.0 110.398 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 38.5 p -146.31 171.49 14.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.678 1.191 . . . . 0.0 109.208 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -51.42 -34.71 36.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.421 1.088 . . . . 0.0 111.621 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -56.59 -26.82 56.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.97 1.308 . . . . 0.0 112.071 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -82.9 -39.59 21.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.485 0.714 . . . . 0.0 111.839 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.2 108.4 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.119 0.967 . . . . 0.0 110.369 -169.7 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 147.23 -162.48 28.62 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.989 0.804 . . . . 0.0 111.334 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.19 88.3 6.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.226 1.01 . . . . 0.0 109.255 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.5 154.5 41.82 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.108 0.963 . . . . 0.0 109.298 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.0 m -149.73 108.75 3.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.039 0.936 . . . . 0.0 109.308 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.8 m -79.83 133.26 36.27 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -127.95 141.57 51.5 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.276 1.03 . . . . 0.0 110.078 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.42 120.69 6.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.117 0.967 . . . . 0.0 109.637 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.4 m -100.53 77.61 1.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.793 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.93 -52.65 29.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -109.41 177.78 4.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.613 1.165 . . . . 0.0 108.748 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.96 70.65 1.48 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 169.72 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -145.56 -43.25 0.22 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.566 1.547 . . . . 0.0 110.289 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp 64.11 91.22 0.08 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.854 1.662 . . . . 0.0 109.681 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -89.48 147.4 24.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.998 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -150.52 164.24 36.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.542 0.337 . . . . 0.0 111.61 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.2 t -147.11 129.12 15.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.701 1.2 . . . . 0.0 108.233 174.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -107.68 151.4 25.71 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.24 1.416 . . . . 0.0 112.688 -168.803 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -144.88 121.91 11.39 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.993 1.317 . . . . 0.0 108.956 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.24 102.51 14.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.1 p -89.57 124.15 34.29 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.64 0.776 . . . . 0.0 109.419 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -120.68 147.3 45.46 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.905 0.882 . . . . 0.0 110.133 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -79.16 104.01 9.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.796 0.838 . . . . 0.0 109.894 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.27 170.31 14.77 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.413 0.685 . . . . 0.0 111.27 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.6 p -126.44 -67.31 0.87 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.094 1.358 . . . . 0.0 107.627 173.579 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -100.07 145.98 27.31 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.888 1.275 . . . . 0.0 108.441 169.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 33.7 p -83.3 -70.91 0.53 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.729 0.812 . . . . 0.0 109.01 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.9 mm . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.187 -1.387 . . . . 0.0 108.498 -179.552 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 129' ' ' SER . . . . . 0.531 ' N ' ' HG ' ' A' ' 162' ' ' SER . 8.3 m . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.66 -52.28 18.71 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.253 0.621 . . . . 0.0 109.374 171.881 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.4 m -161.66 146.51 13.21 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.875 2.07 . . . . 0.0 106.868 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 160.58 -80.17 0.15 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -164.85 114.07 0.88 Allowed Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 124.059 0.944 . . . . 0.0 108.746 172.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.81 -171.98 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.531 2.821 . . . . 0.0 111.401 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 77.57 104.81 0.07 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 127.199 2.2 . . . . 0.0 111.6 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.26 -50.39 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.465 1.106 . . . . 0.0 109.343 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.62 -70.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.399 0.68 . . . . 0.0 109.518 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ttt 64.23 116.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.569 1.948 . . . . 0.0 112.834 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.64 151.46 47.26 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.1 p -78.56 -62.64 1.62 Allowed 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.148 -0.345 . . . . 0.0 110.263 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -158.77 -51.66 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.426 1.09 . . . . 0.0 109.055 -171.139 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 34.6 mm -79.69 126.9 79.54 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.14 139.82 34.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.665 2.91 . . . . 0.0 112.519 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.18 119.75 12.6 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.4 mm -77.66 102.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.3 mt -92.22 143.66 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.337 1.055 . . . . 0.0 108.208 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -120.64 79.91 1.55 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.533 1.133 . . . . 0.0 110.12 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -89.5 -177.72 5.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.527 1.131 . . . . 0.0 111.064 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -142.31 117.57 10.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 169.202 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.65 123.55 9.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.631 0.773 . . . . 0.0 109.983 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.36 -39.74 2.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.823 1.201 . . . . 0.0 111.167 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -89.31 165.63 14.28 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.695 0.748 . . . . 0.0 111.363 -171.359 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -67.71 129.87 41.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -128.0 124.47 37.27 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.484 1.113 . . . . 0.0 109.561 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.03 134.76 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.5 mm -101.09 100.85 14.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.4 76.23 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 111.108 -165.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.1 p -125.58 45.02 2.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.291 1.037 . . . . 0.0 110.406 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 0.817 ' HB2' ' O ' ' A' ' 188' ' ' SER . 41.1 ptt180 -67.25 151.38 47.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.906 0.483 . . . . 0.0 110.771 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.1 175.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.929 1.292 . . . . 0.0 111.366 -169.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.528 ' HG1' ' N ' ' A' ' 129' ' ' SER . 52.1 p -75.73 -24.28 56.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -172.594 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 129' ' ' SER . 14.7 m -158.36 149.92 16.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.031 0.832 . . . . 0.0 110.824 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.72 -36.35 41.47 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.011 3.141 . . . . 0.0 113.654 168.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.59 -36.59 35.62 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.327 1.851 . . . . 0.0 111.935 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 41.6 mm -50.46 -42.74 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.861 1.264 . . . . 0.0 111.19 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 60.58 83.71 0.14 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.037 1.335 . . . . 0.0 111.044 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.68 147.49 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.609 0.764 . . . . 0.0 108.987 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.3 m -124.83 138.77 54.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.84 1.256 . . . . 0.0 107.852 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.0 tp -88.93 125.75 35.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -128.26 -179.55 5.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.878 1.271 . . . . 0.0 110.035 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -147.72 148.19 30.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 108.223 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -58.1 134.22 84.17 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.116 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.72 -59.97 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.962 1.022 . . . . 0.0 111.828 0.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.8 mt -141.83 38.26 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 110.162 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.6 148.28 40.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 170.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 91.0 m -125.75 118.32 25.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.757 0.823 . . . . 0.0 109.904 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.04 88.67 6.2 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 79.5 mt -61.36 130.44 91.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.636 0.775 . . . . 0.0 109.306 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.37 85.32 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.204 2.602 . . . . 0.0 110.247 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -60.78 -22.92 64.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.275 1.43 . . . . 0.0 113.28 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.72 28.07 65.89 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 118.374 0.534 . . . . 0.0 112.646 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.56 -64.26 0.72 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.078 1.351 . . . . 0.0 107.705 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -84.6 -58.43 2.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.8 mt -91.74 89.78 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 78.4 mt -95.22 116.35 36.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -89.1 129.55 35.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -135.6 122.17 20.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.289 1.036 . . . . 0.0 108.289 170.384 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 188' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 60.7 p -58.8 -26.46 64.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 112.379 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -98.75 10.93 40.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.883 0.873 . . . . 0.0 113.147 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -145.55 -57.85 0.32 Allowed 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.83 0.741 . . . . 0.0 110.603 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.31 -164.66 29.36 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.79 111.41 22.4 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.53 97.41 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.1 110.84 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 92.1 p -65.15 -35.62 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.518 0.599 . . . . 0.0 112.499 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -140.33 101.84 4.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.836 1.255 . . . . 0.0 107.99 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.11 157.58 25.1 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.365 0.666 . . . . 0.0 110.177 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 80.3 p -133.06 164.28 27.37 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.725 0.81 . . . . 0.0 110.177 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -59.63 -32.13 70.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.283 0.633 . . . . 0.0 110.969 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -60.3 -25.74 65.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.262 1.025 . . . . 0.0 111.947 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.29 -12.29 59.63 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.654 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.61 105.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.44 1.018 . . . . 0.0 109.212 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.82 -159.04 28.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.5 81.36 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.918 0.887 . . . . 0.0 110.562 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 97.9 mt -65.83 150.91 47.8 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 27.7 m -150.01 114.64 5.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.466 0.706 . . . . 0.0 109.416 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 84.6 m -78.23 124.48 28.12 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -121.55 141.49 51.01 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.316 1.047 . . . . 0.0 110.447 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.07 102.06 2.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.558 1.143 . . . . 0.0 109.198 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.2 m -89.88 86.34 6.61 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.92 -56.07 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.279 0.632 . . . . 0.0 109.786 -174.263 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -158.03 -75.51 0.08 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.981 0.913 . . . . 0.0 109.415 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.29 -46.54 78.1 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 123.362 0.506 . . . . 0.0 112.398 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -140.06 162.39 35.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.235 0.614 . . . . 0.0 111.395 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.59 101.96 9.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -89.85 133.2 34.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.55 161.71 42.02 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 62.7 p -139.72 133.6 30.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.518 1.127 . . . . 0.0 109.086 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 26.0 m-80 -106.87 145.55 32.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.209 1.004 . . . . 0.0 111.743 -170.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -143.06 105.43 4.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.714 1.606 . . . . 0.0 109.235 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.69 108.67 19.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.9 p -89.26 90.65 8.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.462 0.705 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -89.61 103.43 16.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 -56.28 143.45 33.92 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.993 0.815 . . . . 0.0 110.777 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.38 138.39 57.56 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 35.2 p -64.96 -47.71 76.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.67 0.788 . . . . 0.0 109.893 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.02 149.83 30.91 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.143 1.377 . . . . 0.0 109.333 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 m -81.62 73.16 8.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.854 0.862 . . . . 0.0 109.371 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 50.1 mt . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.226 -1.368 . . . . 0.0 107.714 178.979 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 120.697 0.284 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.94 65.42 6.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.9 0.88 . . . . 0.0 109.458 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.2 m -75.5 76.58 2.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.921 1.288 . . . . 0.0 110.027 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.4 -134.29 2.55 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.976 -2.049 . . . . 0.0 107.976 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -75.41 126.84 87.17 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 117.431 0.616 . . . . 0.0 109.393 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.39 -37.41 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.166 2.577 . . . . 0.0 111.37 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -62.08 143.42 56.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 112.366 -174.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.29 -55.85 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -92.45 126.75 37.67 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 108.922 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.17 141.01 42.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.077 1.351 . . . . 0.0 108.996 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.16 121.09 12.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.549 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -68.91 -39.51 79.62 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.8 -0.563 . . . . 0.0 111.222 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -158.92 -58.34 0.07 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.6 mm -87.77 130.99 44.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.96 147.4 26.22 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.549 2.833 . . . . 0.0 112.429 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.87 118.98 11.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.2 94.68 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.6 mt -89.54 108.28 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -76.9 89.25 3.49 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.09 0.956 . . . . 0.0 108.552 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -104.36 173.51 6.27 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.395 1.478 . . . . 0.0 111.387 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 94.1 m -138.36 120.74 15.96 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -59.67 144.67 47.31 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.719 0.408 . . . . 0.0 110.364 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.22 -37.32 3.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -89.15 170.15 10.86 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.728 0.811 . . . . 0.0 110.672 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.57 145.57 54.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.815 0.446 . . . . 0.0 110.813 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.5 tp -143.31 108.5 5.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.88 1.272 . . . . 0.0 108.451 -172.064 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.64 131.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mm -108.63 91.52 8.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.73 89.19 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.459 2.773 . . . . 0.0 111.851 -164.368 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.7 p -135.62 48.73 2.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.557 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ARG . . . . . 1.283 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -62.87 157.38 21.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.253 0.549 . . . . 0.0 112.174 176.603 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.85 175.01 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.819 1.648 . . . . 0.0 108.94 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 p -63.7 -42.4 97.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.474 0.71 . . . . 0.0 112.04 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.9 m -142.72 140.89 19.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.999 0.92 . . . . 0.0 110.24 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.17 -26.9 42.03 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.669 2.913 . . . . 0.0 112.027 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -52.77 -31.82 40.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.313 1.445 . . . . 0.0 112.082 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.78 -35.07 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.982 1.313 . . . . 0.0 110.915 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 m 69.02 91.29 0.09 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.537 1.535 . . . . 0.0 110.383 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.33 141.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.8 m -110.45 126.84 54.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.719 1.208 . . . . 0.0 108.092 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.0 tp -89.23 133.34 34.48 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -133.82 174.82 10.04 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.767 1.227 . . . . 0.0 109.764 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -149.23 148.21 29.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.645 0.778 . . . . 0.0 109.413 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.7 134.95 82.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.928 0.891 . . . . 0.0 109.96 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.27 -59.2 0.13 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 119.917 1.006 . . . . 0.0 111.697 1.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -142.52 44.2 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.597 1.159 . . . . 0.0 109.943 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -82.03 152.03 26.84 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 89.7 m -131.71 119.09 20.87 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.133 0.973 . . . . 0.0 108.942 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.95 113.35 26.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.283 1.433 . . . . 0.0 108.569 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.74 130.9 74.96 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.74 91.4 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.861 2.374 . . . . 0.0 109.731 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -64.31 -22.6 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.478 1.111 . . . . 0.0 113.144 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.48 59.22 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.233 -0.76 . . . . 0.0 113.428 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -137.12 -60.12 0.69 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.649 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -79.7 -66.48 0.87 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -89.56 94.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 40.9 mt -94.6 121.68 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -89.21 127.83 35.78 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.09 100.8 4.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.773 1.229 . . . . 0.0 108.38 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' SER . . . . . 1.283 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.7 p -53.79 -27.74 30.91 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -73.01 -28.43 62.36 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.113 0.965 . . . . 0.0 112.611 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.31 -63.34 1.34 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.728 0.811 . . . . 0.0 110.65 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.21 26.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.84 111.71 22.83 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.35 94.54 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.14 85.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -58.19 -29.5 65.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.481 1.512 . . . . 0.0 113.336 -170.774 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -132.62 97.25 4.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.09 156.91 36.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.055 0.542 . . . . 0.0 110.393 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 43.0 p -125.53 154.43 42.15 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.143 0.977 . . . . 0.0 109.67 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -55.28 -32.55 62.5 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.172 0.989 . . . . 0.0 111.671 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -53.49 -37.35 62.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.642 1.177 . . . . 0.0 111.481 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -83.34 4.37 27.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.397 1.079 . . . . 0.0 113.2 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.3 mt -73.87 115.51 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.62 -111.5 0.48 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.8 tp -144.98 100.71 3.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.96 0.904 . . . . 0.0 109.975 -172.022 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.7 156.67 19.88 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.816 0.846 . . . . 0.0 109.128 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.7 m -147.28 117.73 7.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.395 1.078 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 60.4 m -85.04 140.01 31.33 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -133.94 147.44 51.06 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.995 0.918 . . . . 0.0 109.91 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.91 130.63 6.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.332 0.653 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.8 m -100.06 133.88 43.8 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.954 1.302 . . . . 0.0 109.329 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.7 t -100.49 -62.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.261 1.024 . . . . 0.0 108.524 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -140.31 84.79 1.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.066 0.947 . . . . 0.0 109.106 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.22 -57.47 5.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.05 0.834 . . . . 0.0 111.928 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.49 129.25 36.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.766 0.827 . . . . 0.0 110.289 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.86 156.8 30.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.634 0.73 . . . . 0.0 111.046 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -125.41 154.57 41.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -151.2 162.74 40.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 t -151.44 141.42 22.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.924 0.89 . . . . 0.0 109.639 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 57.4 m-80 -109.17 147.49 32.42 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.288 1.435 . . . . 0.0 112.794 -168.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -143.76 101.9 3.83 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.457 1.503 . . . . 0.0 109.118 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.1 tt -80.31 110.98 16.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 108.772 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.9 p -89.4 93.29 9.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.532 1.133 . . . . 0.0 109.024 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -89.92 120.56 31.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.23 1.412 . . . . 0.0 108.749 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -73.11 109.58 6.75 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -66.89 -57.4 7.03 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.268 1.027 . . . . 0.0 111.346 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 6.3 p -91.36 78.6 5.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -88.01 65.45 8.23 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 73.6 p -85.73 66.23 9.53 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.68 1.592 . . . . 0.0 108.886 -175.392 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.31 -1.329 . . . . 0.0 108.909 -178.853 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -166.46 142.08 4.59 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.109 0.964 . . . . 0.0 109.4 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.6 p -123.86 58.69 1.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.891 1.276 . . . . 0.0 108.005 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -129.02 -61.16 0.11 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -121.37 126.82 26.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 169.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.65 -61.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.56 2.173 . . . . 0.0 111.341 -173.782 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -71.56 132.9 45.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.348 0.659 . . . . 0.0 111.729 -171.674 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.89 -61.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -81.98 109.59 16.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ttt -123.92 123.6 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.92 0.888 . . . . 0.0 110.252 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.95 147.3 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.998 0.919 . . . . 0.0 110.709 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 m -154.44 -58.5 0.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.064 1.345 . . . . 0.0 109.25 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -97.32 79.74 2.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.867 0.867 . . . . 0.0 110.273 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.4 mm 78.36 128.4 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 128.142 2.577 . . . . 0.0 109.748 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.74 138.32 33.32 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.348 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.67 120.55 11.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.099 0.56 . . . . 0.0 109.981 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.8 mm -76.53 122.6 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.0 mt -122.75 102.94 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -75.79 83.79 2.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.283 1.033 . . . . 0.0 109.524 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -92.87 155.62 17.49 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.068 0.947 . . . . 0.0 111.383 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 83.5 m -115.72 112.77 22.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -57.7 137.58 56.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.465 0.706 . . . . 0.0 109.88 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 104.31 -36.38 4.42 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.15 0.881 . . . . 0.0 111.385 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.5 179.48 6.05 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.525 0.73 . . . . 0.0 110.897 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.06 137.82 45.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.29 108.79 8.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.85 -175.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -90.0 128.85 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 108.176 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -109.25 94.02 14.58 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.68 100.47 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.347 2.698 . . . . 0.0 110.643 -166.399 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -145.03 59.14 1.3 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 110.126 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -66.9 155.67 37.82 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.03 164.81 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.733 1.213 . . . . 0.0 110.646 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -61.85 -45.25 94.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.509 1.524 . . . . 0.0 111.517 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.0 m -135.82 145.67 53.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.321 1.048 . . . . 0.0 110.204 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.48 -26.09 34.66 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.352 2.701 . . . . 0.0 111.366 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -53.97 -29.31 42.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.781 1.632 . . . . 0.0 112.312 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.57 -51.91 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.066 0.946 . . . . 0.0 109.873 172.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 11.7 m 63.39 93.39 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.494 1.517 . . . . 0.0 110.612 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.02 144.5 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.763 0.825 . . . . 0.0 109.231 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.5 m -112.76 129.82 56.29 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.764 1.226 . . . . 0.0 107.739 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.97 126.4 35.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -126.4 -177.34 3.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.326 1.051 . . . . 0.0 109.424 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -159.24 147.77 17.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 108.889 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.33 134.91 85.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.962 0.905 . . . . 0.0 110.645 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.41 -58.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.897 0.999 . . . . 0.0 111.649 0.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -141.82 38.46 1.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.71 1.204 . . . . 0.0 109.765 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.1 139.5 38.07 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 87.5 m -113.81 114.63 26.55 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.606 0.762 . . . . 0.0 109.477 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.98 85.43 6.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.4 129.32 88.99 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.412 0.685 . . . . 0.0 109.522 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.69 81.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.116 2.544 . . . . 0.0 109.921 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -60.42 -23.09 64.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.622 1.569 . . . . 0.0 113.426 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.29 32.67 65.1 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.58 0.61 . . . . 0.0 112.167 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -138.91 -59.12 0.6 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.235 1.414 . . . . 0.0 108.162 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -94.67 -56.57 2.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.813 1.245 . . . . 0.0 108.411 171.186 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.2 96.67 6.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 125.362 1.465 . . . . 0.0 108.179 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.63 148.08 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -120.31 138.58 53.63 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 125.113 1.365 . . . . 0.0 109.313 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -141.81 116.44 9.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.94 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 80.2 p -53.92 -32.52 53.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.947 1.299 . . . . 0.0 112.992 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.1 mtm-85 -83.28 -5.78 59.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.738 0.815 . . . . 0.0 112.848 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -141.13 -62.21 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.196 0.907 . . . . 0.0 111.719 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.45 -162.04 31.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.0 123.03 38.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.635 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.8 mp -103.28 98.12 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.01 96.27 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.1 p -55.9 -40.22 72.73 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.234 1.414 . . . . 0.0 112.842 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.13 99.67 6.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.821 1.248 . . . . 0.0 107.848 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.72 139.27 56.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.393 0.677 . . . . 0.0 110.527 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 59.3 p -131.98 -177.43 4.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.189 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -51.14 -32.2 22.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.032 1.333 . . . . 0.0 112.387 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -53.71 -29.77 40.74 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.508 1.123 . . . . 0.0 112.171 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -110.6 47.24 0.99 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.752 0.821 . . . . 0.0 110.918 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.09 94.28 2.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 150.23 -158.29 27.6 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.821 1.2 . . . . 0.0 110.445 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.4 tp -85.93 92.29 8.62 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.857 0.863 . . . . 0.0 109.949 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.63 159.11 31.53 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.7 m -148.26 108.28 4.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.195 0.998 . . . . 0.0 109.29 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.23 118.83 19.36 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -113.58 131.85 55.95 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.682 1.193 . . . . 0.0 110.297 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.16 50.3 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.303 1.441 . . . . 0.0 109.501 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 93.8 m -140.73 118.43 11.66 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.07 -54.95 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.847 0.859 . . . . 0.0 109.353 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -130.39 -65.08 0.82 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.173 0.989 . . . . 0.0 109.554 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -166.93 40.68 0.25 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -93.67 -47.08 6.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.209 1.404 . . . . 0.0 110.343 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 tp 63.68 88.56 0.1 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.932 1.693 . . . . 0.0 110.35 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.55 140.82 29.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.76 141.53 40.93 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.298 0.639 . . . . 0.0 109.909 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 35.3 p -133.44 123.89 26.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 108.099 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -102.3 144.59 30.6 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.031 0.932 . . . . 0.0 112.813 -169.202 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -142.96 107.72 4.87 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.857 1.663 . . . . 0.0 108.252 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.58 108.51 20.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.852 0.861 . . . . 0.0 109.174 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 32.1 p -89.62 114.82 26.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.099 0.96 . . . . 0.0 109.925 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -89.85 135.78 33.43 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.316 1.046 . . . . 0.0 109.148 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -75.82 105.21 6.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -76.48 74.2 3.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.369 1.468 . . . . 0.0 109.953 -175.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 26.0 p -65.87 -66.68 0.52 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.117 0.967 . . . . 0.0 109.493 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -89.78 -71.64 0.6 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.926 0.891 . . . . 0.0 108.712 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.1 t -156.55 41.14 0.35 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.252 1.021 . . . . 0.0 109.167 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 19.8 mm . . . . . 0 C--O 1.25 1.111 0 CA-C-O 116.992 -1.48 . . . . 0.0 109.33 -173.092 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.631 0.253 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -78.68 76.38 5.18 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.088 0.955 . . . . 0.0 110.189 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.0 t -140.8 158.98 43.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.343 1.457 . . . . 0.0 108.237 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.53 -65.46 3.41 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -169.754 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -73.58 153.15 89.67 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 123.845 0.858 . . . . 0.0 109.958 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.87 -27.21 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.19 2.594 . . . . 0.0 111.405 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -65.58 132.24 48.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.101 1.361 . . . . 0.0 112.554 -169.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.44 -49.63 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -81.38 101.26 9.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.28 0.632 . . . . 0.0 109.697 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.57 136.33 33.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 139' ' ' TYR . 1.2 p90 -79.42 48.16 0.88 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.623 0.769 . . . . 0.0 111.352 175.242 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 m -34.25 111.46 0.11 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.718 2.007 . . . . 0.0 110.76 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 1.61 71.52 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.838 2.455 . . . . 0.0 114.748 -167.127 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.7 mt 157.56 132.33 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 129.466 3.106 . . . . 0.0 108.584 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 148.11 60.16 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.316 2.677 . . . . 0.0 110.613 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.01 119.37 14.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.243 0.617 . . . . 0.0 109.472 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -78.99 99.81 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.63 115.44 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -80.09 83.61 5.95 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.691 1.197 . . . . 0.0 108.652 173.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -89.34 172.99 8.63 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.218 0.607 . . . . 0.0 112.159 -169.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.7 m -142.24 114.07 8.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.608 1.163 . . . . 0.0 108.189 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.55 145.51 18.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.884 0.873 . . . . 0.0 110.883 174.227 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.01 -48.17 1.8 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.144 0.878 . . . . 0.0 111.155 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -89.52 -178.21 5.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.796 0.838 . . . . 0.0 111.057 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.98 142.42 49.38 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.119 0.568 . . . . 0.0 110.948 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -139.72 110.18 6.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.455 1.502 . . . . 0.0 106.998 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.1 t -90.49 134.81 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.129 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.58 93.55 8.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.56 80.27 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.186 2.59 . . . . 0.0 111.977 -164.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 25.1 p -120.32 52.8 1.12 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.569 1.148 . . . . 0.0 110.722 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -57.56 147.81 25.89 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.288 1.035 . . . . 0.0 110.956 172.897 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -113.27 155.75 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 123.983 0.913 . . . . 0.0 111.305 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.0 p -70.02 -32.95 71.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.563 1.545 . . . . 0.0 111.496 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -126.38 113.04 23.38 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 124.979 1.312 . . . . 0.0 107.462 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -68.42 -20.51 41.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.238 2.625 . . . . 0.0 111.582 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -52.9 -36.25 59.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.688 172.055 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.78 86.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 30.8 m -66.64 126.18 28.14 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.804 0.842 . . . . 0.0 108.97 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.65 149.63 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.035 0.934 . . . . 0.0 109.634 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.5 m -105.84 115.78 30.82 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.912 1.285 . . . . 0.0 108.06 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 tp -89.62 104.17 16.75 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.378 0.671 . . . . 0.0 109.397 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.92 173.37 7.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 109.8 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -148.94 146.86 28.05 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.406 1.082 . . . . 0.0 108.666 169.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.62 134.5 86.07 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.816 0.846 . . . . 0.0 110.37 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.52 -59.39 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.883 0.994 . . . . 0.0 111.92 0.712 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.75 41.29 1.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.571 1.148 . . . . 0.0 109.944 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -83.27 153.31 24.73 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 m -123.78 107.87 11.89 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.277 1.031 . . . . 0.0 108.641 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.2 78.22 5.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.8 mt -59.66 131.44 88.55 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.357 1.063 . . . . 0.0 109.868 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.17 87.95 0.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.255 2.637 . . . . 0.0 110.31 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.39 -23.08 66.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.323 1.049 . . . . 0.0 112.743 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.89 -15.3 61.89 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.719 -1.045 . . . . 0.0 113.674 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.86 -60.58 1.65 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.508 1.154 . . . . 0.0 109.441 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -76.54 -67.72 0.67 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 mt -89.77 99.17 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.1 mt -98.7 120.75 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -89.09 95.95 10.52 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.012 0.525 . . . . 0.0 109.716 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.94 101.1 13.81 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.9 p -56.9 -27.81 61.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.157 0.983 . . . . 0.0 113.634 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -104.53 22.37 15.1 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.31 1.044 . . . . 0.0 112.153 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -147.09 -60.06 0.28 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.572 0.624 . . . . 0.0 110.306 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.5 -168.14 35.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.56 112.64 23.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.96 98.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -82.98 97.28 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 72.8 p -61.21 -37.53 83.33 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.153 0.981 . . . . 0.0 112.345 -175.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -121.21 87.96 2.85 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.532 1.133 . . . . 0.0 109.28 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.07 163.23 15.25 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.319 0.247 . . . . 0.0 110.7 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 46.5 p -139.86 160.25 40.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.899 0.88 . . . . 0.0 109.947 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -58.71 -34.26 71.13 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.74 0.816 . . . . 0.0 110.869 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -61.12 -34.61 75.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.966 0.907 . . . . 0.0 111.275 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.95 -8.4 56.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.596 0.758 . . . . 0.0 112.645 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.5 mt -65.4 127.26 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.01 -119.97 0.95 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.7 tp -144.76 95.25 2.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.234 1.014 . . . . 0.0 108.797 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 153.42 28.96 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 41.1 m -143.57 102.86 4.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.196 0.998 . . . . 0.0 108.979 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.72 132.09 43.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -134.03 135.59 43.46 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.125 0.97 . . . . 0.0 109.672 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.14 119.48 8.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.583 1.153 . . . . 0.0 108.613 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 m -89.69 59.13 4.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.082 0.553 . . . . 0.0 110.275 -172.213 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.86 141.06 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 57.53 24.43 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.051 1.34 . . . . 0.0 112.177 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.1 -5.9 23.83 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.112 -0.827 . . . . 0.0 113.231 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -89.92 129.56 36.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.573 1.186 . . . . 0.0 108.255 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.38 85.91 1.12 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.501 0.72 . . . . 0.0 109.439 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -88.93 141.24 28.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.65 162.9 39.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.228 0.611 . . . . 0.0 111.449 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.7 t -143.23 128.34 18.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.974 1.309 . . . . 0.0 107.713 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -106.07 150.98 25.25 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.416 1.486 . . . . 0.0 112.446 -169.088 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -142.74 105.3 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.488 1.515 . . . . 0.0 108.573 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -79.4 108.64 13.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.5 p -89.23 91.65 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -98.17 121.82 40.57 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.653 1.581 . . . . 0.0 107.608 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -68.2 143.16 55.44 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.097 0.862 . . . . 0.0 109.699 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 157.63 24.69 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.736 169.299 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 70.2 p -75.15 -8.64 57.14 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.202 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -89.25 46.91 1.42 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.442 0.697 . . . . 0.0 111.107 -171.244 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 t -167.07 179.31 5.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.238 1.415 . . . . 0.0 108.97 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.2 pt . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.774 -1.584 . . . . 0.0 111.294 -179.801 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 . . . . . 0 CA--C 1.533 0.296 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.43 -45.32 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.903 2.402 . . . . 0.0 111.214 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -64.26 144.65 56.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.646 1.178 . . . . 0.0 111.129 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.6 t -78.12 -47.14 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 143.46 51.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.286 1.434 . . . . 0.0 108.889 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.5 ptm -139.94 163.0 33.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.037 0.935 . . . . 0.0 109.683 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.55 155.72 32.14 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.592 0.757 . . . . 0.0 110.307 169.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.7 t -82.71 -69.04 0.65 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.48 -52.77 0.36 Allowed 'General case' 0 CA--C 1.523 -0.063 0 C-N-CA 125.454 1.502 . . . . 0.0 108.107 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.7 mt -75.86 127.06 86.24 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.12 146.89 16.53 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.833 3.022 . . . . 0.0 112.722 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.24 117.57 9.44 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.4 mm -81.12 97.52 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.4 mt -89.75 110.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -80.07 81.16 6.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.453 1.101 . . . . 0.0 108.942 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.8 ptm -89.82 176.03 6.99 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.491 1.116 . . . . 0.0 112.114 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.4 m -146.46 142.03 27.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.153 1.381 . . . . 0.0 107.356 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.03 146.77 52.49 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.989 0.516 . . . . 0.0 110.909 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.43 -11.71 54.46 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.554 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -89.84 165.96 13.81 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.534 1.167 . . . . 0.0 110.983 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 95.49 2.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.062 0.945 . . . . 0.0 109.019 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.87 104.55 17.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.218 1.007 . . . . 0.0 108.963 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.85 129.43 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.11 99.58 17.54 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.82 85.14 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.217 2.611 . . . . 0.0 111.425 -167.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.4 48.31 2.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.59 1.156 . . . . 0.0 109.593 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.699 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.0 ptt180 -67.92 157.29 35.31 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.617 0.767 . . . . 0.0 110.902 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.34 147.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.476 1.11 . . . . 0.0 110.896 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 41.5 p -55.65 -48.42 75.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.594 1.158 . . . . 0.0 111.487 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.6 m -113.29 109.58 51.46 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 124.849 1.26 . . . . 0.0 107.819 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.23 -32.89 11.09 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 124.528 3.485 . . . . 0.0 114.247 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -50.74 -37.56 42.52 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.649 1.58 . . . . 0.0 112.284 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.1 mt -51.68 -51.76 25.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 124.746 1.219 . . . . 0.0 110.453 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 68.23 111.68 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.514 1.525 . . . . 0.0 111.462 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.8 t -89.5 151.69 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.0 109.063 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 m -112.96 121.53 44.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.758 1.223 . . . . 0.0 107.979 172.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.51 98.18 11.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.644 0.777 . . . . 0.0 109.026 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -90.77 174.4 7.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.592 0.757 . . . . 0.0 109.977 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -144.26 145.05 31.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.155 1.382 . . . . 0.0 107.613 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.9 134.2 92.5 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.673 0.789 . . . . 0.0 110.638 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.9 -58.96 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.928 1.01 . . . . 0.0 111.853 0.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -140.28 41.94 1.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.567 1.147 . . . . 0.0 110.06 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -79.6 156.85 27.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.7 m -132.76 113.15 12.62 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.662 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.91 86.28 6.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.3 mm -60.49 127.11 86.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 109.604 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 86.14 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.969 2.446 . . . . 0.0 109.955 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -58.18 -25.29 61.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.916 1.286 . . . . 0.0 113.233 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 72.69 33.74 60.27 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.08 -61.33 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.126 1.37 . . . . 0.0 107.973 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -99.67 -53.08 3.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.681 1.193 . . . . 0.0 108.468 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.47 89.06 3.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -96.38 119.23 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -89.0 94.75 10.06 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.441 0.696 . . . . 0.0 109.142 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -89.85 98.68 11.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.699 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 68.1 p -51.96 -27.05 11.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 113.734 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.28 17.72 23.52 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.138 0.975 . . . . 0.0 113.167 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -144.78 -56.45 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.809 0.731 . . . . 0.0 110.894 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.97 -169.61 38.2 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.15 110.6 21.32 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 172.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.1 mt -92.22 94.72 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.561 1.544 . . . . 0.0 108.342 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.28 95.68 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -53.43 -37.13 62.26 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.673 1.189 . . . . 0.0 113.112 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -130.79 96.29 4.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.165 0.986 . . . . 0.0 108.566 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.23 140.86 57.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 111.574 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.8 p -133.06 179.97 5.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.52 1.128 . . . . 0.0 109.42 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -54.49 -30.65 53.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.679 1.192 . . . . 0.0 112.12 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -58.77 -20.63 51.44 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.48 1.112 . . . . 0.0 112.032 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -115.48 37.65 3.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.184 1.394 . . . . 0.0 110.82 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -120.75 100.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.7 -165.0 34.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 57.9 tp -89.29 91.72 8.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.041 0.936 . . . . 0.0 109.285 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.6 152.91 37.59 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.4 m -143.27 105.98 4.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.225 1.01 . . . . 0.0 108.515 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 87.1 m -74.11 132.71 42.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -130.81 142.08 50.37 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.323 1.049 . . . . 0.0 110.205 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.97 115.07 4.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.52 0.728 . . . . 0.0 110.315 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 53.9 m -89.81 124.07 34.34 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 44.8 t -118.74 -101.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.607 0.763 . . . . 0.0 109.448 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -88.29 59.07 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.969 1.308 . . . . 0.0 109.712 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 57.66 38.97 90.28 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -150.31 124.05 9.19 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.432 1.093 . . . . 0.0 108.492 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 65.5 tp -83.41 116.16 22.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.374 1.07 . . . . 0.0 109.5 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -100.58 151.94 21.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 164.28 35.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.713 0.405 . . . . 0.0 111.176 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.5 t -154.4 139.54 17.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.483 0.713 . . . . 0.0 109.797 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -106.65 147.04 30.02 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.959 1.304 . . . . 0.0 112.836 -168.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -142.78 104.79 4.4 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.13 109.64 18.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.5 p -89.59 94.49 9.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 109.014 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -89.87 128.36 36.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.971 1.709 . . . . 0.0 109.537 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 . . . . . 0 C--N 1.339 0.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.922 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 . . . . . 0 CA--C 1.534 0.338 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.25 -53.59 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.754 2.303 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.11 144.71 50.19 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.033 0.933 . . . . 0.0 111.736 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.4 46.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.57 -85.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.231 1.412 . . . . 0.0 108.121 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 ttt 71.08 132.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.631 1.972 . . . . 0.0 113.315 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.68 147.39 53.11 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.708 0.803 . . . . 0.0 110.058 173.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -77.96 -57.66 3.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -32.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.245 1.018 . . . . 0.0 111.646 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.79 117.77 69.15 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 135.59 68.74 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.03 2.487 . . . . 0.0 110.954 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -68.06 133.74 49.48 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.7 mm -82.34 95.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.755 0.822 . . . . 0.0 108.879 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.69 101.96 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -74.36 85.98 1.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.462 1.105 . . . . 0.0 108.951 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 9.6 ptm -89.17 166.86 13.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.629 0.772 . . . . 0.0 111.233 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.9 m -139.35 126.0 20.62 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.37 141.61 58.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.431 0.692 . . . . 0.0 110.342 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.97 -19.61 41.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.864 -0.965 . . . . 0.0 112.785 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -89.99 165.48 14.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.511 1.155 . . . . 0.0 110.749 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.32 96.01 2.76 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 109.197 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.98 109.96 20.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 108.975 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.51 127.15 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 44.2 mm -104.15 93.12 5.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.56 114.8 3.95 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.729 2.286 . . . . 0.0 109.877 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.7 p -162.42 56.22 0.22 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.816 0.847 . . . . 0.0 109.387 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 188' ' ' SER . 37.3 ptt180 -64.36 158.53 23.34 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.49 0.716 . . . . 0.0 110.861 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.73 168.29 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.399 1.08 . . . . 0.0 110.369 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.7 p -53.27 -39.19 63.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.307 1.443 . . . . 0.0 112.407 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 m -159.9 152.67 17.87 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 110.148 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.92 -20.33 51.43 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.559 2.839 . . . . 0.0 112.104 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.99 -28.61 66.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.106 1.362 . . . . 0.0 111.927 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.81 -45.48 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.775 0.83 . . . . 0.0 109.05 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.8 m 66.4 95.25 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.728 1.611 . . . . 0.0 110.861 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.47 144.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.358 1.063 . . . . 0.0 109.356 -173.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.0 m -115.75 124.81 51.72 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.643 1.177 . . . . 0.0 108.833 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.3 tp -89.71 100.31 13.14 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.761 0.824 . . . . 0.0 109.434 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.96 170.24 10.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.136 0.974 . . . . 0.0 109.76 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -147.14 148.55 31.69 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -58.89 132.32 86.71 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.633 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -79.26 -59.46 0.11 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.937 1.013 . . . . 0.0 111.741 3.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.6 mt -144.09 46.65 1.43 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.541 1.136 . . . . 0.0 109.753 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.75 164.8 25.31 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 m -145.07 100.29 3.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.7 mt -89.67 72.45 7.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.575 1.15 . . . . 0.0 108.439 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.8 mm -56.25 124.63 61.45 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.851 1.26 . . . . 0.0 110.385 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.22 107.34 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.925 3.083 . . . . 0.0 112.682 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.0 -29.89 58.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.307 0.643 . . . . 0.0 110.867 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.95 19.32 51.61 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.341 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -132.17 -58.68 0.95 Allowed 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.63 1.172 . . . . 0.0 108.157 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -78.42 -65.78 0.94 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.17 94.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.4 mt -95.79 117.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -89.17 124.35 34.27 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -127.03 107.98 10.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.567 1.147 . . . . 0.0 108.766 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.1 p -56.43 -25.49 50.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 0.0 113.304 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -76.0 -23.38 55.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.834 0.853 . . . . 0.0 112.243 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -129.57 -65.84 0.83 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.74 0.816 . . . . 0.0 111.035 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.89 35.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.02 111.98 23.26 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.9 99.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.218 1.407 . . . . 0.0 107.373 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 16.2 mt -97.69 96.67 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.7 1.2 . . . . 0.0 108.046 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 81.9 p -53.15 -35.47 59.79 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.693 1.197 . . . . 0.0 114.114 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -140.62 88.63 2.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.826 0.851 . . . . 0.0 109.201 -174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.16 155.73 19.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.927 0.491 . . . . 0.0 112.25 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.6 p -146.32 -176.78 5.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 109.28 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -55.23 -32.63 62.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.573 1.149 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -59.1 -19.34 43.66 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 112.509 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -93.59 -34.66 13.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.253 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.74 120.36 9.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.03 -136.87 5.65 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.4 tp -120.48 87.76 2.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.041 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 57.2 mt -69.28 149.35 48.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.887 0.875 . . . . 0.0 108.946 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 45.2 m -146.38 113.27 6.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 56.9 m -82.03 122.01 27.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -118.07 145.55 44.75 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.95 133.95 10.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.882 0.873 . . . . 0.0 109.869 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 57.2 m -102.12 131.55 48.55 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.731 0.813 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.88 118.6 34.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.4 m120 43.94 59.06 3.32 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.594 1.558 . . . . 0.0 112.058 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.87 -24.96 6.22 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.554 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -89.22 102.7 15.36 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.504 1.152 . . . . 0.0 109.195 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.09 103.74 4.66 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.27 149.28 23.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.31 146.03 51.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.249 1.42 . . . . 0.0 107.947 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 71.0 p -136.84 111.84 8.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -88.24 145.22 25.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.214 1.005 . . . . 0.0 111.138 -172.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -146.15 109.4 4.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.548 1.539 . . . . 0.0 108.172 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.81 105.86 15.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 93.9 9.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.169 0.988 . . . . 0.0 109.31 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -91.14 146.38 23.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.652 1.181 . . . . 0.0 107.974 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 . . . . . 0 N--CA 1.454 -0.236 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 173.733 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 . . . . . 0 CA--C 1.537 0.458 0 CA-C-O 119.022 -0.513 . . . . 0.0 109.78 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.38 -47.34 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.325 2.683 . . . . 0.0 110.29 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -68.16 161.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.018 1.327 . . . . 0.0 112.154 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.8 t -110.55 -58.5 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.68 120.25 29.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.5 ptm -133.72 154.82 50.67 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.816 0.846 . . . . 0.0 109.534 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.29 157.75 28.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.01 0.524 . . . . 0.0 111.177 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -97.09 -136.57 0.26 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -94.24 93.87 8.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.8 mt 127.95 121.22 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 131.025 3.73 . . . . 0.0 107.564 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.64 149.99 17.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.312 3.341 . . . . 0.0 113.343 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.59 116.69 6.45 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -76.64 100.65 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.86 121.38 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.938 0.895 . . . . 0.0 108.923 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -77.22 94.18 4.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 108.518 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.57 151.3 22.0 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.896 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 43.7 m -129.07 124.57 35.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -56.24 -73.46 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.73 55.98 4.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.478 0.561 . . . . 0.0 112.341 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -143.31 -97.61 0.11 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.15 1.38 . . . . 0.0 108.065 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -166.0 152.74 9.61 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.764 1.226 . . . . 0.0 108.626 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.1 tp -143.63 108.31 4.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.964 1.306 . . . . 0.0 108.472 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 131.21 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.08 94.13 28.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.04 80.88 2.88 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.309 2.672 . . . . 0.0 111.428 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.02 54.12 1.04 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.361 1.064 . . . . 0.0 109.171 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -68.86 162.28 26.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.16 0.984 . . . . 0.0 111.48 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.79 170.98 12.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.433 1.093 . . . . 0.0 113.075 -169.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.2 p -77.12 -19.83 56.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.632 1.973 . . . . 0.0 112.572 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 t -156.92 140.54 11.37 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.186 0.903 . . . . 0.0 110.274 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -47.81 -39.67 31.49 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.647 3.565 . . . . 0.0 115.454 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.52 -21.78 62.86 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 52.9 mt -80.57 76.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 49.4 m -67.83 123.23 19.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -89.47 142.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 109.357 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 25.8 m -93.18 106.01 18.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 38.1 tp -89.2 118.58 29.0 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -122.91 -177.91 3.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.094 1.358 . . . . 0.0 109.434 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -152.62 150.3 29.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.77 131.5 78.58 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.996 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.84 -61.09 0.03 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.822 0.972 . . . . 0.0 111.972 5.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -142.34 48.48 1.56 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.858 1.263 . . . . 0.0 109.057 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.84 177.25 6.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.187 0.595 . . . . 0.0 109.942 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.3 m -146.04 104.41 3.83 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.87 81.67 6.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.52 130.84 92.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.13 0.972 . . . . 0.0 109.151 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.64 85.38 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.138 2.559 . . . . 0.0 110.426 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -61.37 -22.1 64.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.166 1.386 . . . . 0.0 113.216 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 74.67 26.1 68.23 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.442 0.565 . . . . 0.0 112.811 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.92 -66.02 0.76 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -79.84 -64.59 1.15 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.2 mt -89.87 91.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.576 1.15 . . . . 0.0 108.047 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.75 116.67 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 108.271 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -89.38 109.07 20.02 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.585 0.754 . . . . 0.0 109.891 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -107.22 108.56 20.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.4 p -63.51 -18.76 64.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -109.7 18.77 19.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.316 1.046 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -149.03 -55.61 0.19 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.715 0.689 . . . . 0.0 110.836 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.23 -170.91 32.78 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.97 113.8 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.91 97.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.28 91.93 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.3 p -70.32 -7.73 44.94 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.912 0.885 . . . . 0.0 113.287 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -150.04 99.97 2.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -81.2 160.8 24.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 44.5 p -142.51 169.84 16.83 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.966 0.906 . . . . 0.0 109.682 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -53.19 -37.33 61.85 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.491 1.116 . . . . 0.0 111.659 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -55.05 -37.89 67.31 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.186 1.394 . . . . 0.0 111.226 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.44 17.53 11.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.92 1.288 . . . . 0.0 112.23 -171.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 79.5 mt -86.32 116.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 145.4 -160.01 28.0 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 121.455 0.475 . . . . 0.0 112.869 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.52 86.19 6.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.398 1.079 . . . . 0.0 110.511 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -69.69 144.2 52.91 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.5 m -139.04 107.89 5.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.251 1.02 . . . . 0.0 108.923 -173.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.4 m -81.63 138.4 35.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -134.58 145.57 48.8 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.755 0.822 . . . . 0.0 110.526 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.71 144.63 15.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.137 0.975 . . . . 0.0 109.325 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -120.88 142.75 49.38 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.877 1.271 . . . . 0.0 109.562 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.74 153.3 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 52.99 -99.0 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.318 1.447 . . . . 0.0 110.623 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -149.66 47.38 0.62 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.83 129.54 16.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.421 1.088 . . . . 0.0 109.986 177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.8 tp -81.76 144.87 30.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.555 . . . . 0.0 109.796 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -126.61 154.81 43.45 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.904 1.281 . . . . 0.0 108.204 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -150.44 163.29 38.77 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.071 0.548 . . . . 0.0 110.828 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.4 t -151.29 140.9 21.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.76 0.824 . . . . 0.0 109.487 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -115.09 146.23 41.53 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.995 1.318 . . . . 0.0 112.717 -168.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -143.26 105.04 4.35 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.425 1.49 . . . . 0.0 108.554 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.63 103.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.8 p -89.73 95.38 10.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.261 1.024 . . . . 0.0 108.783 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -89.69 141.17 28.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.815 0.446 . . . . 0.0 109.844 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.455 -0.192 0 C-N-CA 124.926 1.291 . . . . 0.0 109.872 -173.417 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 . . . . . 0 CA--C 1.534 0.334 0 N-CA-C 108.135 -1.061 . . . . 0.0 108.135 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.58 -52.76 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.937 2.425 . . . . 0.0 110.766 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -68.38 125.61 27.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.071 0.948 . . . . 0.0 111.323 -173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.4 t -74.05 -42.4 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -70.77 -79.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.607 0.763 . . . . 0.0 110.253 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 tpt 69.36 137.77 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.59 1.956 . . . . 0.0 112.641 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -147.05 0.19 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.0 110.104 172.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.4 t -134.72 -67.38 0.56 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -145.65 -53.62 0.27 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 125.027 1.331 . . . . 0.0 108.908 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -69.15 130.56 91.14 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.419 1.088 . . . . 0.0 108.285 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.52 139.15 33.82 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.857 2.371 . . . . 0.0 110.18 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -74.81 127.53 33.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -79.81 105.64 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.576 0.75 . . . . 0.0 110.054 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.2 mt -96.83 110.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -76.9 88.35 3.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.7 ptm -89.92 142.04 28.08 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.327 0.651 . . . . 0.0 111.641 -170.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 60.6 m -114.56 110.04 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.16 152.36 28.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.754 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.2 -36.57 3.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.258 0.932 . . . . 0.0 110.961 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -89.42 -177.0 5.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.93 0.892 . . . . 0.0 111.457 -171.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.68 99.68 9.75 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.699 0.8 . . . . 0.0 109.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 39.3 tp -92.76 104.25 16.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.184 0.994 . . . . 0.0 109.169 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.93 121.56 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.96 104.73 27.28 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 169.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.12 37.5 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.173 2.582 . . . . 0.0 113.443 -161.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 28.4 p -87.84 57.74 4.5 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-O 121.429 0.633 . . . . 0.0 110.271 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.884 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -75.94 153.49 36.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.42 1.088 . . . . 0.0 110.291 176.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.31 169.92 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.208 1.403 . . . . 0.0 110.3 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.9 p -61.85 -42.33 98.92 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.882 0.873 . . . . 0.0 111.805 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 m -143.93 140.54 17.25 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.935 0.894 . . . . 0.0 109.731 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -28.42 29.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.607 2.872 . . . . 0.0 112.761 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.29 -24.55 65.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.383 0.673 . . . . 0.0 112.282 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -52.18 -40.13 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.878 1.271 . . . . 0.0 110.238 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.5 m 67.58 99.09 0.05 Allowed 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.494 1.518 . . . . 0.0 110.681 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.16 122.62 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.2 m -88.12 107.78 18.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.71 95.23 10.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.796 0.839 . . . . 0.0 109.631 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -89.91 166.74 13.32 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.599 0.759 . . . . 0.0 110.377 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.72 142.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.138 0.975 . . . . 0.0 109.26 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.54 132.83 93.11 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 111.395 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 -59.65 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 119.992 1.033 . . . . 0.0 112.18 3.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.5 mt -138.31 36.93 2.29 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.45 152.65 34.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.7 m -131.71 113.27 13.36 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.026 0.93 . . . . 0.0 108.646 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.79 80.61 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.0 128.72 89.66 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.19 0.996 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.28 86.18 1.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.965 2.443 . . . . 0.0 110.358 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.35 -23.17 64.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.939 1.296 . . . . 0.0 112.889 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.9 67.69 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.884 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -135.36 -63.13 0.69 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.949 1.3 . . . . 0.0 108.231 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -85.24 -59.28 2.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.9 mt -89.62 91.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.9 mt -93.58 113.46 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -89.13 123.44 33.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.0 0.52 . . . . 0.0 109.823 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -127.61 114.63 17.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.884 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 48.0 p -57.13 -29.6 63.7 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.311 0.644 . . . . 0.0 112.51 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -80.6 -29.2 36.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.886 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -114.45 -50.32 2.8 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.891 0.876 . . . . 0.0 111.374 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 150.2 -164.85 29.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.11 105.81 18.03 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -89.14 90.96 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 24.4 mt -82.11 81.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.8 p -46.84 -47.7 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.85 2.06 . . . . 0.0 112.933 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -118.48 92.14 3.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.91 156.28 31.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.598 0.759 . . . . 0.0 110.758 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 60.4 p -137.96 167.66 21.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.752 1.221 . . . . 0.0 108.829 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -53.26 -30.9 40.87 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.298 1.039 . . . . 0.0 112.257 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -52.69 -36.37 57.11 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.8 -32.71 74.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.473 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.9 mt -53.48 111.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.08 0.952 . . . . 0.0 110.15 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 159.5 -171.7 35.98 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.82 99.2 11.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.164 0.986 . . . . 0.0 109.027 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.23 157.26 30.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.2 m -147.77 99.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.126 1.371 . . . . 0.0 108.042 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 24.6 m -79.15 131.35 36.19 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -124.28 135.32 53.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.165 0.986 . . . . 0.0 109.69 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.98 158.16 36.07 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.484 0.713 . . . . 0.0 110.495 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.9 m -138.0 146.79 43.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.62 1.168 . . . . 0.0 109.617 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.13 -70.69 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.901 1.28 . . . . 0.0 108.468 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -98.0 36.0 1.63 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.949 0.9 . . . . 0.0 111.421 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.05 30.05 74.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.441 0.544 . . . . 0.0 112.154 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -90.01 -43.32 10.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.694 1.198 . . . . 0.0 111.032 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 52.6 tp 66.24 89.29 0.1 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.911 1.684 . . . . 0.0 109.455 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -89.52 154.94 19.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.446 1.098 . . . . 0.0 108.381 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -140.26 159.12 42.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.686 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.9 t -151.84 123.34 7.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -108.85 149.92 28.41 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.606 1.162 . . . . 0.0 111.621 -168.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -142.89 113.67 7.53 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.307 1.043 . . . . 0.0 109.236 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.6 tt -84.5 106.72 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.1 p -89.26 99.48 12.46 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -89.32 138.58 31.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.749 1.62 . . . . 0.0 109.603 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.532 0.261 0 C-N-CA 124.072 0.949 . . . . 0.0 109.489 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.535 0.382 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -32.76 10.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.157 1.905 . . . . 0.0 111.118 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -56.74 129.85 42.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.073 1.349 . . . . 0.0 112.045 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.87 -54.93 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.583 0.753 . . . . 0.0 109.214 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.52 148.39 32.22 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.991 0.917 . . . . 0.0 109.348 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 ttp -147.65 135.43 21.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.421 1.089 . . . . 0.0 108.632 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -61.77 137.88 58.28 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.246 0.618 . . . . 0.0 110.035 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.9 p -74.18 -51.1 16.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.62 0.368 . . . . 0.0 110.675 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -155.07 -53.67 0.09 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 109.579 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.6 mm -83.98 119.88 74.07 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.075 0.95 . . . . 0.0 108.791 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.24 139.61 86.32 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.279 2.653 . . . . 0.0 111.225 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.24 136.44 57.18 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -89.22 91.34 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.279 1.032 . . . . 0.0 108.262 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -88.78 108.29 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -73.27 95.84 2.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.805 1.242 . . . . 0.0 109.541 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 19.0 ptm -102.1 162.64 12.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.847 1.259 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 75.2 m -133.16 130.28 38.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -58.94 119.91 8.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.471 0.709 . . . . 0.0 109.176 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 121.2 -33.64 4.28 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.648 1.118 . . . . 0.0 111.719 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -89.0 171.05 10.15 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.967 0.884 . . . . 0.0 110.673 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -71.53 148.4 46.75 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.199 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.5 tp -139.77 106.75 5.43 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.63 128.58 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.39 98.27 13.97 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.79 79.43 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.507 2.804 . . . . 0.0 111.027 -165.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.9 p -126.9 42.19 3.37 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.484 1.114 . . . . 0.0 110.344 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -58.02 158.32 6.9 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.152 0.981 . . . . 0.0 110.919 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.33 154.23 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 110.716 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.3 p -61.24 -44.29 97.5 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.751 1.22 . . . . 0.0 110.818 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -104.29 103.49 39.11 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.2 -11.43 32.17 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.718 2.945 . . . . 0.0 113.777 -170.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.76 -21.24 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.663 0.785 . . . . 0.0 111.908 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.12 106.46 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.7 m -74.16 117.11 15.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.41 150.87 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.13 0.972 . . . . 0.0 108.575 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 m -103.18 111.45 23.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 108.449 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.8 tp -89.48 101.26 13.94 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -91.62 170.52 9.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.623 0.769 . . . . 0.0 110.22 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -145.99 146.37 30.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.65 1.18 . . . . 0.0 108.556 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.67 133.58 82.58 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.881 0.873 . . . . 0.0 110.772 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.42 -59.57 0.11 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.682 0 CA-C-N 119.816 0.97 . . . . 0.0 111.87 0.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -141.46 38.63 1.7 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.755 1.222 . . . . 0.0 109.804 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -77.37 153.99 33.19 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 43.7 m -125.12 111.58 15.48 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.927 0.891 . . . . 0.0 109.147 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.7 mp -89.98 82.62 6.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.09 129.03 90.22 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.01 0.924 . . . . 0.0 109.175 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -72.8 85.51 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.138 2.558 . . . . 0.0 110.319 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.96 -22.36 64.37 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.015 1.326 . . . . 0.0 113.327 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 69.34 44.75 63.82 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -150.07 -67.09 0.2 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -90.7 -55.08 3.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.5 mt -93.23 89.7 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -98.13 121.09 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.119 0.968 . . . . 0.0 108.503 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -89.08 93.87 9.74 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -89.79 96.91 10.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.6 p -61.73 -13.63 24.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -101.26 4.8 42.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 112.079 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -140.32 -58.7 0.54 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.848 0.859 . . . . 0.0 110.668 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.6 -169.42 37.85 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.738 1.161 . . . . 0.0 110.336 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -89.09 110.86 21.53 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.68 94.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.75 1.22 . . . . 0.0 107.834 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.89 95.73 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.1 p -60.67 -28.87 68.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.155 0.982 . . . . 0.0 113.511 -170.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.41 89.94 2.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.02 119.35 9.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.224 0.61 . . . . 0.0 110.043 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 39.3 p -89.94 171.67 9.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.349 0.66 . . . . 0.0 109.255 174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.95 -33.2 62.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.63 0.772 . . . . 0.0 111.493 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -59.57 -32.4 70.32 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.38 1.072 . . . . 0.0 111.932 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.22 -8.96 58.19 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.968 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -71.79 107.86 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.985 1.266 . . . . 0.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 158.39 -160.83 31.26 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.5 98.58 11.72 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.372 1.069 . . . . 0.0 109.917 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.36 154.04 25.46 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.31 0.644 . . . . 0.0 109.332 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 54.9 m -146.71 106.29 3.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.096 0.958 . . . . 0.0 109.409 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.88 140.09 43.58 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -135.71 138.69 42.99 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.161 0.985 . . . . 0.0 110.288 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.71 140.37 18.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.98 0.912 . . . . 0.0 109.976 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 55.9 m -122.52 92.65 3.76 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.661 1.184 . . . . 0.0 108.863 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.33 -62.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.101 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -92.11 174.13 7.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.47 1.108 . . . . 0.0 109.497 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.92 2.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -148.32 -44.73 0.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.388 1.075 . . . . 0.0 110.981 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.2 tp 70.63 128.91 0.03 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 126.796 2.038 . . . . 0.0 110.158 -170.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.02 147.31 50.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.655 1.182 . . . . 0.0 107.927 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -150.59 158.76 44.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.87 0.468 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 49.6 p -136.6 132.12 34.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.935 0.894 . . . . 0.0 108.824 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -111.62 144.71 40.43 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.681 1.192 . . . . 0.0 110.782 -169.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -146.47 117.54 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.441 1.096 . . . . 0.0 109.023 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.01 107.57 19.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -89.33 98.99 12.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -89.14 126.4 35.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.228 1.411 . . . . 0.0 109.249 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 . . . . . 0 N--CA 1.453 -0.323 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.91 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 . . . . . 0 CA--C 1.534 0.364 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.83 -50.45 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.093 2.529 . . . . 0.0 111.474 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -76.7 146.41 38.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.817 0.847 . . . . 0.0 112.476 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.64 55.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -166.36 -71.66 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.8 tpt 69.76 157.07 0.15 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 111.349 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.97 172.14 13.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.0 0.92 . . . . 0.0 109.32 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.8 t -145.02 -66.28 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.304 0.641 . . . . 0.0 110.383 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -95.08 -64.35 1.07 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.47 0.708 . . . . 0.0 112.624 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.76 113.42 64.93 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.388 1.075 . . . . 0.0 110.195 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.83 142.69 96.36 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.317 2.678 . . . . 0.0 111.122 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -73.05 128.24 34.91 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.6 85.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.306 0.642 . . . . 0.0 109.378 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 mt -92.55 80.25 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -60.55 135.62 57.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.43 175.63 11.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.604 0.761 . . . . 0.0 111.196 -171.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -146.97 142.8 27.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.536 1.534 . . . . 0.0 108.162 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 150.63 44.72 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.119 0.567 . . . . 0.0 111.24 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.8 -34.41 4.07 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.557 0.599 . . . . 0.0 112.042 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -88.98 157.02 18.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.248 1.019 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.92 136.0 54.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.084 0.554 . . . . 0.0 110.469 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.5 tp -122.6 114.27 20.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.576 1.55 . . . . 0.0 107.847 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.49 127.58 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.7 mm -106.26 100.08 27.33 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 171.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.67 62.3 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.554 2.836 . . . . 0.0 111.492 -169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -104.11 51.49 0.78 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.029 0.932 . . . . 0.0 109.305 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -66.26 161.75 21.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 m -127.62 166.51 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 0.0 111.709 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 p -65.34 -36.58 84.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.067 1.347 . . . . 0.0 112.035 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 51.3 m -145.42 146.22 29.14 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.453 0.701 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.79 -42.86 24.39 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.65 3.566 . . . . 0.0 115.004 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -59.12 -20.26 52.01 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.028 0.931 . . . . 0.0 113.245 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 23.1 mm -77.71 74.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 27.7 m -70.19 120.1 15.38 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.243 0.617 . . . . 0.0 109.812 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.72 147.16 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.102 0.961 . . . . 0.0 109.641 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.8 m -106.17 113.31 26.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.22 121.66 31.74 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -126.22 173.65 9.11 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -138.82 149.24 44.72 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.949 0.899 . . . . 0.0 108.785 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -58.16 133.39 84.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.637 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.5 -59.85 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.72 0 CA-C-N 119.943 1.015 . . . . 0.0 112.197 3.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -142.01 40.27 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.305 1.042 . . . . 0.0 110.391 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.48 149.56 40.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.2 m -132.53 110.19 10.31 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.62 85.19 5.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.805 1.242 . . . . 0.0 108.26 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.39 127.6 93.39 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.54 104.6 1.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.876 2.384 . . . . 0.0 110.722 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.29 -31.48 71.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.637 0.775 . . . . 0.0 111.991 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.11 17.91 45.23 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.611 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -133.23 -58.99 0.89 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.599 1.16 . . . . 0.0 108.516 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.6 tpp85 -78.03 -66.04 0.9 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.52 92.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 68.8 mt -92.07 114.68 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -88.92 93.26 9.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -89.84 103.06 15.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.9 p -54.74 -29.16 52.98 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -108.32 24.98 12.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.135 0.974 . . . . 0.0 111.902 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -146.63 -58.57 0.29 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.162 0.585 . . . . 0.0 110.673 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.9 -172.25 37.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.92 0.772 . . . . 0.0 111.172 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -89.27 109.23 20.14 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.4 96.0 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.986 1.314 . . . . 0.0 107.616 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.98 101.21 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 80.3 p -57.09 -36.15 70.26 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -139.36 99.14 3.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.43 163.82 10.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.554 0.741 . . . . 0.0 112.027 -173.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.8 p -131.01 155.21 47.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.027 0.931 . . . . 0.0 109.709 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -56.51 -30.27 62.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.238 1.015 . . . . 0.0 111.777 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.04 -24.14 51.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.687 1.195 . . . . 0.0 112.441 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -86.04 -9.29 57.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.226 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.23 105.86 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.228 0.922 . . . . 0.0 108.63 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.94 -163.22 34.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.85 89.72 8.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.015 0.926 . . . . 0.0 109.481 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 45.1 mt -69.1 147.4 51.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 102.79 3.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.885 1.274 . . . . 0.0 108.318 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 75.0 m -80.7 138.91 36.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -134.69 142.23 46.75 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.184 0.993 . . . . 0.0 110.145 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.97 126.36 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.134 0.973 . . . . 0.0 109.25 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 85.5 m -103.19 134.21 46.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.657 1.183 . . . . 0.0 109.158 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.72 -78.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.392 0.677 . . . . 0.0 109.968 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.84 49.4 1.77 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.681 0.792 . . . . 0.0 110.965 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.96 38.46 60.35 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -170.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -150.06 121.02 7.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.178 1.391 . . . . 0.0 107.657 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.0 tt -77.56 111.2 13.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -92.05 154.09 18.98 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -151.47 162.99 39.98 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.827 0.451 . . . . 0.0 112.147 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.0 t -148.13 135.6 20.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.916 0.886 . . . . 0.0 108.782 169.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.71 152.47 34.22 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.195 0.998 . . . . 0.0 111.952 -169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -145.0 118.49 9.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.149 1.379 . . . . 0.0 109.005 -173.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.08 111.48 22.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.0 p -89.87 103.3 15.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.21 0.604 . . . . 0.0 109.65 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -89.38 134.12 34.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.131 0.973 . . . . 0.0 109.203 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.802 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -73.35 -46.68 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.058 2.505 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -69.61 152.15 45.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 111.948 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.57 -50.57 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -79.15 -82.22 0.1 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.128 0.971 . . . . 0.0 110.532 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.8 ttt 66.83 139.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.553 1.941 . . . . 0.0 112.032 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -146.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.741 1.216 . . . . 0.0 110.588 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 p -129.79 -69.07 0.69 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 108.072 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 -38.31 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.447 1.499 . . . . 0.0 109.989 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.08 125.95 92.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -69.66 129.4 17.64 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.804 2.336 . . . . 0.0 109.636 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.94 123.63 20.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.334 0.654 . . . . 0.0 111.011 -169.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.22 117.11 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.755 1.222 . . . . 0.0 108.953 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.01 133.67 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.57 1.148 . . . . 0.0 109.204 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -84.3 147.96 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.804 1.242 . . . . 0.0 109.043 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -150.1 167.18 27.56 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.329 0.652 . . . . 0.0 111.619 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.1 m -140.25 113.64 8.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -52.11 136.51 29.57 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.52 0.728 . . . . 0.0 110.62 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.47 -38.64 3.02 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.499 1.047 . . . . 0.0 110.948 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -89.5 166.36 13.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.632 0.773 . . . . 0.0 110.546 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.88 144.75 52.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.366 0.666 . . . . 0.0 109.914 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 51.0 tp -134.86 152.9 52.13 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.175 1.39 . . . . 0.0 107.768 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.79 135.52 63.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.052 0.941 . . . . 0.0 108.483 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.4 mm -109.14 97.19 24.17 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.47 68.84 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.55 2.833 . . . . 0.0 112.525 -163.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -116.2 55.14 0.81 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.656 1.182 . . . . 0.0 109.795 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 188' ' ' SER . 25.6 ptt-85 -69.0 161.45 28.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.256 1.422 . . . . 0.0 111.023 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.36 165.19 17.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.856 1.262 . . . . 0.0 112.393 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 38.2 p -73.02 -27.51 61.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.807 1.643 . . . . 0.0 112.473 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -142.21 136.19 14.72 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.945 0.898 . . . . 0.0 109.161 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 -25.96 50.61 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.389 2.726 . . . . 0.0 113.297 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -62.55 -23.03 66.77 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.349 0.522 . . . . 0.0 112.154 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.1 mt -80.14 78.82 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.7 m -66.55 121.33 15.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.7 t -89.27 145.24 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.7 m -103.75 122.65 45.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.28 132.17 35.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -130.98 175.34 9.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.695 1.198 . . . . 0.0 109.3 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -151.52 147.98 27.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.053 0.941 . . . . 0.0 109.295 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.91 135.74 87.28 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 110.15 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.91 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.902 1.001 . . . . 0.0 112.007 1.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.2 mt -140.56 41.74 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.451 1.101 . . . . 0.0 109.979 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -82.67 139.65 33.58 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 84.8 m -116.93 112.01 20.43 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.45 72.14 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.876 1.27 . . . . 0.0 109.111 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.7 mm -56.34 126.69 69.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.792 0.837 . . . . 0.0 109.609 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.7 103.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.995 3.13 . . . . 0.0 112.684 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.84 -19.47 57.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.752 0.821 . . . . 0.0 111.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.13 -5.27 83.63 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.626 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -105.26 -63.88 1.19 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.564 1.182 . . . . 0.0 107.901 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -79.26 -64.91 1.08 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.836 0.854 . . . . 0.0 108.725 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.33 97.57 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 89.9 mt -99.64 117.6 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -88.95 121.5 31.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -124.35 112.39 16.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.135 1.374 . . . . 0.0 107.878 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.626 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 28.9 p -59.31 -25.95 64.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 113.502 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -111.39 27.5 9.62 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.134 0.973 . . . . 0.0 111.93 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -149.14 -53.33 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.927 0.491 . . . . 0.0 110.266 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 145.88 -159.77 28.0 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.24 110.82 21.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.07 98.6 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.4 mm -83.05 82.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 69.7 p -55.15 -33.28 62.81 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.286 1.035 . . . . 0.0 113.47 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 89.42 2.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.86 158.43 16.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.984 0.514 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.6 p -136.12 161.27 36.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.733 0.813 . . . . 0.0 109.879 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -57.11 -32.78 66.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.889 0.875 . . . . 0.0 111.398 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.42 -34.39 70.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.358 1.063 . . . . 0.0 111.44 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.97 13.49 10.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.326 1.05 . . . . 0.0 112.484 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -85.14 121.8 37.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.71 -159.44 25.4 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.288 0.471 . . . . 0.0 112.794 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.89 91.45 6.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.596 1.158 . . . . 0.0 110.743 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.96 160.31 30.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.668 0.787 . . . . 0.0 109.475 170.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.1 m -147.81 102.04 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.717 1.207 . . . . 0.0 109.087 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.6 m -75.28 139.35 42.45 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -138.37 139.02 38.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.601 0.761 . . . . 0.0 111.187 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.52 152.83 27.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.796 1.239 . . . . 0.0 109.822 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.2 m -135.71 107.99 7.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.98 -64.18 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -150.06 114.13 5.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.363 1.065 . . . . 0.0 108.58 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 81.86 -59.69 4.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.78 0.705 . . . . 0.0 113.143 170.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.03 135.62 33.45 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.298 0.639 . . . . 0.0 110.694 -169.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.55 105.5 11.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -89.52 135.09 33.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -150.73 160.39 43.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.538 0.335 . . . . 0.0 110.824 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.8 t -152.86 130.59 11.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.477 0.711 . . . . 0.0 109.97 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -104.57 150.99 24.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.673 1.189 . . . . 0.0 112.066 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -140.18 113.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.525 1.13 . . . . 0.0 108.812 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -82.99 101.63 11.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.5 p -89.17 92.58 9.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -89.8 165.79 13.94 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 . . . . . 0 N--CA 1.454 -0.225 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.369 178.378 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 . . . . . 0 CA--C 1.535 0.401 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.67 -51.58 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.422 2.748 . . . . 0.0 111.63 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -71.54 119.65 16.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 111.574 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.01 -53.22 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 126.24 54.83 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.124 1.37 . . . . 0.0 107.832 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.1 ptm -128.49 170.3 13.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.963 1.305 . . . . 0.0 109.685 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.56 147.41 52.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 m -90.6 -136.44 0.13 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.96 104.14 16.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.4 mm 108.64 127.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 130.742 3.617 . . . . 0.0 107.924 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.68 137.65 15.46 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.236 3.291 . . . . 0.0 113.066 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.27 126.7 30.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -80.78 100.0 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.17 105.83 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -83.41 76.61 9.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.373 1.469 . . . . 0.0 109.231 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.33 171.85 9.46 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.107 0.563 . . . . 0.0 111.041 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.9 m -143.46 116.82 9.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.58 164.94 10.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 94.21 -41.06 2.64 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.2 mtp-105 -88.88 -179.57 5.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.774 1.629 . . . . 0.0 109.674 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.75 137.38 45.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.34 103.93 11.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.22 125.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 mm -101.08 100.73 13.84 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -83.79 48.99 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 112.846 -161.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -91.59 57.61 3.32 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.84 0.856 . . . . 0.0 110.378 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -56.73 143.2 37.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.118 0.967 . . . . 0.0 111.126 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.59 165.94 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.817 1.247 . . . . 0.0 110.591 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.376 1.07 . . . . 0.0 112.508 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.2 m -155.5 146.7 16.64 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.644 0.777 . . . . 0.0 110.299 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.5 -30.63 28.8 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.724 2.949 . . . . 0.0 111.855 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -56.36 -27.32 55.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.101 1.36 . . . . 0.0 112.497 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.4 -35.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.135 1.374 . . . . 0.0 110.861 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m 67.59 88.52 0.11 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.314 1.446 . . . . 0.0 110.028 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.45 132.56 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 108.835 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 m -102.31 119.11 38.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.327 1.051 . . . . 0.0 108.721 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.4 tp -89.49 101.52 14.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -89.48 165.23 14.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.056 0.942 . . . . 0.0 109.905 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -147.8 146.39 29.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.31 1.044 . . . . 0.0 108.928 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.81 134.91 89.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.605 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.91 -58.69 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 119.854 0.984 . . . . 0.0 111.819 0.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.1 mt -139.89 38.94 1.98 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.794 1.238 . . . . 0.0 109.824 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -80.76 160.29 24.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -137.85 114.41 10.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.876 0.87 . . . . 0.0 109.034 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 mp -89.9 83.98 6.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.73 121.76 75.14 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.65 120.65 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.309 2.673 . . . . 0.0 112.735 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -81.25 -15.43 55.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.475 0.71 . . . . 0.0 111.565 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 66.76 29.98 75.54 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.057 0.837 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -139.94 -67.55 0.43 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.575 1.15 . . . . 0.0 108.169 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.7 ttp-105 -79.16 -56.16 4.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 mt -89.57 90.08 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.432 1.493 . . . . 0.0 106.998 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 67.8 mt -90.83 113.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -89.01 93.2 9.52 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.41 99.48 12.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.3 p -57.82 -26.82 62.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -76.87 -19.29 57.64 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.122 0.969 . . . . 0.0 112.423 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -125.83 -64.59 1.05 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.063 0.945 . . . . 0.0 110.752 -173.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 170.56 -173.36 44.41 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 117.9 0.318 . . . . 0.0 112.332 -173.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -89.36 107.55 19.13 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.2 mt -89.82 94.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 31.0 mt -81.96 85.87 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.9 p -52.15 -35.75 49.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.41 1.484 . . . . 0.0 114.3 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -123.44 91.87 3.57 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.003 0.921 . . . . 0.0 108.878 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.63 40.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.325 0.65 . . . . 0.0 110.242 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 77.9 p -138.66 172.34 13.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.66 1.184 . . . . 0.0 109.273 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -59.17 -26.84 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.648 0.779 . . . . 0.0 112.016 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -53.73 -43.92 69.47 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.402 0.681 . . . . 0.0 110.74 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -68.76 -8.37 42.47 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.0 131.15 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 143.15 -108.31 0.51 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 45.4 tp -157.14 111.34 2.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.0 109.413 -170.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -101.44 150.51 22.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.227 1.011 . . . . 0.0 109.089 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 98.2 m -142.86 116.52 9.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.102 0.961 . . . . 0.0 109.143 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 30.5 m -81.91 142.49 32.42 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -129.96 142.72 50.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.511 1.124 . . . . 0.0 109.984 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.265 1.026 . . . . 0.0 110.104 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.0 m -142.03 132.64 25.42 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.5 t -135.49 -76.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.971 0.908 . . . . 0.0 108.856 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -85.35 51.18 2.11 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.805 0.842 . . . . 0.0 110.774 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.8 -31.53 1.48 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.664 0.649 . . . . 0.0 113.511 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -88.62 142.69 27.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.782 1.233 . . . . 0.0 109.98 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.7 tp -80.02 106.16 11.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -89.02 146.6 24.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 157.32 42.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.471 0.708 . . . . 0.0 110.045 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 t -147.0 129.72 16.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.434 0.694 . . . . 0.0 109.753 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -102.56 141.01 36.08 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.64 1.576 . . . . 0.0 112.487 -169.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -140.34 100.6 3.93 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.076 1.351 . . . . 0.0 108.893 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.5 110.48 16.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.517 1.127 . . . . 0.0 108.639 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.6 p -89.59 89.02 7.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.801 0.84 . . . . 0.0 109.762 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -95.03 89.44 5.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 . . . . . 0 N--CA 1.455 -0.212 0 C-N-CA 122.979 0.512 . . . . 0.0 110.335 178.787 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 . . . . . 0 CA--C 1.536 0.418 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.89 -50.63 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.534 2.156 . . . . 0.0 111.211 -170.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -77.33 159.93 29.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.992 0.917 . . . . 0.0 111.449 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.16 -61.41 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.05 123.88 32.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 23.4 ttt -144.51 145.44 31.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.508 0.723 . . . . 0.0 110.208 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -152.74 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.655 1.182 . . . . 0.0 110.622 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.1 t -131.43 -64.82 0.79 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.005 0.922 . . . . 0.0 108.924 170.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.71 -36.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.579 0.752 . . . . 0.0 111.579 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.4 mt -81.36 116.59 63.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.03 136.15 71.32 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.007 2.471 . . . . 0.0 111.743 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.39 124.43 24.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.352 0.661 . . . . 0.0 109.948 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.9 126.56 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.4 mt -130.08 137.56 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.512 1.125 . . . . 0.0 108.131 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -89.3 102.07 14.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.332 1.053 . . . . 0.0 108.772 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -89.31 176.42 6.94 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 m -147.82 130.4 15.89 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.67 141.38 55.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.969 0.908 . . . . 0.0 110.157 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.82 -42.94 2.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.231 0.443 . . . . 0.0 112.156 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -89.85 -179.28 5.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.814 0.845 . . . . 0.0 112.049 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -66.19 149.73 49.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.1 tp -148.03 112.37 5.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.266 1.026 . . . . 0.0 108.716 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.92 132.11 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.4 mm -108.23 96.4 18.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.92 46.51 1.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.261 2.641 . . . . 0.0 113.714 -163.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 26.0 p -89.81 59.77 4.74 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.501 0.72 . . . . 0.0 109.138 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -71.2 156.79 39.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.689 0.796 . . . . 0.0 110.884 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.53 167.7 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.905 1.282 . . . . 0.0 111.664 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.6 p -63.33 -33.77 76.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.006 1.322 . . . . 0.0 111.695 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.7 m -157.68 151.14 18.97 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 124.376 1.071 . . . . 0.0 109.733 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.54 -31.66 87.53 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.389 2.726 . . . . 0.0 111.64 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.25 -32.26 16.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.768 1.627 . . . . 0.0 112.559 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.4 mm -51.72 -41.95 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.56 1.144 . . . . 0.0 111.043 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.0 m 63.15 91.01 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.207 1.403 . . . . 0.0 111.168 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.45 133.13 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 109.483 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.9 m -98.45 114.29 26.6 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 tp -89.46 106.85 18.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -94.42 158.13 15.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 110.213 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -129.18 136.95 50.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.732 1.613 . . . . 0.0 106.677 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -55.92 126.7 66.77 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.32 -170.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -77.47 -62.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.616 0 CA-C-N 119.733 0.94 . . . . 0.0 112.851 6.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.1 mt -143.79 37.81 1.32 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.172 0.989 . . . . 0.0 110.244 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.23 126.84 31.73 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.7 m -89.82 115.59 27.27 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.325 0.65 . . . . 0.0 110.157 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.67 86.7 6.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.02 130.35 94.46 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.208 1.003 . . . . 0.0 109.101 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.8 81.95 1.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.209 2.606 . . . . 0.0 110.002 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.63 -18.65 62.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.036 1.334 . . . . 0.0 113.137 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.23 26.48 70.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.602 0.62 . . . . 0.0 112.679 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -140.27 -63.66 0.48 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.758 1.223 . . . . 0.0 108.53 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -88.45 -57.36 2.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.713 1.205 . . . . 0.0 107.951 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.5 mt -89.97 93.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.8 mt -93.5 112.19 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -89.08 95.37 10.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.168 0.587 . . . . 0.0 109.691 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.97 97.55 11.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.6 p -50.53 -37.47 39.44 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -97.27 21.2 10.32 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 112.504 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -147.46 -57.69 0.25 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.978 0.808 . . . . 0.0 111.317 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 161.5 -177.05 37.95 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.046 0.831 . . . . 0.0 111.187 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.13 110.19 20.96 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.12 93.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 50.2 mt -83.09 100.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.8 p -63.94 -39.38 94.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.037 0.535 . . . . 0.0 112.286 -172.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -118.97 90.59 3.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.524 1.13 . . . . 0.0 108.693 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.86 124.15 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 67.3 p -91.83 166.77 12.58 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.0 110.94 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -57.39 -34.1 68.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.251 1.02 . . . . 0.0 111.804 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -56.14 -33.94 65.65 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.418 1.087 . . . . 0.0 111.477 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.75 -2.85 31.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.031 0.932 . . . . 0.0 112.651 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.06 87.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 163.39 -163.1 35.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.1 tp -86.95 117.12 25.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 110.795 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 95.5 mt -99.93 150.26 22.58 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.503 1.521 . . . . 0.0 109.114 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 51.3 m -146.7 103.33 3.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.746 1.218 . . . . 0.0 108.867 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 48.6 m -74.97 143.93 43.42 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.91 140.0 43.74 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.063 0.945 . . . . 0.0 109.611 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.36 114.82 6.32 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.652 0.781 . . . . 0.0 110.52 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.7 m -89.94 125.76 35.49 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.809 1.244 . . . . 0.0 109.481 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.17 -71.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.154 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -145.7 94.26 2.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.02 -53.56 4.76 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.558 0.599 . . . . 0.0 111.762 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 145.25 25.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.303 1.041 . . . . 0.0 109.25 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.3 156.02 28.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.717 0.77 . . . . 0.0 111.433 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -124.75 154.83 40.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.582 1.953 . . . . 0.0 106.027 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -136.86 158.57 44.15 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.05 0.386 . . . . 0.0 111.4 -175.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.7 m -144.13 109.89 5.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -106.67 151.9 24.49 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.404 0.682 . . . . 0.0 111.171 -170.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -142.39 127.51 18.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.317 1.047 . . . . 0.0 109.008 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.0 tt -87.09 97.17 10.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.8 p -89.0 88.76 7.71 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.38 154.36 20.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 7.3 ptm85 . . . . . 0 CA--C 1.532 0.285 0 CA-C-N 118.266 0.485 . . . . 0.0 111.185 175.818 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 . . . . . 0 CA--C 1.532 0.281 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -73.81 -39.99 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.779 2.319 . . . . 0.0 110.135 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -59.63 135.94 57.83 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.081 0.952 . . . . 0.0 110.898 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.25 -43.78 97.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.55 148.05 31.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.133 1.373 . . . . 0.0 108.176 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ptm -127.57 165.13 20.52 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.538 1.135 . . . . 0.0 110.546 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 152.09 26.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.423 0.689 . . . . 0.0 110.106 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.1 t -80.26 -69.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -143.56 -53.97 0.37 Allowed 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.937 1.295 . . . . 0.0 108.659 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 88.8 mt -72.87 127.93 88.86 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -67.65 119.89 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.558 2.172 . . . . 0.0 108.893 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.8 116.84 2.74 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.118 0.967 . . . . 0.0 109.701 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.7 mt -78.49 102.24 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.15 68.66 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -59.2 128.32 36.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.14 169.1 18.82 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.754 0.311 . . . . 0.0 111.732 -170.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 m -112.55 138.48 49.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 107.994 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.91 165.83 12.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.166 0.587 . . . . 0.0 111.587 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.24 -43.14 3.21 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.957 0.789 . . . . 0.0 111.998 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -89.18 174.78 7.67 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.407 1.083 . . . . 0.0 110.823 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.91 160.33 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.143 -174.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 49.4 tp -148.9 111.97 4.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.627 1.171 . . . . 0.0 108.608 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.02 125.11 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -104.81 102.54 35.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.13 61.01 6.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.603 2.868 . . . . 0.0 111.591 -167.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 31.8 p -105.16 50.09 0.79 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.906 0.882 . . . . 0.0 109.327 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.99 153.92 42.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.008 1.323 . . . . 0.0 110.507 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 m -116.06 160.37 15.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 124.407 1.083 . . . . 0.0 111.277 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.3 p -70.15 -57.45 4.92 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.616 1.167 . . . . 0.0 109.744 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 25.4 p -100.07 111.73 62.72 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -178.353 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.83 -12.84 33.58 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.615 2.877 . . . . 0.0 113.389 -168.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -69.05 -22.85 64.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.082 0.401 . . . . 0.0 111.266 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 32.6 mt -78.35 83.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -66.3 127.37 31.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.353 1.061 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 70.2 t -89.59 146.64 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.053 0.941 . . . . 0.0 109.243 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 m -106.93 111.36 23.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.773 1.229 . . . . 0.0 108.153 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.8 tp -89.37 98.07 11.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -89.75 169.84 10.94 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.957 0.903 . . . . 0.0 109.52 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -148.63 145.83 27.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.634 0.774 . . . . 0.0 109.194 169.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.77 133.76 78.76 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.653 172.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.16 -59.89 0.1 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 119.978 1.028 . . . . 0.0 112.057 2.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.5 mt -144.23 39.22 1.31 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 110.034 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -81.93 152.13 26.92 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.1 m -130.72 108.53 9.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.739 1.216 . . . . 0.0 108.309 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.74 82.65 6.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.008 0.923 . . . . 0.0 108.573 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 129.14 93.79 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.48 90.15 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.882 2.388 . . . . 0.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -59.52 -24.21 63.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.311 1.444 . . . . 0.0 113.173 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 75.61 28.54 61.13 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.427 0.537 . . . . 0.0 112.819 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.55 -58.4 0.68 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.897 1.279 . . . . 0.0 108.385 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -85.1 -55.14 4.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.197 1.399 . . . . 0.0 108.567 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.8 100.1 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 125.048 1.339 . . . . 0.0 108.134 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.13 118.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -89.15 94.36 9.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.78 100.91 13.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.7 p -56.45 -26.93 55.35 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -114.59 32.16 6.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.285 1.434 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -150.09 -58.35 0.19 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.301 0.64 . . . . 0.0 110.378 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 155.68 -171.13 33.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.691 1.138 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -89.4 106.4 18.42 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.35 90.89 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 52.1 mt -79.48 95.14 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.1 p -61.66 -25.76 67.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.9 90.02 2.55 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.788 0.835 . . . . 0.0 108.958 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.7 128.32 35.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.435 1.094 . . . . 0.0 111.265 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 54.0 p -147.89 179.52 7.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.976 1.31 . . . . 0.0 109.45 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -39.18 -35.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.91 2.084 . . . . 0.0 113.691 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -42.87 -44.43 4.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.517 1.927 . . . . 0.0 112.361 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -103.33 -10.09 18.95 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 113.847 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.87 111.82 7.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.415 1.007 . . . . 0.0 109.709 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 151.23 -162.15 29.39 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.9 tp -81.77 90.31 6.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.29 146.96 54.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.829 0.852 . . . . 0.0 108.971 172.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 48.8 m -143.39 99.25 3.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.48 1.112 . . . . 0.0 108.169 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.53 132.18 43.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -126.57 141.62 51.8 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.262 1.025 . . . . 0.0 109.826 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.31 106.5 3.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.014 0.926 . . . . 0.0 109.708 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.1 m -91.2 107.17 19.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.307 1.043 . . . . 0.0 108.609 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -79.69 -61.65 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -130.23 -114.98 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.39 -17.27 78.86 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.43 107.42 19.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.001 0.92 . . . . 0.0 110.275 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.69 101.13 12.48 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -89.43 152.28 21.57 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -150.36 162.64 40.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.489 0.315 . . . . 0.0 111.411 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.0 t -146.0 135.28 22.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.997 0.919 . . . . 0.0 109.319 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -112.55 149.79 32.22 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.579 1.152 . . . . 0.0 111.989 -168.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -146.04 133.55 20.85 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.643 1.177 . . . . 0.0 109.191 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -102.79 105.68 16.14 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 105.58 17.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.26 134.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.652 1.181 . . . . 0.0 108.666 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 . . . . . 0 N--CA 1.453 -0.3 0 C-N-CA 124.584 1.154 . . . . 0.0 109.529 176.685 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 . . . . . 0 CA--C 1.535 0.387 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -169.65 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.598 2.865 . . . . 0.0 110.905 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 75.88 103.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 126.045 1.738 . . . . 0.0 111.782 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.12 -48.78 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -105.55 111.28 23.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.8 ptm -120.28 156.35 31.42 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.074 0.95 . . . . 0.0 110.113 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -179.54 2.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.72 0.808 . . . . 0.0 110.82 174.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 m -142.98 -154.77 0.54 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.98 92.46 0.72 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.6 mt 114.43 117.43 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 131.485 3.914 . . . . 0.0 107.122 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.44 142.0 24.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.212 3.275 . . . . 0.0 113.366 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.94 110.57 3.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mt -74.03 133.01 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.8 115.7 43.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.47 86.9 4.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.026 0.93 . . . . 0.0 109.385 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 18.8 ptm -89.61 158.9 17.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.193 0.997 . . . . 0.0 111.148 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.5 m -124.57 108.23 11.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -63.48 152.1 39.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 111.023 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 97.94 -34.52 5.14 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -89.47 177.23 6.62 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -74.78 135.37 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.44 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.01 109.64 11.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.755 1.222 . . . . 0.0 109.192 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.6 t -89.94 122.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -93.17 108.45 33.02 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.39 84.03 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.414 2.742 . . . . 0.0 110.381 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.9 p -140.45 45.88 1.82 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.777 0.831 . . . . 0.0 109.801 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.6 ptt180 -69.03 157.8 36.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.98 175.55 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.706 1.603 . . . . 0.0 109.459 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.0 p -73.33 -71.94 0.28 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.406 0.682 . . . . 0.0 110.413 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -99.66 151.21 37.38 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.501 1.121 . . . . 0.0 110.639 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.98 -30.24 39.58 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.871 2.381 . . . . 0.0 110.794 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -50.76 -30.57 14.37 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.2 1.8 . . . . 0.0 112.827 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 mm -50.27 -41.31 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.825 1.25 . . . . 0.0 111.047 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 61.07 80.98 0.2 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.08 1.352 . . . . 0.0 110.686 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.55 138.99 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.9 m -118.74 129.29 55.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.087 1.355 . . . . 0.0 107.951 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.47 100.89 13.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -89.39 168.88 11.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.749 1.22 . . . . 0.0 109.949 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -143.96 137.69 27.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.526 1.53 . . . . 0.0 107.865 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -60.58 134.32 91.68 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 118.631 -0.7 . . . . 0.0 110.556 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.4 -59.72 0.11 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 119.901 1.0 . . . . 0.0 112.01 -0.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.07 40.51 1.79 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.589 1.156 . . . . 0.0 110.164 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.56 167.42 14.61 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.8 m -146.78 133.27 19.73 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.627 0.371 . . . . 0.0 110.723 -173.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.24 87.5 3.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.527 1.531 . . . . 0.0 107.089 175.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mm -61.85 129.37 91.62 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.963 0.905 . . . . 0.0 109.544 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.29 79.83 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.261 2.641 . . . . 0.0 110.382 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.61 -25.72 67.52 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 113.318 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.43 43.22 54.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -150.09 -57.79 0.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.746 1.218 . . . . 0.0 108.317 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -95.95 -49.87 5.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.383 1.473 . . . . 0.0 107.914 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.4 mt -103.0 93.52 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 124.43 1.092 . . . . 0.0 108.424 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.8 119.71 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -90.0 100.6 13.39 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.152 0.581 . . . . 0.0 109.496 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -95.79 108.17 20.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 172.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 53.3 p -55.67 -35.12 65.64 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.362 0.665 . . . . 0.0 112.392 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -101.29 21.53 13.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.935 0.894 . . . . 0.0 112.661 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -145.9 -55.88 0.29 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.658 0.663 . . . . 0.0 111.51 171.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 159.19 -172.98 35.97 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -89.61 112.63 23.92 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.54 97.05 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.472 1.109 . . . . 0.0 108.599 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.71 98.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.4 p -59.02 -35.21 72.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.541 1.136 . . . . 0.0 113.303 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -130.32 81.73 2.02 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.527 1.131 . . . . 0.0 108.337 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 156.77 24.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.381 0.672 . . . . 0.0 111.734 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 70.3 p -145.66 -178.4 6.08 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.21 1.404 . . . . 0.0 109.06 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -54.74 -32.54 59.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.127 0.971 . . . . 0.0 112.376 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -31.45 55.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.494 0.718 . . . . 0.0 111.872 176.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -81.7 -40.62 22.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.519 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.11 119.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 118.467 0.576 . . . . 0.0 109.668 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.34 -160.51 20.72 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.352 0.977 . . . . 0.0 111.178 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 41.1 tp -79.26 84.36 5.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.142 0.977 . . . . 0.0 111.142 -172.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 43.5 mt -75.61 153.83 37.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.4 m -148.88 115.35 5.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.15 125.92 30.84 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -128.19 148.18 50.6 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.68 0.792 . . . . 0.0 110.517 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.29 133.1 10.36 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.265 0.626 . . . . 0.0 110.857 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.6 m -89.66 114.65 26.31 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.17 141.52 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 64.78 -76.93 0.04 OUTLIER 'General case' 0 C--N 1.343 0.287 0 C-N-CA 126.304 1.842 . . . . 0.0 110.269 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -171.8 44.45 0.18 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -150.05 127.69 11.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.572 1.149 . . . . 0.0 108.741 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.2 tp -81.03 102.54 10.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.123 0.969 . . . . 0.0 108.829 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -89.23 153.39 20.95 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -140.3 153.38 46.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.474 1.11 . . . . 0.0 109.953 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.7 t -149.35 122.81 9.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.365 0.666 . . . . 0.0 109.348 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -98.27 148.23 23.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.169 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.65 103.49 4.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.297 1.439 . . . . 0.0 108.56 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.29 94.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.2 p -88.39 99.08 11.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -89.47 172.1 9.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.596 1.158 . . . . 0.0 109.706 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? . . . . . 0 N--CA 1.451 -0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 109.585 173.701 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 . . . . . 0 N--CA 1.453 -0.287 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.93 -62.24 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.662 2.241 . . . . 0.0 110.549 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -75.14 130.22 38.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.18 0.992 . . . . 0.0 112.327 -173.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.11 -59.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -91.74 123.84 35.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ptm -152.03 166.23 32.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.834 0.854 . . . . 0.0 110.282 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -170.75 0.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.305 1.042 . . . . 0.0 110.971 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.8 t -123.08 -68.85 0.86 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.42 -52.81 0.72 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.01 1.324 . . . . 0.0 109.063 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.1 mm -72.78 130.54 85.22 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.26 149.76 64.18 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.594 2.196 . . . . 0.0 109.989 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.73 121.29 15.11 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.8 110.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.907 0.883 . . . . 0.0 108.755 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.37 93.52 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -74.72 81.77 2.07 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.24 1.016 . . . . 0.0 109.237 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 170.53 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.61 0.764 . . . . 0.0 111.89 -169.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -121.61 118.41 29.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.818 1.247 . . . . 0.0 108.165 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.1 149.79 22.74 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.97 -34.0 3.46 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.718 0.675 . . . . 0.0 112.079 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -89.82 176.11 6.96 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.857 0.863 . . . . 0.0 110.854 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.213 0.605 . . . . 0.0 111.706 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.6 tp -140.69 105.14 4.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.297 1.439 . . . . 0.0 107.718 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.2 t -89.85 132.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -108.99 94.61 15.15 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -84.66 66.33 6.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.319 2.68 . . . . 0.0 111.741 -166.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.6 p -100.83 58.73 0.92 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.125 0.97 . . . . 0.0 108.756 171.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -69.95 155.69 40.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.623 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 169.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.574 1.149 . . . . 0.0 111.953 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 p -67.89 -65.69 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.044 1.338 . . . . 0.0 110.072 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -111.97 149.98 41.69 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.647 1.179 . . . . 0.0 110.398 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.86 -27.62 43.5 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.516 2.81 . . . . 0.0 112.889 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.06 -16.69 60.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.9 mm -77.27 83.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 55.8 m -73.34 113.3 10.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.9 t -89.41 142.59 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.772 0.829 . . . . 0.0 109.256 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -98.97 111.8 24.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.26 100.32 13.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.75 168.43 12.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.32 0.648 . . . . 0.0 110.382 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -143.96 145.63 32.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.979 1.312 . . . . 0.0 108.342 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -58.19 134.25 84.5 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.007 0.923 . . . . 0.0 110.772 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.37 -59.13 0.13 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.784 0.959 . . . . 0.0 111.745 0.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -140.89 38.89 1.8 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.741 1.217 . . . . 0.0 109.859 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -79.19 158.85 27.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.4 m -131.44 126.02 34.02 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.76 0.824 . . . . 0.0 109.232 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.83 99.56 10.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.171 1.388 . . . . 0.0 107.533 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.32 128.81 93.09 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.39 85.3 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.892 2.395 . . . . 0.0 109.825 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.84 -22.31 62.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.171 1.388 . . . . 0.0 113.246 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 76.84 26.29 62.91 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.575 -0.569 . . . . 0.0 112.679 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.38 -63.77 0.58 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.827 1.251 . . . . 0.0 108.365 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -85.44 -60.09 2.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 27.4 mt -89.81 93.37 4.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.6 mt -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -88.95 96.36 10.69 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.33 105.13 17.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.7 p -51.68 -51.26 57.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.082 0.953 . . . . 0.0 112.9 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -95.07 28.97 2.57 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.825 . . . . 0.0 112.382 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -144.95 -60.39 0.36 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.765 0.826 . . . . 0.0 110.987 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 158.45 -176.09 35.45 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -89.36 107.52 19.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 mt -89.32 95.44 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.14 87.69 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.4 p -56.39 -31.55 63.96 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.713 1.205 . . . . 0.0 113.702 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -139.74 86.97 2.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.8 162.12 9.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.81 0.844 . . . . 0.0 111.43 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.6 p -126.8 153.16 45.97 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 0.0 108.801 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -53.62 -32.62 52.03 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.01 0.924 . . . . 0.0 111.829 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -55.74 -36.23 67.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.524 1.129 . . . . 0.0 111.82 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.44 -0.37 29.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.125 0.97 . . . . 0.0 112.938 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.0 mt -72.64 121.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 162.28 -116.51 0.72 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.77 107.32 4.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.056 0.942 . . . . 0.0 109.164 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.1 152.24 20.69 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.1 m -142.33 109.79 5.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.138 0.975 . . . . 0.0 108.389 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 77.6 m -76.78 136.38 38.99 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -130.7 142.63 50.43 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.392 1.077 . . . . 0.0 110.185 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.25 39.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.428 1.091 . . . . 0.0 109.516 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.5 m -142.19 127.25 18.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.02 -76.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 0.0 109.233 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.37 52.52 2.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.98 44.44 56.23 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.216 0.913 . . . . 0.0 111.669 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -150.09 128.78 12.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.539 1.136 . . . . 0.0 108.35 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.29 104.31 9.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -89.61 139.05 30.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -150.78 166.1 31.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.866 0.303 . . . . 0.0 111.442 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.57 137.47 14.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.917 0.887 . . . . 0.0 109.779 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -105.86 143.26 34.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.227 1.411 . . . . 0.0 112.75 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.97 103.55 4.66 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.586 1.555 . . . . 0.0 108.571 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.61 109.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 p -89.27 97.7 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -89.36 160.42 16.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.787 1.235 . . . . 0.0 108.695 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 . . . . . 0 CA--C 1.535 0.403 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.852 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 . . . . . 0 CA--C 1.535 0.392 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.06 -47.23 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.913 2.408 . . . . 0.0 110.633 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.6 143.45 53.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 111.995 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -79.25 -52.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -109.58 122.77 48.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.577 1.551 . . . . 0.0 108.842 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.4 ptm -122.3 157.6 31.38 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.146 0.978 . . . . 0.0 109.736 170.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 218' ' ' THR . 0.2 OUTLIER -71.24 162.77 28.88 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.849 0.46 . . . . 0.0 110.717 173.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -92.62 -136.66 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -97.26 106.52 18.86 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 25.4 mm 119.73 122.3 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 131.688 3.995 . . . . 0.0 107.332 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -44.81 139.29 7.77 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.668 3.579 . . . . 0.0 114.101 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.45 119.2 10.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.225 0.61 . . . . 0.0 110.213 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.77 103.34 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.201 1.4 . . . . 0.0 108.861 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.0 mt -108.89 123.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.205 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -81.47 91.98 6.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.02 1.328 . . . . 0.0 108.726 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 13.9 ptm -89.3 168.34 12.33 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 111.803 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 m -136.67 142.58 43.18 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.23 1.412 . . . . 0.0 108.637 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.64 148.63 51.64 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.941 0.897 . . . . 0.0 110.85 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.34 -41.58 2.93 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.564 0.602 . . . . 0.0 113.228 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -88.64 -179.05 5.95 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.437 0.695 . . . . 0.0 110.586 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.2 156.22 39.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.5 tp -150.01 111.41 4.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.59 134.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -109.67 93.32 13.99 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 170.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.63 77.72 3.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.452 2.768 . . . . 0.0 112.163 -166.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.3 p -124.6 46.84 2.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.449 1.5 . . . . 0.0 109.814 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 188' ' ' SER . 29.4 ptt-85 -63.01 158.45 19.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.873 0.869 . . . . 0.0 111.006 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.2 m -114.31 155.22 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 124.427 1.091 . . . . 0.0 111.51 -174.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 p -57.68 -61.31 2.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.115 1.366 . . . . 0.0 109.873 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.8 t -98.56 120.33 59.39 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.291 1.037 . . . . 0.0 108.957 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.76 -32.69 6.31 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 125.08 3.853 . . . . 0.0 114.912 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -57.97 -27.96 63.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.591 1.156 . . . . 0.0 112.657 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.6 94.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 33.2 m -71.28 118.12 13.67 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.2 t -89.61 147.9 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.063 0.945 . . . . 0.0 109.18 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.3 m -101.75 111.24 23.43 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.379 1.072 . . . . 0.0 108.229 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.33 102.63 15.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -89.92 168.29 12.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.73 0.812 . . . . 0.0 110.183 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -146.61 146.25 30.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.75 1.22 . . . . 0.0 108.214 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 134.65 85.14 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.915 0.886 . . . . 0.0 110.777 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.33 -59.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.685 0 CA-C-N 119.737 0.942 . . . . 0.0 111.857 0.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.05 38.82 1.77 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 109.715 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -78.23 155.14 30.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 61.9 m -127.63 113.71 16.42 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.05 0.94 . . . . 0.0 109.101 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.78 87.57 7.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.9 133.92 95.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.169 0.988 . . . . 0.0 108.836 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.89 83.75 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.39 2.726 . . . . 0.0 110.779 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -69.61 -18.05 63.58 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 113.069 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.7 31.8 73.68 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -133.59 -71.86 0.51 Allowed 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -82.94 -56.2 3.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.5 mm -89.31 84.41 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.7 114.08 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -89.07 94.81 10.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.229 0.611 . . . . 0.0 109.74 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -89.84 95.81 10.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 77.7 p -58.46 -21.39 51.27 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -108.66 24.89 12.41 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.677 1.191 . . . . 0.0 111.856 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -147.03 -57.56 0.26 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.453 0.701 . . . . 0.0 110.264 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.21 -168.95 35.97 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.227 1.394 . . . . 0.0 109.878 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.0 114.36 25.54 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.15 96.95 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 21.8 mm -75.87 80.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.7 p -56.92 -35.33 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.829 1.252 . . . . 0.0 113.292 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -118.96 88.24 2.89 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.503 1.121 . . . . 0.0 108.675 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.64 144.52 52.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.24 0.616 . . . . 0.0 110.419 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 75.3 p -138.35 167.48 21.78 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.324 1.05 . . . . 0.0 110.602 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -61.38 -36.65 80.83 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.244 1.017 . . . . 0.0 111.45 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -52.65 -41.86 64.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.814 0.846 . . . . 0.0 110.697 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.68 0.62 29.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 112.828 -174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.0 mt -73.89 109.79 6.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 161.6 -162.57 34.03 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 117.953 0.342 . . . . 0.0 112.263 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -92.68 103.0 15.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.914 1.285 . . . . 0.0 110.164 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.01 155.44 19.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.766 0.827 . . . . 0.0 108.827 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 38.7 m -149.74 114.01 5.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.278 0.631 . . . . 0.0 109.891 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 57.0 m -80.86 138.7 36.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -131.55 137.4 48.45 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.512 1.125 . . . . 0.0 109.399 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.41 151.39 28.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.8 0.84 . . . . 0.0 109.46 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.4 m -129.98 139.37 51.07 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.436 1.094 . . . . 0.0 108.949 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t -132.03 136.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.45 -85.34 0.02 OUTLIER 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -157.99 46.84 0.46 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -143.14 116.85 9.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.974 1.31 . . . . 0.0 107.83 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.9 tp -77.79 143.8 37.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.89 0.876 . . . . 0.0 109.31 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -132.51 150.13 52.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.25 1.42 . . . . 0.0 108.059 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -141.74 157.48 44.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.23 1.012 . . . . 0.0 110.137 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 139' ' ' TYR . 2.7 t -155.53 130.98 9.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.022 0.529 . . . . 0.0 110.131 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -109.42 143.41 39.04 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.499 1.519 . . . . 0.0 111.968 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -141.25 109.11 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 108.95 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.5 tt -90.19 101.9 14.62 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -89.75 91.33 8.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.156 0.983 . . . . 0.0 108.355 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -93.11 150.79 20.27 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 . . . . . 0 CA--C 1.532 0.254 0 CA-C-N 118.534 0.606 . . . . 0.0 109.808 175.04 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 . . . . . 0 CA--C 1.536 0.416 0 CA-C-O 119.35 -0.357 . . . . 0.0 110.489 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.12 -48.05 0.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.531 2.821 . . . . 0.0 112.032 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -68.12 140.84 56.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.443 0.697 . . . . 0.0 111.947 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -89.63 -53.84 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -75.64 -81.79 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.436 1.094 . . . . 0.0 110.454 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . 0.259 26.5 ptm 51.49 172.35 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.99 2.516 . . . . 0.0 115.314 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.0 -146.32 0.05 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.902 1.681 . . . . 0.0 110.016 174.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.5 p -131.93 -81.14 0.51 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -128.68 -51.03 1.25 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.619 1.568 . . . . 0.0 108.175 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.26 129.58 79.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.16 135.32 45.1 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.709 2.939 . . . . 0.0 112.391 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.37 128.96 37.99 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.43 127.36 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.5 mt -123.59 133.41 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -96.81 84.16 3.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.457 1.503 . . . . 0.0 107.487 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 8.2 ptm -89.03 164.35 15.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.892 0.377 . . . . 0.0 111.185 -172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -149.46 131.88 15.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.82 155.53 33.69 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.089 0.555 . . . . 0.0 110.706 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.01 -42.73 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -89.05 173.38 8.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.914 1.286 . . . . 0.0 110.94 -172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.49 137.43 44.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.995 0.918 . . . . 0.0 110.269 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.3 tp -127.71 106.95 9.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.479 1.512 . . . . 0.0 107.742 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.2 t -90.56 132.34 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.01 97.52 25.29 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.85 82.16 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.642 2.894 . . . . 0.0 111.667 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.1 p -127.34 55.35 1.6 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.083 1.353 . . . . 0.0 109.206 174.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -65.95 155.45 36.47 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 111.038 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.07 177.43 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.357 1.463 . . . . 0.0 108.53 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -78.88 -29.7 44.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.161 0.984 . . . . 0.0 111.959 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.6 m -149.13 146.41 21.27 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.382 0.673 . . . . 0.0 110.127 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.38 -31.99 33.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.569 2.846 . . . . 0.0 112.743 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -58.56 -26.56 63.71 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.593 0.757 . . . . 0.0 112.359 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.5 mm -54.61 -40.34 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.704 1.201 . . . . 0.0 110.605 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.7 m 61.96 91.2 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.986 1.314 . . . . 0.0 111.431 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.6 t -88.95 143.4 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 91.6 m -104.99 122.43 45.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.2 tp -89.18 125.37 35.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -125.4 -176.4 3.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.079 0.952 . . . . 0.0 109.9 174.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -143.65 143.87 31.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.36 1.864 . . . . 0.0 107.205 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.55 128.03 67.53 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 123.548 0.739 . . . . 0.0 111.23 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.35 -61.77 0.04 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.877 0.992 . . . . 0.0 112.101 1.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.73 39.99 1.4 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.579 1.152 . . . . 0.0 110.275 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -77.98 122.6 25.75 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.8 m -89.73 114.32 25.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.002 0.521 . . . . 0.0 111.001 -169.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 mp -90.01 87.06 6.76 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.47 129.79 93.86 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.78 88.45 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.14 2.56 . . . . 0.0 110.148 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.7 -23.6 67.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.588 1.155 . . . . 0.0 113.071 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.56 20.2 60.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.566 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.76 -60.48 0.83 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.527 1.131 . . . . 0.0 108.174 173.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -78.68 -68.08 0.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.7 mt -89.47 91.93 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 95.0 mt -93.13 118.51 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -88.98 96.33 10.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -89.87 101.78 14.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 77.6 p -52.7 -37.81 59.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.915 0.886 . . . . 0.0 113.215 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -99.0 25.83 6.36 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.984 0.914 . . . . 0.0 112.182 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -150.39 -56.69 0.17 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.513 0.597 . . . . 0.0 111.382 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.44 -173.45 34.9 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -89.42 114.78 26.29 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.1 mt -94.66 94.1 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.95 88.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 79.9 p -57.56 -38.19 74.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.196 1.399 . . . . 0.0 112.453 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -119.55 88.88 3.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.236 1.015 . . . . 0.0 108.517 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.97 146.19 55.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.749 0.419 . . . . 0.0 110.517 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 81.1 p -137.66 173.0 12.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 109.142 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -51.63 -31.27 24.67 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.266 1.427 . . . . 0.0 112.258 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -52.07 -35.94 49.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 112.374 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -87.8 -5.42 58.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.055 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.6 mt -72.15 116.06 13.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 120.251 1.387 . . . . 0.0 108.347 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.15 -104.51 0.26 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.5 tp -152.3 96.72 2.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.917 0.887 . . . . 0.0 109.183 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.4 155.98 23.19 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.171 0.589 . . . . 0.0 109.565 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 30.4 m -146.67 106.26 3.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.753 1.221 . . . . 0.0 109.156 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 47.7 m -78.45 143.16 36.95 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -136.29 135.17 38.72 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.507 1.123 . . . . 0.0 109.899 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.62 164.05 37.75 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.359 1.064 . . . . 0.0 110.327 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.7 m -146.07 135.93 23.43 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.878 0.871 . . . . 0.0 108.736 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.9 -78.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.223 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -88.23 49.91 1.88 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.703 -170.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.28 -24.55 1.71 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.614 0.626 . . . . 0.0 113.45 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -88.91 132.99 34.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.732 1.213 . . . . 0.0 109.585 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.5 tp -76.43 107.82 8.96 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.45 143.05 27.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.21 161.38 42.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.711 0.405 . . . . 0.0 110.529 174.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.8 t -153.84 133.85 13.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.568 0.747 . . . . 0.0 109.37 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -110.36 151.93 26.85 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.844 1.258 . . . . 0.0 112.793 -168.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.55 104.41 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.435 1.494 . . . . 0.0 108.861 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.3 tt -78.23 99.4 6.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.115 0.966 . . . . 0.0 108.635 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.1 p -90.09 90.84 8.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.413 1.485 . . . . 0.0 109.606 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -89.95 155.06 19.38 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 . . . . . 0 N--CA 1.454 -0.273 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.143 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 . . . . . 0 CA--C 1.534 0.338 0 CA-C-O 119.654 -0.212 . . . . 0.0 110.624 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.23 -40.91 1.45 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.103 2.535 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -68.44 118.46 11.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.217 1.007 . . . . 0.0 112.069 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.13 -58.4 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -93.14 134.48 35.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.3 ptm -159.96 170.38 21.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.208 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -153.26 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.748 1.619 . . . . 0.0 110.722 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.7 t -133.11 -69.02 0.57 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.71 -56.25 0.57 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 124.919 1.288 . . . . 0.0 108.671 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.77 132.2 94.8 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.29 129.11 20.76 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.525 2.15 . . . . 0.0 109.503 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.1 117.55 6.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.579 0.752 . . . . 0.0 110.697 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mm -72.75 110.6 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.789 1.236 . . . . 0.0 108.634 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 mt -118.14 113.1 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 124.551 1.14 . . . . 0.0 108.559 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 136.41 42.96 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -144.83 157.81 44.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.923 0.489 . . . . 0.0 111.154 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.5 m -105.03 114.62 28.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.83 140.14 56.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.071 0.549 . . . . 0.0 110.232 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 101.4 -35.03 5.18 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.356 0.979 . . . . 0.0 111.202 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -89.63 -177.81 5.38 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.741 0.817 . . . . 0.0 111.446 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.16 148.0 50.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.4 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.0 tp -145.24 106.82 4.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.427 1.091 . . . . 0.0 108.744 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.7 t -94.41 120.53 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.592 1.157 . . . . 0.0 107.887 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.7 mm -89.95 109.79 35.31 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.0 72.54 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.437 2.758 . . . . 0.0 111.081 -168.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 20.3 p -126.02 50.96 1.81 Allowed 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 124.63 1.172 . . . . 0.0 109.563 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.367 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.9 174.22 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.7 1.6 . . . . 0.0 109.331 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -74.99 -29.01 60.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -148.29 144.28 18.53 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.624 0.647 . . . . 0.0 111.607 -169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.1 -39.75 26.09 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.501 3.467 . . . . 0.0 113.535 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -49.34 -37.22 23.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.455 1.502 . . . . 0.0 112.083 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.1 mt -77.97 87.63 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.8 m -78.09 110.6 13.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.46 150.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.375 1.07 . . . . 0.0 108.28 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.9 m -110.46 124.68 52.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.186 0.994 . . . . 0.0 108.646 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 tp -89.4 101.13 13.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.55 169.05 11.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.013 0.925 . . . . 0.0 109.892 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.49 145.58 31.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 108.118 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -57.36 134.27 81.5 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.586 0.754 . . . . 0.0 110.872 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.27 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.707 0 CA-C-N 119.819 0.971 . . . . 0.0 111.716 -0.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.3 39.27 1.74 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.721 1.208 . . . . 0.0 109.996 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -79.66 161.35 25.89 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 171.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -138.44 120.63 15.76 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.368 0.667 . . . . 0.0 110.027 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.4 mp -92.18 81.05 5.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.9 mm -60.94 120.4 53.56 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.421 1.088 . . . . 0.0 109.655 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.79 119.49 6.78 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.149 2.566 . . . . 0.0 111.958 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -84.68 -16.17 42.78 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.632 0.773 . . . . 0.0 111.621 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.81 39.8 89.76 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -150.28 -66.91 0.2 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.711 0.804 . . . . 0.0 109.004 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.7 -54.95 3.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.652 1.181 . . . . 0.0 107.852 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 54.4 mt -95.52 91.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.11 120.31 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -88.93 94.62 10.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -89.43 99.44 12.44 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.8 p -51.04 -41.29 59.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -97.88 24.7 6.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.218 1.007 . . . . 0.0 112.292 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -145.81 -57.08 0.31 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.454 0.701 . . . . 0.0 110.94 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.54 -173.6 37.12 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.02 110.06 20.81 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.3 mt -91.4 93.15 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.078 1.351 . . . . 0.0 108.125 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.31 100.82 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.6 p -61.89 -32.15 72.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.733 0.813 . . . . 0.0 112.608 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.03 95.16 4.5 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.589 1.156 . . . . 0.0 108.915 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.8 138.88 44.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.154 0.581 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 72.8 p -142.84 -178.56 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.902 1.281 . . . . 0.0 109.357 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -45.66 -40.77 9.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.21 1.404 . . . . 0.0 112.109 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -51.99 -32.08 32.22 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.314 1.446 . . . . 0.0 112.472 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -90.16 -38.23 13.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.286 1.034 . . . . 0.0 110.786 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.2 mt -65.95 106.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.324 0.65 . . . . 0.0 109.864 -171.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.28 29.07 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 47.4 tp -83.32 87.82 6.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.472 1.109 . . . . 0.0 109.659 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 89.7 mt -76.73 154.71 33.86 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.02 0.928 . . . . 0.0 109.148 172.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -148.97 112.11 4.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.331 0.652 . . . . 0.0 109.585 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 66.5 m -78.44 132.92 37.5 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -131.21 143.38 50.54 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.994 0.918 . . . . 0.0 110.962 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.76 172.92 17.36 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.034 1.334 . . . . 0.0 109.524 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 75.1 m -144.42 139.54 28.44 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.087 0.955 . . . . 0.0 108.874 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.63 -75.53 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.78 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.94 46.92 1.24 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.844 0.858 . . . . 0.0 111.546 -170.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.77 41.03 50.12 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -170.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -149.27 120.59 7.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.326 1.45 . . . . 0.0 107.376 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.74 111.49 7.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -90.16 143.36 26.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -150.43 161.73 41.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.577 0.351 . . . . 0.0 110.631 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 t -153.02 132.01 12.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.757 0.823 . . . . 0.0 109.153 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -105.84 144.66 32.26 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.975 1.31 . . . . 0.0 111.552 -169.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -139.29 113.19 8.6 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.081 1.352 . . . . 0.0 109.038 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -88.87 99.16 12.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.0 p -89.57 106.81 18.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -112.39 179.61 3.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.224 1.41 . . . . 0.0 110.557 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 . . . . . 0 CA--C 1.53 0.188 0 C-N-CA 123.846 0.858 . . . . 0.0 112.111 -178.374 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 . . . . . 0 CA--C 1.533 0.325 0 N-CA-C 108.84 -0.8 . . . . 0.0 108.84 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -82.05 -175.86 2.73 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.72 2.947 . . . . 0.0 110.319 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 73.88 103.11 0.07 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.555 1.942 . . . . 0.0 111.948 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.22 -52.54 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -96.26 78.18 3.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.024 0.93 . . . . 0.0 108.728 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ttt -80.94 139.91 35.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -172.78 0.3 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.363 1.065 . . . . 0.0 112.076 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.4 t -148.48 -162.37 1.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 108.891 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.7 95.94 0.69 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 32.4 mm 116.6 120.08 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 1 C-N-CA 132.131 4.172 . . . . 0.0 107.332 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.15 139.59 32.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.346 2.697 . . . . 0.0 110.113 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -65.78 130.08 42.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.267 0.627 . . . . 0.0 111.273 -177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -72.52 138.03 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.396 1.078 . . . . 0.0 109.82 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.8 mt -128.45 127.87 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.017 1.327 . . . . 0.0 107.873 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -90.9 125.05 35.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -150.31 176.6 10.74 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.498 0.719 . . . . 0.0 110.367 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.3 m -150.08 143.05 24.86 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 170.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.77 141.56 55.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.483 0.313 . . . . 0.0 110.16 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.5 -35.75 4.81 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.11 0.862 . . . . 0.0 111.69 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.76 169.78 11.34 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.708 0.754 . . . . 0.0 110.586 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.49 147.73 37.63 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.22 108.88 4.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -171.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.75 130.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -106.87 97.27 16.96 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.59 77.3 4.11 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.068 2.512 . . . . 0.0 111.134 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -115.46 53.66 0.83 Allowed 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.918 1.287 . . . . 0.0 109.183 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -66.47 148.39 51.95 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.273 0.629 . . . . 0.0 110.738 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.08 175.58 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 109.793 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.9 p -67.26 -40.49 86.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.832 0.853 . . . . 0.0 111.823 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -150.74 149.04 24.71 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.274 0.63 . . . . 0.0 111.064 -171.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.23 -37.98 40.58 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.749 2.966 . . . . 0.0 112.613 166.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -53.24 -29.26 31.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.975 1.71 . . . . 0.0 113.03 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.8 mm -55.5 -34.74 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.012 0.925 . . . . 0.0 110.796 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.1 m 63.85 80.23 0.24 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.313 1.445 . . . . 0.0 110.564 173.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.79 141.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.6 m -120.92 128.57 52.89 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.681 1.192 . . . . 0.0 108.173 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.1 tp -89.16 131.79 35.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -134.77 177.24 7.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 109.651 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -146.62 148.94 32.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.995 0.918 . . . . 0.0 109.439 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.11 137.52 88.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.586 0.754 . . . . 0.0 109.721 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.74 -59.28 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.985 1.031 . . . . 0.0 111.857 0.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.3 mt -140.01 42.98 1.94 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.615 1.166 . . . . 0.0 109.768 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.65 145.28 27.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.9 m -122.2 128.55 51.34 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 124.202 1.001 . . . . 0.0 108.659 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.0 mt -111.9 79.23 1.19 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.656 1.582 . . . . 0.0 107.693 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.55 132.66 91.12 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 109.613 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.86 87.08 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.25 2.634 . . . . 0.0 110.402 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.26 -23.2 66.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.809 1.244 . . . . 0.0 112.859 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 82.84 17.43 67.81 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.573 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -129.07 -63.16 0.97 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -73.87 -68.43 0.52 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.7 mt -89.5 95.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.0 mt -95.9 115.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -89.35 117.07 28.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.475 0.71 . . . . 0.0 110.005 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -115.01 108.63 16.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.9 p -58.54 -29.42 66.33 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.74 0.816 . . . . 0.0 113.176 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -102.6 22.64 13.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.917 0.887 . . . . 0.0 112.177 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -149.17 -57.86 0.21 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.457 0.571 . . . . 0.0 111.115 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.58 -172.11 34.27 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -89.35 113.0 24.24 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.87 95.06 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.71 89.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 170.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 65.1 p -60.08 -35.04 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.785 1.234 . . . . 0.0 112.54 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.05 93.89 4.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.282 1.033 . . . . 0.0 108.391 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.26 150.81 38.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.468 0.707 . . . . 0.0 110.398 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 38.5 p -146.31 171.49 14.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.678 1.191 . . . . 0.0 109.208 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -51.42 -34.71 36.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.421 1.088 . . . . 0.0 111.621 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -56.59 -26.82 56.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.97 1.308 . . . . 0.0 112.071 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -82.9 -39.59 21.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.485 0.714 . . . . 0.0 111.839 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.2 108.4 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.119 0.967 . . . . 0.0 110.369 -169.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 147.23 -162.48 28.62 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.989 0.804 . . . . 0.0 111.334 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.19 88.3 6.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.226 1.01 . . . . 0.0 109.255 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.5 154.5 41.82 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.108 0.963 . . . . 0.0 109.298 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.0 m -149.73 108.75 3.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.039 0.936 . . . . 0.0 109.308 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.8 m -79.83 133.26 36.27 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -127.95 141.57 51.5 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.276 1.03 . . . . 0.0 110.078 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.42 120.69 6.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.117 0.967 . . . . 0.0 109.637 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.4 m -100.53 77.61 1.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.793 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.93 -52.65 29.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -109.41 177.78 4.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.613 1.165 . . . . 0.0 108.748 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.96 70.65 1.48 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 169.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -145.56 -43.25 0.22 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.566 1.547 . . . . 0.0 110.289 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp 64.11 91.22 0.08 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.854 1.662 . . . . 0.0 109.681 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -89.48 147.4 24.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -150.52 164.24 36.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.542 0.337 . . . . 0.0 111.61 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.2 t -147.11 129.12 15.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.701 1.2 . . . . 0.0 108.233 174.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -107.68 151.4 25.71 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.24 1.416 . . . . 0.0 112.688 -168.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -144.88 121.91 11.39 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.993 1.317 . . . . 0.0 108.956 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.24 102.51 14.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.1 p -89.57 124.15 34.29 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.64 0.776 . . . . 0.0 109.419 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -120.68 147.3 45.46 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.905 0.882 . . . . 0.0 110.133 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 . . . . . 0 N--CA 1.451 -0.413 0 C-N-CA 123.796 0.838 . . . . 0.0 109.894 178.684 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 . . . . . 0 N--CA 1.453 -0.295 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.81 -171.98 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.531 2.821 . . . . 0.0 111.401 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 77.57 104.81 0.07 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 127.199 2.2 . . . . 0.0 111.6 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.26 -50.39 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.465 1.106 . . . . 0.0 109.343 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.62 -70.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.399 0.68 . . . . 0.0 109.518 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ttt 64.23 116.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.569 1.948 . . . . 0.0 112.834 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.64 151.46 47.26 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.1 p -78.56 -62.64 1.62 Allowed 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.148 -0.345 . . . . 0.0 110.263 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -158.77 -51.66 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.426 1.09 . . . . 0.0 109.055 -171.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 34.6 mm -79.69 126.9 79.54 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.14 139.82 34.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.665 2.91 . . . . 0.0 112.519 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.18 119.75 12.6 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.4 mm -77.66 102.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.3 mt -92.22 143.66 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.337 1.055 . . . . 0.0 108.208 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -120.64 79.91 1.55 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.533 1.133 . . . . 0.0 110.12 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -89.5 -177.72 5.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.527 1.131 . . . . 0.0 111.064 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -142.31 117.57 10.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 169.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.65 123.55 9.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.631 0.773 . . . . 0.0 109.983 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.36 -39.74 2.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.823 1.201 . . . . 0.0 111.167 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -89.31 165.63 14.28 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.695 0.748 . . . . 0.0 111.363 -171.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -67.71 129.87 41.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -128.0 124.47 37.27 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.484 1.113 . . . . 0.0 109.561 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.03 134.76 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.5 mm -101.09 100.85 14.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.4 76.23 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 111.108 -165.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.1 p -125.58 45.02 2.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.291 1.037 . . . . 0.0 110.406 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 0.817 ' HB2' ' O ' ' A' ' 188' ' ' SER . 41.1 ptt180 -67.25 151.38 47.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.906 0.483 . . . . 0.0 110.771 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.1 175.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.929 1.292 . . . . 0.0 111.366 -169.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 52.1 p -75.73 -24.28 56.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -172.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 14.7 m -158.36 149.92 16.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.031 0.832 . . . . 0.0 110.824 177.035 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.72 -36.35 41.47 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.011 3.141 . . . . 0.0 113.654 168.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.59 -36.59 35.62 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.327 1.851 . . . . 0.0 111.935 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 41.6 mm -50.46 -42.74 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.861 1.264 . . . . 0.0 111.19 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 60.58 83.71 0.14 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.037 1.335 . . . . 0.0 111.044 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.68 147.49 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.609 0.764 . . . . 0.0 108.987 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.3 m -124.83 138.77 54.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.84 1.256 . . . . 0.0 107.852 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.0 tp -88.93 125.75 35.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -128.26 -179.55 5.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.878 1.271 . . . . 0.0 110.035 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -147.72 148.19 30.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 108.223 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -58.1 134.22 84.17 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.116 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.72 -59.97 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.962 1.022 . . . . 0.0 111.828 0.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.8 mt -141.83 38.26 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 110.162 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.6 148.28 40.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 170.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 91.0 m -125.75 118.32 25.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.757 0.823 . . . . 0.0 109.904 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.04 88.67 6.2 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 79.5 mt -61.36 130.44 91.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.636 0.775 . . . . 0.0 109.306 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.37 85.32 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.204 2.602 . . . . 0.0 110.247 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -60.78 -22.92 64.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.275 1.43 . . . . 0.0 113.28 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.72 28.07 65.89 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 118.374 0.534 . . . . 0.0 112.646 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.56 -64.26 0.72 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.078 1.351 . . . . 0.0 107.705 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -84.6 -58.43 2.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.8 mt -91.74 89.78 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 78.4 mt -95.22 116.35 36.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -89.1 129.55 35.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -135.6 122.17 20.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.289 1.036 . . . . 0.0 108.289 170.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 60.7 p -58.8 -26.46 64.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 112.379 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -98.75 10.93 40.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.883 0.873 . . . . 0.0 113.147 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -145.55 -57.85 0.32 Allowed 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.83 0.741 . . . . 0.0 110.603 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.31 -164.66 29.36 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.79 111.41 22.4 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.53 97.41 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.1 110.84 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 92.1 p -65.15 -35.62 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.518 0.599 . . . . 0.0 112.499 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -140.33 101.84 4.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.836 1.255 . . . . 0.0 107.99 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.11 157.58 25.1 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.365 0.666 . . . . 0.0 110.177 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 80.3 p -133.06 164.28 27.37 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.725 0.81 . . . . 0.0 110.177 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -59.63 -32.13 70.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.283 0.633 . . . . 0.0 110.969 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -60.3 -25.74 65.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.262 1.025 . . . . 0.0 111.947 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.29 -12.29 59.63 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.654 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.61 105.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.44 1.018 . . . . 0.0 109.212 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.82 -159.04 28.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.5 81.36 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.918 0.887 . . . . 0.0 110.562 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 97.9 mt -65.83 150.91 47.8 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 27.7 m -150.01 114.64 5.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.466 0.706 . . . . 0.0 109.416 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 84.6 m -78.23 124.48 28.12 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -121.55 141.49 51.01 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.316 1.047 . . . . 0.0 110.447 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.07 102.06 2.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.558 1.143 . . . . 0.0 109.198 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.2 m -89.88 86.34 6.61 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.92 -56.07 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.279 0.632 . . . . 0.0 109.786 -174.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -158.03 -75.51 0.08 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.981 0.913 . . . . 0.0 109.415 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.29 -46.54 78.1 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 123.362 0.506 . . . . 0.0 112.398 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -140.06 162.39 35.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.235 0.614 . . . . 0.0 111.395 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.59 101.96 9.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -89.85 133.2 34.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.55 161.71 42.02 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 62.7 p -139.72 133.6 30.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.518 1.127 . . . . 0.0 109.086 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -106.87 145.55 32.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.209 1.004 . . . . 0.0 111.743 -170.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -143.06 105.43 4.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.714 1.606 . . . . 0.0 109.235 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.69 108.67 19.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.9 p -89.26 90.65 8.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.462 0.705 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -89.61 103.43 16.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 . . . . . 0 CA--C 1.531 0.23 0 CA-C-N 118.993 0.815 . . . . 0.0 110.777 -177.246 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 . . . . . 0 CA--C 1.536 0.42 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.39 -37.41 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.166 2.577 . . . . 0.0 111.37 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -62.08 143.42 56.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 112.366 -174.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.29 -55.85 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -92.45 126.75 37.67 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 108.922 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.17 141.01 42.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.077 1.351 . . . . 0.0 108.996 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.16 121.09 12.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -68.91 -39.51 79.62 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.8 -0.563 . . . . 0.0 111.222 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -158.92 -58.34 0.07 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.6 mm -87.77 130.99 44.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.96 147.4 26.22 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.549 2.833 . . . . 0.0 112.429 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.87 118.98 11.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.2 94.68 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.6 mt -89.54 108.28 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -76.9 89.25 3.49 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.09 0.956 . . . . 0.0 108.552 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -104.36 173.51 6.27 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.395 1.478 . . . . 0.0 111.387 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 94.1 m -138.36 120.74 15.96 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -59.67 144.67 47.31 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.719 0.408 . . . . 0.0 110.364 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.22 -37.32 3.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -89.15 170.15 10.86 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.728 0.811 . . . . 0.0 110.672 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.57 145.57 54.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.815 0.446 . . . . 0.0 110.813 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.5 tp -143.31 108.5 5.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.88 1.272 . . . . 0.0 108.451 -172.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.64 131.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mm -108.63 91.52 8.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.73 89.19 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.459 2.773 . . . . 0.0 111.851 -164.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.7 p -135.62 48.73 2.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.557 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . 1.283 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -62.87 157.38 21.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.253 0.549 . . . . 0.0 112.174 176.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.85 175.01 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.819 1.648 . . . . 0.0 108.94 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 p -63.7 -42.4 97.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.474 0.71 . . . . 0.0 112.04 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.9 m -142.72 140.89 19.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.999 0.92 . . . . 0.0 110.24 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.17 -26.9 42.03 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.669 2.913 . . . . 0.0 112.027 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -52.77 -31.82 40.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.313 1.445 . . . . 0.0 112.082 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.78 -35.07 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.982 1.313 . . . . 0.0 110.915 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 m 69.02 91.29 0.09 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.537 1.535 . . . . 0.0 110.383 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.33 141.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.8 m -110.45 126.84 54.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.719 1.208 . . . . 0.0 108.092 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.0 tp -89.23 133.34 34.48 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -133.82 174.82 10.04 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.767 1.227 . . . . 0.0 109.764 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -149.23 148.21 29.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.645 0.778 . . . . 0.0 109.413 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.7 134.95 82.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.928 0.891 . . . . 0.0 109.96 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.27 -59.2 0.13 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 119.917 1.006 . . . . 0.0 111.697 1.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -142.52 44.2 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.597 1.159 . . . . 0.0 109.943 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -82.03 152.03 26.84 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 89.7 m -131.71 119.09 20.87 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.133 0.973 . . . . 0.0 108.942 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.95 113.35 26.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.283 1.433 . . . . 0.0 108.569 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.74 130.9 74.96 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.74 91.4 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.861 2.374 . . . . 0.0 109.731 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -64.31 -22.6 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.478 1.111 . . . . 0.0 113.144 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.48 59.22 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.233 -0.76 . . . . 0.0 113.428 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -137.12 -60.12 0.69 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.649 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -79.7 -66.48 0.87 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -89.56 94.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 40.9 mt -94.6 121.68 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -89.21 127.83 35.78 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.09 100.8 4.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.773 1.229 . . . . 0.0 108.38 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . 1.283 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.7 p -53.79 -27.74 30.91 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -73.01 -28.43 62.36 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.113 0.965 . . . . 0.0 112.611 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.31 -63.34 1.34 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.728 0.811 . . . . 0.0 110.65 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.21 26.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.84 111.71 22.83 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.35 94.54 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.14 85.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -58.19 -29.5 65.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.481 1.512 . . . . 0.0 113.336 -170.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -132.62 97.25 4.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.09 156.91 36.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.055 0.542 . . . . 0.0 110.393 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 43.0 p -125.53 154.43 42.15 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.143 0.977 . . . . 0.0 109.67 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -55.28 -32.55 62.5 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.172 0.989 . . . . 0.0 111.671 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -53.49 -37.35 62.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.642 1.177 . . . . 0.0 111.481 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -83.34 4.37 27.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.397 1.079 . . . . 0.0 113.2 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.3 mt -73.87 115.51 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.62 -111.5 0.48 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.8 tp -144.98 100.71 3.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.96 0.904 . . . . 0.0 109.975 -172.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.7 156.67 19.88 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.816 0.846 . . . . 0.0 109.128 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.7 m -147.28 117.73 7.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.395 1.078 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 60.4 m -85.04 140.01 31.33 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -133.94 147.44 51.06 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.995 0.918 . . . . 0.0 109.91 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.91 130.63 6.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.332 0.653 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.8 m -100.06 133.88 43.8 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.954 1.302 . . . . 0.0 109.329 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.7 t -100.49 -62.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.261 1.024 . . . . 0.0 108.524 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -140.31 84.79 1.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.066 0.947 . . . . 0.0 109.106 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.22 -57.47 5.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.05 0.834 . . . . 0.0 111.928 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.49 129.25 36.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.766 0.827 . . . . 0.0 110.289 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.86 156.8 30.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.634 0.73 . . . . 0.0 111.046 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -125.41 154.57 41.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -151.2 162.74 40.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 t -151.44 141.42 22.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.924 0.89 . . . . 0.0 109.639 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.17 147.49 32.42 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.288 1.435 . . . . 0.0 112.794 -168.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -143.76 101.9 3.83 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.457 1.503 . . . . 0.0 109.118 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.1 tt -80.31 110.98 16.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 108.772 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.9 p -89.4 93.29 9.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.532 1.133 . . . . 0.0 109.024 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -89.92 120.56 31.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.23 1.412 . . . . 0.0 108.749 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 . . . . . 0 CA--C 1.531 0.221 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.662 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 . . . . . 0 CA--C 1.533 0.314 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.65 -61.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.56 2.173 . . . . 0.0 111.341 -173.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -71.56 132.9 45.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.348 0.659 . . . . 0.0 111.729 -171.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.89 -61.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -81.98 109.59 16.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ttt -123.92 123.6 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.92 0.888 . . . . 0.0 110.252 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.95 147.3 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.998 0.919 . . . . 0.0 110.709 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 m -154.44 -58.5 0.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.064 1.345 . . . . 0.0 109.25 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -97.32 79.74 2.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.867 0.867 . . . . 0.0 110.273 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.4 mm 78.36 128.4 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 128.142 2.577 . . . . 0.0 109.748 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.74 138.32 33.32 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.348 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.67 120.55 11.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.099 0.56 . . . . 0.0 109.981 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.8 mm -76.53 122.6 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.0 mt -122.75 102.94 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -75.79 83.79 2.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.283 1.033 . . . . 0.0 109.524 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -92.87 155.62 17.49 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.068 0.947 . . . . 0.0 111.383 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 83.5 m -115.72 112.77 22.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -57.7 137.58 56.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.465 0.706 . . . . 0.0 109.88 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 104.31 -36.38 4.42 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.15 0.881 . . . . 0.0 111.385 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.5 179.48 6.05 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.525 0.73 . . . . 0.0 110.897 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.06 137.82 45.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.29 108.79 8.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.85 -175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -90.0 128.85 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 108.176 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -109.25 94.02 14.58 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.68 100.47 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.347 2.698 . . . . 0.0 110.643 -166.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -145.03 59.14 1.3 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 110.126 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -66.9 155.67 37.82 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.03 164.81 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.733 1.213 . . . . 0.0 110.646 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -61.85 -45.25 94.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.509 1.524 . . . . 0.0 111.517 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.0 m -135.82 145.67 53.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.321 1.048 . . . . 0.0 110.204 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.48 -26.09 34.66 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.352 2.701 . . . . 0.0 111.366 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -53.97 -29.31 42.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.781 1.632 . . . . 0.0 112.312 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.57 -51.91 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.066 0.946 . . . . 0.0 109.873 172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 11.7 m 63.39 93.39 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.494 1.517 . . . . 0.0 110.612 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.02 144.5 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.763 0.825 . . . . 0.0 109.231 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.5 m -112.76 129.82 56.29 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.764 1.226 . . . . 0.0 107.739 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.97 126.4 35.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -126.4 -177.34 3.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.326 1.051 . . . . 0.0 109.424 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -159.24 147.77 17.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 108.889 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.33 134.91 85.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.962 0.905 . . . . 0.0 110.645 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.41 -58.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.897 0.999 . . . . 0.0 111.649 0.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -141.82 38.46 1.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.71 1.204 . . . . 0.0 109.765 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.1 139.5 38.07 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 87.5 m -113.81 114.63 26.55 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.606 0.762 . . . . 0.0 109.477 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.98 85.43 6.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.4 129.32 88.99 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.412 0.685 . . . . 0.0 109.522 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.69 81.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.116 2.544 . . . . 0.0 109.921 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -60.42 -23.09 64.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.622 1.569 . . . . 0.0 113.426 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.29 32.67 65.1 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.58 0.61 . . . . 0.0 112.167 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -138.91 -59.12 0.6 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.235 1.414 . . . . 0.0 108.162 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -94.67 -56.57 2.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.813 1.245 . . . . 0.0 108.411 171.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.2 96.67 6.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 125.362 1.465 . . . . 0.0 108.179 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.63 148.08 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -120.31 138.58 53.63 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 125.113 1.365 . . . . 0.0 109.313 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -141.81 116.44 9.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.94 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 80.2 p -53.92 -32.52 53.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.947 1.299 . . . . 0.0 112.992 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.1 mtm-85 -83.28 -5.78 59.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.738 0.815 . . . . 0.0 112.848 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -141.13 -62.21 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.196 0.907 . . . . 0.0 111.719 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.45 -162.04 31.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.0 123.03 38.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.8 mp -103.28 98.12 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.01 96.27 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.1 p -55.9 -40.22 72.73 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.234 1.414 . . . . 0.0 112.842 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.13 99.67 6.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.821 1.248 . . . . 0.0 107.848 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.72 139.27 56.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.393 0.677 . . . . 0.0 110.527 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 59.3 p -131.98 -177.43 4.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.189 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -51.14 -32.2 22.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.032 1.333 . . . . 0.0 112.387 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -53.71 -29.77 40.74 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.508 1.123 . . . . 0.0 112.171 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -110.6 47.24 0.99 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.752 0.821 . . . . 0.0 110.918 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.09 94.28 2.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 150.23 -158.29 27.6 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.821 1.2 . . . . 0.0 110.445 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.4 tp -85.93 92.29 8.62 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.857 0.863 . . . . 0.0 109.949 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.63 159.11 31.53 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.7 m -148.26 108.28 4.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.195 0.998 . . . . 0.0 109.29 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.23 118.83 19.36 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -113.58 131.85 55.95 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.682 1.193 . . . . 0.0 110.297 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.16 50.3 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.303 1.441 . . . . 0.0 109.501 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 93.8 m -140.73 118.43 11.66 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.07 -54.95 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.847 0.859 . . . . 0.0 109.353 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -130.39 -65.08 0.82 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.173 0.989 . . . . 0.0 109.554 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -166.93 40.68 0.25 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -93.67 -47.08 6.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.209 1.404 . . . . 0.0 110.343 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 tp 63.68 88.56 0.1 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.932 1.693 . . . . 0.0 110.35 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.55 140.82 29.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.76 141.53 40.93 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.298 0.639 . . . . 0.0 109.909 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 35.3 p -133.44 123.89 26.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 108.099 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -102.3 144.59 30.6 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.031 0.932 . . . . 0.0 112.813 -169.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -142.96 107.72 4.87 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.857 1.663 . . . . 0.0 108.252 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.58 108.51 20.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.852 0.861 . . . . 0.0 109.174 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 32.1 p -89.62 114.82 26.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.099 0.96 . . . . 0.0 109.925 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -89.85 135.78 33.43 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.316 1.046 . . . . 0.0 109.148 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 . . . . . 0 N--CA 1.453 -0.307 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 169.722 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 . . . . . 0 N--CA 1.452 -0.329 0 N-CA-C 109.958 -0.386 . . . . 0.0 109.958 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.87 -27.21 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.19 2.594 . . . . 0.0 111.405 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -65.58 132.24 48.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.101 1.361 . . . . 0.0 112.554 -169.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.44 -49.63 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -81.38 101.26 9.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.28 0.632 . . . . 0.0 109.697 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.57 136.33 33.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 139' ' ' TYR . 1.2 p90 -79.42 48.16 0.88 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.623 0.769 . . . . 0.0 111.352 175.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 m -34.25 111.46 0.11 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.718 2.007 . . . . 0.0 110.76 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 1.61 71.52 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.838 2.455 . . . . 0.0 114.748 -167.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.7 mt 157.56 132.33 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 129.466 3.106 . . . . 0.0 108.584 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 148.11 60.16 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.316 2.677 . . . . 0.0 110.613 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.01 119.37 14.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.243 0.617 . . . . 0.0 109.472 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -78.99 99.81 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.63 115.44 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -80.09 83.61 5.95 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.691 1.197 . . . . 0.0 108.652 173.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -89.34 172.99 8.63 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.218 0.607 . . . . 0.0 112.159 -169.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.7 m -142.24 114.07 8.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.608 1.163 . . . . 0.0 108.189 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.55 145.51 18.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.884 0.873 . . . . 0.0 110.883 174.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.01 -48.17 1.8 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.144 0.878 . . . . 0.0 111.155 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -89.52 -178.21 5.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.796 0.838 . . . . 0.0 111.057 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.98 142.42 49.38 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.119 0.568 . . . . 0.0 110.948 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -139.72 110.18 6.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.455 1.502 . . . . 0.0 106.998 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.1 t -90.49 134.81 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.58 93.55 8.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.56 80.27 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.186 2.59 . . . . 0.0 111.977 -164.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 25.1 p -120.32 52.8 1.12 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.569 1.148 . . . . 0.0 110.722 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -57.56 147.81 25.89 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.288 1.035 . . . . 0.0 110.956 172.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -113.27 155.75 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 123.983 0.913 . . . . 0.0 111.305 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.0 p -70.02 -32.95 71.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.563 1.545 . . . . 0.0 111.496 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -126.38 113.04 23.38 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 124.979 1.312 . . . . 0.0 107.462 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -68.42 -20.51 41.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.238 2.625 . . . . 0.0 111.582 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -52.9 -36.25 59.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.688 172.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.78 86.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 30.8 m -66.64 126.18 28.14 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.804 0.842 . . . . 0.0 108.97 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.65 149.63 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.035 0.934 . . . . 0.0 109.634 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.5 m -105.84 115.78 30.82 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.912 1.285 . . . . 0.0 108.06 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 tp -89.62 104.17 16.75 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.378 0.671 . . . . 0.0 109.397 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.92 173.37 7.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 109.8 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -148.94 146.86 28.05 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.406 1.082 . . . . 0.0 108.666 169.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.62 134.5 86.07 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.816 0.846 . . . . 0.0 110.37 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.52 -59.39 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.883 0.994 . . . . 0.0 111.92 0.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.75 41.29 1.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.571 1.148 . . . . 0.0 109.944 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -83.27 153.31 24.73 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 m -123.78 107.87 11.89 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.277 1.031 . . . . 0.0 108.641 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.2 78.22 5.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.8 mt -59.66 131.44 88.55 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.357 1.063 . . . . 0.0 109.868 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.17 87.95 0.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.255 2.637 . . . . 0.0 110.31 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.39 -23.08 66.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.323 1.049 . . . . 0.0 112.743 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.89 -15.3 61.89 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.719 -1.045 . . . . 0.0 113.674 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.86 -60.58 1.65 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.508 1.154 . . . . 0.0 109.441 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -76.54 -67.72 0.67 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 mt -89.77 99.17 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.1 mt -98.7 120.75 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -89.09 95.95 10.52 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.012 0.525 . . . . 0.0 109.716 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.94 101.1 13.81 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.9 p -56.9 -27.81 61.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.157 0.983 . . . . 0.0 113.634 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -104.53 22.37 15.1 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.31 1.044 . . . . 0.0 112.153 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -147.09 -60.06 0.28 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.572 0.624 . . . . 0.0 110.306 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.5 -168.14 35.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.56 112.64 23.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.96 98.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -82.98 97.28 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 72.8 p -61.21 -37.53 83.33 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.153 0.981 . . . . 0.0 112.345 -175.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -121.21 87.96 2.85 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.532 1.133 . . . . 0.0 109.28 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.07 163.23 15.25 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.319 0.247 . . . . 0.0 110.7 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 46.5 p -139.86 160.25 40.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.899 0.88 . . . . 0.0 109.947 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -58.71 -34.26 71.13 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.74 0.816 . . . . 0.0 110.869 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -61.12 -34.61 75.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.966 0.907 . . . . 0.0 111.275 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.95 -8.4 56.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.596 0.758 . . . . 0.0 112.645 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.5 mt -65.4 127.26 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.01 -119.97 0.95 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.7 tp -144.76 95.25 2.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.234 1.014 . . . . 0.0 108.797 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 153.42 28.96 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 41.1 m -143.57 102.86 4.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.196 0.998 . . . . 0.0 108.979 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.72 132.09 43.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -134.03 135.59 43.46 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.125 0.97 . . . . 0.0 109.672 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.14 119.48 8.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.583 1.153 . . . . 0.0 108.613 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 m -89.69 59.13 4.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.082 0.553 . . . . 0.0 110.275 -172.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.86 141.06 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 57.53 24.43 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.051 1.34 . . . . 0.0 112.177 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.1 -5.9 23.83 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.112 -0.827 . . . . 0.0 113.231 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -89.92 129.56 36.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.573 1.186 . . . . 0.0 108.255 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.38 85.91 1.12 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.501 0.72 . . . . 0.0 109.439 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -88.93 141.24 28.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.65 162.9 39.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.228 0.611 . . . . 0.0 111.449 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.7 t -143.23 128.34 18.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.974 1.309 . . . . 0.0 107.713 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -106.07 150.98 25.25 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.416 1.486 . . . . 0.0 112.446 -169.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -142.74 105.3 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.488 1.515 . . . . 0.0 108.573 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -79.4 108.64 13.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.5 p -89.23 91.65 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -98.17 121.82 40.57 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.653 1.581 . . . . 0.0 107.608 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 . . . . . 0 C--N 1.34 0.157 0 CA-C-N 119.097 0.862 . . . . 0.0 109.699 174.225 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.477 ' N ' ' HG1' ' A' ' 161' ' ' THR . 55.0 m . . . . . 0 N--CA 1.473 0.705 0 CA-C-O 119.845 -0.121 . . . . 0.0 111.204 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 19.9 t70 -59.27 -61.14 2.86 Favored 'General case' 0 CA--C 1.531 0.239 0 C-N-CA 123.23 0.612 . . . . 0.0 109.821 178.871 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 55.2 p -86.65 68.17 10.07 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -178.65 -74.31 0.06 OUTLIER Glycine 0 C--N 1.338 0.689 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 179.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 42.0 ttp85 -172.81 128.51 0.55 Allowed Pre-proline 0 CA--C 1.533 0.296 0 C-N-CA 124.555 1.142 . . . . 0.0 108.221 -179.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 68.4 Cg_endo -71.43 -45.32 0.84 Allowed 'Trans proline' 0 N--CA 1.453 -0.875 0 C-N-CA 122.903 2.402 . . . . 0.0 111.214 -178.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.5 m-85 -64.26 144.65 56.99 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 124.646 1.178 . . . . 0.0 111.129 -175.298 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 92.6 t -78.12 -47.14 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.172 0 N-CA-C 108.855 -0.794 . . . . 0.0 108.855 170.954 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -126.24 143.46 51.14 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 125.286 1.434 . . . . 0.0 108.889 177.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 24.5 ptm -139.94 163.0 33.83 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.037 0.935 . . . . 0.0 109.683 179.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -64.55 155.72 32.14 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.592 0.757 . . . . 0.0 110.307 169.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 47.7 t -82.71 -69.04 0.65 Allowed 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 176.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -143.48 -52.77 0.36 Allowed 'General case' 0 CA--C 1.523 -0.063 0 C-N-CA 125.454 1.502 . . . . 0.0 108.107 178.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 79.7 mt -75.86 127.06 86.24 Favored Pre-proline 0 N--CA 1.449 -0.487 0 N-CA-C 107.123 -1.436 . . . . 0.0 107.123 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_exo -50.12 146.89 16.53 Favored 'Trans proline' 0 N--CA 1.459 -0.514 0 C-N-CA 123.833 3.022 . . . . 0.0 112.722 174.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -67.24 117.57 9.44 Favored 'General case' 0 CA--C 1.531 0.234 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.25 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 25.4 mm -81.12 97.52 3.48 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.241 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 -178.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.4 mt -89.75 110.71 22.11 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.151 0 N-CA-C 107.992 -1.114 . . . . 0.0 107.992 177.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 80.7 m-70 -80.07 81.16 6.38 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.453 1.101 . . . . 0.0 108.942 176.67 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.8 ptm -89.82 176.03 6.99 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 124.491 1.116 . . . . 0.0 112.114 -173.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 55.4 m -146.46 142.03 27.71 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 125.153 1.381 . . . . 0.0 107.356 173.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -63.03 146.77 52.49 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 122.989 0.516 . . . . 0.0 110.909 -176.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.43 -11.71 54.46 Favored Glycine 0 CA--C 1.529 0.944 0 CA-C-O 119.017 -0.88 . . . . 0.0 113.554 177.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 28.9 mmm180 -89.84 165.96 13.81 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 118.534 1.167 . . . . 0.0 110.983 -175.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -74.54 95.49 2.79 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.062 0.945 . . . . 0.0 109.019 176.153 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 32.9 tp -89.87 104.55 17.11 Favored 'General case' 0 N--CA 1.451 -0.386 0 C-N-CA 124.218 1.007 . . . . 0.0 108.963 -179.937 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.3 t -89.85 129.43 40.78 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.287 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 173.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.11 99.58 17.54 Favored Pre-proline 0 CA--C 1.536 0.412 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 170.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -79.82 85.14 1.89 Allowed 'Trans proline' 0 N--CA 1.455 -0.773 0 C-N-CA 123.217 2.611 . . . . 0.0 111.425 -167.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 27.4 p -132.4 48.31 2.43 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.59 1.156 . . . . 0.0 109.593 173.792 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.699 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.0 ptt180 -67.92 157.29 35.31 Favored 'General case' 0 N--CA 1.455 -0.184 0 C-N-CA 123.617 0.767 . . . . 0.0 110.902 178.25 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -122.34 147.73 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.089 0 C-N-CA 124.476 1.11 . . . . 0.0 110.896 -174.839 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.477 ' HG1' ' N ' ' A' ' 129' ' ' SER . 41.5 p -55.65 -48.42 75.04 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 124.594 1.158 . . . . 0.0 111.487 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.6 m -113.29 109.58 51.46 Favored Pre-proline 0 N--CA 1.453 -0.302 0 C-N-CA 124.849 1.26 . . . . 0.0 107.819 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_exo -46.23 -32.89 11.09 Favored 'Trans proline' 0 N--CA 1.461 -0.426 0 C-N-CA 124.528 3.485 . . . . 0.0 114.247 177.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -50.74 -37.56 42.52 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 125.649 1.58 . . . . 0.0 112.284 179.296 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 76.1 mt -51.68 -51.76 25.09 Favored 'Isoleucine or valine' 0 C--N 1.342 0.252 0 C-N-CA 124.746 1.219 . . . . 0.0 110.453 -178.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 18.7 m 68.23 111.68 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.514 1.525 . . . . 0.0 111.462 176.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.8 t -89.5 151.69 3.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.192 0 C-N-CA 123.947 0.899 . . . . 0.0 109.063 -178.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 33.7 m -112.96 121.53 44.94 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 124.758 1.223 . . . . 0.0 107.979 172.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.0 tp -89.51 98.18 11.62 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.644 0.777 . . . . 0.0 109.026 -177.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.9 mmtt -90.77 174.4 7.49 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.592 0.757 . . . . 0.0 109.977 174.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -144.26 145.05 31.79 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.155 1.382 . . . . 0.0 107.613 169.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -60.9 134.2 92.5 Favored Pre-proline 0 CA--C 1.538 0.507 0 C-N-CA 123.673 0.789 . . . . 0.0 110.638 -177.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.9 -58.96 0.14 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.928 1.01 . . . . 0.0 111.853 0.402 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -140.28 41.94 1.92 Allowed 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.567 1.147 . . . . 0.0 110.06 -175.882 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 41.1 m-20 -79.6 156.85 27.49 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 169.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.7 m -132.76 113.15 12.62 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 123.896 0.878 . . . . 0.0 109.662 -174.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.9 mp -89.91 86.28 6.58 Favored 'General case' 0 N--CA 1.454 -0.271 0 N-CA-C 107.337 -1.357 . . . . 0.0 107.337 175.571 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.3 mm -60.49 127.11 86.22 Favored Pre-proline 0 CA--C 1.536 0.413 0 C-N-CA 124.023 0.929 . . . . 0.0 109.604 -177.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 92.8 Cg_endo -74.11 86.14 1.31 Allowed 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.969 2.446 . . . . 0.0 109.955 177.352 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -58.18 -25.29 61.37 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 124.916 1.286 . . . . 0.0 113.233 179.784 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 72.69 33.74 60.27 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 61.3 mttp -138.08 -61.33 0.61 Allowed 'General case' 0 C--N 1.339 0.131 0 C-N-CA 125.126 1.37 . . . . 0.0 107.973 -179.006 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.5 ttp180 -99.67 -53.08 3.28 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 124.681 1.193 . . . . 0.0 108.468 172.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 48.2 mt -89.47 89.06 3.03 Favored 'Isoleucine or valine' 0 C--N 1.342 0.274 0 N-CA-C 106.779 -1.563 . . . . 0.0 106.779 177.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -96.38 119.23 44.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 N-CA-C 108.103 -1.073 . . . . 0.0 108.103 -178.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.1 t-105 -89.0 94.75 10.06 Favored 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.441 0.696 . . . . 0.0 109.142 -176.818 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 66.0 t0 -89.85 98.68 11.91 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.565 -1.272 . . . . 0.0 107.565 173.366 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.699 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 68.1 p -51.96 -27.05 11.94 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 113.734 177.49 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 11.4 mmm180 -105.28 17.72 23.52 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.138 0.975 . . . . 0.0 113.167 -178.22 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 36.7 ttpt -144.78 -56.45 0.34 Allowed 'General case' 0 CA--C 1.531 0.24 0 CA-C-N 118.809 0.731 . . . . 0.0 110.894 170.206 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.97 -169.61 38.2 Favored Glycine 0 CA--C 1.529 0.926 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 -179.176 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -89.15 110.6 21.32 Favored 'General case' 0 C--N 1.339 0.14 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 172.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 36.1 mt -92.22 94.72 4.95 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.513 0 C-N-CA 125.561 1.544 . . . . 0.0 108.342 -175.105 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.9 mp -84.28 95.68 4.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 169.686 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 83.1 p -53.43 -37.13 62.26 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.673 1.189 . . . . 0.0 113.112 -172.546 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 35.2 m120 -130.79 96.29 4.05 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.165 0.986 . . . . 0.0 108.566 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.23 140.86 57.86 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.451 0.7 . . . . 0.0 111.574 -178.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.8 p -133.06 179.97 5.85 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 124.52 1.128 . . . . 0.0 109.42 176.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 41.7 p90 -54.49 -30.65 53.98 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.679 1.192 . . . . 0.0 112.12 176.279 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 5.3 mmpt? -58.77 -20.63 51.44 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.48 1.112 . . . . 0.0 112.032 175.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 17.0 mp0 -115.48 37.65 3.5 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 125.184 1.394 . . . . 0.0 110.82 175.387 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 52.5 mt -120.75 100.38 8.96 Favored 'Isoleucine or valine' 0 C--N 1.34 0.181 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 169.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.7 -165.0 34.93 Favored Glycine 0 CA--C 1.527 0.822 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 -179.133 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 57.9 tp -89.29 91.72 8.87 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.041 0.936 . . . . 0.0 109.285 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.0 mp -75.6 152.91 37.59 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.735 -0.839 . . . . 0.0 108.735 173.513 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 32.4 m -143.27 105.98 4.48 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 124.225 1.01 . . . . 0.0 108.515 -177.032 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 87.1 m -74.11 132.71 42.54 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.922 -1.14 . . . . 0.0 107.922 170.32 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 84.3 mt-10 -130.81 142.08 50.37 Favored 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.323 1.049 . . . . 0.0 110.205 -177.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.97 115.07 4.37 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 123.52 0.728 . . . . 0.0 110.315 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 53.9 m -89.81 124.07 34.34 Favored 'General case' 0 C--N 1.339 0.152 0 N-CA-C 108.302 -0.999 . . . . 0.0 108.302 172.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 44.8 t -118.74 -101.09 0.07 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.253 0 C-N-CA 123.607 0.763 . . . . 0.0 109.448 -171.062 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 21.8 p-10 -88.29 59.07 5.05 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.969 1.308 . . . . 0.0 109.712 -173.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 57.66 38.97 90.28 Favored Glycine 0 CA--C 1.529 0.933 0 N-CA-C 110.86 -0.896 . . . . 0.0 110.86 -172.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 19.3 t-160 -150.31 124.05 9.19 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.432 1.093 . . . . 0.0 108.492 -174.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 65.5 tp -83.41 116.16 22.37 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 124.374 1.07 . . . . 0.0 109.5 177.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -100.58 151.94 21.01 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.599 -1.26 . . . . 0.0 107.599 169.372 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.05 164.28 35.95 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 122.713 0.405 . . . . 0.0 111.176 175.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.5 t -154.4 139.54 17.46 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 123.483 0.713 . . . . 0.0 109.797 170.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 19.8 m120 -106.65 147.04 30.02 Favored 'General case' 0 C--N 1.342 0.24 0 C-N-CA 124.959 1.304 . . . . 0.0 112.836 -168.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 78.2 m-85 -142.78 104.79 4.4 Favored 'General case' 0 C--N 1.341 0.207 0 C-N-CA 125.226 1.41 . . . . 0.0 109.01 -175.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -85.13 109.64 18.42 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 107.905 -1.146 . . . . 0.0 107.905 177.242 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 19.5 p -89.59 94.49 9.88 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.239 1.016 . . . . 0.0 109.014 -178.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 53.7 t60 -89.87 128.36 36.17 Favored 'General case' 0 N--CA 1.453 -0.317 0 C-N-CA 125.971 1.709 . . . . 0.0 109.537 -177.866 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 68.3 ttt180 -66.37 109.93 2.9 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 169.922 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 16.1 tt0 -58.99 144.1 46.18 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.535 1.134 . . . . 0.0 110.44 177.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 60.2 p -81.4 66.36 6.92 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.889 0.876 . . . . 0.0 109.393 179.541 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 30.4 p-10 -127.72 -53.95 1.33 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 125.219 1.407 . . . . 0.0 110.165 178.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.2 t -164.67 -163.5 0.73 Allowed 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.275 1.43 . . . . 0.0 108.312 179.677 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 8.1 tp . . . . . 0 C--O 1.25 1.085 0 CA-C-O 117.771 -1.109 . . . . 0.0 109.456 174.542 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 42.7 m . . . . . 0 N--CA 1.474 0.759 0 CA-C-O 120.771 0.319 . . . . 0.0 111.206 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 29.4 t70 -86.04 165.35 16.73 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.647 0.779 . . . . 0.0 111.04 -177.943 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.9 p -61.34 -42.11 98.15 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.661 1.184 . . . . 0.0 110.842 171.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -166.56 -111.82 0.25 Allowed Glycine 0 CA--C 1.526 0.779 0 N-CA-C 110.386 -1.086 . . . . 0.0 110.386 177.958 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.1 ttp180 -169.56 134.18 1.24 Allowed Pre-proline 0 CA--C 1.534 0.338 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 178.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 28.9 Cg_endo -66.25 -53.59 0.62 Allowed 'Trans proline' 0 N--CA 1.454 -0.813 0 C-N-CA 122.754 2.303 . . . . 0.0 111.204 -179.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 91.0 m-85 -71.11 144.71 50.19 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 124.033 0.933 . . . . 0.0 111.736 -173.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 6.0 t -116.4 46.47 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 108.097 -1.075 . . . . 0.0 108.097 175.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -162.57 -85.92 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.231 1.412 . . . . 0.0 108.121 170.784 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 13.0 ttt 71.08 132.71 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 126.631 1.972 . . . . 0.0 113.315 172.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.68 147.39 53.11 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.708 0.803 . . . . 0.0 110.058 173.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 33.6 t -77.96 -57.66 3.68 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 178.015 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -162.14 -32.55 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.245 1.018 . . . . 0.0 111.646 178.036 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 96.8 mt -86.79 117.77 69.15 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 173.12 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -58.45 135.59 68.74 Favored 'Trans proline' 0 N--CA 1.458 -0.611 0 C-N-CA 123.03 2.487 . . . . 0.0 110.954 172.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 19.1 mp0 -68.06 133.74 49.48 Favored 'General case' 0 CA--C 1.53 0.199 0 N-CA-C 109.792 -0.448 . . . . 0.0 109.792 -177.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.7 mm -82.34 95.25 3.15 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.205 0 C-N-CA 123.755 0.822 . . . . 0.0 108.879 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.7 mt -89.69 101.96 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.4 p-80 -74.36 85.98 1.98 Allowed 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.462 1.105 . . . . 0.0 108.951 174.552 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 9.6 ptm -89.17 166.86 13.55 Favored 'General case' 0 CA--C 1.529 0.161 0 C-N-CA 123.629 0.772 . . . . 0.0 111.233 -173.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 87.9 m -139.35 126.0 20.62 Favored 'General case' 0 C--O 1.231 0.104 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 177.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 45.0 mt-10 -62.37 141.61 58.23 Favored 'General case' 0 N--CA 1.454 -0.229 0 C-N-CA 123.431 0.692 . . . . 0.0 110.342 -178.165 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.97 -19.61 41.06 Favored Glycine 0 CA--C 1.53 0.984 0 CA-C-O 118.864 -0.965 . . . . 0.0 112.785 -179.633 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 5.4 mmp_? -89.99 165.48 14.02 Favored 'General case' 0 C--N 1.342 0.241 0 CA-C-N 118.511 1.155 . . . . 0.0 110.749 -177.11 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 38.4 tt0 -74.32 96.01 2.76 Favored 'General case' 0 N--CA 1.453 -0.277 0 C-N-CA 123.609 0.763 . . . . 0.0 109.197 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 41.3 tp -89.98 109.96 20.97 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.932 1.293 . . . . 0.0 108.975 -179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 78.7 t -89.51 127.15 42.34 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.39 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 173.553 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 44.2 mm -104.15 93.12 5.2 Favored Pre-proline 0 CA--C 1.532 0.255 0 N-CA-C 106.252 -1.759 . . . . 0.0 106.252 171.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 70.8 Cg_endo -70.56 114.8 3.95 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 122.729 2.286 . . . . 0.0 109.877 -171.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.7 p -162.42 56.22 0.22 Allowed 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.816 0.847 . . . . 0.0 109.387 178.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.528 ' HB2' ' O ' ' A' ' 188' ' ' SER . 37.3 ptt180 -64.36 158.53 23.34 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 123.49 0.716 . . . . 0.0 110.861 179.023 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.7 m -131.73 168.29 24.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 124.399 1.08 . . . . 0.0 110.369 178.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.7 p -53.27 -39.19 63.72 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 125.307 1.443 . . . . 0.0 112.407 177.301 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 3.6 m -159.9 152.67 17.87 Favored Pre-proline 0 CA--C 1.532 0.284 0 C-N-CA 123.689 0.796 . . . . 0.0 110.148 -178.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -66.92 -20.33 51.43 Favored 'Trans proline' 0 N--CA 1.459 -0.532 0 C-N-CA 123.559 2.839 . . . . 0.0 112.104 177.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 18.0 m120 -58.99 -28.61 66.53 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 125.106 1.362 . . . . 0.0 111.927 176.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 1.7 mp -58.81 -45.48 91.4 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.309 0 C-N-CA 123.775 0.83 . . . . 0.0 109.05 172.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 13.8 m 66.4 95.25 0.06 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.728 1.611 . . . . 0.0 110.861 175.309 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 48.7 t -89.47 144.61 8.74 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.157 0 C-N-CA 124.358 1.063 . . . . 0.0 109.356 -173.159 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 38.0 m -115.75 124.81 51.72 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.643 1.177 . . . . 0.0 108.833 178.107 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 56.3 tp -89.71 100.31 13.14 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.761 0.824 . . . . 0.0 109.434 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.8 mmtt -89.96 170.24 10.53 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.136 0.974 . . . . 0.0 109.76 174.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 31.2 ttpt -147.14 148.55 31.69 Favored 'General case' 0 N--CA 1.457 -0.122 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 169.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.9 t80 -58.89 132.32 86.71 Favored Pre-proline 0 CA--C 1.537 0.465 0 CA-C-O 118.561 -0.733 . . . . 0.0 109.633 173.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -79.26 -59.46 0.11 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.937 1.013 . . . . 0.0 111.741 3.278 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.6 mt -144.09 46.65 1.43 Allowed 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 124.541 1.136 . . . . 0.0 109.753 -175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 6.2 m-20 -71.75 164.8 25.31 Favored 'General case' 0 CA--C 1.528 0.124 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 170.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 18.5 m -145.07 100.29 3.46 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 107.963 -1.125 . . . . 0.0 107.963 173.894 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 40.7 mt -89.67 72.45 7.74 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.575 1.15 . . . . 0.0 108.439 -173.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.8 mm -56.25 124.63 61.45 Favored Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 124.851 1.26 . . . . 0.0 110.385 -176.144 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.8 Cg_exo -53.22 107.34 0.19 Allowed 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.925 3.083 . . . . 0.0 112.682 172.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -76.0 -29.89 58.32 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.307 0.643 . . . . 0.0 110.867 174.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 88.95 19.32 51.61 Favored Glycine 0 CA--C 1.529 0.943 0 CA-C-O 119.176 -0.791 . . . . 0.0 113.341 175.84 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -132.17 -58.68 0.95 Allowed 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.63 1.172 . . . . 0.0 108.157 172.95 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 79.1 ttt-85 -78.42 -65.78 0.94 Allowed 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.669 -0.863 . . . . 0.0 108.669 171.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 62.0 mt -89.17 94.71 4.96 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 178.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.4 mt -95.79 117.93 40.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 176.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.2 t-105 -89.17 124.35 34.27 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.114 -0.699 . . . . 0.0 109.114 -178.626 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 31.8 t0 -127.03 107.98 10.53 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.567 1.147 . . . . 0.0 108.766 176.565 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.528 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.1 p -56.43 -25.49 50.63 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.29 1.036 . . . . 0.0 113.304 177.366 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 87.8 mtm180 -76.0 -23.38 55.24 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 123.834 0.853 . . . . 0.0 112.243 -179.69 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.1 ttmt -129.57 -65.84 0.83 Allowed 'General case' 0 C--N 1.343 0.295 0 C-N-CA 123.74 0.816 . . . . 0.0 111.035 -170.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 163.97 -162.89 35.54 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -170.9 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 98.8 m-85 -90.02 111.98 23.26 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.788 -0.819 . . . . 0.0 108.788 173.116 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 61.6 mt -89.9 99.34 9.29 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 125.218 1.407 . . . . 0.0 107.373 178.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 16.2 mt -97.69 96.67 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 124.7 1.2 . . . . 0.0 108.046 -176.932 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 81.9 p -53.15 -35.47 59.79 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.693 1.197 . . . . 0.0 114.114 -169.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 34.6 m120 -140.62 88.63 2.21 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 123.826 0.851 . . . . 0.0 109.201 -174.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.16 155.73 19.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 122.927 0.491 . . . . 0.0 112.25 -178.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 71.6 p -146.32 -176.78 5.3 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 124.649 1.18 . . . . 0.0 109.28 179.628 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -55.23 -32.63 62.45 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.573 1.149 . . . . 0.0 112.071 173.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 2.3 mmmp? -59.1 -19.34 43.66 Favored 'General case' 0 C--N 1.341 0.237 0 C-N-CA 123.733 0.813 . . . . 0.0 112.509 175.977 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 47.5 mm-40 -93.59 -34.66 13.24 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 123.961 0.904 . . . . 0.0 111.253 175.905 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 84.6 mt -62.74 120.36 9.06 Favored 'Isoleucine or valine' 0 C--N 1.342 0.245 0 N-CA-C 109.233 -0.654 . . . . 0.0 109.233 -177.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.03 -136.87 5.65 Favored Glycine 0 C--N 1.337 0.633 0 N-CA-C 110.026 -1.229 . . . . 0.0 110.026 178.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.4 tp -120.48 87.76 2.81 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.609 1.164 . . . . 0.0 108.041 177.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 57.2 mt -69.28 149.35 48.59 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 123.887 0.875 . . . . 0.0 108.946 175.271 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 45.2 m -146.38 113.27 6.09 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.829 -0.804 . . . . 0.0 108.829 -179.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 56.9 m -82.03 122.01 27.27 Favored 'General case' 0 N--CA 1.455 -0.217 0 N-CA-C 107.307 -1.368 . . . . 0.0 107.307 172.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -118.07 145.55 44.75 Favored 'General case' 0 C--N 1.34 0.158 0 C-N-CA 124.022 0.929 . . . . 0.0 110.665 -177.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.95 133.95 10.32 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 123.882 0.873 . . . . 0.0 109.869 -177.369 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 57.2 m -102.12 131.55 48.55 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 123.731 0.813 . . . . 0.0 109.87 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 77.1 t -132.88 118.6 34.13 Favored 'Isoleucine or valine' 0 C--N 1.339 0.135 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 172.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 28.4 m120 43.94 59.06 3.32 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 125.594 1.558 . . . . 0.0 112.058 175.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 84.87 -24.96 6.22 Favored Glycine 0 CA--C 1.531 1.076 0 CA-C-O 119.229 -0.762 . . . . 0.0 113.554 177.07 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 65.7 m80 -89.22 102.7 15.36 Favored 'General case' 0 N--CA 1.455 -0.212 0 CA-C-N 118.504 1.152 . . . . 0.0 109.195 -174.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 48.7 tp -74.09 103.74 4.66 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 171.362 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 82.8 m-85 -89.27 149.28 23.14 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 175.396 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 65.9 mttm -132.31 146.03 51.69 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 125.249 1.42 . . . . 0.0 107.947 177.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 71.0 p -136.84 111.84 8.95 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 173.611 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 35.4 m120 -88.24 145.22 25.99 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.214 1.005 . . . . 0.0 111.138 -172.844 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 77.5 m-85 -146.15 109.4 4.69 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 125.548 1.539 . . . . 0.0 108.172 -179.823 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -83.81 105.86 15.04 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.942 -0.762 . . . . 0.0 108.942 -177.089 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -89.51 93.9 9.67 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.169 0.988 . . . . 0.0 109.31 177.515 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 33.7 t60 -91.14 146.38 23.88 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.652 1.181 . . . . 0.0 107.974 170.853 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 9.8 ptm85 -71.54 139.17 49.36 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 109.634 -0.506 . . . . 0.0 109.634 173.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.2 tt0 -68.6 161.86 27.12 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 124.117 0.967 . . . . 0.0 109.893 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 39.5 p -52.45 128.83 26.95 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.098 0.959 . . . . 0.0 110.264 179.09 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 40.9 m-80 -89.05 64.14 6.97 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.616 0.767 . . . . 0.0 109.164 -169.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 31.5 p -76.24 -61.71 1.86 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.93 1.292 . . . . 0.0 109.611 179.785 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 20.8 tt . . . . . 0 C--O 1.25 1.099 0 CA-C-O 117.092 -1.432 . . . . 0.0 109.413 179.312 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 51.4 p . . . . . 0 N--CA 1.474 0.749 0 N-CA-C 111.405 0.15 . . . . 0.0 111.405 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 21.2 t70 -158.16 156.91 31.7 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.738 1.215 . . . . 0.0 109.13 179.134 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 24.7 p -54.73 -56.72 16.24 Favored 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.074 1.349 . . . . 0.0 110.203 172.709 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 145.37 64.34 0.02 OUTLIER Glycine 0 C--N 1.337 0.596 0 N-CA-C 109.668 -1.373 . . . . 0.0 109.668 176.191 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 60.1 ttp180 -72.55 123.88 90.08 Favored Pre-proline 0 CA--C 1.537 0.458 0 CA-C-O 119.022 -0.513 . . . . 0.0 109.78 -178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -68.38 -47.34 1.58 Allowed 'Trans proline' 0 N--CA 1.454 -0.815 0 C-N-CA 123.325 2.683 . . . . 0.0 110.29 176.722 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -68.16 161.91 25.99 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 125.018 1.327 . . . . 0.0 112.154 -177.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 70.8 t -110.55 -58.5 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.183 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 169.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 2.4 tm-20 -88.68 120.25 29.91 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 171.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.5 ptm -133.72 154.82 50.67 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.816 0.846 . . . . 0.0 109.534 171.327 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -65.29 157.75 28.21 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.01 0.524 . . . . 0.0 111.177 176.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 22.8 t -97.09 -136.57 0.26 Allowed 'General case' 0 CA--C 1.531 0.223 0 N-CA-C 107.442 -1.318 . . . . 0.0 107.442 170.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 6.4 mp0 -94.24 93.87 8.0 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 172.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.8 mt 127.95 121.22 0.0 OUTLIER Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 131.025 3.73 . . . . 0.0 107.564 176.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_exo -51.64 149.99 17.58 Favored 'Trans proline' 0 C--N 1.349 0.58 0 C-N-CA 124.312 3.341 . . . . 0.0 113.343 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.5 mp0 -64.59 116.69 6.45 Favored 'General case' 0 CA--C 1.529 0.145 0 N-CA-C 109.58 -0.526 . . . . 0.0 109.58 178.447 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 46.4 mm -76.64 100.65 2.51 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.247 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 175.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 58.1 mt -103.86 121.38 55.31 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.146 0 C-N-CA 123.938 0.895 . . . . 0.0 108.923 178.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 1.2 p80 -77.22 94.18 4.08 Favored 'General case' 0 CA--C 1.528 0.119 0 C-N-CA 124.583 1.153 . . . . 0.0 108.518 169.846 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 12.4 ptm -89.57 151.3 22.0 Favored 'General case' 0 C--N 1.341 0.212 0 CA-C-O 120.775 0.321 . . . . 0.0 110.896 -177.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 43.7 m -129.07 124.57 35.18 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 106.866 -1.531 . . . . 0.0 106.866 172.732 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.6 mt-10 -56.24 -73.46 0.06 Allowed 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.956 0.902 . . . . 0.0 111.893 -170.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . -80.73 55.98 4.74 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.478 0.561 . . . . 0.0 112.341 -175.244 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 41.2 mmt180 -143.31 -97.61 0.11 Allowed 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 125.15 1.38 . . . . 0.0 108.065 174.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 27.2 tt0 -166.0 152.74 9.61 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.764 1.226 . . . . 0.0 108.626 179.098 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.1 tp -143.63 108.31 4.88 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.964 1.306 . . . . 0.0 108.472 -176.853 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.6 t -92.89 131.21 40.56 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.175 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.399 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -113.08 94.13 28.75 Favored Pre-proline 0 CA--C 1.535 0.376 0 N-CA-C 107.059 -1.46 . . . . 0.0 107.059 174.319 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 96.1 Cg_endo -81.04 80.88 2.88 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 123.309 2.672 . . . . 0.0 111.428 -169.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 32.0 p -120.02 54.12 1.04 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.361 1.064 . . . . 0.0 109.171 170.328 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.5 ptm180 -68.86 162.28 26.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.16 0.984 . . . . 0.0 111.48 179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.6 m -122.79 170.98 12.43 Favored 'Isoleucine or valine' 0 C--N 1.341 0.22 0 C-N-CA 124.433 1.093 . . . . 0.0 113.075 -169.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 22.2 p -77.12 -19.83 56.43 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 126.632 1.973 . . . . 0.0 112.572 -179.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 31.3 t -156.92 140.54 11.37 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 119.186 0.903 . . . . 0.0 110.274 176.338 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 99.6 Cg_exo -47.81 -39.67 31.49 Favored 'Trans proline' 0 C--N 1.35 0.633 0 C-N-CA 124.647 3.565 . . . . 0.0 115.454 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -60.52 -21.78 62.86 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 112.71 0.633 . . . . 0.0 112.71 -177.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 52.9 mt -80.57 76.83 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 179.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 49.4 m -67.83 123.23 19.99 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 177.426 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 64.7 t -89.47 142.88 12.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.229 0 C-N-CA 123.928 0.891 . . . . 0.0 109.357 -175.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 25.8 m -93.18 106.01 18.02 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 175.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 38.1 tp -89.2 118.58 29.0 Favored 'General case' 0 C--N 1.339 0.149 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 179.793 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 52.0 mtmt -122.91 -177.91 3.8 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 125.094 1.358 . . . . 0.0 109.434 178.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 65.7 tttm -152.62 150.3 29.35 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 175.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 67.3 t80 -56.77 131.5 78.58 Favored Pre-proline 0 CA--C 1.537 0.46 0 CA-C-O 118.6 -0.714 . . . . 0.0 109.996 179.588 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -80.84 -61.09 0.03 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.768 0 CA-C-N 119.822 0.972 . . . . 0.0 111.972 5.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -142.34 48.48 1.56 Allowed 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.858 1.263 . . . . 0.0 109.057 -175.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 40.0 m-20 -74.84 177.25 6.37 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 123.187 0.595 . . . . 0.0 109.942 175.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.3 m -146.04 104.41 3.83 Favored 'General case' 0 N--CA 1.457 -0.099 0 N-CA-C 108.513 -0.921 . . . . 0.0 108.513 175.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.1 mp -89.87 81.67 6.3 Favored 'General case' 0 N--CA 1.453 -0.32 0 N-CA-C 107.286 -1.376 . . . . 0.0 107.286 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.6 mt -61.52 130.84 92.31 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.13 0.972 . . . . 0.0 109.151 -176.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.64 85.38 1.13 Allowed 'Trans proline' 0 N--CA 1.454 -0.831 0 C-N-CA 123.138 2.559 . . . . 0.0 110.426 178.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -61.37 -22.1 64.65 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 125.166 1.386 . . . . 0.0 113.216 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 74.67 26.1 68.23 Favored Glycine 0 CA--C 1.53 0.981 0 CA-C-N 118.442 0.565 . . . . 0.0 112.811 177.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 99.0 mttt -130.92 -66.02 0.76 Allowed 'General case' 0 C--N 1.339 0.144 0 N-CA-C 107.173 -1.418 . . . . 0.0 107.173 174.843 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -79.84 -64.59 1.15 Allowed 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 169.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.2 mt -89.87 91.85 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 C-N-CA 124.576 1.15 . . . . 0.0 108.047 -172.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 91.9 mt -96.75 116.67 39.51 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.15 0 C-N-CA 124.515 1.126 . . . . 0.0 108.271 -178.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 6.0 t-105 -89.38 109.07 20.02 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 123.585 0.754 . . . . 0.0 109.891 -177.764 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -107.22 108.56 20.05 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 173.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 67.4 p -63.51 -18.76 64.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 -174.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 31.2 mmt180 -109.7 18.77 19.9 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.316 1.046 . . . . 0.0 111.989 -179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 63.9 tttm -149.03 -55.61 0.19 Allowed 'General case' 0 C--N 1.342 0.243 0 CA-C-N 118.715 0.689 . . . . 0.0 110.836 -179.097 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 154.23 -170.91 32.78 Favored Glycine 0 C--N 1.338 0.692 0 N-CA-C 110.705 -0.958 . . . . 0.0 110.705 -178.534 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.1 m-85 -89.97 113.8 25.53 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 169.683 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.7 mp -89.91 97.54 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 1.6 mp -78.28 91.93 1.32 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.261 -2.496 . . . . 0.0 104.261 169.652 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 77.3 p -70.32 -7.73 44.94 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.912 0.885 . . . . 0.0 113.287 -174.496 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 3.2 t30 -150.04 99.97 2.88 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 171.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -81.2 160.8 24.23 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 178.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 44.5 p -142.51 169.84 16.83 Favored 'General case' 0 N--CA 1.456 -0.175 0 C-N-CA 123.966 0.906 . . . . 0.0 109.682 -176.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -53.19 -37.33 61.85 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.491 1.116 . . . . 0.0 111.659 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 53.8 mtmt -55.05 -37.89 67.31 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 125.186 1.394 . . . . 0.0 111.226 176.552 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 42.0 mt-10 -93.44 17.53 11.29 Favored 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 124.92 1.288 . . . . 0.0 112.23 -171.557 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 79.5 mt -86.32 116.33 28.94 Favored 'Isoleucine or valine' 0 C--N 1.343 0.29 0 N-CA-C 107.456 -1.312 . . . . 0.0 107.456 170.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 145.4 -160.01 28.0 Favored Glycine 0 C--N 1.34 0.788 0 CA-C-O 121.455 0.475 . . . . 0.0 112.869 170.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 32.6 tp -81.52 86.19 6.38 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.398 1.079 . . . . 0.0 110.511 -172.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -69.69 144.2 52.91 Favored 'General case' 0 C--N 1.34 0.186 0 N-CA-C 108.142 -1.058 . . . . 0.0 108.142 169.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 88.5 m -139.04 107.89 5.96 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.251 1.02 . . . . 0.0 108.923 -173.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.4 m -81.63 138.4 35.33 Favored 'General case' 0 N--CA 1.454 -0.255 0 N-CA-C 108.234 -1.025 . . . . 0.0 108.234 171.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.2 mt-10 -134.58 145.57 48.8 Favored 'General case' 0 C--N 1.34 0.176 0 C-N-CA 123.755 0.822 . . . . 0.0 110.526 176.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -159.71 144.63 15.24 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 124.137 0.975 . . . . 0.0 109.325 178.021 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -120.88 142.75 49.38 Favored 'General case' 0 C--N 1.339 0.149 0 C-N-CA 124.877 1.271 . . . . 0.0 109.562 -175.383 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 92.8 t -136.74 153.3 30.06 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.233 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 174.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 74.6 m-20 52.99 -99.0 0.08 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 125.318 1.447 . . . . 0.0 110.623 -178.954 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -149.66 47.38 0.62 Allowed Glycine 0 CA--C 1.527 0.831 0 N-CA-C 109.216 -1.553 . . . . 0.0 109.216 170.553 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -146.83 129.54 16.11 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 124.421 1.088 . . . . 0.0 109.986 177.531 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 60.8 tp -81.76 144.87 30.79 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 125.589 1.555 . . . . 0.0 109.796 -178.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.3 m-85 -126.61 154.81 43.45 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 124.904 1.281 . . . . 0.0 108.204 169.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 7.4 ptpp? -150.44 163.29 38.77 Favored 'General case' 0 N--CA 1.455 -0.225 0 C-N-CA 123.071 0.548 . . . . 0.0 110.828 175.216 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.4 t -151.29 140.9 21.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.76 0.824 . . . . 0.0 109.487 172.717 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m120 -115.09 146.23 41.53 Favored 'General case' 0 C--N 1.341 0.203 0 C-N-CA 124.995 1.318 . . . . 0.0 112.717 -168.802 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 56.6 m-85 -143.26 105.04 4.35 Favored 'General case' 0 C--N 1.34 0.181 0 C-N-CA 125.425 1.49 . . . . 0.0 108.554 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.2 tt -86.63 103.68 15.34 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 179.633 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 82.8 p -89.73 95.38 10.22 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.261 1.024 . . . . 0.0 108.783 -178.185 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 31.5 p-80 -89.69 141.17 28.86 Favored 'General case' 0 CA--C 1.531 0.236 0 C-N-CA 122.815 0.446 . . . . 0.0 109.844 -179.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -72.09 98.6 2.13 Favored 'General case' 0 N--CA 1.455 -0.192 0 C-N-CA 124.926 1.291 . . . . 0.0 109.872 -173.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -97.25 107.88 20.49 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 124.405 1.082 . . . . 0.0 108.246 177.047 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 39.9 p -61.3 -49.57 76.49 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.525 0.73 . . . . 0.0 110.528 179.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 43.0 t30 -150.44 152.16 33.87 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 124.48 1.112 . . . . 0.0 108.908 176.267 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.5 t -72.09 142.3 49.2 Favored 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 123.142 0.577 . . . . 0.0 109.533 174.87 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.251 1.165 0 CA-C-O 116.922 -1.514 . . . . 0.0 109.884 -179.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 78.9 p . . . . . 0 N--CA 1.475 0.781 0 N-CA-C 111.876 0.324 . . . . 0.0 111.876 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.3 p-10 -79.35 -47.52 15.65 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.712 0.805 . . . . 0.0 110.036 175.924 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 42.7 m -155.68 101.13 2.13 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.024 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 163.57 71.91 0.02 OUTLIER Glycine 0 C--N 1.336 0.575 0 N-CA-C 109.935 -1.266 . . . . 0.0 109.935 -179.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 43.4 ttp180 -110.99 129.37 24.04 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 124.731 1.213 . . . . 0.0 108.135 175.212 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.9 Cg_endo -71.58 -52.76 0.2 Allowed 'Trans proline' 0 N--CA 1.453 -0.904 0 C-N-CA 122.937 2.425 . . . . 0.0 110.766 -177.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 68.9 m-85 -68.38 125.61 27.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.071 0.948 . . . . 0.0 111.323 -173.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 62.4 t -74.05 -42.4 52.31 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 170.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 15.9 tp10 -70.77 -79.99 0.06 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 123.607 0.763 . . . . 0.0 110.253 -178.435 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 12.5 tpt 69.36 137.77 0.04 OUTLIER 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.59 1.956 . . . . 0.0 112.641 178.069 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -90.33 -147.05 0.19 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.921 0.888 . . . . 0.0 110.104 172.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 46.4 t -134.72 -67.38 0.56 Allowed 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 169.568 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -145.65 -53.62 0.27 Allowed 'General case' 0 C--N 1.338 0.101 0 C-N-CA 125.027 1.331 . . . . 0.0 108.908 178.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 91.1 mt -69.15 130.56 91.14 Favored Pre-proline 0 CA--C 1.536 0.434 0 C-N-CA 124.419 1.088 . . . . 0.0 108.285 -178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_endo -71.52 139.15 33.82 Favored 'Trans proline' 0 N--CA 1.453 -0.857 0 C-N-CA 122.857 2.371 . . . . 0.0 110.18 -179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -74.81 127.53 33.39 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -176.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.4 mm -79.81 105.64 9.67 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.245 0 C-N-CA 123.576 0.75 . . . . 0.0 110.054 -173.678 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 60.2 mt -96.83 110.02 24.13 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.15 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 171.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.8 p80 -76.9 88.35 3.47 Favored 'General case' 0 CA--C 1.538 0.485 0 N-CA-C 108.884 -0.784 . . . . 0.0 108.884 173.789 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 11.7 ptm -89.92 142.04 28.08 Favored 'General case' 0 C--N 1.344 0.327 0 C-N-CA 123.327 0.651 . . . . 0.0 111.641 -170.258 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 60.6 m -114.56 110.04 19.19 Favored 'General case' 0 N--CA 1.452 -0.37 0 N-CA-C 106.527 -1.657 . . . . 0.0 106.527 169.907 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -61.16 152.36 28.8 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-O 120.699 0.285 . . . . 0.0 110.754 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.2 -36.57 3.97 Favored Glycine 0 CA--C 1.531 1.045 0 C-N-CA 124.258 0.932 . . . . 0.0 110.961 -170.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 55.5 mmt-85 -89.42 -177.0 5.24 Favored 'General case' 0 CA--C 1.531 0.232 0 C-N-CA 123.93 0.892 . . . . 0.0 111.457 -171.677 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.4 tt0 -82.68 99.68 9.75 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.699 0.8 . . . . 0.0 109.723 178.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 39.3 tp -92.76 104.25 16.54 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.184 0.994 . . . . 0.0 109.169 179.69 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 49.4 t -89.93 121.56 40.3 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 176.286 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 30.8 mm -98.96 104.73 27.28 Favored Pre-proline 0 CA--C 1.535 0.4 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 169.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -84.12 37.5 0.64 Allowed 'Trans proline' 0 N--CA 1.458 -0.572 0 C-N-CA 123.173 2.582 . . . . 0.0 113.443 -161.186 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 28.4 p -87.84 57.74 4.5 Favored 'General case' 0 C--N 1.339 0.133 0 CA-C-O 121.429 0.633 . . . . 0.0 110.271 177.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.884 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -75.94 153.49 36.58 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 124.42 1.088 . . . . 0.0 110.291 176.97 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.7 m -125.31 169.92 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.174 0 C-N-CA 125.208 1.403 . . . . 0.0 110.3 -173.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.9 p -61.85 -42.33 98.92 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.882 0.873 . . . . 0.0 111.805 -179.736 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 45.7 m -143.93 140.54 17.25 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.935 0.894 . . . . 0.0 109.731 -175.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 70.4 Cg_endo -68.96 -28.42 29.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.607 2.872 . . . . 0.0 112.761 -175.419 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -60.29 -24.55 65.05 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.383 0.673 . . . . 0.0 112.282 -177.781 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 83.5 mt -52.18 -40.13 29.37 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.312 0 C-N-CA 124.878 1.271 . . . . 0.0 110.238 174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.5 m 67.58 99.09 0.05 Allowed 'General case' 0 C--N 1.342 0.243 0 C-N-CA 125.494 1.518 . . . . 0.0 110.681 175.365 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 91.7 t -89.16 122.62 40.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 -176.604 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 42.2 m -88.12 107.78 18.93 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.006 -1.109 . . . . 0.0 108.006 177.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 43.5 tp -89.71 95.23 10.16 Favored 'General case' 0 N--CA 1.455 -0.196 0 C-N-CA 123.796 0.839 . . . . 0.0 109.631 -175.61 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -89.91 166.74 13.32 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.599 0.759 . . . . 0.0 110.377 175.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 1.1 tmmt? -151.72 142.97 23.33 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.138 0.975 . . . . 0.0 109.26 173.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -61.54 132.83 93.11 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 124.2 1.0 . . . . 0.0 111.395 -172.626 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -79.38 -59.65 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.704 0 CA-C-N 119.992 1.033 . . . . 0.0 112.18 3.745 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.5 mt -138.31 36.93 2.29 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.574 1.15 . . . . 0.0 110.054 -176.009 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.8 m-20 -77.45 152.65 34.15 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 173.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.7 m -131.71 113.27 13.36 Favored 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 124.026 0.93 . . . . 0.0 108.646 -178.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.79 80.61 6.49 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 -178.454 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 30.1 mm -61.0 128.72 89.66 Favored Pre-proline 0 CA--C 1.536 0.431 0 C-N-CA 124.19 0.996 . . . . 0.0 109.317 -179.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_endo -73.28 86.18 1.17 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 122.965 2.443 . . . . 0.0 110.358 178.382 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -60.35 -23.17 64.05 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.939 1.296 . . . . 0.0 112.889 178.35 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 77.1 23.9 67.69 Favored Glycine 0 CA--C 1.529 0.924 0 CA-C-O 119.454 -0.637 . . . . 0.0 112.884 176.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 33.8 mmtp -135.36 -63.13 0.69 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.949 1.3 . . . . 0.0 108.231 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 60.8 ttp85 -85.24 -59.28 2.37 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 172.267 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 73.9 mt -89.62 91.61 3.7 Favored 'Isoleucine or valine' 0 C--N 1.34 0.191 0 N-CA-C 106.941 -1.503 . . . . 0.0 106.941 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 70.9 mt -93.58 113.46 28.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.159 0 N-CA-C 107.93 -1.137 . . . . 0.0 107.93 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 16.1 t-105 -89.13 123.44 33.4 Favored 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 123.0 0.52 . . . . 0.0 109.823 -177.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -127.61 114.63 17.63 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 107.68 -1.23 . . . . 0.0 107.68 171.33 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.884 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 48.0 p -57.13 -29.6 63.7 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.311 0.644 . . . . 0.0 112.51 176.738 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 98.4 mtt180 -80.6 -29.2 36.9 Favored 'General case' 0 CA--C 1.532 0.255 0 CA-C-O 118.568 -0.73 . . . . 0.0 112.886 -174.371 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -114.45 -50.32 2.8 Favored 'General case' 0 C--N 1.344 0.331 0 C-N-CA 123.891 0.876 . . . . 0.0 111.374 -175.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 150.2 -164.85 29.77 Favored Glycine 0 CA--C 1.527 0.835 0 N-CA-C 110.873 -0.891 . . . . 0.0 110.873 -178.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -89.11 105.81 18.03 Favored 'General case' 0 N--CA 1.455 -0.176 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 171.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 57.9 mt -89.14 90.96 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.515 0 N-CA-C 106.63 -1.618 . . . . 0.0 106.63 -175.75 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 24.4 mt -82.11 81.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.314 0 N-CA-C 106.88 -1.526 . . . . 0.0 106.88 177.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 58.8 p -46.84 -47.7 21.11 Favored 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 126.85 2.06 . . . . 0.0 112.933 -172.424 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 12.3 t-20 -118.48 92.14 3.74 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 172.666 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.91 156.28 31.53 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 123.598 0.759 . . . . 0.0 110.758 176.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 60.4 p -137.96 167.66 21.31 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.752 1.221 . . . . 0.0 108.829 177.726 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.1 p90 -53.26 -30.9 40.87 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.298 1.039 . . . . 0.0 112.257 176.337 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.1 mttm -52.69 -36.37 57.11 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.212 1.405 . . . . 0.0 112.158 -178.434 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -66.8 -32.71 74.17 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-O 118.549 -0.738 . . . . 0.0 112.473 -177.613 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 72.9 mt -53.48 111.57 0.29 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.355 0 C-N-CA 124.08 0.952 . . . . 0.0 110.15 -172.125 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 159.5 -171.7 35.98 Favored Glycine 0 CA--C 1.527 0.83 0 N-CA-C 111.761 -0.536 . . . . 0.0 111.761 179.42 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.5 tp -87.82 99.2 11.93 Favored 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 124.164 0.986 . . . . 0.0 109.027 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.6 mp -77.23 157.26 30.94 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 175.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 44.2 m -147.77 99.36 3.08 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.126 1.371 . . . . 0.0 108.042 -177.177 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 24.6 m -79.15 131.35 36.19 Favored 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 172.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 63.1 mt-10 -124.28 135.32 53.3 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.165 0.986 . . . . 0.0 109.69 -176.485 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.98 158.16 36.07 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 123.484 0.713 . . . . 0.0 110.495 178.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.9 m -138.0 146.79 43.53 Favored 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 124.62 1.168 . . . . 0.0 109.617 -173.804 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 54.4 t -130.13 -70.69 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.206 0 C-N-CA 124.901 1.28 . . . . 0.0 108.468 175.31 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.9 p30 -98.0 36.0 1.63 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 123.949 0.9 . . . . 0.0 111.421 -174.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 62.05 30.05 74.45 Favored Glycine 0 CA--C 1.532 1.128 0 C-N-CA 123.441 0.544 . . . . 0.0 112.154 -176.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 42.9 t-80 -90.01 -43.32 10.6 Favored 'General case' 0 CA--C 1.53 0.178 0 C-N-CA 124.694 1.198 . . . . 0.0 111.032 -176.795 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 52.6 tp 66.24 89.29 0.1 Allowed 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.911 1.684 . . . . 0.0 109.455 -169.829 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 90.5 m-85 -89.52 154.94 19.61 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.446 1.098 . . . . 0.0 108.381 173.046 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 90.7 mttt -140.26 159.12 42.89 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 123.521 0.728 . . . . 0.0 109.686 176.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.9 t -151.84 123.34 7.84 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 108.099 -1.075 . . . . 0.0 108.099 172.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.4 m120 -108.85 149.92 28.41 Favored 'General case' 0 C--N 1.34 0.191 0 C-N-CA 124.606 1.162 . . . . 0.0 111.621 -168.986 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.6 m-85 -142.89 113.67 7.53 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 124.307 1.043 . . . . 0.0 109.236 -174.932 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 4.6 tt -84.5 106.72 16.29 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 178.412 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 51.1 p -89.26 99.48 12.46 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.372 -0.973 . . . . 0.0 108.372 -179.814 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 36.2 t60 -89.32 138.58 31.31 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 125.749 1.62 . . . . 0.0 109.603 -176.507 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.0 97.08 2.77 Favored 'General case' 0 CA--C 1.532 0.261 0 C-N-CA 124.072 0.949 . . . . 0.0 109.489 -179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.8 tt0 -94.28 133.17 38.11 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 126.092 1.757 . . . . 0.0 108.556 173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 35.9 p -68.0 -91.94 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 109.348 -0.612 . . . . 0.0 109.348 175.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 30.9 m120 -150.21 48.01 0.91 Allowed 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.292 1.037 . . . . 0.0 109.63 178.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 43.9 p -82.62 -60.48 2.17 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 122.897 0.479 . . . . 0.0 109.784 179.592 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 17.8 tt . . . . . 0 C--O 1.249 1.055 0 C-N-CA 124.206 1.002 . . . . 0.0 109.071 177.552 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 57.5 p . . . . . 0 N--CA 1.475 0.778 0 N-CA-C 111.475 0.176 . . . . 0.0 111.475 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.0 m-20 -53.39 -49.84 66.39 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 123.851 0.86 . . . . 0.0 109.383 171.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.3 p -77.77 91.44 4.09 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 106.998 -1.482 . . . . 0.0 106.998 169.425 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -40.93 -66.72 0.84 Allowed Glycine 0 C--N 1.342 0.898 0 C-N-CA 125.964 1.745 . . . . 0.0 112.892 -173.172 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -177.64 154.03 1.01 Allowed Pre-proline 0 CA--C 1.535 0.382 0 C-N-CA 127.398 2.279 . . . . 0.0 107.107 172.226 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -71.93 -32.76 10.79 Favored 'Trans proline' 0 N--CA 1.457 -0.674 0 C-N-CA 122.157 1.905 . . . . 0.0 111.118 -178.03 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 82.1 m-85 -56.74 129.85 42.97 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 125.073 1.349 . . . . 0.0 112.045 -177.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 93.1 t -68.87 -54.93 17.66 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.165 0 C-N-CA 123.583 0.753 . . . . 0.0 109.214 175.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -110.52 148.39 32.22 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.991 0.917 . . . . 0.0 109.348 174.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 34.6 ttp -147.65 135.43 21.05 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.421 1.089 . . . . 0.0 108.632 -177.318 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 1.1 p90 -61.77 137.88 58.28 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.246 0.618 . . . . 0.0 110.035 174.722 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 34.9 p -74.18 -51.1 16.53 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 122.62 0.368 . . . . 0.0 110.675 -179.256 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -155.07 -53.67 0.09 Allowed 'General case' 0 N--CA 1.455 -0.204 0 C-N-CA 123.711 0.804 . . . . 0.0 109.579 -175.976 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 41.6 mm -83.98 119.88 74.07 Favored Pre-proline 0 CA--C 1.537 0.445 0 C-N-CA 124.075 0.95 . . . . 0.0 108.791 177.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_exo -56.24 139.61 86.32 Favored 'Trans proline' 0 C--N 1.348 0.501 0 C-N-CA 123.279 2.653 . . . . 0.0 111.225 172.491 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 12.2 tp10 -64.24 136.44 57.18 Favored 'General case' 0 CA--C 1.531 0.231 0 N-CA-C 110.188 -0.301 . . . . 0.0 110.188 -178.618 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -89.22 91.34 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.279 1.032 . . . . 0.0 108.262 -178.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.7 mt -88.78 108.29 18.75 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.106 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 -176.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 m80 -73.27 95.84 2.2 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 124.805 1.242 . . . . 0.0 109.541 -178.596 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 19.0 ptm -102.1 162.64 12.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.847 1.259 . . . . 0.0 111.118 179.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 75.2 m -133.16 130.28 38.96 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 169.688 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -58.94 119.91 8.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 123.471 0.709 . . . . 0.0 109.176 179.586 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 121.2 -33.64 4.28 Favored Glycine 0 CA--C 1.529 0.915 0 C-N-CA 124.648 1.118 . . . . 0.0 111.719 -177.347 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 87.1 mtt180 -89.0 171.05 10.15 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 117.967 0.884 . . . . 0.0 110.673 -173.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -71.53 148.4 46.75 Favored 'General case' 0 N--CA 1.454 -0.239 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.199 174.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 25.5 tp -139.77 106.75 5.43 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.589 1.156 . . . . 0.0 108.272 -175.13 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 46.5 t -89.63 128.58 41.55 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.405 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 175.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 33.9 mm -104.39 98.27 13.97 Favored Pre-proline 0 CA--C 1.534 0.36 0 N-CA-C 106.062 -1.829 . . . . 0.0 106.062 170.084 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -79.79 79.43 3.36 Favored 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.507 2.804 . . . . 0.0 111.027 -165.797 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.9 p -126.9 42.19 3.37 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.484 1.114 . . . . 0.0 110.344 176.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 30.1 ptt-85 -58.02 158.32 6.9 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.152 0.981 . . . . 0.0 110.919 173.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.33 154.23 25.15 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.152 0.981 . . . . 0.0 110.716 -173.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.3 p -61.24 -44.29 97.5 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 124.751 1.22 . . . . 0.0 110.818 178.667 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 50.1 m -104.29 103.49 39.11 Favored Pre-proline 0 N--CA 1.452 -0.37 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 179.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -67.2 -11.43 32.17 Favored 'Trans proline' 0 N--CA 1.46 -0.45 0 C-N-CA 123.718 2.945 . . . . 0.0 113.777 -170.321 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -72.76 -21.24 61.04 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 123.663 0.785 . . . . 0.0 111.908 174.233 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.2 mt -71.12 106.46 1.92 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.21 0 N-CA-C 108.744 -0.835 . . . . 0.0 108.744 179.559 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 58.7 m -74.16 117.11 15.58 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 108.369 -0.974 . . . . 0.0 108.369 173.375 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 63.4 t -89.41 150.87 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.213 0 C-N-CA 124.13 0.972 . . . . 0.0 108.575 -179.231 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 68.9 m -103.18 111.45 23.83 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.377 1.071 . . . . 0.0 108.449 179.614 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.8 tp -89.48 101.26 13.94 Favored 'General case' 0 N--CA 1.456 -0.174 0 N-CA-C 109.296 -0.631 . . . . 0.0 109.296 -178.776 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -91.62 170.52 9.86 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.623 0.769 . . . . 0.0 110.22 171.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 64.8 tttm -145.99 146.37 30.98 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.65 1.18 . . . . 0.0 108.556 170.198 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -57.67 133.58 82.58 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 123.881 0.873 . . . . 0.0 110.772 -176.82 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.42 -59.57 0.11 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.682 0 CA-C-N 119.816 0.97 . . . . 0.0 111.87 0.911 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.5 mt -141.46 38.63 1.7 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.755 1.222 . . . . 0.0 109.804 -176.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.9 m-20 -77.37 153.99 33.19 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 172.822 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 43.7 m -125.12 111.58 15.48 Favored 'General case' 0 C--N 1.339 0.126 0 C-N-CA 123.927 0.891 . . . . 0.0 109.147 -177.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.7 mp -89.98 82.62 6.13 Favored 'General case' 0 N--CA 1.454 -0.238 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 178.101 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 80.3 mt -61.09 129.03 90.22 Favored Pre-proline 0 CA--C 1.537 0.454 0 C-N-CA 124.01 0.924 . . . . 0.0 109.175 -176.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -72.8 85.51 1.15 Allowed 'Trans proline' 0 N--CA 1.453 -0.886 0 C-N-CA 123.138 2.558 . . . . 0.0 110.319 178.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -60.96 -22.36 64.37 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 125.015 1.326 . . . . 0.0 113.327 179.886 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 69.34 44.75 63.82 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 110.878 -0.889 . . . . 0.0 110.878 -179.322 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 1.1 tppm? -150.07 -67.09 0.2 Allowed 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 -179.091 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 43.6 ttm-85 -90.7 -55.08 3.71 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 169.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 21.5 mt -93.23 89.7 2.79 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.253 0 N-CA-C 107.451 -1.314 . . . . 0.0 107.451 -175.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 86.4 mt -98.13 121.09 48.29 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 C-N-CA 124.119 0.968 . . . . 0.0 108.503 -176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 15.9 t-105 -89.08 93.87 9.74 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 179.239 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -89.79 96.91 10.9 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.237 -1.764 . . . . 0.0 106.237 169.899 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.6 p -61.73 -13.63 24.88 Favored 'General case' 0 CA--C 1.534 0.346 0 N-CA-C 113.953 1.094 . . . . 0.0 113.953 -177.004 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 76.2 mtt85 -101.26 4.8 42.11 Favored 'General case' 0 CA--C 1.539 0.523 0 C-N-CA 125.138 1.375 . . . . 0.0 112.079 179.319 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.3 tptt -140.32 -58.7 0.54 Allowed 'General case' 0 C--N 1.344 0.353 0 C-N-CA 123.848 0.859 . . . . 0.0 110.668 -179.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.6 -169.42 37.85 Favored Glycine 0 CA--C 1.529 0.952 0 C-N-CA 124.738 1.161 . . . . 0.0 110.336 -178.857 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.9 m-85 -89.09 110.86 21.53 Favored 'General case' 0 C--N 1.339 0.137 0 N-CA-C 107.545 -1.28 . . . . 0.0 107.545 171.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.2 mt -91.68 94.92 5.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.496 0 C-N-CA 124.75 1.22 . . . . 0.0 107.834 -179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 2.5 mp -80.89 95.73 2.71 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 169.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.1 p -60.67 -28.87 68.92 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.155 0.982 . . . . 0.0 113.511 -170.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -135.41 89.94 2.56 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 175.553 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.02 119.35 9.29 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.224 0.61 . . . . 0.0 110.043 178.846 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 39.3 p -89.94 171.67 9.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.349 0.66 . . . . 0.0 109.255 174.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 51.3 p90 -54.95 -33.2 62.1 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.63 0.772 . . . . 0.0 111.493 175.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -59.57 -32.4 70.32 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 124.38 1.072 . . . . 0.0 111.932 -179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -76.22 -8.96 58.19 Favored 'General case' 0 CA--C 1.534 0.347 0 CA-C-O 118.454 -0.784 . . . . 0.0 112.968 -179.627 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 76.0 mt -71.79 107.86 3.0 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.388 0 CA-C-N 119.985 1.266 . . . . 0.0 108.793 179.379 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 158.39 -160.83 31.26 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 112.059 -0.417 . . . . 0.0 112.059 174.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.5 tp -88.5 98.58 11.72 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.372 1.069 . . . . 0.0 109.917 -176.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.0 mp -82.36 154.04 25.46 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.31 0.644 . . . . 0.0 109.332 173.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 54.9 m -146.71 106.29 3.94 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.096 0.958 . . . . 0.0 109.409 -175.051 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.88 140.09 43.58 Favored 'General case' 0 N--CA 1.456 -0.149 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 79.9 mt-10 -135.71 138.69 42.99 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.161 0.985 . . . . 0.0 110.288 -177.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.71 140.37 18.0 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 123.98 0.912 . . . . 0.0 109.976 177.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 55.9 m -122.52 92.65 3.76 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.661 1.184 . . . . 0.0 108.863 -176.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 58.3 t -80.33 -62.89 1.26 Allowed 'Isoleucine or valine' 0 C--N 1.338 0.101 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 173.275 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -92.11 174.13 7.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.47 1.108 . . . . 0.0 109.497 179.606 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -76.55 68.92 2.39 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 108.606 -1.798 . . . . 0.0 108.606 170.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 40.4 t-80 -148.32 -44.73 0.15 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.388 1.075 . . . . 0.0 110.981 -169.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.2 tp 70.63 128.91 0.03 OUTLIER 'General case' 0 C--N 1.344 0.326 0 C-N-CA 126.796 2.038 . . . . 0.0 110.158 -170.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -127.02 147.31 50.14 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.655 1.182 . . . . 0.0 107.927 175.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.5 ptpt -150.59 158.76 44.52 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 122.87 0.468 . . . . 0.0 110.616 178.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 49.6 p -136.6 132.12 34.66 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 123.935 0.894 . . . . 0.0 108.824 176.274 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 6.1 m120 -111.62 144.71 40.43 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.681 1.192 . . . . 0.0 110.782 -169.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 40.4 m-85 -146.47 117.54 7.77 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 124.441 1.096 . . . . 0.0 109.023 -176.328 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.7 tt -89.01 107.57 19.11 Favored 'General case' 0 N--CA 1.455 -0.223 0 N-CA-C 107.686 -1.227 . . . . 0.0 107.686 176.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 60.7 p -89.33 98.99 12.08 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 -178.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -89.14 126.4 35.45 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.228 1.411 . . . . 0.0 109.249 -172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 16.8 tpt180 -69.8 103.56 2.21 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 172.91 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.1 pt20 -67.91 143.33 55.72 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.419 0.688 . . . . 0.0 111.753 -171.509 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 67.2 p -72.8 -36.34 67.55 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.998 0.919 . . . . 0.0 110.836 178.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.6 p30 -147.04 164.15 33.96 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.765 1.226 . . . . 0.0 109.619 -177.059 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 8.8 t -124.59 46.32 2.33 Favored 'General case' 0 CA--C 1.534 0.364 0 C-N-CA 124.704 1.202 . . . . 0.0 110.565 -173.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 20.4 tt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.991 -1.48 . . . . 0.0 110.383 -179.502 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 14.1 t . . . . . 0 N--CA 1.474 0.775 0 CA-C-O 121.086 0.469 . . . . 0.0 110.679 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 22.5 t70 -66.55 -70.0 0.27 Allowed 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 123.69 0.796 . . . . 0.0 109.821 -179.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 27.8 m -86.27 59.07 5.42 Favored 'General case' 0 CA--C 1.534 0.347 0 N-CA-C 108.253 -1.018 . . . . 0.0 108.253 178.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -159.1 -127.64 0.93 Allowed Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.367 -1.893 . . . . 0.0 108.367 -178.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.6 ttp180 -77.89 117.36 65.36 Favored Pre-proline 0 CA--C 1.534 0.364 0 N-CA-C 108.277 -1.008 . . . . 0.0 108.277 177.103 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -65.83 -50.45 1.7 Allowed 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 123.093 2.529 . . . . 0.0 111.474 -173.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -76.7 146.41 38.07 Favored 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 123.817 0.847 . . . . 0.0 112.476 -171.856 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 41.0 t -100.64 55.03 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.454 -0.272 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 168.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -166.36 -71.66 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.415 0 N-CA-C 108.851 -0.796 . . . . 0.0 108.851 173.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 11.8 tpt 69.76 157.07 0.15 Allowed 'General case' 0 CA--C 1.537 0.475 0 C-N-CA 126.145 1.778 . . . . 0.0 111.349 -176.568 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -142.97 172.14 13.09 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.0 0.92 . . . . 0.0 109.32 171.804 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 36.8 t -145.02 -66.28 0.32 Allowed 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 123.304 0.641 . . . . 0.0 110.383 173.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -95.08 -64.35 1.07 Allowed 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 123.47 0.708 . . . . 0.0 112.624 -169.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 46.6 mm -104.76 113.42 64.93 Favored Pre-proline 0 CA--C 1.535 0.398 0 C-N-CA 124.388 1.075 . . . . 0.0 110.195 -169.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 51.8 Cg_exo -57.83 142.69 96.36 Favored 'Trans proline' 0 N--CA 1.458 -0.562 0 C-N-CA 123.317 2.678 . . . . 0.0 111.122 171.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 92.5 mt-10 -73.05 128.24 34.91 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 110.087 -0.338 . . . . 0.0 110.087 -178.092 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 28.2 mm -82.6 85.55 1.8 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.313 0 C-N-CA 123.306 0.642 . . . . 0.0 109.378 -175.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 16.4 mt -92.55 80.25 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.156 0 N-CA-C 107.777 -1.194 . . . . 0.0 107.777 176.223 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 29.8 p80 -60.55 135.62 57.81 Favored 'General case' 0 CA--C 1.533 0.295 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 176.532 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -150.43 175.63 11.68 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.604 0.761 . . . . 0.0 111.196 -171.895 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.6 m -146.97 142.8 27.91 Favored 'General case' 0 N--CA 1.453 -0.312 0 C-N-CA 125.536 1.534 . . . . 0.0 108.162 -178.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -63.96 150.63 44.72 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.119 0.567 . . . . 0.0 111.24 179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.8 -34.41 4.07 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 123.557 0.599 . . . . 0.0 112.042 -176.771 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 45.0 mtp180 -88.98 157.02 18.52 Favored 'General case' 0 C--N 1.34 0.184 0 C-N-CA 124.248 1.019 . . . . 0.0 109.672 179.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -66.92 136.0 54.68 Favored 'General case' 0 N--CA 1.454 -0.255 0 C-N-CA 123.084 0.554 . . . . 0.0 110.469 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 30.5 tp -122.6 114.27 20.4 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 125.576 1.55 . . . . 0.0 107.847 177.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 60.8 t -99.49 127.58 52.12 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.267 0 N-CA-C 107.864 -1.161 . . . . 0.0 107.864 174.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.7 mm -106.26 100.08 27.33 Favored Pre-proline 0 CA--C 1.535 0.366 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 171.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -82.67 62.3 7.79 Favored 'Trans proline' 0 N--CA 1.456 -0.727 0 C-N-CA 123.554 2.836 . . . . 0.0 111.492 -169.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -104.11 51.49 0.78 Allowed 'General case' 0 N--CA 1.457 -0.115 0 C-N-CA 124.029 0.932 . . . . 0.0 109.305 171.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 19.3 ptt-85 -66.26 161.75 21.56 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.625 1.17 . . . . 0.0 110.863 174.654 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 14.8 m -127.62 166.51 24.39 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.295 0 C-N-CA 124.897 1.279 . . . . 0.0 111.709 -169.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.9 p -65.34 -36.58 84.47 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 125.067 1.347 . . . . 0.0 112.035 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 51.3 m -145.42 146.22 29.14 Favored Pre-proline 0 CA--C 1.536 0.428 0 C-N-CA 123.453 0.701 . . . . 0.0 110.522 179.97 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -46.79 -42.86 24.39 Favored 'Trans proline' 0 C--N 1.349 0.586 0 C-N-CA 124.65 3.566 . . . . 0.0 115.004 177.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -59.12 -20.26 52.01 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.028 0.931 . . . . 0.0 113.245 -178.957 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 23.1 mm -77.71 74.14 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.387 0 N-CA-C 107.775 -1.195 . . . . 0.0 107.775 174.676 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 27.7 m -70.19 120.1 15.38 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.243 0.617 . . . . 0.0 109.812 -177.566 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 73.6 t -89.72 147.16 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.113 0 C-N-CA 124.102 0.961 . . . . 0.0 109.641 -177.868 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 44.8 m -106.17 113.31 26.77 Favored 'General case' 0 N--CA 1.454 -0.257 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 172.051 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 58.1 tp -89.22 121.66 31.74 Favored 'General case' 0 C--N 1.338 0.104 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 178.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 56.2 mttt -126.22 173.65 9.11 Favored 'General case' 0 N--CA 1.457 -0.123 0 C-N-CA 124.52 1.128 . . . . 0.0 110.467 179.426 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 24.5 ttpt -138.82 149.24 44.72 Favored 'General case' 0 C--N 1.34 0.18 0 C-N-CA 123.949 0.899 . . . . 0.0 108.785 169.645 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -58.16 133.39 84.32 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-O 118.536 -0.745 . . . . 0.0 109.637 173.525 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -78.5 -59.85 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.72 0 CA-C-N 119.943 1.015 . . . . 0.0 112.197 3.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.0 mt -142.01 40.27 1.65 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 124.305 1.042 . . . . 0.0 110.391 -174.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 19.2 m-20 -74.48 149.56 40.26 Favored 'General case' 0 C--O 1.227 -0.105 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 171.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.2 m -132.53 110.19 10.31 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.171 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 7.3 mp -91.62 85.19 5.62 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.805 1.242 . . . . 0.0 108.26 -177.059 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -66.39 127.6 93.39 Favored Pre-proline 0 CA--C 1.537 0.478 0 N-CA-C 108.586 -0.894 . . . . 0.0 108.586 -179.579 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.2 Cg_endo -72.54 104.6 1.74 Allowed 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.876 2.384 . . . . 0.0 110.722 -178.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.3 p-10 -67.29 -31.48 71.82 Favored 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 123.637 0.775 . . . . 0.0 111.991 179.01 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 92.11 17.91 45.23 Favored Glycine 0 CA--C 1.531 1.074 0 CA-C-O 118.996 -0.891 . . . . 0.0 113.611 175.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 2.3 mptp? -133.23 -58.99 0.89 Allowed 'General case' 0 C--N 1.341 0.222 0 C-N-CA 124.599 1.16 . . . . 0.0 108.516 174.838 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 15.6 tpp85 -78.03 -66.04 0.9 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.033 -1.099 . . . . 0.0 108.033 171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.52 92.7 4.04 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.211 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 68.8 mt -92.07 114.68 29.54 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.172 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.0 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.8 t-105 -88.92 93.26 9.53 Favored 'General case' 0 N--CA 1.455 -0.199 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 -179.517 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 52.9 t0 -89.84 103.06 15.75 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 107.117 -1.438 . . . . 0.0 107.117 173.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 51.9 p -54.74 -29.16 52.98 Favored 'General case' 0 CA--C 1.533 0.307 0 N-CA-C 113.722 1.008 . . . . 0.0 113.722 -177.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.2 mmt85 -108.32 24.98 12.21 Favored 'General case' 0 CA--C 1.536 0.413 0 C-N-CA 124.135 0.974 . . . . 0.0 111.902 -178.116 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 57.7 tttm -146.63 -58.57 0.29 Allowed 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.162 0.585 . . . . 0.0 110.673 171.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.9 -172.25 37.16 Favored Glycine 0 CA--C 1.529 0.944 0 C-N-CA 123.92 0.772 . . . . 0.0 111.172 -179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 73.9 m-85 -89.27 109.23 20.14 Favored 'General case' 0 C--N 1.341 0.211 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 170.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 54.9 mt -94.4 96.0 5.62 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.986 1.314 . . . . 0.0 107.616 -177.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.7 mp -83.98 101.21 8.26 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 106.498 -1.667 . . . . 0.0 106.498 170.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 80.3 p -57.09 -36.15 70.26 Favored 'General case' 0 CA--C 1.53 0.21 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -169.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 18.8 m120 -139.36 99.14 3.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.473 -1.306 . . . . 0.0 107.473 178.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.43 163.82 10.23 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.554 0.741 . . . . 0.0 112.027 -173.747 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.8 p -131.01 155.21 47.23 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.027 0.931 . . . . 0.0 109.709 179.404 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 54.9 p90 -56.51 -30.27 62.82 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.238 1.015 . . . . 0.0 111.777 176.738 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 68.3 mttm -57.04 -24.14 51.62 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.687 1.195 . . . . 0.0 112.441 178.057 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -86.04 -9.29 57.03 Favored 'General case' 0 CA--C 1.532 0.277 0 CA-C-O 118.302 -0.856 . . . . 0.0 113.226 -178.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 77.4 mt -65.23 105.86 0.59 Allowed 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 CA-C-N 119.228 0.922 . . . . 0.0 108.63 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.94 -163.22 34.12 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 111.662 -0.575 . . . . 0.0 111.662 178.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 58.4 tp -86.85 89.72 8.07 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.015 0.926 . . . . 0.0 109.481 -178.043 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 45.1 mt -69.1 147.4 51.51 Favored 'General case' 0 N--CA 1.456 -0.137 0 N-CA-C 108.885 -0.783 . . . . 0.0 108.885 171.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 85.9 m -147.27 102.79 3.52 Favored 'General case' 0 N--CA 1.45 -0.473 0 C-N-CA 124.885 1.274 . . . . 0.0 108.318 -169.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 75.0 m -80.7 138.91 36.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 108.412 -0.958 . . . . 0.0 108.412 170.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 55.4 mt-10 -134.69 142.23 46.75 Favored 'General case' 0 C--N 1.34 0.166 0 C-N-CA 124.184 0.993 . . . . 0.0 110.145 -178.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -155.97 126.36 6.7 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.134 0.973 . . . . 0.0 109.25 176.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 85.5 m -103.19 134.21 46.98 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 124.657 1.183 . . . . 0.0 109.158 179.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 49.0 t -130.72 -78.6 0.17 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 123.392 0.677 . . . . 0.0 109.968 179.54 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.1 m120 -85.84 49.4 1.77 Allowed 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.681 0.792 . . . . 0.0 110.965 -169.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 53.96 38.46 60.35 Favored Glycine 0 CA--C 1.531 1.048 0 N-CA-C 110.925 -0.87 . . . . 0.0 110.925 -170.289 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 26.9 t-80 -150.06 121.02 7.66 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 125.178 1.391 . . . . 0.0 107.657 -174.669 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 10.0 tt -77.56 111.2 13.05 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 176.246 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 74.3 m-85 -92.05 154.09 18.98 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 169.907 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 9.3 ptmm? -151.47 162.99 39.98 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 122.827 0.451 . . . . 0.0 112.147 -177.941 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.0 t -148.13 135.6 20.62 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.916 0.886 . . . . 0.0 108.782 169.64 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -116.71 152.47 34.22 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 124.195 0.998 . . . . 0.0 111.952 -169.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 53.2 m-85 -145.0 118.49 9.08 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 125.149 1.379 . . . . 0.0 109.005 -173.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -91.08 111.48 22.97 Favored 'General case' 0 N--CA 1.456 -0.156 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 176.244 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.0 p -89.87 103.3 15.97 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 123.21 0.604 . . . . 0.0 109.65 176.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 39.8 t-80 -89.38 134.12 34.22 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 124.131 0.973 . . . . 0.0 109.203 178.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 59.9 ttp85 -74.64 96.93 3.08 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.284 -0.636 . . . . 0.0 109.284 176.802 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -68.88 -47.95 64.6 Favored 'General case' 0 CA--C 1.532 0.268 0 CA-C-N 117.877 0.308 . . . . 0.0 110.559 177.278 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 53.9 p -144.46 177.64 8.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 125.215 1.406 . . . . 0.0 108.818 177.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -131.61 63.3 1.61 Allowed 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.346 -0.983 . . . . 0.0 108.346 172.001 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 61.4 p -112.59 170.75 7.96 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 125.847 1.659 . . . . 0.0 109.533 178.533 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.107 0 CA-C-O 116.887 -1.53 . . . . 0.0 110.667 178.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.3 p . . . . . 0 N--CA 1.473 0.707 0 CA-C-O 119.521 -0.276 . . . . 0.0 110.906 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.8 m-20 -74.17 -59.99 2.47 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 108.319 -0.993 . . . . 0.0 108.319 174.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 9.7 t -117.8 -18.56 9.55 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.784 1.633 . . . . 0.0 110.378 170.003 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 74.42 -84.63 0.74 Allowed Glycine 0 C--N 1.342 0.863 0 N-CA-C 108.631 -1.788 . . . . 0.0 108.631 -173.376 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 38.9 ttp85 -83.6 125.62 73.19 Favored Pre-proline 0 N--CA 1.452 -0.349 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 174.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -73.35 -46.68 0.34 Allowed 'Trans proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.058 2.505 . . . . 0.0 110.929 -179.902 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.6 m-85 -69.61 152.15 45.08 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.042 0.937 . . . . 0.0 111.948 -173.95 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 63.6 t -85.57 -50.57 14.38 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.145 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 169.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -79.15 -82.22 0.1 Allowed 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 124.128 0.971 . . . . 0.0 110.532 -175.006 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.8 ttt 66.83 139.05 0.03 OUTLIER 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 126.553 1.941 . . . . 0.0 112.032 -172.741 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -73.58 -146.36 0.02 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 124.741 1.216 . . . . 0.0 110.588 171.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 28.8 p -129.79 -69.07 0.69 Allowed 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.526 1.13 . . . . 0.0 108.072 169.547 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.7 pt-20 -156.45 -38.31 0.08 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.447 1.499 . . . . 0.0 109.989 178.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 65.7 mt -70.08 125.95 92.21 Favored Pre-proline 0 CA--C 1.534 0.336 0 N-CA-C 107.29 -1.374 . . . . 0.0 107.29 173.517 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 88.7 Cg_endo -69.66 129.4 17.64 Favored 'Trans proline' 0 N--CA 1.454 -0.844 0 C-N-CA 122.804 2.336 . . . . 0.0 109.636 -177.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -65.94 123.63 20.33 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 123.334 0.654 . . . . 0.0 111.011 -169.333 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 49.6 mm -69.22 117.11 11.35 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 C-N-CA 124.755 1.222 . . . . 0.0 108.953 179.347 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 8.2 mt -127.01 133.67 67.87 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.208 0 C-N-CA 124.57 1.148 . . . . 0.0 109.204 177.341 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 15.4 m80 -84.3 147.96 26.93 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.804 1.242 . . . . 0.0 109.043 174.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 5.0 ppp? -150.1 167.18 27.56 Favored 'General case' 0 C--N 1.339 0.132 0 C-N-CA 123.329 0.652 . . . . 0.0 111.619 174.521 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 59.1 m -140.25 113.64 8.54 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.2 -1.408 . . . . 0.0 107.2 171.305 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -52.11 136.51 29.57 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 123.52 0.728 . . . . 0.0 110.62 174.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 99.47 -38.64 3.02 Favored Glycine 0 CA--C 1.53 0.989 0 C-N-CA 124.499 1.047 . . . . 0.0 110.948 -172.261 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.2 mmm180 -89.5 166.36 13.73 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.632 0.773 . . . . 0.0 110.546 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -69.88 144.75 52.41 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 123.366 0.666 . . . . 0.0 109.914 177.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 51.0 tp -134.86 152.9 52.13 Favored 'General case' 0 CA--C 1.53 0.194 0 C-N-CA 125.175 1.39 . . . . 0.0 107.768 172.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -126.79 135.52 63.46 Favored 'Isoleucine or valine' 0 C--N 1.34 0.183 0 C-N-CA 124.052 0.941 . . . . 0.0 108.483 174.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 27.4 mm -109.14 97.19 24.17 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 106.529 -1.656 . . . . 0.0 106.529 173.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -82.47 68.84 7.59 Favored 'Trans proline' 0 N--CA 1.456 -0.688 0 C-N-CA 123.55 2.833 . . . . 0.0 112.525 -163.436 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -116.2 55.14 0.81 Allowed 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 124.656 1.182 . . . . 0.0 109.795 174.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.626 ' HB2' ' O ' ' A' ' 188' ' ' SER . 25.6 ptt-85 -69.0 161.45 28.93 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 125.256 1.422 . . . . 0.0 111.023 174.615 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 17.7 m -121.36 165.19 17.24 Favored 'Isoleucine or valine' 0 C--N 1.34 0.174 0 C-N-CA 124.856 1.262 . . . . 0.0 112.393 -171.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 38.2 p -73.02 -27.51 61.81 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 125.807 1.643 . . . . 0.0 112.473 -177.818 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 22.8 t -142.21 136.19 14.72 Favored Pre-proline 0 CA--C 1.533 0.314 0 C-N-CA 123.945 0.898 . . . . 0.0 109.161 -178.185 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -66.1 -25.96 50.61 Favored 'Trans proline' 0 N--CA 1.457 -0.64 0 C-N-CA 123.389 2.726 . . . . 0.0 113.297 -171.501 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 1.9 p-10 -62.55 -23.03 66.77 Favored 'General case' 0 CA--C 1.533 0.323 0 CA-C-N 118.349 0.522 . . . . 0.0 112.154 178.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 53.1 mt -80.14 78.82 1.01 Allowed 'Isoleucine or valine' 0 N--CA 1.453 -0.321 0 N-CA-C 108.218 -1.031 . . . . 0.0 108.218 -178.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 57.7 m -66.55 121.33 15.1 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 176.092 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.7 t -89.27 145.24 7.63 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.192 0 N-CA-C 107.804 -1.184 . . . . 0.0 107.804 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 62.7 m -103.75 122.65 45.52 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.867 -1.16 . . . . 0.0 107.867 173.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 54.6 tp -89.28 132.17 35.03 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 177.075 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 43.1 mttp -130.98 175.34 9.16 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.695 1.198 . . . . 0.0 109.3 177.035 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -151.52 147.98 27.48 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.053 0.941 . . . . 0.0 109.295 178.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.4 t80 -58.91 135.74 87.28 Favored Pre-proline 0 CA--C 1.538 0.493 0 C-N-CA 123.77 0.828 . . . . 0.0 110.15 178.046 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.5 Cg_endo -78.91 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.761 0 CA-C-N 119.902 1.001 . . . . 0.0 112.007 1.888 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.2 mt -140.56 41.74 1.88 Allowed 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.451 1.101 . . . . 0.0 109.979 -175.431 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 44.4 m-20 -82.67 139.65 33.58 Favored 'General case' 0 C--O 1.227 -0.123 0 N-CA-C 108.18 -1.045 . . . . 0.0 108.18 173.479 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 84.8 m -116.93 112.01 20.43 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.437 -0.949 . . . . 0.0 108.437 176.65 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 43.5 mt -96.45 72.14 2.74 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.876 1.27 . . . . 0.0 109.111 -174.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 41.7 mm -56.34 126.69 69.55 Favored Pre-proline 0 CA--C 1.537 0.472 0 C-N-CA 123.792 0.837 . . . . 0.0 109.609 179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -50.7 103.5 0.07 OUTLIER 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 123.995 3.13 . . . . 0.0 112.684 173.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -76.84 -19.47 57.47 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.752 0.821 . . . . 0.0 111.878 179.911 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.13 -5.27 83.63 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.774 -1.014 . . . . 0.0 113.626 175.069 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 38.7 mmtm -105.26 -63.88 1.19 Allowed 'General case' 0 C--N 1.341 0.227 0 CA-C-N 118.564 1.182 . . . . 0.0 107.901 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 52.0 ttp180 -79.26 -64.91 1.08 Allowed 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 123.836 0.854 . . . . 0.0 108.725 173.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 38.2 mt -89.33 97.57 7.16 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.204 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 -174.778 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 89.9 mt -99.64 117.6 45.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 178.089 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 17.9 t-105 -88.95 121.5 31.37 Favored 'General case' 0 N--CA 1.456 -0.144 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 -177.249 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 64.9 t0 -124.35 112.39 16.91 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.135 1.374 . . . . 0.0 107.878 177.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.626 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 28.9 p -59.31 -25.95 64.58 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.336 1.055 . . . . 0.0 113.502 -179.339 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 85.8 mmt-85 -111.39 27.5 9.62 Favored 'General case' 0 CA--C 1.534 0.332 0 C-N-CA 124.134 0.973 . . . . 0.0 111.93 -177.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 56.7 tptt -149.14 -53.33 0.17 Allowed 'General case' 0 C--N 1.338 0.098 0 C-N-CA 122.927 0.491 . . . . 0.0 110.266 171.507 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 145.88 -159.77 28.0 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 109.678 -1.369 . . . . 0.0 109.678 -177.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 90.9 m-85 -89.24 110.82 21.54 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 169.814 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 70.1 mt -89.07 98.6 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.488 0 N-CA-C 106.309 -1.738 . . . . 0.0 106.309 -178.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 6.4 mm -83.05 82.6 1.68 Allowed 'Isoleucine or valine' 0 N--CA 1.45 -0.438 0 N-CA-C 106.462 -1.681 . . . . 0.0 106.462 178.123 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 69.7 p -55.15 -33.28 62.81 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 124.286 1.035 . . . . 0.0 113.47 -170.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -132.87 89.42 2.62 Favored 'General case' 0 N--CA 1.455 -0.178 0 N-CA-C 107.838 -1.171 . . . . 0.0 107.838 172.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.86 158.43 16.01 Favored 'General case' 0 N--CA 1.455 -0.178 0 C-N-CA 122.984 0.514 . . . . 0.0 110.703 177.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 82.6 p -136.12 161.27 36.17 Favored 'General case' 0 N--CA 1.457 -0.1 0 C-N-CA 123.733 0.813 . . . . 0.0 109.879 -178.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.2 p90 -57.11 -32.78 66.67 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.889 0.875 . . . . 0.0 111.398 175.054 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -58.42 -34.39 70.74 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.358 1.063 . . . . 0.0 111.44 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -87.97 13.49 10.87 Favored 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 124.326 1.05 . . . . 0.0 112.484 -175.533 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.8 mt -85.14 121.8 37.46 Favored 'Isoleucine or valine' 0 C--N 1.342 0.26 0 N-CA-C 107.718 -1.216 . . . . 0.0 107.718 173.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 138.71 -159.44 25.4 Favored Glycine 0 CA--C 1.528 0.899 0 C-N-CA 123.288 0.471 . . . . 0.0 112.794 175.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.89 91.45 6.0 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 124.596 1.158 . . . . 0.0 110.743 -173.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 82.0 mt -74.96 160.31 30.73 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.668 0.787 . . . . 0.0 109.475 170.037 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 18.1 m -147.81 102.04 3.37 Favored 'General case' 0 CA--C 1.533 0.29 0 C-N-CA 124.717 1.207 . . . . 0.0 109.087 -176.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.6 m -75.28 139.35 42.45 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 169.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 72.1 mt-10 -138.37 139.02 38.82 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 123.601 0.761 . . . . 0.0 111.187 -176.828 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.52 152.83 27.82 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.796 1.239 . . . . 0.0 109.822 176.79 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.2 m -135.71 107.99 7.28 Favored 'General case' 0 C--N 1.339 0.123 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -179.633 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 65.9 t -75.98 -64.18 0.91 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 N-CA-C 108.403 -0.962 . . . . 0.0 108.403 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 65.2 m-80 -150.06 114.13 5.12 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.363 1.065 . . . . 0.0 108.58 175.068 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 81.86 -59.69 4.84 Favored Glycine 0 CA--C 1.527 0.841 0 C-N-CA 123.78 0.705 . . . . 0.0 113.143 170.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -89.03 135.62 33.45 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 123.298 0.639 . . . . 0.0 110.694 -169.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.6 tp -80.55 105.5 11.85 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 173.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.7 m-85 -89.52 135.09 33.8 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.182 -1.414 . . . . 0.0 107.182 174.304 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.6 pttm -150.73 160.39 43.88 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 122.538 0.335 . . . . 0.0 110.824 -178.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 4.8 t -152.86 130.59 11.61 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.477 0.711 . . . . 0.0 109.97 178.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 23.6 m120 -104.57 150.99 24.16 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.673 1.189 . . . . 0.0 112.066 -169.833 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.9 m-85 -140.18 113.23 8.27 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.525 1.13 . . . . 0.0 108.812 179.412 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -82.99 101.63 11.22 Favored 'General case' 0 N--CA 1.452 -0.365 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 173.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 20.5 p -89.17 92.58 9.25 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.444 -0.947 . . . . 0.0 108.444 179.125 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -89.8 165.79 13.94 Favored 'General case' 0 CA--C 1.529 0.172 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 169.792 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 22.5 mtp-105 -70.69 -82.46 0.04 OUTLIER 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 120.601 -0.44 . . . . 0.0 110.369 178.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 3.1 pt20 -175.12 -165.91 0.2 Allowed 'General case' 0 N--CA 1.446 -0.669 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 -169.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 34.9 p -70.31 94.47 0.93 Allowed 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 172.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 81.1 m-20 -88.72 66.14 7.96 Favored 'General case' 0 CA--C 1.529 0.137 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -174.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.5 t -74.99 168.51 19.83 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.006 0.922 . . . . 0.0 110.804 178.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.8 pt . . . . . 0 C--O 1.252 1.19 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.246 179.988 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 45.5 m . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 111.654 0.242 . . . . 0.0 111.654 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -72.87 80.86 1.17 Allowed 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 124.431 1.092 . . . . 0.0 109.424 -179.717 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.9 p -127.8 -85.99 0.58 Allowed 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 125.356 1.462 . . . . 0.0 108.982 -172.997 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.88 -63.93 3.74 Favored Glycine 0 CA--C 1.527 0.813 0 C-N-CA 124.156 0.884 . . . . 0.0 110.976 -179.663 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 29.7 ptt180 -159.51 152.6 18.36 Favored Pre-proline 0 CA--C 1.535 0.401 0 C-N-CA 124.644 1.178 . . . . 0.0 108.693 177.412 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 32.8 Cg_endo -66.67 -51.58 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.803 0 C-N-CA 123.422 2.748 . . . . 0.0 111.63 178.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 72.3 m-85 -71.54 119.65 16.0 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 123.88 0.872 . . . . 0.0 111.574 -171.107 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.0 t -66.01 -53.22 39.92 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 108.05 -1.093 . . . . 0.0 108.05 172.799 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -111.71 126.24 54.83 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.124 1.37 . . . . 0.0 107.832 173.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.1 ptm -128.49 170.3 13.33 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 124.963 1.305 . . . . 0.0 109.685 176.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -64.56 147.41 52.92 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 170.018 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.9 m -90.6 -136.44 0.13 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 108.295 -1.002 . . . . 0.0 108.295 177.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -88.96 104.14 16.69 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 169.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 23.4 mm 108.64 127.25 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.455 0 C-N-CA 130.742 3.617 . . . . 0.0 107.924 178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 82.2 Cg_exo -46.68 137.65 15.46 Favored 'Trans proline' 0 C--N 1.351 0.705 0 C-N-CA 124.236 3.291 . . . . 0.0 113.066 175.246 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.5 mm-40 -70.27 126.7 30.4 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 -175.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 31.8 mm -80.78 100.0 4.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.225 0 N-CA-C 109.011 -0.737 . . . . 0.0 109.011 -177.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 19.7 mt -89.17 105.83 16.31 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.248 0 N-CA-C 107.672 -1.233 . . . . 0.0 107.672 176.661 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 7.6 p-80 -83.41 76.61 9.91 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 125.373 1.469 . . . . 0.0 109.231 175.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.33 171.85 9.46 Favored 'General case' 0 C--N 1.339 0.115 0 C-N-CA 123.107 0.563 . . . . 0.0 111.041 -178.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 7.9 m -143.46 116.82 9.05 Favored 'General case' 0 N--CA 1.452 -0.36 0 N-CA-C 105.738 -1.949 . . . . 0.0 105.738 175.169 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -64.58 164.94 10.88 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 112.919 0.711 . . . . 0.0 112.919 -169.583 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 94.21 -41.06 2.64 Favored Glycine 0 CA--C 1.53 0.986 0 N-CA-C 110.04 -1.224 . . . . 0.0 110.04 -170.194 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 20.2 mtp-105 -88.88 -179.57 5.99 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 125.774 1.629 . . . . 0.0 109.674 -176.87 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 14.0 pt-20 -72.75 137.38 45.84 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 122.396 0.278 . . . . 0.0 111.184 178.631 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.1 tp -113.34 103.93 11.8 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 106.798 -1.556 . . . . 0.0 106.798 171.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.9 t -91.22 125.17 43.98 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.425 0 N-CA-C 107.921 -1.141 . . . . 0.0 107.921 176.756 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.2 mm -101.08 100.73 13.84 Favored Pre-proline 0 CA--C 1.534 0.347 0 N-CA-C 105.931 -1.877 . . . . 0.0 105.931 170.06 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 43.8 Cg_endo -83.79 48.99 2.74 Favored 'Trans proline' 0 CA--C 1.536 0.602 0 C-N-CA 123.671 2.914 . . . . 0.0 112.846 -161.901 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.8 p -91.59 57.61 3.32 Favored 'General case' 0 N--CA 1.456 -0.141 0 C-N-CA 123.84 0.856 . . . . 0.0 110.378 -179.7 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.3 ptp85 -56.73 143.2 37.48 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.118 0.967 . . . . 0.0 111.126 175.692 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.6 m -124.59 165.94 20.79 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.1 0 C-N-CA 124.817 1.247 . . . . 0.0 110.591 178.657 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -66.72 -29.93 70.04 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.376 1.07 . . . . 0.0 112.508 -179.483 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 24.2 m -155.5 146.7 16.64 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 123.644 0.777 . . . . 0.0 110.299 179.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -68.5 -30.63 28.8 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.724 2.949 . . . . 0.0 111.855 178.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 63.5 m-80 -56.36 -27.32 55.66 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 125.101 1.36 . . . . 0.0 112.497 -177.141 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 96.5 mt -52.4 -35.72 20.51 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 125.135 1.374 . . . . 0.0 110.861 174.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.1 m 67.59 88.52 0.11 Allowed 'General case' 0 C--N 1.341 0.233 0 C-N-CA 125.314 1.446 . . . . 0.0 110.028 175.659 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.0 t -89.45 132.56 33.87 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.243 0 C-N-CA 123.972 0.909 . . . . 0.0 108.835 -174.731 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 39.8 m -102.31 119.11 38.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 C-N-CA 124.327 1.051 . . . . 0.0 108.721 179.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 63.4 tp -89.49 101.52 14.19 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 108.956 -0.757 . . . . 0.0 108.956 -179.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -89.48 165.23 14.44 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.056 0.942 . . . . 0.0 109.905 174.688 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 66.3 tttp -147.8 146.39 29.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.31 1.044 . . . . 0.0 108.928 173.05 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.5 t80 -59.81 134.91 89.73 Favored Pre-proline 0 CA--C 1.537 0.471 0 C-N-CA 123.837 0.855 . . . . 0.0 110.605 -177.159 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -77.91 -58.69 0.14 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.67 0 CA-C-N 119.854 0.984 . . . . 0.0 111.819 0.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.1 mt -139.89 38.94 1.98 Allowed 'General case' 0 CA--C 1.533 0.324 0 C-N-CA 124.794 1.238 . . . . 0.0 109.824 -176.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -80.76 160.29 24.94 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 173.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -137.85 114.41 10.41 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.876 0.87 . . . . 0.0 109.034 -178.776 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.9 mp -89.9 83.98 6.19 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.293 -1.003 . . . . 0.0 108.293 176.294 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.2 mt -64.73 121.76 75.14 Favored Pre-proline 0 CA--C 1.537 0.451 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 176.796 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 74.6 Cg_exo -54.65 120.65 8.43 Favored 'Trans proline' 0 N--CA 1.456 -0.715 0 C-N-CA 123.309 2.673 . . . . 0.0 112.735 178.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 34.1 p-10 -81.25 -15.43 55.59 Favored 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 123.475 0.71 . . . . 0.0 111.565 172.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 66.76 29.98 75.54 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.057 0.837 . . . . 0.0 112.042 -178.869 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.8 mtmm -139.94 -67.55 0.43 Allowed 'General case' 0 C--N 1.34 0.187 0 C-N-CA 124.575 1.15 . . . . 0.0 108.169 -179.267 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 30.7 ttp-105 -79.16 -56.16 4.57 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 171.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 16.2 mt -89.57 90.08 3.28 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.393 0 C-N-CA 125.432 1.493 . . . . 0.0 106.998 178.762 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 67.8 mt -90.83 113.86 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.29 0 N-CA-C 107.256 -1.387 . . . . 0.0 107.256 177.575 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.4 t-105 -89.01 93.2 9.52 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.995 -0.742 . . . . 0.0 108.995 -177.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -92.41 99.48 12.22 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 78.3 p -57.82 -26.82 62.51 Favored 'General case' 0 CA--C 1.533 0.319 0 N-CA-C 113.543 0.942 . . . . 0.0 113.543 -174.897 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 12.2 mtm-85 -76.87 -19.29 57.64 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 124.122 0.969 . . . . 0.0 112.423 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 4.4 tmtt? -125.83 -64.59 1.05 Allowed 'General case' 0 C--N 1.344 0.362 0 C-N-CA 124.063 0.945 . . . . 0.0 110.752 -173.867 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 170.56 -173.36 44.41 Favored Glycine 0 CA--C 1.529 0.908 0 CA-C-N 117.9 0.318 . . . . 0.0 112.332 -173.79 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.7 m-85 -89.36 107.55 19.13 Favored 'General case' 0 C--N 1.341 0.2 0 N-CA-C 108.076 -1.083 . . . . 0.0 108.076 172.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 62.2 mt -89.82 94.5 4.89 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.318 0 N-CA-C 107.719 -1.215 . . . . 0.0 107.719 -178.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 31.0 mt -81.96 85.87 1.7 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.19 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 173.317 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 94.9 p -52.15 -35.75 49.48 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.41 1.484 . . . . 0.0 114.3 -169.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -123.44 91.87 3.57 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.003 0.921 . . . . 0.0 108.878 176.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -71.62 155.63 40.3 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 123.325 0.65 . . . . 0.0 110.242 175.164 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 77.9 p -138.66 172.34 13.03 Favored 'General case' 0 CA--C 1.529 0.163 0 C-N-CA 124.66 1.184 . . . . 0.0 109.273 -179.063 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -59.17 -26.84 65.13 Favored 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 123.648 0.779 . . . . 0.0 112.016 176.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 40.6 mmtm -53.73 -43.92 69.47 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 123.402 0.681 . . . . 0.0 110.74 173.126 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 55.7 mm-40 -68.76 -8.37 42.47 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 113.79 1.033 . . . . 0.0 113.79 -172.831 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 78.7 mt -66.0 131.15 31.81 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.249 0 N-CA-C 108.419 -0.956 . . . . 0.0 108.419 175.824 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 143.15 -108.31 0.51 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 111.134 -0.786 . . . . 0.0 111.134 174.372 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 45.4 tp -157.14 111.34 2.67 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 123.655 0.782 . . . . 0.0 109.413 -170.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 5.6 mp -101.44 150.51 22.96 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.227 1.011 . . . . 0.0 109.089 173.67 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 98.2 m -142.86 116.52 9.21 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.102 0.961 . . . . 0.0 109.143 -176.421 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 30.5 m -81.91 142.49 32.42 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 171.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 68.0 mt-10 -129.96 142.72 50.6 Favored 'General case' 0 CA--C 1.528 0.098 0 C-N-CA 124.511 1.124 . . . . 0.0 109.984 -179.509 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.34 162.83 40.04 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.265 1.026 . . . . 0.0 110.104 -178.323 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 58.0 m -142.03 132.64 25.42 Favored 'General case' 0 CA--C 1.528 0.134 0 C-N-CA 124.032 0.933 . . . . 0.0 108.833 -177.437 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 64.5 t -135.49 -76.99 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.208 0 C-N-CA 123.971 0.908 . . . . 0.0 108.856 177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -85.35 51.18 2.11 Favored 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 123.805 0.842 . . . . 0.0 110.774 -172.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.8 -31.53 1.48 Allowed Glycine 0 CA--C 1.534 1.224 0 C-N-CA 123.664 0.649 . . . . 0.0 113.511 179.498 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 59.2 t60 -88.62 142.69 27.48 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 124.782 1.233 . . . . 0.0 109.98 -172.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 66.7 tp -80.02 106.16 11.83 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 108.498 -0.927 . . . . 0.0 108.498 174.521 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 86.5 m-85 -89.02 146.6 24.75 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 174.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.57 157.32 42.86 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 123.471 0.708 . . . . 0.0 110.045 177.247 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.6 t -147.0 129.72 16.1 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 123.434 0.694 . . . . 0.0 109.753 -179.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 31.3 m120 -102.56 141.01 36.08 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.64 1.576 . . . . 0.0 112.487 -169.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 93.4 m-85 -140.34 100.6 3.93 Favored 'General case' 0 C--N 1.34 0.155 0 C-N-CA 125.076 1.351 . . . . 0.0 108.893 -178.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.0 tt -81.5 110.48 16.94 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 124.517 1.127 . . . . 0.0 108.639 -177.147 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 10.6 p -89.59 89.02 7.64 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 123.801 0.84 . . . . 0.0 109.762 -178.384 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 19.0 t-80 -95.03 89.44 5.58 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.206 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 64.1 ttt-85 -55.17 133.0 48.86 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 122.979 0.512 . . . . 0.0 110.335 178.787 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -167.09 171.57 10.87 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.842 0.857 . . . . 0.0 110.399 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 45.5 p -135.02 38.42 2.99 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 124.887 1.275 . . . . 0.0 108.626 171.304 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -150.41 48.44 0.89 Allowed 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.258 1.023 . . . . 0.0 110.448 -173.12 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.6 t -62.82 -38.88 92.49 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 123.296 0.639 . . . . 0.0 110.921 176.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 41.7 pt . . . . . 0 C--O 1.251 1.181 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.949 176.082 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 50.9 m . . . . . 0 N--CA 1.474 0.737 0 N-CA-C 111.972 0.36 . . . . 0.0 111.972 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 37.4 t70 -74.5 89.33 2.16 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 122.723 0.409 . . . . 0.0 110.023 179.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 17.6 m -77.64 66.77 3.41 Favored 'General case' 0 CA--C 1.534 0.334 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 173.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 82.14 140.05 3.25 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.403 1.001 . . . . 0.0 110.766 -174.95 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 65.9 ttp85 -62.35 132.04 93.98 Favored Pre-proline 0 CA--C 1.536 0.418 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 171.626 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -67.89 -50.63 0.79 Allowed 'Trans proline' 0 N--CA 1.455 -0.762 0 C-N-CA 122.534 2.156 . . . . 0.0 111.211 -170.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 67.8 m-85 -77.33 159.93 29.18 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.992 0.917 . . . . 0.0 111.449 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 88.5 t -97.16 -61.41 2.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.389 -1.708 . . . . 0.0 106.389 169.478 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -87.05 123.88 32.61 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 172.113 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 23.4 ttt -144.51 145.44 31.85 Favored 'General case' 0 N--CA 1.454 -0.227 0 C-N-CA 123.508 0.723 . . . . 0.0 110.208 179.73 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -79.9 -152.74 0.08 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 124.655 1.182 . . . . 0.0 110.622 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.1 t -131.43 -64.82 0.79 Allowed 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 124.005 0.922 . . . . 0.0 108.924 170.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 13.1 pt-20 -154.71 -36.15 0.09 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.579 0.752 . . . . 0.0 111.579 -178.162 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 42.4 mt -81.36 116.59 63.8 Favored Pre-proline 0 CA--C 1.536 0.442 0 N-CA-C 107.935 -1.135 . . . . 0.0 107.935 175.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_exo -59.03 136.15 71.32 Favored 'Trans proline' 0 N--CA 1.458 -0.568 0 C-N-CA 123.007 2.471 . . . . 0.0 111.743 177.105 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -71.39 124.43 24.58 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 123.352 0.661 . . . . 0.0 109.948 -178.785 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 42.1 mm -67.9 126.56 27.92 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.223 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 177.056 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 25.4 mt -130.08 137.56 56.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 124.512 1.125 . . . . 0.0 108.131 173.033 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 33.6 p-80 -89.3 102.07 14.74 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.332 1.053 . . . . 0.0 108.772 173.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.3 ppp? -89.31 176.42 6.94 Favored 'General case' 0 C--N 1.34 0.176 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 172.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 11.5 m -147.82 130.4 15.89 Favored 'General case' 0 N--CA 1.453 -0.305 0 N-CA-C 108.641 -0.874 . . . . 0.0 108.641 174.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 -59.67 141.38 55.19 Favored 'General case' 0 N--CA 1.452 -0.335 0 C-N-CA 123.969 0.908 . . . . 0.0 110.157 -179.684 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 89.82 -42.94 2.96 Favored Glycine 0 CA--C 1.528 0.882 0 C-N-CA 123.231 0.443 . . . . 0.0 112.156 178.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 65.9 mtm180 -89.85 -179.28 5.69 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 123.814 0.845 . . . . 0.0 112.049 -171.944 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 15.6 mp0 -66.19 149.73 49.87 Favored 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 125.533 1.533 . . . . 0.0 110.989 -178.779 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 60.1 tp -148.03 112.37 5.26 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.266 1.026 . . . . 0.0 108.716 173.454 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 48.1 t -89.92 132.11 35.43 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.23 0 N-CA-C 108.094 -1.076 . . . . 0.0 108.094 174.642 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 38.4 mm -108.23 96.4 18.34 Favored Pre-proline 0 CA--C 1.536 0.419 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 172.443 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 58.2 Cg_endo -84.92 46.51 1.88 Allowed 'Trans proline' 0 N--CA 1.458 -0.567 0 C-N-CA 123.261 2.641 . . . . 0.0 113.714 -163.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 26.0 p -89.81 59.77 4.74 Favored 'General case' 0 C--N 1.34 0.16 0 C-N-CA 123.501 0.72 . . . . 0.0 109.138 171.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 29.7 ptt-85 -71.2 156.79 39.15 Favored 'General case' 0 N--CA 1.454 -0.26 0 C-N-CA 123.689 0.796 . . . . 0.0 110.884 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 10.3 m -124.53 167.7 18.17 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.905 1.282 . . . . 0.0 111.664 -170.817 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 40.6 p -63.33 -33.77 76.24 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.006 1.322 . . . . 0.0 111.695 177.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 10.7 m -157.68 151.14 18.97 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 124.376 1.071 . . . . 0.0 109.733 -179.149 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -61.54 -31.66 87.53 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.389 2.726 . . . . 0.0 111.64 177.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.8 m120 -50.25 -32.26 16.26 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 125.768 1.627 . . . . 0.0 112.559 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 38.4 mm -51.72 -41.95 30.23 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.346 0 C-N-CA 124.56 1.144 . . . . 0.0 111.043 176.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 25.0 m 63.15 91.01 0.07 Allowed 'General case' 0 C--N 1.342 0.264 0 C-N-CA 125.207 1.403 . . . . 0.0 111.168 174.513 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 94.5 t -89.45 133.13 32.39 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.156 0 C-N-CA 123.354 0.662 . . . . 0.0 109.483 -176.281 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.9 m -98.45 114.29 26.6 Favored 'General case' 0 N--CA 1.454 -0.275 0 N-CA-C 107.73 -1.211 . . . . 0.0 107.73 173.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 67.0 tp -89.46 106.85 18.72 Favored 'General case' 0 N--CA 1.454 -0.258 0 N-CA-C 108.625 -0.88 . . . . 0.0 108.625 179.032 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 64.8 mmtt -94.42 158.13 15.7 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 123.929 0.892 . . . . 0.0 110.213 174.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 7.7 tmtm? -129.18 136.95 50.83 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 125.732 1.613 . . . . 0.0 106.677 169.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 73.2 t80 -55.92 126.7 66.77 Favored Pre-proline 0 CA--C 1.538 0.495 0 CA-C-O 118.602 -0.713 . . . . 0.0 111.32 -170.07 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -77.47 -62.68 0.03 OUTLIER 'Cis proline' 0 N--CA 1.458 -0.616 0 CA-C-N 119.733 0.94 . . . . 0.0 112.851 6.3 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.1 mt -143.79 37.81 1.32 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.172 0.989 . . . . 0.0 110.244 -174.239 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 26.0 m-20 -76.23 126.84 31.73 Favored 'General case' 0 C--N 1.338 0.1 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 176.745 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 24.7 m -89.82 115.59 27.27 Favored 'General case' 0 C--N 1.333 -0.122 0 C-N-CA 123.325 0.65 . . . . 0.0 110.157 -172.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.1 mp -89.67 86.7 6.77 Favored 'General case' 0 N--CA 1.456 -0.154 0 N-CA-C 106.912 -1.514 . . . . 0.0 106.912 172.424 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.7 mt -64.02 130.35 94.46 Favored Pre-proline 0 CA--C 1.536 0.441 0 C-N-CA 124.208 1.003 . . . . 0.0 109.101 -176.655 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 97.1 Cg_endo -73.8 81.95 1.8 Allowed 'Trans proline' 0 N--CA 1.454 -0.812 0 C-N-CA 123.209 2.606 . . . . 0.0 110.002 177.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -62.63 -18.65 62.68 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.036 1.334 . . . . 0.0 113.137 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.23 26.48 70.42 Favored Glycine 0 CA--C 1.529 0.928 0 C-N-CA 123.602 0.62 . . . . 0.0 112.679 175.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 37.9 mtmm -140.27 -63.66 0.48 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.758 1.223 . . . . 0.0 108.53 -178.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -88.45 -57.36 2.95 Favored 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.713 1.205 . . . . 0.0 107.951 174.384 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 14.5 mt -89.97 93.4 4.34 Favored 'Isoleucine or valine' 0 C--N 1.34 0.171 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 172.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.8 mt -93.5 112.19 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 178.658 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 4.8 t-105 -89.08 95.37 10.29 Favored 'General case' 0 N--CA 1.456 -0.173 0 C-N-CA 123.168 0.587 . . . . 0.0 109.691 -175.698 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -89.97 97.55 11.26 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.233 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 81.6 p -50.53 -37.47 39.44 Favored 'General case' 0 CA--C 1.533 0.303 0 N-CA-C 113.631 0.975 . . . . 0.0 113.631 -175.189 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 22.7 mmt85 -97.27 21.2 10.32 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 123.777 0.831 . . . . 0.0 112.504 -176.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 20.8 ttmm -147.46 -57.69 0.25 Allowed 'General case' 0 C--N 1.343 0.3 0 CA-C-N 118.978 0.808 . . . . 0.0 111.317 179.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 161.5 -177.05 37.95 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 124.046 0.831 . . . . 0.0 111.187 -179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.13 110.19 20.96 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 170.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.7 mt -89.12 93.49 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 -179.439 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 50.2 mt -83.09 100.04 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.914 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.8 p -63.94 -39.38 94.02 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.037 0.535 . . . . 0.0 112.286 -172.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 47.3 t-20 -118.97 90.59 3.36 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 124.524 1.13 . . . . 0.0 108.693 177.258 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.86 124.15 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.807 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 67.3 p -91.83 166.77 12.58 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.687 0.795 . . . . 0.0 110.94 -177.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 42.3 p90 -57.39 -34.1 68.52 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.251 1.02 . . . . 0.0 111.804 176.217 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.9 mttt -56.14 -33.94 65.65 Favored 'General case' 0 CA--C 1.531 0.224 0 C-N-CA 124.418 1.087 . . . . 0.0 111.477 179.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -75.75 -2.85 31.7 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 124.031 0.932 . . . . 0.0 112.651 -176.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 85.1 mt -72.06 87.95 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.343 0.292 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 169.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 163.39 -163.1 35.39 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.802 -0.519 . . . . 0.0 111.802 -175.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.1 tp -86.95 117.12 25.47 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.695 1.198 . . . . 0.0 110.795 -174.337 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 95.5 mt -99.93 150.26 22.58 Favored 'General case' 0 C--N 1.339 0.141 0 C-N-CA 125.503 1.521 . . . . 0.0 109.114 169.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 51.3 m -146.7 103.33 3.64 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.746 1.218 . . . . 0.0 108.867 -172.136 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 48.6 m -74.97 143.93 43.42 Favored 'General case' 0 C--N 1.339 0.11 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 170.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 39.1 mt-10 -135.91 140.0 43.74 Favored 'General case' 0 C--N 1.34 0.172 0 C-N-CA 124.063 0.945 . . . . 0.0 109.611 178.717 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.36 114.82 6.32 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.652 0.781 . . . . 0.0 110.52 -178.144 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 15.7 m -89.94 125.76 35.49 Favored 'General case' 0 C--N 1.34 0.163 0 C-N-CA 124.809 1.244 . . . . 0.0 109.481 177.086 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 94.1 t -89.17 -71.72 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.34 0.154 0 N-CA-C 108.436 -0.95 . . . . 0.0 108.436 176.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 72.8 m-20 -145.7 94.26 2.47 Favored 'General case' 0 N--CA 1.455 -0.188 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 177.128 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 82.02 -53.56 4.76 Favored Glycine 0 CA--C 1.528 0.85 0 C-N-CA 123.558 0.599 . . . . 0.0 111.762 178.353 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.56 145.25 25.4 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.303 1.041 . . . . 0.0 109.25 -178.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -117.3 156.02 28.52 Favored 'General case' 0 N--CA 1.451 -0.411 0 CA-C-O 121.717 0.77 . . . . 0.0 111.433 177.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 50.3 m-85 -124.75 154.83 40.29 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 126.582 1.953 . . . . 0.0 106.027 -177.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 8.6 mtmp? -136.86 158.57 44.15 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-N 118.05 0.386 . . . . 0.0 111.4 -175.242 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 91.7 m -144.13 109.89 5.28 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 175.044 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -106.67 151.9 24.49 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.404 0.682 . . . . 0.0 111.171 -170.261 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 59.8 m-85 -142.39 127.51 18.54 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 124.317 1.047 . . . . 0.0 109.008 175.959 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.0 tt -87.09 97.17 10.59 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 106.147 -1.797 . . . . 0.0 106.147 169.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.8 p -89.0 88.76 7.71 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 179.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -89.38 154.36 20.13 Favored 'General case' 0 N--CA 1.456 -0.134 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 173.326 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 7.3 ptm85 -63.2 -36.46 83.71 Favored 'General case' 0 CA--C 1.532 0.285 0 CA-C-N 118.266 0.485 . . . . 0.0 111.185 175.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -176.96 168.8 2.45 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 125.072 1.349 . . . . 0.0 108.5 -178.72 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 47.1 p -70.66 176.91 3.81 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 123.546 0.738 . . . . 0.0 109.279 169.751 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -88.36 83.41 6.88 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 -177.879 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 24.0 p -61.42 -52.08 66.04 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.235 1.014 . . . . 0.0 109.862 174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 43.0 pt . . . . . 0 C--O 1.25 1.092 0 CA-C-O 116.852 -1.547 . . . . 0.0 110.027 -175.236 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.464 ' N ' ' HG ' ' A' ' 162' ' ' SER . 33.2 t . . . . . 0 N--CA 1.474 0.756 0 N-CA-C 111.632 0.234 . . . . 0.0 111.632 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 23.7 t70 -62.41 -49.99 73.27 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.027 0.931 . . . . 0.0 110.528 176.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 7.9 t -152.41 -0.76 0.28 Allowed 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.482 0.713 . . . . 0.0 112.919 179.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -90.47 -156.28 32.23 Favored Glycine 0 C--N 1.342 0.889 0 N-CA-C 108.953 -1.659 . . . . 0.0 108.953 176.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.3 ttp180 -73.97 123.01 88.91 Favored Pre-proline 0 CA--C 1.532 0.281 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -176.593 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 79.2 Cg_endo -73.81 -39.99 1.6 Allowed 'Trans proline' 0 N--CA 1.451 -1.018 0 C-N-CA 122.779 2.319 . . . . 0.0 110.135 178.953 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.6 m-85 -59.63 135.94 57.83 Favored 'General case' 0 N--CA 1.454 -0.263 0 C-N-CA 124.081 0.952 . . . . 0.0 110.898 178.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 95.1 t -61.25 -43.78 97.14 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.298 0 N-CA-C 109.268 -0.642 . . . . 0.0 109.268 174.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 40.7 tt0 -146.55 148.05 31.77 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 125.133 1.373 . . . . 0.0 108.176 176.135 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ptm -127.57 165.13 20.52 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.538 1.135 . . . . 0.0 110.546 178.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -60.33 152.09 26.06 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.423 0.689 . . . . 0.0 110.106 169.727 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.1 t -80.26 -69.48 0.59 Allowed 'General case' 0 CA--C 1.531 0.243 0 N-CA-C 109.342 -0.614 . . . . 0.0 109.342 177.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 46.0 mt-10 -143.56 -53.97 0.37 Allowed 'General case' 0 C--N 1.338 0.072 0 C-N-CA 124.937 1.295 . . . . 0.0 108.659 -179.857 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 88.8 mt -72.87 127.93 88.86 Favored Pre-proline 0 N--CA 1.451 -0.417 0 N-CA-C 107.129 -1.434 . . . . 0.0 107.129 176.62 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 62.9 Cg_endo -67.65 119.89 6.91 Favored 'Trans proline' 0 N--CA 1.454 -0.842 0 C-N-CA 122.558 2.172 . . . . 0.0 108.893 178.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 32.5 tt0 -53.8 116.84 2.74 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.118 0.967 . . . . 0.0 109.701 -178.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 4.7 mt -78.49 102.24 4.56 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.376 0 N-CA-C 109.387 -0.598 . . . . 0.0 109.387 -174.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 22.0 mt -92.15 68.66 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 172.945 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 17.6 p80 -59.2 128.32 36.57 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.397 1.079 . . . . 0.0 108.995 174.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -145.14 169.1 18.82 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-O 120.754 0.311 . . . . 0.0 111.732 -170.552 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 15.2 m -112.55 138.48 49.25 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.822 1.249 . . . . 0.0 107.994 175.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -65.91 165.83 12.38 Favored 'General case' 0 CA--C 1.533 0.303 0 C-N-CA 123.166 0.587 . . . . 0.0 111.587 -177.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 86.24 -43.14 3.21 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 123.957 0.789 . . . . 0.0 111.998 178.285 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 4.5 mtm180 -89.18 174.78 7.67 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 124.407 1.083 . . . . 0.0 110.823 -176.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -72.91 160.33 32.3 Favored 'General case' 0 N--CA 1.455 -0.224 0 CA-C-N 115.913 -0.585 . . . . 0.0 112.143 -174.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 49.4 tp -148.9 111.97 4.9 Favored 'General case' 0 N--CA 1.451 -0.387 0 C-N-CA 124.627 1.171 . . . . 0.0 108.608 -177.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 42.3 t -93.02 125.11 45.61 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.264 0 N-CA-C 108.395 -0.965 . . . . 0.0 108.395 176.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -104.81 102.54 35.69 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 106.738 -1.578 . . . . 0.0 106.738 170.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 44.6 Cg_endo -84.13 61.01 6.49 Favored 'Trans proline' 0 N--CA 1.455 -0.746 0 C-N-CA 123.603 2.868 . . . . 0.0 111.591 -167.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 31.8 p -105.16 50.09 0.79 Allowed 'General case' 0 CA--C 1.528 0.127 0 C-N-CA 123.906 0.882 . . . . 0.0 109.327 171.161 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 17.3 ptm180 -66.99 153.92 42.45 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.008 1.323 . . . . 0.0 110.507 174.585 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 24.1 m -116.06 160.37 15.48 Favored 'Isoleucine or valine' 0 C--N 1.338 0.09 0 C-N-CA 124.407 1.083 . . . . 0.0 111.277 -175.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 33.3 p -70.15 -57.45 4.92 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.616 1.167 . . . . 0.0 109.744 176.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.464 ' HG ' ' N ' ' A' ' 129' ' ' SER . 25.4 p -100.07 111.73 62.72 Favored Pre-proline 0 N--CA 1.45 -0.464 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 -178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 82.9 Cg_endo -69.83 -12.84 33.58 Favored 'Trans proline' 0 N--CA 1.458 -0.581 0 C-N-CA 123.615 2.877 . . . . 0.0 113.389 -168.557 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -69.05 -22.85 64.0 Favored 'General case' 0 CA--C 1.533 0.303 0 CA-C-N 118.082 0.401 . . . . 0.0 111.266 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 32.6 mt -78.35 83.46 0.97 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.213 0 N-CA-C 107.763 -1.199 . . . . 0.0 107.763 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 32.9 m -66.3 127.37 31.99 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.353 1.061 . . . . 0.0 109.143 178.049 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 70.2 t -89.59 146.64 5.93 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 124.053 0.941 . . . . 0.0 109.243 -175.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 35.5 m -106.93 111.36 23.82 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.773 1.229 . . . . 0.0 108.153 177.315 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.8 tp -89.37 98.07 11.56 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.971 -0.751 . . . . 0.0 108.971 -177.269 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 71.6 mmtt -89.75 169.84 10.94 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.957 0.903 . . . . 0.0 109.52 174.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 25.3 ttpp -148.63 145.83 27.93 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 123.634 0.774 . . . . 0.0 109.194 169.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 69.8 t80 -56.77 133.76 78.76 Favored Pre-proline 0 CA--C 1.538 0.499 0 CA-C-O 118.647 -0.692 . . . . 0.0 109.653 172.033 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.7 Cg_endo -77.16 -59.89 0.1 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 119.978 1.028 . . . . 0.0 112.057 2.206 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.5 mt -144.23 39.22 1.31 Allowed 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.475 1.11 . . . . 0.0 110.034 -175.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 21.5 t0 -81.93 152.13 26.92 Favored 'General case' 0 CA--C 1.529 0.165 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 174.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.1 m -130.72 108.53 9.95 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.739 1.216 . . . . 0.0 108.309 -179.677 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 5.5 mp -89.74 82.65 6.25 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 124.008 0.923 . . . . 0.0 108.573 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 71.6 mt -64.06 129.14 93.79 Favored Pre-proline 0 CA--C 1.537 0.47 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 177.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -72.48 90.15 0.81 Allowed 'Trans proline' 0 N--CA 1.454 -0.847 0 C-N-CA 122.882 2.388 . . . . 0.0 110.462 -179.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -59.52 -24.21 63.47 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.311 1.444 . . . . 0.0 113.173 179.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 75.61 28.54 61.13 Favored Glycine 0 CA--C 1.529 0.937 0 C-N-CA 123.427 0.537 . . . . 0.0 112.819 176.478 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -137.55 -58.4 0.68 Allowed 'General case' 0 CA--C 1.53 0.209 0 C-N-CA 124.897 1.279 . . . . 0.0 108.385 174.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 50.6 ttt85 -85.1 -55.14 4.2 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 125.197 1.399 . . . . 0.0 108.567 171.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -101.8 100.1 9.72 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.171 0 C-N-CA 125.048 1.339 . . . . 0.0 108.134 -176.583 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 14.3 mm -93.13 118.63 39.28 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.149 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.342 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 8.8 t-105 -89.15 94.36 9.9 Favored 'General case' 0 N--CA 1.456 -0.158 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 175.618 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -89.78 100.91 13.62 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 174.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 37.7 p -56.45 -26.93 55.35 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 -174.812 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.0 mmt85 -114.59 32.16 6.15 Favored 'General case' 0 CA--C 1.536 0.412 0 C-N-CA 125.285 1.434 . . . . 0.0 110.969 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 6.7 tmtt? -150.09 -58.35 0.19 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.301 0.64 . . . . 0.0 110.378 174.304 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 155.68 -171.13 33.65 Favored Glycine 0 CA--C 1.529 0.94 0 C-N-CA 124.691 1.138 . . . . 0.0 110.387 -179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 69.4 m-85 -89.4 106.4 18.42 Favored 'General case' 0 C--N 1.339 0.151 0 N-CA-C 107.612 -1.255 . . . . 0.0 107.612 170.001 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 26.3 mt -89.35 90.89 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 106.975 -1.491 . . . . 0.0 106.975 178.933 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 52.1 mt -79.48 95.14 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 173.233 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 84.1 p -61.66 -25.76 67.59 Favored 'General case' 0 CA--C 1.532 0.283 0 N-CA-C 113.704 1.001 . . . . 0.0 113.704 -170.747 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.9 90.02 2.55 Favored 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 123.788 0.835 . . . . 0.0 108.958 -177.837 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.7 128.32 35.48 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.435 1.094 . . . . 0.0 111.265 -177.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 54.0 p -147.89 179.52 7.66 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 124.976 1.31 . . . . 0.0 109.45 175.445 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.0 p90 -39.18 -35.37 0.23 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 126.91 2.084 . . . . 0.0 113.691 178.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 97.6 mttt -42.87 -44.43 4.51 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 126.517 1.927 . . . . 0.0 112.361 176.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -103.33 -10.09 18.95 Favored 'General case' 0 C--N 1.342 0.27 0 C-N-CA 124.39 1.076 . . . . 0.0 113.847 -176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 50.6 mt -72.87 111.82 7.9 Favored 'Isoleucine or valine' 0 C--N 1.341 0.217 0 CA-C-N 119.415 1.007 . . . . 0.0 109.709 -174.163 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 151.23 -162.15 29.39 Favored Glycine 0 C--N 1.339 0.746 0 N-CA-C 110.656 -0.977 . . . . 0.0 110.656 177.965 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.9 tp -81.77 90.31 6.36 Favored 'General case' 0 N--CA 1.453 -0.294 0 N-CA-C 108.635 -0.876 . . . . 0.0 108.635 176.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 84.5 mt -66.29 146.96 54.0 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 123.829 0.852 . . . . 0.0 108.971 172.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 48.8 m -143.39 99.25 3.4 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 124.48 1.112 . . . . 0.0 108.169 -177.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 85.8 m -72.53 132.18 43.49 Favored 'General case' 0 N--CA 1.456 -0.168 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 170.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.6 mt-10 -126.57 141.62 51.8 Favored 'General case' 0 C--N 1.339 0.137 0 C-N-CA 124.262 1.025 . . . . 0.0 109.826 -179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -149.31 106.5 3.6 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 124.014 0.926 . . . . 0.0 109.708 -178.893 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 87.1 m -91.2 107.17 19.02 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 124.307 1.043 . . . . 0.0 108.609 175.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 51.3 t -79.69 -61.65 1.65 Allowed 'Isoleucine or valine' 0 CA--C 1.529 0.155 0 N-CA-C 108.992 -0.744 . . . . 0.0 108.992 -179.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 83.2 m-20 -130.23 -114.98 0.24 Allowed 'General case' 0 CA--C 1.531 0.25 0 N-CA-C 107.122 -1.436 . . . . 0.0 107.122 175.766 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.39 -17.27 78.86 Favored Glycine 0 CA--C 1.532 1.149 0 N-CA-C 111.712 -0.555 . . . . 0.0 111.712 169.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 39.9 m170 -89.43 107.42 19.06 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.001 0.92 . . . . 0.0 110.275 -173.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 8.1 tt -85.69 101.13 12.48 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 169.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.4 m-85 -89.43 152.28 21.57 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.255 -1.017 . . . . 0.0 108.255 174.19 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 19.9 ptpt -150.36 162.64 40.16 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 122.489 0.315 . . . . 0.0 111.411 175.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.0 t -146.0 135.28 22.89 Favored 'General case' 0 N--CA 1.454 -0.232 0 C-N-CA 123.997 0.919 . . . . 0.0 109.319 172.229 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 4.5 m-80 -112.55 149.79 32.22 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.579 1.152 . . . . 0.0 111.989 -168.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 50.5 m-85 -146.04 133.55 20.85 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 124.643 1.177 . . . . 0.0 109.191 -179.53 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 3.8 tt -102.79 105.68 16.14 Favored 'General case' 0 CA--C 1.528 0.125 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -178.835 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.5 p -89.72 105.58 17.9 Favored 'General case' 0 N--CA 1.454 -0.251 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 178.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.2 t60 -89.26 134.49 34.02 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 124.652 1.181 . . . . 0.0 108.666 177.205 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 75.3 ttt-85 -73.25 80.34 1.32 Allowed 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 124.584 1.154 . . . . 0.0 109.529 176.685 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 36.1 tt0 -87.03 70.41 10.27 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.619 1.168 . . . . 0.0 109.186 179.565 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 41.7 p -90.83 53.5 2.42 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.177 -1.045 . . . . 0.0 108.177 170.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 1.7 t30 -89.78 65.03 6.66 Favored 'General case' 0 C--N 1.34 0.192 0 C-N-CA 124.049 0.94 . . . . 0.0 108.591 -175.828 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.9 p -85.65 62.29 7.37 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.163 0.985 . . . . 0.0 108.669 179.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.498 -1.239 . . . . 0.0 108.818 -175.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 8.8 t . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 110.873 -0.047 . . . . 0.0 110.873 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.51 -41.36 94.19 Favored 'General case' 0 CA--C 1.531 0.244 0 C-N-CA 124.87 1.268 . . . . 0.0 110.476 174.674 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 35.2 p -65.67 -46.16 80.15 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.476 1.11 . . . . 0.0 111.207 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -107.8 -140.42 9.41 Favored Glycine 0 CA--C 1.527 0.783 0 C-N-CA 124.107 0.86 . . . . 0.0 111.342 -176.78 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 50.1 ttp180 -84.94 132.9 44.43 Favored Pre-proline 0 CA--C 1.535 0.387 0 C-N-CA 124.76 1.224 . . . . 0.0 108.351 175.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -74.49 -169.65 0.63 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.598 2.865 . . . . 0.0 110.905 177.206 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 40.3 m-85 75.88 103.76 0.07 Allowed 'General case' 0 N--CA 1.457 -0.081 0 C-N-CA 126.045 1.738 . . . . 0.0 111.782 175.433 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 86.0 t -61.12 -48.78 87.48 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.254 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 170.521 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 11.1 tp10 -105.55 111.28 23.92 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.5 -1.296 . . . . 0.0 107.5 173.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 26.8 ptm -120.28 156.35 31.42 Favored 'General case' 0 C--N 1.34 0.194 0 C-N-CA 124.074 0.95 . . . . 0.0 110.113 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -179.54 2.32 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 123.72 0.808 . . . . 0.0 110.82 174.407 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 14.7 m -142.98 -154.77 0.54 Allowed 'General case' 0 N--CA 1.453 -0.297 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 173.677 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.7 mt-10 -69.98 92.46 0.72 Allowed 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.156 -0.683 . . . . 0.0 109.156 176.11 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 45.6 mt 114.43 117.43 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.476 0 C-N-CA 131.485 3.914 . . . . 0.0 107.122 -178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_exo -49.44 142.0 24.11 Favored 'Trans proline' 0 C--N 1.349 0.554 0 C-N-CA 124.212 3.275 . . . . 0.0 113.366 176.279 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -67.94 110.57 3.94 Favored 'General case' 0 N--CA 1.454 -0.272 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 177.109 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mt -74.03 133.01 32.47 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 179.712 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 42.4 mt -125.8 115.7 43.83 Favored 'Isoleucine or valine' 0 C--N 1.34 0.164 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 94.6 m-70 -78.47 86.9 4.48 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.026 0.93 . . . . 0.0 109.385 177.068 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 18.8 ptm -89.61 158.9 17.42 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 124.193 0.997 . . . . 0.0 111.148 -178.419 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 89.5 m -124.57 108.23 11.86 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 174.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 16.9 pt-20 -63.48 152.1 39.37 Favored 'General case' 0 N--CA 1.454 -0.233 0 CA-C-O 120.91 0.386 . . . . 0.0 111.023 -179.344 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 97.94 -34.52 5.14 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.379 -1.089 . . . . 0.0 110.379 -170.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 14.7 mmp_? -89.47 177.23 6.62 Favored 'General case' 0 C--N 1.341 0.221 0 C-N-CA 124.271 1.028 . . . . 0.0 110.523 -175.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.1 tt0 -74.78 135.37 41.72 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 123.438 0.695 . . . . 0.0 109.44 172.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 55.7 tp -130.01 109.64 11.02 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.755 1.222 . . . . 0.0 109.192 -177.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.6 t -89.94 122.96 41.88 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 172.35 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 43.4 mm -93.17 108.45 33.02 Favored Pre-proline 0 CA--C 1.535 0.381 0 N-CA-C 107.407 -1.331 . . . . 0.0 107.407 172.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -79.39 84.03 2.13 Favored 'Trans proline' 0 N--CA 1.453 -0.88 0 C-N-CA 123.414 2.742 . . . . 0.0 110.381 -171.469 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.9 p -140.45 45.88 1.82 Allowed 'General case' 0 CA--C 1.527 0.084 0 C-N-CA 123.777 0.831 . . . . 0.0 109.801 176.614 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.655 ' HB2' ' O ' ' A' ' 188' ' ' SER . 38.6 ptt180 -69.03 157.8 36.06 Favored 'General case' 0 N--CA 1.453 -0.304 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.361 -178.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 33.5 m -129.98 175.55 10.54 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.367 0 C-N-CA 125.706 1.603 . . . . 0.0 109.459 -176.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 27.0 p -73.33 -71.94 0.28 Allowed 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 123.406 0.682 . . . . 0.0 110.413 179.757 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -99.66 151.21 37.38 Favored Pre-proline 0 CA--C 1.532 0.285 0 C-N-CA 124.501 1.121 . . . . 0.0 110.639 -173.049 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -66.98 -30.24 39.58 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 122.871 2.381 . . . . 0.0 110.794 172.493 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.6 m120 -50.76 -30.57 14.37 Favored 'General case' 0 C--N 1.342 0.246 0 C-N-CA 126.2 1.8 . . . . 0.0 112.827 177.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 40.5 mm -50.27 -41.31 18.91 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.358 0 C-N-CA 124.825 1.25 . . . . 0.0 111.047 175.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 61.07 80.98 0.2 Allowed 'General case' 0 C--N 1.342 0.246 0 C-N-CA 125.08 1.352 . . . . 0.0 110.686 175.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 34.3 t -89.55 138.99 18.19 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.187 0 N-CA-C 109.023 -0.732 . . . . 0.0 109.023 -178.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.9 m -118.74 129.29 55.18 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.087 1.355 . . . . 0.0 107.951 175.047 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 59.6 tp -89.47 100.89 13.59 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.562 -0.903 . . . . 0.0 108.562 -179.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 74.2 mmtt -89.39 168.88 11.87 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 124.749 1.22 . . . . 0.0 109.949 178.195 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 21.8 tptm -143.96 137.69 27.94 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 125.526 1.53 . . . . 0.0 107.865 177.468 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 68.8 t80 -60.58 134.32 91.68 Favored Pre-proline 0 CA--C 1.538 0.481 0 CA-C-O 118.631 -0.7 . . . . 0.0 110.556 -179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -76.4 -59.72 0.11 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.659 0 CA-C-N 119.901 1.0 . . . . 0.0 112.01 -0.811 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.4 mt -141.07 40.51 1.79 Allowed 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.589 1.156 . . . . 0.0 110.164 -175.518 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -86.56 167.42 14.61 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 169.807 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 22.8 m -146.78 133.27 19.73 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 122.627 0.371 . . . . 0.0 110.723 -173.043 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -100.24 87.5 3.46 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 125.527 1.531 . . . . 0.0 107.089 175.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 31.3 mm -61.85 129.37 91.62 Favored Pre-proline 0 CA--C 1.537 0.46 0 C-N-CA 123.963 0.905 . . . . 0.0 109.544 -176.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 95.6 Cg_endo -74.29 79.83 2.35 Favored 'Trans proline' 0 N--CA 1.455 -0.766 0 C-N-CA 123.261 2.641 . . . . 0.0 110.382 178.764 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -61.61 -25.72 67.52 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 125.412 1.485 . . . . 0.0 113.318 -179.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.43 43.22 54.44 Favored Glycine 0 CA--C 1.527 0.829 0 N-CA-C 111.48 -0.648 . . . . 0.0 111.48 179.81 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 16.2 tppt? -150.09 -57.79 0.18 Allowed 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 124.746 1.218 . . . . 0.0 108.317 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.9 ttt-85 -95.95 -49.87 5.11 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.383 1.473 . . . . 0.0 107.914 169.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 15.4 mt -103.0 93.52 2.72 Favored 'Isoleucine or valine' 0 C--N 1.34 0.194 0 C-N-CA 124.43 1.092 . . . . 0.0 108.424 -176.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -90.8 119.71 38.42 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.16 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 176.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -90.0 100.6 13.39 Favored 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 123.152 0.581 . . . . 0.0 109.496 175.71 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -95.79 108.17 20.48 Favored 'General case' 0 N--CA 1.454 -0.235 0 N-CA-C 107.497 -1.298 . . . . 0.0 107.497 172.006 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.655 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 53.3 p -55.67 -35.12 65.64 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 123.362 0.665 . . . . 0.0 112.392 179.838 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 21.2 mmt180 -101.29 21.53 13.93 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 123.935 0.894 . . . . 0.0 112.661 -176.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 37.7 ttpt -145.9 -55.88 0.29 Allowed 'General case' 0 C--N 1.343 0.285 0 CA-C-N 118.658 0.663 . . . . 0.0 111.51 171.249 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 159.19 -172.98 35.97 Favored Glycine 0 CA--C 1.527 0.815 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -177.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 91.1 m-85 -89.61 112.63 23.92 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 170.003 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 3.7 mp -93.54 97.05 6.64 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.352 0 C-N-CA 124.472 1.109 . . . . 0.0 108.599 179.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.4 mp -84.71 98.48 6.08 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.226 0 N-CA-C 106.635 -1.617 . . . . 0.0 106.635 169.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 88.4 p -59.02 -35.21 72.89 Favored 'General case' 0 CA--C 1.532 0.284 0 C-N-CA 124.541 1.136 . . . . 0.0 113.303 -173.014 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.2 t-20 -130.32 81.73 2.02 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 124.527 1.131 . . . . 0.0 108.337 179.188 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -63.12 156.77 24.05 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 123.381 0.672 . . . . 0.0 111.734 -177.671 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 70.3 p -145.66 -178.4 6.08 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.21 1.404 . . . . 0.0 109.06 -177.952 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.2 p90 -54.74 -32.54 59.91 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.127 0.971 . . . . 0.0 112.376 174.717 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -54.4 -31.45 55.06 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 123.494 0.718 . . . . 0.0 111.872 176.162 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 14.8 mp0 -81.7 -40.62 22.53 Favored 'General case' 0 N--CA 1.455 -0.208 0 CA-C-O 118.718 -0.658 . . . . 0.0 110.519 175.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 70.1 mt -58.11 119.27 2.88 Favored 'Isoleucine or valine' 0 C--N 1.344 0.345 0 CA-C-N 118.467 0.576 . . . . 0.0 109.668 -175.806 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 126.34 -160.51 20.72 Favored Glycine 0 CA--C 1.526 0.747 0 C-N-CA 124.352 0.977 . . . . 0.0 111.178 177.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 41.1 tp -79.26 84.36 5.21 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.142 0.977 . . . . 0.0 111.142 -172.366 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 43.5 mt -75.61 153.83 37.04 Favored 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 169.267 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.4 m -148.88 115.35 5.88 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 109.355 -0.609 . . . . 0.0 109.355 179.478 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 28.0 m -81.15 125.92 30.84 Favored 'General case' 0 C--N 1.339 0.133 0 N-CA-C 107.599 -1.259 . . . . 0.0 107.599 172.174 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 76.4 mt-10 -128.19 148.18 50.6 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.68 0.792 . . . . 0.0 110.517 -176.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -156.29 133.1 10.36 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 123.265 0.626 . . . . 0.0 110.857 -178.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 44.6 m -89.66 114.65 26.31 Favored 'General case' 0 C--N 1.34 0.157 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 175.212 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.4 t -133.17 141.52 44.46 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.128 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -178.309 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 71.4 m-80 64.78 -76.93 0.04 OUTLIER 'General case' 0 C--N 1.343 0.287 0 C-N-CA 126.304 1.842 . . . . 0.0 110.269 -172.574 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -171.8 44.45 0.18 Allowed Glycine 0 CA--C 1.526 0.771 0 N-CA-C 108.24 -1.944 . . . . 0.0 108.24 172.666 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 37.2 t-80 -150.05 127.69 11.62 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.572 1.149 . . . . 0.0 108.741 -172.141 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 55.2 tp -81.03 102.54 10.26 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.123 0.969 . . . . 0.0 108.829 176.4 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 98.9 m-85 -89.23 153.39 20.95 Favored 'General case' 0 N--CA 1.457 -0.103 0 N-CA-C 108.763 -0.829 . . . . 0.0 108.763 175.549 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 64.4 mttm -140.3 153.38 46.44 Favored 'General case' 0 N--CA 1.455 -0.183 0 C-N-CA 124.474 1.11 . . . . 0.0 109.953 -173.718 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.7 t -149.35 122.81 9.08 Favored 'General case' 0 N--CA 1.454 -0.268 0 C-N-CA 123.365 0.666 . . . . 0.0 109.348 169.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -98.27 148.23 23.84 Favored 'General case' 0 N--CA 1.456 -0.132 0 C-N-CA 125.117 1.367 . . . . 0.0 112.169 -169.716 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 88.8 m-85 -142.65 103.49 4.23 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 125.297 1.439 . . . . 0.0 108.56 179.29 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -80.29 94.38 6.09 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.166 -1.42 . . . . 0.0 107.166 174.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 81.2 p -88.39 99.08 11.99 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -172.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 83.4 t60 -89.47 172.1 9.24 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 124.596 1.158 . . . . 0.0 109.706 -177.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 10.8 mpt_? -67.17 -88.04 0.01 OUTLIER 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.466 1.106 . . . . 0.0 109.585 173.701 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.3 pt20 -159.66 168.28 26.39 Favored 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.075 -0.966 . . . . 0.0 111.045 -171.459 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 41.2 p -79.27 54.07 1.61 Allowed 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.433 1.493 . . . . 0.0 110.82 -177.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 24.5 m120 -147.3 -48.1 0.18 Allowed 'General case' 0 N--CA 1.456 -0.169 0 C-N-CA 126.878 2.071 . . . . 0.0 107.048 179.369 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 32.1 m -61.1 -60.04 4.39 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 169.537 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 25.1 mm . . . . . 0 C--O 1.25 1.131 0 N-CA-C 106.436 -1.69 . . . . 0.0 106.436 169.1 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 61.2 p . . . . . 0 N--CA 1.474 0.755 0 N-CA-C 111.952 0.353 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 5.1 m-20 -83.05 74.59 9.96 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.534 1.134 . . . . 0.0 109.576 -178.548 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 11.8 t -59.7 157.1 12.53 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 125.298 1.439 . . . . 0.0 111.59 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -63.82 -39.31 97.28 Favored Glycine 0 CA--C 1.53 1.016 0 C-N-CA 123.676 0.655 . . . . 0.0 111.68 177.473 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 40.0 ttm180 -145.63 134.18 10.9 Favored Pre-proline 0 N--CA 1.453 -0.287 0 N-CA-C 107.382 -1.34 . . . . 0.0 107.382 175.817 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 30.7 Cg_endo -61.93 -62.24 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.043 0 C-N-CA 122.662 2.241 . . . . 0.0 110.549 177.556 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 77.7 m-85 -75.14 130.22 38.85 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.18 0.992 . . . . 0.0 112.327 -173.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 54.9 t -84.11 -59.82 2.57 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.189 0 N-CA-C 106.571 -1.64 . . . . 0.0 106.571 169.21 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 76.7 tt0 -91.74 123.84 35.43 Favored 'General case' 0 N--CA 1.452 -0.369 0 N-CA-C 108.286 -1.005 . . . . 0.0 108.286 177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ptm -152.03 166.23 32.21 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 123.834 0.854 . . . . 0.0 110.282 -179.813 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -73.14 -170.75 0.8 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 124.305 1.042 . . . . 0.0 110.971 175.012 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 39.8 t -123.08 -68.85 0.86 Allowed 'General case' 0 N--CA 1.453 -0.303 0 N-CA-C 107.674 -1.232 . . . . 0.0 107.674 169.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 80.9 mm-40 -136.42 -52.81 0.72 Allowed 'General case' 0 C--N 1.339 0.117 0 C-N-CA 125.01 1.324 . . . . 0.0 109.063 178.041 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 33.1 mm -72.78 130.54 85.22 Favored Pre-proline 0 CA--C 1.535 0.391 0 N-CA-C 108.211 -1.033 . . . . 0.0 108.211 179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 74.9 Cg_endo -70.26 149.76 64.18 Favored 'Trans proline' 0 N--CA 1.455 -0.771 0 C-N-CA 122.594 2.196 . . . . 0.0 109.989 178.493 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -66.73 121.29 15.11 Favored 'General case' 0 CA--C 1.53 0.175 0 N-CA-C 109.128 -0.693 . . . . 0.0 109.128 179.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 40.4 mm -80.8 110.35 16.21 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.202 0 C-N-CA 123.907 0.883 . . . . 0.0 108.755 -178.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 20.2 mt -116.37 93.52 2.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 N-CA-C 108.3 -1.0 . . . . 0.0 108.3 177.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 5.3 p80 -74.72 81.77 2.07 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.24 1.016 . . . . 0.0 109.237 172.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.6 170.53 10.4 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 123.61 0.764 . . . . 0.0 111.89 -169.752 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 17.9 m -121.61 118.41 29.13 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 124.818 1.247 . . . . 0.0 108.165 176.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.1 149.79 22.74 Favored 'General case' 0 CA--C 1.532 0.274 0 C-N-CA 122.747 0.419 . . . . 0.0 110.687 176.888 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 85.97 -34.0 3.46 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 123.718 0.675 . . . . 0.0 112.079 -174.325 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 51.9 mmt-85 -89.82 176.11 6.96 Favored 'General case' 0 C--N 1.341 0.233 0 C-N-CA 123.857 0.863 . . . . 0.0 110.854 -175.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.18 144.07 53.87 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 123.213 0.605 . . . . 0.0 111.706 178.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.6 tp -140.69 105.14 4.87 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 125.297 1.439 . . . . 0.0 107.718 -178.421 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 47.2 t -89.85 132.01 35.62 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 N-CA-C 108.06 -1.089 . . . . 0.0 108.06 175.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.8 mm -108.99 94.61 15.15 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 105.975 -1.861 . . . . 0.0 105.975 169.734 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -84.66 66.33 6.54 Favored 'Trans proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.319 2.68 . . . . 0.0 111.741 -166.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.6 p -100.83 58.73 0.92 Allowed 'General case' 0 N--CA 1.456 -0.126 0 C-N-CA 124.125 0.97 . . . . 0.0 108.756 171.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 7.1 ptm180 -69.95 155.69 40.21 Favored 'General case' 0 N--CA 1.452 -0.369 0 CA-C-N 116.027 -0.533 . . . . 0.0 111.623 -175.112 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 18.2 m -117.61 169.34 8.24 Favored 'Isoleucine or valine' 0 C--N 1.338 0.102 0 C-N-CA 124.574 1.149 . . . . 0.0 111.953 -173.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 17.6 p -67.89 -65.69 0.66 Allowed 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 125.044 1.338 . . . . 0.0 110.072 178.792 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 49.2 m -111.97 149.98 41.69 Favored Pre-proline 0 CA--C 1.535 0.394 0 C-N-CA 124.647 1.179 . . . . 0.0 110.398 -173.483 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -66.86 -27.62 43.5 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 123.516 2.81 . . . . 0.0 112.889 -176.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 3.7 p-10 -63.06 -16.69 60.74 Favored 'General case' 0 CA--C 1.534 0.345 0 N-CA-C 112.706 0.632 . . . . 0.0 112.706 177.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 30.9 mm -77.27 83.06 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 177.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 55.8 m -73.34 113.3 10.26 Favored 'General case' 0 N--CA 1.453 -0.299 0 N-CA-C 108.502 -0.925 . . . . 0.0 108.502 174.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 56.9 t -89.41 142.59 12.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 C-N-CA 123.772 0.829 . . . . 0.0 109.256 -176.728 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 61.6 m -98.97 111.8 24.09 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 175.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 52.3 tp -89.26 100.32 13.13 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 108.628 -0.878 . . . . 0.0 108.628 -177.463 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 33.4 mmtp -89.75 168.43 12.1 Favored 'General case' 0 N--CA 1.455 -0.197 0 C-N-CA 123.32 0.648 . . . . 0.0 110.382 175.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.8 tttp -143.96 145.63 32.38 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.979 1.312 . . . . 0.0 108.342 171.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -58.19 134.25 84.5 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 124.007 0.923 . . . . 0.0 110.772 -177.025 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -77.37 -59.13 0.13 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.665 0 CA-C-N 119.784 0.959 . . . . 0.0 111.745 0.071 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.6 mt -140.89 38.89 1.8 Allowed 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 124.741 1.217 . . . . 0.0 109.859 -176.882 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 59.9 m-20 -79.19 158.85 27.59 Favored 'General case' 0 CA--C 1.529 0.159 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 172.052 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 29.4 m -131.44 126.02 34.02 Favored 'General case' 0 CA--C 1.529 0.144 0 C-N-CA 123.76 0.824 . . . . 0.0 109.232 -178.2 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.5 mp -98.83 99.56 10.65 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.171 1.388 . . . . 0.0 107.533 178.202 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 2.1 mp -68.32 128.81 93.09 Favored Pre-proline 0 CA--C 1.537 0.446 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -178.585 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -73.39 85.3 1.28 Allowed 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 122.892 2.395 . . . . 0.0 109.825 175.716 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.9 p30 -59.84 -22.31 62.09 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 125.171 1.388 . . . . 0.0 113.246 -179.448 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 76.84 26.29 62.91 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-O 119.575 -0.569 . . . . 0.0 112.679 176.238 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 98.8 mttt -137.38 -63.77 0.58 Allowed 'General case' 0 C--N 1.339 0.138 0 C-N-CA 124.827 1.251 . . . . 0.0 108.365 177.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 59.7 ttp85 -85.44 -60.09 2.13 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 108.16 -1.052 . . . . 0.0 108.16 172.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 27.4 mt -89.81 93.37 4.32 Favored 'Isoleucine or valine' 0 C--N 1.341 0.215 0 N-CA-C 107.549 -1.278 . . . . 0.0 107.549 176.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 41.6 mt -95.89 118.12 41.49 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.162 0 N-CA-C 108.226 -1.027 . . . . 0.0 108.226 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -88.95 96.36 10.69 Favored 'General case' 0 C--N 1.34 0.154 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 -179.979 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -93.33 105.13 17.23 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 106.885 -1.524 . . . . 0.0 106.885 174.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 49.7 p -51.68 -51.26 57.35 Favored 'General case' 0 N--CA 1.456 -0.151 0 C-N-CA 124.082 0.953 . . . . 0.0 112.9 -169.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 90.7 mtt180 -95.07 28.97 2.57 Favored 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 123.764 0.825 . . . . 0.0 112.382 -174.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 23.3 tptm -144.95 -60.39 0.36 Allowed 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.765 0.826 . . . . 0.0 110.987 179.281 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 158.45 -176.09 35.45 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.348 -0.701 . . . . 0.0 111.348 -179.612 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 87.3 m-85 -89.36 107.52 19.11 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 107.291 -1.374 . . . . 0.0 107.291 169.927 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.7 mt -89.32 95.44 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.409 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 -178.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 40.5 mt -82.14 87.69 1.86 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.329 0 N-CA-C 105.873 -1.899 . . . . 0.0 105.873 172.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 86.4 p -56.39 -31.55 63.96 Favored 'General case' 0 CA--C 1.53 0.173 0 C-N-CA 124.713 1.205 . . . . 0.0 113.702 -169.8 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 31.5 m120 -139.74 86.97 2.14 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -179.672 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -61.8 162.12 9.24 Favored 'General case' 0 N--CA 1.453 -0.285 0 C-N-CA 123.81 0.844 . . . . 0.0 111.43 -179.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 69.6 p -126.8 153.16 45.97 Favored 'General case' 0 N--CA 1.455 -0.187 0 C-N-CA 124.171 0.988 . . . . 0.0 108.801 174.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.5 p90 -53.62 -32.62 52.03 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.01 0.924 . . . . 0.0 111.829 177.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 96.2 mttt -55.74 -36.23 67.04 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 124.524 1.129 . . . . 0.0 111.82 177.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 52.8 mt-10 -78.44 -0.37 29.02 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.125 0.97 . . . . 0.0 112.938 -175.675 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 96.0 mt -72.64 121.72 23.75 Favored 'Isoleucine or valine' 0 C--N 1.341 0.221 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 174.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 162.28 -116.51 0.72 Allowed Glycine 0 CA--C 1.525 0.663 0 N-CA-C 109.676 -1.37 . . . . 0.0 109.676 178.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 60.1 tp -143.77 107.32 4.61 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.056 0.942 . . . . 0.0 109.164 -174.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.8 mp -91.1 152.24 20.69 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 173.887 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 87.1 m -142.33 109.79 5.68 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 124.138 0.975 . . . . 0.0 108.389 -178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 77.6 m -76.78 136.38 38.99 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 172.089 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 75.9 mt-10 -130.7 142.63 50.43 Favored 'General case' 0 CA--C 1.529 0.154 0 C-N-CA 124.392 1.077 . . . . 0.0 110.185 -178.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.27 156.25 39.3 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.428 1.091 . . . . 0.0 109.516 177.256 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.5 m -142.19 127.25 18.44 Favored 'General case' 0 N--CA 1.456 -0.128 0 N-CA-C 108.242 -1.022 . . . . 0.0 108.242 -179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 40.1 t -132.02 -76.69 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 C-N-CA 123.566 0.746 . . . . 0.0 109.233 -179.228 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 44.5 m-80 -88.37 52.52 2.47 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 123.618 0.767 . . . . 0.0 110.738 -170.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.98 44.44 56.23 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 124.216 0.913 . . . . 0.0 111.669 -176.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 29.0 t-80 -150.09 128.78 12.37 Favored 'General case' 0 N--CA 1.454 -0.246 0 C-N-CA 124.539 1.136 . . . . 0.0 108.35 -174.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 59.4 tp -79.29 104.31 9.82 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 108.985 -0.746 . . . . 0.0 108.985 176.342 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 72.1 m-85 -89.61 139.05 30.93 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 171.694 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 20.0 ptpt -150.78 166.1 31.52 Favored 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 117.866 0.303 . . . . 0.0 111.442 174.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -155.57 137.47 14.46 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.917 0.887 . . . . 0.0 109.779 178.176 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 30.8 m120 -105.86 143.26 34.26 Favored 'General case' 0 C--N 1.343 0.289 0 C-N-CA 125.227 1.411 . . . . 0.0 112.75 -169.004 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 81.7 m-85 -139.97 103.55 4.66 Favored 'General case' 0 C--N 1.342 0.25 0 C-N-CA 125.586 1.555 . . . . 0.0 108.571 -176.055 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 11.7 tp -78.61 109.51 12.88 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 108.432 -0.951 . . . . 0.0 108.432 -179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.1 p -89.27 97.7 11.35 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 177.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 51.8 t-80 -89.36 160.42 16.85 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 124.787 1.235 . . . . 0.0 108.695 177.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 49.8 ttt85 -80.12 -116.71 0.02 OUTLIER 'General case' 0 CA--C 1.535 0.403 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 172.852 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 5.9 pt20 -174.21 -169.42 0.46 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 124.839 1.256 . . . . 0.0 108.324 -177.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.4 p -74.8 78.09 2.09 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 169.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 11.7 p-10 -88.77 79.08 7.52 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.758 0.79 . . . . 0.0 109.143 -173.197 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 62.2 p -53.23 -45.23 68.61 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.611 1.164 . . . . 0.0 110.739 178.24 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 1.8 mp . . . . . 0 C--O 1.251 1.144 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 169.783 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 46.3 m . . . . . 0 N--CA 1.474 0.744 0 N-CA-C 111.592 0.219 . . . . 0.0 111.592 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 8.9 m-20 -59.04 -52.26 66.52 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 123.657 0.783 . . . . 0.0 109.719 176.455 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 16.5 m -85.3 61.85 7.12 Favored 'General case' 0 CA--C 1.534 0.34 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 173.688 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.67 -92.76 0.6 Allowed Glycine 0 C--N 1.339 0.707 0 N-CA-C 110.272 -1.131 . . . . 0.0 110.272 -175.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 49.3 ttp180 -171.03 133.77 0.93 Allowed Pre-proline 0 CA--C 1.535 0.392 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 177.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -68.06 -47.23 1.84 Allowed 'Trans proline' 0 N--CA 1.454 -0.838 0 C-N-CA 122.913 2.408 . . . . 0.0 110.633 176.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 57.6 m-85 -69.6 143.45 53.3 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.066 0.946 . . . . 0.0 111.995 -175.53 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 68.8 t -79.25 -52.46 15.07 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 169.277 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 51.1 tt0 -109.58 122.77 48.17 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 125.577 1.551 . . . . 0.0 108.842 179.727 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.4 ptm -122.3 157.6 31.38 Favored 'General case' 0 C--N 1.339 0.145 0 C-N-CA 124.146 0.978 . . . . 0.0 109.736 170.744 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.409 ' CD1' ' HA ' ' A' ' 218' ' ' THR . 0.2 OUTLIER -71.24 162.77 28.88 Favored 'General case' 0 CA--C 1.53 0.211 0 C-N-CA 122.849 0.46 . . . . 0.0 110.717 173.858 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 23.0 t -92.62 -136.66 0.17 Allowed 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 173.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 12.9 mm-40 -97.26 106.52 18.86 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 107.085 -1.45 . . . . 0.0 107.085 168.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 25.4 mm 119.73 122.3 0.0 OUTLIER Pre-proline 0 CA--C 1.535 0.39 0 C-N-CA 131.688 3.995 . . . . 0.0 107.332 172.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_exo -44.81 139.29 7.77 Favored 'Trans proline' 0 C--N 1.35 0.607 0 C-N-CA 124.668 3.579 . . . . 0.0 114.101 178.241 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -65.45 119.2 10.6 Favored 'General case' 0 CA--C 1.532 0.262 0 C-N-CA 123.225 0.61 . . . . 0.0 110.213 -175.921 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 47.3 mm -76.77 103.34 3.98 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.325 0 C-N-CA 125.201 1.4 . . . . 0.0 108.861 -178.504 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 53.0 mt -108.89 123.96 65.13 Favored 'Isoleucine or valine' 0 C--N 1.341 0.235 0 C-N-CA 124.46 1.104 . . . . 0.0 109.205 178.852 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 16.7 m-70 -81.47 91.98 6.4 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.02 1.328 . . . . 0.0 108.726 175.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 13.9 ptm -89.3 168.34 12.33 Favored 'General case' 0 CA--C 1.532 0.257 0 CA-C-O 120.991 0.424 . . . . 0.0 111.803 -177.692 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 21.4 m -136.67 142.58 43.18 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 125.23 1.412 . . . . 0.0 108.637 -179.087 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 36.4 mm-40 -66.64 148.63 51.64 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 123.941 0.897 . . . . 0.0 110.85 177.543 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 83.34 -41.58 2.93 Favored Glycine 0 CA--C 1.528 0.894 0 C-N-CA 123.564 0.602 . . . . 0.0 113.228 171.147 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 68.8 mtm180 -88.64 -179.05 5.95 Favored 'General case' 0 C--O 1.232 0.165 0 C-N-CA 123.437 0.695 . . . . 0.0 110.586 -170.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -72.2 156.22 39.38 Favored 'General case' 0 N--CA 1.453 -0.311 0 CA-C-N 116.159 -0.473 . . . . 0.0 111.131 178.517 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 20.5 tp -150.01 111.41 4.44 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.609 -1.256 . . . . 0.0 107.609 -176.389 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 38.2 t -89.59 134.88 27.52 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.143 0 N-CA-C 109.152 -0.684 . . . . 0.0 109.152 -176.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 29.5 mm -109.67 93.32 13.99 Favored Pre-proline 0 CA--C 1.537 0.462 0 N-CA-C 106.39 -1.707 . . . . 0.0 106.39 170.804 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -78.63 77.72 3.94 Favored 'Trans proline' 0 N--CA 1.457 -0.647 0 C-N-CA 123.452 2.768 . . . . 0.0 112.163 -166.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.3 p -124.6 46.84 2.22 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 125.449 1.5 . . . . 0.0 109.814 173.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 188' ' ' SER . 29.4 ptt-85 -63.01 158.45 19.37 Favored 'General case' 0 N--CA 1.456 -0.168 0 C-N-CA 123.873 0.869 . . . . 0.0 111.006 176.757 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.2 m -114.31 155.22 15.55 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.121 0 C-N-CA 124.427 1.091 . . . . 0.0 111.51 -174.279 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 25.0 p -57.68 -61.31 2.6 Favored 'General case' 0 N--CA 1.452 -0.352 0 C-N-CA 125.115 1.366 . . . . 0.0 109.873 177.276 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 32.8 t -98.56 120.33 59.39 Favored Pre-proline 0 CA--C 1.534 0.351 0 C-N-CA 124.291 1.037 . . . . 0.0 108.957 176.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_exo -44.76 -32.69 6.31 Favored 'Trans proline' 0 C--N 1.347 0.48 0 C-N-CA 125.08 3.853 . . . . 0.0 114.912 174.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 56.0 m-80 -57.97 -27.96 63.93 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.591 1.156 . . . . 0.0 112.657 -178.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 73.7 mt -73.6 94.7 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 108.846 -0.798 . . . . 0.0 108.846 -177.955 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 33.2 m -71.28 118.12 13.67 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 175.077 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.2 t -89.61 147.9 4.9 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.171 0 C-N-CA 124.063 0.945 . . . . 0.0 109.18 -178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 66.3 m -101.75 111.24 23.43 Favored 'General case' 0 N--CA 1.455 -0.186 0 C-N-CA 124.379 1.072 . . . . 0.0 108.229 176.83 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 57.4 tp -89.33 102.63 15.3 Favored 'General case' 0 N--CA 1.455 -0.195 0 N-CA-C 108.801 -0.814 . . . . 0.0 108.801 -179.485 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.0 mmtp -89.92 168.29 12.15 Favored 'General case' 0 N--CA 1.454 -0.258 0 C-N-CA 123.73 0.812 . . . . 0.0 110.183 172.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 60.7 tttp -146.61 146.25 30.36 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 124.75 1.22 . . . . 0.0 108.214 170.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.3 t80 -58.36 134.65 85.14 Favored Pre-proline 0 CA--C 1.538 0.502 0 C-N-CA 123.915 0.886 . . . . 0.0 110.777 -176.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.6 Cg_endo -77.33 -59.25 0.13 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.685 0 CA-C-N 119.737 0.942 . . . . 0.0 111.857 0.556 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.0 mt -141.05 38.82 1.77 Allowed 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 124.729 1.212 . . . . 0.0 109.715 -176.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 58.8 m-20 -78.23 155.14 30.46 Favored 'General case' 0 N--CA 1.456 -0.165 0 N-CA-C 108.533 -0.914 . . . . 0.0 108.533 173.015 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 61.9 m -127.63 113.71 16.42 Favored 'General case' 0 CA--C 1.528 0.124 0 C-N-CA 124.05 0.94 . . . . 0.0 109.101 -177.74 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.8 mp -89.78 87.57 7.03 Favored 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 177.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 81.9 mt -62.9 133.92 95.46 Favored Pre-proline 0 CA--C 1.537 0.447 0 C-N-CA 124.169 0.988 . . . . 0.0 108.836 -178.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -70.89 83.75 0.88 Allowed 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 123.39 2.726 . . . . 0.0 110.779 178.722 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 51.6 p-10 -69.61 -18.05 63.58 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.823 1.249 . . . . 0.0 113.069 -179.742 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 68.7 31.8 73.68 Favored Glycine 0 CA--C 1.53 0.982 0 N-CA-C 111.84 -0.504 . . . . 0.0 111.84 -177.288 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 60.2 mtmt -133.59 -71.86 0.51 Allowed 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 177.542 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 32.8 ttm180 -82.94 -56.2 3.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.969 -1.123 . . . . 0.0 107.969 169.649 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 13.5 mm -89.31 84.41 2.32 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 -174.326 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 73.9 mt -93.7 114.08 29.7 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 179.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 9.7 t-105 -89.07 94.81 10.07 Favored 'General case' 0 N--CA 1.457 -0.117 0 C-N-CA 123.229 0.611 . . . . 0.0 109.74 -175.781 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.8 t0 -89.84 95.81 10.4 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 171.422 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.465 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 77.7 p -58.46 -21.39 51.27 Favored 'General case' 0 CA--C 1.534 0.359 0 N-CA-C 114.07 1.137 . . . . 0.0 114.07 -175.167 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 27.4 mmm180 -108.66 24.89 12.41 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 124.677 1.191 . . . . 0.0 111.856 178.908 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 81.0 tttt -147.03 -57.56 0.26 Allowed 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.453 0.701 . . . . 0.0 110.264 172.286 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.21 -168.95 35.97 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 125.227 1.394 . . . . 0.0 109.878 -178.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 89.0 m-85 -89.0 114.36 25.54 Favored 'General case' 0 C--N 1.339 0.142 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 169.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 56.4 mt -89.15 96.95 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.59 0 N-CA-C 106.199 -1.778 . . . . 0.0 106.199 -179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 21.8 mm -75.87 80.68 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.362 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 173.195 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 90.7 p -56.92 -35.33 68.9 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.829 1.252 . . . . 0.0 113.292 -169.579 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 2.7 t30 -118.96 88.24 2.89 Favored 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 124.503 1.121 . . . . 0.0 108.675 176.789 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -69.64 144.52 52.91 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.24 0.616 . . . . 0.0 110.419 176.672 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 75.3 p -138.35 167.48 21.78 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.324 1.05 . . . . 0.0 110.602 -178.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 56.1 p90 -61.38 -36.65 80.83 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.244 1.017 . . . . 0.0 111.45 -178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 72.3 mmtt -52.65 -41.86 64.16 Favored 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 123.814 0.846 . . . . 0.0 110.697 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -79.68 0.62 29.6 Favored 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 124.353 1.061 . . . . 0.0 112.828 -174.669 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 86.0 mt -73.89 109.79 6.88 Favored 'Isoleucine or valine' 0 C--N 1.342 0.264 0 N-CA-C 106.64 -1.615 . . . . 0.0 106.64 169.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 161.6 -162.57 34.03 Favored Glycine 0 CA--C 1.526 0.733 0 CA-C-N 117.953 0.342 . . . . 0.0 112.263 179.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 63.9 tp -92.68 103.0 15.42 Favored 'General case' 0 N--CA 1.454 -0.259 0 C-N-CA 124.914 1.285 . . . . 0.0 110.164 -174.904 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 6.4 mp -90.01 155.44 19.09 Favored 'General case' 0 CA--C 1.53 0.183 0 C-N-CA 123.766 0.827 . . . . 0.0 108.827 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 38.7 m -149.74 114.01 5.19 Favored 'General case' 0 N--CA 1.456 -0.159 0 C-N-CA 123.278 0.631 . . . . 0.0 109.891 -176.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 57.0 m -80.86 138.7 36.2 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 108.745 -0.835 . . . . 0.0 108.745 172.229 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 54.0 mt-10 -131.55 137.4 48.45 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.512 1.125 . . . . 0.0 109.399 179.817 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -154.41 151.39 28.94 Favored 'General case' 0 N--CA 1.456 -0.144 0 C-N-CA 123.8 0.84 . . . . 0.0 109.46 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.4 m -129.98 139.37 51.07 Favored 'General case' 0 C--N 1.339 0.125 0 C-N-CA 124.436 1.094 . . . . 0.0 108.949 -176.292 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 98.5 t -132.03 136.62 56.38 Favored 'Isoleucine or valine' 0 C--N 1.34 0.168 0 N-CA-C 107.747 -1.205 . . . . 0.0 107.747 174.453 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 85.3 m-20 63.45 -85.34 0.02 OUTLIER 'General case' 0 C--N 1.342 0.256 0 C-N-CA 125.922 1.689 . . . . 0.0 111.092 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -157.99 46.84 0.46 Allowed Glycine 0 CA--C 1.525 0.662 0 N-CA-C 108.546 -1.822 . . . . 0.0 108.546 173.447 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 11.9 t-80 -143.14 116.85 9.25 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 124.974 1.31 . . . . 0.0 107.83 -172.231 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 62.9 tp -77.79 143.8 37.64 Favored 'General case' 0 CA--C 1.53 0.19 0 C-N-CA 123.89 0.876 . . . . 0.0 109.31 177.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 83.8 m-85 -132.51 150.13 52.21 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 125.25 1.42 . . . . 0.0 108.059 173.436 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -141.74 157.48 44.99 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 124.23 1.012 . . . . 0.0 110.137 -178.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . 0.409 ' HA ' ' CD1' ' A' ' 139' ' ' TYR . 2.7 t -155.53 130.98 9.66 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 123.022 0.529 . . . . 0.0 110.131 169.186 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -109.42 143.41 39.04 Favored 'General case' 0 C--N 1.342 0.251 0 C-N-CA 125.499 1.519 . . . . 0.0 111.968 -169.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 57.5 m-85 -141.25 109.11 5.69 Favored 'General case' 0 C--N 1.34 0.193 0 C-N-CA 125.075 1.35 . . . . 0.0 108.95 -176.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.5 tt -90.19 101.9 14.62 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 107.862 -1.162 . . . . 0.0 107.862 177.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 68.3 p -89.75 91.33 8.59 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.156 0.983 . . . . 0.0 108.355 -179.988 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 18.2 p80 -93.11 150.79 20.27 Favored 'General case' 0 CA--C 1.529 0.141 0 N-CA-C 108.588 -0.894 . . . . 0.0 108.588 176.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 25.7 ptt180 -61.48 147.72 44.29 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 118.534 0.606 . . . . 0.0 109.808 175.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 13.7 pt20 -63.78 -166.57 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 C-N-CA 123.915 0.886 . . . . 0.0 112.745 -177.247 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 43.3 p -69.41 79.58 0.38 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.371 1.068 . . . . 0.0 110.192 176.4 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 16.6 m-80 -89.21 77.69 7.45 Favored 'General case' 0 N--CA 1.455 -0.18 0 N-CA-C 107.32 -1.363 . . . . 0.0 107.32 177.57 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 40.9 p -82.05 59.38 4.36 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.889 1.275 . . . . 0.0 110.362 -175.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 9.4 tp . . . . . 0 C--O 1.251 1.171 0 CA-C-O 117.636 -1.173 . . . . 0.0 110.68 -179.066 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 9.1 m . . . . . 0 N--CA 1.475 0.794 0 CA-C-O 120.647 0.26 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 32.8 t70 -157.2 148.32 21.8 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.923 0.889 . . . . 0.0 109.138 -178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.9 t -64.95 -24.12 67.42 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 123.948 0.899 . . . . 0.0 112.483 -179.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -70.52 -62.53 3.62 Favored Glycine 0 C--N 1.339 0.71 0 N-CA-C 110.391 -1.084 . . . . 0.0 110.391 177.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.0 ptt180 -167.11 157.45 10.06 Favored Pre-proline 0 CA--C 1.536 0.416 0 C-N-CA 123.582 0.753 . . . . 0.0 110.489 -176.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -70.12 -48.05 0.71 Allowed 'Trans proline' 0 N--CA 1.458 -0.61 0 C-N-CA 123.531 2.821 . . . . 0.0 112.032 174.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 75.5 m-85 -68.12 140.84 56.2 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 123.443 0.697 . . . . 0.0 111.947 -170.898 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 45.4 t -89.63 -53.84 8.63 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.193 0 N-CA-C 108.592 -0.892 . . . . 0.0 108.592 173.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 49.5 mt-10 -75.64 -81.79 0.08 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 124.436 1.094 . . . . 0.0 110.454 -175.7 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . 0.259 26.5 ptm 51.49 172.35 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.457 0 C-N-CA 127.99 2.516 . . . . 0.0 115.314 -172.827 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -81.0 -146.32 0.05 Allowed 'General case' 0 CA--C 1.536 0.405 0 C-N-CA 125.902 1.681 . . . . 0.0 110.016 174.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 30.5 p -131.93 -81.14 0.51 Allowed 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.46 -1.311 . . . . 0.0 107.46 169.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 16.2 mp0 -128.68 -51.03 1.25 Allowed 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 125.619 1.568 . . . . 0.0 108.175 173.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 68.6 mt -76.26 129.58 79.84 Favored Pre-proline 0 CA--C 1.537 0.454 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -179.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 87.3 Cg_exo -51.16 135.32 45.1 Favored 'Trans proline' 0 N--CA 1.458 -0.592 0 C-N-CA 123.709 2.939 . . . . 0.0 112.391 172.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 20.8 mm-40 -70.37 128.96 37.99 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 179.875 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 34.6 mm -70.43 127.36 32.24 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.266 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 176.13 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 17.5 mt -123.59 133.41 69.26 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 107.972 -1.121 . . . . 0.0 107.972 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 11.6 m-70 -96.81 84.16 3.55 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.457 1.503 . . . . 0.0 107.487 178.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 8.2 ptm -89.03 164.35 15.11 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-O 120.892 0.377 . . . . 0.0 111.185 -172.843 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 27.6 m -149.46 131.88 15.67 Favored 'General case' 0 N--CA 1.455 -0.177 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 177.905 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 47.4 mt-10 -64.82 155.53 33.69 Favored 'General case' 0 CA--C 1.53 0.197 0 C-N-CA 123.089 0.555 . . . . 0.0 110.706 -179.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 87.01 -42.73 3.17 Favored Glycine 0 CA--C 1.53 1.001 0 N-CA-C 111.396 -0.682 . . . . 0.0 111.396 -176.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 57.4 mtp180 -89.05 173.38 8.48 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.914 1.286 . . . . 0.0 110.94 -172.173 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 33.7 tt0 -73.49 137.43 44.46 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.995 0.918 . . . . 0.0 110.269 178.031 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 24.3 tp -127.71 106.95 9.49 Favored 'General case' 0 N--CA 1.453 -0.294 0 C-N-CA 125.479 1.512 . . . . 0.0 107.742 176.584 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.2 t -90.56 132.34 35.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 175.763 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 40.0 mm -109.01 97.52 25.29 Favored Pre-proline 0 CA--C 1.536 0.417 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 172.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 83.9 Cg_endo -79.85 82.16 2.57 Favored 'Trans proline' 0 N--CA 1.457 -0.661 0 C-N-CA 123.642 2.894 . . . . 0.0 111.667 -166.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.1 p -127.34 55.35 1.6 Allowed 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 125.083 1.353 . . . . 0.0 109.206 174.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 11.8 ptm180 -65.95 155.45 36.47 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-O 120.827 0.346 . . . . 0.0 111.038 -178.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 16.8 m -117.07 177.43 2.28 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.292 0 C-N-CA 125.357 1.463 . . . . 0.0 108.53 171.065 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 30.3 p -78.88 -29.7 44.57 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.161 0.984 . . . . 0.0 111.959 -179.786 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 16.6 m -149.13 146.41 21.27 Favored Pre-proline 0 CA--C 1.533 0.301 0 C-N-CA 123.382 0.673 . . . . 0.0 110.127 -173.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -67.38 -31.99 33.5 Favored 'Trans proline' 0 N--CA 1.457 -0.628 0 C-N-CA 123.569 2.846 . . . . 0.0 112.743 -177.869 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -58.56 -26.56 63.71 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 123.593 0.757 . . . . 0.0 112.359 -177.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 39.5 mm -54.61 -40.34 50.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.285 0 C-N-CA 124.704 1.201 . . . . 0.0 110.605 175.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.7 m 61.96 91.2 0.07 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 124.986 1.314 . . . . 0.0 111.431 172.283 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 62.6 t -88.95 143.4 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 179.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 91.6 m -104.99 122.43 45.83 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 174.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 46.2 tp -89.18 125.37 35.03 Favored 'General case' 0 N--CA 1.454 -0.239 0 N-CA-C 107.898 -1.149 . . . . 0.0 107.898 175.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 58.3 mttt -125.4 -176.4 3.58 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 124.079 0.952 . . . . 0.0 109.9 174.098 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -143.65 143.87 31.64 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 126.36 1.864 . . . . 0.0 107.205 178.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.0 t80 -55.55 128.03 67.53 Favored Pre-proline 0 CA--C 1.538 0.496 0 C-N-CA 123.548 0.739 . . . . 0.0 111.23 -173.262 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -76.35 -61.77 0.04 OUTLIER 'Cis proline' 0 N--CA 1.457 -0.641 0 CA-C-N 119.877 0.992 . . . . 0.0 112.101 1.294 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.6 mt -143.73 39.99 1.4 Allowed 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.579 1.152 . . . . 0.0 110.275 -174.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -77.98 122.6 25.75 Favored 'General case' 0 C--O 1.225 -0.19 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 173.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.8 m -89.73 114.32 25.97 Favored 'General case' 0 C--N 1.33 -0.25 0 C-N-CA 123.002 0.521 . . . . 0.0 111.001 -169.543 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 11.3 mp -90.01 87.06 6.76 Favored 'General case' 0 CA--C 1.53 0.179 0 N-CA-C 107.233 -1.395 . . . . 0.0 107.233 172.774 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 76.2 mt -63.47 129.79 93.86 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.053 -0.721 . . . . 0.0 109.053 -177.828 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 76.4 Cg_endo -72.78 88.45 0.91 Allowed 'Trans proline' 0 N--CA 1.454 -0.836 0 C-N-CA 123.14 2.56 . . . . 0.0 110.148 178.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.1 p-10 -64.7 -23.6 67.3 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 124.588 1.155 . . . . 0.0 113.071 -177.055 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 83.56 20.2 60.53 Favored Glycine 0 CA--C 1.53 1.028 0 CA-C-O 119.286 -0.73 . . . . 0.0 113.566 174.878 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 58.6 mtpt -133.76 -60.48 0.83 Allowed 'General case' 0 C--N 1.341 0.209 0 C-N-CA 124.527 1.131 . . . . 0.0 108.174 173.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 51.3 ttm-85 -78.68 -68.08 0.68 Allowed 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 107.809 -1.182 . . . . 0.0 107.809 169.981 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.7 mt -89.47 91.93 3.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.514 -1.291 . . . . 0.0 107.514 -177.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 95.0 mt -93.13 118.51 39.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.246 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 178.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 5.6 t-105 -88.98 96.33 10.68 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 -178.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.8 t0 -89.87 101.78 14.48 Favored 'General case' 0 N--CA 1.452 -0.344 0 N-CA-C 107.142 -1.429 . . . . 0.0 107.142 174.181 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 77.6 p -52.7 -37.81 59.64 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.915 0.886 . . . . 0.0 113.215 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 33.4 mmm-85 -99.0 25.83 6.36 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.984 0.914 . . . . 0.0 112.182 -175.496 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.0 tttp -150.39 -56.69 0.17 Allowed 'General case' 0 C--N 1.341 0.222 0 CA-C-N 118.513 0.597 . . . . 0.0 111.382 176.43 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 157.44 -173.45 34.9 Favored Glycine 0 CA--C 1.527 0.796 0 N-CA-C 110.555 -1.018 . . . . 0.0 110.555 -175.5 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 93.6 m-85 -89.42 114.78 26.29 Favored 'General case' 0 CA--C 1.521 -0.139 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 172.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 47.1 mt -94.66 94.1 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 C-N-CA 125.252 1.421 . . . . 0.0 107.57 -177.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -78.95 88.17 1.22 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.229 0 N-CA-C 106.232 -1.766 . . . . 0.0 106.232 170.003 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 79.9 p -57.56 -38.19 74.36 Favored 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 125.196 1.399 . . . . 0.0 112.453 -173.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 14.8 t-20 -119.55 88.88 3.02 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 124.236 1.015 . . . . 0.0 108.517 175.394 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.97 146.19 55.33 Favored 'General case' 0 N--CA 1.456 -0.171 0 C-N-CA 122.749 0.419 . . . . 0.0 110.517 178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 81.1 p -137.66 173.0 12.12 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.459 1.104 . . . . 0.0 109.142 176.812 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 50.7 p90 -51.63 -31.27 24.67 Favored 'General case' 0 CA--C 1.533 0.301 0 C-N-CA 125.266 1.427 . . . . 0.0 112.258 178.087 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 14.0 mmmm -52.07 -35.94 49.11 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 124.975 1.31 . . . . 0.0 112.374 176.649 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 11.4 mp0 -87.8 -5.42 58.64 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 118.26 -0.876 . . . . 0.0 113.055 -178.379 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 92.6 mt -72.15 116.06 13.5 Favored 'Isoleucine or valine' 0 C--N 1.341 0.231 0 CA-C-N 120.251 1.387 . . . . 0.0 108.347 176.933 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.15 -104.51 0.26 Allowed Glycine 0 C--N 1.339 0.73 0 N-CA-C 111.281 -0.728 . . . . 0.0 111.281 173.824 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 61.5 tp -152.3 96.72 2.2 Favored 'General case' 0 N--CA 1.456 -0.162 0 C-N-CA 123.917 0.887 . . . . 0.0 109.183 -169.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 10.1 mp -83.4 155.98 23.19 Favored 'General case' 0 C--N 1.34 0.159 0 C-N-CA 123.171 0.589 . . . . 0.0 109.565 177.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 30.4 m -146.67 106.26 3.94 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.753 1.221 . . . . 0.0 109.156 -172.064 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 47.7 m -78.45 143.16 36.95 Favored 'General case' 0 C--N 1.34 0.167 0 N-CA-C 108.532 -0.914 . . . . 0.0 108.532 171.219 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 88.8 mt-10 -136.29 135.17 38.72 Favored 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 124.507 1.123 . . . . 0.0 109.899 -175.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.62 164.05 37.75 Favored 'General case' 0 C--N 1.341 0.197 0 C-N-CA 124.359 1.064 . . . . 0.0 110.327 -178.289 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 36.7 m -146.07 135.93 23.43 Favored 'General case' 0 C--N 1.339 0.122 0 C-N-CA 123.878 0.871 . . . . 0.0 108.736 -178.76 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 61.0 t -133.9 -78.32 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.223 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 175.089 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 22.8 m120 -88.23 49.91 1.88 Allowed 'General case' 0 CA--C 1.529 0.143 0 C-N-CA 123.919 0.888 . . . . 0.0 110.703 -170.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 76.28 -24.55 1.71 Allowed Glycine 0 CA--C 1.534 1.242 0 C-N-CA 123.614 0.626 . . . . 0.0 113.45 -178.504 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 35.9 t-80 -88.91 132.99 34.44 Favored 'General case' 0 N--CA 1.451 -0.398 0 C-N-CA 124.732 1.213 . . . . 0.0 109.585 -173.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 69.5 tp -76.43 107.82 8.96 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 173.862 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 89.9 m-85 -89.45 143.05 27.12 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 173.853 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.21 161.38 42.53 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 122.711 0.405 . . . . 0.0 110.529 174.028 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 2.8 t -153.84 133.85 13.19 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.568 0.747 . . . . 0.0 109.37 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 17.1 m-80 -110.36 151.93 26.85 Favored 'General case' 0 C--N 1.341 0.211 0 C-N-CA 124.844 1.258 . . . . 0.0 112.793 -168.889 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.8 m-85 -144.55 104.41 4.05 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.435 1.494 . . . . 0.0 108.861 -174.047 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.3 tt -78.23 99.4 6.24 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.115 0.966 . . . . 0.0 108.635 179.877 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 12.1 p -90.09 90.84 8.3 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 125.413 1.485 . . . . 0.0 109.606 -178.716 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 7.7 p80 -89.95 155.06 19.38 Favored 'General case' 0 CA--C 1.528 0.12 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 174.077 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 3.9 ptp85 -74.46 127.52 33.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 176.143 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -68.53 -35.81 77.96 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.668 1.187 . . . . 0.0 111.437 -176.421 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.6 p -45.21 -37.62 4.71 Favored 'General case' 0 C--N 1.341 0.232 0 C-N-CA 125.763 1.625 . . . . 0.0 111.52 177.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 2.3 p30 -134.34 74.45 1.54 Allowed 'General case' 0 N--CA 1.452 -0.361 0 C-N-CA 123.964 0.905 . . . . 0.0 109.077 169.528 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 53.3 m -54.9 110.49 0.67 Allowed 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 124.953 1.301 . . . . 0.0 109.077 170.346 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.123 0 CA-C-O 116.76 -1.591 . . . . 0.0 111.464 -178.514 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 43.8 t . . . . . 0 N--CA 1.473 0.722 0 N-CA-C 111.544 0.202 . . . . 0.0 111.544 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 -63.3 -36.15 82.71 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.988 0.915 . . . . 0.0 110.103 169.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 50.2 p -95.95 52.28 1.3 Allowed 'General case' 0 C--N 1.342 0.243 0 N-CA-C 108.236 -1.024 . . . . 0.0 108.236 169.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -82.51 68.83 3.46 Favored Glycine 0 C--N 1.339 0.704 0 N-CA-C 109.959 -1.256 . . . . 0.0 109.959 -178.438 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 9.3 ptp180 -65.76 143.56 98.59 Favored Pre-proline 0 CA--C 1.534 0.338 0 C-N-CA 122.411 0.284 . . . . 0.0 110.624 -178.365 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -73.23 -40.91 1.45 Allowed 'Trans proline' 0 N--CA 1.451 -0.973 0 C-N-CA 123.103 2.535 . . . . 0.0 110.729 177.982 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 70.3 m-85 -68.44 118.46 11.53 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.217 1.007 . . . . 0.0 112.069 -172.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 59.5 t -74.13 -58.4 4.86 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 107.38 -1.341 . . . . 0.0 107.38 170.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 41.8 mm-40 -93.14 134.48 35.25 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.232 1.013 . . . . 0.0 108.877 174.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 27.3 ptm -159.96 170.38 21.46 Favored 'General case' 0 N--CA 1.452 -0.35 0 C-N-CA 123.54 0.736 . . . . 0.0 111.208 178.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -74.29 -153.26 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.49 0 C-N-CA 125.748 1.619 . . . . 0.0 110.722 172.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 38.7 t -133.11 -69.02 0.57 Allowed 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.183 -1.043 . . . . 0.0 108.183 169.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.1 mt-10 -139.71 -56.25 0.57 Allowed 'General case' 0 C--N 1.338 0.103 0 C-N-CA 124.919 1.288 . . . . 0.0 108.671 178.997 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 37.9 mm -65.77 132.2 94.8 Favored Pre-proline 0 CA--C 1.536 0.405 0 N-CA-C 107.879 -1.156 . . . . 0.0 107.879 176.717 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -66.29 129.11 20.76 Favored 'Trans proline' 0 N--CA 1.452 -0.922 0 C-N-CA 122.525 2.15 . . . . 0.0 109.503 -179.23 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -63.1 117.55 6.64 Favored 'General case' 0 N--CA 1.454 -0.269 0 C-N-CA 123.579 0.752 . . . . 0.0 110.697 -168.829 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 21.3 mm -72.75 110.6 6.06 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 C-N-CA 124.789 1.236 . . . . 0.0 108.634 -179.311 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 40.5 mt -118.14 113.1 41.07 Favored 'Isoleucine or valine' 0 C--N 1.341 0.197 0 C-N-CA 124.551 1.14 . . . . 0.0 108.559 177.833 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.11 136.41 42.96 Favored 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 109.041 -0.726 . . . . 0.0 109.041 169.71 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 2.6 ppp? -144.83 157.81 44.03 Favored 'General case' 0 N--CA 1.456 -0.131 0 C-N-CA 122.923 0.489 . . . . 0.0 111.154 176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 81.5 m -105.03 114.62 28.92 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.594 -1.262 . . . . 0.0 107.594 178.515 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 38.6 tt0 -59.83 140.14 56.81 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 123.071 0.549 . . . . 0.0 110.232 -179.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 101.4 -35.03 5.18 Favored Glycine 0 CA--C 1.528 0.846 0 C-N-CA 124.356 0.979 . . . . 0.0 111.202 -175.261 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 32.1 mmt180 -89.63 -177.81 5.38 Favored 'General case' 0 C--N 1.341 0.21 0 C-N-CA 123.741 0.817 . . . . 0.0 111.446 -172.26 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -69.16 148.0 50.55 Favored 'General case' 0 N--CA 1.454 -0.234 0 CA-C-N 115.366 -0.834 . . . . 0.0 111.4 177.359 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 36.0 tp -145.24 106.82 4.23 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 124.427 1.091 . . . . 0.0 108.744 -177.294 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 45.7 t -94.41 120.53 43.96 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.285 0 C-N-CA 124.592 1.157 . . . . 0.0 107.887 175.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 34.7 mm -89.95 109.79 35.31 Favored Pre-proline 0 CA--C 1.534 0.356 0 N-CA-C 107.475 -1.306 . . . . 0.0 107.475 174.064 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 65.2 Cg_endo -81.0 72.54 6.47 Favored 'Trans proline' 0 N--CA 1.457 -0.663 0 C-N-CA 123.437 2.758 . . . . 0.0 111.081 -168.133 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 20.3 p -126.02 50.96 1.81 Allowed 'General case' 0 N--CA 1.457 -0.125 0 C-N-CA 124.63 1.172 . . . . 0.0 109.563 177.045 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 9.2 ptm180 -68.35 156.11 38.44 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.862 -0.608 . . . . 0.0 111.367 -175.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 32.4 m -126.9 174.22 11.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.296 0 C-N-CA 125.7 1.6 . . . . 0.0 109.331 177.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 81.0 p -74.99 -29.01 60.77 Favored 'General case' 0 CA--C 1.532 0.276 0 N-CA-C 112.984 0.735 . . . . 0.0 112.984 -172.536 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 19.6 m -148.29 144.28 18.53 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 118.624 0.647 . . . . 0.0 111.607 -169.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -47.1 -39.75 26.09 Favored 'Trans proline' 0 C--N 1.349 0.584 0 C-N-CA 124.501 3.467 . . . . 0.0 113.535 168.774 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 13.5 m120 -49.34 -37.22 23.74 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 125.455 1.502 . . . . 0.0 112.083 178.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 65.1 mt -77.97 87.63 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.85 -1.167 . . . . 0.0 107.85 177.431 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 31.8 m -78.09 110.6 13.2 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 109.187 -0.671 . . . . 0.0 109.187 178.16 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 98.9 t -89.46 150.25 3.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.183 0 C-N-CA 124.375 1.07 . . . . 0.0 108.28 178.108 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 58.9 m -110.46 124.68 52.22 Favored 'General case' 0 CA--C 1.529 0.135 0 C-N-CA 124.186 0.994 . . . . 0.0 108.646 175.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.2 tp -89.4 101.13 13.81 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 178.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -89.55 169.05 11.68 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 124.013 0.925 . . . . 0.0 109.892 174.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 84.2 tttt -144.49 145.58 31.95 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 124.53 1.132 . . . . 0.0 108.118 169.758 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -57.36 134.27 81.5 Favored Pre-proline 0 CA--C 1.539 0.528 0 C-N-CA 123.586 0.754 . . . . 0.0 110.872 -177.837 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.27 -59.3 0.12 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.707 0 CA-C-N 119.819 0.971 . . . . 0.0 111.716 -0.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 91.4 mt -141.3 39.27 1.74 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 124.721 1.208 . . . . 0.0 109.996 -176.571 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 60.5 m-20 -79.66 161.35 25.89 Favored 'General case' 0 CA--C 1.53 0.183 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 171.19 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 31.4 m -138.44 120.63 15.76 Favored 'General case' 0 C--N 1.34 0.187 0 C-N-CA 123.368 0.667 . . . . 0.0 110.027 -176.186 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 9.4 mp -92.18 81.05 5.01 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.656 -1.238 . . . . 0.0 107.656 176.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 25.9 mm -60.94 120.4 53.56 Favored Pre-proline 0 CA--C 1.537 0.48 0 C-N-CA 124.421 1.088 . . . . 0.0 109.655 -178.689 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 50.0 Cg_exo -57.79 119.49 6.78 Favored 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 123.149 2.566 . . . . 0.0 111.958 174.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 46.0 p-10 -84.68 -16.17 42.78 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.632 0.773 . . . . 0.0 111.621 173.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 67.81 39.8 89.76 Favored Glycine 0 C--N 1.342 0.867 0 N-CA-C 111.041 -0.823 . . . . 0.0 111.041 -176.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 20.0 ttmm -150.28 -66.91 0.2 Allowed 'General case' 0 C--N 1.34 0.179 0 C-N-CA 123.711 0.804 . . . . 0.0 109.004 -177.522 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 70.8 ttt180 -87.7 -54.95 3.99 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.652 1.181 . . . . 0.0 107.852 172.162 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 54.4 mt -95.52 91.34 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 82.3 mt -97.11 120.31 46.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.223 0 N-CA-C 107.681 -1.229 . . . . 0.0 107.681 178.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.0 t-105 -88.93 94.62 10.0 Favored 'General case' 0 N--CA 1.454 -0.253 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 178.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 13.1 t0 -89.43 99.44 12.44 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 106.446 -1.687 . . . . 0.0 106.446 175.185 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 79.8 p -51.04 -41.29 59.76 Favored 'General case' 0 N--CA 1.456 -0.151 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -173.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 97.3 mtt180 -97.88 24.7 6.63 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.218 1.007 . . . . 0.0 112.292 -174.638 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 19.3 ttmm -145.81 -57.08 0.31 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.454 0.701 . . . . 0.0 110.94 174.296 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.54 -173.6 37.12 Favored Glycine 0 CA--C 1.528 0.859 0 N-CA-C 111.397 -0.681 . . . . 0.0 111.397 -177.483 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -89.02 110.06 20.81 Favored 'General case' 0 C--N 1.339 0.132 0 N-CA-C 107.336 -1.357 . . . . 0.0 107.336 171.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 32.3 mt -91.4 93.15 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.477 0 C-N-CA 125.078 1.351 . . . . 0.0 108.125 -176.868 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -85.31 100.82 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 169.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 87.6 p -61.89 -32.15 72.5 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.733 0.813 . . . . 0.0 112.608 -176.197 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 13.3 t-20 -123.03 95.16 4.5 Favored 'General case' 0 C--N 1.339 0.139 0 C-N-CA 124.589 1.156 . . . . 0.0 108.915 177.318 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -73.8 138.88 44.78 Favored 'General case' 0 N--CA 1.454 -0.251 0 C-N-CA 123.154 0.581 . . . . 0.0 110.261 178.501 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 72.8 p -142.84 -178.56 5.87 Favored 'General case' 0 CA--C 1.53 0.2 0 C-N-CA 124.902 1.281 . . . . 0.0 109.357 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.4 p90 -45.66 -40.77 9.56 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 125.21 1.404 . . . . 0.0 112.109 174.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.4 mtmp? -51.99 -32.08 32.22 Favored 'General case' 0 C--N 1.342 0.255 0 C-N-CA 125.314 1.446 . . . . 0.0 112.472 178.696 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 8.8 mp0 -90.16 -38.23 13.63 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.286 1.034 . . . . 0.0 110.786 177.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 97.2 mt -65.95 106.99 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.341 0.203 0 C-N-CA 123.324 0.65 . . . . 0.0 109.864 -171.546 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 153.27 -160.28 29.07 Favored Glycine 0 CA--C 1.527 0.789 0 N-CA-C 110.383 -1.087 . . . . 0.0 110.383 179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 47.4 tp -83.32 87.82 6.96 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.472 1.109 . . . . 0.0 109.659 -178.178 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 89.7 mt -76.73 154.71 33.86 Favored 'General case' 0 N--CA 1.456 -0.125 0 C-N-CA 124.02 0.928 . . . . 0.0 109.148 172.012 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 24.7 m -148.97 112.11 4.92 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.331 0.652 . . . . 0.0 109.585 179.817 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 66.5 m -78.44 132.92 37.5 Favored 'General case' 0 C--N 1.338 0.106 0 N-CA-C 107.964 -1.124 . . . . 0.0 107.964 170.422 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 62.9 mt-10 -131.21 143.38 50.54 Favored 'General case' 0 C--N 1.341 0.212 0 C-N-CA 123.994 0.918 . . . . 0.0 110.962 -178.745 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.76 172.92 17.36 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 125.034 1.334 . . . . 0.0 109.524 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 75.1 m -144.42 139.54 28.44 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.087 0.955 . . . . 0.0 108.874 -177.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 89.3 t -133.63 -75.53 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.342 0.267 0 C-N-CA 123.761 0.824 . . . . 0.0 109.78 176.218 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.7 m120 -83.94 46.92 1.24 Allowed 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.844 0.858 . . . . 0.0 111.546 -170.019 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 51.77 41.03 50.12 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.664 -0.974 . . . . 0.0 110.664 -170.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 21.6 t-80 -149.27 120.59 7.86 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 125.326 1.45 . . . . 0.0 107.376 -171.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 7.4 tt -72.74 111.49 7.94 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 108.974 -0.751 . . . . 0.0 108.974 177.051 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 97.9 m-85 -90.16 143.36 26.84 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 169.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -150.43 161.73 41.95 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 122.577 0.351 . . . . 0.0 110.631 176.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.9 t -153.02 132.01 12.56 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.757 0.823 . . . . 0.0 109.153 178.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -105.84 144.66 32.26 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.975 1.31 . . . . 0.0 111.552 -169.445 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 54.9 m-85 -139.29 113.19 8.6 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 125.081 1.352 . . . . 0.0 109.038 -178.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -88.87 99.16 12.17 Favored 'General case' 0 N--CA 1.452 -0.373 0 N-CA-C 107.247 -1.39 . . . . 0.0 107.247 174.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.0 p -89.57 106.81 18.7 Favored 'General case' 0 N--CA 1.454 -0.245 0 N-CA-C 108.708 -0.849 . . . . 0.0 108.708 -179.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 12.9 p80 -112.39 179.61 3.94 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 125.224 1.41 . . . . 0.0 110.557 -177.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -64.19 172.42 2.46 Favored 'General case' 0 CA--C 1.53 0.188 0 C-N-CA 123.846 0.858 . . . . 0.0 112.111 -178.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 21.2 tt0 -133.61 74.04 1.54 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 123.796 0.838 . . . . 0.0 109.223 174.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 38.1 p -83.06 62.07 6.38 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 123.96 0.904 . . . . 0.0 108.814 174.192 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -89.42 -55.24 3.74 Favored 'General case' 0 N--CA 1.456 -0.145 0 C-N-CA 124.138 0.975 . . . . 0.0 109.563 -174.911 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.7 t -71.38 159.47 34.5 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.002 0.521 . . . . 0.0 110.235 175.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 68.0 mt . . . . . 0 C--O 1.25 1.131 0 CA-C-O 117.174 -1.393 . . . . 0.0 108.526 179.483 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.8 t . . . . . 0 N--CA 1.473 0.711 0 CA-C-O 120.293 0.092 . . . . 0.0 111.033 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 7.4 p-10 -58.74 -34.09 70.99 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.58 0.752 . . . . 0.0 110.876 172.433 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 21.8 p -59.54 118.01 5.56 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.496 1.118 . . . . 0.0 109.249 172.12 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 64.19 42.99 97.74 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 124.158 0.885 . . . . 0.0 111.919 -178.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.8 ttp180 -97.91 113.08 63.26 Favored Pre-proline 0 CA--C 1.533 0.325 0 C-N-CA 124.164 0.986 . . . . 0.0 108.84 174.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 45.9 Cg_endo -82.05 -175.86 2.73 Favored 'Trans proline' 0 N--CA 1.452 -0.953 0 C-N-CA 123.72 2.947 . . . . 0.0 110.319 176.729 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 51.4 m-85 73.88 103.11 0.07 Allowed 'General case' 0 N--CA 1.456 -0.164 0 C-N-CA 126.555 1.942 . . . . 0.0 111.948 176.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 76.0 t -59.22 -52.54 59.59 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.269 0 C-N-CA 124.542 1.137 . . . . 0.0 108.495 171.787 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 55.3 tt0 -96.26 78.18 3.07 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 124.024 0.93 . . . . 0.0 108.728 173.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.2 ttt -80.94 139.91 35.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 171.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -67.87 -172.78 0.3 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.363 1.065 . . . . 0.0 112.076 177.619 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 9.4 t -148.48 -162.37 1.54 Allowed 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.092 0.957 . . . . 0.0 108.891 174.54 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 45.7 mt-10 -68.7 95.94 0.69 Allowed 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 108.543 -0.91 . . . . 0.0 108.543 173.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 32.4 mm 116.6 120.08 0.0 OUTLIER Pre-proline 0 CA--C 1.536 0.441 1 C-N-CA 132.131 4.172 . . . . 0.0 107.332 177.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -72.15 139.59 32.76 Favored 'Trans proline' 0 N--CA 1.456 -0.721 0 C-N-CA 123.346 2.697 . . . . 0.0 110.113 -178.479 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 5.2 pm0 -65.78 130.08 42.03 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.267 0.627 . . . . 0.0 111.273 -177.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 23.8 mm -72.52 138.03 22.3 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.267 0 C-N-CA 124.396 1.078 . . . . 0.0 109.82 -179.639 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 47.8 mt -128.45 127.87 67.54 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 125.017 1.327 . . . . 0.0 107.873 170.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 50.8 p-80 -90.9 125.05 35.64 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 108.297 -1.001 . . . . 0.0 108.297 171.676 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.7 ppp? -150.31 176.6 10.74 Favored 'General case' 0 C--O 1.226 -0.155 0 C-N-CA 123.498 0.719 . . . . 0.0 110.367 -176.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 53.3 m -150.08 143.05 24.86 Favored 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.206 -1.405 . . . . 0.0 107.206 170.737 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -59.77 141.56 55.0 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 122.483 0.313 . . . . 0.0 110.16 176.09 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 107.5 -35.75 4.81 Favored Glycine 0 CA--C 1.53 0.995 0 C-N-CA 124.11 0.862 . . . . 0.0 111.69 -175.43 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 92.4 mtt180 -88.76 169.78 11.34 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.708 0.754 . . . . 0.0 110.586 -171.591 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -76.49 147.73 37.63 Favored 'General case' 0 C--N 1.34 0.163 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 171.247 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -147.22 108.88 4.35 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -171.123 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 40.8 t -89.75 130.13 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.169 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 177.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 49.1 mm -106.87 97.27 16.96 Favored Pre-proline 0 CA--C 1.531 0.212 0 N-CA-C 106.657 -1.608 . . . . 0.0 106.657 169.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -80.59 77.3 4.11 Favored 'Trans proline' 0 N--CA 1.453 -0.902 0 C-N-CA 123.068 2.512 . . . . 0.0 111.134 -169.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 29.3 p -115.46 53.66 0.83 Allowed 'General case' 0 C--N 1.338 0.081 0 C-N-CA 124.918 1.287 . . . . 0.0 109.183 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -66.47 148.39 51.95 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.273 0.629 . . . . 0.0 110.738 -179.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 27.5 m -128.08 175.58 9.46 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.315 0 C-N-CA 125.616 1.566 . . . . 0.0 109.793 -176.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 50.9 p -67.26 -40.49 86.21 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.832 0.853 . . . . 0.0 111.823 -178.618 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -150.74 149.04 24.71 Favored Pre-proline 0 CA--C 1.532 0.268 0 C-N-CA 123.274 0.63 . . . . 0.0 111.064 -171.019 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 76.1 Cg_exo -49.23 -37.98 40.58 Favored 'Trans proline' 0 C--N 1.348 0.503 0 C-N-CA 123.749 2.966 . . . . 0.0 112.613 166.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 15.0 m120 -53.24 -29.26 31.64 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.975 1.71 . . . . 0.0 113.03 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 37.8 mm -55.5 -34.74 35.64 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.438 0 C-N-CA 124.012 0.925 . . . . 0.0 110.796 175.382 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 24.1 m 63.85 80.23 0.24 Allowed 'General case' 0 C--N 1.34 0.19 0 C-N-CA 125.313 1.445 . . . . 0.0 110.564 173.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.79 141.27 14.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.217 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 179.925 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 63.6 m -120.92 128.57 52.89 Favored 'General case' 0 N--CA 1.454 -0.225 0 C-N-CA 124.681 1.192 . . . . 0.0 108.173 174.123 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 48.1 tp -89.16 131.79 35.13 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 178.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 41.4 mttp -134.77 177.24 7.94 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 124.959 1.304 . . . . 0.0 109.651 -179.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 5.5 ttpm? -146.62 148.94 32.6 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.995 0.918 . . . . 0.0 109.439 175.364 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 58.6 t80 -59.11 137.52 88.07 Favored Pre-proline 0 CA--C 1.538 0.515 0 C-N-CA 123.586 0.754 . . . . 0.0 109.721 174.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -78.74 -59.28 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.762 0 CA-C-N 119.985 1.031 . . . . 0.0 111.857 0.706 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 87.3 mt -140.01 42.98 1.94 Allowed 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.615 1.166 . . . . 0.0 109.768 -175.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -85.65 145.28 27.39 Favored 'General case' 0 N--CA 1.457 -0.114 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 172.614 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 88.9 m -122.2 128.55 51.34 Favored 'General case' 0 N--CA 1.458 -0.069 0 C-N-CA 124.202 1.001 . . . . 0.0 108.659 177.64 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 56.0 mt -111.9 79.23 1.19 Allowed 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.656 1.582 . . . . 0.0 107.693 -175.205 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 69.9 mt -60.55 132.66 91.12 Favored Pre-proline 0 CA--C 1.538 0.483 0 C-N-CA 124.417 1.087 . . . . 0.0 109.613 -174.178 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -70.86 87.08 0.7 Allowed 'Trans proline' 0 N--CA 1.455 -0.758 0 C-N-CA 123.25 2.634 . . . . 0.0 110.402 177.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -66.26 -23.2 66.36 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.809 1.244 . . . . 0.0 112.859 -177.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 82.84 17.43 67.81 Favored Glycine 0 CA--C 1.53 1.007 0 CA-C-O 119.193 -0.782 . . . . 0.0 113.573 175.014 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 97.7 mttt -129.07 -63.16 0.97 Allowed 'General case' 0 C--N 1.341 0.218 0 N-CA-C 107.845 -1.169 . . . . 0.0 107.845 172.805 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 34.0 ttm105 -73.87 -68.43 0.52 Allowed 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 107.859 -1.163 . . . . 0.0 107.859 169.815 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 24.7 mt -89.5 95.09 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.158 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 -176.675 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 80.0 mt -95.9 115.18 34.41 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.228 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 178.795 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 10.8 t-105 -89.35 117.07 28.03 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 123.475 0.71 . . . . 0.0 110.005 -176.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 63.2 t0 -115.01 108.63 16.94 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 63.9 p -58.54 -29.42 66.33 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.74 0.816 . . . . 0.0 113.176 -178.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.7 mmt85 -102.6 22.64 13.25 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.917 0.887 . . . . 0.0 112.177 -178.08 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.1 tttt -149.17 -57.86 0.21 Allowed 'General case' 0 C--N 1.341 0.199 0 CA-C-N 118.457 0.571 . . . . 0.0 111.115 174.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.58 -172.11 34.27 Favored Glycine 0 CA--C 1.527 0.82 0 N-CA-C 110.919 -0.872 . . . . 0.0 110.919 -176.162 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.0 m-85 -89.35 113.0 24.24 Favored 'General case' 0 C--N 1.34 0.182 0 N-CA-C 107.729 -1.212 . . . . 0.0 107.729 170.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 39.8 mt -89.87 95.06 5.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.361 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 176.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 3.6 mp -79.71 89.21 1.43 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 170.108 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 65.1 p -60.08 -35.04 74.32 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.785 1.234 . . . . 0.0 112.54 -174.552 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 21.2 t-20 -119.05 93.89 4.25 Favored 'General case' 0 N--CA 1.455 -0.214 0 C-N-CA 124.282 1.033 . . . . 0.0 108.391 172.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -62.26 150.81 38.12 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 123.468 0.707 . . . . 0.0 110.398 176.349 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 38.5 p -146.31 171.49 14.9 Favored 'General case' 0 N--CA 1.455 -0.189 0 C-N-CA 124.678 1.191 . . . . 0.0 109.208 -176.345 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 49.7 p90 -51.42 -34.71 36.03 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.421 1.088 . . . . 0.0 111.621 171.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -56.59 -26.82 56.54 Favored 'General case' 0 C--N 1.342 0.239 0 C-N-CA 124.97 1.308 . . . . 0.0 112.071 178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 62.6 mm-40 -82.9 -39.59 21.33 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.485 0.714 . . . . 0.0 111.839 178.486 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 64.8 mt -59.2 108.4 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.211 0 C-N-CA 124.119 0.967 . . . . 0.0 110.369 -169.7 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 147.23 -162.48 28.62 Favored Glycine 0 CA--C 1.526 0.753 0 C-N-CA 123.989 0.804 . . . . 0.0 111.334 177.282 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 54.5 tp -81.19 88.3 6.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.226 1.01 . . . . 0.0 109.255 -179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 80.9 mt -70.5 154.5 41.82 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 124.108 0.963 . . . . 0.0 109.298 173.644 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 25.0 m -149.73 108.75 3.9 Favored 'General case' 0 N--CA 1.452 -0.345 0 C-N-CA 124.039 0.936 . . . . 0.0 109.308 -174.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 73.8 m -79.83 133.26 36.27 Favored 'General case' 0 C--N 1.339 0.144 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 169.273 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -127.95 141.57 51.5 Favored 'General case' 0 C--N 1.339 0.124 0 C-N-CA 124.276 1.03 . . . . 0.0 110.078 -175.425 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -152.42 120.69 6.3 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 124.117 0.967 . . . . 0.0 109.637 178.535 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 26.4 m -100.53 77.61 1.93 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.666 1.186 . . . . 0.0 108.793 -179.139 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 69.8 t -69.93 -52.65 29.18 Favored 'Isoleucine or valine' 0 C--N 1.338 0.096 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 176.973 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 77.9 m-20 -109.41 177.78 4.64 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.613 1.165 . . . . 0.0 108.748 173.367 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -73.96 70.65 1.48 Allowed Glycine 0 CA--C 1.527 0.841 0 N-CA-C 108.428 -1.869 . . . . 0.0 108.428 169.72 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 17.6 t60 -145.56 -43.25 0.22 Allowed 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 125.566 1.547 . . . . 0.0 110.289 -169.45 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 63.0 tp 64.11 91.22 0.08 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 125.854 1.662 . . . . 0.0 109.681 -173.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 87.9 m-85 -89.48 147.4 24.01 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 107.949 -1.13 . . . . 0.0 107.949 175.998 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.0 pttp -150.52 164.24 36.46 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 122.542 0.337 . . . . 0.0 111.61 179.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 5.2 t -147.11 129.12 15.47 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 124.701 1.2 . . . . 0.0 108.233 174.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.8 m-80 -107.68 151.4 25.71 Favored 'General case' 0 C--N 1.34 0.177 0 C-N-CA 125.24 1.416 . . . . 0.0 112.688 -168.803 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -144.88 121.91 11.39 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.993 1.317 . . . . 0.0 108.956 -177.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.8 tt -96.24 102.51 14.31 Favored 'General case' 0 N--CA 1.456 -0.145 0 N-CA-C 108.706 -0.85 . . . . 0.0 108.706 -177.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 22.1 p -89.57 124.15 34.29 Favored 'General case' 0 N--CA 1.456 -0.147 0 C-N-CA 123.64 0.776 . . . . 0.0 109.419 178.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 37.5 p-80 -120.68 147.3 45.46 Favored 'General case' 0 C--N 1.341 0.2 0 C-N-CA 123.905 0.882 . . . . 0.0 110.133 176.2 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 50.8 ttp180 -79.16 104.01 9.49 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.796 0.838 . . . . 0.0 109.894 178.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -83.27 170.31 14.77 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 123.413 0.685 . . . . 0.0 111.27 178.857 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 33.6 p -126.44 -67.31 0.87 Allowed 'General case' 0 CA--C 1.529 0.15 0 C-N-CA 125.094 1.358 . . . . 0.0 107.627 173.579 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 44.4 t30 -100.07 145.98 27.31 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.888 1.275 . . . . 0.0 108.441 169.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 33.7 p -83.3 -70.91 0.53 Allowed 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.729 0.812 . . . . 0.0 109.01 177.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.9 mm . . . . . 0 C--O 1.25 1.12 0 CA-C-O 117.187 -1.387 . . . . 0.0 108.498 -179.552 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . 0.531 ' N ' ' HG ' ' A' ' 162' ' ' SER . 8.3 m . . . . . 0 N--CA 1.471 0.62 0 N-CA-C 111.63 0.233 . . . . 0.0 111.63 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 9.2 p-10 -71.66 -52.28 18.71 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 123.253 0.621 . . . . 0.0 109.374 171.881 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 20.4 m -161.66 146.51 13.21 Favored 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 126.875 2.07 . . . . 0.0 106.868 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 160.58 -80.17 0.15 Allowed Glycine 0 C--N 1.337 0.635 0 N-CA-C 109.022 -1.631 . . . . 0.0 109.022 178.078 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 34.6 ttm180 -164.85 114.07 0.88 Allowed Pre-proline 0 N--CA 1.453 -0.295 0 C-N-CA 124.059 0.944 . . . . 0.0 108.746 172.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 80.8 Cg_endo -80.81 -171.98 1.39 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.531 2.821 . . . . 0.0 111.401 178.767 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 77.57 104.81 0.07 Allowed 'General case' 0 C--N 1.339 0.149 0 C-N-CA 127.199 2.2 . . . . 0.0 111.6 177.063 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 91.6 t -64.26 -50.39 76.82 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.231 0 C-N-CA 124.465 1.106 . . . . 0.0 109.343 176.815 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -67.62 -70.87 0.23 Allowed 'General case' 0 CA--C 1.531 0.24 0 C-N-CA 123.399 0.68 . . . . 0.0 109.518 178.53 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 22.8 ttt 64.23 116.49 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 126.569 1.948 . . . . 0.0 112.834 -177.49 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -67.64 151.46 47.26 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 109.859 -0.423 . . . . 0.0 109.859 171.582 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 17.1 p -78.56 -62.64 1.62 Allowed 'General case' 0 N--CA 1.453 -0.281 0 O-C-N 122.148 -0.345 . . . . 0.0 110.263 179.34 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 42.6 tt0 -158.77 -51.66 0.06 Allowed 'General case' 0 N--CA 1.454 -0.262 0 C-N-CA 124.426 1.09 . . . . 0.0 109.055 -171.139 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 34.6 mm -79.69 126.9 79.54 Favored Pre-proline 0 CA--C 1.535 0.389 0 N-CA-C 108.045 -1.095 . . . . 0.0 108.045 177.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 80.7 Cg_exo -50.14 139.82 34.19 Favored 'Trans proline' 0 N--CA 1.458 -0.614 0 C-N-CA 123.665 2.91 . . . . 0.0 112.519 174.038 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -67.18 119.75 12.6 Favored 'General case' 0 CA--C 1.53 0.208 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.4 mm -77.66 102.07 3.85 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.238 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 -179.545 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.3 mt -92.22 143.66 10.89 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.207 0 C-N-CA 124.337 1.055 . . . . 0.0 108.208 174.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 59.3 m-70 -120.64 79.91 1.55 Allowed 'General case' 0 C--N 1.341 0.196 0 C-N-CA 124.533 1.133 . . . . 0.0 110.12 176.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 20.1 ptt? -89.5 -177.72 5.4 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.527 1.131 . . . . 0.0 111.064 -177.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 62.5 m -142.31 117.57 10.15 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 106.682 -1.599 . . . . 0.0 106.682 169.202 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 1.6 pm0 -50.65 123.55 9.11 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.631 0.773 . . . . 0.0 109.983 173.375 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 120.36 -39.74 2.36 Favored Glycine 0 CA--C 1.529 0.941 0 C-N-CA 124.823 1.201 . . . . 0.0 111.167 -172.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 84.0 mtt180 -89.31 165.63 14.28 Favored 'General case' 0 C--N 1.341 0.218 0 CA-C-N 117.695 0.748 . . . . 0.0 111.363 -171.359 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -67.71 129.87 41.26 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.425 -0.954 . . . . 0.0 108.425 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 48.2 tp -128.0 124.47 37.27 Favored 'General case' 0 N--CA 1.456 -0.13 0 C-N-CA 124.484 1.113 . . . . 0.0 109.561 177.626 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 95.4 t -95.03 134.76 31.27 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 169.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 39.5 mm -101.09 100.85 14.18 Favored Pre-proline 0 CA--C 1.535 0.374 0 N-CA-C 105.922 -1.881 . . . . 0.0 105.922 169.473 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 84.8 Cg_endo -80.4 76.23 4.63 Favored 'Trans proline' 0 N--CA 1.457 -0.657 0 C-N-CA 123.365 2.71 . . . . 0.0 111.108 -165.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 23.1 p -125.58 45.02 2.69 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 124.291 1.037 . . . . 0.0 110.406 179.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 0.817 ' HB2' ' O ' ' A' ' 188' ' ' SER . 41.1 ptt180 -67.25 151.38 47.61 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 122.906 0.483 . . . . 0.0 110.771 176.925 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 28.4 m -126.1 175.17 8.68 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.191 0 C-N-CA 124.929 1.292 . . . . 0.0 111.366 -169.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.528 ' HG1' ' N ' ' A' ' 129' ' ' SER . 52.1 p -75.73 -24.28 56.12 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 124.791 1.236 . . . . 0.0 112.998 -172.594 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . 0.531 ' HG ' ' N ' ' A' ' 129' ' ' SER . 14.7 m -158.36 149.92 16.89 Favored Pre-proline 0 CA--C 1.534 0.345 0 CA-C-N 119.031 0.832 . . . . 0.0 110.824 177.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_exo -49.72 -36.35 41.47 Favored 'Trans proline' 0 CA--C 1.534 0.507 0 C-N-CA 124.011 3.141 . . . . 0.0 113.654 168.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.59 -36.59 35.62 Favored 'General case' 0 C--N 1.343 0.283 0 C-N-CA 126.327 1.851 . . . . 0.0 111.935 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 41.6 mm -50.46 -42.74 21.81 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.357 0 C-N-CA 124.861 1.264 . . . . 0.0 111.19 177.666 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 23.9 m 60.58 83.71 0.14 Allowed 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 125.037 1.335 . . . . 0.0 111.044 175.5 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 17.8 t -89.68 147.49 5.17 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.147 0 C-N-CA 123.609 0.764 . . . . 0.0 108.987 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 57.3 m -124.83 138.77 54.25 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.84 1.256 . . . . 0.0 107.852 171.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 60.0 tp -88.93 125.75 35.09 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 107.826 -1.176 . . . . 0.0 107.826 178.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 34.1 mttm -128.26 -179.55 5.07 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 124.878 1.271 . . . . 0.0 110.035 -179.371 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 77.6 tttt -147.72 148.19 30.73 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 124.538 1.135 . . . . 0.0 108.223 174.775 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 63.6 t80 -58.1 134.22 84.17 Favored Pre-proline 0 CA--C 1.539 0.521 0 CA-C-O 118.642 -0.694 . . . . 0.0 110.116 178.193 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -77.72 -59.97 0.09 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.729 0 CA-C-N 119.962 1.022 . . . . 0.0 111.828 0.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.8 mt -141.83 38.26 1.63 Allowed 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 124.677 1.191 . . . . 0.0 110.162 -175.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 17.8 t70 -74.6 148.28 40.9 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 170.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 91.0 m -125.75 118.32 25.32 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 123.757 0.823 . . . . 0.0 109.904 -176.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -93.04 88.67 6.2 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.05 -1.463 . . . . 0.0 107.05 173.382 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 79.5 mt -61.36 130.44 91.76 Favored Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 123.636 0.775 . . . . 0.0 109.306 -175.768 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 71.6 Cg_endo -72.37 85.32 1.08 Allowed 'Trans proline' 0 N--CA 1.454 -0.804 0 C-N-CA 123.204 2.602 . . . . 0.0 110.247 178.205 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.8 p30 -60.78 -22.92 64.59 Favored 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 125.275 1.43 . . . . 0.0 113.28 -179.75 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 73.72 28.07 65.89 Favored Glycine 0 CA--C 1.529 0.937 0 CA-C-N 118.374 0.534 . . . . 0.0 112.646 177.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 28.2 mtpp -133.56 -64.26 0.72 Allowed 'General case' 0 N--CA 1.456 -0.174 0 C-N-CA 125.078 1.351 . . . . 0.0 107.705 176.179 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 35.4 ttm180 -84.6 -58.43 2.73 Favored 'General case' 0 N--CA 1.453 -0.296 0 N-CA-C 108.509 -0.923 . . . . 0.0 108.509 169.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 20.8 mt -91.74 89.78 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.27 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -176.701 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 78.4 mt -95.22 116.35 36.46 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.237 0 N-CA-C 108.542 -0.91 . . . . 0.0 108.542 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 25.6 t-105 -89.1 129.55 35.69 Favored 'General case' 0 N--CA 1.455 -0.187 0 N-CA-C 109.603 -0.517 . . . . 0.0 109.603 -179.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 16.8 t0 -135.6 122.17 20.78 Favored 'General case' 0 N--CA 1.453 -0.304 0 C-N-CA 124.289 1.036 . . . . 0.0 108.289 170.384 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 0.817 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 60.7 p -58.8 -26.46 64.11 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 124.023 0.929 . . . . 0.0 112.379 175.08 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 30.0 mmt180 -98.75 10.93 40.13 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.883 0.873 . . . . 0.0 113.147 -175.12 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 17.6 tppt? -145.55 -57.85 0.32 Allowed 'General case' 0 C--N 1.343 0.296 0 CA-C-N 118.83 0.741 . . . . 0.0 110.603 177.253 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 149.31 -164.66 29.36 Favored Glycine 0 CA--C 1.528 0.879 0 N-CA-C 110.326 -1.11 . . . . 0.0 110.326 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 95.3 m-85 -89.79 111.41 22.4 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 169.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.0 mm -89.53 97.41 7.02 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -176.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 10.6 mm -84.1 110.84 19.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.338 0 N-CA-C 106.623 -1.621 . . . . 0.0 106.623 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 92.1 p -65.15 -35.62 81.69 Favored 'General case' 0 CA--C 1.532 0.252 0 CA-C-N 118.518 0.599 . . . . 0.0 112.499 -178.019 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -140.33 101.84 4.22 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.836 1.255 . . . . 0.0 107.99 -178.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -64.11 157.58 25.1 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.365 0.666 . . . . 0.0 110.177 175.422 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 80.3 p -133.06 164.28 27.37 Favored 'General case' 0 C--O 1.231 0.083 0 C-N-CA 123.725 0.81 . . . . 0.0 110.177 -177.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 53.7 p90 -59.63 -32.13 70.16 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.283 0.633 . . . . 0.0 110.969 172.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 94.9 mttt -60.3 -25.74 65.98 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.262 1.025 . . . . 0.0 111.947 178.115 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 49.6 mt-10 -80.29 -12.29 59.63 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.13 -0.938 . . . . 0.0 112.654 -179.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 88.0 mt -65.61 105.35 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.344 0.343 0 CA-C-N 119.44 1.018 . . . . 0.0 109.212 -178.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 152.82 -159.04 28.24 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 111.544 -0.622 . . . . 0.0 111.544 176.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 40.8 tp -85.5 81.36 8.73 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 123.918 0.887 . . . . 0.0 110.562 -173.034 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 97.9 mt -65.83 150.91 47.8 Favored 'General case' 0 C--N 1.341 0.218 0 N-CA-C 108.52 -0.919 . . . . 0.0 108.52 169.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 27.7 m -150.01 114.64 5.27 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 123.466 0.706 . . . . 0.0 109.416 -175.178 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 84.6 m -78.23 124.48 28.12 Favored 'General case' 0 N--CA 1.456 -0.16 0 N-CA-C 107.637 -1.246 . . . . 0.0 107.637 169.734 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 60.9 mt-10 -121.55 141.49 51.01 Favored 'General case' 0 C--N 1.338 0.105 0 C-N-CA 124.316 1.047 . . . . 0.0 110.447 -175.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -151.07 102.06 2.93 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.558 1.143 . . . . 0.0 109.198 178.563 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 59.2 m -89.88 86.34 6.61 Favored 'General case' 0 C--N 1.339 0.134 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 170.686 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 48.9 t -66.92 -56.07 15.34 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.18 0 C-N-CA 123.279 0.632 . . . . 0.0 109.786 -174.263 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 15.6 m-80 -158.03 -75.51 0.08 Allowed 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 123.981 0.913 . . . . 0.0 109.415 177.62 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -66.29 -46.54 78.1 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 123.362 0.506 . . . . 0.0 112.398 -170.009 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 43.7 m-70 -140.06 162.39 35.33 Favored 'General case' 0 C--N 1.339 0.15 0 C-N-CA 123.235 0.614 . . . . 0.0 111.395 -169.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 27.3 tp -80.59 101.96 9.5 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 169.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -89.85 133.2 34.87 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 106.53 -1.656 . . . . 0.0 106.53 172.234 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.55 161.71 42.02 Favored 'General case' 0 C--O 1.231 0.107 0 N-CA-C 112.004 0.372 . . . . 0.0 112.004 -177.572 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 62.7 p -139.72 133.6 30.74 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 124.518 1.127 . . . . 0.0 109.086 176.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -106.87 145.55 32.03 Favored 'General case' 0 C--N 1.34 0.178 0 C-N-CA 124.209 1.004 . . . . 0.0 111.743 -170.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -143.06 105.43 4.44 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 125.714 1.606 . . . . 0.0 109.235 -173.682 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.4 tt -89.69 108.67 19.81 Favored 'General case' 0 N--CA 1.454 -0.27 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 18.9 p -89.26 90.65 8.44 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.462 0.705 . . . . 0.0 109.283 179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 35.6 t60 -89.61 103.43 16.08 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 171.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 44.8 ptt85 -56.28 143.45 33.92 Favored 'General case' 0 CA--C 1.531 0.23 0 CA-C-N 118.993 0.815 . . . . 0.0 110.777 -177.246 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 3.8 pt20 -66.38 138.39 57.56 Favored 'General case' 0 N--CA 1.454 -0.24 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 176.201 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 35.2 p -64.96 -47.71 76.63 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.67 0.788 . . . . 0.0 109.893 178.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -150.02 149.83 30.91 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 125.143 1.377 . . . . 0.0 109.333 179.493 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 m -81.62 73.16 8.67 Favored 'General case' 0 CA--C 1.531 0.247 0 C-N-CA 123.854 0.862 . . . . 0.0 109.371 -178.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 50.1 mt . . . . . 0 C--O 1.25 1.114 0 CA-C-O 117.226 -1.368 . . . . 0.0 107.714 178.979 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 77.2 p . . . . . 0 N--CA 1.474 0.732 0 CA-C-O 120.697 0.284 . . . . 0.0 111.159 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -80.94 65.42 6.07 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.9 0.88 . . . . 0.0 109.458 179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 18.2 m -75.5 76.58 2.54 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.921 1.288 . . . . 0.0 110.027 -174.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 176.4 -134.29 2.55 Favored Glycine 0 CA--C 1.524 0.624 0 N-CA-C 107.976 -2.049 . . . . 0.0 107.976 -179.281 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 52.4 ttp180 -75.41 126.84 87.17 Favored Pre-proline 0 CA--C 1.536 0.42 0 CA-C-N 117.431 0.616 . . . . 0.0 109.393 177.502 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 98.4 Cg_endo -77.39 -37.41 1.0 Allowed 'Trans proline' 0 N--CA 1.454 -0.828 0 C-N-CA 123.166 2.577 . . . . 0.0 111.37 178.497 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 79.0 m-85 -62.08 143.42 56.67 Favored 'General case' 0 N--CA 1.455 -0.217 0 C-N-CA 124.946 1.298 . . . . 0.0 112.366 -174.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 90.0 t -91.29 -55.85 5.77 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 107.602 -1.259 . . . . 0.0 107.602 171.266 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 53.9 tt0 -92.45 126.75 37.67 Favored 'General case' 0 C--N 1.341 0.234 0 C-N-CA 123.803 0.841 . . . . 0.0 108.922 173.673 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 18.4 ttt -137.17 141.01 42.18 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.077 1.351 . . . . 0.0 108.996 179.404 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -63.16 121.09 12.79 Favored 'General case' 0 CA--C 1.533 0.302 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 171.549 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 15.3 m -68.91 -39.51 79.62 Favored 'General case' 0 CA--C 1.531 0.242 0 O-C-N 121.8 -0.563 . . . . 0.0 111.222 -176.73 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.1 tt0 -158.92 -58.34 0.07 Allowed 'General case' 0 N--CA 1.455 -0.175 0 C-N-CA 124.042 0.937 . . . . 0.0 109.084 179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 36.6 mm -87.77 130.99 44.77 Favored Pre-proline 0 CA--C 1.536 0.421 0 N-CA-C 108.167 -1.049 . . . . 0.0 108.167 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 84.1 Cg_exo -51.96 147.4 26.22 Favored 'Trans proline' 0 N--CA 1.459 -0.512 0 C-N-CA 123.549 2.833 . . . . 0.0 112.429 173.321 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 1.4 mp0 -67.87 118.98 11.81 Favored 'General case' 0 CA--C 1.53 0.173 0 N-CA-C 109.169 -0.678 . . . . 0.0 109.169 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 30.2 mm -80.2 94.68 2.18 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 N-CA-C 108.639 -0.875 . . . . 0.0 108.639 179.292 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 37.6 mt -89.54 108.28 19.06 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.313 0 N-CA-C 107.913 -1.143 . . . . 0.0 107.913 178.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 93.3 m-70 -76.9 89.25 3.49 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.09 0.956 . . . . 0.0 108.552 172.675 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.8 ppp? -104.36 173.51 6.27 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 125.395 1.478 . . . . 0.0 111.387 -175.001 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 94.1 m -138.36 120.74 15.96 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 107.438 -1.319 . . . . 0.0 107.438 172.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -59.67 144.67 47.31 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 122.719 0.408 . . . . 0.0 110.364 176.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.22 -37.32 3.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 111.174 -0.771 . . . . 0.0 111.174 -171.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 25.2 mmm180 -89.15 170.15 10.86 Favored 'General case' 0 C--N 1.34 0.189 0 C-N-CA 123.728 0.811 . . . . 0.0 110.672 -176.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -67.57 145.57 54.75 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 122.815 0.446 . . . . 0.0 110.813 176.411 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.5 tp -143.31 108.5 5.0 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.88 1.272 . . . . 0.0 108.451 -172.064 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.8 t -89.64 131.16 37.63 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.281 0 N-CA-C 107.742 -1.207 . . . . 0.0 107.742 174.737 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 41.4 mm -108.63 91.52 8.81 Favored Pre-proline 0 CA--C 1.536 0.408 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 171.139 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 98.5 Cg_endo -77.73 89.19 1.35 Allowed 'Trans proline' 0 N--CA 1.455 -0.77 0 C-N-CA 123.459 2.773 . . . . 0.0 111.851 -164.368 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 21.7 p -135.62 48.73 2.2 Favored 'General case' 0 CA--C 1.529 0.156 0 C-N-CA 124.424 1.089 . . . . 0.0 110.557 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . 1.283 ' HB2' ' O ' ' A' ' 188' ' ' SER . 0.0 OUTLIER -62.87 157.38 21.62 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 121.253 0.549 . . . . 0.0 112.174 176.603 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 22.0 m -125.85 175.01 8.71 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 C-N-CA 125.819 1.648 . . . . 0.0 108.94 178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 47.0 p -63.7 -42.4 97.97 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.474 0.71 . . . . 0.0 112.04 -179.766 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 73.9 m -142.72 140.89 19.0 Favored Pre-proline 0 CA--C 1.533 0.32 0 C-N-CA 123.999 0.92 . . . . 0.0 110.24 -177.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -67.17 -26.9 42.03 Favored 'Trans proline' 0 N--CA 1.459 -0.533 0 C-N-CA 123.669 2.913 . . . . 0.0 112.027 -179.309 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 50.1 m-20 -52.77 -31.82 40.32 Favored 'General case' 0 CA--C 1.532 0.282 0 C-N-CA 125.313 1.445 . . . . 0.0 112.082 178.585 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 97.0 mt -53.78 -35.07 26.21 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.374 0 C-N-CA 124.982 1.313 . . . . 0.0 110.915 176.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 26.8 m 69.02 91.29 0.09 Allowed 'General case' 0 C--N 1.341 0.197 0 C-N-CA 125.537 1.535 . . . . 0.0 110.383 174.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 46.6 t -89.33 141.26 14.56 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.268 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -179.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 89.8 m -110.45 126.84 54.75 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 124.719 1.208 . . . . 0.0 108.092 178.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 62.0 tp -89.23 133.34 34.48 Favored 'General case' 0 N--CA 1.454 -0.248 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 175.67 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 78.3 mttt -133.82 174.82 10.04 Favored 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 124.767 1.227 . . . . 0.0 109.764 -179.648 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 61.6 tttp -149.23 148.21 29.31 Favored 'General case' 0 N--CA 1.454 -0.275 0 C-N-CA 123.645 0.778 . . . . 0.0 109.413 178.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.8 t80 -57.7 134.95 82.78 Favored Pre-proline 0 CA--C 1.538 0.506 0 C-N-CA 123.928 0.891 . . . . 0.0 109.96 176.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 62.0 Cg_endo -78.27 -59.2 0.13 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.782 0 CA-C-N 119.917 1.006 . . . . 0.0 111.697 1.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 89.7 mt -142.52 44.2 1.62 Allowed 'General case' 0 CA--C 1.534 0.338 0 C-N-CA 124.597 1.159 . . . . 0.0 109.943 -175.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -82.03 152.03 26.84 Favored 'General case' 0 C--N 1.339 0.119 0 N-CA-C 108.601 -0.888 . . . . 0.0 108.601 171.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 89.7 m -131.71 119.09 20.87 Favored 'General case' 0 N--CA 1.457 -0.098 0 C-N-CA 124.133 0.973 . . . . 0.0 108.942 179.122 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 6.0 mp -101.95 113.35 26.5 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 125.283 1.433 . . . . 0.0 108.569 -176.111 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 1.9 mp -76.74 130.9 74.96 Favored Pre-proline 0 CA--C 1.536 0.414 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 179.086 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -71.74 91.4 0.71 Allowed 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 122.861 2.374 . . . . 0.0 109.731 175.636 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.0 p-10 -64.31 -22.6 67.01 Favored 'General case' 0 CA--C 1.535 0.38 0 C-N-CA 124.478 1.111 . . . . 0.0 113.144 -176.45 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 85.01 19.48 59.22 Favored Glycine 0 CA--C 1.53 0.976 0 CA-C-O 119.233 -0.76 . . . . 0.0 113.428 174.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 67.7 mttm -137.12 -60.12 0.69 Allowed 'General case' 0 C--N 1.341 0.201 0 C-N-CA 124.297 1.039 . . . . 0.0 108.649 175.426 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 56.9 ttp85 -79.7 -66.48 0.87 Allowed 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 107.902 -1.147 . . . . 0.0 107.902 172.152 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 41.5 mt -89.56 94.59 4.92 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 N-CA-C 107.356 -1.35 . . . . 0.0 107.356 176.876 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 40.9 mt -94.6 121.68 45.41 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 177.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 18.9 t-105 -89.21 127.83 35.78 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 -179.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 11.4 m-20 -137.09 100.8 4.37 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.773 1.229 . . . . 0.0 108.38 -179.709 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . 1.283 ' O ' ' HB2' ' A' ' 159' ' ' ARG . 78.7 p -53.79 -27.74 30.91 Favored 'General case' 0 CA--C 1.533 0.315 0 N-CA-C 113.602 0.964 . . . . 0.0 113.602 179.475 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 83.8 mtp180 -73.01 -28.43 62.36 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 124.113 0.965 . . . . 0.0 112.611 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 38.7 ttmt -121.31 -63.34 1.34 Allowed 'General case' 0 C--N 1.342 0.282 0 C-N-CA 123.728 0.811 . . . . 0.0 110.65 -175.265 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 162.07 -155.21 26.41 Favored Glycine 0 CA--C 1.527 0.814 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 -178.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -89.84 111.71 22.83 Favored 'General case' 0 C--N 1.339 0.141 0 N-CA-C 108.434 -0.95 . . . . 0.0 108.434 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 37.3 mt -89.35 94.54 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 107.14 -1.43 . . . . 0.0 107.14 178.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 37.9 mt -81.14 85.37 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.364 0 N-CA-C 106.441 -1.688 . . . . 0.0 106.441 174.233 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 78.9 p -58.19 -29.5 65.7 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.481 1.512 . . . . 0.0 113.336 -170.774 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -132.62 97.25 4.02 Favored 'General case' 0 N--CA 1.455 -0.204 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 172.523 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -68.09 156.91 36.43 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.055 0.542 . . . . 0.0 110.393 176.35 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 43.0 p -125.53 154.43 42.15 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.143 0.977 . . . . 0.0 109.67 177.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -55.28 -32.55 62.5 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.172 0.989 . . . . 0.0 111.671 176.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 62.0 mttp -53.49 -37.35 62.64 Favored 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 124.642 1.177 . . . . 0.0 111.481 176.929 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 58.6 mt-10 -83.34 4.37 27.61 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.397 1.079 . . . . 0.0 113.2 -173.015 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 74.3 mt -73.87 115.51 15.02 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.264 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 160.62 -111.5 0.48 Allowed Glycine 0 C--N 1.339 0.701 0 N-CA-C 110.912 -0.875 . . . . 0.0 110.912 178.093 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 62.8 tp -144.98 100.71 3.53 Favored 'General case' 0 C--N 1.341 0.22 0 C-N-CA 123.96 0.904 . . . . 0.0 109.975 -172.022 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 9.5 mp -86.7 156.67 19.88 Favored 'General case' 0 C--N 1.34 0.185 0 C-N-CA 123.816 0.846 . . . . 0.0 109.128 175.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 60.7 m -147.28 117.73 7.45 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.395 1.078 . . . . 0.0 108.786 -176.172 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 60.4 m -85.04 140.01 31.33 Favored 'General case' 0 N--CA 1.458 -0.068 0 N-CA-C 108.111 -1.07 . . . . 0.0 108.111 170.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -133.94 147.44 51.06 Favored 'General case' 0 C--N 1.342 0.245 0 C-N-CA 123.995 0.918 . . . . 0.0 109.91 175.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -158.91 130.63 6.47 Favored 'General case' 0 CA--C 1.53 0.174 0 C-N-CA 123.332 0.653 . . . . 0.0 110.91 -179.52 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.8 m -100.06 133.88 43.8 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 124.954 1.302 . . . . 0.0 109.329 174.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 85.7 t -100.49 -62.75 1.89 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.218 0 C-N-CA 124.261 1.024 . . . . 0.0 108.524 174.24 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 8.0 p-10 -140.31 84.79 1.98 Allowed 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.066 0.947 . . . . 0.0 109.106 -177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 83.22 -57.47 5.07 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 124.05 0.834 . . . . 0.0 111.928 175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -89.49 129.25 36.01 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 123.766 0.827 . . . . 0.0 110.289 -174.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -77.86 156.8 30.16 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-O 121.634 0.73 . . . . 0.0 111.046 173.264 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -125.41 154.57 41.72 Favored 'General case' 0 N--CA 1.448 -0.535 0 N-CA-C 105.861 -1.903 . . . . 0.0 105.861 170.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.6 pttm -151.2 162.74 40.32 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 111.926 0.343 . . . . 0.0 111.926 -178.822 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 1.3 t -151.44 141.42 22.07 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 123.924 0.89 . . . . 0.0 109.639 177.165 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -109.17 147.49 32.42 Favored 'General case' 0 C--N 1.341 0.227 0 C-N-CA 125.288 1.435 . . . . 0.0 112.794 -168.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 84.5 m-85 -143.76 101.9 3.83 Favored 'General case' 0 C--N 1.341 0.218 0 C-N-CA 125.457 1.503 . . . . 0.0 109.118 -173.073 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 6.1 tt -80.31 110.98 16.26 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.055 0.942 . . . . 0.0 108.772 -179.332 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 6.9 p -89.4 93.29 9.47 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.532 1.133 . . . . 0.0 109.024 -178.268 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 38.6 t-80 -89.92 120.56 31.25 Favored 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 125.23 1.412 . . . . 0.0 108.749 179.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 74.5 ttt180 -73.11 109.58 6.75 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 109.063 -0.717 . . . . 0.0 109.063 173.662 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -66.89 -57.4 7.03 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.268 1.027 . . . . 0.0 111.346 -175.669 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 6.3 p -91.36 78.6 5.7 Favored 'General case' 0 N--CA 1.448 -0.558 0 N-CA-C 106.298 -1.741 . . . . 0.0 106.298 175.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 3.0 p30 -88.01 65.45 8.23 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 -175.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 73.6 p -85.73 66.23 9.53 Favored 'General case' 0 N--CA 1.45 -0.435 0 C-N-CA 125.68 1.592 . . . . 0.0 108.886 -175.392 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 45.1 mm . . . . . 0 C--O 1.251 1.133 0 CA-C-O 117.31 -1.329 . . . . 0.0 108.909 -178.853 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 58.5 m . . . . . 0 N--CA 1.474 0.738 0 N-CA-C 111.848 0.314 . . . . 0.0 111.848 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 20.0 t70 -166.46 142.08 4.59 Favored 'General case' 0 N--CA 1.456 -0.15 0 C-N-CA 124.109 0.964 . . . . 0.0 109.4 -179.118 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 34.6 p -123.86 58.69 1.16 Allowed 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.891 1.276 . . . . 0.0 108.005 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . -129.02 -61.16 0.11 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 108.898 -1.681 . . . . 0.0 108.898 179.043 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.7 ttp180 -121.37 126.82 26.38 Favored Pre-proline 0 CA--C 1.533 0.314 0 N-CA-C 107.254 -1.387 . . . . 0.0 107.254 169.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -73.65 -61.89 0.04 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.023 0 C-N-CA 122.56 2.173 . . . . 0.0 111.341 -173.782 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 78.3 m-85 -71.56 132.9 45.33 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 123.348 0.659 . . . . 0.0 111.729 -171.674 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 55.1 t -80.89 -61.77 1.63 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.201 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 171.726 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.6 pt-20 -81.98 109.59 16.46 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.874 -1.158 . . . . 0.0 107.874 170.608 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 28.0 ttt -123.92 123.6 40.77 Favored 'General case' 0 N--CA 1.455 -0.191 0 C-N-CA 123.92 0.888 . . . . 0.0 110.252 -170.338 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -62.95 147.3 50.89 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 123.998 0.919 . . . . 0.0 110.709 174.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 42.4 m -154.44 -58.5 0.11 Allowed 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 125.064 1.345 . . . . 0.0 109.25 169.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 47.6 mt-10 -97.32 79.74 2.82 Favored 'General case' 0 CA--C 1.516 -0.34 0 C-N-CA 123.867 0.867 . . . . 0.0 110.273 -169.837 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 27.4 mm 78.36 128.4 0.03 OUTLIER Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 128.142 2.577 . . . . 0.0 109.748 175.831 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_exo -49.74 138.32 33.32 Favored 'Trans proline' 0 N--CA 1.458 -0.58 0 C-N-CA 123.436 2.757 . . . . 0.0 112.348 176.296 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -62.67 120.55 11.41 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.099 0.56 . . . . 0.0 109.981 -176.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 39.8 mm -76.53 122.6 31.18 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 N-CA-C 108.639 -0.874 . . . . 0.0 108.639 177.031 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 49.0 mt -122.75 102.94 12.47 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 177.157 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 10.3 p80 -75.79 83.79 2.75 Favored 'General case' 0 CA--C 1.532 0.256 0 C-N-CA 124.283 1.033 . . . . 0.0 109.524 175.582 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 3.6 ppp? -92.87 155.62 17.49 Favored 'General case' 0 C--N 1.341 0.208 0 C-N-CA 124.068 0.947 . . . . 0.0 111.383 -173.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 83.5 m -115.72 112.77 22.55 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 176.401 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 77.9 tt0 -57.7 137.58 56.33 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 123.465 0.706 . . . . 0.0 109.88 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 104.31 -36.38 4.42 Favored Glycine 0 CA--C 1.53 0.973 0 C-N-CA 124.15 0.881 . . . . 0.0 111.385 -174.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 29.7 mmt180 -89.5 179.48 6.05 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 123.525 0.73 . . . . 0.0 110.897 -172.491 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -73.06 137.82 45.53 Favored 'General case' 0 N--CA 1.455 -0.205 0 N-CA-C 109.708 -0.479 . . . . 0.0 109.708 176.103 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 18.9 tp -134.29 108.79 8.42 Favored 'General case' 0 N--CA 1.45 -0.463 0 C-N-CA 125.069 1.348 . . . . 0.0 108.85 -175.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 61.1 t -90.0 128.85 41.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 124.322 1.049 . . . . 0.0 108.176 175.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 37.5 mm -109.25 94.02 14.58 Favored Pre-proline 0 CA--C 1.535 0.368 0 N-CA-C 105.623 -1.992 . . . . 0.0 105.623 169.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -78.68 100.47 1.36 Allowed 'Trans proline' 0 N--CA 1.453 -0.869 0 C-N-CA 123.347 2.698 . . . . 0.0 110.643 -166.399 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 30.9 p -145.03 59.14 1.3 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.85 0.86 . . . . 0.0 110.126 -178.093 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 34.1 ptt-85 -66.9 155.67 37.82 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 116.415 -0.357 . . . . 0.0 111.139 179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 15.5 m -123.03 164.81 19.97 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 124.733 1.213 . . . . 0.0 110.646 178.649 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 23.3 p -61.85 -45.25 94.63 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 125.509 1.524 . . . . 0.0 111.517 -179.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 52.0 m -135.82 145.67 53.85 Favored Pre-proline 0 CA--C 1.533 0.313 0 C-N-CA 124.321 1.048 . . . . 0.0 110.204 -175.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 75.6 Cg_endo -68.48 -26.09 34.66 Favored 'Trans proline' 0 N--CA 1.458 -0.571 0 C-N-CA 123.352 2.701 . . . . 0.0 111.366 175.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 14.4 m120 -53.97 -29.31 42.3 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 125.781 1.632 . . . . 0.0 112.312 176.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 46.4 mm -54.57 -51.91 45.87 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.257 0 C-N-CA 124.066 0.946 . . . . 0.0 109.873 172.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 11.7 m 63.39 93.39 0.06 Allowed 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.494 1.517 . . . . 0.0 110.612 178.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 41.1 t -89.02 144.5 8.96 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.165 0 C-N-CA 123.763 0.825 . . . . 0.0 109.231 -171.411 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 85.5 m -112.76 129.82 56.29 Favored 'General case' 0 N--CA 1.453 -0.291 0 C-N-CA 124.764 1.226 . . . . 0.0 107.739 174.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 55.6 tp -88.97 126.4 35.39 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 107.588 -1.264 . . . . 0.0 107.588 176.829 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 60.4 mttt -126.4 -177.34 3.95 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.326 1.051 . . . . 0.0 109.424 176.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -159.24 147.77 17.99 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.447 1.099 . . . . 0.0 108.889 -177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 64.2 t80 -58.33 134.91 85.06 Favored Pre-proline 0 CA--C 1.538 0.512 0 C-N-CA 123.962 0.905 . . . . 0.0 110.645 -179.082 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -77.41 -58.81 0.14 OUTLIER 'Cis proline' 0 N--CA 1.456 -0.715 0 CA-C-N 119.897 0.999 . . . . 0.0 111.649 0.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 90.0 mt -141.82 38.46 1.64 Allowed 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 124.71 1.204 . . . . 0.0 109.765 -176.873 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 55.3 m-20 -79.1 139.5 38.07 Favored 'General case' 0 N--CA 1.457 -0.115 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 174.47 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 87.5 m -113.81 114.63 26.55 Favored 'General case' 0 C--N 1.339 0.123 0 C-N-CA 123.606 0.762 . . . . 0.0 109.477 -178.074 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 10.4 mp -89.98 85.43 6.34 Favored 'General case' 0 N--CA 1.453 -0.304 0 N-CA-C 107.508 -1.293 . . . . 0.0 107.508 175.894 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 27.3 mm -60.4 129.32 88.99 Favored Pre-proline 0 CA--C 1.538 0.484 0 C-N-CA 123.412 0.685 . . . . 0.0 109.522 -179.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 89.0 Cg_endo -73.69 81.74 1.81 Allowed 'Trans proline' 0 N--CA 1.455 -0.787 0 C-N-CA 123.116 2.544 . . . . 0.0 109.921 176.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 1.7 p30 -60.42 -23.09 64.12 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.622 1.569 . . . . 0.0 113.426 -178.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 71.29 32.67 65.1 Favored Glycine 0 CA--C 1.529 0.964 0 C-N-CA 123.58 0.61 . . . . 0.0 112.167 179.051 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 9.5 mtmp? -138.91 -59.12 0.6 Allowed 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 125.235 1.414 . . . . 0.0 108.162 179.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 65.6 ttp85 -94.67 -56.57 2.74 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 124.813 1.245 . . . . 0.0 108.411 171.186 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 34.8 mt -94.2 96.67 6.2 Favored 'Isoleucine or valine' 0 C--N 1.34 0.192 0 C-N-CA 125.362 1.465 . . . . 0.0 108.179 179.854 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 1.9 mp -87.63 148.08 4.83 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.231 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 173.523 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 22.6 t-105 -120.31 138.58 53.63 Favored 'General case' 0 C--N 1.339 0.129 0 C-N-CA 125.113 1.365 . . . . 0.0 109.313 177.131 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -141.81 116.44 9.7 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.37 1.068 . . . . 0.0 108.94 172.751 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 80.2 p -53.92 -32.52 53.79 Favored 'General case' 0 CA--C 1.531 0.212 0 C-N-CA 124.947 1.299 . . . . 0.0 112.992 175.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 77.1 mtm-85 -83.28 -5.78 59.25 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 123.738 0.815 . . . . 0.0 112.848 -175.696 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 61.2 tttm -141.13 -62.21 0.47 Allowed 'General case' 0 C--N 1.344 0.329 0 CA-C-N 119.196 0.907 . . . . 0.0 111.719 -169.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 156.45 -162.04 31.26 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.101 -1.199 . . . . 0.0 110.101 -174.215 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 97.3 m-85 -95.0 123.03 38.25 Favored 'General case' 0 C--N 1.34 0.155 0 N-CA-C 108.678 -0.86 . . . . 0.0 108.678 171.635 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 4.8 mp -103.28 98.12 6.43 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.327 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 178.769 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.6 mp -85.01 96.27 4.73 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 N-CA-C 107.128 -1.434 . . . . 0.0 107.128 174.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 63.1 p -55.9 -40.22 72.73 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 125.234 1.414 . . . . 0.0 112.842 -174.82 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 -125.13 99.67 6.2 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.821 1.248 . . . . 0.0 107.848 175.876 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -67.72 139.27 56.7 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 123.393 0.677 . . . . 0.0 110.527 179.594 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 59.3 p -131.98 -177.43 4.44 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 124.677 1.191 . . . . 0.0 109.189 177.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 44.0 p90 -51.14 -32.2 22.23 Favored 'General case' 0 CA--C 1.533 0.32 0 C-N-CA 125.032 1.333 . . . . 0.0 112.387 175.479 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 4.0 mmpt? -53.71 -29.77 40.74 Favored 'General case' 0 C--N 1.341 0.216 0 C-N-CA 124.508 1.123 . . . . 0.0 112.171 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 24.9 mp0 -110.6 47.24 0.99 Allowed 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.752 0.821 . . . . 0.0 110.918 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 37.7 mt -131.09 94.28 2.04 Favored 'Isoleucine or valine' 0 C--N 1.341 0.225 0 N-CA-C 108.013 -1.106 . . . . 0.0 108.013 174.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 150.23 -158.29 27.6 Favored Glycine 0 CA--C 1.528 0.891 0 C-N-CA 124.821 1.2 . . . . 0.0 110.445 -178.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 46.4 tp -85.93 92.29 8.62 Favored 'General case' 0 CA--C 1.53 0.187 0 C-N-CA 123.857 0.863 . . . . 0.0 109.949 -177.495 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 7.9 mp -75.63 159.11 31.53 Favored 'General case' 0 C--N 1.341 0.219 0 N-CA-C 109.025 -0.731 . . . . 0.0 109.025 173.245 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 19.7 m -148.26 108.28 4.06 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.195 0.998 . . . . 0.0 109.29 -176.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 68.9 m -76.23 118.83 19.36 Favored 'General case' 0 C--N 1.34 0.19 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 169.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 81.1 mt-10 -113.58 131.85 55.95 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.682 1.193 . . . . 0.0 110.297 -176.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -136.41 152.16 50.3 Favored 'General case' 0 N--CA 1.456 -0.154 0 C-N-CA 125.303 1.441 . . . . 0.0 109.501 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 93.8 m -140.73 118.43 11.66 Favored 'General case' 0 CA--C 1.528 0.114 0 N-CA-C 108.696 -0.853 . . . . 0.0 108.696 179.409 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 53.5 t -74.07 -54.95 13.7 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.164 0 C-N-CA 123.847 0.859 . . . . 0.0 109.353 175.63 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 5.0 t-20 -130.39 -65.08 0.82 Allowed 'General case' 0 C--N 1.34 0.18 0 C-N-CA 124.173 0.989 . . . . 0.0 109.554 -172.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . -166.93 40.68 0.25 Allowed Glycine 0 CA--C 1.528 0.887 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 174.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 48.5 t-80 -93.67 -47.08 6.96 Favored 'General case' 0 N--CA 1.453 -0.284 0 C-N-CA 125.209 1.404 . . . . 0.0 110.343 -173.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 49.3 tp 63.68 88.56 0.1 Allowed 'General case' 0 N--CA 1.454 -0.228 0 C-N-CA 125.932 1.693 . . . . 0.0 110.35 -171.257 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -89.55 140.82 29.16 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 106.784 -1.561 . . . . 0.0 106.784 169.48 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 23.2 pttp -137.76 141.53 40.93 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 123.298 0.639 . . . . 0.0 109.909 179.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 35.3 p -133.44 123.89 26.09 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 124.581 1.152 . . . . 0.0 108.099 -178.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 24.2 m-80 -102.3 144.59 30.6 Favored 'General case' 0 C--N 1.34 0.174 0 C-N-CA 124.031 0.932 . . . . 0.0 112.813 -169.202 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -142.96 107.72 4.87 Favored 'General case' 0 C--N 1.341 0.206 0 C-N-CA 125.857 1.663 . . . . 0.0 108.252 -174.349 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 1.9 tt -92.58 108.51 20.03 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 123.852 0.861 . . . . 0.0 109.174 -175.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 32.1 p -89.62 114.82 26.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.099 0.96 . . . . 0.0 109.925 -178.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -89.85 135.78 33.43 Favored 'General case' 0 C--N 1.34 0.17 0 C-N-CA 124.316 1.046 . . . . 0.0 109.148 172.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 27.6 ptt-85 -75.82 105.21 6.73 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.848 -0.797 . . . . 0.0 108.848 169.722 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 9.3 tt0 -76.48 74.2 3.22 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 125.369 1.468 . . . . 0.0 109.953 -175.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 26.0 p -65.87 -66.68 0.52 Allowed 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 124.117 0.967 . . . . 0.0 109.493 178.362 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -89.78 -71.64 0.6 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.926 0.891 . . . . 0.0 108.712 174.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 15.1 t -156.55 41.14 0.35 Allowed 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 124.252 1.021 . . . . 0.0 109.167 173.458 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 19.8 mm . . . . . 0 C--O 1.25 1.111 0 CA-C-O 116.992 -1.48 . . . . 0.0 109.33 -173.092 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' SER . . . . . . . . . . . . . 44.2 m . . . . . 0 N--CA 1.474 0.729 0 CA-C-O 120.631 0.253 . . . . 0.0 111.3 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ASP . . . . . . . . . . . . . 66.3 m-20 -78.68 76.38 5.18 Favored 'General case' 0 C--N 1.339 0.142 0 C-N-CA 124.088 0.955 . . . . 0.0 110.189 -177.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' THR . . . . . . . . . . . . . 13.0 t -140.8 158.98 43.18 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 125.343 1.457 . . . . 0.0 108.237 175.463 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' GLY . . . . . . . . . . . . . . . 78.53 -65.46 3.41 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 108.32 -1.912 . . . . 0.0 108.32 -169.754 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 8.3 ptp85 -73.58 153.15 89.67 Favored Pre-proline 0 N--CA 1.452 -0.329 0 C-N-CA 123.845 0.858 . . . . 0.0 109.958 170.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' PRO . . . . . . . . . . . . . 60.5 Cg_endo -82.87 -27.21 2.1 Favored 'Trans proline' 0 N--CA 1.452 -0.966 0 C-N-CA 123.19 2.594 . . . . 0.0 111.405 176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' PHE . . . . . . . . . . . . . 69.0 m-85 -65.58 132.24 48.37 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.101 1.361 . . . . 0.0 112.554 -169.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' VAL . . . . . . . . . . . . . 67.0 t -76.44 -49.63 24.07 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.237 0 N-CA-C 108.024 -1.102 . . . . 0.0 108.024 169.622 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' GLU . . . . . . . . . . . . . 14.9 tp10 -81.38 101.26 9.72 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 123.28 0.632 . . . . 0.0 109.697 179.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -89.57 136.33 33.09 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 108.522 -0.918 . . . . 0.0 108.522 174.841 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' TYR . . . . . 0.4 ' O ' ' CG ' ' A' ' 139' ' ' TYR . 1.2 p90 -79.42 48.16 0.88 Allowed 'General case' 0 CA--C 1.538 0.504 0 C-N-CA 123.623 0.769 . . . . 0.0 111.352 175.242 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' SER . . . . . . . . . . . . . 43.3 m -34.25 111.46 0.11 Allowed 'General case' 0 C--N 1.342 0.265 0 C-N-CA 126.718 2.007 . . . . 0.0 110.76 -177.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' GLU . . . . . . . . . . . . . 41.2 mt-10 1.61 71.52 0.0 OUTLIER 'General case' 0 C--N 1.342 0.275 0 C-N-CA 127.838 2.455 . . . . 0.0 114.748 -167.127 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ILE . . . . . . . . . . . . . 3.7 mt 157.56 132.33 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.478 0 C-N-CA 129.466 3.106 . . . . 0.0 108.584 168.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -70.41 148.11 60.16 Favored 'Trans proline' 0 N--CA 1.456 -0.704 0 C-N-CA 123.316 2.677 . . . . 0.0 110.613 -179.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -70.01 119.37 14.11 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 123.243 0.617 . . . . 0.0 109.472 -178.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' ILE . . . . . . . . . . . . . 37.0 mm -78.99 99.81 3.41 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.185 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 178.811 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ILE . . . . . . . . . . . . . 55.7 mt -90.63 115.44 29.93 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 174.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' HIS . . . . . . . . . . . . . 21.7 p-80 -80.09 83.61 5.95 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.691 1.197 . . . . 0.0 108.652 173.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' MET . . . . . . . . . . . . . 4.9 ppp? -89.34 172.99 8.63 Favored 'General case' 0 C--N 1.34 0.173 0 C-N-CA 123.218 0.607 . . . . 0.0 112.159 -169.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' THR . . . . . . . . . . . . . 30.7 m -142.24 114.07 8.03 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.608 1.163 . . . . 0.0 108.189 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -54.55 145.51 18.57 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 123.884 0.873 . . . . 0.0 110.883 174.227 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' GLY . . . . . . . . . . . . . . . 96.01 -48.17 1.8 Allowed Glycine 0 CA--C 1.528 0.855 0 C-N-CA 124.144 0.878 . . . . 0.0 111.155 -176.512 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ARG . . . . . . . . . . . . . 71.8 mtm180 -89.52 -178.21 5.51 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.796 0.838 . . . . 0.0 111.057 -173.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -71.98 142.42 49.38 Favored 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 123.119 0.568 . . . . 0.0 110.948 -178.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' LEU . . . . . . . . . . . . . 2.0 tt -139.72 110.18 6.64 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 125.455 1.502 . . . . 0.0 106.998 178.325 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . . . . . . . . . 50.1 t -90.49 134.81 28.2 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.174 0 N-CA-C 108.775 -0.824 . . . . 0.0 108.775 176.129 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' ILE . . . . . . . . . . . . . 36.3 mm -106.58 93.55 8.7 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 106.234 -1.765 . . . . 0.0 106.234 171.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -79.56 80.27 3.12 Favored 'Trans proline' 0 N--CA 1.455 -0.764 0 C-N-CA 123.186 2.59 . . . . 0.0 111.977 -164.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' CYS . . . . . . . . . . . . . 25.1 p -120.32 52.8 1.12 Allowed 'General case' 0 C--N 1.34 0.168 0 C-N-CA 124.569 1.148 . . . . 0.0 110.722 176.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ARG . . . . . . . . . . . . . 22.4 ptt-85 -57.56 147.81 25.89 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.288 1.035 . . . . 0.0 110.956 172.897 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' VAL . . . . . . . . . . . . . 13.3 m -113.27 155.75 14.4 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.097 0 C-N-CA 123.983 0.913 . . . . 0.0 111.305 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . . . . . . . . . 24.0 p -70.02 -32.95 71.36 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 125.563 1.545 . . . . 0.0 111.496 176.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' SER . . . . . . . . . . . . . 68.0 m -126.38 113.04 23.38 Favored Pre-proline 0 N--CA 1.453 -0.285 0 C-N-CA 124.979 1.312 . . . . 0.0 107.462 178.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PRO . . . . . . . . . . . . . 78.1 Cg_endo -68.42 -20.51 41.93 Favored 'Trans proline' 0 N--CA 1.457 -0.669 0 C-N-CA 123.238 2.625 . . . . 0.0 111.582 -175.478 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 -52.9 -36.25 59.17 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 125.197 1.399 . . . . 0.0 111.688 172.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ILE . . . . . . . . . . . . . 68.3 mt -77.78 86.81 0.98 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.354 0 N-CA-C 107.833 -1.173 . . . . 0.0 107.833 178.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' THR . . . . . . . . . . . . . 30.8 m -66.64 126.18 28.14 Favored 'General case' 0 N--CA 1.453 -0.275 0 C-N-CA 123.804 0.842 . . . . 0.0 108.97 176.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' VAL . . . . . . . . . . . . . 71.7 t -89.65 149.63 3.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.207 0 C-N-CA 124.035 0.934 . . . . 0.0 109.634 -174.792 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' THR . . . . . . . . . . . . . 64.5 m -105.84 115.78 30.82 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 124.912 1.285 . . . . 0.0 108.06 175.324 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' LEU . . . . . . . . . . . . . 49.3 tp -89.62 104.17 16.75 Favored 'General case' 0 C--N 1.339 0.136 0 C-N-CA 123.378 0.671 . . . . 0.0 109.397 -178.549 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' LYS . . . . . . . . . . . . . 72.4 mmtt -94.92 173.37 7.63 Favored 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 124.513 1.125 . . . . 0.0 109.8 173.735 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' LYS . . . . . . . . . . . . . 63.6 tttm -148.94 146.86 28.05 Favored 'General case' 0 N--CA 1.455 -0.194 0 C-N-CA 124.406 1.082 . . . . 0.0 108.666 169.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' PHE . . . . . . . . . . . . . 65.6 t80 -58.62 134.5 86.07 Favored Pre-proline 0 CA--C 1.538 0.518 0 C-N-CA 123.816 0.846 . . . . 0.0 110.37 178.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -77.52 -59.39 0.12 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.756 0 CA-C-N 119.883 0.994 . . . . 0.0 111.92 0.712 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . . . . . . . . . 88.9 mt -141.75 41.29 1.7 Allowed 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 124.571 1.148 . . . . 0.0 109.944 -175.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 57.2 m-20 -83.27 153.31 24.73 Favored 'General case' 0 CA--C 1.528 0.134 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 174.422 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' THR . . . . . . . . . . . . . 27.6 m -123.78 107.87 11.89 Favored 'General case' 0 CA--C 1.529 0.142 0 C-N-CA 124.277 1.031 . . . . 0.0 108.641 -178.604 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -91.2 78.22 5.85 Favored 'General case' 0 N--CA 1.454 -0.273 0 N-CA-C 107.404 -1.332 . . . . 0.0 107.404 -178.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' ILE . . . . . . . . . . . . . 83.8 mt -59.66 131.44 88.55 Favored Pre-proline 0 CA--C 1.537 0.466 0 C-N-CA 124.357 1.063 . . . . 0.0 109.868 -174.076 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -71.17 87.95 0.72 Allowed 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.255 2.637 . . . . 0.0 110.31 177.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ASP . . . . . . . . . . . . . 5.6 p-10 -66.39 -23.08 66.27 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.323 1.049 . . . . 0.0 112.743 -177.946 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' GLY . . . . . . . . . . . . . . . 97.89 -15.3 61.89 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-O 118.719 -1.045 . . . . 0.0 113.674 173.789 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' LYS . . . . . . . . . . . . . 30.5 mmmt -106.86 -60.58 1.65 Allowed 'General case' 0 C--N 1.342 0.246 0 CA-C-N 118.508 1.154 . . . . 0.0 109.441 179.457 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' ARG . . . . . . . . . . . . . 77.4 ttt-85 -76.54 -67.72 0.67 Allowed 'General case' 0 N--CA 1.454 -0.269 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 174.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ILE . . . . . . . . . . . . . 17.0 mt -89.77 99.17 9.01 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 107.614 -1.254 . . . . 0.0 107.614 179.038 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' ILE . . . . . . . . . . . . . 9.1 mt -98.7 120.75 48.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.209 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 -179.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' TRP . . . . . . . . . . . . . 7.7 t-105 -89.09 95.95 10.52 Favored 'General case' 0 C--N 1.339 0.112 0 C-N-CA 123.012 0.525 . . . . 0.0 109.716 -176.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -89.94 101.1 13.81 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.146 -1.428 . . . . 0.0 107.146 171.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' SER . . . . . . . . . . . . . 57.9 p -56.9 -27.81 61.2 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.157 0.983 . . . . 0.0 113.634 -177.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' ARG . . . . . . . . . . . . . 28.1 mmt180 -104.53 22.37 15.1 Favored 'General case' 0 CA--C 1.536 0.406 0 C-N-CA 124.31 1.044 . . . . 0.0 112.153 -179.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' LYS . . . . . . . . . . . . . 83.5 tttt -147.09 -60.06 0.28 Allowed 'General case' 0 C--N 1.341 0.196 0 CA-C-N 118.572 0.624 . . . . 0.0 110.306 173.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' GLY . . . . . . . . . . . . . . . 160.5 -168.14 35.92 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 110.626 -0.99 . . . . 0.0 110.626 -177.193 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -89.56 112.64 23.89 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 107.88 -1.156 . . . . 0.0 107.88 171.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' ILE . . . . . . . . . . . . . 58.3 mt -89.96 98.05 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.446 0 N-CA-C 107.356 -1.349 . . . . 0.0 107.356 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ILE . . . . . . . . . . . . . 4.0 mp -82.98 97.28 4.3 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' SER . . . . . . . . . . . . . 72.8 p -61.21 -37.53 83.33 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 124.153 0.981 . . . . 0.0 112.345 -175.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' ASN . . . . . . . . . . . . . 11.4 t-20 -121.21 87.96 2.85 Favored 'General case' 0 C--N 1.34 0.167 0 C-N-CA 124.532 1.133 . . . . 0.0 109.28 178.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' ALA . . . . . . . . . . . . . . . -65.07 163.23 15.25 Favored 'General case' 0 CA--C 1.529 0.158 0 C-N-CA 122.319 0.247 . . . . 0.0 110.7 176.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' THR . . . . . . . . . . . . . 46.5 p -139.86 160.25 40.34 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 123.899 0.88 . . . . 0.0 109.947 -178.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -58.71 -34.26 71.13 Favored 'General case' 0 CA--C 1.532 0.275 0 C-N-CA 123.74 0.816 . . . . 0.0 110.869 172.391 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' LYS . . . . . . . . . . . . . 51.2 mtpt -61.12 -34.61 75.25 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 123.966 0.907 . . . . 0.0 111.275 177.631 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 21.4 tt0 -74.95 -8.4 56.37 Favored 'General case' 0 CA--C 1.537 0.481 0 C-N-CA 123.596 0.758 . . . . 0.0 112.645 -177.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' ILE . . . . . . . . . . . . . 94.5 mt -65.4 127.26 26.12 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 173.551 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' GLY . . . . . . . . . . . . . . . 157.01 -119.97 0.95 Allowed Glycine 0 C--N 1.338 0.663 0 N-CA-C 110.542 -1.023 . . . . 0.0 110.542 177.235 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' LEU . . . . . . . . . . . . . 59.7 tp -144.76 95.25 2.67 Favored 'General case' 0 N--CA 1.454 -0.231 0 C-N-CA 124.234 1.014 . . . . 0.0 108.797 -174.02 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' LEU . . . . . . . . . . . . . 8.5 mp -79.94 153.42 28.96 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 176.376 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' THR . . . . . . . . . . . . . 41.1 m -143.57 102.86 4.01 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.196 0.998 . . . . 0.0 108.979 -172.013 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' CYS . . . . . . . . . . . . . 83.9 m -72.72 132.09 43.2 Favored 'General case' 0 N--CA 1.456 -0.163 0 N-CA-C 107.528 -1.286 . . . . 0.0 107.528 169.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLU . . . . . . . . . . . . . 5.8 tm-20 -134.03 135.59 43.46 Favored 'General case' 0 C--N 1.339 0.146 0 C-N-CA 124.125 0.97 . . . . 0.0 109.672 -174.118 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' ALA . . . . . . . . . . . . . . . -147.14 119.48 8.39 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 124.583 1.153 . . . . 0.0 108.613 175.104 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 5.1 m -89.69 59.13 4.56 Favored 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 123.082 0.553 . . . . 0.0 110.275 -172.213 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' VAL . . . . . . . . . . . . . 57.4 t -73.86 141.06 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.226 0 N-CA-C 109.393 -0.595 . . . . 0.0 109.393 -177.373 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' ASN . . . . . . . . . . . . . 62.5 m-20 57.53 24.43 10.33 Favored 'General case' 0 CA--C 1.535 0.368 0 C-N-CA 125.051 1.34 . . . . 0.0 112.177 -176.595 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' GLY . . . . . . . . . . . . . . . 74.1 -5.9 23.83 Favored Glycine 0 CA--C 1.535 1.291 0 CA-C-O 119.112 -0.827 . . . . 0.0 113.231 -174.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' HIS . . . . . . . . . . . . . 10.6 m170 -89.92 129.56 36.26 Favored 'General case' 0 N--CA 1.454 -0.226 0 CA-C-N 118.573 1.186 . . . . 0.0 108.255 -179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' LEU . . . . . . . . . . . . . 6.4 tp -72.38 85.91 1.12 Allowed 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.501 0.72 . . . . 0.0 109.439 179.361 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' TYR . . . . . . . . . . . . . 77.2 m-85 -88.93 141.24 28.66 Favored 'General case' 0 C--N 1.341 0.212 0 N-CA-C 108.019 -1.104 . . . . 0.0 108.019 176.267 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.65 162.9 39.79 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 123.228 0.611 . . . . 0.0 111.449 178.342 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' THR . . . . . . . . . . . . . 3.7 t -143.23 128.34 18.62 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.974 1.309 . . . . 0.0 107.713 174.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ASN . . . . . . . . . . . . . 9.6 m-80 -106.07 150.98 25.25 Favored 'General case' 0 C--N 1.341 0.215 0 C-N-CA 125.416 1.486 . . . . 0.0 112.446 -169.088 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' TYR . . . . . . . . . . . . . 82.2 m-85 -142.74 105.3 4.48 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 125.488 1.515 . . . . 0.0 108.573 -173.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' LEU . . . . . . . . . . . . . 5.3 tt -79.4 108.64 13.07 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.052 -1.092 . . . . 0.0 108.052 179.727 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' THR . . . . . . . . . . . . . 11.5 p -89.23 91.65 8.86 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.25 -1.018 . . . . 0.0 108.25 -179.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' HIS . . . . . . . . . . . . . 56.6 t60 -98.17 121.82 40.57 Favored 'General case' 0 N--CA 1.455 -0.199 0 C-N-CA 125.653 1.581 . . . . 0.0 107.608 176.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' ARG . . . . . . . . . . . . . 48.4 ptt85 -68.2 143.16 55.44 Favored 'General case' 0 C--N 1.34 0.157 0 CA-C-N 119.097 0.862 . . . . 0.0 109.699 174.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.03 157.63 24.69 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.494 -0.482 . . . . 0.0 109.736 169.299 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' THR . . . . . . . . . . . . . 70.2 p -75.15 -8.64 57.14 Favored 'General case' 0 CA--C 1.534 0.364 0 N-CA-C 112.935 0.717 . . . . 0.0 112.935 -175.202 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' ASN . . . . . . . . . . . . . 43.5 m-80 -89.25 46.91 1.42 Allowed 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 123.442 0.697 . . . . 0.0 111.107 -171.244 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' THR . . . . . . . . . . . . . 14.4 t -167.07 179.31 5.24 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.238 1.415 . . . . 0.0 108.97 176.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' ILE . . . . . . . . . . . . . 44.2 pt . . . . . 0 C--O 1.25 1.114 0 CA-C-O 116.774 -1.584 . . . . 0.0 111.294 -179.801 . . . . . . . . 0 0 . 1 stop_ save_